data_2n0s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n0s _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.921 -0.4 . . . . 10.0 109.921 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m -69.53 155.04 41.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.572 -0.286 . . . . 10.0 110.271 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -60.29 -31.84 70.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.646 -0.252 . . . . 10.0 111.202 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.551 HG22 HG12 ' A' ' 212' ' ' ILE . 93.7 t -66.83 -45.07 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.939 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -62.83 -36.6 83.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.616 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -59.83 -34.68 73.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -69.87 -40.85 75.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.082 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.76 -28.32 69.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.63 -0.714 . . . . 10.0 111.055 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.38 80.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.861 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -70.65 -35.35 72.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.678 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 91.0 mt -66.51 -32.32 73.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.161 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.09 -25.3 66.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.19 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -72.91 136.37 79.97 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.258 -0.428 . . . . 10.0 109.94 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.95 152.7 28.28 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.991 2.461 . . . . 10.0 111.98 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -61.44 -35.28 77.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.303 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.52 14.53 24.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.074 -0.512 . . . . 10.0 112.239 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 44' ' ' ARG . 14.4 t70 -68.35 134.88 91.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.393 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.39 -22.78 67.37 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.271 2.647 . . . . 10.0 113.998 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.3 4.56 24.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 10.0 111.265 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 6.4 tpt180 -82.38 130.47 35.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.516 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 176' ' ' ASP . 18.9 mttp -108.69 178.21 4.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.802 -0.636 . . . . 10.0 109.655 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.16 117.17 23.31 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 t -102.94 102.58 13.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.247 0.546 . . . . 10.0 111.066 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 179' ' ' MET . 2.8 m -97.95 144.24 27.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.531 -0.758 . . . . 10.0 109.295 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 13.7 p -130.66 141.9 45.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.828 0.347 . . . . 10.0 111.52 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 21.7 pt20 -121.86 126.93 49.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 10.0 109.933 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.696 HG11 HD21 ' A' ' 75' ' ' LEU . 3.0 t -110.27 155.4 11.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.581 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.02 144.7 29.28 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.544 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.72 -33.67 88.38 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.937 2.424 . . . . 10.0 111.944 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.3 67.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.643 HG13 HG23 ' A' ' 214' ' ' THR . 98.5 t -85.49 -39.95 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.058 0.456 . . . . 10.0 109.779 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -57.44 -31.72 66.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.697 -0.683 . . . . 10.0 112.284 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.56 -39.21 16.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.992 0.738 . . . . 10.0 112.992 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.18 -14.3 38.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.416 0.895 . . . . 10.0 113.416 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 tp -58.83 -24.04 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 112.046 0.387 . . . . 10.0 112.046 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.44 -33.27 73.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 10.0 111.342 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -65.34 -29.8 70.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 10.0 111.195 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.41 -17.51 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.96 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.5 mt -105.62 3.02 28.72 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.385 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.66 41.56 15.36 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.051 -0.595 . . . . 10.0 112.094 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.4 mt -125.51 178.88 5.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.767 0.318 . . . . 10.0 110.527 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.77 144.14 55.4 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.792 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.45 119.92 7.47 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.726 2.284 . . . . 10.0 111.672 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.67 0.74 56.48 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 10.0 113.348 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.62 75.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.966 0.383 . . . . 10.0 111.234 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.39 126.3 31.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.676 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.7 p -81.98 156.81 69.52 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.359 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.53 -34.82 92.25 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.237 1.958 . . . . 10.0 110.875 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -68.24 -41.24 81.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.805 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -61.72 -41.74 98.02 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.036 0.446 . . . . 10.0 110.528 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.696 HD21 HG11 ' A' ' 51' ' ' VAL . 48.7 tp -62.08 -48.43 80.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.543 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.2 94.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.004 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.505 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 36.7 tp10 -61.52 -42.91 99.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.239 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.07 -44.62 91.0 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.01 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.2 mt -62.1 -42.85 99.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.894 0.378 . . . . 10.0 111.206 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -62.99 -31.72 72.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.955 0.407 . . . . 10.0 110.808 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 81' ' ' ARG . 57.4 mtt-85 -81.44 -9.35 59.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.62 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.6 mt -78.72 -15.3 58.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.428 . . . . 10.0 110.252 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.44 -1.48 11.35 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.478 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -66.64 159.44 27.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.338 . . . . 10.0 111.066 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -104.57 -44.52 4.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.466 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -130.67 131.88 45.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.302 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.68 112.71 40.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.638 0.256 . . . . 10.0 110.872 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 33.7 m-85 -114.52 166.52 11.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.436 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -114.92 148.17 39.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.218 -0.446 . . . . 10.0 109.821 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 m -64.67 -20.81 66.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.671 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.1 -36.32 68.03 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.777 0.288 . . . . 10.0 111.777 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -67.01 -40.5 87.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.141 0.496 . . . . 10.0 109.973 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.84 -36.27 81.64 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.941 -0.864 . . . . 10.0 110.941 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.62 -35.06 79.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.731 0.301 . . . . 10.0 110.474 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -33.53 71.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.872 -0.604 . . . . 10.0 109.873 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 424' ' ' LEU . 85.9 mt -75.41 -41.27 56.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.692 -0.685 . . . . 10.0 110.032 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.4 m -59.93 -44.02 94.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.582 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.461 HG12 ' HB3' ' A' ' 259' ' ' ALA . 30.9 mt -57.35 -40.99 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.816 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 92.8 mmm -68.71 -51.01 46.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.319 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.477 ' OE2' ' HA ' ' A' ' 432' ' ' PRO . 64.1 mm-40 -64.14 -53.67 45.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.64 -39.39 91.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.357 . . . . 10.0 110.549 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.08 99.65 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.845 -0.693 . . . . 10.0 111.378 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.3 m -67.64 -40.44 84.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.518 0.199 . . . . 10.0 110.795 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 9.7 tt0 -65.04 -39.22 93.01 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.579 -0.526 . . . . 10.0 109.579 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 tp -63.88 -49.04 74.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.892 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.5 tp -59.95 -38.53 82.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.939 -0.573 . . . . 10.0 109.745 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -61.26 -49.36 77.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.972 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.467 ' HG2' ' HG2' ' A' ' 121' ' ' GLU . 40.2 mtt180 -59.03 -38.7 79.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.28 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.43 -56.19 8.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.338 -0.392 . . . . 10.0 111.232 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.6 m -55.52 -43.68 75.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 10.0 112.039 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -61.88 -35.37 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.886 0.328 . . . . 10.0 111.886 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -71.83 -28.6 63.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 10.0 110.258 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.587 ' O ' ' HD2' ' A' ' 309' ' ' ARG . 73.5 mt -83.54 -12.92 55.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.286 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.72 ' HA ' ' NH1' ' A' ' 309' ' ' ARG . 4.3 mm-40 -91.38 -42.69 10.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.909 -0.587 . . . . 10.0 109.483 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.021 -0.99 . . . . 10.0 111.012 179.853 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.467 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.352 0.596 . . . . 10.0 111.437 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -85.37 -160.71 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.822 2.348 . . . . 10.0 112.822 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 124' ' ' PRO . 82.7 mt -131.29 162.64 54.66 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.654 -0.869 . . . . 10.0 108.654 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 16.7 Cg_exo -68.8 169.76 57.46 Favored 'Cis proline' 0 C--N 1.347 0.458 0 C-N-CA 124.381 -1.091 . . . . 10.0 113.015 0.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 27.1 ttt -113.58 132.98 55.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.375 -0.829 . . . . 10.0 110.217 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.531 ' HD1' ' HB ' ' A' ' 372' ' ' VAL . 33.7 m-85 -111.73 145.79 38.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.174 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.03 140.73 40.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.695 0.622 . . . . 10.0 110.126 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.688 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -103.73 17.01 25.03 Favored 'General case' 0 CA--C 1.537 0.479 1 N-CA-C 130.104 7.075 . . . . 10.0 130.104 -179.214 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 131' ' ' PRO . 68.1 m -81.33 -31.01 33.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 112.142 -2.299 . . . . 10.0 114.393 -166.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 375' ' ' MET . 48.7 m -82.36 124.49 78.09 Favored Pre-proline 0 C--N 1.401 2.835 3 O-C-N 142.034 12.084 . . . . 10.0 113.466 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 129' ' ' CYS . 37.7 Cg_endo -68.54 -23.15 37.43 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.138 2.559 . . . . 10.0 112.246 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.97 -32.91 56.15 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 -73.75 -45.36 52.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.46 -0.37 . . . . 10.0 111.04 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.688 HD11 ' O ' ' A' ' 128' ' ' SER . 97.1 mt -58.57 -35.15 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.101 0.408 . . . . 10.0 112.101 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.97 -35.09 80.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.228 0.537 . . . . 10.0 110.531 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 34.9 ttm -70.12 -40.56 74.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 10.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 148' ' ' VAL . 2.5 pp -75.21 -11.98 60.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.868 0.366 . . . . 10.0 111.742 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -96.78 -31.44 12.63 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -108.77 -41.66 4.71 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.634 0.976 . . . . 10.0 113.634 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.2 m -90.75 -44.73 9.27 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.314 0.857 . . . . 10.0 113.314 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -127.59 71.92 77.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 112.025 0.38 . . . . 10.0 112.025 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 73.2 Cg_endo -75.22 11.25 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.55 2.167 . . . . 10.0 112.662 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.98 -7.77 29.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.201 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.5 mt -106.39 14.93 26.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.77 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.593 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 76.9 mt -55.05 -54.72 47.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 113.267 0.84 . . . . 10.0 113.267 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 17.4 Cg_exo -68.06 -9.98 27.44 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.451 2.101 . . . . 10.0 113.009 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 125' ' ' MET . 49.3 m-85 -82.53 -25.08 33.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.131 0.491 . . . . 10.0 110.914 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 137' ' ' LEU . 2.7 t -88.53 156.76 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.152 -0.476 . . . . 10.0 109.759 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 t -70.66 154.19 42.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.337 . . . . 10.0 110.923 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 96.3 p -96.77 3.9 52.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.088 0.471 . . . . 10.0 110.304 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.9 m -76.0 144.9 40.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.153 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.432 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 30.4 mtpt -86.01 164.76 17.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.944 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.439 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 0.1 OUTLIER -69.66 152.7 96.12 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.466 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.17 -53.84 5.39 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.802 3.001 . . . . 10.0 113.884 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.439 ' OE1' ' HB2' ' A' ' 153' ' ' SER . 0.0 OUTLIER -62.13 -37.73 86.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 10.0 111.669 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.559 ' HE2' ' HD2' ' A' ' 197' ' ' PHE . 67.1 mmm -73.14 -23.53 60.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.319 -0.401 . . . . 10.0 111.189 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 40.0 mtt -76.87 -50.1 14.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.3 tp -61.65 -42.53 99.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.46 -0.791 . . . . 10.0 110.844 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.52 ' HA ' ' SD ' ' A' ' 179' ' ' MET . . . -59.47 -40.79 88.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.045 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.47 -35.54 68.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.496 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 3.2 ttt -66.9 -44.66 80.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.675 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 33.0 m -69.52 -30.86 46.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.314 0.487 . . . . 10.0 112.314 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -85.9 6.96 25.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.14 0.422 . . . . 10.0 112.14 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.4 p -129.85 -81.28 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.403 -0.362 . . . . 10.0 110.466 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.578 ' HE2' ' HA ' ' A' ' 240' ' ' MET . 11.3 t80 -56.29 -49.37 74.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.481 . . . . 10.0 111.472 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.656 HD11 ' HE3' ' A' ' 170' ' ' LYS . 41.8 tp -65.93 -39.43 90.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.989 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.63 88.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.512 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.51 -42.38 82.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.912 -0.586 . . . . 10.0 111.107 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -65.98 -46.84 76.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.847 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.656 ' HE3' HD11 ' A' ' 166' ' ' LEU . 72.9 mttt -73.73 -27.15 61.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.702 0.287 . . . . 10.0 111.277 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 88.2 44.0 5.45 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.749 -0.739 . . . . 10.0 112.227 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 21.4 mt -126.8 145.11 34.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -74.9 142.38 76.43 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 110.074 -0.343 . . . . 10.0 110.074 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.456 ' HB2' HD13 ' A' ' 205' ' ' LEU . 45.1 Cg_exo -57.78 -22.07 51.41 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.996 2.464 . . . . 10.0 112.978 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.33 -12.7 56.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.977 0.417 . . . . 10.0 111.485 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 59.3 m-20 -101.36 11.41 39.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.181 0.515 . . . . 10.0 109.74 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 95.4 mtp -122.69 118.84 29.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.899 -0.592 . . . . 10.0 111.263 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.31 133.32 58.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.057 -1.09 . . . . 10.0 108.057 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.52 ' SD ' ' HA ' ' A' ' 159' ' ' ALA . 9.6 ttt -123.0 134.56 54.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.565 0.698 . . . . 10.0 112.805 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 20.8 t -117.84 151.6 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.3 p -135.96 141.68 44.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.721 0.296 . . . . 10.0 110.602 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' A' ' 51' ' ' VAL . 16.7 mm -105.04 106.6 20.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 213' ' ' THR . 31.0 mmt -117.4 146.9 39.47 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.227 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.11 15.55 2.19 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.748 2.299 . . . . 10.0 112.705 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 20.8 m -141.28 138.54 33.26 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.978 0.362 . . . . 10.0 111.978 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -30.99 69.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.675 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -65.3 -14.23 60.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.946 -0.57 . . . . 10.0 112.452 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 188' ' ' LYS . 59.2 mmtt -70.07 -27.31 64.52 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.903 0.334 . . . . 10.0 111.903 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -67.26 -44.33 79.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.576 -0.527 . . . . 10.0 109.576 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m -64.09 -29.1 70.26 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.039 0.447 . . . . 10.0 110.246 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.67 -44.86 80.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 208' ' ' LEU . . . -78.36 -12.42 60.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.745 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.42 2.09 51.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.792 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 194' ' ' ARG . 58.4 mtt-85 -64.62 119.43 10.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.691 0.282 . . . . 10.0 110.691 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -38.05 -60.27 0.77 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.271 1.582 . . . . 10.0 115.271 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -66.77 -2.06 4.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 115.012 1.486 . . . . 10.0 115.012 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.559 ' HD2' ' HE2' ' A' ' 156' ' ' MET . 6.2 m-85 -86.71 55.65 3.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.355 0.598 . . . . 10.0 109.848 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.17 169.43 8.74 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.591 -0.732 . . . . 10.0 111.538 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.05 143.15 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.037 -0.982 . . . . 10.0 110.28 -179.786 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.763 ' C ' ' H ' ' A' ' 205' ' ' LEU . 11.5 m . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 120.925 0.393 . . . . 10.0 110.984 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.806 ' C ' ' CB ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.228 -0.075 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -92.48 140.4 29.61 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.436 -0.209 . . . . 10.0 110.436 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 197' ' ' PHE . 56.4 mt-30 -69.6 -41.04 76.28 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.507 ' HB3' ' HB1' ' A' ' 192' ' ' ALA . 13.0 tp -128.52 115.86 18.78 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.62 -47.25 8.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.304 1.224 . . . . 10.0 114.304 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -132.65 143.46 49.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.085 0.772 . . . . 10.0 113.085 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.5 t -126.25 129.23 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.463 -0.939 . . . . 10.0 108.463 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.551 HG12 HG22 ' A' ' 28' ' ' VAL . 55.6 mt -120.22 141.76 39.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 183' ' ' MET . 60.3 p -90.1 164.04 14.63 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.99 -0.284 . . . . 10.0 111.292 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.643 HG23 HG13 ' A' ' 55' ' ' VAL . 1.8 m -55.5 -47.39 76.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.602 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.43 -43.09 89.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 10.0 112.007 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 220' ' ' ILE . 52.7 mt-10 -67.76 -48.31 66.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.145 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.412 HD22 HG21 ' A' ' 182' ' ' ILE . 31.2 tp -57.98 -46.13 85.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.866 0.365 . . . . 10.0 110.969 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.77 -34.74 89.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.952 -0.567 . . . . 10.0 112.291 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.8 -34.17 69.14 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.838 -0.213 . . . . 10.0 110.821 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 216' ' ' GLU . 90.8 mt -64.66 -42.82 96.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -59.12 -46.39 88.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.381 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -68.85 -29.48 67.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.349 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.29 -36.66 74.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.988 0.423 . . . . 10.0 110.938 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -86.43 -10.82 53.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.178 -0.465 . . . . 10.0 111.428 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.45 40.33 13.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.247 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 53.5 mt -120.57 107.88 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.829 0.347 . . . . 10.0 110.325 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -93.28 118.08 30.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.647 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.65 HD23 HD12 ' A' ' 231' ' ' LEU . 85.1 mt -61.43 -30.34 70.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 10.0 111.628 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.85 -5.55 38.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.165 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.19 27.39 7.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.576 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.65 HD12 HD23 ' A' ' 228' ' ' LEU . 77.9 mt -115.34 148.34 40.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.101 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.14 172.93 15.41 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.487 2.125 . . . . 10.0 111.595 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.81 101.72 4.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.399 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 77' ' ' GLU . . . -75.44 -148.83 2.09 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 116.005 -0.543 . . . . 10.0 112.745 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -152.07 154.99 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.853 0.358 . . . . 10.0 111.418 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -100.09 161.82 13.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.75 -0.659 . . . . 10.0 109.966 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -101.75 150.11 23.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -95.03 119.5 65.76 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.378 -0.373 . . . . 10.0 110.05 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.04 -15.8 35.63 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.206 2.604 . . . . 10.0 112.495 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.578 ' HA ' ' HE2' ' A' ' 165' ' ' TYR . 98.9 mmm -75.19 -14.3 60.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.934 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 91.84 -18.83 51.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.818 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.0 m -134.24 157.71 41.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 110.354 -0.239 . . . . 10.0 110.354 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 90.19 155.04 30.62 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.783 -0.723 . . . . 10.0 112.319 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.34 130.19 46.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.694 0.283 . . . . 10.0 110.703 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 125.07 176.69 14.63 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.525 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -81.15 -1.05 43.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.874 0.337 . . . . 10.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.42 6.13 84.13 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.917 -0.658 . . . . 10.0 112.26 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.6 t -108.48 135.81 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.692 HD11 ' HD3' ' A' ' 419' ' ' PRO . 90.1 mt -81.75 159.34 23.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.68 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -67.44 110.67 3.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.976 -0.557 . . . . 10.0 110.832 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.549 ' HA3' ' HB2' ' A' ' 413' ' ' ARG . . . 148.56 141.84 3.54 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.802 -0.713 . . . . 10.0 112.064 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.4 t -84.36 155.02 22.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.997 0.427 . . . . 10.0 111.148 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.22 -16.32 19.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.476 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.51 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 86.11 -6.78 80.51 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.107 -0.568 . . . . 10.0 112.396 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.75 158.4 10.22 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.008 -0.837 . . . . 10.0 111.008 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.23 -55.53 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.863 0.331 . . . . 10.0 110.909 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' MET . . . . . 0.599 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 19.3 ttp -56.99 -48.22 78.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.65 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.51 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 18.2 tt0 -63.26 -48.27 78.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.131 0.419 . . . . 10.0 112.131 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . 0.461 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . -64.26 -34.99 79.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.503 0.192 . . . . 10.0 111.335 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.73 73.26 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.45 -41.07 98.48 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.728 -0.669 . . . . 10.0 109.8 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 44.4 ttm105 -59.28 -50.16 75.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.47 -0.787 . . . . 10.0 111.018 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 50.9 m -57.56 -43.62 84.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.053 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.24 77.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.911 0.386 . . . . 10.0 110.72 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 273' ' ' LEU . 50.3 t80 -63.26 -48.8 76.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.705 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.416 ' OE2' ' HA ' ' A' ' 272' ' ' PRO . 59.5 mt-10 -63.91 -27.37 69.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.111 0.782 . . . . 10.0 113.111 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 82.2 mt -86.82 -26.64 23.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.03 0.443 . . . . 10.0 111.046 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -84.93 -36.97 21.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.679 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.443 HG21 ' CE1' ' A' ' 265' ' ' TYR . 63.0 p -100.81 -32.74 10.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.718 0.636 . . . . 10.0 112.718 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 87.23 0.99 84.59 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.732 -0.947 . . . . 10.0 110.732 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 42.0 p -109.38 145.09 31.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 110.286 -0.264 . . . . 10.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.416 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 42.6 Cg_endo -69.26 146.2 62.47 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.604 2.202 . . . . 10.0 112.203 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.531 HD12 ' HD2' ' A' ' 274' ' ' PRO . 32.1 tp -115.2 123.56 31.51 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.931 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.531 ' HD2' HD12 ' A' ' 273' ' ' LEU . 87.7 Cg_endo -80.29 -157.3 0.08 OUTLIER 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.696 2.264 . . . . 10.0 111.3 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -79.28 140.07 37.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.569 0.224 . . . . 10.0 110.584 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 90.5 mt -91.69 128.2 37.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.984 0.421 . . . . 10.0 111.248 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 7.1 m -96.1 93.47 6.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.182 0.515 . . . . 10.0 111.002 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 288' ' ' LYS . 4.3 mm? -64.54 122.33 16.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.515 -0.766 . . . . 10.0 111.346 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.2 m -105.18 138.87 40.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.516 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.97 144.12 56.96 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.765 0.283 . . . . 10.0 111.765 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.598 HG22 ' HG2' ' A' ' 289' ' ' GLU . 16.7 t -93.84 123.71 46.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.31 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -66.06 118.81 10.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.208 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.99 -23.85 12.46 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.906 -0.664 . . . . 10.0 111.808 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.406 ' HB3' HG13 ' A' ' 287' ' ' ILE . 75.7 mtm -126.98 98.65 5.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.985 0.421 . . . . 10.0 110.351 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -69.17 133.28 47.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.176 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 89.64 -6.99 82.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.038 -0.601 . . . . 10.0 112.459 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.406 HG13 ' HB3' ' A' ' 284' ' ' MET . 37.1 mm -101.19 127.92 53.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.87 0.367 . . . . 10.0 110.312 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 278' ' ' LEU . 65.8 mttm -122.97 142.81 50.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . 0.598 ' HG2' HG22 ' A' ' 281' ' ' VAL . 15.8 pt-20 -126.05 163.56 22.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.119 0.485 . . . . 10.0 111.562 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.417 ' CG2' ' HB ' ' A' ' 346' ' ' VAL . 10.0 t -157.19 131.4 8.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.861 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -105.7 121.83 44.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.279 -0.419 . . . . 10.0 109.944 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 36.2 mt -109.12 111.7 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.457 -0.338 . . . . 10.0 111.419 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.07 103.55 3.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.584 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 87.4 mtp -98.38 115.12 27.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.127 0.489 . . . . 10.0 111.442 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 269' ' ' THR . 70.2 t -109.3 124.79 32.99 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.632 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.01 129.77 34.84 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.737 2.291 . . . . 10.0 112.631 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -62.11 132.23 93.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.848 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.11 118.4 5.35 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.584 2.189 . . . . 10.0 111.978 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 95.07 21.47 25.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.875 -0.679 . . . . 10.0 112.797 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.1 p -119.78 164.04 16.56 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.7 -0.294 . . . . 10.0 110.478 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.667 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 71.4 tttt -62.83 -32.12 73.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.992 0.425 . . . . 10.0 109.911 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -60.59 -36.64 79.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.645 -0.707 . . . . 10.0 111.177 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -70.36 -36.71 74.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.98 -0.554 . . . . 10.0 110.428 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -28.29 62.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.779 -0.646 . . . . 10.0 111.312 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 90.0 mt -58.18 -53.91 52.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.44 -1.67 31.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.295 0.48 . . . . 10.0 112.295 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -104.5 -36.0 7.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.946 0.403 . . . . 10.0 111.07 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -26.41 54.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.717 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . 0.72 ' NH1' ' HA ' ' A' ' 114' ' ' GLU . 5.1 ptp85 -148.42 165.36 31.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.531 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -138.25 -57.67 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.015 0.436 . . . . 10.0 110.591 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.745 -0.645 . . . . 10.0 110.077 179.419 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.909 -0.476 . . . . 10.0 111.909 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.64 -26.07 33.72 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.792 2.328 . . . . 10.0 111.555 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.509 ' HB2' ' CE2' ' A' ' 147' ' ' TYR . 93.1 mt -113.13 105.1 13.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.732 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.76 31.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.498 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -56.19 137.29 52.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.706 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -79.69 -12.68 59.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.979 0.419 . . . . 10.0 111.607 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 114.25 -10.68 22.27 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.829 -0.7 . . . . 10.0 111.405 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 89.79 141.8 8.92 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.003 -0.618 . . . . 10.0 112.084 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -77.75 96.01 4.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.093 0.473 . . . . 10.0 110.106 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -103.22 163.16 15.82 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.791 -0.718 . . . . 10.0 112.737 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -147.5 153.78 39.94 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.452 ' HA ' ' HA3' ' A' ' 340' ' ' GLY . 6.2 t -144.36 161.04 40.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.917 0.389 . . . . 10.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' SER . . . . . 0.457 ' HB2' ' OD1' ' A' ' 337' ' ' ASP . 1.4 m -110.19 166.26 11.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.726 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -72.96 7.06 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 335' ' ' SER . 2.0 p-10 -104.0 -16.76 15.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.968 0.413 . . . . 10.0 110.269 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.34 -4.13 33.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 10.0 113.293 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -108.52 122.04 46.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.99 0.424 . . . . 10.0 110.69 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 334' ' ' THR . . . -136.67 -145.1 4.95 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.864 -0.684 . . . . 10.0 111.917 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 179.0 -165.46 34.42 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.55 -0.62 . . . . 10.0 111.55 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.449 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 14.5 tt -137.89 138.56 43.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 13.2 t -102.25 119.33 38.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.298 0.57 . . . . 10.0 110.414 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 11.7 tp -79.0 126.19 30.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.683 -0.689 . . . . 10.0 111.407 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -95.09 106.11 18.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.583 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 371' ' ' PHE . 29.4 t -107.46 139.81 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.12 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 372' ' ' VAL . . . -136.69 144.9 44.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.804 0.335 . . . . 10.0 110.962 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 52.5 t -119.58 125.83 74.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.318 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.557 ' HB2' HD22 ' A' ' 358' ' ' LEU . . . -108.8 119.77 40.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.066 -0.515 . . . . 10.0 109.912 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -100.92 103.06 14.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.574 -0.285 . . . . 10.0 111.398 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 113.11 146.01 9.55 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.605 -0.807 . . . . 10.0 114.239 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.11 -32.4 68.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.186 0.517 . . . . 10.0 109.842 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -75.73 -10.83 84.84 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.916 -0.874 . . . . 10.0 110.916 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.604 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 3.2 t-20 -91.49 -31.4 15.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.643 -0.503 . . . . 10.0 109.643 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.2 93.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.663 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -58.84 -40.91 85.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.495 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 8.7 pttm -83.86 -10.86 57.7 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.431 0.53 . . . . 10.0 112.431 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . 0.557 HD22 ' HB2' ' A' ' 349' ' ' ALA . 29.1 tp -91.95 -49.44 6.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.816 0.341 . . . . 10.0 111.119 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 85.0 mt -58.25 -37.55 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 10.0 111.103 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.94 -26.75 68.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.266 -0.424 . . . . 10.0 111.346 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -78.86 -33.15 46.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 10.0 109.926 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 91.0 mtp -75.06 -37.54 61.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.001 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -63.14 -34.57 77.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.011 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -79.38 -12.75 59.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.263 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 84.4 15.47 68.77 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.843 -0.694 . . . . 10.0 112.395 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -83.28 -52.38 6.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.023 0.439 . . . . 10.0 109.94 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.425 ' HB1' ' HE2' ' A' ' 369' ' ' TYR . . . -94.09 100.28 12.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.579 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.61 115.0 26.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' TYR . . . . . 0.425 ' HE2' ' HB1' ' A' ' 367' ' ' ALA . 85.1 m-85 -137.9 159.86 40.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.677 -0.49 . . . . 10.0 109.677 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -107.16 -39.46 5.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.968 0.413 . . . . 10.0 110.979 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . 0.599 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 20.5 t80 -128.16 123.57 34.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.368 -0.605 . . . . 10.0 109.368 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . 0.531 ' HB ' ' HD1' ' A' ' 126' ' ' PHE . 45.4 t -129.38 126.57 63.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.848 0.356 . . . . 10.0 111.746 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -104.12 124.09 48.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.672 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.74 121.92 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.843 0.354 . . . . 10.0 110.896 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' MET . . . . . 0.6 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 67.2 mtt -105.65 152.36 23.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.343 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 121.029 0.443 . . . . 10.0 110.998 -179.893 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 112.572 0.582 . . . . 10.0 112.572 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -128.56 48.77 0.95 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.511 -0.852 . . . . 10.0 112.663 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -87.54 168.97 38.7 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.449 -0.881 . . . . 10.0 111.74 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -67.79 -15.19 66.41 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.232 -0.508 . . . . 10.0 113.294 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -89.29 -5.44 72.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.696 -0.764 . . . . 10.0 111.749 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -82.42 156.3 68.66 Favored Pre-proline 0 C--O 1.239 0.501 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.8 160.73 39.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.715 2.277 . . . . 10.0 111.532 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 107.54 14.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.92 0.391 . . . . 10.0 111.282 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.778 -0.646 . . . . 10.0 109.868 179.617 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.884 0.373 . . . . 10.0 111.391 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -64.26 -37.18 86.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.662 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -62.97 -44.93 94.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.063 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -68.44 -35.76 78.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.029 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -66.36 -40.2 89.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.518 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -73.4 -29.67 62.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.05 -0.523 . . . . 10.0 111.622 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -91.61 10.07 29.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 10.0 111.784 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 9.5 mt -66.55 -41.45 88.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.738 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -136.16 153.46 51.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.495 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . 0.496 ' HB3' ' OD1' ' A' ' 407' ' ' ASP . 63.8 t30 -79.52 174.24 11.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.583 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.55 -39.51 84.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . 0.496 ' OD1' ' HB3' ' A' ' 405' ' ' ASN . 11.7 p30 -70.72 -46.63 62.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.351 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -60.63 -35.32 75.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.646 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -71.12 -40.63 71.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.888 0.375 . . . . 10.0 111.293 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 10.8 m -73.97 -31.14 62.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.996 -0.547 . . . . 10.0 111.829 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 5.6 m -87.0 107.69 18.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 40.2 tp -85.65 136.65 33.29 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.692 -0.484 . . . . 10.0 109.692 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . 0.549 ' HB2' ' HA3' ' A' ' 251' ' ' GLY . 3.9 tmm_? -145.77 125.12 13.05 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.216 -0.29 . . . . 10.0 110.216 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.626 ' HB2' ' OE1' ' A' ' 417' ' ' GLU . 5.3 mtt85 -100.83 158.52 15.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.136 0.493 . . . . 10.0 110.462 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.6 m -64.5 -24.91 67.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.551 0.945 . . . . 10.0 113.551 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . 0.464 ' CE1' ' HD3' ' A' ' 414' ' ' ARG 0.282 32.5 p-80 -78.71 4.23 14.31 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . 0.626 ' OE1' ' HB2' ' A' ' 414' ' ' ARG . 1.7 mp0 -112.12 -3.93 14.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.992 0.425 . . . . 10.0 109.975 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 421' ' ' ILE . 50.4 t-20 -77.75 118.37 71.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.624 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.692 ' HD3' HD11 ' A' ' 249' ' ' LEU . 37.7 Cg_exo -59.05 -38.68 86.13 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.022 2.481 . . . . 10.0 111.636 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 53.9 m -65.28 -46.27 81.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.313 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 418' ' ' ASN . 39.2 mm -65.22 -43.02 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.132 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.589 ' NH2' ' HA ' ' A' ' 417' ' ' GLU . 97.1 mtt180 -58.97 -45.45 90.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.366 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -63.33 -49.64 73.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.93 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.589 HD23 HD21 ' A' ' 96' ' ' LEU . 61.3 tp -56.37 -39.17 72.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.998 0.427 . . . . 10.0 110.947 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . 0.869 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.1 m-85 -77.35 4.62 10.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.948 -0.569 . . . . 10.0 111.498 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -118.76 -54.61 2.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.739 0.304 . . . . 10.0 111.692 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -25.27 53.47 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.714 1.005 . . . . 10.0 113.714 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -126.71 -50.13 1.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 114.589 1.329 . . . . 10.0 114.589 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . 0.869 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 90.9 mt -73.08 -39.74 65.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.391 0.886 . . . . 10.0 113.391 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 86.25 -60.57 4.56 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.574 -0.822 . . . . 10.0 112.836 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 432' ' ' PRO . 2.1 tt0 -165.95 151.1 7.77 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.615 0.208 . . . . 10.0 110.727 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.477 ' HA ' ' OE2' ' A' ' 100' ' ' GLU . 32.5 Cg_exo -59.64 142.4 98.74 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.819 2.346 . . . . 10.0 111.312 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 7.9 mp 63.35 16.95 9.92 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.708 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -78.67 -168.79 34.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.2 -0.524 . . . . 10.0 112.214 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . 0.435 ' O ' ' HG3' ' A' ' 439' ' ' GLU . 31.4 t-80 -59.99 -60.83 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.512 0.196 . . . . 10.0 111.328 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.444 ' HD2' ' OE2' ' A' ' 439' ' ' GLU . 8.3 tptt -59.4 -35.46 74.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.278 -0.419 . . . . 10.0 111.29 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -65.19 -42.84 93.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.156 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 9.6 t-80 -68.02 -26.9 66.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.901 0.382 . . . . 10.0 110.521 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . 0.444 ' OE2' ' HD2' ' A' ' 436' ' ' LYS . 45.4 mt-10 -73.06 -64.88 0.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 62.4 mt -99.04 -17.96 18.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.986 1.476 . . . . 10.0 114.986 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 60.8 mt -100.0 -11.14 20.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.557 0.577 . . . . 10.0 112.557 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 28.0 m-70 -122.59 163.6 19.7 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 121.305 -0.158 . . . . 10.0 110.595 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 5.9 t -155.07 -171.95 4.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.667 0.27 . . . . 10.0 111.081 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -133.84 168.09 19.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.374 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' TYR . . . . . 0.538 ' HD2' HG23 ' A' ' 145' ' ' ILE . 51.0 m-85 -109.85 161.02 15.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.446 -0.343 . . . . 10.0 110.358 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.15 120.91 66.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.977 0.418 . . . . 10.0 111.31 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.13 107.23 3.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.738 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.26 -6.32 11.89 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.128 -0.789 . . . . 10.0 111.128 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.045 179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.998 -0.371 . . . . 10.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.25 154.17 35.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.594 -0.521 . . . . 10.0 109.594 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -62.86 -22.96 67.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.88 0.371 . . . . 10.0 111.698 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.62 -45.45 50.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.882 -0.785 . . . . 10.0 108.882 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -63.93 -32.62 74.22 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.697 -0.683 . . . . 10.0 109.772 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.543 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 60.2 mt-30 -61.87 -19.1 62.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.414 -0.812 . . . . 10.0 111.059 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -98.76 -47.43 5.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.016 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.527 HD23 HD12 ' A' ' 35' ' ' LEU . 96.0 mt -59.71 -26.7 65.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.994 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.78 -50.43 73.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.728 0.299 . . . . 10.0 111.001 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -75.7 -26.09 57.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.728 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.527 HD12 HD23 ' A' ' 32' ' ' LEU . 62.4 mt -70.32 -30.79 67.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.847 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.42 -25.45 61.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.289 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -70.66 130.24 89.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.22 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.17 153.88 15.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 123.125 2.55 . . . . 10.0 112.086 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -63.05 -25.21 68.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.136 0.493 . . . . 10.0 110.423 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -101.51 15.95 27.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.381 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.824 ' HB3' ' HB2' ' A' ' 44' ' ' ARG . 15.8 t70 -69.36 136.39 88.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.278 -0.268 . . . . 10.0 110.278 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.96 -24.49 73.31 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.962 2.442 . . . . 10.0 113.033 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.32 10.85 23.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.957 0.408 . . . . 10.0 110.983 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.824 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 7.4 tpt180 -72.28 137.55 46.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.032 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -118.72 173.81 6.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.579 -0.737 . . . . 10.0 109.233 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.4 111.06 21.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 t -99.56 104.27 15.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.224 0.535 . . . . 10.0 111.091 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.2 m -96.87 141.05 30.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.352 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 14.5 p -128.56 139.31 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.705 0.288 . . . . 10.0 111.567 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 12.8 pt20 -120.78 125.31 47.25 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.778 -0.453 . . . . 10.0 109.778 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.608 HG11 HD21 ' A' ' 75' ' ' LEU . 14.1 t -111.3 143.81 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.346 -0.388 . . . . 10.0 111.183 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.7 145.82 31.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.544 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.86 -30.17 84.4 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.003 2.469 . . . . 10.0 112.433 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.08 -23.37 65.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.94 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.699 HG13 HG23 ' A' ' 214' ' ' THR . 86.8 t -81.13 -38.56 16.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.624 -0.51 . . . . 10.0 109.624 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -59.46 -29.6 67.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.835 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -85.58 -33.7 7.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.508 0.558 . . . . 10.0 112.508 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.43 ' HB1' ' HD2' ' A' ' 388' ' ' PRO . . . -91.74 -17.1 25.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.117 0.784 . . . . 10.0 113.117 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.52 -20.84 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 10.0 111.381 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 65' ' ' LEU . . . -70.26 -37.69 74.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.684 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.433 ' CD ' HH21 ' A' ' 399' ' ' ARG . 32.4 mt-10 -64.15 -29.76 70.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.523 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.416 HG21 ' HA3' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -69.03 -15.63 63.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 10.0 110.858 179.329 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 mt -109.17 -5.56 15.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.149 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.39 27.4 22.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.908 -0.663 . . . . 10.0 112.23 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.493 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 mt -112.95 164.24 13.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.6 0.238 . . . . 10.0 110.492 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.96 140.9 88.93 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.731 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.44 118.82 5.62 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.881 2.387 . . . . 10.0 112.127 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.94 0.0 55.05 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.6 -0.809 . . . . 10.0 113.279 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.79 -38.11 73.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 10.0 111.051 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.11 131.34 41.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.716 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -83.52 157.1 65.08 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.598 0.237 . . . . 10.0 110.403 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.4 -35.26 91.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.225 1.95 . . . . 10.0 111.345 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.507 ' HB2' ' OE1' ' A' ' 233' ' ' GLU . 31.4 mmtp -71.8 -36.96 70.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.946 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -61.27 -42.3 98.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.091 0.472 . . . . 10.0 110.529 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.608 HD21 HG11 ' A' ' 51' ' ' VAL . 45.0 tp -63.84 -46.45 84.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.588 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.32 95.42 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.835 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.406 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 38.1 tp10 -61.75 -42.7 99.32 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.817 -0.629 . . . . 10.0 110.367 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -44.34 91.22 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.964 -0.636 . . . . 10.0 112.003 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 51' ' ' VAL . 16.3 mt -61.77 -40.49 95.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 10.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -62.94 -31.01 72.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.763 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -81.51 -8.73 59.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 10.0 111.803 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.0 mt -79.16 -9.3 59.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.022 0.439 . . . . 10.0 110.761 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.85 -0.43 28.77 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.691 -0.766 . . . . 10.0 112.354 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.75 159.58 27.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 10.0 110.971 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -101.7 -59.4 1.71 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.859 0.362 . . . . 10.0 110.995 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -115.97 125.06 52.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.827 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.3 t -105.48 108.79 25.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.283 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 30.1 m-85 -110.76 168.76 9.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.923 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.43 155.8 27.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.822 -0.626 . . . . 10.0 110.058 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 m -76.64 -21.79 55.0 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.98 0.733 . . . . 10.0 112.98 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.483 HD11 ' HH ' ' A' ' 404' ' ' TYR . 44.9 mt -61.43 -37.46 83.58 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.317 -0.239 . . . . 10.0 111.069 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -61.01 -38.37 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.232 0.539 . . . . 10.0 109.598 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.66 -35.26 55.51 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.776 -0.93 . . . . 10.0 110.776 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.11 77.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.696 0.284 . . . . 10.0 110.379 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.33 -35.48 73.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 10.0 109.662 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.42 -42.39 65.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.531 -0.759 . . . . 10.0 109.594 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.6 m -60.51 -42.43 96.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.617 -0.72 . . . . 10.0 110.622 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.9 mt -59.98 -39.95 81.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.771 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.8 mmm -65.92 -51.73 56.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.976 -0.557 . . . . 10.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -65.55 -45.44 83.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.873 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.488 ' HA ' ' OE1' ' A' ' 101' ' ' GLU . 1.8 tp10 -61.52 -43.55 98.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 10.0 110.929 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.05 95.29 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 110.981 -0.848 . . . . 10.0 110.981 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.558 ' HB2' HD13 ' A' ' 433' ' ' LEU . 19.7 m -69.27 -43.64 73.51 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.614 -0.293 . . . . 10.0 110.497 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.423 ' HG2' HD21 ' A' ' 433' ' ' LEU . 0.0 OUTLIER -60.18 -47.02 87.69 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.802 -0.444 . . . . 10.0 109.802 178.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.413 ' CD2' HD23 ' A' ' 261' ' ' LEU . 23.3 tp -59.16 -54.68 44.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.726 -0.67 . . . . 10.0 111.059 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.0 tp -59.35 -39.17 82.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.907 0.384 . . . . 10.0 110.593 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.606 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 53.9 t60 -61.86 -53.09 60.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.526 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 121' ' ' GLU . 68.2 mtt180 -59.72 -38.66 82.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.715 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 41.7 tp -67.21 -50.86 59.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.842 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.5 m -58.14 -44.95 88.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.912 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 23.1 mm-40 -57.95 -31.19 66.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.948 0.404 . . . . 10.0 111.573 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -79.65 -37.28 36.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 65.3 mt -69.31 -32.48 71.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.984 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.567 ' HG2' HD22 ' A' ' 305' ' ' LEU . 22.7 mt-10 -79.54 -7.16 58.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.284 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.139 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.356 -179.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 108' ' ' ARG . 1.5 pm0 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.862 0.363 . . . . 10.0 110.891 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -90.09 -172.07 0.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.988 2.458 . . . . 10.0 112.801 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.423 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 91.1 mt -133.93 157.38 77.87 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.486 -0.931 . . . . 10.0 108.486 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 369' ' ' TYR . 37.5 Cg_endo -64.92 167.46 45.46 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 124.513 -1.036 . . . . 10.0 113.802 0.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 24.6 ttt -113.92 134.08 55.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.739 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.61 ' HD1' ' HB ' ' A' ' 372' ' ' VAL . 33.3 m-85 -110.8 144.6 39.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.21 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.439 HG23 ' HZ ' ' A' ' 371' ' ' PHE . 0.0 OUTLIER -81.87 156.09 25.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.885 0.328 . . . . 10.0 111.885 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 m -111.63 54.18 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.262 0.553 . . . . 10.0 110.285 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.2 p -90.58 -39.51 12.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 10.0 112.086 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.783 ' SG ' ' HA ' ' A' ' 375' ' ' MET . 36.5 m -105.38 117.87 57.14 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.785 ' HG3' ' HE3' ' A' ' 188' ' ' LYS . 36.5 Cg_endo -64.46 -29.48 62.17 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.015 2.477 . . . . 10.0 111.743 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.21 -39.94 98.5 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.785 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -36.88 69.79 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 45.7 mm -62.92 -44.87 99.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.844 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.16 92.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.584 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 58.5 ttp -68.87 -34.73 75.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 10.0 109.773 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 tp -64.2 -54.45 33.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.754 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -59.8 -24.95 64.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.852 0.686 . . . . 10.0 112.852 -178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.64 -52.67 4.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.218 0.822 . . . . 10.0 113.218 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 m -84.24 -44.18 14.15 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 114.902 1.445 . . . . 10.0 114.902 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -131.7 73.25 79.3 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.9 -12.43 34.41 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.406 2.071 . . . . 10.0 111.82 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.94 -16.14 61.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.127 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.57 ' HA ' ' HD2' ' A' ' 147' ' ' TYR . 69.2 mt -98.97 9.52 43.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.566 HG23 ' HD2' ' A' ' 445' ' ' TYR . 52.4 mt -55.93 -52.46 72.28 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 33.4 Cg_exo -61.46 -23.28 76.43 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.338 2.025 . . . . 10.0 112.9 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.57 ' HD2' ' HA ' ' A' ' 144' ' ' LEU . 98.7 m-85 -75.78 -19.57 58.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.0 0.429 . . . . 10.0 111.047 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 144' ' ' LEU . 4.2 t -86.99 159.13 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.786 -0.449 . . . . 10.0 109.786 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.52 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . 31.5 t -69.4 167.62 16.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.991 0.424 . . . . 10.0 110.778 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.4 p -106.56 6.81 30.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.349 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.52 179.42 7.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 10.0 112.124 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 156' ' ' MET . 40.8 mtpt -122.25 169.79 10.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.3 p -68.53 152.56 96.56 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 121.049 -0.26 . . . . 10.0 110.471 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.66 -46.72 23.14 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.265 2.643 . . . . 10.0 112.974 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -35.7 80.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.803 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.442 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 60.1 mmm -74.52 -19.11 60.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.137 0.494 . . . . 10.0 110.833 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 30.9 mtt -80.66 -48.25 12.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.302 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.91 -42.26 99.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.59 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.68 81.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.64 61.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.812 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -72.69 -44.56 61.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.682 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.9 m -69.49 -28.68 38.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 179' ' ' MET . 27.5 mttt -85.73 2.6 44.8 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.824 0.305 . . . . 10.0 111.824 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 168' ' ' GLU . 13.5 p -122.82 -79.62 0.62 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.608 -0.269 . . . . 10.0 110.74 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.578 ' HE2' ' HA ' ' A' ' 240' ' ' MET . 33.8 t80 -55.58 -53.19 59.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.964 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.723 HD11 ' HE3' ' A' ' 170' ' ' LYS . 24.3 tp -61.94 -41.11 97.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 10.0 111.277 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.27 -50.18 74.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.202 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 164' ' ' SER . 41.6 mt-10 -68.41 -37.2 80.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.363 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -64.93 -49.08 71.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.247 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.723 ' HE3' HD11 ' A' ' 166' ' ' LEU . 91.2 mttt -76.88 -15.08 59.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.136 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 73.71 37.2 52.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.765 -0.731 . . . . 10.0 111.647 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.96 135.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.99 133.9 91.89 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.48 -0.327 . . . . 10.0 110.488 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.404 ' HB2' HD13 ' A' ' 205' ' ' LEU . 32.0 Cg_exo -59.55 -16.76 37.85 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.911 2.407 . . . . 10.0 112.399 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -71.94 -22.42 61.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.747 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -107.51 23.88 13.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.236 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 96.0 mtp -125.9 115.21 19.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.127 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.55 131.88 51.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.416 ' HB3' HD12 ' A' ' 208' ' ' LEU . 0.0 OUTLIER -112.4 119.87 39.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.149 0.5 . . . . 10.0 111.225 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 46.4 t -116.46 135.82 55.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.7 p -124.46 135.85 53.56 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.803 0.297 . . . . 10.0 111.803 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 212' ' ' ILE . 30.3 mm -99.93 103.11 14.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 213' ' ' THR . 32.4 mmt -114.26 148.43 40.09 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.944 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 183' ' ' MET . 2.5 Cg_endo -83.19 19.31 1.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.283 2.655 . . . . 10.0 112.665 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 73.1 m -145.93 129.17 16.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.05 0.453 . . . . 10.0 111.227 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -28.1 67.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.602 -0.726 . . . . 10.0 111.174 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -80.7 17.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.075 -0.511 . . . . 10.0 112.029 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.785 ' HE3' ' HG3' ' A' ' 131' ' ' PRO . 0.0 OUTLIER -87.87 -33.88 18.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.657 0.265 . . . . 10.0 111.349 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -65.01 -30.64 71.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.915 0.388 . . . . 10.0 110.171 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.81 -25.58 66.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.661 -0.699 . . . . 10.0 111.9 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 131' ' ' PRO . 31.1 tt0 -76.25 -46.9 25.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -73.5 -5.91 43.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.564 -0.744 . . . . 10.0 111.16 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.36 -18.85 57.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.517 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.453 ' HD3' ' CZ2' ' A' ' 196' ' ' TRP . 78.0 mtt-85 -59.02 118.16 5.5 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.744 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -41.79 -47.99 4.22 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.709 1.374 . . . . 10.0 114.709 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' TRP . . . . . 0.453 ' CZ2' ' HD3' ' A' ' 194' ' ' ARG . 43.9 p90 -62.27 -9.59 8.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.998 1.481 . . . . 10.0 114.998 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -85.74 56.3 3.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.577 0.703 . . . . 10.0 110.811 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -110.07 171.07 7.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.384 -0.825 . . . . 10.0 110.375 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.59 80.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.688 0.28 . . . . 10.0 110.65 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.3 t0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.116 -0.945 . . . . 10.0 112.17 179.596 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.761 ' C ' ' H ' ' A' ' 205' ' ' LEU . 48.1 m . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.876 0.369 . . . . 10.0 111.102 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.788 ' C ' ' CB ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.229 -0.004 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -94.27 148.82 21.83 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.956 0.16 . . . . 10.0 110.799 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -70.36 -38.62 74.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.166 -1.049 . . . . 10.0 108.166 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 179' ' ' MET . 29.8 tp -131.85 121.45 24.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.601 -1.629 . . . . 10.0 106.601 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.98 -44.68 7.24 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.891 1.071 . . . . 10.0 113.891 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 8.7 m-70 -130.36 141.88 50.55 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.987 0.736 . . . . 10.0 112.987 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.72 123.78 60.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.652 -0.869 . . . . 10.0 108.652 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 71.7 mt -119.78 140.05 45.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 183' ' ' MET . 41.1 p -90.23 166.95 13.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.052 0.453 . . . . 10.0 111.96 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.699 HG23 HG13 ' A' ' 55' ' ' VAL . 2.5 m -56.09 -46.71 78.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.476 -0.784 . . . . 10.0 111.773 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.8 m -61.26 -39.79 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.434 ' O ' HG13 ' A' ' 220' ' ' ILE . 41.9 mt-10 -68.7 -46.96 67.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.795 0.331 . . . . 10.0 110.638 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 31.1 tp -62.25 -43.07 99.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.34 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.416 ' HA3' HG21 ' A' ' 62' ' ' THR . . . -60.08 -36.27 89.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.186 -0.531 . . . . 10.0 112.252 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -38.87 80.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.571 0.224 . . . . 10.0 110.462 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 216' ' ' GLU . 79.7 mt -59.1 -45.3 92.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.18 -0.464 . . . . 10.0 110.08 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -59.77 -45.86 90.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.861 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.28 -46.81 82.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.787 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.92 -30.97 71.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 10.0 111.942 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -80.93 -12.7 59.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.926 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.78 30.51 47.74 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.914 -0.66 . . . . 10.0 111.868 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.6 mt -113.21 114.72 47.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.953 0.406 . . . . 10.0 110.532 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.454 ' O ' ' HG ' ' A' ' 231' ' ' LEU . 54.8 t30 -104.07 122.14 44.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.317 -0.401 . . . . 10.0 110.035 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.524 HD23 HD12 ' A' ' 231' ' ' LEU . 76.2 mt -60.4 -32.6 71.48 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.316 0.385 . . . . 10.0 111.735 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.04 -16.95 63.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.737 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.43 3.03 34.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 10.0 110.694 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.524 HD12 HD23 ' A' ' 228' ' ' LEU . 95.9 mt -96.65 151.03 37.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.327 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.18 -179.89 5.62 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.593 2.195 . . . . 10.0 111.123 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.507 ' OE1' ' HB2' ' A' ' 73' ' ' LYS . 2.8 mm-40 -80.55 103.45 10.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.739 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 73' ' ' LYS . . . -80.83 -152.62 8.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.017 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -150.98 157.86 43.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.867 0.333 . . . . 10.0 111.061 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -98.54 166.29 11.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.837 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -106.32 152.39 23.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -98.48 121.53 56.36 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.826 0.346 . . . . 10.0 110.944 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.82 -16.62 56.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.169 2.579 . . . . 10.0 112.079 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.578 ' HA ' ' HE2' ' A' ' 165' ' ' TYR . 85.5 mmm -81.15 -10.13 59.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.964 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 105.5 -66.34 0.27 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.029 -0.605 . . . . 10.0 112.043 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 17.0 m -104.69 165.2 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.573 0.225 . . . . 10.0 110.939 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 103.05 118.23 4.44 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.923 -0.656 . . . . 10.0 112.147 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.9 m -64.25 133.86 53.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.047 0.451 . . . . 10.0 111.605 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.02 -167.84 18.64 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.405 -0.678 . . . . 10.0 111.405 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.61 -8.66 58.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.929 0.395 . . . . 10.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 91.8 -1.87 75.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 10.0 112.311 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.63 129.31 39.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.833 -0.432 . . . . 10.0 109.833 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.654 ' HB2' ' HD3' ' A' ' 413' ' ' ARG . 63.5 mt -73.35 144.16 46.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.493 -0.322 . . . . 10.0 110.93 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.551 ' CE1' ' HG2' ' A' ' 408' ' ' GLU . 71.7 t80 -59.37 128.32 36.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.921 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 413' ' ' ARG . . . 128.71 150.27 7.15 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.867 -0.682 . . . . 10.0 111.758 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 8.3 t -92.38 145.1 24.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.883 0.373 . . . . 10.0 110.732 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -9.3 53.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.115 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 89.64 -11.73 69.27 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.955 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.53 165.11 12.35 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.199 -0.76 . . . . 10.0 111.199 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 29.2 t -58.49 -60.73 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.767 0.283 . . . . 10.0 111.22 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' MET . . . . . 0.504 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 25.6 ttp -51.89 -56.05 16.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 10.0 112.155 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -57.86 -49.9 75.12 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.005 0.743 . . . . 10.0 113.005 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.94 85.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.101 0.408 . . . . 10.0 112.101 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.62 76.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.062 0.458 . . . . 10.0 110.136 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.413 HD23 ' CD2' ' A' ' 105' ' ' LEU . 50.4 mt -63.83 -41.42 97.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.085 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 266' ' ' GLU . 46.0 ttm105 -59.04 -50.08 75.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.689 -0.687 . . . . 10.0 111.362 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 60.9 m -55.38 -40.74 71.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.613 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.67 -41.76 65.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.924 0.392 . . . . 10.0 110.737 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -63.76 -47.64 80.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 10.0 112.055 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 262' ' ' ARG . 46.2 mt-10 -66.75 -7.77 23.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.929 0.715 . . . . 10.0 112.929 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 80.7 mt -108.58 -41.09 4.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.003 0.43 . . . . 10.0 110.47 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -71.27 -40.28 71.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 21.1 p -102.65 -18.54 15.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.968 -0.56 . . . . 10.0 111.874 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.01 -35.61 2.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.487 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.34 145.45 82.78 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 110.327 -0.249 . . . . 10.0 110.327 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.486 ' HA ' ' HG2' ' A' ' 266' ' ' GLU . 62.5 Cg_endo -73.56 155.87 49.85 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.443 2.096 . . . . 10.0 112.354 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.499 HD12 ' HD2' ' A' ' 274' ' ' PRO . 28.1 tp -115.41 125.31 28.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.945 -0.57 . . . . 10.0 110.32 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.499 ' HD2' HD12 ' A' ' 273' ' ' LEU . 80.7 Cg_endo -77.46 -157.9 0.08 OUTLIER 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.701 2.267 . . . . 10.0 111.591 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -78.53 134.27 37.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.662 -0.496 . . . . 10.0 109.662 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.99 131.62 36.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.057 0.456 . . . . 10.0 111.785 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 1.2 m -103.51 101.43 11.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.78 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.463 HD13 ' HB ' ' A' ' 290' ' ' THR . 3.8 mm? -72.29 132.54 44.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.672 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 26.1 m -106.65 142.07 36.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.85 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -73.37 141.08 47.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.806 0.336 . . . . 10.0 111.13 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 66.8 t -98.88 108.11 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.042 -0.526 . . . . 10.0 109.618 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 77.3 mtm-85 -63.94 133.13 52.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.841 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 114.46 -31.12 6.57 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.776 -0.93 . . . . 10.0 110.776 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 59.5 mtm -132.67 89.02 2.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.77 103.58 0.27 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.606 -0.725 . . . . 10.0 112.034 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . 0.563 ' HA3' ' ND2' ' A' ' 354' ' ' ASN . . . 132.59 -19.08 4.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.527 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 42.5 mm -92.94 131.79 39.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -123.8 160.69 26.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.384 -0.598 . . . . 10.0 109.384 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.83 165.6 30.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.022 0.439 . . . . 10.0 111.397 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.463 ' HB ' HD13 ' A' ' 278' ' ' LEU . 14.5 t -157.29 145.54 19.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.123 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -113.79 124.13 51.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.686 0.279 . . . . 10.0 110.861 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 31.2 mt -112.84 105.15 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.593 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 3.9 p -72.4 100.69 2.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.416 . . . . 10.0 110.121 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 78.6 mtp -90.54 104.15 16.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.184 0.516 . . . . 10.0 111.952 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 25.6 t -102.1 111.77 64.66 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.592 -0.892 . . . . 10.0 108.592 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.64 142.14 32.44 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.287 2.658 . . . . 10.0 113.641 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . 0.431 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . . . -71.16 134.71 85.06 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.256 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 297' ' ' ALA . 36.8 Cg_exo -62.25 120.58 8.21 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.474 2.116 . . . . 10.0 111.913 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 94.48 20.14 30.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.012 -0.613 . . . . 10.0 113.084 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 90.3 p -110.61 163.8 13.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.91 -0.404 . . . . 10.0 109.91 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.64 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 28.1 pttt -71.05 -27.41 63.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.028 -0.73 . . . . 10.0 109.028 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -64.27 -41.53 96.87 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.875 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -64.3 -40.62 96.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.665 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -70.4 -25.8 63.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.506 -0.77 . . . . 10.0 112.27 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 67.5 mt -57.5 -57.33 13.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.707 0.289 . . . . 10.0 111.325 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.403 HD21 HD22 ' A' ' 113' ' ' LEU . 90.1 mt -73.48 -10.64 59.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 10.0 111.341 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -89.21 -36.61 15.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.485 . . . . 10.0 110.488 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.1 -30.64 25.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.108 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -142.02 117.84 10.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.095 0.474 . . . . 10.0 111.163 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -109.09 1.08 20.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.214 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.964 -1.017 . . . . 10.0 109.262 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.824 -0.51 . . . . 10.0 111.824 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.84 -27.58 67.45 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.753 2.302 . . . . 10.0 112.014 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 89.8 mt -115.53 93.51 4.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.287 0.565 . . . . 10.0 110.239 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -79.76 111.82 16.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.509 -0.769 . . . . 10.0 110.548 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -65.1 136.84 57.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.116 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -83.83 -7.2 59.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.547 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 105.38 -7.21 42.98 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.8 -0.714 . . . . 10.0 111.728 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . 0.41 ' HA2' ' NH2' ' A' ' 345' ' ' ARG . . . 91.61 156.78 33.06 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.659 -0.782 . . . . 10.0 111.51 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . 0.426 ' O ' HG22 ' A' ' 343' ' ' THR . . . -91.31 86.94 6.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.115 0.484 . . . . 10.0 110.077 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -88.4 157.39 27.83 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.707 -0.759 . . . . 10.0 112.664 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . 0.408 ' C ' ' HG1' ' A' ' 334' ' ' THR . 29.9 p90 -135.67 152.26 51.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.141 -0.318 . . . . 10.0 110.141 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 55.9 m -155.41 126.14 6.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.601 0.238 . . . . 10.0 110.502 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.35 165.89 14.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.449 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -63.9 -14.73 55.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.62 0.6 . . . . 10.0 112.62 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.9 -11.57 59.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.424 -0.353 . . . . 10.0 111.898 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 105.23 -0.71 40.62 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.476 -0.869 . . . . 10.0 113.986 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 334' ' ' THR . 23.3 mtm180 -77.78 122.92 26.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.476 0.638 . . . . 10.0 110.905 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -118.04 139.33 14.62 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -152.98 -176.78 25.88 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.729 -0.948 . . . . 10.0 110.729 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.594 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 15.1 tt -144.32 139.67 24.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 117.096 0.448 . . . . 10.0 110.724 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 331' ' ' ALA . 11.7 t -99.73 120.99 40.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.211 0.529 . . . . 10.0 110.179 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 14.6 tp -79.28 122.78 26.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.893 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . 0.41 ' NH2' ' HA2' ' A' ' 330' ' ' GLY . 59.9 mtm180 -93.01 102.39 14.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.914 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 31.7 t -103.0 137.1 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.439 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -128.89 149.14 50.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.378 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.5 124.3 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.125 -0.488 . . . . 10.0 109.953 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -108.78 119.46 39.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.2 -0.454 . . . . 10.0 110.103 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.5 106.65 16.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.126 0.488 . . . . 10.0 111.333 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 109.7 133.46 6.65 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.014 -0.613 . . . . 10.0 112.14 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.82 -36.92 80.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 10.0 110.875 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 357' ' ' LYS . . . -68.12 -28.14 73.46 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.219 -0.752 . . . . 10.0 111.219 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.613 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 1.3 m-20 -80.91 -37.11 30.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.67 94.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.9 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -57.45 -46.52 83.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.119 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.613 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 10.5 mtmm -64.01 -47.24 81.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.687 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.8 tp -61.74 -50.31 72.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 10.0 111.797 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 90.9 mt -55.76 -42.28 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.588 -0.278 . . . . 10.0 111.37 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 12.0 m -61.37 -43.22 99.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.982 0.42 . . . . 10.0 110.54 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.474 ' HZ2' ' CD ' ' A' ' 366' ' ' GLU . 10.3 mttm -70.57 -29.19 65.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.198 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 75.4 mtp -69.91 -40.85 75.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.075 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -66.7 -26.98 67.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.045 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.19 -9.55 59.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.764 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 87.09 9.22 74.0 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.054 -0.593 . . . . 10.0 112.801 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . 0.474 ' CD ' ' HZ2' ' A' ' 361' ' ' LYS . 38.5 mt-10 -75.66 -50.9 14.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.846 0.355 . . . . 10.0 110.645 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -98.46 100.79 12.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.777 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -97.69 109.53 22.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.155 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' TYR . . . . . 0.463 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 82.1 m-85 -136.99 159.79 40.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.999 -0.371 . . . . 10.0 109.999 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -103.43 -34.59 8.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.038 0.447 . . . . 10.0 111.547 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . 0.504 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 45.0 t80 -132.16 129.11 39.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . 0.61 ' HB ' ' HD1' ' A' ' 126' ' ' PHE . 43.6 t -129.67 119.03 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.813 0.671 . . . . 10.0 112.813 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.453 ' OE2' ' HB2' ' A' ' 257' ' ' MET . 5.2 tp10 -91.59 113.86 26.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.77 -1.196 . . . . 10.0 107.77 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 58.2 mt -109.27 118.16 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.257 0.551 . . . . 10.0 112.325 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' MET . . . . . 0.783 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 62.0 mtt -111.82 142.22 44.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.623 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.196 0.522 . . . . 10.0 110.925 179.738 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--O 1.236 0.345 0 N-CA-C 111.952 0.352 . . . . 10.0 111.952 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -109.33 34.92 5.22 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.035 -0.53 . . . . 10.0 112.377 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -80.63 162.99 45.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.762 -0.732 . . . . 10.0 112.206 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -72.69 -12.95 78.29 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.034 -0.603 . . . . 10.0 113.18 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -91.76 2.48 76.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.626 -0.797 . . . . 10.0 111.788 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -92.09 153.46 43.24 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' PRO . . . . . 0.43 ' HD2' ' HB1' ' A' ' 58' ' ' ALA . 31.3 Cg_exo -64.09 172.15 6.6 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.618 2.212 . . . . 10.0 111.239 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 109.65 8.1 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 28.3 m . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.097 178.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.958 0.409 . . . . 10.0 111.111 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -62.79 -39.59 94.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.704 -0.68 . . . . 10.0 111.113 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -64.14 -39.0 93.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.075 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.433 HH21 ' CD ' ' A' ' 61' ' ' GLU . 98.8 mtt180 -68.1 -39.35 82.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.27 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -63.19 -41.91 99.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.867 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -71.45 -27.78 63.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.413 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -96.88 14.9 23.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.828 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.6 mt -64.56 -40.17 95.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.989 0.423 . . . . 10.0 110.738 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.483 ' HH ' HD11 ' A' ' 91' ' ' LEU . 81.6 m-85 -133.78 158.64 42.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.787 -0.642 . . . . 10.0 109.439 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -79.0 165.49 23.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.478 HD13 ' HD2' ' A' ' 409' ' ' LYS . 3.9 mm? -61.02 -34.08 74.29 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.889 0.7 . . . . 10.0 112.889 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -74.09 -28.11 61.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.956 0.408 . . . . 10.0 111.256 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . 0.551 ' HG2' ' CE1' ' A' ' 250' ' ' PHE . 36.2 mt-10 -77.44 -32.62 54.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.709 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . 0.478 ' HD2' HD13 ' A' ' 406' ' ' LEU . 90.4 mttt -66.29 -35.22 79.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 10.0 111.79 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.3 6.83 21.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.029 0.443 . . . . 10.0 111.767 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 23.6 m -118.87 93.94 4.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.98 0.419 . . . . 10.0 110.683 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 30.1 tp -77.66 111.77 13.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.547 -0.538 . . . . 10.0 109.547 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . 0.654 ' HD3' ' HB2' ' A' ' 249' ' ' LEU . 5.2 tmm_? -107.76 148.41 29.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.125 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -116.63 137.0 52.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.508 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 4.6 m -69.05 -30.88 69.33 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.041 0.386 . . . . 10.0 112.041 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -69.28 -1.74 8.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -118.28 14.25 13.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.932 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . 0.424 ' HA ' HD11 ' A' ' 249' ' ' LEU . 55.3 t-20 -88.5 113.95 57.65 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.502 ' HD3' HD11 ' A' ' 249' ' ' LEU . 51.1 Cg_exo -54.97 -39.94 88.22 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.18 2.586 . . . . 10.0 112.53 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.6 m -61.28 -42.91 99.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.112 0.482 . . . . 10.0 110.564 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 49.7 mm -72.16 -40.51 66.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.881 -0.599 . . . . 10.0 110.171 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.5 -44.82 95.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.475 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -60.79 -45.19 95.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 10.0 110.618 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.448 ' HB2' ' SD ' ' A' ' 240' ' ' MET . 45.2 tp -64.63 -41.19 96.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.882 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . 0.672 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 1.2 m-85 -68.13 -33.64 74.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.024 -0.534 . . . . 10.0 110.967 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.66 -61.18 2.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.566 0.95 . . . . 10.0 113.566 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.52 16.99 5.76 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.842 1.423 . . . . 10.0 114.842 -176.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -150.73 -63.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.243 0.831 . . . . 10.0 113.243 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . 0.672 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 96.2 mt -67.37 -36.5 81.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.853 0.686 . . . . 10.0 112.853 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 97.47 -68.12 0.79 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.892 -0.67 . . . . 10.0 111.853 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -161.31 157.47 21.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.767 -0.457 . . . . 10.0 109.767 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.466 ' HA ' ' HE1' ' A' ' 425' ' ' TYR . 52.1 Cg_exo -58.28 132.36 48.43 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.582 2.188 . . . . 10.0 110.915 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 103' ' ' SER . 4.6 mp 66.63 9.63 6.78 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.986 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 438' ' ' HIS . . . -70.21 -170.68 8.79 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.32 -0.467 . . . . 10.0 112.865 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -55.28 -62.33 1.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.381 0.511 . . . . 10.0 112.381 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 436' ' ' LYS . 31.3 tptt -60.43 -38.34 83.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.906 0.384 . . . . 10.0 111.83 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 441' ' ' LEU . . . -66.69 -46.09 76.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.084 0.469 . . . . 10.0 111.006 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . 0.512 ' HB2' ' O ' ' A' ' 434' ' ' GLY . 0.1 OUTLIER -70.14 -20.4 63.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.944 0.402 . . . . 10.0 110.976 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -76.07 -65.34 0.93 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.954 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 81.5 mt -92.81 -24.7 18.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.488 1.292 . . . . 10.0 114.488 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 437' ' ' ALA . 68.3 mt -93.0 -6.14 49.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 438' ' ' HIS . 26.0 m-70 -121.71 165.06 16.36 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.27 -0.269 . . . . 10.0 110.949 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 7.5 t -152.15 -168.95 3.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.641 0.258 . . . . 10.0 111.596 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -139.72 161.48 37.43 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.375 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' TYR . . . . . 0.566 ' HD2' HG23 ' A' ' 145' ' ' ILE . 37.9 m-85 -110.58 168.88 9.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.695 -0.229 . . . . 10.0 111.029 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.08 113.3 36.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 10.0 111.013 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -66.18 105.86 1.5 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.482 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 131.51 -20.41 4.66 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.28 -0.728 . . . . 10.0 111.28 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.641 0 C-N-CA 120.844 -0.693 . . . . 10.0 112.069 179.844 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 p -74.93 165.96 24.42 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.923 -0.399 . . . . 10.0 109.923 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 189' ' ' GLN . 96.7 m-70 -64.23 -31.02 72.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.761 0.282 . . . . 10.0 111.761 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.73 -45.15 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.503 -0.555 . . . . 10.0 109.503 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -63.6 -31.32 72.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.386 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.534 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 36.8 mt-30 -62.83 -23.46 67.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.264 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.1 -38.66 10.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.888 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.19 -35.08 76.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.098 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.6 -36.45 74.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.085 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -79.77 -34.83 39.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.382 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.15 -25.4 62.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.239 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.55 -7.5 56.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.011 0.434 . . . . 10.0 110.626 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 91.9 mttt -93.8 121.7 63.87 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.908 -0.587 . . . . 10.0 109.906 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.1 148.89 75.13 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.56 2.173 . . . . 10.0 110.415 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.826 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 61.9 mttt -63.89 -10.41 20.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.978 0.732 . . . . 10.0 112.978 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -98.52 -5.32 32.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.734 0.302 . . . . 10.0 111.288 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.2 135.84 82.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.314 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.91 -17.34 59.31 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.714 2.276 . . . . 10.0 113.171 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.75 14.16 30.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 10.0 110.781 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.826 ' HG2' ' HA ' ' A' ' 39' ' ' LYS . 6.8 tpt180 -87.64 115.51 25.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.504 . . . . 10.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.742 ' HD3' ' HA ' ' A' ' 176' ' ' ASP . 14.0 mttp -93.7 169.11 10.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.816 -0.629 . . . . 10.0 109.882 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.51 111.75 18.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.84 -0.8 . . . . 10.0 108.84 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.33 102.16 13.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.082 0.468 . . . . 10.0 111.646 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.3 m -99.1 140.54 33.11 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.245 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 13.1 p -132.38 135.84 57.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.085 0.469 . . . . 10.0 112.115 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 14.5 pt20 -116.35 127.07 54.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.967 -0.561 . . . . 10.0 109.581 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.445 HG11 HD21 ' A' ' 75' ' ' LEU . 2.0 t -104.03 150.04 7.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.123 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.02 139.08 20.48 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.481 . . . . 10.0 109.962 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.7 -35.03 66.89 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.184 2.59 . . . . 10.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.68 -32.86 74.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.102 0.477 . . . . 10.0 110.768 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.929 HG13 HG23 ' A' ' 214' ' ' THR . 88.0 t -80.53 -40.15 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.776 -0.647 . . . . 10.0 109.374 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -56.6 -33.08 65.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.536 -0.757 . . . . 10.0 112.316 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.38 -37.52 12.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 113.292 0.849 . . . . 10.0 113.292 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.56 -5.56 53.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.528 0.936 . . . . 10.0 113.528 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.34 -26.39 40.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.823 0.344 . . . . 10.0 111.687 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.83 -24.85 65.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.591 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -66.24 -26.14 67.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.279 -0.419 . . . . 10.0 112.049 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.0 p -68.18 -23.59 64.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.066 0.46 . . . . 10.0 110.54 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.6 mt -94.02 -0.78 55.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.164 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.99 18.52 55.85 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.947 -0.644 . . . . 10.0 112.385 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.8 mt -106.34 164.62 11.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.662 0.267 . . . . 10.0 110.764 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.61 153.9 85.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.527 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.43 133.65 59.37 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.567 2.178 . . . . 10.0 111.691 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.49 14.17 62.14 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.667 -0.777 . . . . 10.0 113.082 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.57 -27.04 31.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.953 0.406 . . . . 10.0 111.245 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 p -103.25 129.26 50.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.194 -0.457 . . . . 10.0 109.976 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -77.76 154.74 80.92 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.323 -0.251 . . . . 10.0 110.323 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.84 -41.12 77.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.713 2.276 . . . . 10.0 111.935 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 233' ' ' GLU . 46.8 mttm -66.15 -36.59 83.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.967 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -61.71 -41.67 97.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.013 0.435 . . . . 10.0 110.654 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.445 HD21 HG11 ' A' ' 51' ' ' VAL . 48.8 tp -64.73 -44.53 89.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.432 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.34 95.24 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.73 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.476 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 23.9 tp10 -60.32 -46.9 88.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.881 -0.599 . . . . 10.0 110.29 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.04 -43.81 96.79 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.85 -0.613 . . . . 10.0 112.442 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.44 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 30.6 mt -60.02 -43.93 94.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 10.0 111.124 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -64.18 -32.51 74.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.943 0.401 . . . . 10.0 110.619 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -74.68 -12.62 60.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.386 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.7 mt -77.62 -19.61 55.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 10.0 109.937 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.59 7.58 8.07 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.649 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.44 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 47.3 m-85 -72.81 156.63 38.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.729 0.299 . . . . 10.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -98.03 -58.71 1.92 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.993 0.425 . . . . 10.0 111.357 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . 2.9 mp0 -117.61 128.15 54.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.131 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.4 t -113.52 114.26 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.267 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 86' ' ' GLU . 24.5 m-85 -118.1 170.55 8.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.476 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -118.11 149.04 41.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.4 m -64.78 -20.57 66.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.74 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.447 HD21 ' HH ' ' A' ' 404' ' ' TYR . 24.7 mt -57.91 -34.57 69.97 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.429 ' HD2' HD13 ' A' ' 158' ' ' LEU . 42.9 t80 -66.99 -37.63 84.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.151 0.5 . . . . 10.0 109.96 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.02 -34.47 58.62 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.994 -0.842 . . . . 10.0 110.994 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.89 -36.38 83.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.605 -0.298 . . . . 10.0 110.509 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.13 -33.93 69.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.07 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.421 HD21 HD23 ' A' ' 424' ' ' LEU . 78.9 mt -76.09 -42.79 46.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.988 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m -59.67 -44.33 93.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.667 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.5 mt -58.68 -42.14 84.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.905 -0.589 . . . . 10.0 110.753 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 87.6 mmm -66.95 -48.45 68.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.229 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -66.87 -53.92 27.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.438 ' HG2' ' SG ' ' A' ' 151' ' ' CYS . 18.9 mt-10 -60.42 -40.95 92.86 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.847 0.356 . . . . 10.0 110.932 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.16 99.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.095 -0.574 . . . . 10.0 111.865 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.8 m -67.94 -39.89 83.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.531 0.205 . . . . 10.0 110.853 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.529 ' HA ' ' HD2' ' A' ' 107' ' ' HIS . 19.6 tt0 -64.57 -41.3 96.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.05 -51.15 69.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.117 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.1 tp -57.3 -46.78 82.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.639 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.73 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -64.77 -40.13 94.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.431 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -58.13 -40.73 82.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.035 0.445 . . . . 10.0 110.25 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 45.4 tp -70.03 -42.25 73.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.85 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 m -58.4 -47.48 83.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.835 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 30.2 mm-40 -57.44 -35.88 70.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.129 0.49 . . . . 10.0 110.468 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -75.9 -29.44 58.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.771 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 95.7 mt -76.36 -34.0 58.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.173 0.511 . . . . 10.0 110.343 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -79.81 -43.41 22.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.381 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.093 0 O-C-N 123.831 0.707 . . . . 10.0 111.728 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.795 0.331 . . . . 10.0 110.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -85.27 -165.12 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.798 2.332 . . . . 10.0 112.615 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.404 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 94.1 mt -129.07 157.72 75.03 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.404 ' C ' ' HA ' ' A' ' 123' ' ' LEU . 18.3 Cg_exo -66.37 167.23 55.02 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.296 -1.127 . . . . 10.0 113.129 0.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 25.7 ttt -113.57 133.35 55.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.774 . . . . 10.0 111.007 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -113.79 144.45 42.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.963 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.502 ' HG1' ' HG3' ' A' ' 373' ' ' GLU . 0.0 OUTLIER -74.11 150.32 40.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.67 0.272 . . . . 10.0 110.322 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.662 ' HB2' ' HH ' ' A' ' 445' ' ' TYR . 2.0 p -116.47 20.4 14.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 6.82 28.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.451 ' O ' HG12 ' A' ' 134' ' ' ILE . 54.1 t -120.15 117.78 31.81 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 120.658 0.266 . . . . 10.0 111.567 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 130' ' ' CYS . 28.1 Cg_endo -63.23 -33.79 70.27 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.364 2.71 . . . . 10.0 112.048 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.02 -41.63 97.16 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.946 -0.645 . . . . 10.0 111.571 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -65.8 -44.04 86.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.078 -0.342 . . . . 10.0 110.078 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 130' ' ' CYS . 35.2 mm -57.99 -42.38 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.966 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.45 76.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.168 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.2 tpt -67.2 -34.19 76.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.007 0.432 . . . . 10.0 110.823 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 148' ' ' VAL . 22.0 tp -60.44 -60.7 3.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.57 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -63.73 -20.62 65.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.682 -0.235 . . . . 10.0 111.599 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -81.06 -61.97 1.8 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.607 0.965 . . . . 10.0 113.607 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 m -115.27 1.0 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.714 1.376 . . . . 10.0 114.714 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.533 ' HB3' HD12 ' A' ' 144' ' ' LEU . 53.5 m-85 -134.14 60.65 45.86 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 122.05 -0.406 . . . . 10.0 111.102 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.96 -25.43 32.36 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.364 2.043 . . . . 10.0 113.1 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -87.07 1.05 54.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.987 0.422 . . . . 10.0 111.289 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 141' ' ' TYR . 59.8 mt -105.99 4.27 29.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.462 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.59 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 75.6 mt -57.94 -53.72 62.88 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 49.3 Cg_exo -58.4 -18.94 41.05 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.479 2.119 . . . . 10.0 113.076 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 125' ' ' MET . 96.5 m-85 -78.76 -20.03 50.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.214 0.531 . . . . 10.0 110.459 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.433 HG21 HD22 ' A' ' 137' ' ' LEU . 16.7 t -90.49 154.3 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.587 . . . . 10.0 109.589 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.0 t -68.18 158.31 33.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.069 0.461 . . . . 10.0 111.125 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 88.3 p -100.54 6.41 44.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.237 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . 0.438 ' SG ' ' HG2' ' A' ' 101' ' ' GLU . 4.5 m -80.83 143.9 32.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.228 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -85.66 165.12 17.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.099 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.2 p -67.19 155.11 91.37 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.761 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -45.15 -54.68 4.08 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.604 2.87 . . . . 10.0 114.214 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.465 HE21 ' HB2' ' A' ' 155' ' ' GLN . 0.0 OUTLIER -65.14 -34.31 78.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.709 0.633 . . . . 10.0 112.709 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 78.9 mmm -72.81 -23.81 60.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.064 0.459 . . . . 10.0 110.481 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 36.6 mtt -75.8 -48.88 19.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.328 -0.619 . . . . 10.0 109.328 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.429 HD13 ' HD2' ' A' ' 92' ' ' PHE . 49.2 tp -62.82 -40.22 96.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.372 -0.831 . . . . 10.0 111.038 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.47 81.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.471 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.88 -31.87 57.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.534 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -70.26 -43.26 70.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.691 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.8 m -68.89 -27.48 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 179' ' ' MET . 44.4 mttt -88.94 7.7 33.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.016 0.376 . . . . 10.0 112.016 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.6 p -129.41 -74.67 0.55 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.814 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -62.97 -50.83 69.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.56 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 162' ' ' VAL . 54.8 tp -64.04 -40.8 97.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 10.0 110.787 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.77 -52.04 67.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.919 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -64.04 -43.72 94.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.389 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -62.45 -38.06 88.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 10.0 111.991 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -89.32 -7.48 55.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 69.06 40.87 83.1 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.104 -0.569 . . . . 10.0 112.642 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 43.2 mt -123.5 142.39 40.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -79.51 136.36 56.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 110.018 -0.364 . . . . 10.0 110.018 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 173' ' ' ALA . 51.3 Cg_exo -57.44 -16.05 21.88 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.237 2.624 . . . . 10.0 113.143 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -72.77 -28.88 62.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 10.0 110.864 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.742 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 58.3 m-20 -101.82 29.62 4.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.401 0.62 . . . . 10.0 110.244 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 95.4 mtp -126.89 124.73 40.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.142 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 32.1 t -107.93 119.31 57.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.338 -0.615 . . . . 10.0 109.338 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.532 ' HB3' HD12 ' A' ' 208' ' ' LEU . 0.0 OUTLIER -103.31 109.11 20.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.055 0.455 . . . . 10.0 111.273 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 28.0 t -108.69 142.1 22.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.413 ' OG ' HD21 ' A' ' 208' ' ' LEU . 10.1 p -134.79 138.22 44.08 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.917 -0.313 . . . . 10.0 111.049 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.411 ' CG2' HG11 ' A' ' 55' ' ' VAL . 21.2 mm -100.35 108.95 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.547 ' O ' ' HA ' ' A' ' 213' ' ' THR . 31.9 mmt -116.95 149.38 44.04 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.49 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.68 25.02 0.71 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.828 2.352 . . . . 10.0 112.518 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 30.2 t -156.99 139.29 14.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.588 -0.278 . . . . 10.0 110.719 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.89 -24.11 52.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.156 0.503 . . . . 10.0 110.588 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -70.98 -3.05 17.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.717 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 188' ' ' LYS . 13.4 mmtt -78.13 -27.23 48.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.951 0.405 . . . . 10.0 110.9 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . 0.418 ' HG2' ' CD2' ' A' ' 27' ' ' HIS . 29.3 tp60 -68.45 -34.94 76.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 10.0 109.942 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.56 -26.63 67.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.182 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -76.82 -42.81 38.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.237 0.542 . . . . 10.0 109.81 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.436 ' CB ' HD23 ' A' ' 208' ' ' LEU . . . -74.75 -21.28 59.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.475 -0.784 . . . . 10.0 111.703 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -2.1 38.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.472 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 51.1 mtt180 -63.41 120.71 12.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.187 0.517 . . . . 10.0 110.196 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.09 -42.59 50.46 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.714 1.746 . . . . 10.0 115.714 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' TRP . . . . . 0.435 ' HZ2' HH11 ' A' ' 194' ' ' ARG . 35.3 p90 -67.78 0.73 3.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.465 1.283 . . . . 10.0 114.465 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.48 ' O ' ' HG3' ' A' ' 207' ' ' GLN . 9.7 m-85 -93.87 68.2 3.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.131 0.491 . . . . 10.0 109.949 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 5.9 p -109.38 167.88 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.187 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 207' ' ' GLN . 15.9 t -113.31 103.32 15.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.088 -0.708 . . . . 10.0 109.088 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.947 -1.025 . . . . 10.0 111.644 -179.6 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.756 ' C ' ' H ' ' A' ' 205' ' ' LEU . 1.1 m . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.841 0.353 . . . . 10.0 110.457 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.777 ' C ' ' CB ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.231 0.106 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -82.52 139.84 33.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.258 -0.275 . . . . 10.0 110.258 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 197' ' ' PHE . 54.8 mt-30 -65.59 -42.51 91.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.526 0.679 . . . . 10.0 109.502 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 179' ' ' MET . 19.2 tp -120.06 136.71 54.47 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.84 -64.8 1.09 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.999 0.741 . . . . 10.0 112.999 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.534 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 1.4 m-70 -140.28 144.76 36.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.929 0.395 . . . . 10.0 111.857 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 47.3 t -112.2 131.01 64.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.51 138.13 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.479 -0.563 . . . . 10.0 109.479 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 183' ' ' MET . 72.4 p -87.81 166.93 14.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.121 0.486 . . . . 10.0 111.885 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.929 HG23 HG13 ' A' ' 55' ' ' VAL . 1.4 m -57.3 -45.97 83.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.471 -0.786 . . . . 10.0 111.429 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.7 m -61.99 -42.01 93.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.803 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 220' ' ' ILE . 41.8 mt-10 -66.17 -46.47 77.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 10.0 110.86 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.85 -45.11 95.83 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.002 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -60.71 -37.4 93.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.026 -0.606 . . . . 10.0 111.954 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . 0.486 ' HA ' ' HE3' ' A' ' 222' ' ' LYS . 42.4 m-20 -65.37 -39.33 92.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.625 0.25 . . . . 10.0 110.634 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 216' ' ' GLU . 73.4 mt -60.37 -47.57 91.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.368 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -60.2 -41.64 93.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.084 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 219' ' ' ASN . 36.9 mtmt -66.41 -47.56 72.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -63.79 -38.27 90.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 10.0 111.708 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -76.06 -18.78 59.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 10.0 111.414 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.76 40.59 12.0 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.901 -0.666 . . . . 10.0 112.119 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.5 mt -120.09 92.83 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.891 0.377 . . . . 10.0 110.54 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -76.39 116.15 16.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 10.0 109.971 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.565 ' HA ' HD12 ' A' ' 231' ' ' LEU . 36.1 mt -60.48 -28.8 68.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.873 -0.603 . . . . 10.0 112.141 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.91 -13.0 61.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.477 -0.329 . . . . 10.0 111.76 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -109.93 18.3 20.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.021 0.439 . . . . 10.0 111.042 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 228' ' ' LEU . 96.1 mt -105.46 150.2 38.7 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.614 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.01 176.65 9.59 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.339 2.026 . . . . 10.0 111.478 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 73' ' ' LYS . 8.2 mm-40 -74.08 99.13 3.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.404 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 77' ' ' GLU . . . -73.73 -168.16 15.8 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.997 -0.62 . . . . 10.0 113.08 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -132.45 154.17 50.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.777 0.322 . . . . 10.0 111.348 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -100.41 165.17 11.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.275 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 246' ' ' ALA . 30.4 m-20 -107.98 155.38 20.4 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.693 -0.484 . . . . 10.0 109.693 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -100.42 120.62 55.77 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.714 0.292 . . . . 10.0 110.788 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.18 -14.99 45.28 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.959 2.439 . . . . 10.0 112.093 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.528 ' HE2' ' HB3' ' A' ' 423' ' ' GLU . 98.2 mmm -83.02 10.83 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.955 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 89.69 -61.51 3.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.193 -0.527 . . . . 10.0 111.939 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.4 m -125.35 144.87 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.732 0.301 . . . . 10.0 110.21 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 155.43 162.85 11.6 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.073 -0.585 . . . . 10.0 111.811 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 m -94.33 107.42 19.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.971 0.415 . . . . 10.0 110.429 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 95.77 -164.16 23.91 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.748 -0.739 . . . . 10.0 111.428 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 237' ' ' ASP . . . -80.95 0.87 33.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.93 0.344 . . . . 10.0 111.93 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 13.82 80.25 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.295 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.17 118.87 53.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.493 HD11 ' HD3' ' A' ' 419' ' ' PRO . 75.1 mt -69.85 136.15 50.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.523 -0.308 . . . . 10.0 111.195 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -54.74 122.43 10.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.528 -0.76 . . . . 10.0 111.312 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 148.09 165.73 12.23 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.354 -0.698 . . . . 10.0 111.354 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 6.7 t -107.62 152.12 24.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.121 0.486 . . . . 10.0 111.115 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.27 -10.18 20.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.065 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.485 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 88.08 -30.82 4.96 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.919 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 150.84 167.29 14.46 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.234 -1.146 . . . . 10.0 110.234 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.51 -54.09 36.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 117.402 0.601 . . . . 10.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' MET . . . . . 0.74 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 28.6 ttp -61.6 -49.03 78.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.541 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.485 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 17.1 tt0 -58.14 -46.97 84.72 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.12 0.415 . . . . 10.0 112.12 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.67 -35.93 79.76 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.715 -0.221 . . . . 10.0 111.394 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.62 -46.52 78.96 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.707 -0.479 . . . . 10.0 109.707 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 79.7 mt -63.16 -41.08 99.19 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.793 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.541 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 44.3 ttm105 -57.63 -51.06 71.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.324 -0.853 . . . . 10.0 111.16 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 28.9 m -56.57 -43.84 80.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.405 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.59 -43.15 69.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.909 0.385 . . . . 10.0 111.249 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.534 ' CD2' ' HB2' ' A' ' 273' ' ' LEU . 47.3 t80 -63.18 -47.51 82.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.135 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.426 ' OE2' ' HA ' ' A' ' 272' ' ' PRO . 75.2 mt-10 -66.0 -36.81 84.31 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 76.0 mt -77.65 -7.92 57.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.167 0.508 . . . . 10.0 111.13 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -104.51 -40.65 5.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.484 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' THR . . . . . 0.45 HG21 ' CE1' ' A' ' 265' ' ' TYR . 77.9 p -97.97 -32.67 11.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.986 0.736 . . . . 10.0 112.986 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 89.06 -3.13 84.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.491 -0.861 . . . . 10.0 111.034 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 12.0 p -104.64 139.47 20.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.989 -0.374 . . . . 10.0 109.989 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . 0.426 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 37.0 Cg_endo -68.07 139.54 47.0 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.423 2.082 . . . . 10.0 111.581 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.626 HD12 ' HD2' ' A' ' 274' ' ' PRO . 40.6 tp -101.48 121.65 50.75 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.241 -0.436 . . . . 10.0 111.143 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.626 ' HD2' HD12 ' A' ' 273' ' ' LEU . 73.9 Cg_endo -77.5 -156.19 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.573 2.182 . . . . 10.0 111.335 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -80.94 142.54 33.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.082 -0.34 . . . . 10.0 110.082 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.11 124.6 36.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.069 0.461 . . . . 10.0 112.11 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 4.3 m -90.65 91.9 8.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.238 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.54 123.93 17.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 10.0 111.554 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 6.1 m -98.7 140.84 32.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.491 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.12 128.48 33.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.522 -0.308 . . . . 10.0 110.971 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 289' ' ' GLU . 21.7 t -86.03 110.25 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.351 . . . . 10.0 110.155 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -66.83 123.05 19.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.369 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 117.16 -21.32 10.98 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 63.8 mtm -132.91 85.5 2.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -62.65 109.98 1.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.458 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . 0.422 ' HA3' ' ND2' ' A' ' 354' ' ' ASN . . . 118.08 -13.52 12.65 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.757 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 42.9 mm -97.89 129.44 48.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -119.59 149.94 41.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . 0.457 ' HG2' HG22 ' A' ' 281' ' ' VAL . 21.6 pt-20 -133.39 160.1 38.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.992 0.425 . . . . 10.0 112.07 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.83 134.62 13.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.299 -0.864 . . . . 10.0 109.855 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -112.0 110.1 20.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.548 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 31.5 mt -98.97 121.49 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 10.0 111.504 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' THR . . . . . 0.552 HG23 ' HZ ' ' A' ' 333' ' ' PHE . 4.6 m -76.99 104.45 7.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.226 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' MET . . . . . 0.433 ' HG2' ' HD1' ' A' ' 265' ' ' TYR . 88.6 mtp -100.6 102.46 13.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.985 0.422 . . . . 10.0 111.74 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.54 118.48 54.42 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.979 -0.749 . . . . 10.0 108.979 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.01 132.99 55.04 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.863 2.375 . . . . 10.0 112.566 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.22 134.52 95.99 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.887 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.37 120.04 7.56 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.717 2.278 . . . . 10.0 111.492 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 92.42 39.39 5.36 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.828 -0.701 . . . . 10.0 111.702 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 98.9 p -128.53 165.12 21.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.861 -0.422 . . . . 10.0 109.861 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.618 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 13.2 pttt -73.11 -29.38 62.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.622 -0.51 . . . . 10.0 109.622 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -66.02 -39.51 90.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.905 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 307' ' ' LYS . 13.5 tt0 -64.32 -45.28 88.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.013 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.58 -31.74 73.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.648 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 90.7 mt -58.86 -57.3 13.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 10.0 110.919 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . 0.437 HD21 HD22 ' A' ' 113' ' ' LEU . 92.2 mt -69.26 -26.23 64.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.367 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 303' ' ' GLU . 6.6 tmtt? -79.03 -12.97 60.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.992 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -112.26 -22.74 10.77 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.878 0.696 . . . . 10.0 112.878 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 305' ' ' LEU . 6.9 ptp180 -146.4 123.92 11.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.992 0.425 . . . . 10.0 112.044 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.5 -0.18 4.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.486 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.198 -0.906 . . . . 10.0 109.113 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.438 0 N-CA-C 111.513 -0.635 . . . . 10.0 111.513 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.35 -23.43 51.45 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.729 2.286 . . . . 10.0 111.733 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 147' ' ' TYR . 93.3 mt -119.23 96.48 5.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.137 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -92.66 124.16 36.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.242 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -60.56 129.94 44.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.062 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -72.71 -12.93 61.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.286 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 115.05 -9.59 20.84 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.245 -0.742 . . . . 10.0 111.245 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.52 129.2 2.51 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.855 -0.688 . . . . 10.0 111.565 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -71.78 88.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.08 0.467 . . . . 10.0 110.588 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -105.68 149.06 16.63 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.928 -0.653 . . . . 10.0 112.397 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . 0.552 ' HZ ' HG23 ' A' ' 293' ' ' THR . 3.5 p90 -132.05 151.23 51.87 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' THR . . . . . 0.42 ' HA ' ' HA2' ' A' ' 340' ' ' GLY . 7.8 t -131.78 142.09 49.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.981 0.42 . . . . 10.0 111.196 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 1.7 m -83.75 165.05 19.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.813 -0.631 . . . . 10.0 109.934 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -70.97 -18.19 62.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.894 0.378 . . . . 10.0 110.986 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -26.12 60.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.683 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 126.39 -16.68 6.65 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.464 -0.874 . . . . 10.0 113.561 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -83.15 163.52 20.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.865 0.333 . . . . 10.0 110.881 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 334' ' ' THR . . . -150.26 169.04 30.25 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.731 -0.747 . . . . 10.0 112.293 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -157.19 164.93 33.1 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 14.4 tt -122.32 140.95 44.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.998 0.399 . . . . 10.0 110.724 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.412 ' HB ' ' HE2' ' A' ' 333' ' ' PHE . 4.8 t -96.98 100.09 11.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.233 0.54 . . . . 10.0 110.132 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 21.4 tp -62.95 116.72 5.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.457 -0.792 . . . . 10.0 110.776 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -90.71 100.19 13.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.555 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 46.3 t -104.18 132.59 50.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.63 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . 0.558 ' HB3' HG22 ' A' ' 372' ' ' VAL . . . -125.78 144.75 50.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.785 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.71 118.89 57.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.635 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.481 ' HB3' HG12 ' A' ' 374' ' ' ILE . . . -105.52 97.39 7.23 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.238 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.22 101.0 13.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.006 0.431 . . . . 10.0 110.167 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 126.08 123.83 2.71 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.203 -0.759 . . . . 10.0 111.203 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . 0.817 ' HG ' ' HA ' ' A' ' 376' ' ' ALA . 26.7 mt -59.11 -32.01 69.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.938 0.399 . . . . 10.0 111.786 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . 0.465 ' O ' ' HE3' ' A' ' 357' ' ' LYS . . . -72.43 -26.59 71.51 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.236 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.465 ' HA ' ' HD2' ' A' ' 357' ' ' LYS . 86.6 m-20 -74.03 -23.78 59.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 10.0 111.054 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -66.28 -36.09 82.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.632 -0.507 . . . . 10.0 109.632 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -68.07 -21.33 64.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.332 -0.849 . . . . 10.0 110.545 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 353' ' ' GLY . 60.4 mttt -94.61 -32.39 13.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 10.0 111.572 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.96 -45.83 16.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.916 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 85.1 mt -58.94 -34.48 52.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.095 0.406 . . . . 10.0 112.095 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -43.2 99.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.993 0.425 . . . . 10.0 110.306 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -72.3 -29.06 63.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.613 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 89.5 mtp -70.35 -48.83 54.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.104 -0.498 . . . . 10.0 109.861 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.52 -36.77 83.63 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.45 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.2 -27.54 68.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.609 . . . . 10.0 110.866 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 105.26 0.03 40.81 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.069 -0.586 . . . . 10.0 112.605 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -75.49 -54.41 7.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 10.0 111.335 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -81.85 100.7 9.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.51 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -94.75 106.09 18.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.478 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -137.44 155.35 49.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.103 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -105.28 -38.05 6.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.062 0.458 . . . . 10.0 110.877 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . 0.74 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 53.5 t80 -130.46 129.79 43.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.699 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 347' ' ' ALA . 62.5 t -134.07 127.01 50.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.803 0.335 . . . . 10.0 111.818 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.502 ' HG3' ' HG1' ' A' ' 127' ' ' THR . 14.1 tt0 -101.88 126.74 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.481 HG12 ' HB3' ' A' ' 349' ' ' ALA . 68.9 mt -116.37 120.1 63.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.254 0.549 . . . . 10.0 111.971 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' MET . . . . . . . . . . . . . 10.0 mmt -105.79 155.52 19.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 10.0 109.442 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.817 ' HA ' ' HG ' ' A' ' 352' ' ' LEU . . . . . . . . 0 C--N 1.321 -0.658 0 CA-C-O 120.78 0.324 . . . . 10.0 111.685 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 396' ' ' THR . 28.0 m . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.796 0.332 . . . . 10.0 111.472 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -112.0 27.93 9.79 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.059 -0.591 . . . . 10.0 111.985 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -69.32 169.73 43.23 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.12 -0.562 . . . . 10.0 112.641 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -71.86 -25.47 74.82 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.027 -0.606 . . . . 10.0 113.091 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -76.21 -17.81 79.74 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.275 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -74.01 160.35 81.94 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.903 -0.406 . . . . 10.0 109.903 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.82 159.68 40.55 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.404 2.07 . . . . 10.0 110.983 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.07 135.68 53.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.484 -0.326 . . . . 10.0 110.249 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 13.9 t . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.202 -179.842 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' THR . . . . . 0.454 HG22 HG23 ' A' ' 382' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.608 0.242 . . . . 10.0 111.603 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -62.06 -37.77 86.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.954 0.407 . . . . 10.0 110.716 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -67.97 -39.67 83.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.59 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -63.44 -42.65 98.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.859 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -70.31 -32.8 70.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.972 -0.558 . . . . 10.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -75.08 -46.04 37.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.515 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -85.24 13.29 6.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.839 0.352 . . . . 10.0 111.865 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -36.95 85.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.564 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.511 ' O ' ' HE3' ' A' ' 409' ' ' LYS . 75.4 m-85 -136.61 151.47 49.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.151 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -75.36 160.94 29.72 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.157 -0.682 . . . . 10.0 109.157 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 406' ' ' LEU . 2.1 mm? -57.42 -35.35 69.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.889 0.376 . . . . 10.0 110.864 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.23 -35.45 81.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.418 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.05 -36.6 66.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.462 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . 0.511 ' HE3' ' O ' ' A' ' 404' ' ' TYR . 96.5 mttt -71.02 -32.86 69.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.593 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.1 p -81.6 -3.37 53.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.016 0.436 . . . . 10.0 111.564 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 9.5 m -120.6 96.92 5.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.913 0.387 . . . . 10.0 111.216 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 23.6 tp -78.8 117.19 19.68 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 414' ' ' ARG . 6.1 tmm_? -118.44 139.96 50.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.519 -0.31 . . . . 10.0 111.366 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 417' ' ' GLU . 67.9 mtt85 -101.69 158.94 15.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.386 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 9.2 m -72.59 -33.04 66.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.257 0.466 . . . . 10.0 112.257 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -77.29 4.13 11.37 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.221 0.823 . . . . 10.0 113.221 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . 0.491 ' OE2' ' HD2' ' A' ' 414' ' ' ARG . 0.5 OUTLIER -103.52 -3.74 24.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.643 -0.503 . . . . 10.0 109.643 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -84.3 116.33 64.48 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.505 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . 0.493 ' HD3' HD11 ' A' ' 249' ' ' LEU . 33.5 Cg_exo -59.62 -38.42 82.02 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.994 2.463 . . . . 10.0 111.983 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.1 m -60.78 -43.94 97.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.552 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.18 -40.3 84.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.782 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . 0.439 ' NH2' ' HA ' ' A' ' 417' ' ' GLU . 98.9 mtt180 -59.96 -44.93 94.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.673 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.528 ' HB3' ' HE2' ' A' ' 240' ' ' MET . 46.7 tt0 -61.51 -43.98 97.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.421 HD23 HD21 ' A' ' 96' ' ' LEU . 65.3 tp -63.54 -37.93 89.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.193 0.52 . . . . 10.0 111.216 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.3 m-85 -74.87 -59.81 2.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.198 -0.455 . . . . 10.0 111.747 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.85 -14.51 62.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 115.074 1.509 . . . . 10.0 115.074 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.8 18.25 7.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -161.94 -61.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . 0.601 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 92.8 mt -67.68 -40.7 84.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 99.89 -77.48 0.47 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.053 -0.594 . . . . 10.0 111.702 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . 0.6 ' HG2' ' HD2' ' A' ' 432' ' ' PRO . 1.0 OUTLIER -149.16 153.06 37.38 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.368 -0.605 . . . . 10.0 109.368 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.6 ' HD2' ' HG2' ' A' ' 431' ' ' GLU . 60.4 Cg_exo -55.1 134.8 65.81 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.565 2.177 . . . . 10.0 110.953 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.415 HD21 ' HG3' ' A' ' 104' ' ' GLU . 6.9 mp 66.75 13.61 9.45 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.532 0.52 . . . . 10.0 112.206 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 438' ' ' HIS . . . -69.9 -166.91 5.79 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.513 -0.375 . . . . 10.0 112.979 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -59.64 -62.79 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.848 0.314 . . . . 10.0 111.848 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . 0.516 ' HD2' ' HA ' ' A' ' 436' ' ' LYS . 17.7 tptt -63.03 -34.44 77.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.8 0.334 . . . . 10.0 111.497 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -64.55 -42.15 95.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.078 0.466 . . . . 10.0 110.487 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 0.1 OUTLIER -78.89 -9.68 59.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.03 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -93.19 -48.25 6.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.184 -0.462 . . . . 10.0 112.235 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.52 -34.55 9.5 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 113.828 1.047 . . . . 10.0 113.828 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 58.9 mt -90.25 -12.03 39.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 17.0 m-70 -119.19 167.09 12.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.18 -0.208 . . . . 10.0 110.873 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.5 t -156.37 -170.23 3.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.275 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -135.72 158.26 44.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.242 -0.281 . . . . 10.0 110.242 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' TYR . . . . . 0.662 ' HH ' ' HB2' ' A' ' 128' ' ' SER . 56.6 m-85 -117.62 153.64 32.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.724 0.297 . . . . 10.0 111.262 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.75 128.55 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.007 0.432 . . . . 10.0 111.831 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.41 95.36 0.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.983 -0.553 . . . . 10.0 111.348 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 145.35 -33.32 1.58 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.917 -0.658 . . . . 10.0 111.973 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 111.327 -0.709 . . . . 10.0 111.327 -179.599 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.584 0.23 . . . . 10.0 110.406 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 p -73.93 168.43 19.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.695 -0.23 . . . . 10.0 110.424 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -56.68 -37.88 71.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.534 -0.303 . . . . 10.0 111.532 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 212' ' ' ILE . 59.8 t -72.0 -49.68 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.338 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.66 -27.03 68.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 10.0 111.72 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.518 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 54.3 mt-30 -66.2 -13.72 60.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.78 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.13 -32.86 7.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.486 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.05 -34.04 72.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.944 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.04 81.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.529 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -76.44 -38.02 56.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.694 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.2 -33.08 75.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.55 . . . . 10.0 111.613 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.04 -29.16 69.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 90.0 mttt -73.49 128.21 87.58 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.04 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 37' ' ' LYS . 23.8 Cg_exo -65.25 158.34 52.82 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 122.896 2.397 . . . . 10.0 111.767 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -62.84 -20.64 65.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.244 0.461 . . . . 10.0 112.244 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -97.73 15.17 24.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.901 0.334 . . . . 10.0 111.901 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.428 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 8.6 t70 -94.08 130.78 33.26 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.5 -22.9 73.65 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.814 2.343 . . . . 10.0 113.375 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.9 p -93.84 3.13 55.87 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.923 0.392 . . . . 10.0 111.608 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -87.3 129.37 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.02 -0.536 . . . . 10.0 111.209 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -111.22 -176.21 2.9 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.39 111.4 21.72 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.006 -0.368 . . . . 10.0 110.006 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.93 101.13 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.713 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.8 m -96.31 140.29 31.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.888 -0.597 . . . . 10.0 109.784 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 11.1 p -126.23 144.73 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.799 0.333 . . . . 10.0 111.206 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 13.6 pt20 -128.61 129.14 45.49 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.623 HG11 HD21 ' A' ' 75' ' ' LEU . 5.7 t -113.23 150.07 15.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.882 0.373 . . . . 10.0 110.988 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.53 141.26 22.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.989 -0.55 . . . . 10.0 109.76 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.57 -32.09 62.4 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.168 2.579 . . . . 10.0 112.347 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.41 -22.43 66.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.568 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 HG23 ' A' ' 214' ' ' THR . 86.3 t -89.37 -38.54 11.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.202 0.525 . . . . 10.0 109.705 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -57.34 -29.79 64.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.412 -0.813 . . . . 10.0 112.321 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.35 -36.85 13.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.827 0.677 . . . . 10.0 112.827 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.83 -13.99 38.04 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.988 0.736 . . . . 10.0 112.988 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.61 -26.8 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.026 0.38 . . . . 10.0 112.026 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.39 -27.54 66.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.622 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 399' ' ' ARG . 20.7 mt-10 -68.54 -29.53 68.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 10.0 111.382 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.34 -17.42 64.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.979 0.418 . . . . 10.0 110.569 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.7 mt -99.73 -11.8 20.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.585 . . . . 10.0 109.948 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.08 25.13 13.25 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.805 -0.634 . . . . 10.0 112.193 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -110.92 -175.42 2.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.628 0.251 . . . . 10.0 110.443 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.33 149.1 42.11 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.368 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.74 117.54 4.28 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.546 2.164 . . . . 10.0 111.666 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.35 4.02 47.2 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.856 -0.687 . . . . 10.0 113.203 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.0 -29.91 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 10.0 111.259 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -94.02 126.65 39.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.232 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 p -80.62 155.64 73.49 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.784 0.326 . . . . 10.0 111.326 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -41.84 73.23 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.002 2.468 . . . . 10.0 113.023 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -66.95 -34.0 76.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.59 -0.277 . . . . 10.0 111.669 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -66.68 -37.91 85.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.423 . . . . 10.0 110.481 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.623 HD21 HG11 ' A' ' 51' ' ' VAL . 44.9 tp -64.32 -46.82 81.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.072 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.61 85.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.867 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -61.72 -47.35 85.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.135 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.93 -39.87 96.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.924 -0.655 . . . . 10.0 112.449 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 51' ' ' VAL . 19.5 mt -62.28 -43.96 97.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.962 0.411 . . . . 10.0 111.179 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -65.59 -27.36 68.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.012 0.434 . . . . 10.0 110.595 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -77.13 -11.43 59.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 10.0 111.359 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.2 -14.04 57.95 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.79 7.19 24.05 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.236 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -69.71 145.2 52.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.829 0.347 . . . . 10.0 111.231 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.86 -64.4 1.2 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.155 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -119.6 135.4 54.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.621 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.8 t -113.46 110.9 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.529 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 48.6 m-85 -111.05 162.38 14.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.896 0.379 . . . . 10.0 110.983 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -111.0 146.39 36.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 m -65.54 -19.67 66.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.497 -0.319 . . . . 10.0 111.555 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.448 HD21 ' HH ' ' A' ' 404' ' ' TYR . 23.0 mt -57.67 -36.63 72.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.635 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -67.59 -38.08 83.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.171 0.51 . . . . 10.0 109.902 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.33 -36.99 70.55 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.716 -0.954 . . . . 10.0 110.716 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.54 81.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.522 -0.339 . . . . 10.0 110.387 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -36.15 75.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.78 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.21 -41.31 67.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.564 -0.743 . . . . 10.0 109.6 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.3 m -60.72 -44.66 96.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.75 -0.659 . . . . 10.0 110.524 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.7 mt -58.52 -40.37 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 10.0 110.956 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.2 mmm -62.53 -53.11 59.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.286 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -67.28 -40.2 86.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.174 -0.467 . . . . 10.0 111.732 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 101' ' ' GLU . 2.9 tp10 -61.64 -45.91 92.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.894 0.378 . . . . 10.0 110.55 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.58 -35.02 91.23 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.033 -0.827 . . . . 10.0 111.033 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.0 m -70.81 -41.94 70.91 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.584 -0.308 . . . . 10.0 110.62 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -61.93 -47.27 85.63 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.614 -0.513 . . . . 10.0 109.614 178.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.1 -51.48 69.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.998 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.35 -37.63 81.27 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.989 0.423 . . . . 10.0 109.996 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.588 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 26.5 t60 -62.96 -51.6 66.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.407 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.513 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 68.4 mtt180 -62.49 -32.39 73.29 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.416 -0.357 . . . . 10.0 111.308 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.61 -50.58 29.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.407 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 m -58.01 -45.52 86.75 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.697 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 71.9 mm-40 -57.47 -36.83 71.96 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.054 0.454 . . . . 10.0 110.713 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -77.2 -28.51 53.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.509 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.75 -39.21 76.87 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.38 -41.19 69.99 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.323 -0.853 . . . . 10.0 109.965 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-N 115.582 -0.735 . . . . 10.0 111.963 179.625 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.513 ' HB3' ' HG2' ' A' ' 108' ' ' ARG . 1.3 mp0 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.784 0.326 . . . . 10.0 110.475 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.3 -175.06 0.86 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.913 2.408 . . . . 10.0 112.911 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.422 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 95.2 mt -130.21 158.3 74.6 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 123' ' ' LEU . 36.6 Cg_endo -64.27 167.26 42.79 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 124.318 -1.118 . . . . 10.0 113.667 0.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 27.7 ttt -111.87 131.08 55.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.431 -0.804 . . . . 10.0 110.762 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 372' ' ' VAL . 69.7 m-85 -111.14 139.5 46.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.934 -0.576 . . . . 10.0 109.911 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.55 152.32 36.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.643 0.258 . . . . 10.0 110.617 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.9 33.37 5.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.938 0.399 . . . . 10.0 111.266 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 2.8 m -92.53 17.01 10.72 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.725 0.639 . . . . 10.0 112.725 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.456 ' O ' HG12 ' A' ' 134' ' ' ILE . 0.9 OUTLIER -136.3 120.62 12.75 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 112.079 0.399 . . . . 10.0 112.079 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.54 -40.65 45.72 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.093 2.528 . . . . 10.0 112.366 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 376' ' ' ALA . . . -61.17 -40.44 98.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.906 -0.664 . . . . 10.0 111.827 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -65.68 -48.55 71.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.999 -0.371 . . . . 10.0 109.999 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 130' ' ' CYS . 49.7 mm -58.46 -43.24 86.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.812 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.19 -47.09 86.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.461 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 54.8 ttp -68.91 -30.73 69.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.046 0.451 . . . . 10.0 110.534 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.476 HD22 HG21 ' A' ' 148' ' ' VAL . 10.7 tp -68.19 -57.98 5.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.148 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -59.69 -19.7 51.45 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.91 0.708 . . . . 10.0 112.91 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -104.13 -56.55 2.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.754 1.02 . . . . 10.0 113.754 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.1 m -88.67 -28.65 20.46 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.432 1.271 . . . . 10.0 114.432 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.12 66.71 68.62 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.742 0.645 . . . . 10.0 112.742 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.62 -12.41 29.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.197 1.931 . . . . 10.0 111.58 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -88.34 -13.05 41.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.452 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -101.78 2.57 38.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.462 -0.336 . . . . 10.0 111.825 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.489 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 55.5 mt -54.75 -51.44 78.88 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 113.598 0.962 . . . . 10.0 113.598 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 41.5 Cg_exo -58.69 -20.57 51.51 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.39 2.06 . . . . 10.0 113.292 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 325' ' ' LEU . 97.4 m-85 -79.69 -17.12 54.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.226 0.536 . . . . 10.0 111.028 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.476 HG21 HD22 ' A' ' 137' ' ' LEU . 27.9 t -87.86 152.37 3.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.033 -0.53 . . . . 10.0 109.965 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . 0.459 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . 39.7 t -66.27 160.18 24.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.235 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 p -99.85 1.41 42.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.604 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 60.4 m -75.34 138.79 42.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.335 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 36.2 mtpt -80.77 168.63 18.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.456 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.87 148.9 98.42 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.384 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.44 -51.05 10.23 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.332 2.688 . . . . 10.0 113.458 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -34.02 77.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.073 0.397 . . . . 10.0 112.073 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 56.9 mmm -73.74 -23.84 59.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.049 0.452 . . . . 10.0 110.718 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 39.4 mtt -75.46 -47.72 25.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.097 -0.705 . . . . 10.0 109.097 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.5 tp -63.91 -41.63 97.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.751 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.32 85.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.252 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.53 -36.7 63.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.645 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.465 ' HE3' HD22 ' A' ' 424' ' ' LEU . 2.1 tmt? -66.44 -42.73 87.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.816 -0.629 . . . . 10.0 112.024 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.536 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.9 m -69.55 -29.88 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -85.78 1.73 48.46 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.166 0.432 . . . . 10.0 112.166 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.0 p -122.44 -75.93 0.59 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.845 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -62.05 -52.56 63.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.399 . . . . 10.0 111.542 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.536 ' HB3' ' O ' ' A' ' 162' ' ' VAL . 35.9 tp -61.24 -40.74 95.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.513 -0.312 . . . . 10.0 110.997 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.85 76.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.848 0.356 . . . . 10.0 110.667 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -66.47 -34.8 78.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.59 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -75.24 -37.12 61.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.793 0.33 . . . . 10.0 111.781 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.544 ' HB3' HG12 ' A' ' 172' ' ' ILE . 3.1 tttt -79.49 -20.54 47.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.815 0.34 . . . . 10.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 86.32 14.54 66.06 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.056 -0.592 . . . . 10.0 112.785 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.544 HG12 ' HB3' ' A' ' 170' ' ' LYS . 14.0 pt -103.44 168.64 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.785 0.326 . . . . 10.0 111.057 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -100.01 142.55 24.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.038 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 173' ' ' ALA . 35.8 Cg_exo -59.28 -19.93 52.84 Favored 'Trans proline' 0 N--CA 1.473 0.287 0 C-N-CA 122.995 2.464 . . . . 10.0 112.881 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -77.23 -19.49 56.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.199 0.523 . . . . 10.0 110.608 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -100.77 17.86 20.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.583 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 83.6 mtp -124.62 123.53 40.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.332 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.3 t -110.84 120.09 60.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.583 ' HB3' HD12 ' A' ' 208' ' ' LEU . 0.0 OUTLIER -104.21 123.51 47.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.289 0.566 . . . . 10.0 112.21 -178.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 22.5 t -118.69 135.63 58.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.41 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.423 ' OG ' HD21 ' A' ' 208' ' ' LEU . 3.7 p -123.21 139.04 54.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.724 0.297 . . . . 10.0 111.368 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 212' ' ' ILE . 24.1 mm -101.64 102.19 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.946 -0.761 . . . . 10.0 108.946 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 213' ' ' THR . 32.2 mmt -114.08 150.16 43.13 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.05 -0.523 . . . . 10.0 111.54 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.77 17.48 1.52 Allowed 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.854 2.369 . . . . 10.0 112.894 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 97.3 m -149.55 129.46 13.4 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.108 -0.331 . . . . 10.0 110.108 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -30.07 70.02 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -64.15 -9.55 17.42 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.649 0.611 . . . . 10.0 112.649 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.458 ' HZ1' ' CD ' ' A' ' 191' ' ' GLU . 25.0 mmtt -66.97 -28.2 68.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.349 . . . . 10.0 110.921 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -68.02 -36.75 80.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 10.0 109.989 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -32.56 67.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.815 -0.629 . . . . 10.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.458 ' CD ' ' HZ1' ' A' ' 188' ' ' LYS . 12.0 tt0 -70.63 -41.13 72.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.753 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -75.12 -30.17 60.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.665 -0.698 . . . . 10.0 112.781 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -80.87 70.81 7.75 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.454 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 56.0 mtt180 -115.32 148.4 39.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.434 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -48.93 -63.03 1.22 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.637 0.977 . . . . 10.0 113.637 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -66.97 -2.2 5.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.349 1.24 . . . . 10.0 114.349 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 194' ' ' ARG . 2.6 m-30 -82.22 61.98 5.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.379 0.609 . . . . 10.0 111.599 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 12.1 p -113.15 168.94 9.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 10.0 110.396 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 22.4 t -80.66 83.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.221 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.037 -0.983 . . . . 10.0 111.311 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.758 ' C ' ' H ' ' A' ' 205' ' ' LEU . 7.8 p . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.673 -0.491 . . . . 10.0 109.673 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.796 ' C ' ' CB ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.228 -0.052 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -88.1 144.73 26.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.272 -0.27 . . . . 10.0 110.272 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -67.52 -40.67 85.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.242 0.544 . . . . 10.0 109.535 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' A' ' 179' ' ' MET . 29.5 tp -126.24 137.49 53.53 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.375 -1.343 . . . . 10.0 107.375 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -99.24 -57.89 2.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.47 0.915 . . . . 10.0 113.47 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.518 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 12.6 m-70 -134.32 153.15 52.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.028 0.751 . . . . 10.0 113.028 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 46.0 t -126.72 131.76 70.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.557 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 71.3 mt -122.42 139.52 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 183' ' ' MET . 43.2 p -91.98 167.2 12.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.809 0.3 . . . . 10.0 111.809 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.522 HG23 HG13 ' A' ' 55' ' ' VAL . 2.7 m -52.64 -52.92 53.45 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.003 -0.544 . . . . 10.0 112.077 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.0 m -57.87 -36.19 54.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 220' ' ' ILE . 50.1 mt-10 -73.33 -45.3 56.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.58 -0.282 . . . . 10.0 111.027 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.59 -45.52 92.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.86 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.98 -30.94 78.99 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.931 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -67.97 -41.76 81.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 216' ' ' GLU . 61.7 mt -58.8 -42.77 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.228 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -62.57 -44.74 95.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.554 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -67.51 -43.94 79.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 10.0 111.955 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.71 -23.84 66.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 10.0 111.299 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -94.33 -3.18 50.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.961 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 68.35 38.99 87.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.931 -0.652 . . . . 10.0 112.189 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 57.4 mt -116.07 110.4 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.834 0.349 . . . . 10.0 110.509 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -96.61 113.71 25.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.966 -0.383 . . . . 10.0 109.966 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.616 HD23 HD12 ' A' ' 231' ' ' LEU . 38.6 mt -59.1 -28.97 67.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.807 -0.633 . . . . 10.0 112.183 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.27 -18.46 63.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.6 -0.273 . . . . 10.0 111.569 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -111.26 20.75 17.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.968 0.413 . . . . 10.0 110.974 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.616 HD12 HD23 ' A' ' 228' ' ' LEU . 56.7 mt -104.39 150.92 38.98 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.936 -0.575 . . . . 10.0 110.274 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.47 172.01 16.98 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.284 1.989 . . . . 10.0 111.576 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.8 102.32 11.51 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.642 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -83.48 -154.64 18.05 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.005 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.85 156.99 43.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 10.0 110.716 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -92.66 -174.7 3.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.685 -0.688 . . . . 10.0 110.254 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.5 147.47 42.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.892 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -93.41 120.19 66.72 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.158 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.06 -15.36 47.42 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.133 2.556 . . . . 10.0 112.315 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.588 ' HE2' ' HB3' ' A' ' 423' ' ' GLU . 86.9 mmm -78.64 0.65 25.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 10.0 111.465 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 103.27 -70.06 0.29 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.135 -0.555 . . . . 10.0 112.774 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.44 169.65 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.901 0.382 . . . . 10.0 111.578 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 104.43 136.5 8.84 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.619 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.2 m -80.2 130.35 35.15 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.178 -0.305 . . . . 10.0 110.178 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 120.06 179.72 16.45 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.228 -0.749 . . . . 10.0 111.228 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.25 -2.18 50.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.847 0.356 . . . . 10.0 111.277 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.86 4.03 79.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.18 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.93 118.68 53.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 30.2 mt -75.51 149.95 38.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.384 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.33 106.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.057 0.456 . . . . 10.0 111.153 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 164.84 127.11 0.86 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.078 -0.809 . . . . 10.0 111.078 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 11.2 t -75.18 148.19 39.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.169 0.509 . . . . 10.0 111.562 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.34 -9.46 25.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.657 -0.701 . . . . 10.0 109.497 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.425 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 89.68 -32.22 4.89 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.687 -0.688 . . . . 10.0 112.47 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 151.69 170.31 18.29 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.365 -1.094 . . . . 10.0 110.365 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.86 -55.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.541 0.67 . . . . 10.0 110.406 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' MET . . . . . 0.536 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 23.5 ttp -59.4 -48.28 82.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.406 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.425 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 36.5 tt0 -61.34 -46.19 91.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 10.0 112.138 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.84 81.96 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 121.046 -0.261 . . . . 10.0 111.167 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.74 -47.46 72.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 257' ' ' MET . 90.1 mt -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.826 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.46 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 45.6 ttm105 -58.95 -48.37 81.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.051 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 87.0 m -55.52 -43.32 75.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 10.0 111.546 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.84 -43.93 57.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.849 0.357 . . . . 10.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' TYR . . . . . 0.505 ' HD1' ' HG2' ' A' ' 294' ' ' MET . 84.0 t80 -62.07 -46.09 90.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.079 -0.509 . . . . 10.0 112.063 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 262' ' ' ARG . 52.3 mt-10 -64.98 -23.18 67.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.565 0.579 . . . . 10.0 112.565 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 73.4 mt -90.18 -35.07 15.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.103 0.478 . . . . 10.0 110.467 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -72.62 -43.09 63.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.678 -0.692 . . . . 10.0 111.604 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 70.1 p -96.38 -33.53 11.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.164 -0.471 . . . . 10.0 112.191 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 85.31 9.15 80.15 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.789 -0.925 . . . . 10.0 110.789 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 70.9 p -112.69 146.13 34.41 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.698 -0.251 . . . . 10.0 110.775 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.99 131.69 21.42 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.501 2.134 . . . . 10.0 111.9 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.46 ' HB3' ' HG3' ' A' ' 262' ' ' ARG . 46.9 tp -103.99 121.47 47.71 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.069 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 273' ' ' LEU . 4.5 Cg_exo -76.55 -156.21 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.191 2.594 . . . . 10.0 111.774 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -78.4 141.21 38.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.484 -0.325 . . . . 10.0 110.618 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 95.6 mt -89.81 141.61 28.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 1.5 m -106.59 105.35 15.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.582 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 288' ' ' LYS . 3.4 mm? -77.98 113.94 16.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.823 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.5 m -89.86 152.52 21.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.272 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -79.75 123.63 27.86 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.51 112.7 5.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.074 0.464 . . . . 10.0 110.643 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 16.0 ttm-85 -66.97 108.35 2.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.602 -0.726 . . . . 10.0 110.353 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 123.5 -18.69 7.68 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.006 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' MET . . . . . 0.482 ' SD ' ' HD2' ' A' ' 361' ' ' LYS . 56.4 mtm -139.98 102.54 4.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.012 0.434 . . . . 10.0 110.609 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.71 138.81 48.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.264 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.83 -13.5 67.04 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.587 -0.733 . . . . 10.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 21.7 mm -99.44 127.81 51.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.018 0.437 . . . . 10.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 278' ' ' LEU . 33.6 mmtt -115.62 157.57 23.98 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.11 159.66 44.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.249 0.547 . . . . 10.0 112.371 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 9.1 t -155.99 152.21 27.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.254 -0.885 . . . . 10.0 109.257 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -128.32 123.41 33.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.808 0.337 . . . . 10.0 110.649 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.91 118.41 58.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.913 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.54 97.75 3.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.044 0.449 . . . . 10.0 110.588 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' MET . . . . . 0.505 ' HG2' ' HD1' ' A' ' 265' ' ' TYR . 81.7 mtp -87.1 113.26 22.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.108 -0.497 . . . . 10.0 111.449 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 36.3 t -112.34 120.42 41.52 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.7 135.57 61.08 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.891 2.394 . . . . 10.0 112.782 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . . . -66.97 132.06 93.84 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.779 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 297' ' ' ALA . 38.8 Cg_exo -59.04 114.13 1.88 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.954 2.436 . . . . 10.0 112.286 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.52 -12.1 39.3 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.681 -0.771 . . . . 10.0 113.123 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 97.0 p -84.33 162.53 20.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.885 0.374 . . . . 10.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -64.5 -26.11 68.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.231 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -64.27 -40.0 95.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.317 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -72.48 -46.05 56.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 10.0 109.901 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 2.2 tm-20 -57.28 -46.63 82.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.395 -0.821 . . . . 10.0 111.324 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.15 -53.51 54.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 10.0 112.008 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.5 tt -60.13 -38.5 83.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.315 -0.402 . . . . 10.0 111.804 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -75.65 -33.31 60.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.563 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' HIS . . . . . 0.525 ' HB2' ' O ' ' A' ' 304' ' ' GLU . 0.7 OUTLIER -75.46 -47.52 26.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.78 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -123.33 100.85 7.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.182 0.515 . . . . 10.0 112.073 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -110.19 -1.48 17.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.473 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.365 -0.826 . . . . 10.0 110.529 -179.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.299 -0.721 . . . . 10.0 111.299 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.63 -31.33 94.18 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.838 2.359 . . . . 10.0 112.415 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.411 ' HB2' ' CE1' ' A' ' 147' ' ' TYR . 85.1 mt -109.11 110.95 22.33 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -94.84 120.62 35.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.565 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -67.54 131.98 46.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.779 -0.452 . . . . 10.0 109.779 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.08 -1.71 37.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.609 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 103.26 -6.39 50.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.868 -0.682 . . . . 10.0 111.593 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' GLY . . . . . 0.416 ' HA2' ' NH2' ' A' ' 345' ' ' ARG . . . 92.23 153.86 30.34 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.77 -0.728 . . . . 10.0 111.721 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.5 82.43 8.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.057 0.456 . . . . 10.0 110.182 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -98.29 155.16 20.23 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.8 -0.714 . . . . 10.0 112.938 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -142.76 160.18 40.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.984 -0.376 . . . . 10.0 109.984 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.8 t -141.38 142.59 33.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.91 0.386 . . . . 10.0 110.49 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.44 169.58 8.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.463 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.92 23.88 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 10.0 112.063 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -111.77 -7.85 14.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.276 0.56 . . . . 10.0 109.806 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 102.6 -8.88 55.23 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.728 . . . . 10.0 112.373 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -100.95 176.81 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.054 0.454 . . . . 10.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -173.68 -175.44 41.38 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.922 -0.871 . . . . 10.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -167.65 -173.28 35.61 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.949 -0.643 . . . . 10.0 111.553 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ILE . . . . . 0.427 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 7.9 tt -136.8 131.02 46.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.71 0.291 . . . . 10.0 110.581 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.6 t -90.9 106.87 18.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.103 0.478 . . . . 10.0 110.507 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 25.0 tp -64.07 115.49 4.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.527 -0.76 . . . . 10.0 110.577 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ARG . . . . . 0.428 ' HB3' ' CD1' ' A' ' 369' ' ' TYR . 60.5 mtm180 -86.62 105.23 16.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.86 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.74 130.57 59.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.015 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 372' ' ' VAL . . . -126.87 139.18 53.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.307 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.61 114.16 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.797 -0.446 . . . . 10.0 109.797 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.5 ' HB3' HG12 ' A' ' 374' ' ' ILE . . . -98.59 105.08 17.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.496 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -95.99 108.62 21.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.49 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 112.04 126.06 4.67 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.708 -0.957 . . . . 10.0 110.708 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 43.6 mt -59.17 -37.49 77.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.889 0.376 . . . . 10.0 111.478 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -68.99 -26.56 74.61 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.636 -0.793 . . . . 10.0 111.703 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.812 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 93.3 m-20 -84.75 -40.36 17.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.924 0.392 . . . . 10.0 110.007 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.8 94.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.383 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -55.9 -39.56 71.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.434 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.812 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 9.4 mtmm -70.79 -42.82 69.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.511 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.83 -46.86 85.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 10.0 110.974 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 97.7 mt -56.73 -45.5 82.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.562 . . . . 10.0 110.905 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 22.0 m -60.59 -45.27 94.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.7 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.482 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 36.6 mttm -66.02 -32.76 74.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.325 -0.398 . . . . 10.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 367' ' ' ALA . 87.3 mtp -68.49 -42.99 77.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.026 0.441 . . . . 10.0 110.042 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -69.1 -24.41 64.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.003 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -86.0 -7.88 58.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.044 -0.526 . . . . 10.0 111.064 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 81.2 13.95 79.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.789 -0.719 . . . . 10.0 112.949 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -77.64 -37.83 49.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.228 0.537 . . . . 10.0 110.056 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 362' ' ' MET . . . -135.14 126.06 27.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.583 -0.735 . . . . 10.0 109.388 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -119.94 125.76 49.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.81 0.338 . . . . 10.0 110.977 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' A' ' 345' ' ' ARG . 72.7 m-85 -134.92 158.71 43.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.824 -0.625 . . . . 10.0 109.596 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -97.3 -36.56 10.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.027 0.441 . . . . 10.0 111.248 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . 0.536 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 26.8 t80 -125.56 126.95 45.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.57 -0.529 . . . . 10.0 109.57 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 347' ' ' ALA . 25.3 t -130.3 118.76 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.02 0.438 . . . . 10.0 111.882 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.19 129.84 44.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.985 -1.117 . . . . 10.0 107.985 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 349' ' ' ALA . 59.3 mt -121.37 125.26 73.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.241 0.543 . . . . 10.0 112.076 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' MET . . . . . 0.408 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 13.0 mmt -115.17 145.96 41.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.591 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' ALA . . . . . 0.454 ' HB2' ' HA3' ' A' ' 132' ' ' GLY . . . . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 120.758 0.313 . . . . 10.0 111.122 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.93 0.395 . . . . 10.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -116.61 25.23 9.19 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.989 -0.624 . . . . 10.0 111.972 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -65.7 168.72 31.34 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.248 -0.501 . . . . 10.0 112.896 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -69.24 -24.31 76.02 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.089 -0.577 . . . . 10.0 113.677 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -85.71 -6.13 83.34 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.648 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -82.76 155.31 68.22 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.74 164.69 33.56 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.428 2.085 . . . . 10.0 110.803 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ARG . . . . . 0.521 ' HB2' ' HE ' ' A' ' 389' ' ' ARG . 0.0 OUTLIER -128.66 121.95 29.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.231 0.539 . . . . 10.0 111.619 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.694 . . . . 10.0 110.003 179.809 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 121.31 0.576 . . . . 10.0 110.204 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -67.87 -36.61 80.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.507 -0.77 . . . . 10.0 110.667 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -61.54 -43.03 99.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.636 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 61' ' ' GLU . 99.0 mtt180 -68.39 -41.55 80.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.715 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -64.1 -39.48 94.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.923 -0.58 . . . . 10.0 111.344 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -70.88 -24.52 62.51 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.248 0.462 . . . . 10.0 112.248 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -101.54 14.39 32.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.579 0.585 . . . . 10.0 112.579 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.09 -38.33 85.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.138 0.494 . . . . 10.0 110.775 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' TYR . . . . . 0.501 ' O ' ' HE3' ' A' ' 409' ' ' LYS . 83.4 m-85 -136.14 153.83 51.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.536 -0.756 . . . . 10.0 109.318 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -82.79 165.65 19.68 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.657 -0.498 . . . . 10.0 109.657 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.22 -33.86 59.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.692 0.282 . . . . 10.0 111.641 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -63.6 -54.47 35.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.796 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.43 -33.45 75.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.624 . . . . 10.0 111.411 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 404' ' ' TYR . 95.9 mttt -67.46 -30.18 69.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.662 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 6.1 p -94.17 8.09 42.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.961 0.41 . . . . 10.0 111.312 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 6.3 m -122.08 101.78 7.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.611 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 21.0 tp -83.46 122.36 28.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.176 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 40.9 ttp85 -123.58 148.68 46.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.828 0.347 . . . . 10.0 111.306 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ARG . . . . . 0.431 ' HD3' ' OE2' ' A' ' 417' ' ' GLU . 1.2 mpt_? -116.33 136.38 53.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.408 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.7 m -62.91 -29.37 70.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.319 0.488 . . . . 10.0 112.319 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -73.0 4.93 3.7 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.524 0.565 . . . . 10.0 112.524 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' GLU . . . . . 0.431 ' OE2' ' HD3' ' A' ' 414' ' ' ARG . 20.4 mt-10 -122.81 13.81 9.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.481 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -88.27 117.08 67.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.186 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.67 -35.16 92.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.233 2.622 . . . . 10.0 112.558 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 50.2 m -70.81 -38.66 73.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.893 0.378 . . . . 10.0 110.907 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.26 -42.85 78.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.399 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -61.93 -35.64 79.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.98 -0.555 . . . . 10.0 111.41 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' GLU . . . . . 0.588 ' HB3' ' HE2' ' A' ' 240' ' ' MET . 3.1 tp10 -64.21 -49.84 70.42 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.095 0.474 . . . . 10.0 110.006 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' LEU . . . . . 0.465 HD22 ' HE3' ' A' ' 161' ' ' MET . 61.2 tp -62.54 -38.78 91.35 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . 0.756 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.4 m-85 -74.24 -11.3 60.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.031 -0.531 . . . . 10.0 111.549 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -97.56 -52.74 3.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.182 0.808 . . . . 10.0 113.182 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.06 17.54 18.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.639 1.348 . . . . 10.0 114.639 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -155.63 -63.82 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.107 0.78 . . . . 10.0 113.107 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' LEU . . . . . 0.756 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 67.9 mt -67.38 -50.69 58.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.877 0.695 . . . . 10.0 112.877 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 92.65 -132.66 11.36 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.556 -0.831 . . . . 10.0 111.512 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 24.2 mm-40 -86.5 144.79 38.33 Favored Pre-proline 0 C--N 1.318 -0.769 0 O-C-N 122.662 -0.316 . . . . 10.0 110.698 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 431' ' ' GLU . 44.8 Cg_exo -58.89 147.06 91.13 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.941 2.427 . . . . 10.0 111.264 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 3.5 mp 62.74 17.85 10.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.515 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -76.35 -176.57 42.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.085 -0.579 . . . . 10.0 112.44 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -60.85 -51.8 67.76 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.394 0.278 . . . . 10.0 111.736 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -38.98 93.29 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.847 0.356 . . . . 10.0 110.781 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.42 75.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.986 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' HIS . . . . . 0.653 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 2.5 t-160 -68.81 -31.03 69.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.069 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.1 -40.9 17.7 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.6 mt -96.31 -42.81 7.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 114.577 1.325 . . . . 10.0 114.577 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.58 -17.81 21.99 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.653 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 39.2 m-70 -114.57 171.24 7.75 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.245 -0.285 . . . . 10.0 110.644 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.9 t -162.89 -175.75 4.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.526 0.203 . . . . 10.0 111.058 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -129.89 157.82 41.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.527 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.87 164.19 13.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.35 -0.387 . . . . 10.0 110.187 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 95.1 t -120.87 109.37 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.118 0.485 . . . . 10.0 111.792 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -65.89 115.45 6.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.054 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 122.33 -15.36 8.71 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.34 -0.704 . . . . 10.0 111.34 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 C-N-CA 120.869 -0.682 . . . . 10.0 112.136 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.921 -0.4 . . . . 10.0 109.921 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m -69.53 155.04 41.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.572 -0.286 . . . . 10.0 110.271 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -60.29 -31.84 70.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.646 -0.252 . . . . 10.0 111.202 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.551 HG22 HG12 ' A' ' 212' ' ' ILE . 93.7 t -66.83 -45.07 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.939 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -62.83 -36.6 83.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.616 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -59.83 -34.68 73.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -69.87 -40.85 75.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.082 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.76 -28.32 69.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.63 -0.714 . . . . 10.0 111.055 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.38 80.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.861 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -70.65 -35.35 72.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.678 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 91.0 mt -66.51 -32.32 73.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.161 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.09 -25.3 66.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.19 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -72.91 136.37 79.97 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.258 -0.428 . . . . 10.0 109.94 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.95 152.7 28.28 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.991 2.461 . . . . 10.0 111.98 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -61.44 -35.28 77.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.303 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.52 14.53 24.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.074 -0.512 . . . . 10.0 112.239 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 44' ' ' ARG . 14.4 t70 -68.35 134.88 91.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.393 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.39 -22.78 67.37 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.271 2.647 . . . . 10.0 113.998 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.3 4.56 24.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 10.0 111.265 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 6.4 tpt180 -82.38 130.47 35.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.516 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 176' ' ' ASP . 18.9 mttp -108.69 178.21 4.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.802 -0.636 . . . . 10.0 109.655 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.16 117.17 23.31 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 t -102.94 102.58 13.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.247 0.546 . . . . 10.0 111.066 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 179' ' ' MET . 2.8 m -97.95 144.24 27.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.531 -0.758 . . . . 10.0 109.295 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 13.7 p -130.66 141.9 45.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.828 0.347 . . . . 10.0 111.52 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 21.7 pt20 -121.86 126.93 49.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 10.0 109.933 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.696 HG11 HD21 ' A' ' 75' ' ' LEU . 3.0 t -110.27 155.4 11.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.581 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.02 144.7 29.28 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.544 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.72 -33.67 88.38 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.937 2.424 . . . . 10.0 111.944 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.3 67.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.643 HG13 HG23 ' A' ' 214' ' ' THR . 98.5 t -85.49 -39.95 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.058 0.456 . . . . 10.0 109.779 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -57.44 -31.72 66.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.697 -0.683 . . . . 10.0 112.284 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.56 -39.21 16.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.992 0.738 . . . . 10.0 112.992 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.18 -14.3 38.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.416 0.895 . . . . 10.0 113.416 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 tp -58.83 -24.04 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 112.046 0.387 . . . . 10.0 112.046 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.44 -33.27 73.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 10.0 111.342 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -65.34 -29.8 70.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 10.0 111.195 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.41 -17.51 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.96 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.5 mt -105.62 3.02 28.72 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.385 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.66 41.56 15.36 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.051 -0.595 . . . . 10.0 112.094 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.4 mt -125.51 178.88 5.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.767 0.318 . . . . 10.0 110.527 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.77 144.14 55.4 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.792 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.45 119.92 7.47 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.726 2.284 . . . . 10.0 111.672 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.67 0.74 56.48 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 10.0 113.348 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.62 75.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.966 0.383 . . . . 10.0 111.234 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.39 126.3 31.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.676 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.7 p -81.98 156.81 69.52 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.359 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.53 -34.82 92.25 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.237 1.958 . . . . 10.0 110.875 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -68.24 -41.24 81.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.805 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -61.72 -41.74 98.02 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.036 0.446 . . . . 10.0 110.528 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.696 HD21 HG11 ' A' ' 51' ' ' VAL . 48.7 tp -62.08 -48.43 80.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.543 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.2 94.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.004 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.505 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 36.7 tp10 -61.52 -42.91 99.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.239 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.07 -44.62 91.0 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.01 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.2 mt -62.1 -42.85 99.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.894 0.378 . . . . 10.0 111.206 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -62.99 -31.72 72.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.955 0.407 . . . . 10.0 110.808 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' A' ' 81' ' ' ARG . 57.4 mtt-85 -81.44 -9.35 59.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.62 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.6 mt -78.72 -15.3 58.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.428 . . . . 10.0 110.252 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.44 -1.48 11.35 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.478 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -66.64 159.44 27.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.338 . . . . 10.0 111.066 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -104.57 -44.52 4.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.466 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -130.67 131.88 45.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.302 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.68 112.71 40.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.638 0.256 . . . . 10.0 110.872 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 33.7 m-85 -114.52 166.52 11.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.436 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -114.92 148.17 39.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.218 -0.446 . . . . 10.0 109.821 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 m -64.67 -20.81 66.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.671 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.1 -36.32 68.03 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.777 0.288 . . . . 10.0 111.777 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -67.01 -40.5 87.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.141 0.496 . . . . 10.0 109.973 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.84 -36.27 81.64 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.941 -0.864 . . . . 10.0 110.941 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.62 -35.06 79.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.731 0.301 . . . . 10.0 110.474 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -33.53 71.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.872 -0.604 . . . . 10.0 109.873 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.589 HD21 HD23 ' A' ' 424' ' ' LEU . 85.9 mt -75.41 -41.27 56.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.692 -0.685 . . . . 10.0 110.032 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.4 m -59.93 -44.02 94.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.582 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.461 HG12 ' HB3' ' A' ' 259' ' ' ALA . 30.9 mt -57.35 -40.99 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.816 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 92.8 mmm -68.71 -51.01 46.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.319 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' OE2' ' HA ' ' A' ' 432' ' ' PRO . 64.1 mm-40 -64.14 -53.67 45.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.64 -39.39 91.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.357 . . . . 10.0 110.549 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.08 99.65 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.845 -0.693 . . . . 10.0 111.378 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.3 m -67.64 -40.44 84.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.518 0.199 . . . . 10.0 110.795 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 9.7 tt0 -65.04 -39.22 93.01 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.579 -0.526 . . . . 10.0 109.579 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 tp -63.88 -49.04 74.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.892 178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.5 tp -59.95 -38.53 82.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.939 -0.573 . . . . 10.0 109.745 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -61.26 -49.36 77.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.972 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.467 ' HG2' ' HG2' ' A' ' 121' ' ' GLU . 40.2 mtt180 -59.03 -38.7 79.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.28 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.43 -56.19 8.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.338 -0.392 . . . . 10.0 111.232 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.6 m -55.52 -43.68 75.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 10.0 112.039 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -61.88 -35.37 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.886 0.328 . . . . 10.0 111.886 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -71.83 -28.6 63.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 10.0 110.258 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.587 ' O ' ' HD2' ' A' ' 309' ' ' ARG . 73.5 mt -83.54 -12.92 55.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.286 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.72 ' HA ' ' NH1' ' A' ' 309' ' ' ARG . 4.3 mm-40 -91.38 -42.69 10.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.909 -0.587 . . . . 10.0 109.483 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.021 -0.99 . . . . 10.0 111.012 179.853 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.467 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.352 0.596 . . . . 10.0 111.437 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -85.37 -160.71 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.822 2.348 . . . . 10.0 112.822 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 124' ' ' PRO . 82.7 mt -131.29 162.64 54.66 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.654 -0.869 . . . . 10.0 108.654 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 16.7 Cg_exo -68.8 169.76 57.46 Favored 'Cis proline' 0 C--N 1.347 0.458 0 C-N-CA 124.381 -1.091 . . . . 10.0 113.015 0.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 27.1 ttt -113.58 132.98 55.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.375 -0.829 . . . . 10.0 110.217 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.531 ' HD1' ' HB ' ' A' ' 372' ' ' VAL . 33.7 m-85 -111.73 145.79 38.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.174 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.03 140.73 40.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.695 0.622 . . . . 10.0 110.126 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.688 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -103.73 17.01 25.03 Favored 'General case' 0 CA--C 1.537 0.479 1 N-CA-C 130.104 7.075 . . . . 10.0 130.104 -179.214 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.416 ' O ' ' HD3' ' A' ' 131' ' ' PRO . 68.1 m -81.33 -31.01 33.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 112.142 -2.299 . . . . 10.0 114.393 -166.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 375' ' ' MET . 48.7 m -82.36 124.49 78.09 Favored Pre-proline 0 C--N 1.401 2.835 3 O-C-N 142.034 12.084 . . . . 10.0 113.466 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 129' ' ' CYS . 37.7 Cg_endo -68.54 -23.15 37.43 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.138 2.559 . . . . 10.0 112.246 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.97 -32.91 56.15 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 -73.75 -45.36 52.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.46 -0.37 . . . . 10.0 111.04 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.688 HD11 ' O ' ' A' ' 128' ' ' SER . 97.1 mt -58.57 -35.15 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.101 0.408 . . . . 10.0 112.101 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.97 -35.09 80.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.228 0.537 . . . . 10.0 110.531 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 34.9 ttm -70.12 -40.56 74.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 10.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.914 HD22 HG21 ' A' ' 148' ' ' VAL . 2.5 pp -75.21 -11.98 60.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.868 0.366 . . . . 10.0 111.742 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -96.78 -31.44 12.63 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -108.77 -41.66 4.71 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.634 0.976 . . . . 10.0 113.634 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.2 m -90.75 -44.73 9.27 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.314 0.857 . . . . 10.0 113.314 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -127.59 71.92 77.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 112.025 0.38 . . . . 10.0 112.025 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 73.2 Cg_endo -75.22 11.25 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.55 2.167 . . . . 10.0 112.662 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.98 -7.77 29.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.201 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.5 mt -106.39 14.93 26.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.77 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.593 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 76.9 mt -55.05 -54.72 47.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 113.267 0.84 . . . . 10.0 113.267 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 17.4 Cg_exo -68.06 -9.98 27.44 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.451 2.101 . . . . 10.0 113.009 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 125' ' ' MET . 49.3 m-85 -82.53 -25.08 33.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.131 0.491 . . . . 10.0 110.914 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.914 HG21 HD22 ' A' ' 137' ' ' LEU . 2.7 t -88.53 156.76 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.152 -0.476 . . . . 10.0 109.759 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 t -70.66 154.19 42.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.337 . . . . 10.0 110.923 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 96.3 p -96.77 3.9 52.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.088 0.471 . . . . 10.0 110.304 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.9 m -76.0 144.9 40.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.153 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.432 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 30.4 mtpt -86.01 164.76 17.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.944 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.439 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 0.1 OUTLIER -69.66 152.7 96.12 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.466 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.17 -53.84 5.39 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.802 3.001 . . . . 10.0 113.884 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.439 ' OE1' ' HB2' ' A' ' 153' ' ' SER . 0.0 OUTLIER -62.13 -37.73 86.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 10.0 111.669 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.559 ' HE2' ' HD2' ' A' ' 197' ' ' PHE . 67.1 mmm -73.14 -23.53 60.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.319 -0.401 . . . . 10.0 111.189 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 40.0 mtt -76.87 -50.1 14.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.3 tp -61.65 -42.53 99.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.46 -0.791 . . . . 10.0 110.844 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.52 ' HA ' ' SD ' ' A' ' 179' ' ' MET . . . -59.47 -40.79 88.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.045 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.47 -35.54 68.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.496 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 3.2 ttt -66.9 -44.66 80.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.675 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 33.0 m -69.52 -30.86 46.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.314 0.487 . . . . 10.0 112.314 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -85.9 6.96 25.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.14 0.422 . . . . 10.0 112.14 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.4 p -129.85 -81.28 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.403 -0.362 . . . . 10.0 110.466 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.578 ' HE2' ' HA ' ' A' ' 240' ' ' MET . 11.3 t80 -56.29 -49.37 74.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.481 . . . . 10.0 111.472 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.656 HD11 ' HE3' ' A' ' 170' ' ' LYS . 41.8 tp -65.93 -39.43 90.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.989 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.63 88.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.512 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.51 -42.38 82.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.912 -0.586 . . . . 10.0 111.107 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -65.98 -46.84 76.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.847 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.656 ' HE3' HD11 ' A' ' 166' ' ' LEU . 72.9 mttt -73.73 -27.15 61.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.702 0.287 . . . . 10.0 111.277 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 88.2 44.0 5.45 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.749 -0.739 . . . . 10.0 112.227 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 21.4 mt -126.8 145.11 34.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -74.9 142.38 76.43 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 110.074 -0.343 . . . . 10.0 110.074 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.456 ' HB2' HD13 ' A' ' 205' ' ' LEU . 45.1 Cg_exo -57.78 -22.07 51.41 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.996 2.464 . . . . 10.0 112.978 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.33 -12.7 56.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.977 0.417 . . . . 10.0 111.485 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 59.3 m-20 -101.36 11.41 39.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.181 0.515 . . . . 10.0 109.74 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 95.4 mtp -122.69 118.84 29.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.899 -0.592 . . . . 10.0 111.263 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.31 133.32 58.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.057 -1.09 . . . . 10.0 108.057 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.52 ' SD ' ' HA ' ' A' ' 159' ' ' ALA . 9.6 ttt -123.0 134.56 54.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.565 0.698 . . . . 10.0 112.805 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 20.8 t -117.84 151.6 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.3 p -135.96 141.68 44.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.721 0.296 . . . . 10.0 110.602 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.532 ' HB ' HG13 ' A' ' 51' ' ' VAL . 16.7 mm -105.04 106.6 20.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.508 ' O ' ' HA ' ' A' ' 213' ' ' THR . 31.0 mmt -117.4 146.9 39.47 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.227 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.11 15.55 2.19 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.748 2.299 . . . . 10.0 112.705 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 20.8 m -141.28 138.54 33.26 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.978 0.362 . . . . 10.0 111.978 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -30.99 69.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.675 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -65.3 -14.23 60.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.946 -0.57 . . . . 10.0 112.452 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 188' ' ' LYS . 59.2 mmtt -70.07 -27.31 64.52 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.903 0.334 . . . . 10.0 111.903 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -67.26 -44.33 79.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.576 -0.527 . . . . 10.0 109.576 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m -64.09 -29.1 70.26 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.039 0.447 . . . . 10.0 110.246 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.67 -44.86 80.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 208' ' ' LEU . . . -78.36 -12.42 60.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.745 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.42 2.09 51.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.792 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 194' ' ' ARG . 58.4 mtt-85 -64.62 119.43 10.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.691 0.282 . . . . 10.0 110.691 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -38.05 -60.27 0.77 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.271 1.582 . . . . 10.0 115.271 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -66.77 -2.06 4.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 115.012 1.486 . . . . 10.0 115.012 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.559 ' HD2' ' HE2' ' A' ' 156' ' ' MET . 6.2 m-85 -86.71 55.65 3.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.355 0.598 . . . . 10.0 109.848 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.17 169.43 8.74 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.591 -0.732 . . . . 10.0 111.538 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.05 143.15 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.037 -0.982 . . . . 10.0 110.28 -179.786 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.763 ' C ' ' H ' ' A' ' 205' ' ' LEU . 11.5 m . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 120.925 0.393 . . . . 10.0 110.984 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.806 ' C ' ' CB ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.228 -0.075 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -92.48 140.4 29.61 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.436 -0.209 . . . . 10.0 110.436 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 197' ' ' PHE . 56.4 mt-30 -69.6 -41.04 76.28 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.507 ' HB3' ' HB1' ' A' ' 192' ' ' ALA . 13.0 tp -128.52 115.86 18.78 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.62 -47.25 8.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.304 1.224 . . . . 10.0 114.304 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -132.65 143.46 49.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.085 0.772 . . . . 10.0 113.085 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.5 t -126.25 129.23 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.463 -0.939 . . . . 10.0 108.463 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.551 HG12 HG22 ' A' ' 28' ' ' VAL . 55.6 mt -120.22 141.76 39.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 183' ' ' MET . 60.3 p -90.1 164.04 14.63 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.99 -0.284 . . . . 10.0 111.292 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.643 HG23 HG13 ' A' ' 55' ' ' VAL . 1.8 m -55.5 -47.39 76.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.602 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.43 -43.09 89.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 10.0 112.007 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 220' ' ' ILE . 52.7 mt-10 -67.76 -48.31 66.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.145 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.412 HD22 HG21 ' A' ' 182' ' ' ILE . 31.2 tp -57.98 -46.13 85.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.866 0.365 . . . . 10.0 110.969 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.77 -34.74 89.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.952 -0.567 . . . . 10.0 112.291 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.8 -34.17 69.14 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.838 -0.213 . . . . 10.0 110.821 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 216' ' ' GLU . 90.8 mt -64.66 -42.82 96.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -59.12 -46.39 88.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.381 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -68.85 -29.48 67.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.349 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.29 -36.66 74.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.988 0.423 . . . . 10.0 110.938 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -86.43 -10.82 53.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.178 -0.465 . . . . 10.0 111.428 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.45 40.33 13.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.247 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 53.5 mt -120.57 107.88 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.829 0.347 . . . . 10.0 110.325 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -93.28 118.08 30.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.647 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.65 HD23 HD12 ' A' ' 231' ' ' LEU . 85.1 mt -61.43 -30.34 70.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 10.0 111.628 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.85 -5.55 38.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.165 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.19 27.39 7.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.576 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.65 HD12 HD23 ' A' ' 228' ' ' LEU . 77.9 mt -115.34 148.34 40.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.101 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.14 172.93 15.41 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.487 2.125 . . . . 10.0 111.595 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.81 101.72 4.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.399 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 77' ' ' GLU . . . -75.44 -148.83 2.09 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 116.005 -0.543 . . . . 10.0 112.745 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -152.07 154.99 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.853 0.358 . . . . 10.0 111.418 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -100.09 161.82 13.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.75 -0.659 . . . . 10.0 109.966 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -101.75 150.11 23.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -95.03 119.5 65.76 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.378 -0.373 . . . . 10.0 110.05 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.04 -15.8 35.63 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.206 2.604 . . . . 10.0 112.495 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.578 ' HA ' ' HE2' ' A' ' 165' ' ' TYR . 98.9 mmm -75.19 -14.3 60.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.934 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 91.84 -18.83 51.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.818 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.0 m -134.24 157.71 41.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 110.354 -0.239 . . . . 10.0 110.354 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 90.19 155.04 30.62 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.783 -0.723 . . . . 10.0 112.319 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.34 130.19 46.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.694 0.283 . . . . 10.0 110.703 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 125.07 176.69 14.63 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.525 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -81.15 -1.05 43.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.874 0.337 . . . . 10.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.42 6.13 84.13 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.917 -0.658 . . . . 10.0 112.26 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.6 t -108.48 135.81 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.692 HD11 ' HD3' ' A' ' 419' ' ' PRO . 90.1 mt -81.75 159.34 23.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.68 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -67.44 110.67 3.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.976 -0.557 . . . . 10.0 110.832 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.549 ' HA3' ' HB2' ' A' ' 413' ' ' ARG . . . 148.56 141.84 3.54 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.802 -0.713 . . . . 10.0 112.064 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.4 t -84.36 155.02 22.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.997 0.427 . . . . 10.0 111.148 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.22 -16.32 19.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.476 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.51 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 86.11 -6.78 80.51 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.107 -0.568 . . . . 10.0 112.396 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.75 158.4 10.22 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.008 -0.837 . . . . 10.0 111.008 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.23 -55.53 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.863 0.331 . . . . 10.0 110.909 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' MET . . . . . 0.599 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 19.3 ttp -56.99 -48.22 78.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.65 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.51 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 18.2 tt0 -63.26 -48.27 78.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.131 0.419 . . . . 10.0 112.131 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.461 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . -64.26 -34.99 79.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.503 0.192 . . . . 10.0 111.335 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.73 73.26 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.45 -41.07 98.48 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.728 -0.669 . . . . 10.0 109.8 178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 44.4 ttm105 -59.28 -50.16 75.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.47 -0.787 . . . . 10.0 111.018 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 50.9 m -57.56 -43.62 84.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.053 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.24 77.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.911 0.386 . . . . 10.0 110.72 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.529 ' CD2' ' HB2' ' A' ' 273' ' ' LEU . 50.3 t80 -63.26 -48.8 76.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.705 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.416 ' OE2' ' HA ' ' A' ' 272' ' ' PRO . 59.5 mt-10 -63.91 -27.37 69.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.111 0.782 . . . . 10.0 113.111 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 82.2 mt -86.82 -26.64 23.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.03 0.443 . . . . 10.0 111.046 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -84.93 -36.97 21.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.679 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.443 HG21 ' CE1' ' A' ' 265' ' ' TYR . 63.0 p -100.81 -32.74 10.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.718 0.636 . . . . 10.0 112.718 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 87.23 0.99 84.59 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.732 -0.947 . . . . 10.0 110.732 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 42.0 p -109.38 145.09 31.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 110.286 -0.264 . . . . 10.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.416 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 42.6 Cg_endo -69.26 146.2 62.47 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.604 2.202 . . . . 10.0 112.203 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.531 HD12 ' HD2' ' A' ' 274' ' ' PRO . 32.1 tp -115.2 123.56 31.51 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.931 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.531 ' HD2' HD12 ' A' ' 273' ' ' LEU . 87.7 Cg_endo -80.29 -157.3 0.08 OUTLIER 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.696 2.264 . . . . 10.0 111.3 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -79.28 140.07 37.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.569 0.224 . . . . 10.0 110.584 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 90.5 mt -91.69 128.2 37.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.984 0.421 . . . . 10.0 111.248 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 7.1 m -96.1 93.47 6.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.182 0.515 . . . . 10.0 111.002 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 288' ' ' LYS . 4.3 mm? -64.54 122.33 16.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.515 -0.766 . . . . 10.0 111.346 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.2 m -105.18 138.87 40.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.516 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.97 144.12 56.96 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.765 0.283 . . . . 10.0 111.765 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.598 HG22 ' HG2' ' A' ' 289' ' ' GLU . 16.7 t -93.84 123.71 46.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.31 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -66.06 118.81 10.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.208 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.99 -23.85 12.46 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.906 -0.664 . . . . 10.0 111.808 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.406 ' HB3' HG13 ' A' ' 287' ' ' ILE . 75.7 mtm -126.98 98.65 5.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.985 0.421 . . . . 10.0 110.351 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -69.17 133.28 47.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.176 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 89.64 -6.99 82.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.038 -0.601 . . . . 10.0 112.459 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.406 HG13 ' HB3' ' A' ' 284' ' ' MET . 37.1 mm -101.19 127.92 53.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.87 0.367 . . . . 10.0 110.312 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 278' ' ' LEU . 65.8 mttm -122.97 142.81 50.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . 0.598 ' HG2' HG22 ' A' ' 281' ' ' VAL . 15.8 pt-20 -126.05 163.56 22.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.119 0.485 . . . . 10.0 111.562 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.417 ' CG2' ' HB ' ' A' ' 346' ' ' VAL . 10.0 t -157.19 131.4 8.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.861 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -105.7 121.83 44.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.279 -0.419 . . . . 10.0 109.944 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 36.2 mt -109.12 111.7 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.457 -0.338 . . . . 10.0 111.419 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.07 103.55 3.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.584 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 87.4 mtp -98.38 115.12 27.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.127 0.489 . . . . 10.0 111.442 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 269' ' ' THR . 70.2 t -109.3 124.79 32.99 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.632 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.01 129.77 34.84 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.737 2.291 . . . . 10.0 112.631 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -62.11 132.23 93.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.848 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.11 118.4 5.35 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.584 2.189 . . . . 10.0 111.978 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 95.07 21.47 25.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.875 -0.679 . . . . 10.0 112.797 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.1 p -119.78 164.04 16.56 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.7 -0.294 . . . . 10.0 110.478 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.667 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 71.4 tttt -62.83 -32.12 73.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.992 0.425 . . . . 10.0 109.911 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -60.59 -36.64 79.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.645 -0.707 . . . . 10.0 111.177 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -70.36 -36.71 74.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.98 -0.554 . . . . 10.0 110.428 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -28.29 62.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.779 -0.646 . . . . 10.0 111.312 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 90.0 mt -58.18 -53.91 52.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.44 -1.67 31.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.295 0.48 . . . . 10.0 112.295 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -104.5 -36.0 7.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.946 0.403 . . . . 10.0 111.07 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -26.41 54.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.717 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . 0.72 ' NH1' ' HA ' ' A' ' 114' ' ' GLU . 5.1 ptp85 -148.42 165.36 31.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.531 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -138.25 -57.67 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.015 0.436 . . . . 10.0 110.591 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.745 -0.645 . . . . 10.0 110.077 179.419 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.909 -0.476 . . . . 10.0 111.909 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.64 -26.07 33.72 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.792 2.328 . . . . 10.0 111.555 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.509 ' HB2' ' CE2' ' A' ' 147' ' ' TYR . 93.1 mt -113.13 105.1 13.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.732 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.76 31.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.498 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -56.19 137.29 52.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.706 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -79.69 -12.68 59.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.979 0.419 . . . . 10.0 111.607 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 114.25 -10.68 22.27 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.829 -0.7 . . . . 10.0 111.405 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 89.79 141.8 8.92 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.003 -0.618 . . . . 10.0 112.084 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -77.75 96.01 4.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.093 0.473 . . . . 10.0 110.106 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -103.22 163.16 15.82 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.791 -0.718 . . . . 10.0 112.737 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -147.5 153.78 39.94 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.452 ' HA ' ' HA3' ' A' ' 340' ' ' GLY . 6.2 t -144.36 161.04 40.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.917 0.389 . . . . 10.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' SER . . . . . 0.457 ' HB2' ' OD1' ' A' ' 337' ' ' ASP . 1.4 m -110.19 166.26 11.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.726 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -72.96 7.06 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 335' ' ' SER . 2.0 p-10 -104.0 -16.76 15.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.968 0.413 . . . . 10.0 110.269 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.34 -4.13 33.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 10.0 113.293 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -108.52 122.04 46.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.99 0.424 . . . . 10.0 110.69 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 334' ' ' THR . . . -136.67 -145.1 4.95 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.864 -0.684 . . . . 10.0 111.917 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 179.0 -165.46 34.42 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.55 -0.62 . . . . 10.0 111.55 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.449 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 14.5 tt -137.89 138.56 43.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 13.2 t -102.25 119.33 38.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.298 0.57 . . . . 10.0 110.414 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 11.7 tp -79.0 126.19 30.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.683 -0.689 . . . . 10.0 111.407 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -95.09 106.11 18.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.583 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 371' ' ' PHE . 29.4 t -107.46 139.81 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.12 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 372' ' ' VAL . . . -136.69 144.9 44.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.804 0.335 . . . . 10.0 110.962 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 52.5 t -119.58 125.83 74.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.318 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.557 ' HB2' HD22 ' A' ' 358' ' ' LEU . . . -108.8 119.77 40.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.066 -0.515 . . . . 10.0 109.912 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -100.92 103.06 14.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.574 -0.285 . . . . 10.0 111.398 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' B' ' 41' ' ' ALA . . . 113.11 146.01 9.55 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.605 -0.807 . . . . 10.0 114.239 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.11 -32.4 68.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.186 0.517 . . . . 10.0 109.842 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' B' ' 60' ' ' SER . . . -75.73 -10.83 84.84 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.916 -0.874 . . . . 10.0 110.916 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.604 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 3.2 t-20 -91.49 -31.4 15.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.643 -0.503 . . . . 10.0 109.643 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.2 93.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.663 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -58.84 -40.91 85.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.495 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 8.7 pttm -83.86 -10.86 57.7 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.431 0.53 . . . . 10.0 112.431 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . 0.557 HD22 ' HB2' ' A' ' 349' ' ' ALA . 29.1 tp -91.95 -49.44 6.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.816 0.341 . . . . 10.0 111.119 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 85.0 mt -58.25 -37.55 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 10.0 111.103 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.94 -26.75 68.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.266 -0.424 . . . . 10.0 111.346 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -78.86 -33.15 46.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 10.0 109.926 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 91.0 mtp -75.06 -37.54 61.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.001 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -63.14 -34.57 77.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.011 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -79.38 -12.75 59.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.263 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 84.4 15.47 68.77 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.843 -0.694 . . . . 10.0 112.395 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -83.28 -52.38 6.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.023 0.439 . . . . 10.0 109.94 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.425 ' HB1' ' HE2' ' A' ' 369' ' ' TYR . . . -94.09 100.28 12.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.579 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.61 115.0 26.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' TYR . . . . . 0.425 ' HE2' ' HB1' ' A' ' 367' ' ' ALA . 85.1 m-85 -137.9 159.86 40.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.677 -0.49 . . . . 10.0 109.677 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -107.16 -39.46 5.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.968 0.413 . . . . 10.0 110.979 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . 0.599 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 20.5 t80 -128.16 123.57 34.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.368 -0.605 . . . . 10.0 109.368 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . 0.531 ' HB ' ' HD1' ' A' ' 126' ' ' PHE . 45.4 t -129.38 126.57 63.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.848 0.356 . . . . 10.0 111.746 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -104.12 124.09 48.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.672 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.74 121.92 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.843 0.354 . . . . 10.0 110.896 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' MET . . . . . 0.6 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 67.2 mtt -105.65 152.36 23.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.343 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -101.36 9.26 41.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.029 0.443 . . . . 10.0 110.998 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.47 ' HB3' ' HD2' ' A' ' 378' ' ' PRO . 92.9 m -111.74 160.48 29.49 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.704 -0.68 . . . . 10.0 110.106 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.759 ' HB3' ' HG ' ' B' ' 37' ' ' CYS . 24.9 Cg_endo -62.84 -36.44 61.54 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.616 2.211 . . . . 10.0 112.474 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -157.63 100.71 1.79 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.013 0.435 . . . . 10.0 110.543 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 377' ' ' CYS . . . 78.29 -132.8 12.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.871 -0.68 . . . . 10.0 112.977 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' CYS . . . . . . . . . . . . . 11.5 t -131.14 -8.17 3.84 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.105 0.479 . . . . 10.0 110.819 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.14 4.77 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 112.572 0.582 . . . . 10.0 112.572 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -128.56 48.77 0.95 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.511 -0.852 . . . . 10.0 112.663 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -87.54 168.97 38.7 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.449 -0.881 . . . . 10.0 111.74 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -67.79 -15.19 66.41 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.232 -0.508 . . . . 10.0 113.294 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -89.29 -5.44 72.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.696 -0.764 . . . . 10.0 111.749 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -82.42 156.3 68.66 Favored Pre-proline 0 C--O 1.239 0.501 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.8 160.73 39.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.715 2.277 . . . . 10.0 111.532 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 107.54 14.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.92 0.391 . . . . 10.0 111.282 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 62.4 m -108.43 163.03 13.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.778 -0.646 . . . . 10.0 109.868 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.65 81.75 3.3 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.174 0.511 . . . . 10.0 111.196 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . 0.78 ' HB3' ' HB ' ' A' ' 395' ' ' ILE . 14.3 t0 -165.87 125.32 1.67 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.527 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . 0.416 ' HZ2' ' CD ' ' B' ' 27' ' ' GLU . 22.5 mttt -78.57 -15.0 59.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.015 0.436 . . . . 10.0 110.337 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -124.71 38.76 4.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.501 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.78 ' HB ' ' HB3' ' A' ' 392' ' ' ASP . 10.9 tp -71.48 -18.78 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.341 0.591 . . . . 10.0 110.64 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -42.55 95.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.642 -0.708 . . . . 10.0 111.391 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -64.26 -37.18 86.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.662 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.458 ' HD2' HD12 ' A' ' 395' ' ' ILE . 62.7 mttp -62.97 -44.93 94.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.063 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -68.44 -35.76 78.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.029 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -66.36 -40.2 89.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.518 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -73.4 -29.67 62.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.05 -0.523 . . . . 10.0 111.622 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -91.61 10.07 29.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 10.0 111.784 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 9.5 mt -66.55 -41.45 88.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.738 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -136.16 153.46 51.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.495 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . 0.496 ' HB3' ' OD1' ' A' ' 407' ' ' ASP . 63.8 t30 -79.52 174.24 11.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.583 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.55 -39.51 84.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . 0.496 ' OD1' ' HB3' ' A' ' 405' ' ' ASN . 11.7 p30 -70.72 -46.63 62.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.351 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -60.63 -35.32 75.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.646 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -71.12 -40.63 71.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.888 0.375 . . . . 10.0 111.293 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 10.8 m -73.97 -31.14 62.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.996 -0.547 . . . . 10.0 111.829 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 5.6 m -87.0 107.69 18.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 40.2 tp -85.65 136.65 33.29 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.692 -0.484 . . . . 10.0 109.692 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . 0.549 ' HB2' ' HA3' ' A' ' 251' ' ' GLY . 3.9 tmm_? -145.77 125.12 13.05 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.216 -0.29 . . . . 10.0 110.216 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.626 ' HB2' ' OE1' ' A' ' 417' ' ' GLU . 5.3 mtt85 -100.83 158.52 15.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.136 0.493 . . . . 10.0 110.462 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.6 m -64.5 -24.91 67.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.551 0.945 . . . . 10.0 113.551 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . 0.464 ' CE1' ' HD3' ' A' ' 414' ' ' ARG 0.282 32.5 p-80 -78.71 4.23 14.31 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . 0.626 ' OE1' ' HB2' ' A' ' 414' ' ' ARG . 1.7 mp0 -112.12 -3.93 14.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.992 0.425 . . . . 10.0 109.975 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 421' ' ' ILE . 50.4 t-20 -77.75 118.37 71.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.624 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.692 ' HD3' HD11 ' A' ' 249' ' ' LEU . 37.7 Cg_exo -59.05 -38.68 86.13 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.022 2.481 . . . . 10.0 111.636 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 53.9 m -65.28 -46.27 81.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.313 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 418' ' ' ASN . 39.2 mm -65.22 -43.02 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.132 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.589 ' NH2' ' HA ' ' A' ' 417' ' ' GLU . 97.1 mtt180 -58.97 -45.45 90.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.366 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -63.33 -49.64 73.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.93 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.589 HD23 HD21 ' A' ' 96' ' ' LEU . 61.3 tp -56.37 -39.17 72.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.998 0.427 . . . . 10.0 110.947 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . 0.869 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.1 m-85 -77.35 4.62 10.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.948 -0.569 . . . . 10.0 111.498 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -118.76 -54.61 2.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.739 0.304 . . . . 10.0 111.692 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -25.27 53.47 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.714 1.005 . . . . 10.0 113.714 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -126.71 -50.13 1.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 114.589 1.329 . . . . 10.0 114.589 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . 0.869 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 90.9 mt -73.08 -39.74 65.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.391 0.886 . . . . 10.0 113.391 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 86.25 -60.57 4.56 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.574 -0.822 . . . . 10.0 112.836 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 432' ' ' PRO . 2.1 tt0 -165.95 151.1 7.77 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.615 0.208 . . . . 10.0 110.727 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.477 ' HA ' ' OE2' ' A' ' 100' ' ' GLU . 32.5 Cg_exo -59.64 142.4 98.74 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.819 2.346 . . . . 10.0 111.312 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 7.9 mp 63.35 16.95 9.92 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.708 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -78.67 -168.79 34.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.2 -0.524 . . . . 10.0 112.214 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . 0.435 ' O ' ' HG3' ' A' ' 439' ' ' GLU . 31.4 t-80 -59.99 -60.83 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.512 0.196 . . . . 10.0 111.328 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.444 ' HD2' ' OE2' ' A' ' 439' ' ' GLU . 8.3 tptt -59.4 -35.46 74.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.278 -0.419 . . . . 10.0 111.29 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -65.19 -42.84 93.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.156 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . 0.517 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 9.6 t-80 -68.02 -26.9 66.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.901 0.382 . . . . 10.0 110.521 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . 0.444 ' OE2' ' HD2' ' A' ' 436' ' ' LYS . 45.4 mt-10 -73.06 -64.88 0.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 62.4 mt -99.04 -17.96 18.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.986 1.476 . . . . 10.0 114.986 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 60.8 mt -100.0 -11.14 20.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.557 0.577 . . . . 10.0 112.557 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 28.0 m-70 -122.59 163.6 19.7 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 121.305 -0.158 . . . . 10.0 110.595 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 5.9 t -155.07 -171.95 4.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.667 0.27 . . . . 10.0 111.081 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -133.84 168.09 19.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.374 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' TYR . . . . . 0.538 ' HD2' HG23 ' A' ' 145' ' ' ILE . 51.0 m-85 -109.85 161.02 15.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.446 -0.343 . . . . 10.0 110.358 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.15 120.91 66.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.977 0.418 . . . . 10.0 111.31 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.13 107.23 3.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.738 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.26 -6.32 11.89 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.128 -0.789 . . . . 10.0 111.128 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . 95.86 179.18 36.15 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.045 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.167 -0.92 . . . . 10.0 110.138 -179.904 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.535 ' HE2' ' HB2' ' B' ' 18' ' ' ALA . 97.5 m-85 . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 109.938 -0.393 . . . . 10.0 109.938 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.449 ' HG3' ' OE2' ' B' ' 15' ' ' GLU . 38.3 mttp -84.12 114.02 21.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.129 0.49 . . . . 10.0 110.266 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' B' ' 13' ' ' THR . 6.9 p -112.56 127.77 69.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.38 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.558 ' HB ' HG23 ' B' ' 84' ' ' THR . 1.3 m -85.71 89.56 7.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.273 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 80.7 mt -76.35 109.97 10.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.113 0.482 . . . . 10.0 111.327 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.776 ' HB3' ' HA ' ' B' ' 86' ' ' GLN . 12.9 tppt? -79.88 123.67 27.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.645 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.536 HG21 HD22 ' B' ' 31' ' ' LEU . 0.6 OUTLIER -128.32 166.38 24.64 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.146 -0.479 . . . . 10.0 109.816 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.94 -21.47 72.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.084 1.856 . . . . 10.0 110.73 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.3 9.13 39.35 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.482 -0.781 . . . . 10.0 111.792 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.26 -122.83 4.57 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.297 -0.954 . . . . 10.0 113.185 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -145.03 157.98 43.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.895 0.379 . . . . 10.0 110.466 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . 0.466 ' HB2' ' HE2' ' B' ' 12' ' ' LYS . 1.5 tppt? -143.38 97.83 3.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.445 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' B' ' 3' ' ' VAL . 2.6 m -87.77 92.84 9.26 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 pp -112.79 173.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.338 -0.392 . . . . 10.0 111.444 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.449 ' OE2' ' HG3' ' B' ' 2' ' ' LYS . 8.3 mm-40 -91.55 117.87 30.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.174 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . 0.438 ' HA ' ' HD3' ' B' ' 17' ' ' PRO . 44.6 t -109.8 125.65 30.76 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.755 -0.657 . . . . 10.0 109.659 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' B' ' 16' ' ' CYS . 17.2 Cg_exo -68.96 154.84 70.14 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.818 2.345 . . . . 10.0 110.889 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.535 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . . . -77.84 -14.74 59.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.693 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.44 -5.42 20.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.519 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 2.9 m -119.11 135.52 54.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.836 0.35 . . . . 10.0 111.496 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' B' ' 24' ' ' ASP . 1.8 p90 -65.42 140.05 58.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.96 -0.564 . . . . 10.0 111.022 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.445 ' HB ' ' OG1' ' B' ' 74' ' ' THR . 2.1 mt -53.87 -34.82 26.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.744 -0.662 . . . . 10.0 112.493 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.691 ' HG ' ' HG ' ' B' ' 75' ' ' CYS . 1.3 tm? -53.58 -49.32 67.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.078 0.399 . . . . 10.0 112.078 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.549 ' HB2' ' CZ ' ' B' ' 21' ' ' TYR . 4.9 t70 -64.12 -45.79 87.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.062 0.458 . . . . 10.0 110.895 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -31.55 72.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.596 . . . . 10.0 112.034 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -56.37 13.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.817 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . 0.416 ' CD ' ' HZ2' ' A' ' 393' ' ' LYS . 0.1 OUTLIER -67.98 -36.69 80.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.413 -0.358 . . . . 10.0 111.499 -179.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.0 -27.22 69.27 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.177 0.513 . . . . 10.0 110.275 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.71 -42.9 11.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.499 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.63 82.18 0.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.899 -0.667 . . . . 10.0 112.558 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . 0.536 HD22 HG21 ' B' ' 7' ' ' THR . 13.2 mt -150.04 162.43 40.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.867 0.365 . . . . 10.0 111.081 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -93.26 98.79 11.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.134 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.521 HD21 ' HB ' ' B' ' 87' ' ' THR . 20.9 mt -152.57 149.68 23.11 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.394 -0.366 . . . . 10.0 110.258 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -83.7 117.35 2.33 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.013 2.475 . . . . 10.0 111.661 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.415 ' HA ' ' S1 ' ' B' ' 101' ' ' FES . 11.7 p90 -125.86 128.77 48.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.413 -0.358 . . . . 10.0 111.262 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.6 m -169.1 -57.1 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.735 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' CYS . . . . . 0.759 ' HG ' ' HB3' ' A' ' 378' ' ' PRO . 7.2 p -84.45 -65.06 1.05 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' B' ' 37' ' ' CYS . 3.7 ttp-105 81.58 -32.3 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.22 23.85 0.05 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.401 0.889 . . . . 10.0 113.401 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' B' ' 38' ' ' ARG . . . 69.95 74.14 0.69 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.112 -0.566 . . . . 10.0 112.582 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . 0.465 ' HB3' ' SG ' ' B' ' 37' ' ' CYS . . . -112.23 -76.18 0.6 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.713 0.292 . . . . 10.0 111.495 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.46 145.54 30.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.882 0.373 . . . . 10.0 111.268 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -0.6 57.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.194 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m -72.0 -17.32 62.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.074 0.464 . . . . 10.0 110.977 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . 0.509 ' O ' HG22 ' B' ' 74' ' ' THR . 18.0 m -101.34 31.35 3.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.395 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.02 123.89 37.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.995 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.52 164.99 35.01 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.061 -0.59 . . . . 10.0 111.956 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 1.022 ' HB2' ' HB2' ' B' ' 86' ' ' GLN . 0.1 OUTLIER -110.96 116.67 31.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.247 -0.279 . . . . 10.0 110.247 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.546 ' HB ' ' HA2' ' B' ' 70' ' ' GLY . 4.9 t -73.35 98.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.306 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.64 -38.5 47.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.053 0.454 . . . . 10.0 110.343 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -163.76 -179.89 6.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.631 -0.713 . . . . 10.0 109.35 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.707 ' HA3' ' HB3' ' B' ' 83' ' ' CYS . . . 79.22 -147.29 30.03 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.046 -0.597 . . . . 10.0 112.859 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.98 136.34 20.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.853 0.359 . . . . 10.0 110.786 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 5.5 m -128.07 156.01 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -122.4 119.37 30.83 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.266 0.469 . . . . 10.0 112.266 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -135.08 133.13 38.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 10.0 109.209 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -116.73 -58.56 2.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.026 0.441 . . . . 10.0 110.925 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . 0.491 ' CG ' ' HZ2' ' A' ' 357' ' ' LYS . 17.6 t70 -95.34 99.79 11.67 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.065 -0.716 . . . . 10.0 109.065 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.424 ' HB2' ' H ' ' B' ' 60' ' ' SER . 0.0 OUTLIER -136.66 -160.19 1.03 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.481 0.548 . . . . 10.0 112.481 -178.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.515 ' HA ' ' HA2' ' A' ' 353' ' ' GLY . 3.7 m -93.44 -147.14 0.24 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.031 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -72.62 -16.16 61.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.201 0.445 . . . . 10.0 112.201 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.32 87.06 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.158 0.504 . . . . 10.0 110.198 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.456 ' HB3' ' H ' ' B' ' 64' ' ' ASP . 0.6 OUTLIER -88.23 -153.98 0.26 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.532 -0.758 . . . . 10.0 112.727 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . 0.456 ' H ' ' HB3' ' B' ' 63' ' ' ASP . 43.1 m-20 -53.5 -44.02 68.71 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.972 0.73 . . . . 10.0 112.972 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.76 -37.8 71.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.104 0.478 . . . . 10.0 111.076 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.468 ' HB3' ' HB2' ' B' ' 71' ' ' PHE . 14.7 mm100 -81.93 -38.66 24.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.172 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' MET . . . . . . . . . . . . . 57.2 ttp -60.44 -43.71 96.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.847 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.9 -16.28 72.37 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 116.066 -0.515 . . . . 10.0 112.444 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -90.6 -34.86 15.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.059 0.457 . . . . 10.0 110.163 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.546 ' HA2' ' HB ' ' B' ' 49' ' ' VAL . . . 135.85 37.73 0.18 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.776 -0.726 . . . . 10.0 113.261 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' B' ' 66' ' ' GLN . 52.7 m-85 -129.52 118.25 21.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.134 0.467 . . . . 10.0 110.646 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.13 143.07 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.834 0.35 . . . . 10.0 111.528 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.36 96.2 9.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' THR . . . . . 0.509 HG22 ' O ' ' B' ' 45' ' ' CYS . 9.9 t -61.56 -8.01 3.89 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.33 1.233 . . . . 10.0 114.33 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' CYS . . . . . 0.691 ' HG ' ' HG ' ' B' ' 23' ' ' LEU . 56.0 m -82.18 -25.44 34.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.855 0.359 . . . . 10.0 110.922 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.66 26.83 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.302 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.47 150.26 44.98 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.1 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' B' ' 79' ' ' PRO . 34.5 p90 -133.24 155.36 80.99 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.407 -0.815 . . . . 10.0 109.181 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 0.433 ' HD3' HG12 ' B' ' 22' ' ' ILE . 6.1 Cg_exo -78.23 115.92 3.81 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.505 2.137 . . . . 10.0 111.433 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.07 -20.4 64.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.462 0.648 . . . . 10.0 109.397 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 15.0 m -153.59 159.08 42.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.305 -0.861 . . . . 10.0 109.077 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.28 135.8 57.76 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . 0.707 ' HB3' ' HA3' ' B' ' 52' ' ' GLY . 2.3 p -169.24 -179.95 3.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 10.0 112.259 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.558 HG23 ' HB ' ' B' ' 4' ' ' THR . 22.5 m -105.93 129.69 54.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.298 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 26.3 mm -133.93 128.62 53.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.498 0.189 . . . . 10.0 110.848 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . 1.022 ' HB2' ' HB2' ' B' ' 48' ' ' LYS . 1.3 mp0 -79.28 162.96 25.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' THR . . . . . 0.521 ' HB ' HD21 ' B' ' 33' ' ' LEU . 18.6 p -119.15 -84.91 0.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.503 0.927 . . . . 10.0 113.503 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -62.67 101.74 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.411 0.893 . . . . 10.0 113.411 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.491 ' HB3' ' HD3' ' B' ' 48' ' ' LYS . 0.7 OUTLIER 178.05 87.74 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 O-C-N 123.709 0.631 . . . . 10.0 110.468 178.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -103.33 -5.08 23.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.987 0.422 . . . . 10.0 111.444 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.36 -30.14 37.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.136 -0.483 . . . . 10.0 112.099 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.84 -8.67 45.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pp -111.86 13.38 20.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.122 0.487 . . . . 10.0 111.245 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.637 -0.696 . . . . 10.0 110.412 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' FES . . . . . 0.415 ' S1 ' ' HA ' ' B' ' 35' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.998 -0.371 . . . . 10.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.25 154.17 35.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.594 -0.521 . . . . 10.0 109.594 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -62.86 -22.96 67.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.88 0.371 . . . . 10.0 111.698 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.62 -45.45 50.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.882 -0.785 . . . . 10.0 108.882 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -63.93 -32.62 74.22 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.697 -0.683 . . . . 10.0 109.772 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.543 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 60.2 mt-30 -61.87 -19.1 62.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.414 -0.812 . . . . 10.0 111.059 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -98.76 -47.43 5.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.016 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.527 HD23 HD12 ' A' ' 35' ' ' LEU . 96.0 mt -59.71 -26.7 65.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.994 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.78 -50.43 73.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.728 0.299 . . . . 10.0 111.001 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -75.7 -26.09 57.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.728 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.527 HD12 HD23 ' A' ' 32' ' ' LEU . 62.4 mt -70.32 -30.79 67.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.847 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.42 -25.45 61.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.289 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -70.66 130.24 89.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.22 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.17 153.88 15.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 123.125 2.55 . . . . 10.0 112.086 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -63.05 -25.21 68.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.136 0.493 . . . . 10.0 110.423 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -101.51 15.95 27.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.381 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.824 ' HB3' ' HB2' ' A' ' 44' ' ' ARG . 15.8 t70 -69.36 136.39 88.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.278 -0.268 . . . . 10.0 110.278 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.96 -24.49 73.31 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.962 2.442 . . . . 10.0 113.033 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.32 10.85 23.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.957 0.408 . . . . 10.0 110.983 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.824 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 7.4 tpt180 -72.28 137.55 46.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.032 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -118.72 173.81 6.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.579 -0.737 . . . . 10.0 109.233 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.4 111.06 21.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 t -99.56 104.27 15.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.224 0.535 . . . . 10.0 111.091 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.2 m -96.87 141.05 30.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.352 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 14.5 p -128.56 139.31 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.705 0.288 . . . . 10.0 111.567 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 12.8 pt20 -120.78 125.31 47.25 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.778 -0.453 . . . . 10.0 109.778 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.608 HG11 HD21 ' A' ' 75' ' ' LEU . 14.1 t -111.3 143.81 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.346 -0.388 . . . . 10.0 111.183 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.7 145.82 31.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.544 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.86 -30.17 84.4 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.003 2.469 . . . . 10.0 112.433 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.08 -23.37 65.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.94 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.699 HG13 HG23 ' A' ' 214' ' ' THR . 86.8 t -81.13 -38.56 16.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.624 -0.51 . . . . 10.0 109.624 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -59.46 -29.6 67.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.835 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -85.58 -33.7 7.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.508 0.558 . . . . 10.0 112.508 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.43 ' HB1' ' HD2' ' A' ' 388' ' ' PRO . . . -91.74 -17.1 25.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.117 0.784 . . . . 10.0 113.117 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.52 -20.84 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 10.0 111.381 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 65' ' ' LEU . . . -70.26 -37.69 74.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.684 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.433 ' CD ' HH21 ' A' ' 399' ' ' ARG . 32.4 mt-10 -64.15 -29.76 70.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.523 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.416 HG21 ' HA3' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -69.03 -15.63 63.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 10.0 110.858 179.329 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 mt -109.17 -5.56 15.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.149 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.39 27.4 22.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.908 -0.663 . . . . 10.0 112.23 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.493 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 mt -112.95 164.24 13.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.6 0.238 . . . . 10.0 110.492 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.96 140.9 88.93 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.731 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.44 118.82 5.62 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.881 2.387 . . . . 10.0 112.127 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.94 0.0 55.05 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.6 -0.809 . . . . 10.0 113.279 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.79 -38.11 73.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 10.0 111.051 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.11 131.34 41.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.716 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -83.52 157.1 65.08 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.598 0.237 . . . . 10.0 110.403 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.4 -35.26 91.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.225 1.95 . . . . 10.0 111.345 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.507 ' HB2' ' OE1' ' A' ' 233' ' ' GLU . 31.4 mmtp -71.8 -36.96 70.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.946 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -61.27 -42.3 98.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.091 0.472 . . . . 10.0 110.529 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.608 HD21 HG11 ' A' ' 51' ' ' VAL . 45.0 tp -63.84 -46.45 84.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.588 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.32 95.42 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.835 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.406 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 38.1 tp10 -61.75 -42.7 99.32 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.817 -0.629 . . . . 10.0 110.367 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -44.34 91.22 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.964 -0.636 . . . . 10.0 112.003 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 51' ' ' VAL . 16.3 mt -61.77 -40.49 95.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 10.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -62.94 -31.01 72.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.763 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -81.51 -8.73 59.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 10.0 111.803 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.0 mt -79.16 -9.3 59.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.022 0.439 . . . . 10.0 110.761 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.85 -0.43 28.77 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.691 -0.766 . . . . 10.0 112.354 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.75 159.58 27.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 10.0 110.971 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -101.7 -59.4 1.71 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.859 0.362 . . . . 10.0 110.995 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -115.97 125.06 52.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.827 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.3 t -105.48 108.79 25.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.283 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 30.1 m-85 -110.76 168.76 9.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.923 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.438 ' OD2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.43 155.8 27.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.822 -0.626 . . . . 10.0 110.058 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 m -76.64 -21.79 55.0 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.98 0.733 . . . . 10.0 112.98 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.483 HD11 ' HH ' ' A' ' 404' ' ' TYR . 44.9 mt -61.43 -37.46 83.58 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.317 -0.239 . . . . 10.0 111.069 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -61.01 -38.37 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.232 0.539 . . . . 10.0 109.598 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.66 -35.26 55.51 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.776 -0.93 . . . . 10.0 110.776 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.11 77.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.696 0.284 . . . . 10.0 110.379 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.33 -35.48 73.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 10.0 109.662 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.42 -42.39 65.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.531 -0.759 . . . . 10.0 109.594 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.6 m -60.51 -42.43 96.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.617 -0.72 . . . . 10.0 110.622 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.9 mt -59.98 -39.95 81.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.771 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.8 mmm -65.92 -51.73 56.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.976 -0.557 . . . . 10.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -65.55 -45.44 83.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.873 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.488 ' HA ' ' OE1' ' A' ' 101' ' ' GLU . 1.8 tp10 -61.52 -43.55 98.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 10.0 110.929 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.05 95.29 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 110.981 -0.848 . . . . 10.0 110.981 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.558 ' HB2' HD13 ' A' ' 433' ' ' LEU . 19.7 m -69.27 -43.64 73.51 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.614 -0.293 . . . . 10.0 110.497 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.423 ' HG2' HD21 ' A' ' 433' ' ' LEU . 0.0 OUTLIER -60.18 -47.02 87.69 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.802 -0.444 . . . . 10.0 109.802 178.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.413 ' CD2' HD23 ' A' ' 261' ' ' LEU . 23.3 tp -59.16 -54.68 44.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.726 -0.67 . . . . 10.0 111.059 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.0 tp -59.35 -39.17 82.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.907 0.384 . . . . 10.0 110.593 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.606 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 53.9 t60 -61.86 -53.09 60.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.526 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 121' ' ' GLU . 68.2 mtt180 -59.72 -38.66 82.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.715 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 41.7 tp -67.21 -50.86 59.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.842 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.5 m -58.14 -44.95 88.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.912 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 23.1 mm-40 -57.95 -31.19 66.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.948 0.404 . . . . 10.0 111.573 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -79.65 -37.28 36.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 65.3 mt -69.31 -32.48 71.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.984 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.567 ' HG2' HD22 ' A' ' 305' ' ' LEU . 22.7 mt-10 -79.54 -7.16 58.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.284 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.139 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.356 -179.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 108' ' ' ARG . 1.5 pm0 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.862 0.363 . . . . 10.0 110.891 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -90.09 -172.07 0.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.988 2.458 . . . . 10.0 112.801 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.423 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 91.1 mt -133.93 157.38 77.87 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.486 -0.931 . . . . 10.0 108.486 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 369' ' ' TYR . 37.5 Cg_endo -64.92 167.46 45.46 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 124.513 -1.036 . . . . 10.0 113.802 0.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.549 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 24.6 ttt -113.92 134.08 55.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.739 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.61 ' HD1' ' HB ' ' A' ' 372' ' ' VAL . 33.3 m-85 -110.8 144.6 39.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.21 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.439 HG23 ' HZ ' ' A' ' 371' ' ' PHE . 0.0 OUTLIER -81.87 156.09 25.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.885 0.328 . . . . 10.0 111.885 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 m -111.63 54.18 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.262 0.553 . . . . 10.0 110.285 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.2 p -90.58 -39.51 12.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 10.0 112.086 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.783 ' SG ' ' HA ' ' A' ' 375' ' ' MET . 36.5 m -105.38 117.87 57.14 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.785 ' HG3' ' HE3' ' A' ' 188' ' ' LYS . 36.5 Cg_endo -64.46 -29.48 62.17 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.015 2.477 . . . . 10.0 111.743 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.21 -39.94 98.5 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.785 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -36.88 69.79 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 45.7 mm -62.92 -44.87 99.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.844 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.16 92.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.584 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 58.5 ttp -68.87 -34.73 75.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 10.0 109.773 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 tp -64.2 -54.45 33.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.754 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -59.8 -24.95 64.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.852 0.686 . . . . 10.0 112.852 -178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.64 -52.67 4.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.218 0.822 . . . . 10.0 113.218 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 m -84.24 -44.18 14.15 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 114.902 1.445 . . . . 10.0 114.902 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -131.7 73.25 79.3 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.9 -12.43 34.41 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.406 2.071 . . . . 10.0 111.82 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.94 -16.14 61.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.127 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.57 ' HA ' ' HD2' ' A' ' 147' ' ' TYR . 69.2 mt -98.97 9.52 43.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.566 HG23 ' HD2' ' A' ' 445' ' ' TYR . 52.4 mt -55.93 -52.46 72.28 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 33.4 Cg_exo -61.46 -23.28 76.43 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.338 2.025 . . . . 10.0 112.9 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.57 ' HD2' ' HA ' ' A' ' 144' ' ' LEU . 98.7 m-85 -75.78 -19.57 58.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.0 0.429 . . . . 10.0 111.047 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 144' ' ' LEU . 4.2 t -86.99 159.13 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.786 -0.449 . . . . 10.0 109.786 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.52 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . 31.5 t -69.4 167.62 16.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.991 0.424 . . . . 10.0 110.778 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.4 p -106.56 6.81 30.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.349 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.52 179.42 7.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 10.0 112.124 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 156' ' ' MET . 40.8 mtpt -122.25 169.79 10.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.3 p -68.53 152.56 96.56 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 121.049 -0.26 . . . . 10.0 110.471 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.66 -46.72 23.14 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.265 2.643 . . . . 10.0 112.974 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -35.7 80.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.803 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.442 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 60.1 mmm -74.52 -19.11 60.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.137 0.494 . . . . 10.0 110.833 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 30.9 mtt -80.66 -48.25 12.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.302 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.91 -42.26 99.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.59 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.68 81.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.64 61.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.812 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -72.69 -44.56 61.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.682 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.9 m -69.49 -28.68 38.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 179' ' ' MET . 27.5 mttt -85.73 2.6 44.8 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.824 0.305 . . . . 10.0 111.824 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 168' ' ' GLU . 13.5 p -122.82 -79.62 0.62 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.608 -0.269 . . . . 10.0 110.74 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.578 ' HE2' ' HA ' ' A' ' 240' ' ' MET . 33.8 t80 -55.58 -53.19 59.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.964 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.723 HD11 ' HE3' ' A' ' 170' ' ' LYS . 24.3 tp -61.94 -41.11 97.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 10.0 111.277 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.27 -50.18 74.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.202 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 164' ' ' SER . 41.6 mt-10 -68.41 -37.2 80.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.363 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -64.93 -49.08 71.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.247 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.723 ' HE3' HD11 ' A' ' 166' ' ' LEU . 91.2 mttt -76.88 -15.08 59.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.136 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 73.71 37.2 52.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.765 -0.731 . . . . 10.0 111.647 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.96 135.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.99 133.9 91.89 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.48 -0.327 . . . . 10.0 110.488 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.404 ' HB2' HD13 ' A' ' 205' ' ' LEU . 32.0 Cg_exo -59.55 -16.76 37.85 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.911 2.407 . . . . 10.0 112.399 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -71.94 -22.42 61.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.747 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -107.51 23.88 13.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.236 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 96.0 mtp -125.9 115.21 19.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.127 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.55 131.88 51.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.416 ' HB3' HD12 ' A' ' 208' ' ' LEU . 0.0 OUTLIER -112.4 119.87 39.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.149 0.5 . . . . 10.0 111.225 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 46.4 t -116.46 135.82 55.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.7 p -124.46 135.85 53.56 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.803 0.297 . . . . 10.0 111.803 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 212' ' ' ILE . 30.3 mm -99.93 103.11 14.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 213' ' ' THR . 32.4 mmt -114.26 148.43 40.09 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.944 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 183' ' ' MET . 2.5 Cg_endo -83.19 19.31 1.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.283 2.655 . . . . 10.0 112.665 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 73.1 m -145.93 129.17 16.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.05 0.453 . . . . 10.0 111.227 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -28.1 67.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.602 -0.726 . . . . 10.0 111.174 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.471 HH22 ' HA ' ' B' ' 44' ' ' SER . 8.7 mtm180 -80.7 17.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.075 -0.511 . . . . 10.0 112.029 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.785 ' HE3' ' HG3' ' A' ' 131' ' ' PRO . 0.0 OUTLIER -87.87 -33.88 18.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.657 0.265 . . . . 10.0 111.349 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -65.01 -30.64 71.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.915 0.388 . . . . 10.0 110.171 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.81 -25.58 66.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.661 -0.699 . . . . 10.0 111.9 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 131' ' ' PRO . 31.1 tt0 -76.25 -46.9 25.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -73.5 -5.91 43.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.564 -0.744 . . . . 10.0 111.16 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.36 -18.85 57.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.517 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.453 ' HD3' ' CZ2' ' A' ' 196' ' ' TRP . 78.0 mtt-85 -59.02 118.16 5.5 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.744 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -41.79 -47.99 4.22 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.709 1.374 . . . . 10.0 114.709 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . 0.453 ' CZ2' ' HD3' ' A' ' 194' ' ' ARG . 43.9 p90 -62.27 -9.59 8.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.998 1.481 . . . . 10.0 114.998 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -85.74 56.3 3.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.577 0.703 . . . . 10.0 110.811 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -110.07 171.07 7.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.384 -0.825 . . . . 10.0 110.375 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.59 80.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.688 0.28 . . . . 10.0 110.65 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.3 t0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.116 -0.945 . . . . 10.0 112.17 179.596 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.761 ' C ' ' H ' ' A' ' 205' ' ' LEU . 48.1 m . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.876 0.369 . . . . 10.0 111.102 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.788 ' C ' ' CB ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.229 -0.004 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -94.27 148.82 21.83 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.956 0.16 . . . . 10.0 110.799 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -70.36 -38.62 74.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.166 -1.049 . . . . 10.0 108.166 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.416 HD12 ' HB3' ' A' ' 179' ' ' MET . 29.8 tp -131.85 121.45 24.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.601 -1.629 . . . . 10.0 106.601 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.98 -44.68 7.24 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.891 1.071 . . . . 10.0 113.891 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 8.7 m-70 -130.36 141.88 50.55 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.987 0.736 . . . . 10.0 112.987 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.72 123.78 60.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.652 -0.869 . . . . 10.0 108.652 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 71.7 mt -119.78 140.05 45.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 183' ' ' MET . 41.1 p -90.23 166.95 13.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.052 0.453 . . . . 10.0 111.96 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.699 HG23 HG13 ' A' ' 55' ' ' VAL . 2.5 m -56.09 -46.71 78.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.476 -0.784 . . . . 10.0 111.773 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.8 m -61.26 -39.79 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.434 ' O ' HG13 ' A' ' 220' ' ' ILE . 41.9 mt-10 -68.7 -46.96 67.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.795 0.331 . . . . 10.0 110.638 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 31.1 tp -62.25 -43.07 99.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.34 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.416 ' HA3' HG21 ' A' ' 62' ' ' THR . . . -60.08 -36.27 89.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.186 -0.531 . . . . 10.0 112.252 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -38.87 80.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.571 0.224 . . . . 10.0 110.462 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 216' ' ' GLU . 79.7 mt -59.1 -45.3 92.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.18 -0.464 . . . . 10.0 110.08 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -59.77 -45.86 90.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.861 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.28 -46.81 82.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.787 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.92 -30.97 71.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 10.0 111.942 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -80.93 -12.7 59.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.926 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.78 30.51 47.74 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.914 -0.66 . . . . 10.0 111.868 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.6 mt -113.21 114.72 47.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.953 0.406 . . . . 10.0 110.532 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.454 ' O ' ' HG ' ' A' ' 231' ' ' LEU . 54.8 t30 -104.07 122.14 44.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.317 -0.401 . . . . 10.0 110.035 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.524 HD23 HD12 ' A' ' 231' ' ' LEU . 76.2 mt -60.4 -32.6 71.48 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.316 0.385 . . . . 10.0 111.735 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.04 -16.95 63.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.737 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.43 3.03 34.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 10.0 110.694 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.524 HD12 HD23 ' A' ' 228' ' ' LEU . 95.9 mt -96.65 151.03 37.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.327 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.18 -179.89 5.62 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.593 2.195 . . . . 10.0 111.123 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.507 ' OE1' ' HB2' ' A' ' 73' ' ' LYS . 2.8 mm-40 -80.55 103.45 10.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.739 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 73' ' ' LYS . . . -80.83 -152.62 8.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.017 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -150.98 157.86 43.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.867 0.333 . . . . 10.0 111.061 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -98.54 166.29 11.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.837 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -106.32 152.39 23.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -98.48 121.53 56.36 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.826 0.346 . . . . 10.0 110.944 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.82 -16.62 56.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.169 2.579 . . . . 10.0 112.079 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.578 ' HA ' ' HE2' ' A' ' 165' ' ' TYR . 85.5 mmm -81.15 -10.13 59.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.964 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 105.5 -66.34 0.27 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.029 -0.605 . . . . 10.0 112.043 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 17.0 m -104.69 165.2 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.573 0.225 . . . . 10.0 110.939 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 103.05 118.23 4.44 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.923 -0.656 . . . . 10.0 112.147 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.9 m -64.25 133.86 53.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.047 0.451 . . . . 10.0 111.605 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.02 -167.84 18.64 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.405 -0.678 . . . . 10.0 111.405 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.61 -8.66 58.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.929 0.395 . . . . 10.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 91.8 -1.87 75.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 10.0 112.311 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.63 129.31 39.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.833 -0.432 . . . . 10.0 109.833 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.654 ' HB2' ' HD3' ' A' ' 413' ' ' ARG . 63.5 mt -73.35 144.16 46.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.493 -0.322 . . . . 10.0 110.93 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.551 ' CE1' ' HG2' ' A' ' 408' ' ' GLU . 71.7 t80 -59.37 128.32 36.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.921 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 413' ' ' ARG . . . 128.71 150.27 7.15 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.867 -0.682 . . . . 10.0 111.758 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 8.3 t -92.38 145.1 24.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.883 0.373 . . . . 10.0 110.732 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -9.3 53.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.115 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 89.64 -11.73 69.27 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.955 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.53 165.11 12.35 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.199 -0.76 . . . . 10.0 111.199 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 29.2 t -58.49 -60.73 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.767 0.283 . . . . 10.0 111.22 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' MET . . . . . 0.504 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 25.6 ttp -51.89 -56.05 16.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 10.0 112.155 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -57.86 -49.9 75.12 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.005 0.743 . . . . 10.0 113.005 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.94 85.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.101 0.408 . . . . 10.0 112.101 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.62 76.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.062 0.458 . . . . 10.0 110.136 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.413 HD23 ' CD2' ' A' ' 105' ' ' LEU . 50.4 mt -63.83 -41.42 97.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.085 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 266' ' ' GLU . 46.0 ttm105 -59.04 -50.08 75.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.689 -0.687 . . . . 10.0 111.362 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 60.9 m -55.38 -40.74 71.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.613 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.67 -41.76 65.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.924 0.392 . . . . 10.0 110.737 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -63.76 -47.64 80.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 10.0 112.055 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 262' ' ' ARG . 46.2 mt-10 -66.75 -7.77 23.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.929 0.715 . . . . 10.0 112.929 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 80.7 mt -108.58 -41.09 4.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.003 0.43 . . . . 10.0 110.47 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -71.27 -40.28 71.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 21.1 p -102.65 -18.54 15.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.968 -0.56 . . . . 10.0 111.874 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.01 -35.61 2.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.487 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.34 145.45 82.78 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 110.327 -0.249 . . . . 10.0 110.327 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.486 ' HA ' ' HG2' ' A' ' 266' ' ' GLU . 62.5 Cg_endo -73.56 155.87 49.85 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.443 2.096 . . . . 10.0 112.354 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.499 HD12 ' HD2' ' A' ' 274' ' ' PRO . 28.1 tp -115.41 125.31 28.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.945 -0.57 . . . . 10.0 110.32 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.499 ' HD2' HD12 ' A' ' 273' ' ' LEU . 80.7 Cg_endo -77.46 -157.9 0.08 OUTLIER 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.701 2.267 . . . . 10.0 111.591 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -78.53 134.27 37.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.662 -0.496 . . . . 10.0 109.662 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.99 131.62 36.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.057 0.456 . . . . 10.0 111.785 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 1.2 m -103.51 101.43 11.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.78 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.463 HD13 ' HB ' ' A' ' 290' ' ' THR . 3.8 mm? -72.29 132.54 44.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.672 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 26.1 m -106.65 142.07 36.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.85 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -73.37 141.08 47.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.806 0.336 . . . . 10.0 111.13 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 66.8 t -98.88 108.11 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.042 -0.526 . . . . 10.0 109.618 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 77.3 mtm-85 -63.94 133.13 52.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.841 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 114.46 -31.12 6.57 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.776 -0.93 . . . . 10.0 110.776 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 59.5 mtm -132.67 89.02 2.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.77 103.58 0.27 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.606 -0.725 . . . . 10.0 112.034 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . 0.563 ' HA3' ' ND2' ' A' ' 354' ' ' ASN . . . 132.59 -19.08 4.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.527 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 42.5 mm -92.94 131.79 39.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -123.8 160.69 26.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.384 -0.598 . . . . 10.0 109.384 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.83 165.6 30.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.022 0.439 . . . . 10.0 111.397 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.463 ' HB ' HD13 ' A' ' 278' ' ' LEU . 14.5 t -157.29 145.54 19.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.123 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -113.79 124.13 51.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.686 0.279 . . . . 10.0 110.861 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 31.2 mt -112.84 105.15 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.593 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 3.9 p -72.4 100.69 2.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.416 . . . . 10.0 110.121 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 78.6 mtp -90.54 104.15 16.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.184 0.516 . . . . 10.0 111.952 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 25.6 t -102.1 111.77 64.66 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.592 -0.892 . . . . 10.0 108.592 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.64 142.14 32.44 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.287 2.658 . . . . 10.0 113.641 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . 0.431 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . . . -71.16 134.71 85.06 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.256 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 297' ' ' ALA . 36.8 Cg_exo -62.25 120.58 8.21 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.474 2.116 . . . . 10.0 111.913 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 94.48 20.14 30.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.012 -0.613 . . . . 10.0 113.084 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 90.3 p -110.61 163.8 13.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.91 -0.404 . . . . 10.0 109.91 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.64 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 28.1 pttt -71.05 -27.41 63.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.028 -0.73 . . . . 10.0 109.028 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -64.27 -41.53 96.87 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.875 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -64.3 -40.62 96.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.665 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -70.4 -25.8 63.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.506 -0.77 . . . . 10.0 112.27 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 67.5 mt -57.5 -57.33 13.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.707 0.289 . . . . 10.0 111.325 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.403 HD21 HD22 ' A' ' 113' ' ' LEU . 90.1 mt -73.48 -10.64 59.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 10.0 111.341 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -89.21 -36.61 15.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.485 . . . . 10.0 110.488 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.1 -30.64 25.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.108 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -142.02 117.84 10.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.095 0.474 . . . . 10.0 111.163 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -109.09 1.08 20.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.214 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.964 -1.017 . . . . 10.0 109.262 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.824 -0.51 . . . . 10.0 111.824 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.84 -27.58 67.45 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.753 2.302 . . . . 10.0 112.014 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 89.8 mt -115.53 93.51 4.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.287 0.565 . . . . 10.0 110.239 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -79.76 111.82 16.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.509 -0.769 . . . . 10.0 110.548 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -65.1 136.84 57.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.116 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -83.83 -7.2 59.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.547 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 105.38 -7.21 42.98 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.8 -0.714 . . . . 10.0 111.728 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . 0.41 ' HA2' ' NH2' ' A' ' 345' ' ' ARG . . . 91.61 156.78 33.06 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.659 -0.782 . . . . 10.0 111.51 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . 0.426 ' O ' HG22 ' A' ' 343' ' ' THR . . . -91.31 86.94 6.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.115 0.484 . . . . 10.0 110.077 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.594 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -88.4 157.39 27.83 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.707 -0.759 . . . . 10.0 112.664 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . 0.408 ' C ' ' HG1' ' A' ' 334' ' ' THR . 29.9 p90 -135.67 152.26 51.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.141 -0.318 . . . . 10.0 110.141 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 55.9 m -155.41 126.14 6.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.601 0.238 . . . . 10.0 110.502 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.35 165.89 14.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.449 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -63.9 -14.73 55.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.62 0.6 . . . . 10.0 112.62 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.9 -11.57 59.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.424 -0.353 . . . . 10.0 111.898 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 105.23 -0.71 40.62 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.476 -0.869 . . . . 10.0 113.986 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 334' ' ' THR . 23.3 mtm180 -77.78 122.92 26.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.476 0.638 . . . . 10.0 110.905 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -118.04 139.33 14.62 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -152.98 -176.78 25.88 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.729 -0.948 . . . . 10.0 110.729 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.594 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 15.1 tt -144.32 139.67 24.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 117.096 0.448 . . . . 10.0 110.724 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 331' ' ' ALA . 11.7 t -99.73 120.99 40.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.211 0.529 . . . . 10.0 110.179 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 14.6 tp -79.28 122.78 26.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.893 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . 0.41 ' NH2' ' HA2' ' A' ' 330' ' ' GLY . 59.9 mtm180 -93.01 102.39 14.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.914 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 31.7 t -103.0 137.1 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.439 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -128.89 149.14 50.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.378 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.5 124.3 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.125 -0.488 . . . . 10.0 109.953 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -108.78 119.46 39.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.2 -0.454 . . . . 10.0 110.103 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.5 106.65 16.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.126 0.488 . . . . 10.0 111.333 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 109.7 133.46 6.65 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.014 -0.613 . . . . 10.0 112.14 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.82 -36.92 80.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 10.0 110.875 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' B' ' 60' ' ' SER . . . -68.12 -28.14 73.46 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.219 -0.752 . . . . 10.0 111.219 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.613 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 1.3 m-20 -80.91 -37.11 30.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.67 94.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.9 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . 0.403 ' HZ3' ' CG ' ' B' ' 63' ' ' ASP . 70.3 tttt -57.45 -46.52 83.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.119 178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.613 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 10.5 mtmm -64.01 -47.24 81.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.687 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.8 tp -61.74 -50.31 72.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 10.0 111.797 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 90.9 mt -55.76 -42.28 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.588 -0.278 . . . . 10.0 111.37 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 12.0 m -61.37 -43.22 99.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.982 0.42 . . . . 10.0 110.54 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.474 ' HZ2' ' CD ' ' A' ' 366' ' ' GLU . 10.3 mttm -70.57 -29.19 65.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.198 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 75.4 mtp -69.91 -40.85 75.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.075 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -66.7 -26.98 67.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.045 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.19 -9.55 59.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.764 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 87.09 9.22 74.0 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.054 -0.593 . . . . 10.0 112.801 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . 0.474 ' CD ' ' HZ2' ' A' ' 361' ' ' LYS . 38.5 mt-10 -75.66 -50.9 14.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.846 0.355 . . . . 10.0 110.645 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -98.46 100.79 12.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.777 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -97.69 109.53 22.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.155 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' TYR . . . . . 0.463 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 82.1 m-85 -136.99 159.79 40.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.999 -0.371 . . . . 10.0 109.999 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -103.43 -34.59 8.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.038 0.447 . . . . 10.0 111.547 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . 0.504 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 45.0 t80 -132.16 129.11 39.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . 0.61 ' HB ' ' HD1' ' A' ' 126' ' ' PHE . 43.6 t -129.67 119.03 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.813 0.671 . . . . 10.0 112.813 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.453 ' OE2' ' HB2' ' A' ' 257' ' ' MET . 5.2 tp10 -91.59 113.86 26.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.77 -1.196 . . . . 10.0 107.77 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 58.2 mt -109.27 118.16 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.257 0.551 . . . . 10.0 112.325 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' MET . . . . . 0.783 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 62.0 mtt -111.82 142.22 44.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.623 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -81.05 -28.03 35.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.196 0.522 . . . . 10.0 110.925 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.57 158.58 36.51 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.472 -0.786 . . . . 10.0 110.156 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.427 ' HG3' ' SG ' ' B' ' 42' ' ' CYS . 42.5 Cg_endo -91.21 12.84 2.22 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.357 2.704 . . . . 10.0 112.596 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.403 ' HB3' ' HA3' ' A' ' 383' ' ' GLY . . . -156.56 41.21 0.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.305 -0.407 . . . . 10.0 111.115 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 65.85 -127.48 30.77 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.461 -0.876 . . . . 10.0 112.359 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' CYS . . . . . 0.519 ' HA ' ' S2 ' ' A' ' 501' ' ' SF4 . 3.4 m -95.33 -25.84 16.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.15 0.426 . . . . 10.0 112.15 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 33.2 m -70.0 -17.5 21.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 111.952 0.352 . . . . 10.0 111.952 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 379' ' ' ALA . . . -109.33 34.92 5.22 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.035 -0.53 . . . . 10.0 112.377 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -80.63 162.99 45.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.762 -0.732 . . . . 10.0 112.206 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -72.69 -12.95 78.29 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.034 -0.603 . . . . 10.0 113.18 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -91.76 2.48 76.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.626 -0.797 . . . . 10.0 111.788 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -92.09 153.46 43.24 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' PRO . . . . . 0.43 ' HD2' ' HB1' ' A' ' 58' ' ' ALA . 31.3 Cg_exo -64.09 172.15 6.6 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.618 2.212 . . . . 10.0 111.239 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 109.65 8.1 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 28.3 m -87.6 -177.27 5.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.097 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' THR . . . . . 0.439 ' HA ' ' OH ' ' B' ' 35' ' ' TYR . 0.0 OUTLIER -86.19 44.27 1.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.341 0.591 . . . . 10.0 111.172 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -144.28 120.88 11.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.893 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' B' ' 36' ' ' SER . 21.1 mttm -71.68 -13.81 61.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.325 -0.398 . . . . 10.0 111.93 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -115.77 27.39 9.33 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.984 0.421 . . . . 10.0 111.06 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.566 HD12 ' HD2' ' A' ' 398' ' ' LYS . 9.5 tp -68.76 -21.91 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.332 0.587 . . . . 10.0 110.353 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -42.53 99.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.475 -0.784 . . . . 10.0 111.111 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -62.79 -39.59 94.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.704 -0.68 . . . . 10.0 111.113 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.566 ' HD2' HD12 ' A' ' 395' ' ' ILE . 52.7 mttp -64.14 -39.0 93.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.075 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.433 HH21 ' CD ' ' A' ' 61' ' ' GLU . 98.8 mtt180 -68.1 -39.35 82.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.27 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -63.19 -41.91 99.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.867 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -71.45 -27.78 63.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.413 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -96.88 14.9 23.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.828 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.6 mt -64.56 -40.17 95.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.989 0.423 . . . . 10.0 110.738 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.483 ' HH ' HD11 ' A' ' 91' ' ' LEU . 81.6 m-85 -133.78 158.64 42.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.787 -0.642 . . . . 10.0 109.439 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -79.0 165.49 23.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.478 HD13 ' HD2' ' A' ' 409' ' ' LYS . 3.9 mm? -61.02 -34.08 74.29 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.889 0.7 . . . . 10.0 112.889 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -74.09 -28.11 61.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.956 0.408 . . . . 10.0 111.256 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . 0.551 ' HG2' ' CE1' ' A' ' 250' ' ' PHE . 36.2 mt-10 -77.44 -32.62 54.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.709 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . 0.478 ' HD2' HD13 ' A' ' 406' ' ' LEU . 90.4 mttt -66.29 -35.22 79.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 10.0 111.79 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.3 6.83 21.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.029 0.443 . . . . 10.0 111.767 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 23.6 m -118.87 93.94 4.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.98 0.419 . . . . 10.0 110.683 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 30.1 tp -77.66 111.77 13.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.547 -0.538 . . . . 10.0 109.547 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . 0.654 ' HD3' ' HB2' ' A' ' 249' ' ' LEU . 5.2 tmm_? -107.76 148.41 29.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.125 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -116.63 137.0 52.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.508 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 4.6 m -69.05 -30.88 69.33 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.041 0.386 . . . . 10.0 112.041 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -69.28 -1.74 8.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -118.28 14.25 13.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.932 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . 0.424 ' HA ' HD11 ' A' ' 249' ' ' LEU . 55.3 t-20 -88.5 113.95 57.65 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.502 ' HD3' HD11 ' A' ' 249' ' ' LEU . 51.1 Cg_exo -54.97 -39.94 88.22 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.18 2.586 . . . . 10.0 112.53 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.6 m -61.28 -42.91 99.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.112 0.482 . . . . 10.0 110.564 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 49.7 mm -72.16 -40.51 66.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.881 -0.599 . . . . 10.0 110.171 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.5 -44.82 95.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.475 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -60.79 -45.19 95.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 10.0 110.618 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.448 ' HB2' ' SD ' ' A' ' 240' ' ' MET . 45.2 tp -64.63 -41.19 96.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.882 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . 0.672 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 1.2 m-85 -68.13 -33.64 74.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.024 -0.534 . . . . 10.0 110.967 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.66 -61.18 2.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.566 0.95 . . . . 10.0 113.566 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.52 16.99 5.76 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.842 1.423 . . . . 10.0 114.842 -176.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -150.73 -63.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.243 0.831 . . . . 10.0 113.243 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . 0.672 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 96.2 mt -67.37 -36.5 81.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.853 0.686 . . . . 10.0 112.853 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 97.47 -68.12 0.79 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.892 -0.67 . . . . 10.0 111.853 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -161.31 157.47 21.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.767 -0.457 . . . . 10.0 109.767 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.466 ' HA ' ' HE1' ' A' ' 425' ' ' TYR . 52.1 Cg_exo -58.28 132.36 48.43 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.582 2.188 . . . . 10.0 110.915 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' A' ' 103' ' ' SER . 4.6 mp 66.63 9.63 6.78 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.986 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 438' ' ' HIS . . . -70.21 -170.68 8.79 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.32 -0.467 . . . . 10.0 112.865 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -55.28 -62.33 1.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.381 0.511 . . . . 10.0 112.381 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 436' ' ' LYS . 31.3 tptt -60.43 -38.34 83.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.906 0.384 . . . . 10.0 111.83 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 441' ' ' LEU . . . -66.69 -46.09 76.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.084 0.469 . . . . 10.0 111.006 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . 0.512 ' HB2' ' O ' ' A' ' 434' ' ' GLY . 0.1 OUTLIER -70.14 -20.4 63.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.944 0.402 . . . . 10.0 110.976 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -76.07 -65.34 0.93 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.954 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 81.5 mt -92.81 -24.7 18.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.488 1.292 . . . . 10.0 114.488 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 437' ' ' ALA . 68.3 mt -93.0 -6.14 49.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 438' ' ' HIS . 26.0 m-70 -121.71 165.06 16.36 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.27 -0.269 . . . . 10.0 110.949 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 7.5 t -152.15 -168.95 3.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.641 0.258 . . . . 10.0 111.596 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -139.72 161.48 37.43 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.375 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' TYR . . . . . 0.566 ' HD2' HG23 ' A' ' 145' ' ' ILE . 37.9 m-85 -110.58 168.88 9.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.695 -0.229 . . . . 10.0 111.029 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.08 113.3 36.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 10.0 111.013 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -66.18 105.86 1.5 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.482 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 131.51 -20.41 4.66 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.28 -0.728 . . . . 10.0 111.28 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . 108.12 167.56 21.38 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.844 -0.693 . . . . 10.0 112.069 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.628 -0.701 . . . . 10.0 110.65 -179.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.698 ' HE1' ' HB2' ' B' ' 18' ' ' ALA . 86.0 m-85 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.016 -0.364 . . . . 10.0 110.016 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -88.65 116.03 26.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.86 -0.422 . . . . 10.0 109.86 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.48 124.93 69.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.218 0.532 . . . . 10.0 111.435 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' B' ' 13' ' ' THR . 26.8 m -91.18 113.03 25.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.283 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' B' ' 11' ' ' ASP . 64.5 mt -90.14 132.56 35.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.184 -0.462 . . . . 10.0 109.986 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.75 ' HD2' ' HB3' ' B' ' 11' ' ' ASP . 3.6 tptp -100.54 108.33 20.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.438 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.0 p -115.18 164.81 15.77 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.02 -29.21 87.42 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.346 2.031 . . . . 10.0 111.752 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -76.5 -34.81 58.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.387 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.89 171.72 25.07 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.364 -0.695 . . . . 10.0 111.364 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.75 ' HB3' ' HD2' ' B' ' 6' ' ' LYS . 4.0 p30 -94.36 152.49 18.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.94 0.37 . . . . 10.0 111.032 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -147.14 124.13 11.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.669 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 19.2 m -88.23 99.91 12.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.093 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 21.0 pt -101.25 171.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -112.81 117.8 33.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.124 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 31.6 m -127.08 128.91 24.07 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.91 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.761 ' HD2' ' HB ' ' B' ' 20' ' ' THR . 15.8 Cg_exo -71.8 165.76 31.57 Favored 'Trans proline' 0 CA--C 1.529 0.275 0 C-N-CA 123.059 2.506 . . . . 10.0 110.99 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.698 ' HB2' ' HE1' ' B' ' 1' ' ' TYR . . . -74.52 -16.55 60.83 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.478 0.547 . . . . 10.0 112.478 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -107.52 15.2 25.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.063 0.459 . . . . 10.0 111.301 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.761 ' HB ' ' HD2' ' B' ' 17' ' ' PRO . 5.0 m -129.78 141.92 50.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.486 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -66.53 138.95 57.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.617 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 26.4 mt -56.07 -43.28 75.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 10.0 111.593 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.573 HD11 ' HG2' ' B' ' 38' ' ' ARG . 1.0 OUTLIER -67.06 -21.62 65.89 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -179.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -69.44 -27.23 65.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.208 0.528 . . . . 10.0 110.982 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.86 -25.61 22.07 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.373 -0.603 . . . . 10.0 109.373 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.32 -43.25 74.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.668 -0.696 . . . . 10.0 110.488 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.61 -33.07 75.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.331 0.586 . . . . 10.0 110.121 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -71.98 -37.32 69.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.446 -0.797 . . . . 10.0 110.249 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.48 -34.77 60.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.958 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.61 40.55 1.32 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.075 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.18 144.3 33.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.645 0.259 . . . . 10.0 110.707 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.57 118.78 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.854 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.449 HD23 ' HD2' ' B' ' 34' ' ' PRO . 0.5 OUTLIER -163.96 127.41 1.76 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.335 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.449 ' HD2' HD23 ' B' ' 33' ' ' LEU . 7.0 Cg_exo -74.62 96.79 1.0 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.781 2.321 . . . . 10.0 111.383 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.439 ' OH ' ' HA ' ' A' ' 391' ' ' THR . 43.5 p90 -118.23 156.15 29.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.357 -0.383 . . . . 10.0 110.897 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.494 ' O ' ' HB3' ' A' ' 393' ' ' LYS . 5.0 p -166.45 -88.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.638 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' CYS . . . . . . . . . . . . . 4.1 p -79.32 -56.65 4.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.924 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.573 ' HG2' HD11 ' B' ' 23' ' ' LEU . 0.0 OUTLIER 66.32 39.43 4.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.877 -0.602 . . . . 10.0 111.218 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.05 17.29 23.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.486 . . . . 10.0 111.624 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.92 46.06 54.31 Favored Glycine 0 C--O 1.238 0.361 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.277 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.96 -66.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.372 . . . . 10.0 111.31 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . 0.427 ' SG ' ' HG3' ' A' ' 378' ' ' PRO . 3.7 p -83.06 139.49 33.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.909 0.385 . . . . 10.0 111.429 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.609 ' HA ' HD11 ' B' ' 73' ' ' LEU . 0.7 OUTLIER -100.09 36.4 1.85 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.817 -0.628 . . . . 10.0 110.483 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.471 ' HA ' HH22 ' A' ' 187' ' ' ARG . 0.1 OUTLIER -73.1 -39.77 65.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.746 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 63.77 1.07 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.024 -0.535 . . . . 10.0 111.603 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.57 94.93 9.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.202 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -75.61 148.3 36.74 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.862 -0.608 . . . . 10.0 112.992 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.706 ' HE2' ' HD1' ' B' ' 71' ' ' PHE . 0.0 OUTLIER -103.39 130.91 50.82 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.1 -0.333 . . . . 10.0 110.1 179.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.431 ' HB ' ' HA2' ' B' ' 70' ' ' GLY . 7.2 t -87.48 96.9 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.589 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.88 -38.03 64.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.166 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.67 158.2 35.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.692 -0.685 . . . . 10.0 109.388 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' B' ' 83' ' ' CYS . . . 88.69 -179.3 45.89 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.838 -0.696 . . . . 10.0 112.265 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.8 m -129.25 137.07 50.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.97 0.414 . . . . 10.0 111.288 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.807 HG12 ' HA ' ' B' ' 79' ' ' PRO . 4.2 m -132.67 155.76 41.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.553 ' HB3' ' CE2' ' B' ' 78' ' ' TYR . 17.8 t70 -119.38 145.69 45.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.787 0.327 . . . . 10.0 110.626 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.14 128.14 37.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.159 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.9 -31.9 25.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.145 0.498 . . . . 10.0 110.819 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -134.52 163.68 29.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.919 -0.771 . . . . 10.0 108.919 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.27 172.13 1.57 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.862 0.363 . . . . 10.0 110.626 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.502 ' HA ' ' HA2' ' A' ' 353' ' ' GLY . 0.7 OUTLIER -86.67 -135.64 0.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.546 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -73.04 -8.93 57.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.055 0.455 . . . . 10.0 110.792 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 mp -82.14 76.66 9.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.403 ' CG ' ' HZ3' ' A' ' 356' ' ' LYS . 4.3 m-20 -75.01 -169.53 0.94 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.262 -0.427 . . . . 10.0 111.91 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -27.28 64.1 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.718 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.84 -34.98 75.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.176 0.512 . . . . 10.0 110.279 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' B' ' 71' ' ' PHE . 15.5 mm-40 -87.02 -24.8 24.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.376 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -60.46 -43.61 96.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 10.0 109.802 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.08 -23.58 67.95 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.65 -0.705 . . . . 10.0 112.355 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -85.9 -18.3 33.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.104 0.478 . . . . 10.0 109.899 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.431 ' HA2' ' HB ' ' B' ' 49' ' ' VAL . . . 106.95 32.11 3.65 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.831 -0.699 . . . . 10.0 112.968 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.706 ' HD1' ' HE2' ' B' ' 48' ' ' LYS . 14.7 m-85 -121.35 109.49 14.96 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.498 -0.413 . . . . 10.0 110.484 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 26.0 m -134.02 175.34 11.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 10.0 111.283 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' B' ' 43' ' ' SER . 21.4 tp -115.19 109.32 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.408 -0.59 . . . . 10.0 109.408 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.6 -16.88 17.85 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.829 0.677 . . . . 10.0 112.829 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.29 -22.71 65.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.549 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.73 32.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.963 0.411 . . . . 10.0 110.703 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.39 134.0 55.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . 0.553 ' CE2' ' HB3' ' B' ' 55' ' ' ASP . 0.8 OUTLIER -126.21 140.59 37.44 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.79 -0.641 . . . . 10.0 109.993 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 0.807 ' HA ' HG12 ' B' ' 54' ' ' VAL . 7.1 Cg_exo -73.17 107.98 2.5 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.899 2.4 . . . . 10.0 112.496 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.34 -25.81 62.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 73.5 m -159.69 -175.15 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.166 -0.924 . . . . 10.0 108.845 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.52 135.01 51.06 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.352 0.408 . . . . 10.0 110.129 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . 0.469 ' HB3' ' HA3' ' B' ' 52' ' ' GLY . 1.0 OUTLIER -156.82 171.21 20.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.286 0.565 . . . . 10.0 112.522 -179.046 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -129.27 114.3 16.08 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.603 -1.258 . . . . 10.0 107.603 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 25.5 mm -114.1 131.33 66.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.05 0.759 . . . . 10.0 113.05 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -97.96 85.69 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.62 36.77 0.27 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.604 0.964 . . . . 10.0 113.604 -177.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -144.95 24.73 1.47 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.316 0.487 . . . . 10.0 112.316 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.592 ' HB3' ' HD2' ' B' ' 48' ' ' LYS . 1.6 mm-40 -119.44 90.23 3.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.945 0.402 . . . . 10.0 110.3 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -92.39 -8.02 46.07 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.056 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -87.86 -37.48 16.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 10.0 111.009 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.59 ' HB3' ' HD3' ' B' ' 48' ' ' LYS . . . -74.25 87.94 1.99 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.012 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pp 178.27 -23.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.471 -0.786 . . . . 10.0 110.87 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 33.2 t80 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.37 -0.824 . . . . 10.0 110.576 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' SF4 . . . . . 0.519 ' S2 ' ' HA ' ' A' ' 381' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 p -74.93 165.96 24.42 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.923 -0.399 . . . . 10.0 109.923 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.418 ' CD2' ' HG2' ' A' ' 189' ' ' GLN . 96.7 m-70 -64.23 -31.02 72.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.761 0.282 . . . . 10.0 111.761 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.73 -45.15 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.503 -0.555 . . . . 10.0 109.503 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -63.6 -31.32 72.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.386 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.534 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 36.8 mt-30 -62.83 -23.46 67.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.264 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.1 -38.66 10.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.888 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.19 -35.08 76.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.098 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.6 -36.45 74.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.085 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -79.77 -34.83 39.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.382 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.15 -25.4 62.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.239 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.55 -7.5 56.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.011 0.434 . . . . 10.0 110.626 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 91.9 mttt -93.8 121.7 63.87 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.908 -0.587 . . . . 10.0 109.906 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.1 148.89 75.13 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.56 2.173 . . . . 10.0 110.415 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.826 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 61.9 mttt -63.89 -10.41 20.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.978 0.732 . . . . 10.0 112.978 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -98.52 -5.32 32.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.734 0.302 . . . . 10.0 111.288 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.2 135.84 82.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.314 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.91 -17.34 59.31 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.714 2.276 . . . . 10.0 113.171 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.75 14.16 30.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 10.0 110.781 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.826 ' HG2' ' HA ' ' A' ' 39' ' ' LYS . 6.8 tpt180 -87.64 115.51 25.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.504 . . . . 10.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.742 ' HD3' ' HA ' ' A' ' 176' ' ' ASP . 14.0 mttp -93.7 169.11 10.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.816 -0.629 . . . . 10.0 109.882 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.51 111.75 18.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.84 -0.8 . . . . 10.0 108.84 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.33 102.16 13.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.082 0.468 . . . . 10.0 111.646 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.3 m -99.1 140.54 33.11 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.245 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 13.1 p -132.38 135.84 57.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.085 0.469 . . . . 10.0 112.115 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 14.5 pt20 -116.35 127.07 54.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.967 -0.561 . . . . 10.0 109.581 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.445 HG11 HD21 ' A' ' 75' ' ' LEU . 2.0 t -104.03 150.04 7.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.123 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.02 139.08 20.48 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.481 . . . . 10.0 109.962 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.7 -35.03 66.89 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.184 2.59 . . . . 10.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.68 -32.86 74.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.102 0.477 . . . . 10.0 110.768 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.929 HG13 HG23 ' A' ' 214' ' ' THR . 88.0 t -80.53 -40.15 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.776 -0.647 . . . . 10.0 109.374 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -56.6 -33.08 65.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.536 -0.757 . . . . 10.0 112.316 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.38 -37.52 12.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 113.292 0.849 . . . . 10.0 113.292 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.56 -5.56 53.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.528 0.936 . . . . 10.0 113.528 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.34 -26.39 40.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.823 0.344 . . . . 10.0 111.687 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.83 -24.85 65.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.591 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -66.24 -26.14 67.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.279 -0.419 . . . . 10.0 112.049 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.0 p -68.18 -23.59 64.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.066 0.46 . . . . 10.0 110.54 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.6 mt -94.02 -0.78 55.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.164 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.99 18.52 55.85 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.947 -0.644 . . . . 10.0 112.385 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.8 mt -106.34 164.62 11.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.662 0.267 . . . . 10.0 110.764 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.61 153.9 85.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.527 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.43 133.65 59.37 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.567 2.178 . . . . 10.0 111.691 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.49 14.17 62.14 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.667 -0.777 . . . . 10.0 113.082 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.57 -27.04 31.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.953 0.406 . . . . 10.0 111.245 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 p -103.25 129.26 50.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.194 -0.457 . . . . 10.0 109.976 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -77.76 154.74 80.92 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.323 -0.251 . . . . 10.0 110.323 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.84 -41.12 77.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.713 2.276 . . . . 10.0 111.935 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 233' ' ' GLU . 46.8 mttm -66.15 -36.59 83.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.967 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -61.71 -41.67 97.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.013 0.435 . . . . 10.0 110.654 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.445 HD21 HG11 ' A' ' 51' ' ' VAL . 48.8 tp -64.73 -44.53 89.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.432 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.34 95.24 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.73 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.476 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 23.9 tp10 -60.32 -46.9 88.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.881 -0.599 . . . . 10.0 110.29 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.04 -43.81 96.79 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.85 -0.613 . . . . 10.0 112.442 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.44 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 30.6 mt -60.02 -43.93 94.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 10.0 111.124 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -64.18 -32.51 74.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.943 0.401 . . . . 10.0 110.619 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -74.68 -12.62 60.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.386 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.7 mt -77.62 -19.61 55.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 10.0 109.937 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.59 7.58 8.07 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.649 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.44 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 47.3 m-85 -72.81 156.63 38.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.729 0.299 . . . . 10.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -98.03 -58.71 1.92 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.993 0.425 . . . . 10.0 111.357 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . 2.9 mp0 -117.61 128.15 54.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.131 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.4 t -113.52 114.26 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.267 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 86' ' ' GLU . 24.5 m-85 -118.1 170.55 8.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.476 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -118.11 149.04 41.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.4 m -64.78 -20.57 66.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.74 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.447 HD21 ' HH ' ' A' ' 404' ' ' TYR . 24.7 mt -57.91 -34.57 69.97 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.429 ' HD2' HD13 ' A' ' 158' ' ' LEU . 42.9 t80 -66.99 -37.63 84.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.151 0.5 . . . . 10.0 109.96 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.02 -34.47 58.62 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.994 -0.842 . . . . 10.0 110.994 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.89 -36.38 83.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.605 -0.298 . . . . 10.0 110.509 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.13 -33.93 69.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.07 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD21 HD23 ' A' ' 424' ' ' LEU . 78.9 mt -76.09 -42.79 46.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.988 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m -59.67 -44.33 93.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.667 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.5 mt -58.68 -42.14 84.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.905 -0.589 . . . . 10.0 110.753 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 87.6 mmm -66.95 -48.45 68.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.229 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -66.87 -53.92 27.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.438 ' HG2' ' SG ' ' A' ' 151' ' ' CYS . 18.9 mt-10 -60.42 -40.95 92.86 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.847 0.356 . . . . 10.0 110.932 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.16 99.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.095 -0.574 . . . . 10.0 111.865 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.8 m -67.94 -39.89 83.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.531 0.205 . . . . 10.0 110.853 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.529 ' HA ' ' HD2' ' A' ' 107' ' ' HIS . 19.6 tt0 -64.57 -41.3 96.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.05 -51.15 69.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.117 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.1 tp -57.3 -46.78 82.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.639 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.73 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -64.77 -40.13 94.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.431 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -58.13 -40.73 82.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.035 0.445 . . . . 10.0 110.25 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 45.4 tp -70.03 -42.25 73.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.85 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 m -58.4 -47.48 83.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.835 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 30.2 mm-40 -57.44 -35.88 70.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.129 0.49 . . . . 10.0 110.468 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -75.9 -29.44 58.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.771 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 95.7 mt -76.36 -34.0 58.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.173 0.511 . . . . 10.0 110.343 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -79.81 -43.41 22.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.381 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.093 0 O-C-N 123.831 0.707 . . . . 10.0 111.728 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.795 0.331 . . . . 10.0 110.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -85.27 -165.12 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.798 2.332 . . . . 10.0 112.615 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.404 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 94.1 mt -129.07 157.72 75.03 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.404 ' C ' ' HA ' ' A' ' 123' ' ' LEU . 18.3 Cg_exo -66.37 167.23 55.02 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.296 -1.127 . . . . 10.0 113.129 0.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 25.7 ttt -113.57 133.35 55.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.774 . . . . 10.0 111.007 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -113.79 144.45 42.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.963 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.502 ' HG1' ' HG3' ' A' ' 373' ' ' GLU . 0.0 OUTLIER -74.11 150.32 40.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.67 0.272 . . . . 10.0 110.322 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.662 ' HB2' ' HH ' ' A' ' 445' ' ' TYR . 2.0 p -116.47 20.4 14.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 6.82 28.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.451 ' O ' HG12 ' A' ' 134' ' ' ILE . 54.1 t -120.15 117.78 31.81 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 120.658 0.266 . . . . 10.0 111.567 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 130' ' ' CYS . 28.1 Cg_endo -63.23 -33.79 70.27 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.364 2.71 . . . . 10.0 112.048 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.02 -41.63 97.16 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.946 -0.645 . . . . 10.0 111.571 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -65.8 -44.04 86.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.078 -0.342 . . . . 10.0 110.078 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 130' ' ' CYS . 35.2 mm -57.99 -42.38 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.966 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.45 76.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.168 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' MET . . . . . 0.406 ' SD ' ' HB2' ' B' ' 61' ' ' PHE . 12.2 tpt -67.2 -34.19 76.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.007 0.432 . . . . 10.0 110.823 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 148' ' ' VAL . 22.0 tp -60.44 -60.7 3.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.57 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -63.73 -20.62 65.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.682 -0.235 . . . . 10.0 111.599 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -81.06 -61.97 1.8 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.607 0.965 . . . . 10.0 113.607 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 m -115.27 1.0 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.714 1.376 . . . . 10.0 114.714 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.533 ' HB3' HD12 ' A' ' 144' ' ' LEU . 53.5 m-85 -134.14 60.65 45.86 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 122.05 -0.406 . . . . 10.0 111.102 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.96 -25.43 32.36 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.364 2.043 . . . . 10.0 113.1 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -87.07 1.05 54.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.987 0.422 . . . . 10.0 111.289 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 141' ' ' TYR . 59.8 mt -105.99 4.27 29.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.462 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.59 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 75.6 mt -57.94 -53.72 62.88 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 49.3 Cg_exo -58.4 -18.94 41.05 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.479 2.119 . . . . 10.0 113.076 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 125' ' ' MET . 96.5 m-85 -78.76 -20.03 50.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.214 0.531 . . . . 10.0 110.459 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.433 HG21 HD22 ' A' ' 137' ' ' LEU . 16.7 t -90.49 154.3 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.587 . . . . 10.0 109.589 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.0 t -68.18 158.31 33.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.069 0.461 . . . . 10.0 111.125 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 88.3 p -100.54 6.41 44.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.237 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . 0.438 ' SG ' ' HG2' ' A' ' 101' ' ' GLU . 4.5 m -80.83 143.9 32.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.228 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -85.66 165.12 17.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.099 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.2 p -67.19 155.11 91.37 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.761 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -45.15 -54.68 4.08 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.604 2.87 . . . . 10.0 114.214 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.465 HE21 ' HB2' ' A' ' 155' ' ' GLN . 0.0 OUTLIER -65.14 -34.31 78.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.709 0.633 . . . . 10.0 112.709 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 78.9 mmm -72.81 -23.81 60.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.064 0.459 . . . . 10.0 110.481 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 36.6 mtt -75.8 -48.88 19.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.328 -0.619 . . . . 10.0 109.328 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.429 HD13 ' HD2' ' A' ' 92' ' ' PHE . 49.2 tp -62.82 -40.22 96.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.372 -0.831 . . . . 10.0 111.038 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.47 81.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.471 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.88 -31.87 57.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.534 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -70.26 -43.26 70.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.691 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.476 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.8 m -68.89 -27.48 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 179' ' ' MET . 44.4 mttt -88.94 7.7 33.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.016 0.376 . . . . 10.0 112.016 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.6 p -129.41 -74.67 0.55 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.814 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -62.97 -50.83 69.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.56 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 162' ' ' VAL . 54.8 tp -64.04 -40.8 97.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 10.0 110.787 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.77 -52.04 67.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.919 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -64.04 -43.72 94.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.389 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -62.45 -38.06 88.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 10.0 111.991 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -89.32 -7.48 55.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 69.06 40.87 83.1 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.104 -0.569 . . . . 10.0 112.642 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 43.2 mt -123.5 142.39 40.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -79.51 136.36 56.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 110.018 -0.364 . . . . 10.0 110.018 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 173' ' ' ALA . 51.3 Cg_exo -57.44 -16.05 21.88 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.237 2.624 . . . . 10.0 113.143 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -72.77 -28.88 62.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 10.0 110.864 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.742 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 58.3 m-20 -101.82 29.62 4.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.401 0.62 . . . . 10.0 110.244 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 95.4 mtp -126.89 124.73 40.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.142 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 32.1 t -107.93 119.31 57.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.338 -0.615 . . . . 10.0 109.338 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.532 ' HB3' HD12 ' A' ' 208' ' ' LEU . 0.0 OUTLIER -103.31 109.11 20.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.055 0.455 . . . . 10.0 111.273 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 28.0 t -108.69 142.1 22.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.413 ' OG ' HD21 ' A' ' 208' ' ' LEU . 10.1 p -134.79 138.22 44.08 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.917 -0.313 . . . . 10.0 111.049 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.411 ' CG2' HG11 ' A' ' 55' ' ' VAL . 21.2 mm -100.35 108.95 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.547 ' O ' ' HA ' ' A' ' 213' ' ' THR . 31.9 mmt -116.95 149.38 44.04 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.49 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.68 25.02 0.71 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.828 2.352 . . . . 10.0 112.518 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 30.2 t -156.99 139.29 14.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.588 -0.278 . . . . 10.0 110.719 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.89 -24.11 52.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.156 0.503 . . . . 10.0 110.588 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -70.98 -3.05 17.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.717 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 188' ' ' LYS . 13.4 mmtt -78.13 -27.23 48.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.951 0.405 . . . . 10.0 110.9 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . 0.418 ' HG2' ' CD2' ' A' ' 27' ' ' HIS . 29.3 tp60 -68.45 -34.94 76.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 10.0 109.942 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.56 -26.63 67.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.182 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -76.82 -42.81 38.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.237 0.542 . . . . 10.0 109.81 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.436 ' CB ' HD23 ' A' ' 208' ' ' LEU . . . -74.75 -21.28 59.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.475 -0.784 . . . . 10.0 111.703 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -2.1 38.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.472 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 51.1 mtt180 -63.41 120.71 12.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.187 0.517 . . . . 10.0 110.196 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.09 -42.59 50.46 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.714 1.746 . . . . 10.0 115.714 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . 0.435 ' HZ2' HH11 ' A' ' 194' ' ' ARG . 35.3 p90 -67.78 0.73 3.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.465 1.283 . . . . 10.0 114.465 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.48 ' O ' ' HG3' ' A' ' 207' ' ' GLN . 9.7 m-85 -93.87 68.2 3.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.131 0.491 . . . . 10.0 109.949 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 5.9 p -109.38 167.88 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.187 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.435 HG22 ' HG2' ' A' ' 207' ' ' GLN . 15.9 t -113.31 103.32 15.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.088 -0.708 . . . . 10.0 109.088 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.947 -1.025 . . . . 10.0 111.644 -179.6 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.756 ' C ' ' H ' ' A' ' 205' ' ' LEU . 1.1 m . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.841 0.353 . . . . 10.0 110.457 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.777 ' C ' ' CB ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.231 0.106 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -82.52 139.84 33.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.258 -0.275 . . . . 10.0 110.258 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 197' ' ' PHE . 54.8 mt-30 -65.59 -42.51 91.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.526 0.679 . . . . 10.0 109.502 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 179' ' ' MET . 19.2 tp -120.06 136.71 54.47 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.84 -64.8 1.09 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.999 0.741 . . . . 10.0 112.999 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.534 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 1.4 m-70 -140.28 144.76 36.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.929 0.395 . . . . 10.0 111.857 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 47.3 t -112.2 131.01 64.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.51 138.13 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.479 -0.563 . . . . 10.0 109.479 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 183' ' ' MET . 72.4 p -87.81 166.93 14.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.121 0.486 . . . . 10.0 111.885 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.929 HG23 HG13 ' A' ' 55' ' ' VAL . 1.4 m -57.3 -45.97 83.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.471 -0.786 . . . . 10.0 111.429 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.7 m -61.99 -42.01 93.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.803 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 220' ' ' ILE . 41.8 mt-10 -66.17 -46.47 77.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 10.0 110.86 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.85 -45.11 95.83 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.002 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -60.71 -37.4 93.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.026 -0.606 . . . . 10.0 111.954 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . 0.486 ' HA ' ' HE3' ' A' ' 222' ' ' LYS . 42.4 m-20 -65.37 -39.33 92.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.625 0.25 . . . . 10.0 110.634 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 216' ' ' GLU . 73.4 mt -60.37 -47.57 91.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.368 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -60.2 -41.64 93.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.084 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 219' ' ' ASN . 36.9 mtmt -66.41 -47.56 72.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -63.79 -38.27 90.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 10.0 111.708 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -76.06 -18.78 59.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 10.0 111.414 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.76 40.59 12.0 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.901 -0.666 . . . . 10.0 112.119 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.5 mt -120.09 92.83 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.891 0.377 . . . . 10.0 110.54 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -76.39 116.15 16.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 10.0 109.971 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.565 ' HA ' HD12 ' A' ' 231' ' ' LEU . 36.1 mt -60.48 -28.8 68.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.873 -0.603 . . . . 10.0 112.141 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.91 -13.0 61.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.477 -0.329 . . . . 10.0 111.76 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -109.93 18.3 20.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.021 0.439 . . . . 10.0 111.042 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 228' ' ' LEU . 96.1 mt -105.46 150.2 38.7 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.614 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.01 176.65 9.59 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.339 2.026 . . . . 10.0 111.478 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 73' ' ' LYS . 8.2 mm-40 -74.08 99.13 3.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.404 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 77' ' ' GLU . . . -73.73 -168.16 15.8 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.997 -0.62 . . . . 10.0 113.08 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -132.45 154.17 50.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.777 0.322 . . . . 10.0 111.348 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -100.41 165.17 11.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.275 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 246' ' ' ALA . 30.4 m-20 -107.98 155.38 20.4 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.693 -0.484 . . . . 10.0 109.693 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -100.42 120.62 55.77 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.714 0.292 . . . . 10.0 110.788 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.18 -14.99 45.28 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.959 2.439 . . . . 10.0 112.093 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.528 ' HE2' ' HB3' ' A' ' 423' ' ' GLU . 98.2 mmm -83.02 10.83 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.955 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 89.69 -61.51 3.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.193 -0.527 . . . . 10.0 111.939 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.4 m -125.35 144.87 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.732 0.301 . . . . 10.0 110.21 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 155.43 162.85 11.6 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.073 -0.585 . . . . 10.0 111.811 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 m -94.33 107.42 19.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.971 0.415 . . . . 10.0 110.429 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 95.77 -164.16 23.91 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.748 -0.739 . . . . 10.0 111.428 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 237' ' ' ASP . . . -80.95 0.87 33.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.93 0.344 . . . . 10.0 111.93 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 13.82 80.25 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.295 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.17 118.87 53.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.493 HD11 ' HD3' ' A' ' 419' ' ' PRO . 75.1 mt -69.85 136.15 50.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.523 -0.308 . . . . 10.0 111.195 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -54.74 122.43 10.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.528 -0.76 . . . . 10.0 111.312 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 148.09 165.73 12.23 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.354 -0.698 . . . . 10.0 111.354 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 6.7 t -107.62 152.12 24.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.121 0.486 . . . . 10.0 111.115 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.27 -10.18 20.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.065 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.485 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 88.08 -30.82 4.96 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.919 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 150.84 167.29 14.46 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.234 -1.146 . . . . 10.0 110.234 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.51 -54.09 36.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 117.402 0.601 . . . . 10.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' MET . . . . . 0.74 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 28.6 ttp -61.6 -49.03 78.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.541 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.485 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 17.1 tt0 -58.14 -46.97 84.72 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.12 0.415 . . . . 10.0 112.12 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.67 -35.93 79.76 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.715 -0.221 . . . . 10.0 111.394 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.62 -46.52 78.96 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.707 -0.479 . . . . 10.0 109.707 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 79.7 mt -63.16 -41.08 99.19 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.793 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.541 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 44.3 ttm105 -57.63 -51.06 71.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.324 -0.853 . . . . 10.0 111.16 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 28.9 m -56.57 -43.84 80.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.405 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.59 -43.15 69.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.909 0.385 . . . . 10.0 111.249 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.534 ' CD2' ' HB2' ' A' ' 273' ' ' LEU . 47.3 t80 -63.18 -47.51 82.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.135 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.426 ' OE2' ' HA ' ' A' ' 272' ' ' PRO . 75.2 mt-10 -66.0 -36.81 84.31 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 76.0 mt -77.65 -7.92 57.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.167 0.508 . . . . 10.0 111.13 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -104.51 -40.65 5.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.484 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' THR . . . . . 0.45 HG21 ' CE1' ' A' ' 265' ' ' TYR . 77.9 p -97.97 -32.67 11.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.986 0.736 . . . . 10.0 112.986 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 89.06 -3.13 84.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.491 -0.861 . . . . 10.0 111.034 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 12.0 p -104.64 139.47 20.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.989 -0.374 . . . . 10.0 109.989 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . 0.426 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 37.0 Cg_endo -68.07 139.54 47.0 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.423 2.082 . . . . 10.0 111.581 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.626 HD12 ' HD2' ' A' ' 274' ' ' PRO . 40.6 tp -101.48 121.65 50.75 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.241 -0.436 . . . . 10.0 111.143 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.626 ' HD2' HD12 ' A' ' 273' ' ' LEU . 73.9 Cg_endo -77.5 -156.19 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.573 2.182 . . . . 10.0 111.335 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -80.94 142.54 33.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.082 -0.34 . . . . 10.0 110.082 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.11 124.6 36.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.069 0.461 . . . . 10.0 112.11 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 4.3 m -90.65 91.9 8.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.238 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.54 123.93 17.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 10.0 111.554 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 6.1 m -98.7 140.84 32.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.491 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.12 128.48 33.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.522 -0.308 . . . . 10.0 110.971 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . 0.457 HG22 ' HG2' ' A' ' 289' ' ' GLU . 21.7 t -86.03 110.25 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.351 . . . . 10.0 110.155 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -66.83 123.05 19.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.369 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 117.16 -21.32 10.98 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 63.8 mtm -132.91 85.5 2.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -62.65 109.98 1.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.458 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . 0.422 ' HA3' ' ND2' ' A' ' 354' ' ' ASN . . . 118.08 -13.52 12.65 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.757 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 42.9 mm -97.89 129.44 48.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -119.59 149.94 41.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . 0.457 ' HG2' HG22 ' A' ' 281' ' ' VAL . 21.6 pt-20 -133.39 160.1 38.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.992 0.425 . . . . 10.0 112.07 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.83 134.62 13.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.299 -0.864 . . . . 10.0 109.855 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -112.0 110.1 20.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.548 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 31.5 mt -98.97 121.49 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 10.0 111.504 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' THR . . . . . 0.552 HG23 ' HZ ' ' A' ' 333' ' ' PHE . 4.6 m -76.99 104.45 7.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.226 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.433 ' HG2' ' HD1' ' A' ' 265' ' ' TYR . 88.6 mtp -100.6 102.46 13.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.985 0.422 . . . . 10.0 111.74 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.54 118.48 54.42 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.979 -0.749 . . . . 10.0 108.979 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.01 132.99 55.04 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.863 2.375 . . . . 10.0 112.566 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.22 134.52 95.99 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.887 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.37 120.04 7.56 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.717 2.278 . . . . 10.0 111.492 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 92.42 39.39 5.36 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.828 -0.701 . . . . 10.0 111.702 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 98.9 p -128.53 165.12 21.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.861 -0.422 . . . . 10.0 109.861 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.618 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 13.2 pttt -73.11 -29.38 62.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.622 -0.51 . . . . 10.0 109.622 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -66.02 -39.51 90.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.905 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 307' ' ' LYS . 13.5 tt0 -64.32 -45.28 88.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.013 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.58 -31.74 73.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.648 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 90.7 mt -58.86 -57.3 13.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 10.0 110.919 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . 0.437 HD21 HD22 ' A' ' 113' ' ' LEU . 92.2 mt -69.26 -26.23 64.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.367 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 303' ' ' GLU . 6.6 tmtt? -79.03 -12.97 60.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.992 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -112.26 -22.74 10.77 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.878 0.696 . . . . 10.0 112.878 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 305' ' ' LEU . 6.9 ptp180 -146.4 123.92 11.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.992 0.425 . . . . 10.0 112.044 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.5 -0.18 4.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.486 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.198 -0.906 . . . . 10.0 109.113 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.438 0 N-CA-C 111.513 -0.635 . . . . 10.0 111.513 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.35 -23.43 51.45 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.729 2.286 . . . . 10.0 111.733 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.422 ' HB2' ' CE1' ' A' ' 147' ' ' TYR . 93.3 mt -119.23 96.48 5.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.137 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -92.66 124.16 36.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.242 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -60.56 129.94 44.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.062 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -72.71 -12.93 61.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.286 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 115.05 -9.59 20.84 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.245 -0.742 . . . . 10.0 111.245 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.52 129.2 2.51 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.855 -0.688 . . . . 10.0 111.565 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -71.78 88.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.08 0.467 . . . . 10.0 110.588 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -105.68 149.06 16.63 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.928 -0.653 . . . . 10.0 112.397 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . 0.552 ' HZ ' HG23 ' A' ' 293' ' ' THR . 3.5 p90 -132.05 151.23 51.87 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' THR . . . . . 0.42 ' HA ' ' HA2' ' A' ' 340' ' ' GLY . 7.8 t -131.78 142.09 49.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.981 0.42 . . . . 10.0 111.196 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 1.7 m -83.75 165.05 19.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.813 -0.631 . . . . 10.0 109.934 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -70.97 -18.19 62.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.894 0.378 . . . . 10.0 110.986 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -26.12 60.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.683 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 126.39 -16.68 6.65 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.464 -0.874 . . . . 10.0 113.561 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -83.15 163.52 20.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.865 0.333 . . . . 10.0 110.881 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 334' ' ' THR . . . -150.26 169.04 30.25 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.731 -0.747 . . . . 10.0 112.293 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -157.19 164.93 33.1 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.412 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 14.4 tt -122.32 140.95 44.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.998 0.399 . . . . 10.0 110.724 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.412 ' HB ' ' HE2' ' A' ' 333' ' ' PHE . 4.8 t -96.98 100.09 11.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.233 0.54 . . . . 10.0 110.132 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 21.4 tp -62.95 116.72 5.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.457 -0.792 . . . . 10.0 110.776 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -90.71 100.19 13.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.555 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 46.3 t -104.18 132.59 50.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.63 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . 0.558 ' HB3' HG22 ' A' ' 372' ' ' VAL . . . -125.78 144.75 50.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.785 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.71 118.89 57.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.635 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.481 ' HB3' HG12 ' A' ' 374' ' ' ILE . . . -105.52 97.39 7.23 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.238 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ASN . . . . . 0.941 ' HB3' ' HA ' ' A' ' 378' ' ' PRO . 0.7 OUTLIER -88.22 101.0 13.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.006 0.431 . . . . 10.0 110.167 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 126.08 123.83 2.71 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.203 -0.759 . . . . 10.0 111.203 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.817 ' HG ' ' HA ' ' A' ' 376' ' ' ALA . 26.7 mt -59.11 -32.01 69.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.938 0.399 . . . . 10.0 111.786 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . 0.465 ' O ' ' HE3' ' A' ' 357' ' ' LYS . . . -72.43 -26.59 71.51 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.236 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.465 ' HA ' ' HD2' ' A' ' 357' ' ' LYS . 86.6 m-20 -74.03 -23.78 59.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 10.0 111.054 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -66.28 -36.09 82.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.632 -0.507 . . . . 10.0 109.632 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' B' ' 60' ' ' SER . 17.7 tttt -68.07 -21.33 64.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.332 -0.849 . . . . 10.0 110.545 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 353' ' ' GLY . 60.4 mttt -94.61 -32.39 13.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 10.0 111.572 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.96 -45.83 16.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.916 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 85.1 mt -58.94 -34.48 52.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.095 0.406 . . . . 10.0 112.095 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -43.2 99.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.993 0.425 . . . . 10.0 110.306 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -72.3 -29.06 63.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.613 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 89.5 mtp -70.35 -48.83 54.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.104 -0.498 . . . . 10.0 109.861 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.52 -36.77 83.63 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.45 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.2 -27.54 68.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.609 . . . . 10.0 110.866 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 105.26 0.03 40.81 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.069 -0.586 . . . . 10.0 112.605 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -75.49 -54.41 7.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 10.0 111.335 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -81.85 100.7 9.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.51 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -94.75 106.09 18.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.478 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -137.44 155.35 49.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.103 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -105.28 -38.05 6.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.062 0.458 . . . . 10.0 110.877 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . 0.74 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 53.5 t80 -130.46 129.79 43.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.699 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 347' ' ' ALA . 62.5 t -134.07 127.01 50.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.803 0.335 . . . . 10.0 111.818 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.502 ' HG3' ' HG1' ' A' ' 127' ' ' THR . 14.1 tt0 -101.88 126.74 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.481 HG12 ' HB3' ' A' ' 349' ' ' ALA . 68.9 mt -116.37 120.1 63.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.254 0.549 . . . . 10.0 111.971 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' MET . . . . . . . . . . . . . 10.0 mmt -105.79 155.52 19.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 10.0 109.442 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.817 ' HA ' ' HG ' ' A' ' 352' ' ' LEU . . . -79.24 -28.9 42.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.78 0.324 . . . . 10.0 111.685 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 12.1 m -114.41 149.46 42.19 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.491 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.941 ' HA ' ' HB3' ' A' ' 350' ' ' ASN . 2.9 Cg_endo -83.29 22.56 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.491 2.794 . . . . 10.0 112.24 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -147.64 38.06 0.92 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.279 0.561 . . . . 10.0 109.903 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 69.27 -144.16 40.49 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.736 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' CYS . . . . . 0.706 ' HA ' ' S3 ' ' A' ' 501' ' ' SF4 . 72.4 m -106.94 -10.16 16.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.631 0.253 . . . . 10.0 111.544 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . 0.454 HG23 HG22 ' A' ' 396' ' ' THR . 28.0 m -70.63 -12.63 16.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.796 0.332 . . . . 10.0 111.472 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -112.0 27.93 9.79 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.059 -0.591 . . . . 10.0 111.985 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -69.32 169.73 43.23 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.12 -0.562 . . . . 10.0 112.641 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -71.86 -25.47 74.82 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.027 -0.606 . . . . 10.0 113.091 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -76.21 -17.81 79.74 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.275 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -74.01 160.35 81.94 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.903 -0.406 . . . . 10.0 109.903 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.82 159.68 40.55 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.404 2.07 . . . . 10.0 110.983 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . 0.726 HH21 ' HB3' ' B' ' 34' ' ' PRO . 0.2 OUTLIER -117.07 135.68 53.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.484 -0.326 . . . . 10.0 110.249 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 13.9 t -132.51 162.86 30.14 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.202 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.09 -10.83 59.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.307 0.575 . . . . 10.0 110.187 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -77.53 109.97 11.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.625 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -75.38 1.27 14.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.801 -0.636 . . . . 10.0 111.782 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -124.37 22.36 8.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.17 0.509 . . . . 10.0 110.23 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.541 HD12 ' HD2' ' A' ' 398' ' ' LYS . 8.6 tp -71.29 -29.93 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.344 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.454 HG22 HG23 ' A' ' 382' ' ' VAL . 0.3 OUTLIER -61.82 -39.05 90.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.036 -0.529 . . . . 10.0 111.603 -179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -62.06 -37.77 86.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.954 0.407 . . . . 10.0 110.716 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . 0.541 ' HD2' HD12 ' A' ' 395' ' ' ILE . 52.3 mttp -67.97 -39.67 83.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.59 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -63.44 -42.65 98.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.859 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -70.31 -32.8 70.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.972 -0.558 . . . . 10.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -75.08 -46.04 37.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.515 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -85.24 13.29 6.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.839 0.352 . . . . 10.0 111.865 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -36.95 85.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.564 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.511 ' O ' ' HE3' ' A' ' 409' ' ' LYS . 75.4 m-85 -136.61 151.47 49.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.151 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -75.36 160.94 29.72 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.157 -0.682 . . . . 10.0 109.157 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 406' ' ' LEU . 2.1 mm? -57.42 -35.35 69.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.889 0.376 . . . . 10.0 110.864 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.23 -35.45 81.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.418 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.05 -36.6 66.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.462 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . 0.511 ' HE3' ' O ' ' A' ' 404' ' ' TYR . 96.5 mttt -71.02 -32.86 69.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.593 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.1 p -81.6 -3.37 53.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.016 0.436 . . . . 10.0 111.564 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 9.5 m -120.6 96.92 5.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.913 0.387 . . . . 10.0 111.216 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 23.6 tp -78.8 117.19 19.68 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 414' ' ' ARG . 6.1 tmm_? -118.44 139.96 50.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.519 -0.31 . . . . 10.0 111.366 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 417' ' ' GLU . 67.9 mtt85 -101.69 158.94 15.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.386 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 9.2 m -72.59 -33.04 66.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.257 0.466 . . . . 10.0 112.257 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -77.29 4.13 11.37 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.221 0.823 . . . . 10.0 113.221 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . 0.491 ' OE2' ' HD2' ' A' ' 414' ' ' ARG . 0.5 OUTLIER -103.52 -3.74 24.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.643 -0.503 . . . . 10.0 109.643 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -84.3 116.33 64.48 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.505 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . 0.493 ' HD3' HD11 ' A' ' 249' ' ' LEU . 33.5 Cg_exo -59.62 -38.42 82.02 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.994 2.463 . . . . 10.0 111.983 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.1 m -60.78 -43.94 97.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.552 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.18 -40.3 84.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.782 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . 0.439 ' NH2' ' HA ' ' A' ' 417' ' ' GLU . 98.9 mtt180 -59.96 -44.93 94.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.673 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.528 ' HB3' ' HE2' ' A' ' 240' ' ' MET . 46.7 tt0 -61.51 -43.98 97.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.421 HD23 HD21 ' A' ' 96' ' ' LEU . 65.3 tp -63.54 -37.93 89.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.193 0.52 . . . . 10.0 111.216 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.3 m-85 -74.87 -59.81 2.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.198 -0.455 . . . . 10.0 111.747 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.85 -14.51 62.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 115.074 1.509 . . . . 10.0 115.074 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.8 18.25 7.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -161.94 -61.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . 0.601 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 92.8 mt -67.68 -40.7 84.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 99.89 -77.48 0.47 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.053 -0.594 . . . . 10.0 111.702 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . 0.6 ' HG2' ' HD2' ' A' ' 432' ' ' PRO . 1.0 OUTLIER -149.16 153.06 37.38 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.368 -0.605 . . . . 10.0 109.368 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.6 ' HD2' ' HG2' ' A' ' 431' ' ' GLU . 60.4 Cg_exo -55.1 134.8 65.81 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.565 2.177 . . . . 10.0 110.953 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.415 HD21 ' HG3' ' A' ' 104' ' ' GLU . 6.9 mp 66.75 13.61 9.45 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.532 0.52 . . . . 10.0 112.206 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 438' ' ' HIS . . . -69.9 -166.91 5.79 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.513 -0.375 . . . . 10.0 112.979 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -59.64 -62.79 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.848 0.314 . . . . 10.0 111.848 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.516 ' HD2' ' HA ' ' A' ' 436' ' ' LYS . 17.7 tptt -63.03 -34.44 77.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.8 0.334 . . . . 10.0 111.497 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -64.55 -42.15 95.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.078 0.466 . . . . 10.0 110.487 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 0.1 OUTLIER -78.89 -9.68 59.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.03 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -93.19 -48.25 6.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.184 -0.462 . . . . 10.0 112.235 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.52 -34.55 9.5 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 113.828 1.047 . . . . 10.0 113.828 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 58.9 mt -90.25 -12.03 39.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.484 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 17.0 m-70 -119.19 167.09 12.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.18 -0.208 . . . . 10.0 110.873 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.5 t -156.37 -170.23 3.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.275 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -135.72 158.26 44.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.242 -0.281 . . . . 10.0 110.242 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' TYR . . . . . 0.662 ' HH ' ' HB2' ' A' ' 128' ' ' SER . 56.6 m-85 -117.62 153.64 32.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.724 0.297 . . . . 10.0 111.262 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.75 128.55 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.007 0.432 . . . . 10.0 111.831 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.41 95.36 0.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.983 -0.553 . . . . 10.0 111.348 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 145.35 -33.32 1.58 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.917 -0.658 . . . . 10.0 111.973 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . 123.89 -174.37 16.78 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.327 -0.709 . . . . 10.0 111.327 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . 0.445 HG11 ' HG2' ' A' ' 194' ' ' ARG . 3.1 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.484 -0.77 . . . . 10.0 111.015 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.662 ' HE2' ' HB2' ' B' ' 18' ' ' ALA . 43.5 m-85 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.256 -0.276 . . . . 10.0 110.256 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -84.14 96.26 8.88 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.983 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.41 125.86 65.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.523 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' B' ' 13' ' ' THR . 35.0 m -92.08 115.71 28.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.308 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.485 HD21 HG21 ' B' ' 22' ' ' ILE . 20.8 mt -87.93 129.77 35.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.022 -0.535 . . . . 10.0 111.091 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.475 ' HB3' ' HA ' ' B' ' 86' ' ' GLN . 17.3 tppt? -88.21 97.79 11.2 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.725 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.543 HG22 ' HD2' ' B' ' 8' ' ' PRO . 0.2 OUTLIER -111.82 142.35 26.52 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.594 -0.73 . . . . 10.0 109.194 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . 0.543 ' HD2' HG22 ' B' ' 7' ' ' THR . 18.8 Cg_endo -61.0 -17.02 49.21 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.432 2.088 . . . . 10.0 111.73 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -93.5 9.49 36.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 10.0 111.38 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.65 145.97 7.66 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.996 -0.621 . . . . 10.0 112.364 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.89 149.62 34.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.649 0.261 . . . . 10.0 110.402 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -155.54 129.5 8.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.719 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 8.4 m -92.87 120.58 33.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.872 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 19.2 pt -116.79 155.66 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.175 -0.466 . . . . 10.0 111.119 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -94.4 105.88 17.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.741 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . 0.443 ' HA ' ' HD3' ' B' ' 17' ' ' PRO . 84.2 m -113.51 121.05 38.37 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.987 -0.552 . . . . 10.0 110.275 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.469 ' HD2' ' HB ' ' B' ' 20' ' ' THR . 4.9 Cg_exo -76.14 161.64 35.15 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.689 2.26 . . . . 10.0 110.94 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.662 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . . . -77.48 49.76 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.128 0.489 . . . . 10.0 110.971 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.95 -33.58 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.465 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.469 ' HB ' ' HD2' ' B' ' 17' ' ' PRO . 17.0 m -98.71 143.48 29.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.11 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -73.64 152.07 40.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.082 0.468 . . . . 10.0 111.381 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.485 HG21 HD21 ' B' ' 5' ' ' LEU . 6.1 mt -58.31 -37.94 66.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.874 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.493 ' HB3' HD22 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -63.06 -25.2 68.26 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.207 0.818 . . . . 10.0 113.207 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -70.14 -46.24 65.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.01 0.433 . . . . 10.0 110.821 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.88 -23.47 59.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.471 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.0 82.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.74 -0.663 . . . . 10.0 111.073 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . 0.418 ' HB3' ' CE2' ' B' ' 35' ' ' TYR . 16.4 pt-20 -68.1 -25.73 65.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.046 0.451 . . . . 10.0 110.742 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -68.09 -27.31 66.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.023 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.88 3.2 36.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.43 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.83 74.3 0.93 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.61 -0.805 . . . . 10.0 112.303 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 62.5 mt -131.42 166.29 21.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.663 0.268 . . . . 10.0 110.949 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -97.03 111.88 23.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.212 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.706 HD23 ' HD2' ' B' ' 34' ' ' PRO . 0.2 OUTLIER -154.01 131.17 5.98 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.348 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.726 ' HB3' HH21 ' A' ' 389' ' ' ARG . 73.4 Cg_endo -78.8 72.66 6.34 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.595 2.196 . . . . 10.0 112.519 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' B' ' 27' ' ' GLU . 0.1 OUTLIER -77.14 101.04 5.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.842 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.469 ' HB2' ' H ' ' B' ' 37' ' ' CYS . 0.0 OUTLIER -103.29 -134.94 0.33 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.072 -0.513 . . . . 10.0 111.485 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' CYS . . . . . 0.469 ' H ' ' HB2' ' B' ' 36' ' ' SER . 5.8 p -60.4 -36.04 77.18 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' B' ' 38' ' ' ARG . 5.0 mtp85 69.94 12.76 7.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.942 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.78 36.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.629 0.233 . . . . 10.0 111.629 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.88 43.82 61.12 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.409 -0.424 . . . . 10.0 112.98 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.09 -49.06 3.35 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.543 -0.386 . . . . 10.0 111.8 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . 0.458 ' HB3' ' HD3' ' A' ' 378' ' ' PRO . 0.1 OUTLIER -86.13 165.22 16.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.133 0.492 . . . . 10.0 111.798 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 3.9 p -126.16 6.21 7.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.375 0.607 . . . . 10.0 110.094 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.31 -21.73 55.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.592 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.84 36.74 1.75 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.935 -0.575 . . . . 10.0 109.972 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' B' ' 73' ' ' LEU . . . -89.19 95.01 10.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.715 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.49 156.29 53.48 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.147 -0.549 . . . . 10.0 112.648 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.681 ' HD3' ' HB3' ' B' ' 89' ' ' GLN . 5.9 mptt -110.08 130.42 55.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.732 0.301 . . . . 10.0 110.788 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.457 ' HB ' ' HA2' ' B' ' 70' ' ' GLY . 21.5 t -84.36 112.63 21.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.192 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' B' ' 84' ' ' THR . . . -85.53 -37.72 19.32 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.38 153.42 17.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.444 -0.798 . . . . 10.0 108.893 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.657 ' HA3' ' HB3' ' B' ' 83' ' ' CYS . . . 93.55 -163.69 26.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.789 -0.719 . . . . 10.0 112.199 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -142.62 143.54 32.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.942 0.401 . . . . 10.0 111.071 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.703 HG12 ' HA ' ' B' ' 79' ' ' PRO . 6.7 m -129.48 150.86 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.807 -0.633 . . . . 10.0 109.451 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' B' ' 77' ' ' ALA . 31.1 t0 -95.82 118.73 33.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.882 0.372 . . . . 10.0 111.399 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.05 130.6 55.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.359 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 38.6 t -91.08 -57.93 2.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.877 0.37 . . . . 10.0 111.33 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -141.29 117.93 10.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.376 -0.375 . . . . 10.0 111.091 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.639 ' HG2' HD13 ' B' ' 73' ' ' LEU . 25.6 mt-30 -95.44 158.37 15.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.741 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.46 ' HG ' HD21 ' B' ' 73' ' ' LEU . 0.8 OUTLIER -74.53 -103.28 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.509 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . 0.454 ' HZ ' HD13 ' B' ' 93' ' ' LEU . 5.8 p90 -86.45 -7.27 58.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 10.0 110.744 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.42 173.13 10.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.794 -0.817 . . . . 10.0 108.794 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -142.62 173.41 11.56 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.025 0.203 . . . . 10.0 111.287 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -48.0 -36.92 13.58 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.3 -22.47 61.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.903 0.705 . . . . 10.0 112.903 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.73 ' HB3' ' HB2' ' B' ' 71' ' ' PHE . 12.2 mm-40 -82.95 -10.26 58.88 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.43 0.529 . . . . 10.0 112.43 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' MET . . . . . . . . . . . . . 22.5 ttm -61.09 -52.15 66.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.742 0.306 . . . . 10.0 110.488 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.57 -21.83 79.32 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.775 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -73.86 -23.02 59.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.328 0.585 . . . . 10.0 109.517 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.457 ' HA2' ' HB ' ' B' ' 49' ' ' VAL . . . 101.21 23.78 9.43 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.447 -0.797 . . . . 10.0 112.709 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.73 ' HB2' ' HB3' ' B' ' 66' ' ' GLN . 15.0 m-85 -119.68 108.5 14.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.007 0.403 . . . . 10.0 110.569 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.582 ' HA ' ' NE2' ' B' ' 59' ' ' GLN . 15.8 m -129.63 -170.91 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.52 -0.309 . . . . 10.0 110.562 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.639 HD13 ' HG2' ' B' ' 59' ' ' GLN . 2.8 mp -125.94 114.09 18.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -16.24 59.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.382 0.512 . . . . 10.0 112.382 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' CYS . . . . . 0.465 ' HA ' HD21 ' B' ' 23' ' ' LEU . 0.5 OUTLIER -88.1 -17.3 31.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.954 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 30.99 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 120.864 0.364 . . . . 10.0 111.473 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' B' ' 55' ' ' ASP . . . -149.06 137.45 20.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.749 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -126.86 147.99 63.46 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.957 -0.565 . . . . 10.0 109.757 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 0.703 ' HA ' HG12 ' B' ' 54' ' ' VAL . 50.0 Cg_endo -69.43 119.89 6.79 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.295 1.996 . . . . 10.0 112.293 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -17.03 59.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.628 0.728 . . . . 10.0 109.445 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 67.7 m -159.6 176.25 12.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.942 -1.027 . . . . 10.0 108.511 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -63.13 130.16 43.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.15 -0.315 . . . . 10.0 110.15 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . 0.657 ' HB3' ' HA3' ' B' ' 52' ' ' GLY . 1.6 p -154.83 -176.85 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 10.0 111.822 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.634 ' HB ' ' HB3' ' B' ' 50' ' ' ALA . 0.3 OUTLIER -121.28 122.9 40.91 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.593 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 34.2 mm -124.11 134.43 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 10.0 111.589 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . 0.503 ' HB3' ' HB2' ' B' ' 48' ' ' LYS . 11.5 tt0 -93.3 136.02 33.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 9.7 p -91.03 -73.44 0.54 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.785 1.031 . . . . 10.0 113.785 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -65.79 98.1 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.098 0.777 . . . . 10.0 113.098 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.681 ' HB3' ' HD3' ' B' ' 48' ' ' LYS . 0.8 OUTLIER -173.81 85.7 0.05 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.431 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.47 11.26 32.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.906 0.384 . . . . 10.0 110.766 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.36 -38.35 8.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.96 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.04 73.01 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 10.0 111.549 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.454 HD13 ' HZ ' ' B' ' 61' ' ' PHE . 0.8 OUTLIER -170.77 20.65 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.822 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 4.2 t80 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.747 -0.644 . . . . 10.0 109.406 -179.037 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' SF4 . . . . . 0.706 ' S3 ' ' HA ' ' A' ' 381' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.584 0.23 . . . . 10.0 110.406 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 p -73.93 168.43 19.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.695 -0.23 . . . . 10.0 110.424 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -56.68 -37.88 71.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.534 -0.303 . . . . 10.0 111.532 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 212' ' ' ILE . 59.8 t -72.0 -49.68 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.338 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.66 -27.03 68.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 10.0 111.72 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.518 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 54.3 mt-30 -66.2 -13.72 60.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.78 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.13 -32.86 7.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.486 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.05 -34.04 72.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.944 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.04 81.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.529 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -76.44 -38.02 56.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.694 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.2 -33.08 75.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.55 . . . . 10.0 111.613 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.04 -29.16 69.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 90.0 mttt -73.49 128.21 87.58 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.04 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 37' ' ' LYS . 23.8 Cg_exo -65.25 158.34 52.82 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 122.896 2.397 . . . . 10.0 111.767 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -62.84 -20.64 65.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.244 0.461 . . . . 10.0 112.244 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -97.73 15.17 24.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.901 0.334 . . . . 10.0 111.901 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.428 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 8.6 t70 -94.08 130.78 33.26 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.5 -22.9 73.65 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.814 2.343 . . . . 10.0 113.375 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.9 p -93.84 3.13 55.87 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.923 0.392 . . . . 10.0 111.608 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -87.3 129.37 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.02 -0.536 . . . . 10.0 111.209 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -111.22 -176.21 2.9 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.39 111.4 21.72 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.006 -0.368 . . . . 10.0 110.006 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.93 101.13 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.713 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.8 m -96.31 140.29 31.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.888 -0.597 . . . . 10.0 109.784 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 11.1 p -126.23 144.73 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.799 0.333 . . . . 10.0 111.206 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 13.6 pt20 -128.61 129.14 45.49 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.623 HG11 HD21 ' A' ' 75' ' ' LEU . 5.7 t -113.23 150.07 15.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.882 0.373 . . . . 10.0 110.988 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.53 141.26 22.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.989 -0.55 . . . . 10.0 109.76 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.57 -32.09 62.4 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.168 2.579 . . . . 10.0 112.347 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.41 -22.43 66.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.568 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.522 HG13 HG23 ' A' ' 214' ' ' THR . 86.3 t -89.37 -38.54 11.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.202 0.525 . . . . 10.0 109.705 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -57.34 -29.79 64.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.412 -0.813 . . . . 10.0 112.321 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.35 -36.85 13.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.827 0.677 . . . . 10.0 112.827 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.83 -13.99 38.04 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.988 0.736 . . . . 10.0 112.988 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.61 -26.8 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.026 0.38 . . . . 10.0 112.026 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.39 -27.54 66.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.622 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 399' ' ' ARG . 20.7 mt-10 -68.54 -29.53 68.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 10.0 111.382 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.34 -17.42 64.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.979 0.418 . . . . 10.0 110.569 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.7 mt -99.73 -11.8 20.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.585 . . . . 10.0 109.948 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.08 25.13 13.25 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.805 -0.634 . . . . 10.0 112.193 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -110.92 -175.42 2.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.628 0.251 . . . . 10.0 110.443 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.33 149.1 42.11 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.368 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.74 117.54 4.28 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.546 2.164 . . . . 10.0 111.666 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.35 4.02 47.2 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.856 -0.687 . . . . 10.0 113.203 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.0 -29.91 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 10.0 111.259 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -94.02 126.65 39.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.232 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 p -80.62 155.64 73.49 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.784 0.326 . . . . 10.0 111.326 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -41.84 73.23 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.002 2.468 . . . . 10.0 113.023 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -66.95 -34.0 76.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.59 -0.277 . . . . 10.0 111.669 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -66.68 -37.91 85.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.423 . . . . 10.0 110.481 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.623 HD21 HG11 ' A' ' 51' ' ' VAL . 44.9 tp -64.32 -46.82 81.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.072 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.61 85.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.867 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -61.72 -47.35 85.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.135 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.93 -39.87 96.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.924 -0.655 . . . . 10.0 112.449 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.485 HD11 HG21 ' A' ' 51' ' ' VAL . 19.5 mt -62.28 -43.96 97.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.962 0.411 . . . . 10.0 111.179 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -65.59 -27.36 68.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.012 0.434 . . . . 10.0 110.595 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -77.13 -11.43 59.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 10.0 111.359 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.2 -14.04 57.95 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.79 7.19 24.05 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.236 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -69.71 145.2 52.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.829 0.347 . . . . 10.0 111.231 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.86 -64.4 1.2 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.155 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -119.6 135.4 54.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.621 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.8 t -113.46 110.9 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.529 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 48.6 m-85 -111.05 162.38 14.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.896 0.379 . . . . 10.0 110.983 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -111.0 146.39 36.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 m -65.54 -19.67 66.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.497 -0.319 . . . . 10.0 111.555 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.448 HD21 ' HH ' ' A' ' 404' ' ' TYR . 23.0 mt -57.67 -36.63 72.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.635 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -67.59 -38.08 83.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.171 0.51 . . . . 10.0 109.902 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.33 -36.99 70.55 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.716 -0.954 . . . . 10.0 110.716 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.54 81.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.522 -0.339 . . . . 10.0 110.387 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -36.15 75.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.78 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.21 -41.31 67.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.564 -0.743 . . . . 10.0 109.6 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.3 m -60.72 -44.66 96.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.75 -0.659 . . . . 10.0 110.524 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.7 mt -58.52 -40.37 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 10.0 110.956 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.2 mmm -62.53 -53.11 59.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.286 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -67.28 -40.2 86.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.174 -0.467 . . . . 10.0 111.732 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 101' ' ' GLU . 2.9 tp10 -61.64 -45.91 92.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.894 0.378 . . . . 10.0 110.55 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.58 -35.02 91.23 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.033 -0.827 . . . . 10.0 111.033 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.0 m -70.81 -41.94 70.91 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.584 -0.308 . . . . 10.0 110.62 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -61.93 -47.27 85.63 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.614 -0.513 . . . . 10.0 109.614 178.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.1 -51.48 69.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.998 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.35 -37.63 81.27 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.989 0.423 . . . . 10.0 109.996 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.588 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 26.5 t60 -62.96 -51.6 66.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.407 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.513 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 68.4 mtt180 -62.49 -32.39 73.29 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.416 -0.357 . . . . 10.0 111.308 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.61 -50.58 29.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.407 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 m -58.01 -45.52 86.75 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.697 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 71.9 mm-40 -57.47 -36.83 71.96 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.054 0.454 . . . . 10.0 110.713 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -77.2 -28.51 53.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.509 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.75 -39.21 76.87 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.38 -41.19 69.99 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.323 -0.853 . . . . 10.0 109.965 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-N 115.582 -0.735 . . . . 10.0 111.963 179.625 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.513 ' HB3' ' HG2' ' A' ' 108' ' ' ARG . 1.3 mp0 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.784 0.326 . . . . 10.0 110.475 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -90.3 -175.06 0.86 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.913 2.408 . . . . 10.0 112.911 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.422 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 95.2 mt -130.21 158.3 74.6 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 123' ' ' LEU . 36.6 Cg_endo -64.27 167.26 42.79 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 124.318 -1.118 . . . . 10.0 113.667 0.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 27.7 ttt -111.87 131.08 55.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.431 -0.804 . . . . 10.0 110.762 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 372' ' ' VAL . 69.7 m-85 -111.14 139.5 46.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.934 -0.576 . . . . 10.0 109.911 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.55 152.32 36.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.643 0.258 . . . . 10.0 110.617 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.9 33.37 5.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.938 0.399 . . . . 10.0 111.266 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 2.8 m -92.53 17.01 10.72 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.725 0.639 . . . . 10.0 112.725 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.456 ' O ' HG12 ' A' ' 134' ' ' ILE . 0.9 OUTLIER -136.3 120.62 12.75 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 112.079 0.399 . . . . 10.0 112.079 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.54 -40.65 45.72 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.093 2.528 . . . . 10.0 112.366 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 376' ' ' ALA . . . -61.17 -40.44 98.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.906 -0.664 . . . . 10.0 111.827 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -65.68 -48.55 71.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.999 -0.371 . . . . 10.0 109.999 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 130' ' ' CYS . 49.7 mm -58.46 -43.24 86.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.812 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.19 -47.09 86.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.461 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 54.8 ttp -68.91 -30.73 69.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.046 0.451 . . . . 10.0 110.534 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.476 HD22 HG21 ' A' ' 148' ' ' VAL . 10.7 tp -68.19 -57.98 5.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.148 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -59.69 -19.7 51.45 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.91 0.708 . . . . 10.0 112.91 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -104.13 -56.55 2.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.754 1.02 . . . . 10.0 113.754 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.1 m -88.67 -28.65 20.46 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.432 1.271 . . . . 10.0 114.432 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.12 66.71 68.62 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.742 0.645 . . . . 10.0 112.742 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.62 -12.41 29.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.197 1.931 . . . . 10.0 111.58 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -88.34 -13.05 41.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.452 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -101.78 2.57 38.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.462 -0.336 . . . . 10.0 111.825 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.489 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 55.5 mt -54.75 -51.44 78.88 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 113.598 0.962 . . . . 10.0 113.598 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 41.5 Cg_exo -58.69 -20.57 51.51 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.39 2.06 . . . . 10.0 113.292 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 325' ' ' LEU . 97.4 m-85 -79.69 -17.12 54.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.226 0.536 . . . . 10.0 111.028 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.476 HG21 HD22 ' A' ' 137' ' ' LEU . 27.9 t -87.86 152.37 3.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.033 -0.53 . . . . 10.0 109.965 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . 0.459 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . 39.7 t -66.27 160.18 24.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.235 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 p -99.85 1.41 42.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.604 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 60.4 m -75.34 138.79 42.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.335 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 36.2 mtpt -80.77 168.63 18.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.456 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.87 148.9 98.42 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.384 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.44 -51.05 10.23 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.332 2.688 . . . . 10.0 113.458 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -34.02 77.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.073 0.397 . . . . 10.0 112.073 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 56.9 mmm -73.74 -23.84 59.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.049 0.452 . . . . 10.0 110.718 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 39.4 mtt -75.46 -47.72 25.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.097 -0.705 . . . . 10.0 109.097 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.5 tp -63.91 -41.63 97.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.751 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.32 85.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.252 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.53 -36.7 63.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.645 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.465 ' HE3' HD22 ' A' ' 424' ' ' LEU . 2.1 tmt? -66.44 -42.73 87.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.816 -0.629 . . . . 10.0 112.024 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.536 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.9 m -69.55 -29.88 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -85.78 1.73 48.46 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.166 0.432 . . . . 10.0 112.166 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.0 p -122.44 -75.93 0.59 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.845 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -62.05 -52.56 63.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.399 . . . . 10.0 111.542 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.536 ' HB3' ' O ' ' A' ' 162' ' ' VAL . 35.9 tp -61.24 -40.74 95.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.513 -0.312 . . . . 10.0 110.997 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.85 76.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.848 0.356 . . . . 10.0 110.667 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -66.47 -34.8 78.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.59 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -75.24 -37.12 61.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.793 0.33 . . . . 10.0 111.781 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.544 ' HB3' HG12 ' A' ' 172' ' ' ILE . 3.1 tttt -79.49 -20.54 47.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.815 0.34 . . . . 10.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 86.32 14.54 66.06 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.056 -0.592 . . . . 10.0 112.785 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.544 HG12 ' HB3' ' A' ' 170' ' ' LYS . 14.0 pt -103.44 168.64 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.785 0.326 . . . . 10.0 111.057 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -100.01 142.55 24.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.038 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 173' ' ' ALA . 35.8 Cg_exo -59.28 -19.93 52.84 Favored 'Trans proline' 0 N--CA 1.473 0.287 0 C-N-CA 122.995 2.464 . . . . 10.0 112.881 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -77.23 -19.49 56.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.199 0.523 . . . . 10.0 110.608 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -100.77 17.86 20.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.583 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 83.6 mtp -124.62 123.53 40.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.332 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.3 t -110.84 120.09 60.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.583 ' HB3' HD12 ' A' ' 208' ' ' LEU . 0.0 OUTLIER -104.21 123.51 47.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.289 0.566 . . . . 10.0 112.21 -178.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 22.5 t -118.69 135.63 58.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.41 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.423 ' OG ' HD21 ' A' ' 208' ' ' LEU . 3.7 p -123.21 139.04 54.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.724 0.297 . . . . 10.0 111.368 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 212' ' ' ILE . 24.1 mm -101.64 102.19 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.946 -0.761 . . . . 10.0 108.946 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 213' ' ' THR . 32.2 mmt -114.08 150.16 43.13 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.05 -0.523 . . . . 10.0 111.54 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.77 17.48 1.52 Allowed 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.854 2.369 . . . . 10.0 112.894 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 97.3 m -149.55 129.46 13.4 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.108 -0.331 . . . . 10.0 110.108 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -30.07 70.02 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -64.15 -9.55 17.42 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.649 0.611 . . . . 10.0 112.649 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.458 ' HZ1' ' CD ' ' A' ' 191' ' ' GLU . 25.0 mmtt -66.97 -28.2 68.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.349 . . . . 10.0 110.921 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -68.02 -36.75 80.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 10.0 109.989 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -32.56 67.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.815 -0.629 . . . . 10.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.458 ' CD ' ' HZ1' ' A' ' 188' ' ' LYS . 12.0 tt0 -70.63 -41.13 72.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.753 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -75.12 -30.17 60.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.665 -0.698 . . . . 10.0 112.781 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -80.87 70.81 7.75 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.454 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 56.0 mtt180 -115.32 148.4 39.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.434 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -48.93 -63.03 1.22 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.637 0.977 . . . . 10.0 113.637 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -66.97 -2.2 5.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.349 1.24 . . . . 10.0 114.349 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.454 ' CD2' ' HB2' ' A' ' 194' ' ' ARG . 2.6 m-30 -82.22 61.98 5.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.379 0.609 . . . . 10.0 111.599 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 12.1 p -113.15 168.94 9.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 10.0 110.396 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 22.4 t -80.66 83.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.221 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.037 -0.983 . . . . 10.0 111.311 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.758 ' C ' ' H ' ' A' ' 205' ' ' LEU . 7.8 p . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.673 -0.491 . . . . 10.0 109.673 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.796 ' C ' ' CB ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.228 -0.052 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -88.1 144.73 26.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.272 -0.27 . . . . 10.0 110.272 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -67.52 -40.67 85.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.242 0.544 . . . . 10.0 109.535 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' A' ' 179' ' ' MET . 29.5 tp -126.24 137.49 53.53 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.375 -1.343 . . . . 10.0 107.375 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -99.24 -57.89 2.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.47 0.915 . . . . 10.0 113.47 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.518 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 12.6 m-70 -134.32 153.15 52.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.028 0.751 . . . . 10.0 113.028 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 46.0 t -126.72 131.76 70.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.557 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 71.3 mt -122.42 139.52 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 183' ' ' MET . 43.2 p -91.98 167.2 12.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.809 0.3 . . . . 10.0 111.809 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.522 HG23 HG13 ' A' ' 55' ' ' VAL . 2.7 m -52.64 -52.92 53.45 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.003 -0.544 . . . . 10.0 112.077 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.0 m -57.87 -36.19 54.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 220' ' ' ILE . 50.1 mt-10 -73.33 -45.3 56.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.58 -0.282 . . . . 10.0 111.027 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.59 -45.52 92.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.86 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.98 -30.94 78.99 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.931 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -67.97 -41.76 81.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 216' ' ' GLU . 61.7 mt -58.8 -42.77 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.228 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -62.57 -44.74 95.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.554 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -67.51 -43.94 79.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 10.0 111.955 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.71 -23.84 66.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 10.0 111.299 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -94.33 -3.18 50.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.961 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 68.35 38.99 87.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.931 -0.652 . . . . 10.0 112.189 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 57.4 mt -116.07 110.4 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.834 0.349 . . . . 10.0 110.509 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -96.61 113.71 25.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.966 -0.383 . . . . 10.0 109.966 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.616 HD23 HD12 ' A' ' 231' ' ' LEU . 38.6 mt -59.1 -28.97 67.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.807 -0.633 . . . . 10.0 112.183 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.27 -18.46 63.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.6 -0.273 . . . . 10.0 111.569 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -111.26 20.75 17.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.968 0.413 . . . . 10.0 110.974 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.616 HD12 HD23 ' A' ' 228' ' ' LEU . 56.7 mt -104.39 150.92 38.98 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.936 -0.575 . . . . 10.0 110.274 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.47 172.01 16.98 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.284 1.989 . . . . 10.0 111.576 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.8 102.32 11.51 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.642 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -83.48 -154.64 18.05 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.005 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.85 156.99 43.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 10.0 110.716 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -92.66 -174.7 3.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.685 -0.688 . . . . 10.0 110.254 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.5 147.47 42.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.892 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -93.41 120.19 66.72 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.158 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.06 -15.36 47.42 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.133 2.556 . . . . 10.0 112.315 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.588 ' HE2' ' HB3' ' A' ' 423' ' ' GLU . 86.9 mmm -78.64 0.65 25.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 10.0 111.465 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 103.27 -70.06 0.29 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.135 -0.555 . . . . 10.0 112.774 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.44 169.65 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.901 0.382 . . . . 10.0 111.578 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 104.43 136.5 8.84 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.619 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.2 m -80.2 130.35 35.15 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.178 -0.305 . . . . 10.0 110.178 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 120.06 179.72 16.45 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.228 -0.749 . . . . 10.0 111.228 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.25 -2.18 50.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.847 0.356 . . . . 10.0 111.277 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.86 4.03 79.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.18 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.93 118.68 53.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 30.2 mt -75.51 149.95 38.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.384 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.33 106.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.057 0.456 . . . . 10.0 111.153 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 164.84 127.11 0.86 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.078 -0.809 . . . . 10.0 111.078 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 11.2 t -75.18 148.19 39.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.169 0.509 . . . . 10.0 111.562 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.34 -9.46 25.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.657 -0.701 . . . . 10.0 109.497 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.425 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 89.68 -32.22 4.89 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.687 -0.688 . . . . 10.0 112.47 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 151.69 170.31 18.29 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.365 -1.094 . . . . 10.0 110.365 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.86 -55.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.541 0.67 . . . . 10.0 110.406 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' MET . . . . . 0.536 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 23.5 ttp -59.4 -48.28 82.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.406 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.425 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 36.5 tt0 -61.34 -46.19 91.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 10.0 112.138 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.84 81.96 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 121.046 -0.261 . . . . 10.0 111.167 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.74 -47.46 72.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 257' ' ' MET . 90.1 mt -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.826 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.46 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 45.6 ttm105 -58.95 -48.37 81.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.051 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 87.0 m -55.52 -43.32 75.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 10.0 111.546 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.84 -43.93 57.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.849 0.357 . . . . 10.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . 0.505 ' HD1' ' HG2' ' A' ' 294' ' ' MET . 84.0 t80 -62.07 -46.09 90.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.079 -0.509 . . . . 10.0 112.063 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 262' ' ' ARG . 52.3 mt-10 -64.98 -23.18 67.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.565 0.579 . . . . 10.0 112.565 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 73.4 mt -90.18 -35.07 15.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.103 0.478 . . . . 10.0 110.467 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -72.62 -43.09 63.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.678 -0.692 . . . . 10.0 111.604 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 70.1 p -96.38 -33.53 11.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.164 -0.471 . . . . 10.0 112.191 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 85.31 9.15 80.15 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.789 -0.925 . . . . 10.0 110.789 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 70.9 p -112.69 146.13 34.41 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.698 -0.251 . . . . 10.0 110.775 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.99 131.69 21.42 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.501 2.134 . . . . 10.0 111.9 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.46 ' HB3' ' HG3' ' A' ' 262' ' ' ARG . 46.9 tp -103.99 121.47 47.71 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.069 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 273' ' ' LEU . 4.5 Cg_exo -76.55 -156.21 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.191 2.594 . . . . 10.0 111.774 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -78.4 141.21 38.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.484 -0.325 . . . . 10.0 110.618 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 95.6 mt -89.81 141.61 28.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 1.5 m -106.59 105.35 15.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.582 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 288' ' ' LYS . 3.4 mm? -77.98 113.94 16.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.823 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.5 m -89.86 152.52 21.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.272 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -79.75 123.63 27.86 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.51 112.7 5.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.074 0.464 . . . . 10.0 110.643 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 16.0 ttm-85 -66.97 108.35 2.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.602 -0.726 . . . . 10.0 110.353 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 123.5 -18.69 7.68 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.006 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' MET . . . . . 0.482 ' SD ' ' HD2' ' A' ' 361' ' ' LYS . 56.4 mtm -139.98 102.54 4.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.012 0.434 . . . . 10.0 110.609 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.71 138.81 48.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.264 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.83 -13.5 67.04 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.587 -0.733 . . . . 10.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 21.7 mm -99.44 127.81 51.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.018 0.437 . . . . 10.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 278' ' ' LEU . 33.6 mmtt -115.62 157.57 23.98 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.11 159.66 44.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.249 0.547 . . . . 10.0 112.371 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 9.1 t -155.99 152.21 27.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.254 -0.885 . . . . 10.0 109.257 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -128.32 123.41 33.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.808 0.337 . . . . 10.0 110.649 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.91 118.41 58.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.913 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.54 97.75 3.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.044 0.449 . . . . 10.0 110.588 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' MET . . . . . 0.505 ' HG2' ' HD1' ' A' ' 265' ' ' TYR . 81.7 mtp -87.1 113.26 22.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.108 -0.497 . . . . 10.0 111.449 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 36.3 t -112.34 120.42 41.52 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.7 135.57 61.08 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.891 2.394 . . . . 10.0 112.782 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . . . -66.97 132.06 93.84 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.779 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 297' ' ' ALA . 38.8 Cg_exo -59.04 114.13 1.88 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.954 2.436 . . . . 10.0 112.286 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.52 -12.1 39.3 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.681 -0.771 . . . . 10.0 113.123 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 97.0 p -84.33 162.53 20.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.885 0.374 . . . . 10.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -64.5 -26.11 68.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.231 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -64.27 -40.0 95.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.317 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -72.48 -46.05 56.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 10.0 109.901 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 2.2 tm-20 -57.28 -46.63 82.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.395 -0.821 . . . . 10.0 111.324 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.15 -53.51 54.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 10.0 112.008 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.5 tt -60.13 -38.5 83.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.315 -0.402 . . . . 10.0 111.804 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -75.65 -33.31 60.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.563 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' HIS . . . . . 0.525 ' HB2' ' O ' ' A' ' 304' ' ' GLU . 0.7 OUTLIER -75.46 -47.52 26.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.78 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -123.33 100.85 7.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.182 0.515 . . . . 10.0 112.073 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -110.19 -1.48 17.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.473 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.365 -0.826 . . . . 10.0 110.529 -179.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.299 -0.721 . . . . 10.0 111.299 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.63 -31.33 94.18 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.838 2.359 . . . . 10.0 112.415 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.411 ' HB2' ' CE1' ' A' ' 147' ' ' TYR . 85.1 mt -109.11 110.95 22.33 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -94.84 120.62 35.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.565 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -67.54 131.98 46.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.779 -0.452 . . . . 10.0 109.779 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.08 -1.71 37.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.609 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 103.26 -6.39 50.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.868 -0.682 . . . . 10.0 111.593 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . 0.416 ' HA2' ' NH2' ' A' ' 345' ' ' ARG . . . 92.23 153.86 30.34 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.77 -0.728 . . . . 10.0 111.721 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.5 82.43 8.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.057 0.456 . . . . 10.0 110.182 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -98.29 155.16 20.23 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.8 -0.714 . . . . 10.0 112.938 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -142.76 160.18 40.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.984 -0.376 . . . . 10.0 109.984 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.8 t -141.38 142.59 33.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.91 0.386 . . . . 10.0 110.49 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.44 169.58 8.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.463 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.92 23.88 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 10.0 112.063 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -111.77 -7.85 14.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.276 0.56 . . . . 10.0 109.806 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 102.6 -8.88 55.23 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.728 . . . . 10.0 112.373 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -100.95 176.81 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.054 0.454 . . . . 10.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -173.68 -175.44 41.38 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.922 -0.871 . . . . 10.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -167.65 -173.28 35.61 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.949 -0.643 . . . . 10.0 111.553 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ILE . . . . . 0.427 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 7.9 tt -136.8 131.02 46.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.71 0.291 . . . . 10.0 110.581 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.6 t -90.9 106.87 18.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.103 0.478 . . . . 10.0 110.507 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 25.0 tp -64.07 115.49 4.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.527 -0.76 . . . . 10.0 110.577 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ARG . . . . . 0.428 ' HB3' ' CD1' ' A' ' 369' ' ' TYR . 60.5 mtm180 -86.62 105.23 16.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.86 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.74 130.57 59.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.015 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 372' ' ' VAL . . . -126.87 139.18 53.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.307 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.61 114.16 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.797 -0.446 . . . . 10.0 109.797 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.5 ' HB3' HG12 ' A' ' 374' ' ' ILE . . . -98.59 105.08 17.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.496 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ASN . . . . . 0.901 ' HB3' ' HA ' ' A' ' 378' ' ' PRO . 2.3 m-80 -95.99 108.62 21.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.49 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 112.04 126.06 4.67 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.708 -0.957 . . . . 10.0 110.708 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' LEU . . . . . 0.728 HD12 ' HG ' ' B' ' 43' ' ' SER . 43.6 mt -59.17 -37.49 77.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.889 0.376 . . . . 10.0 111.478 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -68.99 -26.56 74.61 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.636 -0.793 . . . . 10.0 111.703 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.812 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 93.3 m-20 -84.75 -40.36 17.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.924 0.392 . . . . 10.0 110.007 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.8 94.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.383 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . 0.416 ' HZ1' ' CG ' ' B' ' 58' ' ' ASP . 26.2 ttpt -55.9 -39.56 71.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.434 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.812 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 9.4 mtmm -70.79 -42.82 69.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.511 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.83 -46.86 85.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 10.0 110.974 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 97.7 mt -56.73 -45.5 82.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.562 . . . . 10.0 110.905 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 22.0 m -60.59 -45.27 94.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.7 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.482 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 36.6 mttm -66.02 -32.76 74.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.325 -0.398 . . . . 10.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' MET . . . . . 0.467 ' HA ' ' O ' ' A' ' 367' ' ' ALA . 87.3 mtp -68.49 -42.99 77.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.026 0.441 . . . . 10.0 110.042 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -69.1 -24.41 64.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.003 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -86.0 -7.88 58.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.044 -0.526 . . . . 10.0 111.064 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 81.2 13.95 79.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.789 -0.719 . . . . 10.0 112.949 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -77.64 -37.83 49.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.228 0.537 . . . . 10.0 110.056 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 362' ' ' MET . . . -135.14 126.06 27.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.583 -0.735 . . . . 10.0 109.388 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -119.94 125.76 49.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.81 0.338 . . . . 10.0 110.977 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' A' ' 345' ' ' ARG . 72.7 m-85 -134.92 158.71 43.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.824 -0.625 . . . . 10.0 109.596 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -97.3 -36.56 10.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.027 0.441 . . . . 10.0 111.248 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . 0.536 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 26.8 t80 -125.56 126.95 45.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.57 -0.529 . . . . 10.0 109.57 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 347' ' ' ALA . 25.3 t -130.3 118.76 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.02 0.438 . . . . 10.0 111.882 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.19 129.84 44.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.985 -1.117 . . . . 10.0 107.985 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . 0.5 HG12 ' HB3' ' A' ' 349' ' ' ALA . 59.3 mt -121.37 125.26 73.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.241 0.543 . . . . 10.0 112.076 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' MET . . . . . 0.408 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 13.0 mmt -115.17 145.96 41.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.591 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ALA . . . . . 0.454 ' HB2' ' HA3' ' A' ' 132' ' ' GLY . . . -78.14 -26.75 47.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.758 0.313 . . . . 10.0 111.122 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' CYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 14.7 m -120.45 121.29 29.33 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.467 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.901 ' HA ' ' HB3' ' A' ' 350' ' ' ASN . 24.0 Cg_exo -65.79 -9.88 24.59 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.221 2.614 . . . . 10.0 112.39 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -96.41 9.77 40.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.584 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 73.21 -153.71 48.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.737 -0.744 . . . . 10.0 112.342 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' CYS . . . . . . . . . . . . . 20.4 m -88.0 -15.53 36.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.018 0.437 . . . . 10.0 110.976 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 34.7 m -77.94 -14.04 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.93 0.395 . . . . 10.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -116.61 25.23 9.19 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.989 -0.624 . . . . 10.0 111.972 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -65.7 168.72 31.34 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.248 -0.501 . . . . 10.0 112.896 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -69.24 -24.31 76.02 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.089 -0.577 . . . . 10.0 113.677 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -85.71 -6.13 83.34 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.648 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -82.76 155.31 68.22 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.74 164.69 33.56 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.428 2.085 . . . . 10.0 110.803 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . 0.527 ' HD2' ' O ' ' B' ' 33' ' ' LEU . 0.0 OUTLIER -128.66 121.95 29.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.231 0.539 . . . . 10.0 111.619 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 49.2 m -110.26 170.01 8.36 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.694 . . . . 10.0 110.003 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -16.24 62.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.823 0.344 . . . . 10.0 111.751 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.74 126.64 31.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.592 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -86.25 -4.98 59.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.025 -0.534 . . . . 10.0 111.922 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -110.83 15.47 21.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.257 0.551 . . . . 10.0 109.812 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 8.2 tp -63.46 -26.99 42.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.893 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -46.17 86.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.31 0.576 . . . . 10.0 110.204 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -67.87 -36.61 80.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.507 -0.77 . . . . 10.0 110.667 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -61.54 -43.03 99.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.636 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 61' ' ' GLU . 99.0 mtt180 -68.39 -41.55 80.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.715 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -64.1 -39.48 94.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.923 -0.58 . . . . 10.0 111.344 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -70.88 -24.52 62.51 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.248 0.462 . . . . 10.0 112.248 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -101.54 14.39 32.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.579 0.585 . . . . 10.0 112.579 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.09 -38.33 85.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.138 0.494 . . . . 10.0 110.775 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' TYR . . . . . 0.501 ' O ' ' HE3' ' A' ' 409' ' ' LYS . 83.4 m-85 -136.14 153.83 51.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.536 -0.756 . . . . 10.0 109.318 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -82.79 165.65 19.68 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.657 -0.498 . . . . 10.0 109.657 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.22 -33.86 59.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.692 0.282 . . . . 10.0 111.641 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -63.6 -54.47 35.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.796 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.43 -33.45 75.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.624 . . . . 10.0 111.411 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' LYS . . . . . 0.501 ' HE3' ' O ' ' A' ' 404' ' ' TYR . 95.9 mttt -67.46 -30.18 69.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.662 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 6.1 p -94.17 8.09 42.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.961 0.41 . . . . 10.0 111.312 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 6.3 m -122.08 101.78 7.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.611 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 21.0 tp -83.46 122.36 28.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.176 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 40.9 ttp85 -123.58 148.68 46.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.828 0.347 . . . . 10.0 111.306 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ARG . . . . . 0.431 ' HD3' ' OE2' ' A' ' 417' ' ' GLU . 1.2 mpt_? -116.33 136.38 53.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.408 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.7 m -62.91 -29.37 70.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.319 0.488 . . . . 10.0 112.319 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -73.0 4.93 3.7 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.524 0.565 . . . . 10.0 112.524 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' GLU . . . . . 0.431 ' OE2' ' HD3' ' A' ' 414' ' ' ARG . 20.4 mt-10 -122.81 13.81 9.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.481 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -88.27 117.08 67.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.186 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.67 -35.16 92.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.233 2.622 . . . . 10.0 112.558 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 50.2 m -70.81 -38.66 73.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.893 0.378 . . . . 10.0 110.907 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.26 -42.85 78.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.399 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -61.93 -35.64 79.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.98 -0.555 . . . . 10.0 111.41 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLU . . . . . 0.588 ' HB3' ' HE2' ' A' ' 240' ' ' MET . 3.1 tp10 -64.21 -49.84 70.42 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.095 0.474 . . . . 10.0 110.006 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' LEU . . . . . 0.465 HD22 ' HE3' ' A' ' 161' ' ' MET . 61.2 tp -62.54 -38.78 91.35 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.954 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . 0.756 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.4 m-85 -74.24 -11.3 60.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.031 -0.531 . . . . 10.0 111.549 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -97.56 -52.74 3.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.182 0.808 . . . . 10.0 113.182 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.06 17.54 18.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.639 1.348 . . . . 10.0 114.639 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -155.63 -63.82 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.107 0.78 . . . . 10.0 113.107 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' LEU . . . . . 0.756 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 67.9 mt -67.38 -50.69 58.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.877 0.695 . . . . 10.0 112.877 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 92.65 -132.66 11.36 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.556 -0.831 . . . . 10.0 111.512 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 24.2 mm-40 -86.5 144.79 38.33 Favored Pre-proline 0 C--N 1.318 -0.769 0 O-C-N 122.662 -0.316 . . . . 10.0 110.698 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 431' ' ' GLU . 44.8 Cg_exo -58.89 147.06 91.13 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.941 2.427 . . . . 10.0 111.264 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 3.5 mp 62.74 17.85 10.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.515 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -76.35 -176.57 42.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.085 -0.579 . . . . 10.0 112.44 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -60.85 -51.8 67.76 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.394 0.278 . . . . 10.0 111.736 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -38.98 93.29 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.847 0.356 . . . . 10.0 110.781 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.42 75.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.986 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' HIS . . . . . 0.653 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 2.5 t-160 -68.81 -31.03 69.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.069 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.1 -40.9 17.7 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.6 mt -96.31 -42.81 7.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 114.577 1.325 . . . . 10.0 114.577 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.58 -17.81 21.99 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.653 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 39.2 m-70 -114.57 171.24 7.75 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.245 -0.285 . . . . 10.0 110.644 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.9 t -162.89 -175.75 4.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.526 0.203 . . . . 10.0 111.058 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -129.89 157.82 41.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.527 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.87 164.19 13.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.35 -0.387 . . . . 10.0 110.187 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' VAL . . . . . 0.4 ' HB ' HG12 ' A' ' 450' ' ' VAL . 95.1 t -120.87 109.37 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.118 0.485 . . . . 10.0 111.792 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -65.89 115.45 6.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.054 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 122.33 -15.36 8.71 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.34 -0.704 . . . . 10.0 111.34 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . 113.39 143.67 8.67 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.869 -0.682 . . . . 10.0 112.136 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . 0.432 HG11 ' NH1' ' A' ' 194' ' ' ARG . 36.0 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.314 -0.85 . . . . 10.0 110.922 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 120.797 0.332 . . . . 10.0 110.8 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -89.86 101.23 13.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.106 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -109.92 123.72 66.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.949 -0.569 . . . . 10.0 111.153 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.733 ' HB ' HG23 ' B' ' 84' ' ' THR . 15.9 m -89.3 117.91 28.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.969 -0.559 . . . . 10.0 109.995 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 23.9 mt -91.02 126.78 36.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.151 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LYS . . . . . 0.69 ' HB2' ' HA ' ' B' ' 86' ' ' GLN . 9.4 mttm -87.66 75.22 9.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.902 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.19 148.0 77.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.54 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.54 -12.82 32.89 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.485 2.124 . . . . 10.0 111.92 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.27 -1.8 43.99 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.851 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.9 153.37 7.0 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.842 -0.694 . . . . 10.0 111.635 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.85 140.78 40.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.44 0.162 . . . . 10.0 110.723 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -144.16 122.79 12.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.638 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 41.1 m -86.89 121.26 29.13 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' B' ' 25' ' ' ALA . 46.5 pt -113.34 150.05 15.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.083 0.468 . . . . 10.0 111.932 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -92.01 102.16 14.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.536 -0.756 . . . . 10.0 109.722 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' B' ' 17' ' ' PRO . 50.1 t -114.4 128.29 25.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.338 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' B' ' 20' ' ' THR . 14.4 Cg_exo -70.88 164.92 33.95 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.981 2.454 . . . . 10.0 111.152 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.56 -15.36 56.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.12 0.486 . . . . 10.0 111.097 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.65 12.81 35.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.292 0.567 . . . . 10.0 110.847 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' B' ' 17' ' ' PRO . 4.7 m -137.29 143.03 41.93 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.95 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -73.55 150.37 41.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.437 -0.347 . . . . 10.0 111.098 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.484 HG12 ' HD3' ' B' ' 79' ' ' PRO . 21.6 mt -54.53 -33.15 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.922 -0.581 . . . . 10.0 112.099 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.429 ' CD1' HD23 ' B' ' 33' ' ' LEU . 9.9 tp -54.16 -43.24 70.44 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.89 0.7 . . . . 10.0 112.89 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.85 -41.8 98.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.924 0.393 . . . . 10.0 111.938 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.489 ' HB3' HD12 ' B' ' 14' ' ' ILE . . . -74.22 -30.47 62.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.977 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.42 -49.69 75.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.239 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -71.3 -26.4 62.85 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.957 -0.297 . . . . 10.0 111.564 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.04 -37.03 83.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.34 -0.615 . . . . 10.0 109.34 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.91 -8.42 59.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.776 -0.647 . . . . 10.0 110.904 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.39 35.21 20.96 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.891 -0.595 . . . . 10.0 112.818 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.6 158.63 15.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.783 0.325 . . . . 10.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -89.85 113.73 25.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.989 -0.551 . . . . 10.0 111.051 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.729 HD12 ' HD2' ' B' ' 34' ' ' PRO . 19.7 tp -137.15 125.02 14.43 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.782 -0.645 . . . . 10.0 109.277 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.729 ' HD2' HD12 ' B' ' 33' ' ' LEU . 58.2 Cg_endo -71.77 65.94 3.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.067 2.511 . . . . 10.0 113.497 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -89.88 167.02 13.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.892 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' SER . . . . . 0.434 ' N ' ' S1 ' ' B' ' 101' ' ' FES . 2.1 p -152.78 -94.99 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' CYS . . . . . 0.467 ' SG ' ' HG2' ' A' ' 378' ' ' PRO . 25.8 p -72.61 -20.82 61.22 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.313 0.857 . . . . 10.0 113.313 -177.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 68.35 15.59 9.26 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.686 0.279 . . . . 10.0 111.639 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.53 -5.49 35.69 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.564 0.579 . . . . 10.0 112.564 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.446 ' N ' ' S2 ' ' B' ' 101' ' ' FES . . . 74.98 28.13 63.13 Favored Glycine 0 C--O 1.229 -0.199 0 C-N-CA 120.973 -0.632 . . . . 10.0 113.464 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.61 3.63 27.11 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.612 -0.346 . . . . 10.0 111.661 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 m -107.54 129.42 54.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.079 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.728 ' HG ' HD12 ' A' ' 352' ' ' LEU . 2.2 p -79.95 -8.8 59.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.096 0.474 . . . . 10.0 110.264 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -17.51 60.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.177 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 4.4 m -103.63 27.22 7.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.809 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' B' ' 73' ' ' LEU . . . -99.08 106.39 18.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.649 -0.705 . . . . 10.0 110.184 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.44 174.6 54.6 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.07 -0.586 . . . . 10.0 113.073 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.762 ' HD3' ' HB3' ' B' ' 89' ' ' GLN . 1.3 mptt -114.33 137.63 51.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.674 0.273 . . . . 10.0 110.761 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.705 ' HB ' ' HA2' ' B' ' 70' ' ' GLY . 58.3 t -80.75 110.01 15.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.175 -0.466 . . . . 10.0 111.698 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' B' ' 84' ' ' THR . . . -93.19 -29.27 15.81 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.871 -0.789 . . . . 10.0 108.871 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' B' ' 83' ' ' CYS . . . -166.62 155.66 10.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.087 -0.96 . . . . 10.0 108.863 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLY . . . . . 0.728 ' HA3' ' HB3' ' B' ' 83' ' ' CYS . . . 70.37 -165.88 51.34 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.118 -0.563 . . . . 10.0 113.041 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.33 154.04 38.37 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.949 0.405 . . . . 10.0 110.791 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.469 HG22 HG11 ' B' ' 72' ' ' VAL . 13.9 m -119.93 163.93 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.84 110.79 22.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.095 0.474 . . . . 10.0 112.224 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.78 145.65 31.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.345 -0.843 . . . . 10.0 109.061 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -106.69 -60.05 1.72 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.947 0.403 . . . . 10.0 110.826 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ASP . . . . . 0.416 ' CG ' ' HZ1' ' A' ' 356' ' ' LYS . 22.5 t70 -159.71 141.4 13.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.43 ' NE2' ' HB2' ' B' ' 73' ' ' LEU . 0.0 OUTLIER -135.0 -100.93 0.23 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.923 0.342 . . . . 10.0 111.923 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 44.5 p -114.54 -101.55 0.42 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.783 0.325 . . . . 10.0 111.841 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -102.02 76.19 1.58 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.855 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -165.92 107.97 0.75 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.396 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -94.14 164.22 13.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.509 -0.769 . . . . 10.0 109.997 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.22 -29.26 60.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.827 0.346 . . . . 10.0 111.182 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.45 70.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.288 0.566 . . . . 10.0 110.124 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.656 ' HB3' ' HD2' ' B' ' 71' ' ' PHE . 48.3 mt-30 -90.46 -28.93 18.27 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.072 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' MET . . . . . 0.682 ' HA ' ' O ' ' B' ' 71' ' ' PHE . 25.4 ttt -58.04 -53.73 54.99 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.478 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.51 -16.09 73.52 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.886 -0.673 . . . . 10.0 111.805 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -81.18 -9.85 59.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.956 0.408 . . . . 10.0 110.565 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLY . . . . . 0.705 ' HA2' ' HB ' ' B' ' 49' ' ' VAL . . . 110.99 29.31 3.56 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.639 -0.791 . . . . 10.0 113.64 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' PHE . . . . . 0.682 ' O ' ' HA ' ' B' ' 67' ' ' MET . 19.2 m-85 -129.7 130.24 45.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.219 0.51 . . . . 10.0 110.512 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . 0.469 HG11 HG22 ' B' ' 54' ' ' VAL . 4.8 m -144.75 -165.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.605 0.24 . . . . 10.0 110.725 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' B' ' 46' ' ' ALA . 22.7 tp -120.53 143.49 48.55 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.78 -3.69 12.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.956 0.408 . . . . 10.0 110.838 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' CYS . . . . . 0.483 ' H ' ' HG ' ' B' ' 73' ' ' LEU . 42.7 t -72.22 -57.06 4.54 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.332 0.864 . . . . 10.0 113.332 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 14.0 m -126.44 23.82 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.075 0.398 . . . . 10.0 112.075 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . 0.484 ' HB3' ' O ' ' B' ' 73' ' ' LEU . . . -111.83 152.43 27.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.74 0.305 . . . . 10.0 110.744 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -127.51 150.69 73.53 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.877 -0.601 . . . . 10.0 109.636 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' PRO . . . . . 0.484 ' HD3' HG12 ' B' ' 22' ' ' ILE . 70.8 Cg_endo -77.46 127.56 9.04 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.292 1.995 . . . . 10.0 112.14 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.43 -17.74 61.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.379 0.609 . . . . 10.0 109.985 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 8.3 m -152.68 168.09 26.78 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.427 -0.806 . . . . 10.0 109.349 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.24 125.28 24.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . 0.728 ' HB3' ' HA3' ' B' ' 52' ' ' GLY . 1.7 p -149.59 -168.52 3.13 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.93 0.715 . . . . 10.0 112.93 -177.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' THR . . . . . 0.733 HG23 ' HB ' ' B' ' 4' ' ' THR . 0.9 OUTLIER -131.07 126.33 35.54 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.244 -0.889 . . . . 10.0 108.716 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 32.7 mm -130.0 133.71 64.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.764 0.316 . . . . 10.0 111.575 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . 0.69 ' HA ' ' HB2' ' B' ' 6' ' ' LYS . 9.0 tt0 -82.42 146.18 29.46 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.7 p -94.79 -93.88 0.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.797 1.406 . . . . 10.0 114.797 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -65.74 90.11 0.12 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.743 1.016 . . . . 10.0 113.743 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.762 ' HB3' ' HD3' ' B' ' 48' ' ' LYS . 0.7 OUTLIER -150.66 97.35 2.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.137 -0.483 . . . . 10.0 109.834 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.51 ' HA ' HD21 ' B' ' 93' ' ' LEU . 13.9 pt-20 -119.67 18.75 12.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.12 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -107.21 -11.96 15.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.054 0.454 . . . . 10.0 110.591 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -120.0 81.46 1.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.249 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.51 HD21 ' HA ' ' B' ' 90' ' ' GLU . 0.7 OUTLIER 179.49 88.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.524 -0.762 . . . . 10.0 110.357 178.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 45.4 t80 . . . . . 0 C--O 1.246 0.894 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 -179.471 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' FES . . . . . 0.446 ' S2 ' ' N ' ' B' ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.921 -0.4 . . . . 10.0 109.921 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m -69.53 155.04 41.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.572 -0.286 . . . . 10.0 110.271 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -60.29 -31.84 70.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.646 -0.252 . . . . 10.0 111.202 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.544 HG22 HG12 ' A' ' 212' ' ' ILE . 93.7 t -66.83 -45.07 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.939 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -62.83 -36.6 83.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.616 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -59.83 -34.68 73.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -69.87 -40.85 75.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.082 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.76 -28.32 69.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.63 -0.714 . . . . 10.0 111.055 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.38 80.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.861 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -70.65 -35.35 72.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.678 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 91.0 mt -66.51 -32.32 73.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.161 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.09 -25.3 66.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.19 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 93.3 mttt -72.91 136.37 79.97 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.258 -0.428 . . . . 10.0 109.94 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' LYS . 51.5 Cg_exo -54.95 152.7 28.28 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.991 2.461 . . . . 10.0 111.98 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -61.44 -35.28 77.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.303 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.52 14.53 24.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.074 -0.512 . . . . 10.0 112.239 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 44' ' ' ARG . 14.4 t70 -68.35 134.88 91.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.393 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.39 -22.78 67.37 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.271 2.647 . . . . 10.0 113.998 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.3 4.56 24.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 10.0 111.265 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 6.4 tpt180 -82.38 130.47 35.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.516 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 176' ' ' ASP . 18.9 mttp -108.69 178.21 4.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.802 -0.636 . . . . 10.0 109.655 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.16 117.17 23.31 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 t -102.94 102.58 13.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.247 0.546 . . . . 10.0 111.066 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 179' ' ' MET . 2.8 m -97.95 144.24 27.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.531 -0.758 . . . . 10.0 109.295 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 13.7 p -130.66 141.9 45.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.828 0.347 . . . . 10.0 111.52 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 21.7 pt20 -121.86 126.93 49.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 10.0 109.933 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.679 HG11 HD21 ' A' ' 75' ' ' LEU . 3.0 t -110.27 155.4 11.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.581 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.02 144.7 29.28 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.544 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.72 -33.67 88.38 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.937 2.424 . . . . 10.0 111.944 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.3 67.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.65 HG13 HG23 ' A' ' 214' ' ' THR . 98.5 t -85.49 -39.95 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.058 0.456 . . . . 10.0 109.779 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -57.44 -31.72 66.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.697 -0.683 . . . . 10.0 112.284 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.56 -39.21 16.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.992 0.738 . . . . 10.0 112.992 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB2' ' HD3' ' A' ' 399' ' ' ARG . . . -88.18 -14.3 38.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.416 0.895 . . . . 10.0 113.416 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 tp -58.83 -24.04 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 112.046 0.387 . . . . 10.0 112.046 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.44 -33.27 73.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 10.0 111.342 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -65.34 -29.8 70.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 10.0 111.195 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.41 -17.51 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.96 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.5 mt -105.62 3.02 28.72 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.385 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.66 41.56 15.36 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.051 -0.595 . . . . 10.0 112.094 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.4 mt -125.51 178.88 5.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.767 0.318 . . . . 10.0 110.527 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.77 144.14 55.4 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.792 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.45 119.92 7.47 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.726 2.284 . . . . 10.0 111.672 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.67 0.74 56.48 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 10.0 113.348 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.62 75.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.966 0.383 . . . . 10.0 111.234 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.39 126.3 31.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.676 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.7 p -81.98 156.81 69.52 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.359 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.53 -34.82 92.25 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.237 1.958 . . . . 10.0 110.875 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -68.24 -41.24 81.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.805 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -61.72 -41.74 98.02 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.036 0.446 . . . . 10.0 110.528 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.679 HD21 HG11 ' A' ' 51' ' ' VAL . 48.7 tp -62.08 -48.43 80.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.543 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.2 94.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.004 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 36.7 tp10 -61.52 -42.91 99.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.239 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.07 -44.62 91.0 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.01 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.2 mt -62.1 -42.85 99.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.894 0.378 . . . . 10.0 111.206 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -62.99 -31.72 72.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.955 0.407 . . . . 10.0 110.808 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 81' ' ' ARG . 57.4 mtt-85 -81.44 -9.35 59.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.62 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.6 mt -78.72 -15.3 58.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.428 . . . . 10.0 110.252 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.44 -1.48 11.35 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.478 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -66.64 159.44 27.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.338 . . . . 10.0 111.066 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -104.57 -44.52 4.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.466 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -130.67 131.88 45.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.302 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.68 112.71 40.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.638 0.256 . . . . 10.0 110.872 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 33.7 m-85 -114.52 166.52 11.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.436 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -114.92 148.17 39.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.218 -0.446 . . . . 10.0 109.821 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 m -64.67 -20.81 66.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.671 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.1 -36.32 68.03 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.777 0.288 . . . . 10.0 111.777 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -67.01 -40.5 87.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.141 0.496 . . . . 10.0 109.973 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.84 -36.27 81.64 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.941 -0.864 . . . . 10.0 110.941 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.62 -35.06 79.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.731 0.301 . . . . 10.0 110.474 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -33.53 71.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.872 -0.604 . . . . 10.0 109.873 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.602 HD21 HD23 ' A' ' 424' ' ' LEU . 85.9 mt -75.41 -41.27 56.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.692 -0.685 . . . . 10.0 110.032 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.4 m -59.93 -44.02 94.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.582 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.427 HG12 ' HB3' ' A' ' 259' ' ' ALA . 30.9 mt -57.35 -40.99 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.816 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 92.8 mmm -68.71 -51.01 46.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.319 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.476 ' OE2' ' HA ' ' A' ' 432' ' ' PRO . 64.1 mm-40 -64.14 -53.67 45.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.64 -39.39 91.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.357 . . . . 10.0 110.549 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.08 99.65 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.845 -0.693 . . . . 10.0 111.378 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.3 m -67.64 -40.44 84.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.518 0.199 . . . . 10.0 110.795 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -65.04 -39.22 93.01 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.579 -0.526 . . . . 10.0 109.579 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.408 HD21 HD23 ' A' ' 261' ' ' LEU . 41.8 tp -63.88 -49.04 74.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.892 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.5 tp -59.95 -38.53 82.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.939 -0.573 . . . . 10.0 109.745 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -61.26 -49.36 77.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.972 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.486 ' HG2' ' HG2' ' A' ' 121' ' ' GLU . 40.2 mtt180 -59.03 -38.7 79.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.28 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.43 -56.19 8.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.338 -0.392 . . . . 10.0 111.232 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.6 m -55.52 -43.68 75.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 10.0 112.039 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -61.88 -35.37 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.886 0.328 . . . . 10.0 111.886 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -71.83 -28.6 63.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 10.0 110.258 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.583 ' O ' ' HD2' ' A' ' 309' ' ' ARG . 73.5 mt -83.54 -12.92 55.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.286 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.718 ' HA ' ' NH1' ' A' ' 309' ' ' ARG . 4.3 mm-40 -91.38 -42.69 10.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.909 -0.587 . . . . 10.0 109.483 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.021 -0.99 . . . . 10.0 111.012 179.853 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.352 0.596 . . . . 10.0 111.437 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -85.37 -160.71 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.822 2.348 . . . . 10.0 112.822 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 124' ' ' PRO . 82.7 mt -131.29 162.64 54.66 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.654 -0.869 . . . . 10.0 108.654 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 16.7 Cg_exo -68.8 169.76 57.46 Favored 'Cis proline' 0 C--N 1.347 0.458 0 C-N-CA 124.381 -1.091 . . . . 10.0 113.015 0.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 27.1 ttt -113.58 132.98 55.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.375 -0.829 . . . . 10.0 110.217 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.534 ' HD1' ' HB ' ' A' ' 372' ' ' VAL . 33.7 m-85 -111.73 145.79 38.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.174 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.03 140.73 40.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.695 0.622 . . . . 10.0 110.126 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.621 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -103.73 17.01 25.03 Favored 'General case' 0 CA--C 1.537 0.479 1 N-CA-C 130.104 7.075 . . . . 10.0 130.104 -179.214 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.428 ' O ' ' HD3' ' A' ' 131' ' ' PRO . 68.1 m -81.33 -31.01 33.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 112.142 -2.299 . . . . 10.0 114.393 -166.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 375' ' ' MET . 48.7 m -82.36 124.49 78.09 Favored Pre-proline 0 C--N 1.401 2.835 3 O-C-N 142.034 12.084 . . . . 10.0 113.466 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 129' ' ' CYS . 37.7 Cg_endo -68.54 -23.15 37.43 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.138 2.559 . . . . 10.0 112.246 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.97 -32.91 56.15 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 -73.75 -45.36 52.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.46 -0.37 . . . . 10.0 111.04 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.621 HD11 ' O ' ' A' ' 128' ' ' SER . 97.1 mt -58.57 -35.15 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.101 0.408 . . . . 10.0 112.101 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.97 -35.09 80.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.228 0.537 . . . . 10.0 110.531 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 34.9 ttm -70.12 -40.56 74.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 10.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.911 HD22 HG21 ' A' ' 148' ' ' VAL . 2.5 pp -75.21 -11.98 60.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.868 0.366 . . . . 10.0 111.742 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -96.78 -31.44 12.63 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -108.77 -41.66 4.71 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.634 0.976 . . . . 10.0 113.634 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.2 m -90.75 -44.73 9.27 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.314 0.857 . . . . 10.0 113.314 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -127.59 71.92 77.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 112.025 0.38 . . . . 10.0 112.025 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 73.2 Cg_endo -75.22 11.25 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.55 2.167 . . . . 10.0 112.662 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.98 -7.77 29.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.201 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.5 mt -106.39 14.93 26.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.77 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.589 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 76.9 mt -55.05 -54.72 47.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 113.267 0.84 . . . . 10.0 113.267 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 17.4 Cg_exo -68.06 -9.98 27.44 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.451 2.101 . . . . 10.0 113.009 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 125' ' ' MET . 49.3 m-85 -82.53 -25.08 33.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.131 0.491 . . . . 10.0 110.914 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.911 HG21 HD22 ' A' ' 137' ' ' LEU . 2.7 t -88.53 156.76 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.152 -0.476 . . . . 10.0 109.759 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 t -70.66 154.19 42.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.337 . . . . 10.0 110.923 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 96.3 p -96.77 3.9 52.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.088 0.471 . . . . 10.0 110.304 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.9 m -76.0 144.9 40.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.153 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.43 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 30.4 mtpt -86.01 164.76 17.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.944 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.449 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 0.1 OUTLIER -69.66 152.7 96.12 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.466 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.17 -53.84 5.39 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.802 3.001 . . . . 10.0 113.884 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 153' ' ' SER . 0.0 OUTLIER -62.13 -37.73 86.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 10.0 111.669 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 67.1 mmm -73.14 -23.53 60.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.319 -0.401 . . . . 10.0 111.189 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 40.0 mtt -76.87 -50.1 14.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.3 tp -61.65 -42.53 99.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.46 -0.791 . . . . 10.0 110.844 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.516 ' HA ' ' SD ' ' A' ' 179' ' ' MET . . . -59.47 -40.79 88.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.045 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.47 -35.54 68.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.496 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 3.2 ttt -66.9 -44.66 80.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.675 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 33.0 m -69.52 -30.86 46.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.314 0.487 . . . . 10.0 112.314 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -85.9 6.96 25.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.14 0.422 . . . . 10.0 112.14 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.4 p -129.85 -81.28 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.403 -0.362 . . . . 10.0 110.466 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.578 ' HE2' ' HA ' ' A' ' 240' ' ' MET . 11.3 t80 -56.29 -49.37 74.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.481 . . . . 10.0 111.472 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.659 HD11 ' HE3' ' A' ' 170' ' ' LYS . 41.8 tp -65.93 -39.43 90.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.989 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.63 88.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.512 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.51 -42.38 82.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.912 -0.586 . . . . 10.0 111.107 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -65.98 -46.84 76.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.847 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.659 ' HE3' HD11 ' A' ' 166' ' ' LEU . 72.9 mttt -73.73 -27.15 61.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.702 0.287 . . . . 10.0 111.277 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 88.2 44.0 5.45 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.749 -0.739 . . . . 10.0 112.227 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 21.4 mt -126.8 145.11 34.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -74.9 142.38 76.43 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 110.074 -0.343 . . . . 10.0 110.074 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.435 ' HB2' HD13 ' A' ' 205' ' ' LEU . 45.1 Cg_exo -57.78 -22.07 51.41 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.996 2.464 . . . . 10.0 112.978 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.33 -12.7 56.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.977 0.417 . . . . 10.0 111.485 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 59.3 m-20 -101.36 11.41 39.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.181 0.515 . . . . 10.0 109.74 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 95.4 mtp -122.69 118.84 29.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.899 -0.592 . . . . 10.0 111.263 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.31 133.32 58.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.057 -1.09 . . . . 10.0 108.057 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.516 ' SD ' ' HA ' ' A' ' 159' ' ' ALA . 9.6 ttt -123.0 134.56 54.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.565 0.698 . . . . 10.0 112.805 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 20.8 t -117.84 151.6 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.3 p -135.96 141.68 44.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.721 0.296 . . . . 10.0 110.602 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.539 ' HB ' HG13 ' A' ' 51' ' ' VAL . 16.7 mm -105.04 106.6 20.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 213' ' ' THR . 31.0 mmt -117.4 146.9 39.47 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.227 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.11 15.55 2.19 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.748 2.299 . . . . 10.0 112.705 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 20.8 m -141.28 138.54 33.26 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.978 0.362 . . . . 10.0 111.978 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -30.99 69.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.675 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -65.3 -14.23 60.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.946 -0.57 . . . . 10.0 112.452 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 188' ' ' LYS . 59.2 mmtt -70.07 -27.31 64.52 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.903 0.334 . . . . 10.0 111.903 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -67.26 -44.33 79.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.576 -0.527 . . . . 10.0 109.576 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m -64.09 -29.1 70.26 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.039 0.447 . . . . 10.0 110.246 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.67 -44.86 80.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 208' ' ' LEU . . . -78.36 -12.42 60.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.745 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.42 2.09 51.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.792 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 194' ' ' ARG . 58.4 mtt-85 -64.62 119.43 10.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.691 0.282 . . . . 10.0 110.691 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -38.05 -60.27 0.77 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.271 1.582 . . . . 10.0 115.271 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -66.77 -2.06 4.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 115.012 1.486 . . . . 10.0 115.012 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.431 ' O ' ' HG3' ' A' ' 207' ' ' GLN . 6.2 m-85 -86.71 55.65 3.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.355 0.598 . . . . 10.0 109.848 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.17 169.43 8.74 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.591 -0.732 . . . . 10.0 111.538 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.05 143.15 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.037 -0.982 . . . . 10.0 110.28 -179.786 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 120.925 0.393 . . . . 10.0 110.984 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.806 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.228 -0.075 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -92.48 140.4 29.61 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.436 -0.209 . . . . 10.0 110.436 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 197' ' ' PHE . 56.4 mt-30 -69.6 -41.04 76.28 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.487 ' HB3' ' HB1' ' A' ' 192' ' ' ALA . 13.0 tp -128.52 115.86 18.78 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.62 -47.25 8.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.304 1.224 . . . . 10.0 114.304 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -132.65 143.46 49.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.085 0.772 . . . . 10.0 113.085 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.5 t -126.25 129.23 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.463 -0.939 . . . . 10.0 108.463 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.544 HG12 HG22 ' A' ' 28' ' ' VAL . 55.6 mt -120.22 141.76 39.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 183' ' ' MET . 60.3 p -90.1 164.04 14.63 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.99 -0.284 . . . . 10.0 111.292 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.65 HG23 HG13 ' A' ' 55' ' ' VAL . 1.8 m -55.5 -47.39 76.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.602 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.43 -43.09 89.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 10.0 112.007 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.42 ' O ' HG13 ' A' ' 220' ' ' ILE . 52.7 mt-10 -67.76 -48.31 66.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.145 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 182' ' ' ILE . 31.2 tp -57.98 -46.13 85.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.866 0.365 . . . . 10.0 110.969 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.77 -34.74 89.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.952 -0.567 . . . . 10.0 112.291 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.8 -34.17 69.14 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.838 -0.213 . . . . 10.0 110.821 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 216' ' ' GLU . 90.8 mt -64.66 -42.82 96.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -59.12 -46.39 88.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.381 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -68.85 -29.48 67.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.349 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.29 -36.66 74.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.988 0.423 . . . . 10.0 110.938 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -86.43 -10.82 53.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.178 -0.465 . . . . 10.0 111.428 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.45 40.33 13.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.247 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 53.5 mt -120.57 107.88 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.829 0.347 . . . . 10.0 110.325 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -93.28 118.08 30.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.647 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.651 HD23 HD12 ' A' ' 231' ' ' LEU . 85.1 mt -61.43 -30.34 70.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 10.0 111.628 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.85 -5.55 38.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.165 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.19 27.39 7.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.576 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.651 HD12 HD23 ' A' ' 228' ' ' LEU . 77.9 mt -115.34 148.34 40.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.101 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.14 172.93 15.41 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.487 2.125 . . . . 10.0 111.595 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.81 101.72 4.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.399 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 77' ' ' GLU . . . -75.44 -148.83 2.09 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 116.005 -0.543 . . . . 10.0 112.745 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -152.07 154.99 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.853 0.358 . . . . 10.0 111.418 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -100.09 161.82 13.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.75 -0.659 . . . . 10.0 109.966 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -101.75 150.11 23.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -95.03 119.5 65.76 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.378 -0.373 . . . . 10.0 110.05 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.04 -15.8 35.63 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.206 2.604 . . . . 10.0 112.495 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.578 ' HA ' ' HE2' ' A' ' 165' ' ' TYR . 98.9 mmm -75.19 -14.3 60.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.934 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 91.84 -18.83 51.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.818 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.0 m -134.24 157.71 41.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 110.354 -0.239 . . . . 10.0 110.354 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 90.19 155.04 30.62 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.783 -0.723 . . . . 10.0 112.319 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.34 130.19 46.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.694 0.283 . . . . 10.0 110.703 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 125.07 176.69 14.63 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.525 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -81.15 -1.05 43.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.874 0.337 . . . . 10.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.42 6.13 84.13 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.917 -0.658 . . . . 10.0 112.26 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.6 t -108.48 135.81 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.725 HD11 ' HD3' ' A' ' 419' ' ' PRO . 90.1 mt -81.75 159.34 23.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.68 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -67.44 110.67 3.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.976 -0.557 . . . . 10.0 110.832 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.551 ' HA3' ' HB2' ' A' ' 413' ' ' ARG . . . 148.56 141.84 3.54 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.802 -0.713 . . . . 10.0 112.064 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.4 t -84.36 155.02 22.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.997 0.427 . . . . 10.0 111.148 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.22 -16.32 19.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.476 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.51 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 86.11 -6.78 80.51 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.107 -0.568 . . . . 10.0 112.396 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.75 158.4 10.22 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.008 -0.837 . . . . 10.0 111.008 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.23 -55.53 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.863 0.331 . . . . 10.0 110.909 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' MET . . . . . 0.612 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 19.3 ttp -56.99 -48.22 78.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.65 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.51 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 18.2 tt0 -63.26 -48.27 78.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.131 0.419 . . . . 10.0 112.131 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ALA . . . . . 0.427 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . -64.26 -34.99 79.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.503 0.192 . . . . 10.0 111.335 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.73 73.26 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.408 HD23 HD21 ' A' ' 105' ' ' LEU . 68.0 mt -62.45 -41.07 98.48 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.728 -0.669 . . . . 10.0 109.8 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.483 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 44.4 ttm105 -59.28 -50.16 75.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.47 -0.787 . . . . 10.0 111.018 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 50.9 m -57.56 -43.62 84.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.053 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.24 77.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.911 0.386 . . . . 10.0 110.72 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.526 ' CD2' ' HB2' ' A' ' 273' ' ' LEU . 50.3 t80 -63.26 -48.8 76.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.705 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.419 ' OE2' ' HA ' ' A' ' 272' ' ' PRO . 59.5 mt-10 -63.91 -27.37 69.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.111 0.782 . . . . 10.0 113.111 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 82.2 mt -86.82 -26.64 23.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.03 0.443 . . . . 10.0 111.046 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -84.93 -36.97 21.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.679 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.443 HG21 ' CE1' ' A' ' 265' ' ' TYR . 63.0 p -100.81 -32.74 10.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.718 0.636 . . . . 10.0 112.718 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 87.23 0.99 84.59 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.732 -0.947 . . . . 10.0 110.732 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 42.0 p -109.38 145.09 31.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 110.286 -0.264 . . . . 10.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.419 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 42.6 Cg_endo -69.26 146.2 62.47 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.604 2.202 . . . . 10.0 112.203 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.543 HD12 ' HD2' ' A' ' 274' ' ' PRO . 32.1 tp -115.2 123.56 31.51 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.931 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' A' ' 273' ' ' LEU . 87.7 Cg_endo -80.29 -157.3 0.08 OUTLIER 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.696 2.264 . . . . 10.0 111.3 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -79.28 140.07 37.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.569 0.224 . . . . 10.0 110.584 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 90.5 mt -91.69 128.2 37.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.984 0.421 . . . . 10.0 111.248 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 7.1 m -96.1 93.47 6.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.182 0.515 . . . . 10.0 111.002 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 288' ' ' LYS . 4.3 mm? -64.54 122.33 16.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.515 -0.766 . . . . 10.0 111.346 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.2 m -105.18 138.87 40.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.516 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.97 144.12 56.96 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.765 0.283 . . . . 10.0 111.765 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.59 HG22 ' HG2' ' A' ' 289' ' ' GLU . 16.7 t -93.84 123.71 46.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.31 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -66.06 118.81 10.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.208 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.99 -23.85 12.46 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.906 -0.664 . . . . 10.0 111.808 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.434 ' HB3' HG13 ' A' ' 287' ' ' ILE . 75.7 mtm -126.98 98.65 5.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.985 0.421 . . . . 10.0 110.351 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -69.17 133.28 47.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.176 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' GLY . . . . . 0.435 ' HA3' HD21 ' A' ' 354' ' ' ASN . . . 89.64 -6.99 82.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.038 -0.601 . . . . 10.0 112.459 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 284' ' ' MET . 37.1 mm -101.19 127.92 53.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.87 0.367 . . . . 10.0 110.312 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 278' ' ' LEU . 65.8 mttm -122.97 142.81 50.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.59 ' HG2' HG22 ' A' ' 281' ' ' VAL . 15.8 pt-20 -126.05 163.56 22.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.119 0.485 . . . . 10.0 111.562 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.418 ' CG2' ' HB ' ' A' ' 346' ' ' VAL . 10.0 t -157.19 131.4 8.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.861 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -105.7 121.83 44.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.279 -0.419 . . . . 10.0 109.944 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 36.2 mt -109.12 111.7 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.457 -0.338 . . . . 10.0 111.419 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.07 103.55 3.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.584 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 87.4 mtp -98.38 115.12 27.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.127 0.489 . . . . 10.0 111.442 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 269' ' ' THR . 70.2 t -109.3 124.79 32.99 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.632 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.01 129.77 34.84 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.737 2.291 . . . . 10.0 112.631 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -62.11 132.23 93.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.848 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.11 118.4 5.35 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.584 2.189 . . . . 10.0 111.978 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 95.07 21.47 25.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.875 -0.679 . . . . 10.0 112.797 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.1 p -119.78 164.04 16.56 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.7 -0.294 . . . . 10.0 110.478 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.667 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 71.4 tttt -62.83 -32.12 73.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.992 0.425 . . . . 10.0 109.911 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' PHE . . . . . 0.409 ' HA ' HD12 ' A' ' 305' ' ' LEU . 47.9 m-85 -60.59 -36.64 79.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.645 -0.707 . . . . 10.0 111.177 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -70.36 -36.71 74.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.98 -0.554 . . . . 10.0 110.428 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -28.29 62.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.779 -0.646 . . . . 10.0 111.312 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 90.0 mt -58.18 -53.91 52.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.44 -1.67 31.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.295 0.48 . . . . 10.0 112.295 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -104.5 -36.0 7.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.946 0.403 . . . . 10.0 111.07 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -26.41 54.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.717 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ARG . . . . . 0.718 ' NH1' ' HA ' ' A' ' 114' ' ' GLU . 5.1 ptp85 -148.42 165.36 31.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.531 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -138.25 -57.67 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.015 0.436 . . . . 10.0 110.591 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.745 -0.645 . . . . 10.0 110.077 179.419 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.909 -0.476 . . . . 10.0 111.909 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.64 -26.07 33.72 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.792 2.328 . . . . 10.0 111.555 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.511 ' HB2' ' CE2' ' A' ' 147' ' ' TYR . 93.1 mt -113.13 105.1 13.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.732 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.76 31.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.498 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -56.19 137.29 52.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.706 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -79.69 -12.68 59.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.979 0.419 . . . . 10.0 111.607 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 114.25 -10.68 22.27 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.829 -0.7 . . . . 10.0 111.405 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 89.79 141.8 8.92 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.003 -0.618 . . . . 10.0 112.084 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -77.75 96.01 4.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.093 0.473 . . . . 10.0 110.106 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -103.22 163.16 15.82 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.791 -0.718 . . . . 10.0 112.737 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -147.5 153.78 39.94 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.473 ' HA ' ' HA3' ' A' ' 340' ' ' GLY . 6.2 t -144.36 161.04 40.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.917 0.389 . . . . 10.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' SER . . . . . 0.457 ' HB2' ' OD1' ' A' ' 337' ' ' ASP . 1.4 m -110.19 166.26 11.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.726 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -72.96 7.06 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 335' ' ' SER . 2.0 p-10 -104.0 -16.76 15.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.968 0.413 . . . . 10.0 110.269 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.34 -4.13 33.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 10.0 113.293 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -108.52 122.04 46.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.99 0.424 . . . . 10.0 110.69 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 334' ' ' THR . . . -136.67 -145.1 4.95 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.864 -0.684 . . . . 10.0 111.917 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 179.0 -165.46 34.42 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.55 -0.62 . . . . 10.0 111.55 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.456 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 14.5 tt -137.89 138.56 43.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 13.2 t -102.25 119.33 38.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.298 0.57 . . . . 10.0 110.414 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 11.7 tp -79.0 126.19 30.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.683 -0.689 . . . . 10.0 111.407 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -95.09 106.11 18.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.583 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 371' ' ' PHE . 29.4 t -107.46 139.81 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.12 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 372' ' ' VAL . . . -136.69 144.9 44.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.804 0.335 . . . . 10.0 110.962 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 52.5 t -119.58 125.83 74.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.318 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 358' ' ' LEU . . . -108.8 119.77 40.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.066 -0.515 . . . . 10.0 109.912 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -100.92 103.06 14.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.574 -0.285 . . . . 10.0 111.398 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 113.11 146.01 9.55 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.605 -0.807 . . . . 10.0 114.239 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.11 -32.4 68.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.186 0.517 . . . . 10.0 109.842 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -75.73 -10.83 84.84 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.916 -0.874 . . . . 10.0 110.916 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.594 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 3.2 t-20 -91.49 -31.4 15.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.643 -0.503 . . . . 10.0 109.643 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.2 93.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.663 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -58.84 -40.91 85.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.495 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 8.7 pttm -83.86 -10.86 57.7 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.431 0.53 . . . . 10.0 112.431 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 349' ' ' ALA . 29.1 tp -91.95 -49.44 6.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.816 0.341 . . . . 10.0 111.119 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 85.0 mt -58.25 -37.55 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 10.0 111.103 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.94 -26.75 68.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.266 -0.424 . . . . 10.0 111.346 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -78.86 -33.15 46.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 10.0 109.926 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 91.0 mtp -75.06 -37.54 61.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.001 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -63.14 -34.57 77.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.011 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -79.38 -12.75 59.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.263 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 84.4 15.47 68.77 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.843 -0.694 . . . . 10.0 112.395 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -83.28 -52.38 6.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.023 0.439 . . . . 10.0 109.94 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.417 ' HB1' ' HE2' ' A' ' 369' ' ' TYR . . . -94.09 100.28 12.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.579 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.61 115.0 26.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' TYR . . . . . 0.417 ' HE2' ' HB1' ' A' ' 367' ' ' ALA . 85.1 m-85 -137.9 159.86 40.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.677 -0.49 . . . . 10.0 109.677 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -107.16 -39.46 5.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.968 0.413 . . . . 10.0 110.979 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.612 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 20.5 t80 -128.16 123.57 34.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.368 -0.605 . . . . 10.0 109.368 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.534 ' HB ' ' HD1' ' A' ' 126' ' ' PHE . 45.4 t -129.38 126.57 63.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.848 0.356 . . . . 10.0 111.746 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -104.12 124.09 48.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.672 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.74 121.92 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.843 0.354 . . . . 10.0 110.896 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' MET . . . . . 0.6 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 67.2 mtt -105.65 152.36 23.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.343 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 121.029 0.443 . . . . 10.0 110.998 -179.893 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 112.572 0.582 . . . . 10.0 112.572 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -128.56 48.77 0.95 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.511 -0.852 . . . . 10.0 112.663 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -87.54 168.97 38.7 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.449 -0.881 . . . . 10.0 111.74 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -67.79 -15.19 66.41 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.232 -0.508 . . . . 10.0 113.294 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -89.29 -5.44 72.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.696 -0.764 . . . . 10.0 111.749 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -82.42 156.3 68.66 Favored Pre-proline 0 C--O 1.239 0.501 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.8 160.73 39.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.715 2.277 . . . . 10.0 111.532 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 107.54 14.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.92 0.391 . . . . 10.0 111.282 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.778 -0.646 . . . . 10.0 109.868 179.617 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.884 0.373 . . . . 10.0 111.391 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -64.26 -37.18 86.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.662 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -62.97 -44.93 94.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.063 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.401 ' HD3' ' HB2' ' A' ' 58' ' ' ALA . 97.3 mtt180 -68.44 -35.76 78.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.029 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -66.36 -40.2 89.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.518 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -73.4 -29.67 62.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.05 -0.523 . . . . 10.0 111.622 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -91.61 10.07 29.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 10.0 111.784 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 9.5 mt -66.55 -41.45 88.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.738 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -136.16 153.46 51.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.495 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ASN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 407' ' ' ASP . 63.8 t30 -79.52 174.24 11.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.583 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 406' ' ' LEU . 3.6 mm? -59.55 -39.51 84.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 405' ' ' ASN . 11.7 p30 -70.72 -46.63 62.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.351 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -60.63 -35.32 75.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.646 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -71.12 -40.63 71.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.888 0.375 . . . . 10.0 111.293 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 10.8 m -73.97 -31.14 62.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.996 -0.547 . . . . 10.0 111.829 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 5.6 m -87.0 107.69 18.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 40.2 tp -85.65 136.65 33.29 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.692 -0.484 . . . . 10.0 109.692 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ARG . . . . . 0.551 ' HB2' ' HA3' ' A' ' 251' ' ' GLY . 3.9 tmm_? -145.77 125.12 13.05 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.216 -0.29 . . . . 10.0 110.216 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.619 ' HB2' ' OE1' ' A' ' 417' ' ' GLU . 5.3 mtt85 -100.83 158.52 15.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.136 0.493 . . . . 10.0 110.462 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.6 m -64.5 -24.91 67.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.551 0.945 . . . . 10.0 113.551 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' HIS . . . . . . . . . . . . 0.282 28.5 p80 -78.71 4.23 14.31 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' GLU . . . . . 0.619 ' OE1' ' HB2' ' A' ' 414' ' ' ARG . 1.7 mp0 -112.12 -3.93 14.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.992 0.425 . . . . 10.0 109.975 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.42 ' HB3' ' HB ' ' A' ' 421' ' ' ILE . 50.4 t-20 -77.75 118.37 71.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.624 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.725 ' HD3' HD11 ' A' ' 249' ' ' LEU . 37.7 Cg_exo -59.05 -38.68 86.13 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.022 2.481 . . . . 10.0 111.636 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 53.9 m -65.28 -46.27 81.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.313 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 418' ' ' ASN . 39.2 mm -65.22 -43.02 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.132 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' ARG . . . . . 0.587 ' NH2' ' HA ' ' A' ' 417' ' ' GLU . 97.1 mtt180 -58.97 -45.45 90.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.366 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -63.33 -49.64 73.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.93 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.602 HD23 HD21 ' A' ' 96' ' ' LEU . 61.3 tp -56.37 -39.17 72.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.998 0.427 . . . . 10.0 110.947 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' TYR . . . . . 0.882 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.1 m-85 -77.35 4.62 10.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.948 -0.569 . . . . 10.0 111.498 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -118.76 -54.61 2.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.739 0.304 . . . . 10.0 111.692 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -25.27 53.47 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.714 1.005 . . . . 10.0 113.714 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -126.71 -50.13 1.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 114.589 1.329 . . . . 10.0 114.589 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.882 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 90.9 mt -73.08 -39.74 65.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.391 0.886 . . . . 10.0 113.391 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 86.25 -60.57 4.56 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.574 -0.822 . . . . 10.0 112.836 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 432' ' ' PRO . 2.1 tt0 -165.95 151.1 7.77 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.615 0.208 . . . . 10.0 110.727 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.476 ' HA ' ' OE2' ' A' ' 100' ' ' GLU . 32.5 Cg_exo -59.64 142.4 98.74 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.819 2.346 . . . . 10.0 111.312 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 7.9 mp 63.35 16.95 9.92 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.708 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -78.67 -168.79 34.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.2 -0.524 . . . . 10.0 112.214 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 435' ' ' HIS . . . . . 0.426 ' O ' ' HG3' ' A' ' 439' ' ' GLU . 31.4 t-80 -59.99 -60.83 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.512 0.196 . . . . 10.0 111.328 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.443 ' HD2' ' OE2' ' A' ' 439' ' ' GLU . 8.3 tptt -59.4 -35.46 74.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.278 -0.419 . . . . 10.0 111.29 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -65.19 -42.84 93.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.156 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 9.6 t-80 -68.02 -26.9 66.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.901 0.382 . . . . 10.0 110.521 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' GLU . . . . . 0.443 ' OE2' ' HD2' ' A' ' 436' ' ' LYS . 45.4 mt-10 -73.06 -64.88 0.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 62.4 mt -99.04 -17.96 18.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.986 1.476 . . . . 10.0 114.986 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 60.8 mt -100.0 -11.14 20.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.557 0.577 . . . . 10.0 112.557 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 28.0 m-70 -122.59 163.6 19.7 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 121.305 -0.158 . . . . 10.0 110.595 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 5.9 t -155.07 -171.95 4.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.667 0.27 . . . . 10.0 111.081 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -133.84 168.09 19.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.374 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' TYR . . . . . 0.546 ' HD2' HG23 ' A' ' 145' ' ' ILE . 51.0 m-85 -109.85 161.02 15.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.446 -0.343 . . . . 10.0 110.358 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.15 120.91 66.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.977 0.418 . . . . 10.0 111.31 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.13 107.23 3.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.738 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.26 -6.32 11.89 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.128 -0.789 . . . . 10.0 111.128 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.045 179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.998 -0.371 . . . . 10.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.25 154.17 35.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.594 -0.521 . . . . 10.0 109.594 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -62.86 -22.96 67.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.88 0.371 . . . . 10.0 111.698 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.62 -45.45 50.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.882 -0.785 . . . . 10.0 108.882 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -63.93 -32.62 74.22 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.697 -0.683 . . . . 10.0 109.772 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.554 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 60.2 mt-30 -61.87 -19.1 62.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.414 -0.812 . . . . 10.0 111.059 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -98.76 -47.43 5.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.016 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 35' ' ' LEU . 96.0 mt -59.71 -26.7 65.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.994 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.78 -50.43 73.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.728 0.299 . . . . 10.0 111.001 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -75.7 -26.09 57.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.728 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.521 HD12 HD23 ' A' ' 32' ' ' LEU . 62.4 mt -70.32 -30.79 67.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.847 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.42 -25.45 61.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.289 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -70.66 130.24 89.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.22 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.17 153.88 15.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 123.125 2.55 . . . . 10.0 112.086 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -63.05 -25.21 68.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.136 0.493 . . . . 10.0 110.423 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -101.51 15.95 27.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.381 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.842 ' HB3' ' HB2' ' A' ' 44' ' ' ARG . 15.8 t70 -69.36 136.39 88.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.278 -0.268 . . . . 10.0 110.278 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.96 -24.49 73.31 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.962 2.442 . . . . 10.0 113.033 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.32 10.85 23.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.957 0.408 . . . . 10.0 110.983 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.842 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 7.4 tpt180 -72.28 137.55 46.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.032 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -118.72 173.81 6.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.579 -0.737 . . . . 10.0 109.233 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.4 111.06 21.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 t -99.56 104.27 15.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.224 0.535 . . . . 10.0 111.091 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.2 m -96.87 141.05 30.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.352 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 14.5 p -128.56 139.31 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.705 0.288 . . . . 10.0 111.567 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 12.8 pt20 -120.78 125.31 47.25 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.778 -0.453 . . . . 10.0 109.778 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.584 HG11 HD21 ' A' ' 75' ' ' LEU . 14.1 t -111.3 143.81 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.346 -0.388 . . . . 10.0 111.183 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.7 145.82 31.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.544 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.86 -30.17 84.4 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.003 2.469 . . . . 10.0 112.433 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.08 -23.37 65.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.94 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.708 HG13 HG23 ' A' ' 214' ' ' THR . 86.8 t -81.13 -38.56 16.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.624 -0.51 . . . . 10.0 109.624 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -59.46 -29.6 67.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.835 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -85.58 -33.7 7.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.508 0.558 . . . . 10.0 112.508 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 388' ' ' PRO . . . -91.74 -17.1 25.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.117 0.784 . . . . 10.0 113.117 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.52 -20.84 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 10.0 111.381 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' A' ' 65' ' ' LEU . . . -70.26 -37.69 74.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.684 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 399' ' ' ARG . 32.4 mt-10 -64.15 -29.76 70.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.523 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.415 HG21 ' HA3' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -69.03 -15.63 63.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 10.0 110.858 179.329 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 mt -109.17 -5.56 15.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.149 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.39 27.4 22.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.908 -0.663 . . . . 10.0 112.23 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.508 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 mt -112.95 164.24 13.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.6 0.238 . . . . 10.0 110.492 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -69.96 140.9 88.93 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.731 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 66' ' ' ALA . 51.5 Cg_exo -55.44 118.82 5.62 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.881 2.387 . . . . 10.0 112.127 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.94 0.0 55.05 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.6 -0.809 . . . . 10.0 113.279 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.79 -38.11 73.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 10.0 111.051 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.11 131.34 41.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.716 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -83.52 157.1 65.08 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.598 0.237 . . . . 10.0 110.403 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.4 -35.26 91.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.225 1.95 . . . . 10.0 111.345 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.505 ' HB2' ' OE1' ' A' ' 233' ' ' GLU . 31.4 mmtp -71.8 -36.96 70.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.946 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -61.27 -42.3 98.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.091 0.472 . . . . 10.0 110.529 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.584 HD21 HG11 ' A' ' 51' ' ' VAL . 45.0 tp -63.84 -46.45 84.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.588 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.32 95.42 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.835 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -61.75 -42.7 99.32 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.817 -0.629 . . . . 10.0 110.367 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -44.34 91.22 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.964 -0.636 . . . . 10.0 112.003 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD11 HG21 ' A' ' 51' ' ' VAL . 16.3 mt -61.77 -40.49 95.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 10.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -62.94 -31.01 72.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.763 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -81.51 -8.73 59.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 10.0 111.803 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.0 mt -79.16 -9.3 59.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.022 0.439 . . . . 10.0 110.761 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.85 -0.43 28.77 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.691 -0.766 . . . . 10.0 112.354 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.75 159.58 27.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 10.0 110.971 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -101.7 -59.4 1.71 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.859 0.362 . . . . 10.0 110.995 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -115.97 125.06 52.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.827 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.3 t -105.48 108.79 25.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.283 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 30.1 m-85 -110.76 168.76 9.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.923 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.43 155.8 27.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.822 -0.626 . . . . 10.0 110.058 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 m -76.64 -21.79 55.0 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.98 0.733 . . . . 10.0 112.98 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.433 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . 44.9 mt -61.43 -37.46 83.58 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.317 -0.239 . . . . 10.0 111.069 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' HZ ' ' HG2' ' A' ' 240' ' ' MET . 43.5 t80 -61.01 -38.37 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.232 0.539 . . . . 10.0 109.598 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.66 -35.26 55.51 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.776 -0.93 . . . . 10.0 110.776 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.11 77.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.696 0.284 . . . . 10.0 110.379 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.33 -35.48 73.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 10.0 109.662 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.42 -42.39 65.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.531 -0.759 . . . . 10.0 109.594 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.6 m -60.51 -42.43 96.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.617 -0.72 . . . . 10.0 110.622 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.9 mt -59.98 -39.95 81.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.771 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.8 mmm -65.92 -51.73 56.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.976 -0.557 . . . . 10.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -65.55 -45.44 83.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.873 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 101' ' ' GLU . 1.8 tp10 -61.52 -43.55 98.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 10.0 110.929 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.05 95.29 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 110.981 -0.848 . . . . 10.0 110.981 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.573 ' HB2' HD13 ' A' ' 433' ' ' LEU . 19.7 m -69.27 -43.64 73.51 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.614 -0.293 . . . . 10.0 110.497 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.426 ' HG2' HD21 ' A' ' 433' ' ' LEU . 0.0 OUTLIER -60.18 -47.02 87.69 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.802 -0.444 . . . . 10.0 109.802 178.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.415 ' CD2' HD23 ' A' ' 261' ' ' LEU . 23.3 tp -59.16 -54.68 44.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.726 -0.67 . . . . 10.0 111.059 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.0 tp -59.35 -39.17 82.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.907 0.384 . . . . 10.0 110.593 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.605 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 53.9 t60 -61.86 -53.09 60.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.526 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.593 ' HG2' ' HB2' ' A' ' 121' ' ' GLU . 68.2 mtt180 -59.72 -38.66 82.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.715 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 41.7 tp -67.21 -50.86 59.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.842 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.5 m -58.14 -44.95 88.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.912 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 23.1 mm-40 -57.95 -31.19 66.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.948 0.404 . . . . 10.0 111.573 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -79.65 -37.28 36.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 65.3 mt -69.31 -32.48 71.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.984 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.534 ' HG2' HD22 ' A' ' 305' ' ' LEU . 22.7 mt-10 -79.54 -7.16 58.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.284 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.139 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.356 -179.91 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 108' ' ' ARG . 1.5 pm0 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.862 0.363 . . . . 10.0 110.891 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -90.09 -172.07 0.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.988 2.458 . . . . 10.0 112.801 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.423 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 91.1 mt -133.93 157.38 77.87 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.486 -0.931 . . . . 10.0 108.486 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.458 ' HB3' ' O ' ' A' ' 369' ' ' TYR . 37.5 Cg_endo -64.92 167.46 45.46 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 124.513 -1.036 . . . . 10.0 113.802 0.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 24.6 ttt -113.92 134.08 55.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.739 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.611 ' HD1' ' HB ' ' A' ' 372' ' ' VAL . 33.3 m-85 -110.8 144.6 39.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.21 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.439 HG23 ' HZ ' ' A' ' 371' ' ' PHE . 0.0 OUTLIER -81.87 156.09 25.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.885 0.328 . . . . 10.0 111.885 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 m -111.63 54.18 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.262 0.553 . . . . 10.0 110.285 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.2 p -90.58 -39.51 12.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 10.0 112.086 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.781 ' SG ' ' HA ' ' A' ' 375' ' ' MET . 36.5 m -105.38 117.87 57.14 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.809 ' HG3' ' HE3' ' A' ' 188' ' ' LYS . 36.5 Cg_endo -64.46 -29.48 62.17 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.015 2.477 . . . . 10.0 111.743 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.21 -39.94 98.5 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.785 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -36.88 69.79 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 45.7 mm -62.92 -44.87 99.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.844 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.16 92.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.584 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 58.5 ttp -68.87 -34.73 75.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 10.0 109.773 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 tp -64.2 -54.45 33.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.754 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -59.8 -24.95 64.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.852 0.686 . . . . 10.0 112.852 -178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.64 -52.67 4.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.218 0.822 . . . . 10.0 113.218 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 m -84.24 -44.18 14.15 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 114.902 1.445 . . . . 10.0 114.902 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -131.7 73.25 79.3 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.9 -12.43 34.41 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.406 2.071 . . . . 10.0 111.82 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.94 -16.14 61.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.127 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.569 ' HA ' ' HD2' ' A' ' 147' ' ' TYR . 69.2 mt -98.97 9.52 43.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.567 HG23 ' HD2' ' A' ' 445' ' ' TYR . 52.4 mt -55.93 -52.46 72.28 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 33.4 Cg_exo -61.46 -23.28 76.43 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.338 2.025 . . . . 10.0 112.9 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.569 ' HD2' ' HA ' ' A' ' 144' ' ' LEU . 98.7 m-85 -75.78 -19.57 58.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.0 0.429 . . . . 10.0 111.047 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.2 t -86.99 159.13 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.786 -0.449 . . . . 10.0 109.786 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.522 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . 31.5 t -69.4 167.62 16.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.991 0.424 . . . . 10.0 110.778 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.4 p -106.56 6.81 30.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.349 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.52 179.42 7.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 10.0 112.124 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 156' ' ' MET . 40.8 mtpt -122.25 169.79 10.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.3 p -68.53 152.56 96.56 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 121.049 -0.26 . . . . 10.0 110.471 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.66 -46.72 23.14 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.265 2.643 . . . . 10.0 112.974 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -35.7 80.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.803 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.463 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 60.1 mmm -74.52 -19.11 60.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.137 0.494 . . . . 10.0 110.833 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 30.9 mtt -80.66 -48.25 12.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.302 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.91 -42.26 99.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.59 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.68 81.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.64 61.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.812 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -72.69 -44.56 61.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.682 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.9 m -69.49 -28.68 38.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 179' ' ' MET . 27.5 mttt -85.73 2.6 44.8 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.824 0.305 . . . . 10.0 111.824 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 168' ' ' GLU . 13.5 p -122.82 -79.62 0.62 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.608 -0.269 . . . . 10.0 110.74 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.577 ' HE2' ' HA ' ' A' ' 240' ' ' MET . 33.8 t80 -55.58 -53.19 59.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.964 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.714 HD11 ' HE3' ' A' ' 170' ' ' LYS . 24.3 tp -61.94 -41.11 97.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 10.0 111.277 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.27 -50.18 74.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.202 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 164' ' ' SER . 41.6 mt-10 -68.41 -37.2 80.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.363 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -64.93 -49.08 71.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.247 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.714 ' HE3' HD11 ' A' ' 166' ' ' LEU . 91.2 mttt -76.88 -15.08 59.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.136 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 73.71 37.2 52.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.765 -0.731 . . . . 10.0 111.647 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.96 135.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.99 133.9 91.89 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.48 -0.327 . . . . 10.0 110.488 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.419 ' HB2' HD13 ' A' ' 205' ' ' LEU . 32.0 Cg_exo -59.55 -16.76 37.85 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.911 2.407 . . . . 10.0 112.399 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -71.94 -22.42 61.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.747 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -107.51 23.88 13.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.236 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 96.0 mtp -125.9 115.21 19.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.127 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.55 131.88 51.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.43 ' HB2' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -112.4 119.87 39.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.149 0.5 . . . . 10.0 111.225 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 46.4 t -116.46 135.82 55.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.7 p -124.46 135.85 53.56 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.803 0.297 . . . . 10.0 111.803 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 212' ' ' ILE . 30.3 mm -99.93 103.11 14.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 213' ' ' THR . 32.4 mmt -114.26 148.43 40.09 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.944 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 183' ' ' MET . 2.5 Cg_endo -83.19 19.31 1.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.283 2.655 . . . . 10.0 112.665 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 73.1 m -145.93 129.17 16.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.05 0.453 . . . . 10.0 111.227 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -28.1 67.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.602 -0.726 . . . . 10.0 111.174 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -80.7 17.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.075 -0.511 . . . . 10.0 112.029 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.809 ' HE3' ' HG3' ' A' ' 131' ' ' PRO . 0.0 OUTLIER -87.87 -33.88 18.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.657 0.265 . . . . 10.0 111.349 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -65.01 -30.64 71.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.915 0.388 . . . . 10.0 110.171 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.81 -25.58 66.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.661 -0.699 . . . . 10.0 111.9 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 131' ' ' PRO . 31.1 tt0 -76.25 -46.9 25.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -73.5 -5.91 43.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.564 -0.744 . . . . 10.0 111.16 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.36 -18.85 57.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.517 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.468 HH11 ' HZ2' ' A' ' 196' ' ' TRP . 78.0 mtt-85 -59.02 118.16 5.5 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.744 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -41.79 -47.99 4.22 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.709 1.374 . . . . 10.0 114.709 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' TRP . . . . . 0.468 ' HZ2' HH11 ' A' ' 194' ' ' ARG . 43.9 p90 -62.27 -9.59 8.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.998 1.481 . . . . 10.0 114.998 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -85.74 56.3 3.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.577 0.703 . . . . 10.0 110.811 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -110.07 171.07 7.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.384 -0.825 . . . . 10.0 110.375 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.59 80.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.688 0.28 . . . . 10.0 110.65 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.3 t0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.116 -0.945 . . . . 10.0 112.17 179.596 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.876 0.369 . . . . 10.0 111.102 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.788 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.229 -0.004 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -94.27 148.82 21.83 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.956 0.16 . . . . 10.0 110.799 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -70.36 -38.62 74.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.166 -1.049 . . . . 10.0 108.166 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 29.8 tp -131.85 121.45 24.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.601 -1.629 . . . . 10.0 106.601 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.98 -44.68 7.24 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.891 1.071 . . . . 10.0 113.891 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 8.7 m-70 -130.36 141.88 50.55 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.987 0.736 . . . . 10.0 112.987 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.72 123.78 60.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.652 -0.869 . . . . 10.0 108.652 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 71.7 mt -119.78 140.05 45.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 183' ' ' MET . 41.1 p -90.23 166.95 13.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.052 0.453 . . . . 10.0 111.96 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.708 HG23 HG13 ' A' ' 55' ' ' VAL . 2.5 m -56.09 -46.71 78.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.476 -0.784 . . . . 10.0 111.773 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.8 m -61.26 -39.79 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.427 ' O ' HG13 ' A' ' 220' ' ' ILE . 41.9 mt-10 -68.7 -46.96 67.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.795 0.331 . . . . 10.0 110.638 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 31.1 tp -62.25 -43.07 99.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.34 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.415 ' HA3' HG21 ' A' ' 62' ' ' THR . . . -60.08 -36.27 89.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.186 -0.531 . . . . 10.0 112.252 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -38.87 80.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.571 0.224 . . . . 10.0 110.462 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 216' ' ' GLU . 79.7 mt -59.1 -45.3 92.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.18 -0.464 . . . . 10.0 110.08 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -59.77 -45.86 90.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.861 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.28 -46.81 82.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.787 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.92 -30.97 71.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 10.0 111.942 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -80.93 -12.7 59.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.926 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.78 30.51 47.74 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.914 -0.66 . . . . 10.0 111.868 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.6 mt -113.21 114.72 47.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.953 0.406 . . . . 10.0 110.532 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.454 ' O ' ' HG ' ' A' ' 231' ' ' LEU . 54.8 t30 -104.07 122.14 44.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.317 -0.401 . . . . 10.0 110.035 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.524 ' HA ' HD12 ' A' ' 231' ' ' LEU . 76.2 mt -60.4 -32.6 71.48 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.316 0.385 . . . . 10.0 111.735 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.04 -16.95 63.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.737 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.43 3.03 34.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 10.0 110.694 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 228' ' ' LEU . 95.9 mt -96.65 151.03 37.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.327 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.18 -179.89 5.62 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.593 2.195 . . . . 10.0 111.123 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.505 ' OE1' ' HB2' ' A' ' 73' ' ' LYS . 2.8 mm-40 -80.55 103.45 10.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.739 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -80.83 -152.62 8.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.017 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -150.98 157.86 43.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.867 0.333 . . . . 10.0 111.061 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -98.54 166.29 11.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.837 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -106.32 152.39 23.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -98.48 121.53 56.36 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.826 0.346 . . . . 10.0 110.944 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.82 -16.62 56.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.169 2.579 . . . . 10.0 112.079 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.577 ' HA ' ' HE2' ' A' ' 165' ' ' TYR . 85.5 mmm -81.15 -10.13 59.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.964 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 105.5 -66.34 0.27 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.029 -0.605 . . . . 10.0 112.043 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 17.0 m -104.69 165.2 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.573 0.225 . . . . 10.0 110.939 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 103.05 118.23 4.44 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.923 -0.656 . . . . 10.0 112.147 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.9 m -64.25 133.86 53.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.047 0.451 . . . . 10.0 111.605 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.02 -167.84 18.64 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.405 -0.678 . . . . 10.0 111.405 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.61 -8.66 58.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.929 0.395 . . . . 10.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 91.8 -1.87 75.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 10.0 112.311 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.63 129.31 39.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.833 -0.432 . . . . 10.0 109.833 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.64 ' HB2' ' HD3' ' A' ' 413' ' ' ARG . 63.5 mt -73.35 144.16 46.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.493 -0.322 . . . . 10.0 110.93 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.557 ' CE1' ' HG2' ' A' ' 408' ' ' GLU . 71.7 t80 -59.37 128.32 36.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.921 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 413' ' ' ARG . . . 128.71 150.27 7.15 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.867 -0.682 . . . . 10.0 111.758 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 8.3 t -92.38 145.1 24.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.883 0.373 . . . . 10.0 110.732 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -9.3 53.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.115 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 89.64 -11.73 69.27 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.955 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.53 165.11 12.35 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.199 -0.76 . . . . 10.0 111.199 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 29.2 t -58.49 -60.73 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.767 0.283 . . . . 10.0 111.22 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' MET . . . . . 0.51 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 25.6 ttp -51.89 -56.05 16.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 10.0 112.155 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -57.86 -49.9 75.12 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.005 0.743 . . . . 10.0 113.005 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.94 85.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.101 0.408 . . . . 10.0 112.101 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.62 76.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.062 0.458 . . . . 10.0 110.136 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.415 HD23 ' CD2' ' A' ' 105' ' ' LEU . 50.4 mt -63.83 -41.42 97.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.085 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.51 ' O ' ' HG3' ' A' ' 266' ' ' GLU . 46.0 ttm105 -59.04 -50.08 75.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.689 -0.687 . . . . 10.0 111.362 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 60.9 m -55.38 -40.74 71.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.613 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.67 -41.76 65.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.924 0.392 . . . . 10.0 110.737 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -63.76 -47.64 80.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 10.0 112.055 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 272' ' ' PRO . 46.2 mt-10 -66.75 -7.77 23.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.929 0.715 . . . . 10.0 112.929 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 80.7 mt -108.58 -41.09 4.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.003 0.43 . . . . 10.0 110.47 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -71.27 -40.28 71.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 21.1 p -102.65 -18.54 15.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.968 -0.56 . . . . 10.0 111.874 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.01 -35.61 2.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.487 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.34 145.45 82.78 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 110.327 -0.249 . . . . 10.0 110.327 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.511 ' HA ' ' HG2' ' A' ' 266' ' ' GLU . 62.5 Cg_endo -73.56 155.87 49.85 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.443 2.096 . . . . 10.0 112.354 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.511 HD12 ' HD2' ' A' ' 274' ' ' PRO . 28.1 tp -115.41 125.31 28.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.945 -0.57 . . . . 10.0 110.32 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.511 ' HD2' HD12 ' A' ' 273' ' ' LEU . 80.7 Cg_endo -77.46 -157.9 0.08 OUTLIER 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.701 2.267 . . . . 10.0 111.591 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -78.53 134.27 37.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.662 -0.496 . . . . 10.0 109.662 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.99 131.62 36.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.057 0.456 . . . . 10.0 111.785 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 1.2 m -103.51 101.43 11.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.78 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.464 HD13 ' HB ' ' A' ' 290' ' ' THR . 3.8 mm? -72.29 132.54 44.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.672 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 26.1 m -106.65 142.07 36.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.85 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -73.37 141.08 47.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.806 0.336 . . . . 10.0 111.13 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 66.8 t -98.88 108.11 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.042 -0.526 . . . . 10.0 109.618 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 77.3 mtm-85 -63.94 133.13 52.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.841 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 114.46 -31.12 6.57 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.776 -0.93 . . . . 10.0 110.776 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 59.5 mtm -132.67 89.02 2.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.77 103.58 0.27 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.606 -0.725 . . . . 10.0 112.034 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' GLY . . . . . 0.559 ' HA3' ' ND2' ' A' ' 354' ' ' ASN . . . 132.59 -19.08 4.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.527 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 42.5 mm -92.94 131.79 39.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -123.8 160.69 26.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.384 -0.598 . . . . 10.0 109.384 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.83 165.6 30.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.022 0.439 . . . . 10.0 111.397 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.464 ' HB ' HD13 ' A' ' 278' ' ' LEU . 14.5 t -157.29 145.54 19.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.123 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -113.79 124.13 51.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.686 0.279 . . . . 10.0 110.861 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 31.2 mt -112.84 105.15 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.593 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 3.9 p -72.4 100.69 2.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.416 . . . . 10.0 110.121 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 78.6 mtp -90.54 104.15 16.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.184 0.516 . . . . 10.0 111.952 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 25.6 t -102.1 111.77 64.66 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.592 -0.892 . . . . 10.0 108.592 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.64 142.14 32.44 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.287 2.658 . . . . 10.0 113.641 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . . . -71.16 134.71 85.06 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.256 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 297' ' ' ALA . 36.8 Cg_exo -62.25 120.58 8.21 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.474 2.116 . . . . 10.0 111.913 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 94.48 20.14 30.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.012 -0.613 . . . . 10.0 113.084 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 90.3 p -110.61 163.8 13.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.91 -0.404 . . . . 10.0 109.91 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.638 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 28.1 pttt -71.05 -27.41 63.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.028 -0.73 . . . . 10.0 109.028 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -64.27 -41.53 96.87 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.875 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -64.3 -40.62 96.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.665 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -70.4 -25.8 63.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.506 -0.77 . . . . 10.0 112.27 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 67.5 mt -57.5 -57.33 13.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.707 0.289 . . . . 10.0 111.325 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.48 -10.64 59.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 10.0 111.341 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -89.21 -36.61 15.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.485 . . . . 10.0 110.488 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.1 -30.64 25.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.108 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -142.02 117.84 10.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.095 0.474 . . . . 10.0 111.163 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -109.09 1.08 20.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.214 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.964 -1.017 . . . . 10.0 109.262 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.824 -0.51 . . . . 10.0 111.824 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.84 -27.58 67.45 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.753 2.302 . . . . 10.0 112.014 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 89.8 mt -115.53 93.51 4.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.287 0.565 . . . . 10.0 110.239 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -79.76 111.82 16.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.509 -0.769 . . . . 10.0 110.548 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -65.1 136.84 57.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.116 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -83.83 -7.2 59.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.547 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 105.38 -7.21 42.98 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.8 -0.714 . . . . 10.0 111.728 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 91.61 156.78 33.06 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.659 -0.782 . . . . 10.0 111.51 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 343' ' ' THR . . . -91.31 86.94 6.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.115 0.484 . . . . 10.0 110.077 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -88.4 157.39 27.83 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.707 -0.759 . . . . 10.0 112.664 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -135.67 152.26 51.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.141 -0.318 . . . . 10.0 110.141 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 55.9 m -155.41 126.14 6.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.601 0.238 . . . . 10.0 110.502 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.35 165.89 14.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.449 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -63.9 -14.73 55.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.62 0.6 . . . . 10.0 112.62 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.9 -11.57 59.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.424 -0.353 . . . . 10.0 111.898 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 105.23 -0.71 40.62 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.476 -0.869 . . . . 10.0 113.986 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 334' ' ' THR . 23.3 mtm180 -77.78 122.92 26.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.476 0.638 . . . . 10.0 110.905 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -118.04 139.33 14.62 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -152.98 -176.78 25.88 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.729 -0.948 . . . . 10.0 110.729 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.59 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 15.1 tt -144.32 139.67 24.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 117.096 0.448 . . . . 10.0 110.724 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 331' ' ' ALA . 11.7 t -99.73 120.99 40.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.211 0.529 . . . . 10.0 110.179 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 14.6 tp -79.28 122.78 26.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.893 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -93.01 102.39 14.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.914 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 31.7 t -103.0 137.1 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.439 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -128.89 149.14 50.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.378 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.5 124.3 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.125 -0.488 . . . . 10.0 109.953 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -108.78 119.46 39.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.2 -0.454 . . . . 10.0 110.103 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.5 106.65 16.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.126 0.488 . . . . 10.0 111.333 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 109.7 133.46 6.65 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.014 -0.613 . . . . 10.0 112.14 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.82 -36.92 80.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 10.0 110.875 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 357' ' ' LYS . . . -68.12 -28.14 73.46 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.219 -0.752 . . . . 10.0 111.219 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.612 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 1.3 m-20 -80.91 -37.11 30.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.67 94.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.9 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -57.45 -46.52 83.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.119 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 10.5 mtmm -64.01 -47.24 81.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.687 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.8 tp -61.74 -50.31 72.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 10.0 111.797 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 90.9 mt -55.76 -42.28 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.588 -0.278 . . . . 10.0 111.37 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 12.0 m -61.37 -43.22 99.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.982 0.42 . . . . 10.0 110.54 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -70.57 -29.19 65.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.198 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 75.4 mtp -69.91 -40.85 75.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.075 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -66.7 -26.98 67.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.045 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.19 -9.55 59.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.764 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 87.09 9.22 74.0 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.054 -0.593 . . . . 10.0 112.801 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.66 -50.9 14.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.846 0.355 . . . . 10.0 110.645 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -98.46 100.79 12.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.777 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -97.69 109.53 22.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.155 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 82.1 m-85 -136.99 159.79 40.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.999 -0.371 . . . . 10.0 109.999 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -103.43 -34.59 8.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.038 0.447 . . . . 10.0 111.547 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.51 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 45.0 t80 -132.16 129.11 39.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.611 ' HB ' ' HD1' ' A' ' 126' ' ' PHE . 43.6 t -129.67 119.03 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.813 0.671 . . . . 10.0 112.813 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 257' ' ' MET . 5.2 tp10 -91.59 113.86 26.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.77 -1.196 . . . . 10.0 107.77 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 58.2 mt -109.27 118.16 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.257 0.551 . . . . 10.0 112.325 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' MET . . . . . 0.781 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 62.0 mtt -111.82 142.22 44.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.623 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.196 0.522 . . . . 10.0 110.925 179.738 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--O 1.236 0.345 0 N-CA-C 111.952 0.352 . . . . 10.0 111.952 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -109.33 34.92 5.22 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.035 -0.53 . . . . 10.0 112.377 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -80.63 162.99 45.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.762 -0.732 . . . . 10.0 112.206 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -72.69 -12.95 78.29 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.034 -0.603 . . . . 10.0 113.18 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -91.76 2.48 76.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.626 -0.797 . . . . 10.0 111.788 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -92.09 153.46 43.24 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 58' ' ' ALA . 31.3 Cg_exo -64.09 172.15 6.6 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.618 2.212 . . . . 10.0 111.239 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 109.65 8.1 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 28.3 m . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.097 178.924 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.958 0.409 . . . . 10.0 111.111 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -62.79 -39.59 94.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.704 -0.68 . . . . 10.0 111.113 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -64.14 -39.0 93.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.075 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 61' ' ' GLU . 98.8 mtt180 -68.1 -39.35 82.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.27 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -63.19 -41.91 99.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.867 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -71.45 -27.78 63.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.413 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -96.88 14.9 23.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.828 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.6 mt -64.56 -40.17 95.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.989 0.423 . . . . 10.0 110.738 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -133.78 158.64 42.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.787 -0.642 . . . . 10.0 109.439 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -79.0 165.49 23.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' LEU . . . . . 0.491 HD13 ' HD2' ' A' ' 409' ' ' LYS . 3.9 mm? -61.02 -34.08 74.29 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.889 0.7 . . . . 10.0 112.889 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -74.09 -28.11 61.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.956 0.408 . . . . 10.0 111.256 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' GLU . . . . . 0.557 ' HG2' ' CE1' ' A' ' 250' ' ' PHE . 36.2 mt-10 -77.44 -32.62 54.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.709 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' LYS . . . . . 0.491 ' HD2' HD13 ' A' ' 406' ' ' LEU . 90.4 mttt -66.29 -35.22 79.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 10.0 111.79 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.3 6.83 21.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.029 0.443 . . . . 10.0 111.767 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 23.6 m -118.87 93.94 4.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.98 0.419 . . . . 10.0 110.683 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 30.1 tp -77.66 111.77 13.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.547 -0.538 . . . . 10.0 109.547 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ARG . . . . . 0.64 ' HD3' ' HB2' ' A' ' 249' ' ' LEU . 5.2 tmm_? -107.76 148.41 29.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.125 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -116.63 137.0 52.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.508 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 4.6 m -69.05 -30.88 69.33 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.041 0.386 . . . . 10.0 112.041 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -69.28 -1.74 8.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -118.28 14.25 13.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.932 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' ASN . . . . . 0.402 ' HA ' HD11 ' A' ' 249' ' ' LEU . 55.3 t-20 -88.5 113.95 57.65 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.555 ' HD3' HD11 ' A' ' 249' ' ' LEU . 51.1 Cg_exo -54.97 -39.94 88.22 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.18 2.586 . . . . 10.0 112.53 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.6 m -61.28 -42.91 99.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.112 0.482 . . . . 10.0 110.564 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 49.7 mm -72.16 -40.51 66.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.881 -0.599 . . . . 10.0 110.171 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.5 -44.82 95.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.475 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -60.79 -45.19 95.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 10.0 110.618 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.447 ' HB2' ' SD ' ' A' ' 240' ' ' MET . 45.2 tp -64.63 -41.19 96.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.882 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' TYR . . . . . 0.657 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 1.2 m-85 -68.13 -33.64 74.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.024 -0.534 . . . . 10.0 110.967 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.66 -61.18 2.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.566 0.95 . . . . 10.0 113.566 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.52 16.99 5.76 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.842 1.423 . . . . 10.0 114.842 -176.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -150.73 -63.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.243 0.831 . . . . 10.0 113.243 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.657 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 96.2 mt -67.37 -36.5 81.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.853 0.686 . . . . 10.0 112.853 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 97.47 -68.12 0.79 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.892 -0.67 . . . . 10.0 111.853 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -161.31 157.47 21.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.767 -0.457 . . . . 10.0 109.767 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.412 ' HA ' ' HE1' ' A' ' 425' ' ' TYR . 52.1 Cg_exo -58.28 132.36 48.43 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.582 2.188 . . . . 10.0 110.915 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' A' ' 103' ' ' SER . 4.6 mp 66.63 9.63 6.78 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.986 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 438' ' ' HIS . . . -70.21 -170.68 8.79 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.32 -0.467 . . . . 10.0 112.865 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -55.28 -62.33 1.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.381 0.511 . . . . 10.0 112.381 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.43 ' HD2' ' HA ' ' A' ' 436' ' ' LYS . 31.3 tptt -60.43 -38.34 83.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.906 0.384 . . . . 10.0 111.83 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -66.69 -46.09 76.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.084 0.469 . . . . 10.0 111.006 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 434' ' ' GLY . 0.1 OUTLIER -70.14 -20.4 63.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.944 0.402 . . . . 10.0 110.976 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -76.07 -65.34 0.93 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.954 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 81.5 mt -92.81 -24.7 18.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.488 1.292 . . . . 10.0 114.488 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 68.3 mt -93.0 -6.14 49.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 438' ' ' HIS . 26.0 m-70 -121.71 165.06 16.36 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.27 -0.269 . . . . 10.0 110.949 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 7.5 t -152.15 -168.95 3.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.641 0.258 . . . . 10.0 111.596 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -139.72 161.48 37.43 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.375 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' TYR . . . . . 0.567 ' HD2' HG23 ' A' ' 145' ' ' ILE . 37.9 m-85 -110.58 168.88 9.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.695 -0.229 . . . . 10.0 111.029 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.08 113.3 36.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 10.0 111.013 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -66.18 105.86 1.5 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.482 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 131.51 -20.41 4.66 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.28 -0.728 . . . . 10.0 111.28 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.641 0 C-N-CA 120.844 -0.693 . . . . 10.0 112.069 179.844 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 p -74.93 165.96 24.42 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.923 -0.399 . . . . 10.0 109.923 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 189' ' ' GLN . 96.7 m-70 -64.23 -31.02 72.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.761 0.282 . . . . 10.0 111.761 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.73 -45.15 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.503 -0.555 . . . . 10.0 109.503 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -63.6 -31.32 72.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.386 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.542 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 36.8 mt-30 -62.83 -23.46 67.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.264 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.1 -38.66 10.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.888 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.19 -35.08 76.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.098 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.6 -36.45 74.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.085 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -79.77 -34.83 39.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.382 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.15 -25.4 62.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.239 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.55 -7.5 56.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.011 0.434 . . . . 10.0 110.626 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 91.9 mttt -93.8 121.7 63.87 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.908 -0.587 . . . . 10.0 109.906 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.1 148.89 75.13 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.56 2.173 . . . . 10.0 110.415 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.834 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 61.9 mttt -63.89 -10.41 20.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.978 0.732 . . . . 10.0 112.978 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -98.52 -5.32 32.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.734 0.302 . . . . 10.0 111.288 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.2 135.84 82.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.314 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.91 -17.34 59.31 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.714 2.276 . . . . 10.0 113.171 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.75 14.16 30.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 10.0 110.781 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.834 ' HG2' ' HA ' ' A' ' 39' ' ' LYS . 6.8 tpt180 -87.64 115.51 25.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.504 . . . . 10.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.74 ' HD3' ' HA ' ' A' ' 176' ' ' ASP . 14.0 mttp -93.7 169.11 10.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.816 -0.629 . . . . 10.0 109.882 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.51 111.75 18.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.84 -0.8 . . . . 10.0 108.84 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.33 102.16 13.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.082 0.468 . . . . 10.0 111.646 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.3 m -99.1 140.54 33.11 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.245 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 13.1 p -132.38 135.84 57.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.085 0.469 . . . . 10.0 112.115 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 14.5 pt20 -116.35 127.07 54.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.967 -0.561 . . . . 10.0 109.581 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.426 HG11 HD21 ' A' ' 75' ' ' LEU . 2.0 t -104.03 150.04 7.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.123 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.02 139.08 20.48 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.481 . . . . 10.0 109.962 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.7 -35.03 66.89 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.184 2.59 . . . . 10.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.68 -32.86 74.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.102 0.477 . . . . 10.0 110.768 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.939 HG13 HG23 ' A' ' 214' ' ' THR . 88.0 t -80.53 -40.15 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.776 -0.647 . . . . 10.0 109.374 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -56.6 -33.08 65.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.536 -0.757 . . . . 10.0 112.316 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.38 -37.52 12.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 113.292 0.849 . . . . 10.0 113.292 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.56 -5.56 53.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.528 0.936 . . . . 10.0 113.528 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.34 -26.39 40.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.823 0.344 . . . . 10.0 111.687 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.83 -24.85 65.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.591 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -66.24 -26.14 67.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.279 -0.419 . . . . 10.0 112.049 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.0 p -68.18 -23.59 64.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.066 0.46 . . . . 10.0 110.54 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.6 mt -94.02 -0.78 55.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.164 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.99 18.52 55.85 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.947 -0.644 . . . . 10.0 112.385 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.8 mt -106.34 164.62 11.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.662 0.267 . . . . 10.0 110.764 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.61 153.9 85.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.527 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.43 133.65 59.37 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.567 2.178 . . . . 10.0 111.691 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.49 14.17 62.14 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.667 -0.777 . . . . 10.0 113.082 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.57 -27.04 31.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.953 0.406 . . . . 10.0 111.245 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 p -103.25 129.26 50.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.194 -0.457 . . . . 10.0 109.976 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -77.76 154.74 80.92 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.323 -0.251 . . . . 10.0 110.323 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.84 -41.12 77.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.713 2.276 . . . . 10.0 111.935 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.457 ' HD3' ' HB3' ' A' ' 233' ' ' GLU . 46.8 mttm -66.15 -36.59 83.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.967 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -61.71 -41.67 97.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.013 0.435 . . . . 10.0 110.654 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.426 HD21 HG11 ' A' ' 51' ' ' VAL . 48.8 tp -64.73 -44.53 89.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.432 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.34 95.24 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.73 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.469 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 23.9 tp10 -60.32 -46.9 88.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.881 -0.599 . . . . 10.0 110.29 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.04 -43.81 96.79 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.85 -0.613 . . . . 10.0 112.442 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.441 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 30.6 mt -60.02 -43.93 94.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 10.0 111.124 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -64.18 -32.51 74.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.943 0.401 . . . . 10.0 110.619 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -74.68 -12.62 60.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.386 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.7 mt -77.62 -19.61 55.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 10.0 109.937 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.59 7.58 8.07 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.649 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.441 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 47.3 m-85 -72.81 156.63 38.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.729 0.299 . . . . 10.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -98.03 -58.71 1.92 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.993 0.425 . . . . 10.0 111.357 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . 2.9 mp0 -117.61 128.15 54.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.131 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.4 t -113.52 114.26 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.267 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 86' ' ' GLU . 24.5 m-85 -118.1 170.55 8.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.476 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -118.11 149.04 41.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.4 m -64.78 -20.57 66.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.74 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 91' ' ' LEU . 24.7 mt -57.91 -34.57 69.97 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.424 ' HD2' HD13 ' A' ' 158' ' ' LEU . 42.9 t80 -66.99 -37.63 84.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.151 0.5 . . . . 10.0 109.96 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.02 -34.47 58.62 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.994 -0.842 . . . . 10.0 110.994 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.89 -36.38 83.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.605 -0.298 . . . . 10.0 110.509 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.13 -33.93 69.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.07 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.434 HD21 HD23 ' A' ' 424' ' ' LEU . 78.9 mt -76.09 -42.79 46.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.988 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m -59.67 -44.33 93.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.667 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.5 mt -58.68 -42.14 84.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.905 -0.589 . . . . 10.0 110.753 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 87.6 mmm -66.95 -48.45 68.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.229 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -66.87 -53.92 27.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.444 ' HG2' ' SG ' ' A' ' 151' ' ' CYS . 18.9 mt-10 -60.42 -40.95 92.86 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.847 0.356 . . . . 10.0 110.932 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.16 99.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.095 -0.574 . . . . 10.0 111.865 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.8 m -67.94 -39.89 83.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.531 0.205 . . . . 10.0 110.853 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.526 ' HA ' ' HD2' ' A' ' 107' ' ' HIS . 19.6 tt0 -64.57 -41.3 96.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.05 -51.15 69.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.117 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.1 tp -57.3 -46.78 82.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.639 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.73 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -64.77 -40.13 94.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.431 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -58.13 -40.73 82.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.035 0.445 . . . . 10.0 110.25 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 45.4 tp -70.03 -42.25 73.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.85 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 m -58.4 -47.48 83.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.835 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 30.2 mm-40 -57.44 -35.88 70.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.129 0.49 . . . . 10.0 110.468 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.425 ' HE1' ' HA ' ' A' ' 122' ' ' PRO . 44.8 m80 -75.9 -29.44 58.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.771 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 95.7 mt -76.36 -34.0 58.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.173 0.511 . . . . 10.0 110.343 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -79.81 -43.41 22.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.381 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.093 0 O-C-N 123.831 0.707 . . . . 10.0 111.728 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.795 0.331 . . . . 10.0 110.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.425 ' HA ' ' HE1' ' A' ' 112' ' ' HIS . 67.8 Cg_endo -85.27 -165.12 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.798 2.332 . . . . 10.0 112.615 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.401 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 94.1 mt -129.07 157.72 75.03 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 123' ' ' LEU . 18.3 Cg_exo -66.37 167.23 55.02 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.296 -1.127 . . . . 10.0 113.129 0.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 25.7 ttt -113.57 133.35 55.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.774 . . . . 10.0 111.007 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -113.79 144.45 42.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.963 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.459 HG23 ' HZ ' ' A' ' 371' ' ' PHE . 0.0 OUTLIER -74.11 150.32 40.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.67 0.272 . . . . 10.0 110.322 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 p -116.47 20.4 14.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 6.82 28.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.452 ' O ' HG12 ' A' ' 134' ' ' ILE . 54.1 t -120.15 117.78 31.81 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 120.658 0.266 . . . . 10.0 111.567 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.23 -33.79 70.27 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.364 2.71 . . . . 10.0 112.048 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.02 -41.63 97.16 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.946 -0.645 . . . . 10.0 111.571 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -65.8 -44.04 86.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.078 -0.342 . . . . 10.0 110.078 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 130' ' ' CYS . 35.2 mm -57.99 -42.38 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.966 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.45 76.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.168 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.2 tpt -67.2 -34.19 76.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.007 0.432 . . . . 10.0 110.823 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.41 HD22 HG21 ' A' ' 148' ' ' VAL . 22.0 tp -60.44 -60.7 3.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.57 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -63.73 -20.62 65.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.682 -0.235 . . . . 10.0 111.599 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -81.06 -61.97 1.8 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.607 0.965 . . . . 10.0 113.607 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 m -115.27 1.0 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.714 1.376 . . . . 10.0 114.714 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 144' ' ' LEU . 53.5 m-85 -134.14 60.65 45.86 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 122.05 -0.406 . . . . 10.0 111.102 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.96 -25.43 32.36 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.364 2.043 . . . . 10.0 113.1 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -87.07 1.05 54.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.987 0.422 . . . . 10.0 111.289 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 141' ' ' TYR . 59.8 mt -105.99 4.27 29.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.462 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.582 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 75.6 mt -57.94 -53.72 62.88 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.582 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 49.3 Cg_exo -58.4 -18.94 41.05 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.479 2.119 . . . . 10.0 113.076 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 125' ' ' MET . 96.5 m-85 -78.76 -20.03 50.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.214 0.531 . . . . 10.0 110.459 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.41 HG21 HD22 ' A' ' 137' ' ' LEU . 16.7 t -90.49 154.3 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.587 . . . . 10.0 109.589 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.0 t -68.18 158.31 33.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.069 0.461 . . . . 10.0 111.125 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 88.3 p -100.54 6.41 44.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.237 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 101' ' ' GLU . 4.5 m -80.83 143.9 32.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.228 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -85.66 165.12 17.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.099 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.2 p -67.19 155.11 91.37 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.761 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -45.15 -54.68 4.08 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.604 2.87 . . . . 10.0 114.214 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 155' ' ' GLN . 0.0 OUTLIER -65.14 -34.31 78.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.709 0.633 . . . . 10.0 112.709 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 78.9 mmm -72.81 -23.81 60.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.064 0.459 . . . . 10.0 110.481 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 36.6 mtt -75.8 -48.88 19.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.328 -0.619 . . . . 10.0 109.328 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.424 HD13 ' HD2' ' A' ' 92' ' ' PHE . 49.2 tp -62.82 -40.22 96.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.372 -0.831 . . . . 10.0 111.038 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.47 81.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.471 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.88 -31.87 57.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.534 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -70.26 -43.26 70.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.691 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.8 m -68.89 -27.48 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' A' ' 179' ' ' MET . 44.4 mttt -88.94 7.7 33.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.016 0.376 . . . . 10.0 112.016 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.6 p -129.41 -74.67 0.55 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.814 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -62.97 -50.83 69.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.56 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 162' ' ' VAL . 54.8 tp -64.04 -40.8 97.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 10.0 110.787 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.77 -52.04 67.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.919 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -64.04 -43.72 94.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.389 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -62.45 -38.06 88.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 10.0 111.991 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -89.32 -7.48 55.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 69.06 40.87 83.1 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.104 -0.569 . . . . 10.0 112.642 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 43.2 mt -123.5 142.39 40.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -79.51 136.36 56.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 110.018 -0.364 . . . . 10.0 110.018 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 173' ' ' ALA . 51.3 Cg_exo -57.44 -16.05 21.88 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.237 2.624 . . . . 10.0 113.143 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -72.77 -28.88 62.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 10.0 110.864 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.74 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 58.3 m-20 -101.82 29.62 4.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.401 0.62 . . . . 10.0 110.244 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 95.4 mtp -126.89 124.73 40.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.142 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 32.1 t -107.93 119.31 57.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.338 -0.615 . . . . 10.0 109.338 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.519 ' HB2' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -103.31 109.11 20.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.055 0.455 . . . . 10.0 111.273 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 28.0 t -108.69 142.1 22.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.417 ' OG ' HD21 ' A' ' 208' ' ' LEU . 10.1 p -134.79 138.22 44.08 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.917 -0.313 . . . . 10.0 111.049 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.43 HG21 HD22 ' A' ' 217' ' ' LEU . 21.2 mm -100.35 108.95 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 213' ' ' THR . 31.9 mmt -116.95 149.38 44.04 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.49 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.68 25.02 0.71 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.828 2.352 . . . . 10.0 112.518 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 30.2 t -156.99 139.29 14.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.588 -0.278 . . . . 10.0 110.719 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.89 -24.11 52.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.156 0.503 . . . . 10.0 110.588 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -70.98 -3.05 17.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.717 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -78.13 -27.23 48.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.951 0.405 . . . . 10.0 110.9 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLN . . . . . 0.416 ' HG2' ' CD2' ' A' ' 27' ' ' HIS . 29.3 tp60 -68.45 -34.94 76.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 10.0 109.942 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.56 -26.63 67.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.182 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -76.82 -42.81 38.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.237 0.542 . . . . 10.0 109.81 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.427 ' CB ' HD23 ' A' ' 208' ' ' LEU . . . -74.75 -21.28 59.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.475 -0.784 . . . . 10.0 111.703 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -2.1 38.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.479 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 51.1 mtt180 -63.41 120.71 12.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.187 0.517 . . . . 10.0 110.196 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.09 -42.59 50.46 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.714 1.746 . . . . 10.0 115.714 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' TRP . . . . . 0.45 ' HZ2' HH11 ' A' ' 194' ' ' ARG . 35.3 p90 -67.78 0.73 3.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.465 1.283 . . . . 10.0 114.465 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 194' ' ' ARG . 9.7 m-85 -93.87 68.2 3.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.131 0.491 . . . . 10.0 109.949 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 5.9 p -109.38 167.88 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.187 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.448 HG22 ' HG2' ' A' ' 207' ' ' GLN . 15.9 t -113.31 103.32 15.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.088 -0.708 . . . . 10.0 109.088 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.947 -1.025 . . . . 10.0 111.644 -179.6 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.841 0.353 . . . . 10.0 110.457 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.777 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.231 0.106 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -82.52 139.84 33.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.258 -0.275 . . . . 10.0 110.258 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 197' ' ' PHE . 54.8 mt-30 -65.59 -42.51 91.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.526 0.679 . . . . 10.0 109.502 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.518 HD12 ' HB3' ' A' ' 179' ' ' MET . 19.2 tp -120.06 136.71 54.47 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.84 -64.8 1.09 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.999 0.741 . . . . 10.0 112.999 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 1.4 m-70 -140.28 144.76 36.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.929 0.395 . . . . 10.0 111.857 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 47.3 t -112.2 131.01 64.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.51 138.13 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.479 -0.563 . . . . 10.0 109.479 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 183' ' ' MET . 72.4 p -87.81 166.93 14.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.121 0.486 . . . . 10.0 111.885 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.939 HG23 HG13 ' A' ' 55' ' ' VAL . 1.4 m -57.3 -45.97 83.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.471 -0.786 . . . . 10.0 111.429 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.7 m -61.99 -42.01 93.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.803 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 220' ' ' ILE . 41.8 mt-10 -66.17 -46.47 77.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 10.0 110.86 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 182' ' ' ILE . 34.6 tp -60.85 -45.11 95.83 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.002 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -60.71 -37.4 93.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.026 -0.606 . . . . 10.0 111.954 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ASN . . . . . 0.499 ' HA ' ' HE3' ' A' ' 222' ' ' LYS . 42.4 m-20 -65.37 -39.33 92.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.625 0.25 . . . . 10.0 110.634 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 216' ' ' GLU . 73.4 mt -60.37 -47.57 91.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.368 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -60.2 -41.64 93.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.084 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' A' ' 219' ' ' ASN . 36.9 mtmt -66.41 -47.56 72.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -63.79 -38.27 90.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 10.0 111.708 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -76.06 -18.78 59.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 10.0 111.414 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.76 40.59 12.0 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.901 -0.666 . . . . 10.0 112.119 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.5 mt -120.09 92.83 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.891 0.377 . . . . 10.0 110.54 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -76.39 116.15 16.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 10.0 109.971 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.576 ' HA ' HD12 ' A' ' 231' ' ' LEU . 36.1 mt -60.48 -28.8 68.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.873 -0.603 . . . . 10.0 112.141 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.91 -13.0 61.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.477 -0.329 . . . . 10.0 111.76 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -109.93 18.3 20.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.021 0.439 . . . . 10.0 111.042 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 228' ' ' LEU . 96.1 mt -105.46 150.2 38.7 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.614 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.01 176.65 9.59 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.339 2.026 . . . . 10.0 111.478 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 73' ' ' LYS . 8.2 mm-40 -74.08 99.13 3.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.404 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 77' ' ' GLU . . . -73.73 -168.16 15.8 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.997 -0.62 . . . . 10.0 113.08 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -132.45 154.17 50.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.777 0.322 . . . . 10.0 111.348 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -100.41 165.17 11.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.275 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 246' ' ' ALA . 30.4 m-20 -107.98 155.38 20.4 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.693 -0.484 . . . . 10.0 109.693 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -100.42 120.62 55.77 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.714 0.292 . . . . 10.0 110.788 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.18 -14.99 45.28 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.959 2.439 . . . . 10.0 112.093 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.4 ' HE2' ' HB3' ' A' ' 423' ' ' GLU . 98.2 mmm -83.02 10.83 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.955 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 89.69 -61.51 3.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.193 -0.527 . . . . 10.0 111.939 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.4 m -125.35 144.87 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.732 0.301 . . . . 10.0 110.21 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 155.43 162.85 11.6 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.073 -0.585 . . . . 10.0 111.811 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 m -94.33 107.42 19.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.971 0.415 . . . . 10.0 110.429 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 95.77 -164.16 23.91 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.748 -0.739 . . . . 10.0 111.428 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 237' ' ' ASP . . . -80.95 0.87 33.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.93 0.344 . . . . 10.0 111.93 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 13.82 80.25 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.295 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.17 118.87 53.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.524 HD11 ' HD3' ' A' ' 419' ' ' PRO . 75.1 mt -69.85 136.15 50.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.523 -0.308 . . . . 10.0 111.195 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -54.74 122.43 10.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.528 -0.76 . . . . 10.0 111.312 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 148.09 165.73 12.23 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.354 -0.698 . . . . 10.0 111.354 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 6.7 t -107.62 152.12 24.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.121 0.486 . . . . 10.0 111.115 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.27 -10.18 20.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.065 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.488 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 88.08 -30.82 4.96 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.919 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 150.84 167.29 14.46 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.234 -1.146 . . . . 10.0 110.234 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.51 -54.09 36.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 117.402 0.601 . . . . 10.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' MET . . . . . 0.743 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 28.6 ttp -61.6 -49.03 78.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.541 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.488 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 17.1 tt0 -58.14 -46.97 84.72 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.12 0.415 . . . . 10.0 112.12 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.67 -35.93 79.76 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.715 -0.221 . . . . 10.0 111.394 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.62 -46.52 78.96 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.707 -0.479 . . . . 10.0 109.707 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 79.7 mt -63.16 -41.08 99.19 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.793 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.536 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 44.3 ttm105 -57.63 -51.06 71.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.324 -0.853 . . . . 10.0 111.16 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 28.9 m -56.57 -43.84 80.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.405 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.59 -43.15 69.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.909 0.385 . . . . 10.0 111.249 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.531 ' CD2' ' HB2' ' A' ' 273' ' ' LEU . 47.3 t80 -63.18 -47.51 82.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.135 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.448 ' OE2' ' HA ' ' A' ' 272' ' ' PRO . 75.2 mt-10 -66.0 -36.81 84.31 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 76.0 mt -77.65 -7.92 57.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.167 0.508 . . . . 10.0 111.13 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -104.51 -40.65 5.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.484 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' THR . . . . . 0.45 HG21 ' CE1' ' A' ' 265' ' ' TYR . 77.9 p -97.97 -32.67 11.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.986 0.736 . . . . 10.0 112.986 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 89.06 -3.13 84.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.491 -0.861 . . . . 10.0 111.034 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 12.0 p -104.64 139.47 20.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.989 -0.374 . . . . 10.0 109.989 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.448 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 37.0 Cg_endo -68.07 139.54 47.0 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.423 2.082 . . . . 10.0 111.581 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.642 HD12 ' HD2' ' A' ' 274' ' ' PRO . 40.6 tp -101.48 121.65 50.75 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.241 -0.436 . . . . 10.0 111.143 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' PRO . . . . . 0.642 ' HD2' HD12 ' A' ' 273' ' ' LEU . 73.9 Cg_endo -77.5 -156.19 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.573 2.182 . . . . 10.0 111.335 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -80.94 142.54 33.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.082 -0.34 . . . . 10.0 110.082 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.11 124.6 36.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.069 0.461 . . . . 10.0 112.11 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 4.3 m -90.65 91.9 8.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.238 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 278' ' ' LEU . 3.5 mm? -58.54 123.93 17.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 10.0 111.554 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 6.1 m -98.7 140.84 32.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.491 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.12 128.48 33.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.522 -0.308 . . . . 10.0 110.971 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' VAL . . . . . 0.45 HG22 ' HG2' ' A' ' 289' ' ' GLU . 21.7 t -86.03 110.25 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.351 . . . . 10.0 110.155 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -66.83 123.05 19.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.369 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 117.16 -21.32 10.98 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.4 ' HB3' ' CG1' ' A' ' 287' ' ' ILE . 63.8 mtm -132.91 85.5 2.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -62.65 109.98 1.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.458 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' GLY . . . . . 0.42 ' HA3' ' ND2' ' A' ' 354' ' ' ASN . . . 118.08 -13.52 12.65 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.757 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.4 ' CG1' ' HB3' ' A' ' 284' ' ' MET . 42.9 mm -97.89 129.44 48.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -119.59 149.94 41.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLU . . . . . 0.45 ' HG2' HG22 ' A' ' 281' ' ' VAL . 21.6 pt-20 -133.39 160.1 38.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.992 0.425 . . . . 10.0 112.07 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.83 134.62 13.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.299 -0.864 . . . . 10.0 109.855 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -112.0 110.1 20.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.548 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 31.5 mt -98.97 121.49 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 10.0 111.504 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' THR . . . . . 0.552 HG23 ' HZ ' ' A' ' 333' ' ' PHE . 4.6 m -76.99 104.45 7.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.226 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' MET . . . . . 0.432 ' HG2' ' HD1' ' A' ' 265' ' ' TYR . 88.6 mtp -100.6 102.46 13.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.985 0.422 . . . . 10.0 111.74 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.54 118.48 54.42 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.979 -0.749 . . . . 10.0 108.979 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.01 132.99 55.04 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.863 2.375 . . . . 10.0 112.566 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.22 134.52 95.99 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.887 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.37 120.04 7.56 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.717 2.278 . . . . 10.0 111.492 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 92.42 39.39 5.36 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.828 -0.701 . . . . 10.0 111.702 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 98.9 p -128.53 165.12 21.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.861 -0.422 . . . . 10.0 109.861 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.618 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 13.2 pttt -73.11 -29.38 62.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.622 -0.51 . . . . 10.0 109.622 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -66.02 -39.51 90.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.905 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 307' ' ' LYS . 13.5 tt0 -64.32 -45.28 88.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.013 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.58 -31.74 73.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.648 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 90.7 mt -58.86 -57.3 13.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 10.0 110.919 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' LEU . . . . . 0.414 HD21 HD22 ' A' ' 113' ' ' LEU . 92.2 mt -69.26 -26.23 64.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.367 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 303' ' ' GLU . 6.6 tmtt? -79.03 -12.97 60.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.992 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -112.26 -22.74 10.77 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.878 0.696 . . . . 10.0 112.878 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 305' ' ' LEU . 6.9 ptp180 -146.4 123.92 11.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.992 0.425 . . . . 10.0 112.044 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.5 -0.18 4.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.486 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.198 -0.906 . . . . 10.0 109.113 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.438 0 N-CA-C 111.513 -0.635 . . . . 10.0 111.513 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.35 -23.43 51.45 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.729 2.286 . . . . 10.0 111.733 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 147' ' ' TYR . 93.3 mt -119.23 96.48 5.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.137 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -92.66 124.16 36.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.242 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -60.56 129.94 44.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.062 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -72.71 -12.93 61.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.286 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 115.05 -9.59 20.84 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.245 -0.742 . . . . 10.0 111.245 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.52 129.2 2.51 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.855 -0.688 . . . . 10.0 111.565 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -71.78 88.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.08 0.467 . . . . 10.0 110.588 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -105.68 149.06 16.63 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.928 -0.653 . . . . 10.0 112.397 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' PHE . . . . . 0.552 ' HZ ' HG23 ' A' ' 293' ' ' THR . 3.5 p90 -132.05 151.23 51.87 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.435 ' HA ' ' HA2' ' A' ' 340' ' ' GLY . 7.8 t -131.78 142.09 49.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.981 0.42 . . . . 10.0 111.196 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 1.7 m -83.75 165.05 19.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.813 -0.631 . . . . 10.0 109.934 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -70.97 -18.19 62.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.894 0.378 . . . . 10.0 110.986 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -26.12 60.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.683 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 126.39 -16.68 6.65 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.464 -0.874 . . . . 10.0 113.561 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -83.15 163.52 20.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.865 0.333 . . . . 10.0 110.881 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 334' ' ' THR . . . -150.26 169.04 30.25 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.731 -0.747 . . . . 10.0 112.293 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -157.19 164.93 33.1 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.42 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 14.4 tt -122.32 140.95 44.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.998 0.399 . . . . 10.0 110.724 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.42 ' HB ' ' HE2' ' A' ' 333' ' ' PHE . 4.8 t -96.98 100.09 11.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.233 0.54 . . . . 10.0 110.132 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 21.4 tp -62.95 116.72 5.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.457 -0.792 . . . . 10.0 110.776 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -90.71 100.19 13.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.555 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 46.3 t -104.18 132.59 50.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.63 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.556 ' HB3' HG22 ' A' ' 372' ' ' VAL . . . -125.78 144.75 50.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.785 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.71 118.89 57.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.635 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.487 ' HB3' HG12 ' A' ' 374' ' ' ILE . . . -105.52 97.39 7.23 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.238 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.22 101.0 13.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.006 0.431 . . . . 10.0 110.167 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 126.08 123.83 2.71 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.203 -0.759 . . . . 10.0 111.203 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' LEU . . . . . 0.808 ' HG ' ' HA ' ' A' ' 376' ' ' ALA . 26.7 mt -59.11 -32.01 69.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.938 0.399 . . . . 10.0 111.786 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLY . . . . . 0.459 ' O ' ' HE3' ' A' ' 357' ' ' LYS . . . -72.43 -26.59 71.51 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.236 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 357' ' ' LYS . 86.6 m-20 -74.03 -23.78 59.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 10.0 111.054 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -66.28 -36.09 82.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.632 -0.507 . . . . 10.0 109.632 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -68.07 -21.33 64.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.332 -0.849 . . . . 10.0 110.545 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 353' ' ' GLY . 60.4 mttt -94.61 -32.39 13.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 10.0 111.572 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.96 -45.83 16.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.916 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 85.1 mt -58.94 -34.48 52.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.095 0.406 . . . . 10.0 112.095 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -43.2 99.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.993 0.425 . . . . 10.0 110.306 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -72.3 -29.06 63.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.613 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 89.5 mtp -70.35 -48.83 54.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.104 -0.498 . . . . 10.0 109.861 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.52 -36.77 83.63 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.45 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.2 -27.54 68.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.609 . . . . 10.0 110.866 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 105.26 0.03 40.81 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.069 -0.586 . . . . 10.0 112.605 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -75.49 -54.41 7.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 10.0 111.335 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -81.85 100.7 9.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.51 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -94.75 106.09 18.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.478 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -137.44 155.35 49.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.103 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -105.28 -38.05 6.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.062 0.458 . . . . 10.0 110.877 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.743 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 53.5 t80 -130.46 129.79 43.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.699 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 347' ' ' ALA . 62.5 t -134.07 127.01 50.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.803 0.335 . . . . 10.0 111.818 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.458 ' HA ' ' OG1' ' A' ' 127' ' ' THR . 14.1 tt0 -101.88 126.74 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.487 HG12 ' HB3' ' A' ' 349' ' ' ALA . 68.9 mt -116.37 120.1 63.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.254 0.549 . . . . 10.0 111.971 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' MET . . . . . . . . . . . . . 10.0 mmt -105.79 155.52 19.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 10.0 109.442 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 0.808 ' HA ' ' HG ' ' A' ' 352' ' ' LEU . . . . . . . . 0 C--N 1.321 -0.658 0 CA-C-O 120.78 0.324 . . . . 10.0 111.685 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 382' ' ' VAL . . . . . 0.462 HG23 HG22 ' A' ' 396' ' ' THR . 28.0 m . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.796 0.332 . . . . 10.0 111.472 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -112.0 27.93 9.79 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.059 -0.591 . . . . 10.0 111.985 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -69.32 169.73 43.23 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.12 -0.562 . . . . 10.0 112.641 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -71.86 -25.47 74.82 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.027 -0.606 . . . . 10.0 113.091 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -76.21 -17.81 79.74 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.275 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -74.01 160.35 81.94 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.903 -0.406 . . . . 10.0 109.903 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.82 159.68 40.55 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.404 2.07 . . . . 10.0 110.983 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.07 135.68 53.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.484 -0.326 . . . . 10.0 110.249 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 13.9 t . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.202 -179.842 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 396' ' ' THR . . . . . 0.462 HG22 HG23 ' A' ' 382' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.608 0.242 . . . . 10.0 111.603 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -62.06 -37.77 86.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.954 0.407 . . . . 10.0 110.716 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -67.97 -39.67 83.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.59 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -63.44 -42.65 98.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.859 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -70.31 -32.8 70.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.972 -0.558 . . . . 10.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -75.08 -46.04 37.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.515 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -85.24 13.29 6.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.839 0.352 . . . . 10.0 111.865 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -36.95 85.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.564 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.509 ' O ' ' HE3' ' A' ' 409' ' ' LYS . 75.4 m-85 -136.61 151.47 49.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.151 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -75.36 160.94 29.72 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.157 -0.682 . . . . 10.0 109.157 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.42 -35.35 69.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.889 0.376 . . . . 10.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.23 -35.45 81.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.418 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.05 -36.6 66.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.462 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' LYS . . . . . 0.509 ' HE3' ' O ' ' A' ' 404' ' ' TYR . 96.5 mttt -71.02 -32.86 69.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.593 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.1 p -81.6 -3.37 53.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.016 0.436 . . . . 10.0 111.564 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 9.5 m -120.6 96.92 5.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.913 0.387 . . . . 10.0 111.216 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 23.6 tp -78.8 117.19 19.68 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 414' ' ' ARG . 6.1 tmm_? -118.44 139.96 50.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.519 -0.31 . . . . 10.0 111.366 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.493 ' HB2' ' OE1' ' A' ' 417' ' ' GLU . 67.9 mtt85 -101.69 158.94 15.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.386 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 9.2 m -72.59 -33.04 66.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.257 0.466 . . . . 10.0 112.257 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -77.29 4.13 11.37 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.221 0.823 . . . . 10.0 113.221 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' GLU . . . . . 0.493 ' OE1' ' HB2' ' A' ' 414' ' ' ARG . 0.5 OUTLIER -103.52 -3.74 24.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.643 -0.503 . . . . 10.0 109.643 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -84.3 116.33 64.48 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.505 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 419' ' ' PRO . . . . . 0.524 ' HD3' HD11 ' A' ' 249' ' ' LEU . 33.5 Cg_exo -59.62 -38.42 82.02 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.994 2.463 . . . . 10.0 111.983 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.1 m -60.78 -43.94 97.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.552 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.18 -40.3 84.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.782 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' ARG . . . . . 0.435 ' NH2' ' HA ' ' A' ' 417' ' ' GLU . 98.9 mtt180 -59.96 -44.93 94.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.673 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' GLU . . . . . 0.4 ' HB3' ' HE2' ' A' ' 240' ' ' MET . 46.7 tt0 -61.51 -43.98 97.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' LEU . . . . . 0.434 HD23 HD21 ' A' ' 96' ' ' LEU . 65.3 tp -63.54 -37.93 89.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.193 0.52 . . . . 10.0 111.216 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' TYR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.3 m-85 -74.87 -59.81 2.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.198 -0.455 . . . . 10.0 111.747 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.85 -14.51 62.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 115.074 1.509 . . . . 10.0 115.074 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.8 18.25 7.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -161.94 -61.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.585 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 92.8 mt -67.68 -40.7 84.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 99.89 -77.48 0.47 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.053 -0.594 . . . . 10.0 111.702 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 431' ' ' GLU . . . . . 0.596 ' HG2' ' HD2' ' A' ' 432' ' ' PRO . 1.0 OUTLIER -149.16 153.06 37.38 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.368 -0.605 . . . . 10.0 109.368 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.596 ' HD2' ' HG2' ' A' ' 431' ' ' GLU . 60.4 Cg_exo -55.1 134.8 65.81 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.565 2.177 . . . . 10.0 110.953 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.402 HD21 ' HG3' ' A' ' 104' ' ' GLU . 6.9 mp 66.75 13.61 9.45 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.532 0.52 . . . . 10.0 112.206 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -69.9 -166.91 5.79 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.513 -0.375 . . . . 10.0 112.979 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -59.64 -62.79 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.848 0.314 . . . . 10.0 111.848 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 436' ' ' LYS . . . . . 0.512 ' HD2' ' HA ' ' A' ' 436' ' ' LYS . 17.7 tptt -63.03 -34.44 77.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.8 0.334 . . . . 10.0 111.497 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -64.55 -42.15 95.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.078 0.466 . . . . 10.0 110.487 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 0.1 OUTLIER -78.89 -9.68 59.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.03 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -93.19 -48.25 6.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.184 -0.462 . . . . 10.0 112.235 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.52 -34.55 9.5 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 113.828 1.047 . . . . 10.0 113.828 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 58.9 mt -90.25 -12.03 39.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 17.0 m-70 -119.19 167.09 12.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.18 -0.208 . . . . 10.0 110.873 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.5 t -156.37 -170.23 3.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.275 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -135.72 158.26 44.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.242 -0.281 . . . . 10.0 110.242 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -117.62 153.64 32.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.724 0.297 . . . . 10.0 111.262 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.75 128.55 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.007 0.432 . . . . 10.0 111.831 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.41 95.36 0.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.983 -0.553 . . . . 10.0 111.348 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 145.35 -33.32 1.58 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.917 -0.658 . . . . 10.0 111.973 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 111.327 -0.709 . . . . 10.0 111.327 -179.599 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.584 0.23 . . . . 10.0 110.406 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 p -73.93 168.43 19.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.695 -0.23 . . . . 10.0 110.424 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -56.68 -37.88 71.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.534 -0.303 . . . . 10.0 111.532 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 212' ' ' ILE . 59.8 t -72.0 -49.68 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.338 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.66 -27.03 68.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 10.0 111.72 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.529 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 54.3 mt-30 -66.2 -13.72 60.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.78 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.13 -32.86 7.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.486 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.05 -34.04 72.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.944 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.04 81.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.529 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -76.44 -38.02 56.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.694 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.2 -33.08 75.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.55 . . . . 10.0 111.613 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.04 -29.16 69.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 90.0 mttt -73.49 128.21 87.58 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.04 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 37' ' ' LYS . 23.8 Cg_exo -65.25 158.34 52.82 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 122.896 2.397 . . . . 10.0 111.767 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -62.84 -20.64 65.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.244 0.461 . . . . 10.0 112.244 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -97.73 15.17 24.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.901 0.334 . . . . 10.0 111.901 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 8.6 t70 -94.08 130.78 33.26 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.5 -22.9 73.65 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.814 2.343 . . . . 10.0 113.375 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.9 p -93.84 3.13 55.87 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.923 0.392 . . . . 10.0 111.608 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -87.3 129.37 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.02 -0.536 . . . . 10.0 111.209 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -111.22 -176.21 2.9 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.39 111.4 21.72 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.006 -0.368 . . . . 10.0 110.006 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.93 101.13 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.713 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.8 m -96.31 140.29 31.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.888 -0.597 . . . . 10.0 109.784 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 11.1 p -126.23 144.73 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.799 0.333 . . . . 10.0 111.206 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 13.6 pt20 -128.61 129.14 45.49 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.608 HG11 HD21 ' A' ' 75' ' ' LEU . 5.7 t -113.23 150.07 15.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.882 0.373 . . . . 10.0 110.988 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.53 141.26 22.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.989 -0.55 . . . . 10.0 109.76 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.57 -32.09 62.4 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.168 2.579 . . . . 10.0 112.347 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.41 -22.43 66.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.568 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.538 HG13 HG23 ' A' ' 214' ' ' THR . 86.3 t -89.37 -38.54 11.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.202 0.525 . . . . 10.0 109.705 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -57.34 -29.79 64.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.412 -0.813 . . . . 10.0 112.321 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.35 -36.85 13.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.827 0.677 . . . . 10.0 112.827 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.83 -13.99 38.04 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.988 0.736 . . . . 10.0 112.988 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.61 -26.8 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.026 0.38 . . . . 10.0 112.026 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.39 -27.54 66.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.622 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' CD ' HH21 ' A' ' 399' ' ' ARG . 20.7 mt-10 -68.54 -29.53 68.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 10.0 111.382 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.34 -17.42 64.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.979 0.418 . . . . 10.0 110.569 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.7 mt -99.73 -11.8 20.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.585 . . . . 10.0 109.948 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.08 25.13 13.25 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.805 -0.634 . . . . 10.0 112.193 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -110.92 -175.42 2.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.628 0.251 . . . . 10.0 110.443 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.33 149.1 42.11 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.368 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.74 117.54 4.28 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.546 2.164 . . . . 10.0 111.666 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.35 4.02 47.2 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.856 -0.687 . . . . 10.0 113.203 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.0 -29.91 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 10.0 111.259 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -94.02 126.65 39.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.232 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 p -80.62 155.64 73.49 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.784 0.326 . . . . 10.0 111.326 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -41.84 73.23 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.002 2.468 . . . . 10.0 113.023 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -66.95 -34.0 76.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.59 -0.277 . . . . 10.0 111.669 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -66.68 -37.91 85.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.423 . . . . 10.0 110.481 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.608 HD21 HG11 ' A' ' 51' ' ' VAL . 44.9 tp -64.32 -46.82 81.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.072 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.61 85.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.867 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -61.72 -47.35 85.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.135 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.93 -39.87 96.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.924 -0.655 . . . . 10.0 112.449 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.496 HD11 HG21 ' A' ' 51' ' ' VAL . 19.5 mt -62.28 -43.96 97.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.962 0.411 . . . . 10.0 111.179 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -65.59 -27.36 68.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.012 0.434 . . . . 10.0 110.595 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -77.13 -11.43 59.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 10.0 111.359 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.2 -14.04 57.95 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.79 7.19 24.05 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.236 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -69.71 145.2 52.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.829 0.347 . . . . 10.0 111.231 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.86 -64.4 1.2 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.155 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -119.6 135.4 54.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.621 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.8 t -113.46 110.9 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.529 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 48.6 m-85 -111.05 162.38 14.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.896 0.379 . . . . 10.0 110.983 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -111.0 146.39 36.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 m -65.54 -19.67 66.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.497 -0.319 . . . . 10.0 111.555 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.0 mt -57.67 -36.63 72.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.635 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -67.59 -38.08 83.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.171 0.51 . . . . 10.0 109.902 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.33 -36.99 70.55 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.716 -0.954 . . . . 10.0 110.716 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.54 81.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.522 -0.339 . . . . 10.0 110.387 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -36.15 75.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.78 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.21 -41.31 67.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.564 -0.743 . . . . 10.0 109.6 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.3 m -60.72 -44.66 96.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.75 -0.659 . . . . 10.0 110.524 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.7 mt -58.52 -40.37 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 10.0 110.956 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.2 mmm -62.53 -53.11 59.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.286 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -67.28 -40.2 86.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.174 -0.467 . . . . 10.0 111.732 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 101' ' ' GLU . 2.9 tp10 -61.64 -45.91 92.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.894 0.378 . . . . 10.0 110.55 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.58 -35.02 91.23 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.033 -0.827 . . . . 10.0 111.033 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.0 m -70.81 -41.94 70.91 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.584 -0.308 . . . . 10.0 110.62 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -61.93 -47.27 85.63 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.614 -0.513 . . . . 10.0 109.614 178.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.1 -51.48 69.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.998 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.35 -37.63 81.27 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.989 0.423 . . . . 10.0 109.996 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 26.5 t60 -62.96 -51.6 66.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.407 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.527 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 68.4 mtt180 -62.49 -32.39 73.29 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.416 -0.357 . . . . 10.0 111.308 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.61 -50.58 29.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.407 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 m -58.01 -45.52 86.75 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.697 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 71.9 mm-40 -57.47 -36.83 71.96 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.054 0.454 . . . . 10.0 110.713 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.414 ' HE1' ' HA ' ' A' ' 122' ' ' PRO . 28.4 m80 -77.2 -28.51 53.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.509 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.75 -39.21 76.87 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.38 -41.19 69.99 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.323 -0.853 . . . . 10.0 109.965 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-N 115.582 -0.735 . . . . 10.0 111.963 179.625 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 108' ' ' ARG . 1.3 mp0 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.784 0.326 . . . . 10.0 110.475 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.414 ' HA ' ' HE1' ' A' ' 112' ' ' HIS . 74.3 Cg_endo -90.3 -175.06 0.86 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.913 2.408 . . . . 10.0 112.911 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.419 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 95.2 mt -130.21 158.3 74.6 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 123' ' ' LEU . 36.6 Cg_endo -64.27 167.26 42.79 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 124.318 -1.118 . . . . 10.0 113.667 0.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 27.7 ttt -111.87 131.08 55.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.431 -0.804 . . . . 10.0 110.762 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 372' ' ' VAL . 69.7 m-85 -111.14 139.5 46.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.934 -0.576 . . . . 10.0 109.911 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.55 152.32 36.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.643 0.258 . . . . 10.0 110.617 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.9 33.37 5.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.938 0.399 . . . . 10.0 111.266 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 2.8 m -92.53 17.01 10.72 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.725 0.639 . . . . 10.0 112.725 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.461 ' O ' HG12 ' A' ' 134' ' ' ILE . 0.9 OUTLIER -136.3 120.62 12.75 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 112.079 0.399 . . . . 10.0 112.079 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.54 -40.65 45.72 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.093 2.528 . . . . 10.0 112.366 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 376' ' ' ALA . . . -61.17 -40.44 98.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.906 -0.664 . . . . 10.0 111.827 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -65.68 -48.55 71.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.999 -0.371 . . . . 10.0 109.999 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 130' ' ' CYS . 49.7 mm -58.46 -43.24 86.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.812 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.19 -47.09 86.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.461 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 54.8 ttp -68.91 -30.73 69.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.046 0.451 . . . . 10.0 110.534 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 148' ' ' VAL . 10.7 tp -68.19 -57.98 5.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.148 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -59.69 -19.7 51.45 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.91 0.708 . . . . 10.0 112.91 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -104.13 -56.55 2.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.754 1.02 . . . . 10.0 113.754 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.1 m -88.67 -28.65 20.46 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.432 1.271 . . . . 10.0 114.432 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.12 66.71 68.62 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.742 0.645 . . . . 10.0 112.742 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.62 -12.41 29.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.197 1.931 . . . . 10.0 111.58 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -88.34 -13.05 41.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.452 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -101.78 2.57 38.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.462 -0.336 . . . . 10.0 111.825 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.475 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 55.5 mt -54.75 -51.44 78.88 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 113.598 0.962 . . . . 10.0 113.598 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 41.5 Cg_exo -58.69 -20.57 51.51 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.39 2.06 . . . . 10.0 113.292 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 325' ' ' LEU . 97.4 m-85 -79.69 -17.12 54.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.226 0.536 . . . . 10.0 111.028 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.456 HG21 HD22 ' A' ' 137' ' ' LEU . 27.9 t -87.86 152.37 3.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.033 -0.53 . . . . 10.0 109.965 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . 0.465 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . 39.7 t -66.27 160.18 24.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.235 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 p -99.85 1.41 42.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.604 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 60.4 m -75.34 138.79 42.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.335 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 36.2 mtpt -80.77 168.63 18.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.456 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.87 148.9 98.42 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.384 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.44 -51.05 10.23 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.332 2.688 . . . . 10.0 113.458 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.476 ' H ' ' HG3' ' A' ' 155' ' ' GLN . 0.0 OUTLIER -65.67 -34.02 77.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.073 0.397 . . . . 10.0 112.073 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 56.9 mmm -73.74 -23.84 59.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.049 0.452 . . . . 10.0 110.718 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 39.4 mtt -75.46 -47.72 25.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.097 -0.705 . . . . 10.0 109.097 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.5 tp -63.91 -41.63 97.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.751 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.32 85.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.252 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.53 -36.7 63.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.645 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -66.44 -42.73 87.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.816 -0.629 . . . . 10.0 112.024 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.534 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.9 m -69.55 -29.88 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -85.78 1.73 48.46 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.166 0.432 . . . . 10.0 112.166 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.0 p -122.44 -75.93 0.59 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.845 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -62.05 -52.56 63.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.399 . . . . 10.0 111.542 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.534 ' HB3' ' O ' ' A' ' 162' ' ' VAL . 35.9 tp -61.24 -40.74 95.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.513 -0.312 . . . . 10.0 110.997 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.85 76.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.848 0.356 . . . . 10.0 110.667 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -66.47 -34.8 78.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.59 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -75.24 -37.12 61.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.793 0.33 . . . . 10.0 111.781 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.54 ' HB3' HG12 ' A' ' 172' ' ' ILE . 3.1 tttt -79.49 -20.54 47.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.815 0.34 . . . . 10.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 86.32 14.54 66.06 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.056 -0.592 . . . . 10.0 112.785 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 170' ' ' LYS . 14.0 pt -103.44 168.64 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.785 0.326 . . . . 10.0 111.057 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -100.01 142.55 24.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.038 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 173' ' ' ALA . 35.8 Cg_exo -59.28 -19.93 52.84 Favored 'Trans proline' 0 N--CA 1.473 0.287 0 C-N-CA 122.995 2.464 . . . . 10.0 112.881 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -77.23 -19.49 56.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.199 0.523 . . . . 10.0 110.608 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -100.77 17.86 20.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.583 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 83.6 mtp -124.62 123.53 40.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.332 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.3 t -110.84 120.09 60.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.574 ' HB3' HD12 ' A' ' 208' ' ' LEU . 0.0 OUTLIER -104.21 123.51 47.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.289 0.566 . . . . 10.0 112.21 -178.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 22.5 t -118.69 135.63 58.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.41 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.428 ' OG ' HD21 ' A' ' 208' ' ' LEU . 3.7 p -123.21 139.04 54.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.724 0.297 . . . . 10.0 111.368 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 212' ' ' ILE . 24.1 mm -101.64 102.19 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.946 -0.761 . . . . 10.0 108.946 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 213' ' ' THR . 32.2 mmt -114.08 150.16 43.13 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.05 -0.523 . . . . 10.0 111.54 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.77 17.48 1.52 Allowed 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.854 2.369 . . . . 10.0 112.894 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 97.3 m -149.55 129.46 13.4 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.108 -0.331 . . . . 10.0 110.108 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -30.07 70.02 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -64.15 -9.55 17.42 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.649 0.611 . . . . 10.0 112.649 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 188' ' ' LYS . 25.0 mmtt -66.97 -28.2 68.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.349 . . . . 10.0 110.921 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -68.02 -36.75 80.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 10.0 109.989 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -32.56 67.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.815 -0.629 . . . . 10.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -70.63 -41.13 72.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.753 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -75.12 -30.17 60.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.665 -0.698 . . . . 10.0 112.781 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -80.87 70.81 7.75 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 56.0 mtt180 -115.32 148.4 39.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.434 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -48.93 -63.03 1.22 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.637 0.977 . . . . 10.0 113.637 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -66.97 -2.2 5.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.349 1.24 . . . . 10.0 114.349 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.446 ' CD2' ' HB2' ' A' ' 194' ' ' ARG . 2.6 m-30 -82.22 61.98 5.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.379 0.609 . . . . 10.0 111.599 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 12.1 p -113.15 168.94 9.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 10.0 110.396 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 22.4 t -80.66 83.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.221 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.037 -0.983 . . . . 10.0 111.311 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.673 -0.491 . . . . 10.0 109.673 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.796 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.228 -0.052 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -88.1 144.73 26.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.272 -0.27 . . . . 10.0 110.272 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -67.52 -40.67 85.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.242 0.544 . . . . 10.0 109.535 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LEU . . . . . 0.574 HD12 ' HB3' ' A' ' 179' ' ' MET . 29.5 tp -126.24 137.49 53.53 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.375 -1.343 . . . . 10.0 107.375 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -99.24 -57.89 2.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.47 0.915 . . . . 10.0 113.47 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.529 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 12.6 m-70 -134.32 153.15 52.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.028 0.751 . . . . 10.0 113.028 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 46.0 t -126.72 131.76 70.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.557 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 71.3 mt -122.42 139.52 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 183' ' ' MET . 43.2 p -91.98 167.2 12.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.809 0.3 . . . . 10.0 111.809 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.538 HG23 HG13 ' A' ' 55' ' ' VAL . 2.7 m -52.64 -52.92 53.45 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.003 -0.544 . . . . 10.0 112.077 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.0 m -57.87 -36.19 54.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.448 ' O ' HG13 ' A' ' 220' ' ' ILE . 50.1 mt-10 -73.33 -45.3 56.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.58 -0.282 . . . . 10.0 111.027 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.408 HD22 HG21 ' A' ' 182' ' ' ILE . 36.1 tp -62.59 -45.52 92.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.86 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.98 -30.94 78.99 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.931 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -67.97 -41.76 81.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 216' ' ' GLU . 61.7 mt -58.8 -42.77 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.228 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -62.57 -44.74 95.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.554 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -67.51 -43.94 79.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 10.0 111.955 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.71 -23.84 66.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 10.0 111.299 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -94.33 -3.18 50.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.961 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 68.35 38.99 87.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.931 -0.652 . . . . 10.0 112.189 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 57.4 mt -116.07 110.4 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.834 0.349 . . . . 10.0 110.509 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -96.61 113.71 25.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.966 -0.383 . . . . 10.0 109.966 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.619 HD23 HD12 ' A' ' 231' ' ' LEU . 38.6 mt -59.1 -28.97 67.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.807 -0.633 . . . . 10.0 112.183 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.27 -18.46 63.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.6 -0.273 . . . . 10.0 111.569 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -111.26 20.75 17.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.968 0.413 . . . . 10.0 110.974 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.619 HD12 HD23 ' A' ' 228' ' ' LEU . 56.7 mt -104.39 150.92 38.98 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.936 -0.575 . . . . 10.0 110.274 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.47 172.01 16.98 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.284 1.989 . . . . 10.0 111.576 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.8 102.32 11.51 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.642 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -83.48 -154.64 18.05 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.005 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.85 156.99 43.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 10.0 110.716 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -92.66 -174.7 3.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.685 -0.688 . . . . 10.0 110.254 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.5 147.47 42.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.892 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -93.41 120.19 66.72 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.158 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.06 -15.36 47.42 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.133 2.556 . . . . 10.0 112.315 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 86.9 mmm -78.64 0.65 25.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 10.0 111.465 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 103.27 -70.06 0.29 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.135 -0.555 . . . . 10.0 112.774 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.44 169.65 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.901 0.382 . . . . 10.0 111.578 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 104.43 136.5 8.84 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.619 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.2 m -80.2 130.35 35.15 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.178 -0.305 . . . . 10.0 110.178 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 120.06 179.72 16.45 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.228 -0.749 . . . . 10.0 111.228 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.25 -2.18 50.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.847 0.356 . . . . 10.0 111.277 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.86 4.03 79.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.18 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.93 118.68 53.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 30.2 mt -75.51 149.95 38.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.384 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.33 106.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.057 0.456 . . . . 10.0 111.153 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 164.84 127.11 0.86 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.078 -0.809 . . . . 10.0 111.078 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 11.2 t -75.18 148.19 39.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.169 0.509 . . . . 10.0 111.562 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.34 -9.46 25.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.657 -0.701 . . . . 10.0 109.497 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.433 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 89.68 -32.22 4.89 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.687 -0.688 . . . . 10.0 112.47 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 151.69 170.31 18.29 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.365 -1.094 . . . . 10.0 110.365 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.86 -55.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.541 0.67 . . . . 10.0 110.406 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' MET . . . . . 0.541 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 23.5 ttp -59.4 -48.28 82.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.406 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.433 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 36.5 tt0 -61.34 -46.19 91.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 10.0 112.138 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.84 81.96 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 121.046 -0.261 . . . . 10.0 111.167 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.74 -47.46 72.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 257' ' ' MET . 90.1 mt -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.826 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 45.6 ttm105 -58.95 -48.37 81.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.051 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 87.0 m -55.52 -43.32 75.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 10.0 111.546 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.84 -43.93 57.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.849 0.357 . . . . 10.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' TYR . . . . . 0.502 ' HD1' ' HG2' ' A' ' 294' ' ' MET . 84.0 t80 -62.07 -46.09 90.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.079 -0.509 . . . . 10.0 112.063 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 262' ' ' ARG . 52.3 mt-10 -64.98 -23.18 67.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.565 0.579 . . . . 10.0 112.565 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 73.4 mt -90.18 -35.07 15.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.103 0.478 . . . . 10.0 110.467 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -72.62 -43.09 63.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.678 -0.692 . . . . 10.0 111.604 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 70.1 p -96.38 -33.53 11.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.164 -0.471 . . . . 10.0 112.191 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 85.31 9.15 80.15 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.789 -0.925 . . . . 10.0 110.789 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 70.9 p -112.69 146.13 34.41 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.698 -0.251 . . . . 10.0 110.775 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' PRO . . . . . 0.415 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 40.0 Cg_endo -69.99 131.69 21.42 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.501 2.134 . . . . 10.0 111.9 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.454 ' HB3' ' HG3' ' A' ' 262' ' ' ARG . 46.9 tp -103.99 121.47 47.71 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.069 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.55 -156.21 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.191 2.594 . . . . 10.0 111.774 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -78.4 141.21 38.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.484 -0.325 . . . . 10.0 110.618 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 95.6 mt -89.81 141.61 28.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 1.5 m -106.59 105.35 15.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.582 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 288' ' ' LYS . 3.4 mm? -77.98 113.94 16.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.823 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.5 m -89.86 152.52 21.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.272 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -79.75 123.63 27.86 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.51 112.7 5.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.074 0.464 . . . . 10.0 110.643 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 16.0 ttm-85 -66.97 108.35 2.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.602 -0.726 . . . . 10.0 110.353 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 123.5 -18.69 7.68 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.006 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' MET . . . . . 0.481 ' SD ' ' HD2' ' A' ' 361' ' ' LYS . 56.4 mtm -139.98 102.54 4.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.012 0.434 . . . . 10.0 110.609 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.71 138.81 48.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.264 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.83 -13.5 67.04 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.587 -0.733 . . . . 10.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 21.7 mm -99.44 127.81 51.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.018 0.437 . . . . 10.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 278' ' ' LEU . 33.6 mmtt -115.62 157.57 23.98 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.11 159.66 44.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.249 0.547 . . . . 10.0 112.371 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 9.1 t -155.99 152.21 27.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.254 -0.885 . . . . 10.0 109.257 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -128.32 123.41 33.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.808 0.337 . . . . 10.0 110.649 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.91 118.41 58.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.913 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.54 97.75 3.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.044 0.449 . . . . 10.0 110.588 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' MET . . . . . 0.502 ' HG2' ' HD1' ' A' ' 265' ' ' TYR . 81.7 mtp -87.1 113.26 22.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.108 -0.497 . . . . 10.0 111.449 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 36.3 t -112.34 120.42 41.52 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.7 135.57 61.08 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.891 2.394 . . . . 10.0 112.782 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . . . -66.97 132.06 93.84 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.779 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 297' ' ' ALA . 38.8 Cg_exo -59.04 114.13 1.88 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.954 2.436 . . . . 10.0 112.286 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.52 -12.1 39.3 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.681 -0.771 . . . . 10.0 113.123 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 97.0 p -84.33 162.53 20.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.885 0.374 . . . . 10.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -64.5 -26.11 68.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.231 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -64.27 -40.0 95.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.317 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -72.48 -46.05 56.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 10.0 109.901 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 2.2 tm-20 -57.28 -46.63 82.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.395 -0.821 . . . . 10.0 111.324 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.15 -53.51 54.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 10.0 112.008 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.5 tt -60.13 -38.5 83.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.315 -0.402 . . . . 10.0 111.804 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -75.65 -33.31 60.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.563 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 304' ' ' GLU . 0.7 OUTLIER -75.46 -47.52 26.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.78 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -123.33 100.85 7.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.182 0.515 . . . . 10.0 112.073 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -110.19 -1.48 17.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.473 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.365 -0.826 . . . . 10.0 110.529 -179.683 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.299 -0.721 . . . . 10.0 111.299 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.63 -31.33 94.18 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.838 2.359 . . . . 10.0 112.415 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.414 ' HB2' ' CE1' ' A' ' 147' ' ' TYR . 85.1 mt -109.11 110.95 22.33 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -94.84 120.62 35.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.565 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -67.54 131.98 46.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.779 -0.452 . . . . 10.0 109.779 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.08 -1.71 37.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.609 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 103.26 -6.39 50.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.868 -0.682 . . . . 10.0 111.593 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' GLY . . . . . 0.404 ' HA2' ' NH2' ' A' ' 345' ' ' ARG . . . 92.23 153.86 30.34 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.77 -0.728 . . . . 10.0 111.721 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.5 82.43 8.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.057 0.456 . . . . 10.0 110.182 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -98.29 155.16 20.23 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.8 -0.714 . . . . 10.0 112.938 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -142.76 160.18 40.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.984 -0.376 . . . . 10.0 109.984 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.8 t -141.38 142.59 33.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.91 0.386 . . . . 10.0 110.49 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.44 169.58 8.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.463 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.92 23.88 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 10.0 112.063 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -111.77 -7.85 14.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.276 0.56 . . . . 10.0 109.806 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 102.6 -8.88 55.23 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.728 . . . . 10.0 112.373 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -100.95 176.81 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.054 0.454 . . . . 10.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -173.68 -175.44 41.38 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.922 -0.871 . . . . 10.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -167.65 -173.28 35.61 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.949 -0.643 . . . . 10.0 111.553 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ILE . . . . . 0.429 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 7.9 tt -136.8 131.02 46.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.71 0.291 . . . . 10.0 110.581 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.6 t -90.9 106.87 18.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.103 0.478 . . . . 10.0 110.507 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 25.0 tp -64.07 115.49 4.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.527 -0.76 . . . . 10.0 110.577 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 369' ' ' TYR . 60.5 mtm180 -86.62 105.23 16.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.86 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.74 130.57 59.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.015 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 372' ' ' VAL . . . -126.87 139.18 53.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.307 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.61 114.16 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.797 -0.446 . . . . 10.0 109.797 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.504 ' HB3' HG12 ' A' ' 374' ' ' ILE . . . -98.59 105.08 17.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.496 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -95.99 108.62 21.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.49 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 112.04 126.06 4.67 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.708 -0.957 . . . . 10.0 110.708 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 43.6 mt -59.17 -37.49 77.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.889 0.376 . . . . 10.0 111.478 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -68.99 -26.56 74.61 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.636 -0.793 . . . . 10.0 111.703 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.809 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 93.3 m-20 -84.75 -40.36 17.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.924 0.392 . . . . 10.0 110.007 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.8 94.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.383 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -55.9 -39.56 71.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.434 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.809 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 9.4 mtmm -70.79 -42.82 69.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.511 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.83 -46.86 85.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 10.0 110.974 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 97.7 mt -56.73 -45.5 82.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.562 . . . . 10.0 110.905 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 22.0 m -60.59 -45.27 94.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.7 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.481 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 36.6 mttm -66.02 -32.76 74.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.325 -0.398 . . . . 10.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 367' ' ' ALA . 87.3 mtp -68.49 -42.99 77.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.026 0.441 . . . . 10.0 110.042 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -69.1 -24.41 64.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.003 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -86.0 -7.88 58.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.044 -0.526 . . . . 10.0 111.064 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 81.2 13.95 79.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.789 -0.719 . . . . 10.0 112.949 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -77.64 -37.83 49.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.228 0.537 . . . . 10.0 110.056 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 362' ' ' MET . . . -135.14 126.06 27.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.583 -0.735 . . . . 10.0 109.388 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -119.94 125.76 49.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.81 0.338 . . . . 10.0 110.977 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 345' ' ' ARG . 72.7 m-85 -134.92 158.71 43.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.824 -0.625 . . . . 10.0 109.596 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -97.3 -36.56 10.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.027 0.441 . . . . 10.0 111.248 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' PHE . . . . . 0.541 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 26.8 t80 -125.56 126.95 45.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.57 -0.529 . . . . 10.0 109.57 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 126' ' ' PHE . 25.3 t -130.3 118.76 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.02 0.438 . . . . 10.0 111.882 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.19 129.84 44.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.985 -1.117 . . . . 10.0 107.985 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 349' ' ' ALA . 59.3 mt -121.37 125.26 73.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.241 0.543 . . . . 10.0 112.076 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' MET . . . . . 0.406 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 13.0 mmt -115.17 145.96 41.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.591 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' ALA . . . . . 0.457 ' HB2' ' HA3' ' A' ' 132' ' ' GLY . . . . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 120.758 0.313 . . . . 10.0 111.122 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.93 0.395 . . . . 10.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -116.61 25.23 9.19 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.989 -0.624 . . . . 10.0 111.972 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -65.7 168.72 31.34 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.248 -0.501 . . . . 10.0 112.896 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -69.24 -24.31 76.02 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.089 -0.577 . . . . 10.0 113.677 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -85.71 -6.13 83.34 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.648 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -82.76 155.31 68.22 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.74 164.69 33.56 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.428 2.085 . . . . 10.0 110.803 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ARG . . . . . 0.513 ' HB2' ' HE ' ' A' ' 389' ' ' ARG . 0.0 OUTLIER -128.66 121.95 29.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.231 0.539 . . . . 10.0 111.619 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.694 . . . . 10.0 110.003 179.809 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 121.31 0.576 . . . . 10.0 110.204 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -67.87 -36.61 80.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.507 -0.77 . . . . 10.0 110.667 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -61.54 -43.03 99.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.636 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ARG . . . . . 0.405 HH21 ' CD ' ' A' ' 61' ' ' GLU . 99.0 mtt180 -68.39 -41.55 80.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.715 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -64.1 -39.48 94.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.923 -0.58 . . . . 10.0 111.344 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -70.88 -24.52 62.51 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.248 0.462 . . . . 10.0 112.248 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -101.54 14.39 32.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.579 0.585 . . . . 10.0 112.579 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.09 -38.33 85.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.138 0.494 . . . . 10.0 110.775 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' TYR . . . . . 0.506 ' O ' ' HE3' ' A' ' 409' ' ' LYS . 83.4 m-85 -136.14 153.83 51.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.536 -0.756 . . . . 10.0 109.318 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -82.79 165.65 19.68 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.657 -0.498 . . . . 10.0 109.657 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.22 -33.86 59.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.692 0.282 . . . . 10.0 111.641 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -63.6 -54.47 35.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.796 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.43 -33.45 75.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.624 . . . . 10.0 111.411 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' LYS . . . . . 0.506 ' HE3' ' O ' ' A' ' 404' ' ' TYR . 95.9 mttt -67.46 -30.18 69.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.662 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 6.1 p -94.17 8.09 42.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.961 0.41 . . . . 10.0 111.312 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 6.3 m -122.08 101.78 7.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.611 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 21.0 tp -83.46 122.36 28.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.176 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 40.9 ttp85 -123.58 148.68 46.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.828 0.347 . . . . 10.0 111.306 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 417' ' ' GLU . 1.2 mpt_? -116.33 136.38 53.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.408 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.7 m -62.91 -29.37 70.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.319 0.488 . . . . 10.0 112.319 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -73.0 4.93 3.7 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.524 0.565 . . . . 10.0 112.524 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' GLU . . . . . 0.432 ' OE2' ' HD3' ' A' ' 414' ' ' ARG . 20.4 mt-10 -122.81 13.81 9.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.481 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -88.27 117.08 67.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.186 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.67 -35.16 92.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.233 2.622 . . . . 10.0 112.558 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 50.2 m -70.81 -38.66 73.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.893 0.378 . . . . 10.0 110.907 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.26 -42.85 78.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.399 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -61.93 -35.64 79.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.98 -0.555 . . . . 10.0 111.41 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -64.21 -49.84 70.42 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.095 0.474 . . . . 10.0 110.006 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.54 -38.78 91.35 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.954 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' TYR . . . . . 0.756 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.4 m-85 -74.24 -11.3 60.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.031 -0.531 . . . . 10.0 111.549 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -97.56 -52.74 3.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.182 0.808 . . . . 10.0 113.182 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.06 17.54 18.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.639 1.348 . . . . 10.0 114.639 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -155.63 -63.82 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.107 0.78 . . . . 10.0 113.107 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' LEU . . . . . 0.756 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 67.9 mt -67.38 -50.69 58.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.877 0.695 . . . . 10.0 112.877 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 92.65 -132.66 11.36 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.556 -0.831 . . . . 10.0 111.512 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 24.2 mm-40 -86.5 144.79 38.33 Favored Pre-proline 0 C--N 1.318 -0.769 0 O-C-N 122.662 -0.316 . . . . 10.0 110.698 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 431' ' ' GLU . 44.8 Cg_exo -58.89 147.06 91.13 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.941 2.427 . . . . 10.0 111.264 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 3.5 mp 62.74 17.85 10.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.515 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -76.35 -176.57 42.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.085 -0.579 . . . . 10.0 112.44 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -60.85 -51.8 67.76 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.394 0.278 . . . . 10.0 111.736 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -38.98 93.29 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.847 0.356 . . . . 10.0 110.781 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.42 75.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.986 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' HIS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 2.5 t-160 -68.81 -31.03 69.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.069 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.1 -40.9 17.7 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.6 mt -96.31 -42.81 7.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 114.577 1.325 . . . . 10.0 114.577 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.58 -17.81 21.99 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 39.2 m-70 -114.57 171.24 7.75 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.245 -0.285 . . . . 10.0 110.644 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.9 t -162.89 -175.75 4.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.526 0.203 . . . . 10.0 111.058 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -129.89 157.82 41.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.527 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.87 164.19 13.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.35 -0.387 . . . . 10.0 110.187 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 95.1 t -120.87 109.37 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.118 0.485 . . . . 10.0 111.792 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -65.89 115.45 6.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.054 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 122.33 -15.36 8.71 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.34 -0.704 . . . . 10.0 111.34 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 C-N-CA 120.869 -0.682 . . . . 10.0 112.136 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.921 -0.4 . . . . 10.0 109.921 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m -69.53 155.04 41.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.572 -0.286 . . . . 10.0 110.271 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -60.29 -31.84 70.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.646 -0.252 . . . . 10.0 111.202 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.544 HG22 HG12 ' A' ' 212' ' ' ILE . 93.7 t -66.83 -45.07 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.939 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -62.83 -36.6 83.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.616 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -59.83 -34.68 73.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -69.87 -40.85 75.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.082 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.76 -28.32 69.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.63 -0.714 . . . . 10.0 111.055 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.38 80.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.861 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -70.65 -35.35 72.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.678 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 91.0 mt -66.51 -32.32 73.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.161 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.09 -25.3 66.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.19 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 93.3 mttt -72.91 136.37 79.97 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.258 -0.428 . . . . 10.0 109.94 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' LYS . 51.5 Cg_exo -54.95 152.7 28.28 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.991 2.461 . . . . 10.0 111.98 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -61.44 -35.28 77.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.303 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.52 14.53 24.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.074 -0.512 . . . . 10.0 112.239 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 44' ' ' ARG . 14.4 t70 -68.35 134.88 91.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.393 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.39 -22.78 67.37 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.271 2.647 . . . . 10.0 113.998 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.3 4.56 24.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 10.0 111.265 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 6.4 tpt180 -82.38 130.47 35.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.516 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 176' ' ' ASP . 18.9 mttp -108.69 178.21 4.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.802 -0.636 . . . . 10.0 109.655 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.16 117.17 23.31 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 t -102.94 102.58 13.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.247 0.546 . . . . 10.0 111.066 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 179' ' ' MET . 2.8 m -97.95 144.24 27.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.531 -0.758 . . . . 10.0 109.295 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 13.7 p -130.66 141.9 45.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.828 0.347 . . . . 10.0 111.52 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 21.7 pt20 -121.86 126.93 49.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 10.0 109.933 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.679 HG11 HD21 ' A' ' 75' ' ' LEU . 3.0 t -110.27 155.4 11.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.581 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.02 144.7 29.28 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.544 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.72 -33.67 88.38 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.937 2.424 . . . . 10.0 111.944 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.3 67.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.65 HG13 HG23 ' A' ' 214' ' ' THR . 98.5 t -85.49 -39.95 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.058 0.456 . . . . 10.0 109.779 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -57.44 -31.72 66.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.697 -0.683 . . . . 10.0 112.284 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.56 -39.21 16.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.992 0.738 . . . . 10.0 112.992 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB2' ' HD3' ' A' ' 399' ' ' ARG . . . -88.18 -14.3 38.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.416 0.895 . . . . 10.0 113.416 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 tp -58.83 -24.04 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 112.046 0.387 . . . . 10.0 112.046 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.44 -33.27 73.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 10.0 111.342 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -65.34 -29.8 70.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 10.0 111.195 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.41 -17.51 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.96 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.5 mt -105.62 3.02 28.72 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.385 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.66 41.56 15.36 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.051 -0.595 . . . . 10.0 112.094 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.4 mt -125.51 178.88 5.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.767 0.318 . . . . 10.0 110.527 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.77 144.14 55.4 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.792 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.45 119.92 7.47 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.726 2.284 . . . . 10.0 111.672 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.67 0.74 56.48 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 10.0 113.348 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.62 75.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.966 0.383 . . . . 10.0 111.234 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.39 126.3 31.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.676 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.7 p -81.98 156.81 69.52 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.359 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.53 -34.82 92.25 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.237 1.958 . . . . 10.0 110.875 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -68.24 -41.24 81.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.805 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -61.72 -41.74 98.02 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.036 0.446 . . . . 10.0 110.528 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.679 HD21 HG11 ' A' ' 51' ' ' VAL . 48.7 tp -62.08 -48.43 80.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.543 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.2 94.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.004 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 36.7 tp10 -61.52 -42.91 99.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.239 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.07 -44.62 91.0 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.01 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.2 mt -62.1 -42.85 99.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.894 0.378 . . . . 10.0 111.206 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -62.99 -31.72 72.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.955 0.407 . . . . 10.0 110.808 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 81' ' ' ARG . 57.4 mtt-85 -81.44 -9.35 59.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.62 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.6 mt -78.72 -15.3 58.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.428 . . . . 10.0 110.252 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.44 -1.48 11.35 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.478 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -66.64 159.44 27.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.338 . . . . 10.0 111.066 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -104.57 -44.52 4.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.466 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -130.67 131.88 45.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.302 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.68 112.71 40.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.638 0.256 . . . . 10.0 110.872 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 33.7 m-85 -114.52 166.52 11.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.436 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -114.92 148.17 39.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.218 -0.446 . . . . 10.0 109.821 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 m -64.67 -20.81 66.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.671 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.1 -36.32 68.03 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.777 0.288 . . . . 10.0 111.777 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -67.01 -40.5 87.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.141 0.496 . . . . 10.0 109.973 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.84 -36.27 81.64 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.941 -0.864 . . . . 10.0 110.941 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.62 -35.06 79.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.731 0.301 . . . . 10.0 110.474 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -33.53 71.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.872 -0.604 . . . . 10.0 109.873 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.602 HD21 HD23 ' A' ' 424' ' ' LEU . 85.9 mt -75.41 -41.27 56.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.692 -0.685 . . . . 10.0 110.032 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.4 m -59.93 -44.02 94.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.582 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.427 HG12 ' HB3' ' A' ' 259' ' ' ALA . 30.9 mt -57.35 -40.99 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.816 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 92.8 mmm -68.71 -51.01 46.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.319 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.476 ' OE2' ' HA ' ' A' ' 432' ' ' PRO . 64.1 mm-40 -64.14 -53.67 45.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.64 -39.39 91.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.357 . . . . 10.0 110.549 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.08 99.65 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.845 -0.693 . . . . 10.0 111.378 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.3 m -67.64 -40.44 84.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.518 0.199 . . . . 10.0 110.795 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -65.04 -39.22 93.01 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.579 -0.526 . . . . 10.0 109.579 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.408 HD21 HD23 ' A' ' 261' ' ' LEU . 41.8 tp -63.88 -49.04 74.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.892 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.5 tp -59.95 -38.53 82.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.939 -0.573 . . . . 10.0 109.745 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -61.26 -49.36 77.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.972 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.486 ' HG2' ' HG2' ' A' ' 121' ' ' GLU . 40.2 mtt180 -59.03 -38.7 79.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.28 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.43 -56.19 8.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.338 -0.392 . . . . 10.0 111.232 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.6 m -55.52 -43.68 75.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 10.0 112.039 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -61.88 -35.37 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.886 0.328 . . . . 10.0 111.886 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -71.83 -28.6 63.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 10.0 110.258 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.583 ' O ' ' HD2' ' A' ' 309' ' ' ARG . 73.5 mt -83.54 -12.92 55.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.286 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.718 ' HA ' ' NH1' ' A' ' 309' ' ' ARG . 4.3 mm-40 -91.38 -42.69 10.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.909 -0.587 . . . . 10.0 109.483 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.021 -0.99 . . . . 10.0 111.012 179.853 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.352 0.596 . . . . 10.0 111.437 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -85.37 -160.71 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.822 2.348 . . . . 10.0 112.822 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 124' ' ' PRO . 82.7 mt -131.29 162.64 54.66 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.654 -0.869 . . . . 10.0 108.654 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 16.7 Cg_exo -68.8 169.76 57.46 Favored 'Cis proline' 0 C--N 1.347 0.458 0 C-N-CA 124.381 -1.091 . . . . 10.0 113.015 0.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 27.1 ttt -113.58 132.98 55.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.375 -0.829 . . . . 10.0 110.217 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.534 ' HD1' ' HB ' ' A' ' 372' ' ' VAL . 33.7 m-85 -111.73 145.79 38.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.174 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.03 140.73 40.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.695 0.622 . . . . 10.0 110.126 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.621 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -103.73 17.01 25.03 Favored 'General case' 0 CA--C 1.537 0.479 1 N-CA-C 130.104 7.075 . . . . 10.0 130.104 -179.214 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.428 ' O ' ' HD3' ' A' ' 131' ' ' PRO . 68.1 m -81.33 -31.01 33.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 112.142 -2.299 . . . . 10.0 114.393 -166.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 375' ' ' MET . 48.7 m -82.36 124.49 78.09 Favored Pre-proline 0 C--N 1.401 2.835 3 O-C-N 142.034 12.084 . . . . 10.0 113.466 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 129' ' ' CYS . 37.7 Cg_endo -68.54 -23.15 37.43 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.138 2.559 . . . . 10.0 112.246 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.97 -32.91 56.15 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 -73.75 -45.36 52.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.46 -0.37 . . . . 10.0 111.04 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.621 HD11 ' O ' ' A' ' 128' ' ' SER . 97.1 mt -58.57 -35.15 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.101 0.408 . . . . 10.0 112.101 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.97 -35.09 80.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.228 0.537 . . . . 10.0 110.531 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 34.9 ttm -70.12 -40.56 74.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 10.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.911 HD22 HG21 ' A' ' 148' ' ' VAL . 2.5 pp -75.21 -11.98 60.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.868 0.366 . . . . 10.0 111.742 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -96.78 -31.44 12.63 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -108.77 -41.66 4.71 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.634 0.976 . . . . 10.0 113.634 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.2 m -90.75 -44.73 9.27 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.314 0.857 . . . . 10.0 113.314 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -127.59 71.92 77.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 112.025 0.38 . . . . 10.0 112.025 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 73.2 Cg_endo -75.22 11.25 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.55 2.167 . . . . 10.0 112.662 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.98 -7.77 29.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.201 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.5 mt -106.39 14.93 26.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.77 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.589 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 76.9 mt -55.05 -54.72 47.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 113.267 0.84 . . . . 10.0 113.267 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 17.4 Cg_exo -68.06 -9.98 27.44 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.451 2.101 . . . . 10.0 113.009 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 125' ' ' MET . 49.3 m-85 -82.53 -25.08 33.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.131 0.491 . . . . 10.0 110.914 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.911 HG21 HD22 ' A' ' 137' ' ' LEU . 2.7 t -88.53 156.76 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.152 -0.476 . . . . 10.0 109.759 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 t -70.66 154.19 42.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.337 . . . . 10.0 110.923 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 96.3 p -96.77 3.9 52.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.088 0.471 . . . . 10.0 110.304 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.9 m -76.0 144.9 40.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.153 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.43 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 30.4 mtpt -86.01 164.76 17.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.944 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.449 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 0.1 OUTLIER -69.66 152.7 96.12 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.466 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.17 -53.84 5.39 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.802 3.001 . . . . 10.0 113.884 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 153' ' ' SER . 0.0 OUTLIER -62.13 -37.73 86.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 10.0 111.669 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 67.1 mmm -73.14 -23.53 60.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.319 -0.401 . . . . 10.0 111.189 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 40.0 mtt -76.87 -50.1 14.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.3 tp -61.65 -42.53 99.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.46 -0.791 . . . . 10.0 110.844 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.516 ' HA ' ' SD ' ' A' ' 179' ' ' MET . . . -59.47 -40.79 88.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.045 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.47 -35.54 68.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.496 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 3.2 ttt -66.9 -44.66 80.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.675 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 33.0 m -69.52 -30.86 46.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.314 0.487 . . . . 10.0 112.314 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -85.9 6.96 25.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.14 0.422 . . . . 10.0 112.14 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.4 p -129.85 -81.28 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.403 -0.362 . . . . 10.0 110.466 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.578 ' HE2' ' HA ' ' A' ' 240' ' ' MET . 11.3 t80 -56.29 -49.37 74.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.481 . . . . 10.0 111.472 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.659 HD11 ' HE3' ' A' ' 170' ' ' LYS . 41.8 tp -65.93 -39.43 90.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.989 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.63 88.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.512 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.51 -42.38 82.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.912 -0.586 . . . . 10.0 111.107 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -65.98 -46.84 76.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.847 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.659 ' HE3' HD11 ' A' ' 166' ' ' LEU . 72.9 mttt -73.73 -27.15 61.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.702 0.287 . . . . 10.0 111.277 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 88.2 44.0 5.45 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.749 -0.739 . . . . 10.0 112.227 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 21.4 mt -126.8 145.11 34.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -74.9 142.38 76.43 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 110.074 -0.343 . . . . 10.0 110.074 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.435 ' HB2' HD13 ' A' ' 205' ' ' LEU . 45.1 Cg_exo -57.78 -22.07 51.41 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.996 2.464 . . . . 10.0 112.978 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.33 -12.7 56.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.977 0.417 . . . . 10.0 111.485 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 59.3 m-20 -101.36 11.41 39.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.181 0.515 . . . . 10.0 109.74 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 95.4 mtp -122.69 118.84 29.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.899 -0.592 . . . . 10.0 111.263 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.31 133.32 58.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.057 -1.09 . . . . 10.0 108.057 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.516 ' SD ' ' HA ' ' A' ' 159' ' ' ALA . 9.6 ttt -123.0 134.56 54.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.565 0.698 . . . . 10.0 112.805 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 20.8 t -117.84 151.6 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.3 p -135.96 141.68 44.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.721 0.296 . . . . 10.0 110.602 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.539 ' HB ' HG13 ' A' ' 51' ' ' VAL . 16.7 mm -105.04 106.6 20.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 213' ' ' THR . 31.0 mmt -117.4 146.9 39.47 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.227 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.11 15.55 2.19 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.748 2.299 . . . . 10.0 112.705 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 20.8 m -141.28 138.54 33.26 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.978 0.362 . . . . 10.0 111.978 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -30.99 69.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.675 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -65.3 -14.23 60.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.946 -0.57 . . . . 10.0 112.452 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 188' ' ' LYS . 59.2 mmtt -70.07 -27.31 64.52 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.903 0.334 . . . . 10.0 111.903 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -67.26 -44.33 79.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.576 -0.527 . . . . 10.0 109.576 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m -64.09 -29.1 70.26 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.039 0.447 . . . . 10.0 110.246 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.67 -44.86 80.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 208' ' ' LEU . . . -78.36 -12.42 60.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.745 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.42 2.09 51.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.792 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 194' ' ' ARG . 58.4 mtt-85 -64.62 119.43 10.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.691 0.282 . . . . 10.0 110.691 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -38.05 -60.27 0.77 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.271 1.582 . . . . 10.0 115.271 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -66.77 -2.06 4.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 115.012 1.486 . . . . 10.0 115.012 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.431 ' O ' ' HG3' ' A' ' 207' ' ' GLN . 6.2 m-85 -86.71 55.65 3.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.355 0.598 . . . . 10.0 109.848 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.17 169.43 8.74 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.591 -0.732 . . . . 10.0 111.538 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.05 143.15 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.037 -0.982 . . . . 10.0 110.28 -179.786 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 120.925 0.393 . . . . 10.0 110.984 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.806 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.228 -0.075 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -92.48 140.4 29.61 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.436 -0.209 . . . . 10.0 110.436 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 197' ' ' PHE . 56.4 mt-30 -69.6 -41.04 76.28 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.487 ' HB3' ' HB1' ' A' ' 192' ' ' ALA . 13.0 tp -128.52 115.86 18.78 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.62 -47.25 8.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.304 1.224 . . . . 10.0 114.304 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -132.65 143.46 49.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.085 0.772 . . . . 10.0 113.085 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.5 t -126.25 129.23 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.463 -0.939 . . . . 10.0 108.463 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.544 HG12 HG22 ' A' ' 28' ' ' VAL . 55.6 mt -120.22 141.76 39.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 183' ' ' MET . 60.3 p -90.1 164.04 14.63 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.99 -0.284 . . . . 10.0 111.292 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.65 HG23 HG13 ' A' ' 55' ' ' VAL . 1.8 m -55.5 -47.39 76.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.602 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.43 -43.09 89.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 10.0 112.007 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.42 ' O ' HG13 ' A' ' 220' ' ' ILE . 52.7 mt-10 -67.76 -48.31 66.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.145 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 182' ' ' ILE . 31.2 tp -57.98 -46.13 85.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.866 0.365 . . . . 10.0 110.969 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.77 -34.74 89.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.952 -0.567 . . . . 10.0 112.291 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.8 -34.17 69.14 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.838 -0.213 . . . . 10.0 110.821 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 216' ' ' GLU . 90.8 mt -64.66 -42.82 96.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -59.12 -46.39 88.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.381 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -68.85 -29.48 67.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.349 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.29 -36.66 74.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.988 0.423 . . . . 10.0 110.938 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -86.43 -10.82 53.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.178 -0.465 . . . . 10.0 111.428 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.45 40.33 13.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.247 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 53.5 mt -120.57 107.88 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.829 0.347 . . . . 10.0 110.325 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -93.28 118.08 30.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.647 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.651 HD23 HD12 ' A' ' 231' ' ' LEU . 85.1 mt -61.43 -30.34 70.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 10.0 111.628 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.85 -5.55 38.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.165 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.19 27.39 7.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.576 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.651 HD12 HD23 ' A' ' 228' ' ' LEU . 77.9 mt -115.34 148.34 40.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.101 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.14 172.93 15.41 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.487 2.125 . . . . 10.0 111.595 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.81 101.72 4.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.399 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 77' ' ' GLU . . . -75.44 -148.83 2.09 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 116.005 -0.543 . . . . 10.0 112.745 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -152.07 154.99 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.853 0.358 . . . . 10.0 111.418 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -100.09 161.82 13.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.75 -0.659 . . . . 10.0 109.966 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -101.75 150.11 23.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -95.03 119.5 65.76 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.378 -0.373 . . . . 10.0 110.05 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.04 -15.8 35.63 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.206 2.604 . . . . 10.0 112.495 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.578 ' HA ' ' HE2' ' A' ' 165' ' ' TYR . 98.9 mmm -75.19 -14.3 60.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.934 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 91.84 -18.83 51.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.818 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.0 m -134.24 157.71 41.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 110.354 -0.239 . . . . 10.0 110.354 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 90.19 155.04 30.62 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.783 -0.723 . . . . 10.0 112.319 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.34 130.19 46.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.694 0.283 . . . . 10.0 110.703 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 125.07 176.69 14.63 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.525 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -81.15 -1.05 43.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.874 0.337 . . . . 10.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.42 6.13 84.13 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.917 -0.658 . . . . 10.0 112.26 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.6 t -108.48 135.81 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.725 HD11 ' HD3' ' A' ' 419' ' ' PRO . 90.1 mt -81.75 159.34 23.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.68 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -67.44 110.67 3.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.976 -0.557 . . . . 10.0 110.832 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.551 ' HA3' ' HB2' ' A' ' 413' ' ' ARG . . . 148.56 141.84 3.54 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.802 -0.713 . . . . 10.0 112.064 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.4 t -84.36 155.02 22.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.997 0.427 . . . . 10.0 111.148 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.22 -16.32 19.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.476 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.51 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 86.11 -6.78 80.51 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.107 -0.568 . . . . 10.0 112.396 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.75 158.4 10.22 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.008 -0.837 . . . . 10.0 111.008 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.23 -55.53 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.863 0.331 . . . . 10.0 110.909 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' MET . . . . . 0.612 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 19.3 ttp -56.99 -48.22 78.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.65 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.51 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 18.2 tt0 -63.26 -48.27 78.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.131 0.419 . . . . 10.0 112.131 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.427 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . -64.26 -34.99 79.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.503 0.192 . . . . 10.0 111.335 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.73 73.26 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.408 HD23 HD21 ' A' ' 105' ' ' LEU . 68.0 mt -62.45 -41.07 98.48 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.728 -0.669 . . . . 10.0 109.8 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.483 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 44.4 ttm105 -59.28 -50.16 75.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.47 -0.787 . . . . 10.0 111.018 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 50.9 m -57.56 -43.62 84.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.053 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.24 77.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.911 0.386 . . . . 10.0 110.72 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.526 ' CD2' ' HB2' ' A' ' 273' ' ' LEU . 50.3 t80 -63.26 -48.8 76.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.705 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.419 ' OE2' ' HA ' ' A' ' 272' ' ' PRO . 59.5 mt-10 -63.91 -27.37 69.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.111 0.782 . . . . 10.0 113.111 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 82.2 mt -86.82 -26.64 23.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.03 0.443 . . . . 10.0 111.046 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -84.93 -36.97 21.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.679 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.443 HG21 ' CE1' ' A' ' 265' ' ' TYR . 63.0 p -100.81 -32.74 10.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.718 0.636 . . . . 10.0 112.718 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 87.23 0.99 84.59 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.732 -0.947 . . . . 10.0 110.732 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 42.0 p -109.38 145.09 31.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 110.286 -0.264 . . . . 10.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.419 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 42.6 Cg_endo -69.26 146.2 62.47 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.604 2.202 . . . . 10.0 112.203 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.543 HD12 ' HD2' ' A' ' 274' ' ' PRO . 32.1 tp -115.2 123.56 31.51 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.931 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' A' ' 273' ' ' LEU . 87.7 Cg_endo -80.29 -157.3 0.08 OUTLIER 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.696 2.264 . . . . 10.0 111.3 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -79.28 140.07 37.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.569 0.224 . . . . 10.0 110.584 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 90.5 mt -91.69 128.2 37.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.984 0.421 . . . . 10.0 111.248 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 7.1 m -96.1 93.47 6.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.182 0.515 . . . . 10.0 111.002 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 288' ' ' LYS . 4.3 mm? -64.54 122.33 16.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.515 -0.766 . . . . 10.0 111.346 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.2 m -105.18 138.87 40.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.516 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.97 144.12 56.96 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.765 0.283 . . . . 10.0 111.765 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.59 HG22 ' HG2' ' A' ' 289' ' ' GLU . 16.7 t -93.84 123.71 46.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.31 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -66.06 118.81 10.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.208 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.99 -23.85 12.46 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.906 -0.664 . . . . 10.0 111.808 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.434 ' HB3' HG13 ' A' ' 287' ' ' ILE . 75.7 mtm -126.98 98.65 5.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.985 0.421 . . . . 10.0 110.351 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -69.17 133.28 47.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.176 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' GLY . . . . . 0.435 ' HA3' HD21 ' A' ' 354' ' ' ASN . . . 89.64 -6.99 82.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.038 -0.601 . . . . 10.0 112.459 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 284' ' ' MET . 37.1 mm -101.19 127.92 53.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.87 0.367 . . . . 10.0 110.312 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 278' ' ' LEU . 65.8 mttm -122.97 142.81 50.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.59 ' HG2' HG22 ' A' ' 281' ' ' VAL . 15.8 pt-20 -126.05 163.56 22.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.119 0.485 . . . . 10.0 111.562 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.418 ' CG2' ' HB ' ' A' ' 346' ' ' VAL . 10.0 t -157.19 131.4 8.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.861 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -105.7 121.83 44.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.279 -0.419 . . . . 10.0 109.944 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 36.2 mt -109.12 111.7 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.457 -0.338 . . . . 10.0 111.419 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.07 103.55 3.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.584 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 87.4 mtp -98.38 115.12 27.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.127 0.489 . . . . 10.0 111.442 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 269' ' ' THR . 70.2 t -109.3 124.79 32.99 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.632 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.01 129.77 34.84 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.737 2.291 . . . . 10.0 112.631 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -62.11 132.23 93.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.848 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.11 118.4 5.35 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.584 2.189 . . . . 10.0 111.978 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 95.07 21.47 25.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.875 -0.679 . . . . 10.0 112.797 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.1 p -119.78 164.04 16.56 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.7 -0.294 . . . . 10.0 110.478 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.667 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 71.4 tttt -62.83 -32.12 73.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.992 0.425 . . . . 10.0 109.911 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' PHE . . . . . 0.409 ' HA ' HD12 ' A' ' 305' ' ' LEU . 47.9 m-85 -60.59 -36.64 79.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.645 -0.707 . . . . 10.0 111.177 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -70.36 -36.71 74.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.98 -0.554 . . . . 10.0 110.428 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -28.29 62.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.779 -0.646 . . . . 10.0 111.312 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 90.0 mt -58.18 -53.91 52.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.44 -1.67 31.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.295 0.48 . . . . 10.0 112.295 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -104.5 -36.0 7.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.946 0.403 . . . . 10.0 111.07 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -26.41 54.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.717 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ARG . . . . . 0.718 ' NH1' ' HA ' ' A' ' 114' ' ' GLU . 5.1 ptp85 -148.42 165.36 31.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.531 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -138.25 -57.67 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.015 0.436 . . . . 10.0 110.591 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.745 -0.645 . . . . 10.0 110.077 179.419 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.909 -0.476 . . . . 10.0 111.909 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.64 -26.07 33.72 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.792 2.328 . . . . 10.0 111.555 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.511 ' HB2' ' CE2' ' A' ' 147' ' ' TYR . 93.1 mt -113.13 105.1 13.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.732 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.76 31.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.498 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -56.19 137.29 52.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.706 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -79.69 -12.68 59.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.979 0.419 . . . . 10.0 111.607 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 114.25 -10.68 22.27 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.829 -0.7 . . . . 10.0 111.405 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 89.79 141.8 8.92 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.003 -0.618 . . . . 10.0 112.084 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -77.75 96.01 4.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.093 0.473 . . . . 10.0 110.106 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -103.22 163.16 15.82 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.791 -0.718 . . . . 10.0 112.737 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -147.5 153.78 39.94 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.473 ' HA ' ' HA3' ' A' ' 340' ' ' GLY . 6.2 t -144.36 161.04 40.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.917 0.389 . . . . 10.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' SER . . . . . 0.457 ' HB2' ' OD1' ' A' ' 337' ' ' ASP . 1.4 m -110.19 166.26 11.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.726 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -72.96 7.06 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 335' ' ' SER . 2.0 p-10 -104.0 -16.76 15.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.968 0.413 . . . . 10.0 110.269 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.34 -4.13 33.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 10.0 113.293 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -108.52 122.04 46.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.99 0.424 . . . . 10.0 110.69 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 334' ' ' THR . . . -136.67 -145.1 4.95 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.864 -0.684 . . . . 10.0 111.917 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 179.0 -165.46 34.42 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.55 -0.62 . . . . 10.0 111.55 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.456 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 14.5 tt -137.89 138.56 43.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 13.2 t -102.25 119.33 38.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.298 0.57 . . . . 10.0 110.414 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 11.7 tp -79.0 126.19 30.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.683 -0.689 . . . . 10.0 111.407 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -95.09 106.11 18.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.583 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 371' ' ' PHE . 29.4 t -107.46 139.81 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.12 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 372' ' ' VAL . . . -136.69 144.9 44.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.804 0.335 . . . . 10.0 110.962 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 52.5 t -119.58 125.83 74.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.318 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 358' ' ' LEU . . . -108.8 119.77 40.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.066 -0.515 . . . . 10.0 109.912 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -100.92 103.06 14.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.574 -0.285 . . . . 10.0 111.398 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 41' ' ' ALA . . . 113.11 146.01 9.55 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.605 -0.807 . . . . 10.0 114.239 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.11 -32.4 68.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.186 0.517 . . . . 10.0 109.842 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' B' ' 60' ' ' SER . . . -75.73 -10.83 84.84 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.916 -0.874 . . . . 10.0 110.916 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.594 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 3.2 t-20 -91.49 -31.4 15.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.643 -0.503 . . . . 10.0 109.643 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.2 93.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.663 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -58.84 -40.91 85.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.495 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 8.7 pttm -83.86 -10.86 57.7 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.431 0.53 . . . . 10.0 112.431 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 349' ' ' ALA . 29.1 tp -91.95 -49.44 6.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.816 0.341 . . . . 10.0 111.119 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 85.0 mt -58.25 -37.55 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 10.0 111.103 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.94 -26.75 68.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.266 -0.424 . . . . 10.0 111.346 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -78.86 -33.15 46.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 10.0 109.926 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 91.0 mtp -75.06 -37.54 61.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.001 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -63.14 -34.57 77.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.011 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -79.38 -12.75 59.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.263 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 84.4 15.47 68.77 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.843 -0.694 . . . . 10.0 112.395 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -83.28 -52.38 6.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.023 0.439 . . . . 10.0 109.94 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.417 ' HB1' ' HE2' ' A' ' 369' ' ' TYR . . . -94.09 100.28 12.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.579 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.61 115.0 26.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' TYR . . . . . 0.417 ' HE2' ' HB1' ' A' ' 367' ' ' ALA . 85.1 m-85 -137.9 159.86 40.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.677 -0.49 . . . . 10.0 109.677 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -107.16 -39.46 5.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.968 0.413 . . . . 10.0 110.979 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.612 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 20.5 t80 -128.16 123.57 34.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.368 -0.605 . . . . 10.0 109.368 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.534 ' HB ' ' HD1' ' A' ' 126' ' ' PHE . 45.4 t -129.38 126.57 63.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.848 0.356 . . . . 10.0 111.746 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -104.12 124.09 48.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.672 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.74 121.92 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.843 0.354 . . . . 10.0 110.896 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' MET . . . . . 0.6 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 67.2 mtt -105.65 152.36 23.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.343 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -101.36 9.26 41.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.029 0.443 . . . . 10.0 110.998 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 378' ' ' PRO . 92.9 m -111.74 160.48 29.49 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.704 -0.68 . . . . 10.0 110.106 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.583 ' HB3' ' SG ' ' B' ' 37' ' ' CYS . 24.9 Cg_endo -62.84 -36.44 61.54 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.616 2.211 . . . . 10.0 112.474 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -157.63 100.71 1.79 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.013 0.435 . . . . 10.0 110.543 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 377' ' ' CYS . . . 78.29 -132.8 12.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.871 -0.68 . . . . 10.0 112.977 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' CYS . . . . . . . . . . . . . 11.5 t -131.14 -8.17 3.84 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.105 0.479 . . . . 10.0 110.819 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.14 4.77 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 112.572 0.582 . . . . 10.0 112.572 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -128.56 48.77 0.95 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.511 -0.852 . . . . 10.0 112.663 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -87.54 168.97 38.7 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.449 -0.881 . . . . 10.0 111.74 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -67.79 -15.19 66.41 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.232 -0.508 . . . . 10.0 113.294 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -89.29 -5.44 72.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.696 -0.764 . . . . 10.0 111.749 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -82.42 156.3 68.66 Favored Pre-proline 0 C--O 1.239 0.501 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.8 160.73 39.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.715 2.277 . . . . 10.0 111.532 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 107.54 14.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.92 0.391 . . . . 10.0 111.282 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 62.4 m -108.43 163.03 13.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.778 -0.646 . . . . 10.0 109.868 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.65 81.75 3.3 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.174 0.511 . . . . 10.0 111.196 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ASP . . . . . 0.785 ' HB3' ' HB ' ' A' ' 395' ' ' ILE . 14.3 t0 -165.87 125.32 1.67 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.527 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -78.57 -15.0 59.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.015 0.436 . . . . 10.0 110.337 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -124.71 38.76 4.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.501 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.785 ' HB ' ' HB3' ' A' ' 392' ' ' ASP . 10.9 tp -71.48 -18.78 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.341 0.591 . . . . 10.0 110.64 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -42.55 95.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.642 -0.708 . . . . 10.0 111.391 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -64.26 -37.18 86.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.662 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.468 ' HD2' HD12 ' A' ' 395' ' ' ILE . 62.7 mttp -62.97 -44.93 94.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.063 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.401 ' HD3' ' HB2' ' A' ' 58' ' ' ALA . 97.3 mtt180 -68.44 -35.76 78.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.029 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -66.36 -40.2 89.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.518 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -73.4 -29.67 62.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.05 -0.523 . . . . 10.0 111.622 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -91.61 10.07 29.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 10.0 111.784 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 9.5 mt -66.55 -41.45 88.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.738 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -136.16 153.46 51.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.495 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ASN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 407' ' ' ASP . 63.8 t30 -79.52 174.24 11.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.583 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 406' ' ' LEU . 3.6 mm? -59.55 -39.51 84.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 405' ' ' ASN . 11.7 p30 -70.72 -46.63 62.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.351 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -60.63 -35.32 75.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.646 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -71.12 -40.63 71.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.888 0.375 . . . . 10.0 111.293 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 10.8 m -73.97 -31.14 62.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.996 -0.547 . . . . 10.0 111.829 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 5.6 m -87.0 107.69 18.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 40.2 tp -85.65 136.65 33.29 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.692 -0.484 . . . . 10.0 109.692 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ARG . . . . . 0.551 ' HB2' ' HA3' ' A' ' 251' ' ' GLY . 3.9 tmm_? -145.77 125.12 13.05 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.216 -0.29 . . . . 10.0 110.216 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.619 ' HB2' ' OE1' ' A' ' 417' ' ' GLU . 5.3 mtt85 -100.83 158.52 15.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.136 0.493 . . . . 10.0 110.462 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.6 m -64.5 -24.91 67.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.551 0.945 . . . . 10.0 113.551 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' HIS . . . . . . . . . . . . 0.282 28.5 p80 -78.71 4.23 14.31 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' GLU . . . . . 0.619 ' OE1' ' HB2' ' A' ' 414' ' ' ARG . 1.7 mp0 -112.12 -3.93 14.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.992 0.425 . . . . 10.0 109.975 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.42 ' HB3' ' HB ' ' A' ' 421' ' ' ILE . 50.4 t-20 -77.75 118.37 71.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.624 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.725 ' HD3' HD11 ' A' ' 249' ' ' LEU . 37.7 Cg_exo -59.05 -38.68 86.13 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.022 2.481 . . . . 10.0 111.636 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 53.9 m -65.28 -46.27 81.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.313 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 418' ' ' ASN . 39.2 mm -65.22 -43.02 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.132 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' ARG . . . . . 0.587 ' NH2' ' HA ' ' A' ' 417' ' ' GLU . 97.1 mtt180 -58.97 -45.45 90.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.366 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -63.33 -49.64 73.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.93 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.602 HD23 HD21 ' A' ' 96' ' ' LEU . 61.3 tp -56.37 -39.17 72.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.998 0.427 . . . . 10.0 110.947 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' TYR . . . . . 0.882 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.1 m-85 -77.35 4.62 10.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.948 -0.569 . . . . 10.0 111.498 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -118.76 -54.61 2.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.739 0.304 . . . . 10.0 111.692 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -25.27 53.47 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.714 1.005 . . . . 10.0 113.714 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -126.71 -50.13 1.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 114.589 1.329 . . . . 10.0 114.589 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.882 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 90.9 mt -73.08 -39.74 65.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.391 0.886 . . . . 10.0 113.391 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 86.25 -60.57 4.56 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.574 -0.822 . . . . 10.0 112.836 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 432' ' ' PRO . 2.1 tt0 -165.95 151.1 7.77 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.615 0.208 . . . . 10.0 110.727 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.476 ' HA ' ' OE2' ' A' ' 100' ' ' GLU . 32.5 Cg_exo -59.64 142.4 98.74 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.819 2.346 . . . . 10.0 111.312 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 7.9 mp 63.35 16.95 9.92 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.708 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -78.67 -168.79 34.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.2 -0.524 . . . . 10.0 112.214 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' HIS . . . . . 0.426 ' O ' ' HG3' ' A' ' 439' ' ' GLU . 31.4 t-80 -59.99 -60.83 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.512 0.196 . . . . 10.0 111.328 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.443 ' HD2' ' OE2' ' A' ' 439' ' ' GLU . 8.3 tptt -59.4 -35.46 74.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.278 -0.419 . . . . 10.0 111.29 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -65.19 -42.84 93.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.156 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 9.6 t-80 -68.02 -26.9 66.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.901 0.382 . . . . 10.0 110.521 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLU . . . . . 0.443 ' OE2' ' HD2' ' A' ' 436' ' ' LYS . 45.4 mt-10 -73.06 -64.88 0.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 62.4 mt -99.04 -17.96 18.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.986 1.476 . . . . 10.0 114.986 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 60.8 mt -100.0 -11.14 20.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.557 0.577 . . . . 10.0 112.557 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 28.0 m-70 -122.59 163.6 19.7 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 121.305 -0.158 . . . . 10.0 110.595 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 5.9 t -155.07 -171.95 4.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.667 0.27 . . . . 10.0 111.081 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -133.84 168.09 19.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.374 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' TYR . . . . . 0.546 ' HD2' HG23 ' A' ' 145' ' ' ILE . 51.0 m-85 -109.85 161.02 15.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.446 -0.343 . . . . 10.0 110.358 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.15 120.91 66.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.977 0.418 . . . . 10.0 111.31 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.13 107.23 3.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.738 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.26 -6.32 11.89 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.128 -0.789 . . . . 10.0 111.128 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . 95.86 179.18 36.15 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.045 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.167 -0.92 . . . . 10.0 110.138 -179.904 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.556 ' HE2' ' HB2' ' B' ' 18' ' ' ALA . 97.5 m-85 . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 109.938 -0.393 . . . . 10.0 109.938 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.453 ' HG3' ' OE2' ' B' ' 15' ' ' GLU . 38.3 mttp -84.12 114.02 21.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.129 0.49 . . . . 10.0 110.266 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' B' ' 13' ' ' THR . 6.9 p -112.56 127.77 69.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.38 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.561 ' HB ' HG23 ' B' ' 84' ' ' THR . 1.3 m -85.71 89.56 7.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.273 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 80.7 mt -76.35 109.97 10.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.113 0.482 . . . . 10.0 111.327 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.788 ' HB3' ' HA ' ' B' ' 86' ' ' GLN . 12.9 tppt? -79.88 123.67 27.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.645 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.53 HG21 HD22 ' B' ' 31' ' ' LEU . 0.6 OUTLIER -128.32 166.38 24.64 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.146 -0.479 . . . . 10.0 109.816 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.94 -21.47 72.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.084 1.856 . . . . 10.0 110.73 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.3 9.13 39.35 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.482 -0.781 . . . . 10.0 111.792 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.26 -122.83 4.57 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.297 -0.954 . . . . 10.0 113.185 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -145.03 157.98 43.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.895 0.379 . . . . 10.0 110.466 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LYS . . . . . 0.437 ' HB2' ' HE2' ' B' ' 12' ' ' LYS . 1.5 tppt? -143.38 97.83 3.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.445 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' B' ' 3' ' ' VAL . 2.6 m -87.77 92.84 9.26 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.411 ' H ' HG13 ' B' ' 14' ' ' ILE . 1.9 pp -112.79 173.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.338 -0.392 . . . . 10.0 111.444 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.453 ' OE2' ' HG3' ' B' ' 2' ' ' LYS . 8.3 mm-40 -91.55 117.87 30.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.174 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' B' ' 17' ' ' PRO . 44.6 t -109.8 125.65 30.76 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.755 -0.657 . . . . 10.0 109.659 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 16' ' ' CYS . 17.2 Cg_exo -68.96 154.84 70.14 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.818 2.345 . . . . 10.0 110.889 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.556 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . . . -77.84 -14.74 59.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.693 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.44 -5.42 20.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.519 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 2.9 m -119.11 135.52 54.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.836 0.35 . . . . 10.0 111.496 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' B' ' 24' ' ' ASP . 1.8 p90 -65.42 140.05 58.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.96 -0.564 . . . . 10.0 111.022 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.521 ' H ' HG13 ' B' ' 22' ' ' ILE . 2.1 mt -53.87 -34.82 26.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.744 -0.662 . . . . 10.0 112.493 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.479 ' HB3' ' CD2' ' B' ' 21' ' ' TYR . 1.3 tm? -53.58 -49.32 67.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.078 0.399 . . . . 10.0 112.078 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.542 ' HB2' ' CZ ' ' B' ' 21' ' ' TYR . 4.9 t70 -64.12 -45.79 87.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.062 0.458 . . . . 10.0 110.895 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -31.55 72.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.596 . . . . 10.0 112.034 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -56.37 13.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.817 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -36.69 80.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.413 -0.358 . . . . 10.0 111.499 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.0 -27.22 69.27 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.177 0.513 . . . . 10.0 110.275 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.71 -42.9 11.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.499 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.63 82.18 0.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.899 -0.667 . . . . 10.0 112.558 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' LEU . . . . . 0.53 HD22 HG21 ' B' ' 7' ' ' THR . 13.2 mt -150.04 162.43 40.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.867 0.365 . . . . 10.0 111.081 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -93.26 98.79 11.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.134 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.516 HD21 ' HB ' ' B' ' 87' ' ' THR . 20.9 mt -152.57 149.68 23.11 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.394 -0.366 . . . . 10.0 110.258 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 33' ' ' LEU . 2.9 Cg_endo -83.7 117.35 2.33 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.013 2.475 . . . . 10.0 111.661 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.419 ' HA ' ' S1 ' ' B' ' 101' ' ' FES . 11.7 p90 -125.86 128.77 48.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.413 -0.358 . . . . 10.0 111.262 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.6 m -169.1 -57.1 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.735 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 378' ' ' PRO . 7.2 p -84.45 -65.06 1.05 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' B' ' 75' ' ' CYS . 3.7 ttp-105 81.58 -32.3 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.22 23.85 0.05 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.401 0.889 . . . . 10.0 113.401 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.95 74.14 0.69 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.112 -0.566 . . . . 10.0 112.582 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ALA . . . . . 0.49 ' HB3' ' SG ' ' B' ' 37' ' ' CYS . . . -112.23 -76.18 0.6 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.713 0.292 . . . . 10.0 111.495 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.46 145.54 30.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.882 0.373 . . . . 10.0 111.268 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -0.6 57.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.194 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m -72.0 -17.32 62.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.074 0.464 . . . . 10.0 110.977 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' CYS . . . . . 0.508 ' O ' HG22 ' B' ' 74' ' ' THR . 18.0 m -101.34 31.35 3.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.395 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.02 123.89 37.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.995 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.52 164.99 35.01 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.061 -0.59 . . . . 10.0 111.956 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 1.046 ' HB2' ' HB2' ' B' ' 86' ' ' GLN . 0.1 OUTLIER -110.96 116.67 31.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.247 -0.279 . . . . 10.0 110.247 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.55 ' HB ' ' HA2' ' B' ' 70' ' ' GLY . 4.9 t -73.35 98.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.306 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.64 -38.5 47.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.053 0.454 . . . . 10.0 110.343 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -163.76 -179.89 6.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.631 -0.713 . . . . 10.0 109.35 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.733 ' HA3' ' HB3' ' B' ' 83' ' ' CYS . . . 79.22 -147.29 30.03 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.046 -0.597 . . . . 10.0 112.859 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.98 136.34 20.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.853 0.359 . . . . 10.0 110.786 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 5.5 m -128.07 156.01 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -122.4 119.37 30.83 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.266 0.469 . . . . 10.0 112.266 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -135.08 133.13 38.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 10.0 109.209 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -116.73 -58.56 2.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.026 0.441 . . . . 10.0 110.925 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -95.34 99.79 11.67 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.065 -0.716 . . . . 10.0 109.065 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.66 -160.19 1.03 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.481 0.548 . . . . 10.0 112.481 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.51 ' HA ' ' HA2' ' A' ' 353' ' ' GLY . 3.7 m -93.44 -147.14 0.24 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.031 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -72.62 -16.16 61.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.201 0.445 . . . . 10.0 112.201 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.32 87.06 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.158 0.504 . . . . 10.0 110.198 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.504 ' HB3' ' H ' ' B' ' 64' ' ' ASP . 0.6 OUTLIER -88.23 -153.98 0.26 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.532 -0.758 . . . . 10.0 112.727 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ASP . . . . . 0.504 ' H ' ' HB3' ' B' ' 63' ' ' ASP . 43.1 m-20 -53.5 -44.02 68.71 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.972 0.73 . . . . 10.0 112.972 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.76 -37.8 71.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.104 0.478 . . . . 10.0 111.076 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.477 ' HB3' ' HB2' ' B' ' 71' ' ' PHE . 14.7 mm100 -81.93 -38.66 24.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.172 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' MET . . . . . . . . . . . . . 57.2 ttp -60.44 -43.71 96.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.847 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.9 -16.28 72.37 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 116.066 -0.515 . . . . 10.0 112.444 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -90.6 -34.86 15.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.059 0.457 . . . . 10.0 110.163 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLY . . . . . 0.55 ' HA2' ' HB ' ' B' ' 49' ' ' VAL . . . 135.85 37.73 0.18 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.776 -0.726 . . . . 10.0 113.261 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.477 ' HB2' ' HB3' ' B' ' 66' ' ' GLN . 52.7 m-85 -129.52 118.25 21.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.134 0.467 . . . . 10.0 110.646 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.13 143.07 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.834 0.35 . . . . 10.0 111.528 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.36 96.2 9.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.508 HG22 ' O ' ' B' ' 45' ' ' CYS . 9.9 t -61.56 -8.01 3.89 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.33 1.233 . . . . 10.0 114.33 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' B' ' 38' ' ' ARG . 56.0 m -82.18 -25.44 34.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.855 0.359 . . . . 10.0 110.922 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.66 26.83 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.302 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.47 150.26 44.98 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.1 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.403 ' HA ' ' HD3' ' B' ' 79' ' ' PRO . 34.5 p90 -133.24 155.36 80.99 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.407 -0.815 . . . . 10.0 109.181 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 0.441 ' HD3' HG12 ' B' ' 22' ' ' ILE . 6.1 Cg_exo -78.23 115.92 3.81 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.505 2.137 . . . . 10.0 111.433 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.07 -20.4 64.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.462 0.648 . . . . 10.0 109.397 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 15.0 m -153.59 159.08 42.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.305 -0.861 . . . . 10.0 109.077 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.28 135.8 57.76 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' CYS . . . . . 0.733 ' HB3' ' HA3' ' B' ' 52' ' ' GLY . 2.3 p -169.24 -179.95 3.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 10.0 112.259 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.561 HG23 ' HB ' ' B' ' 4' ' ' THR . 22.5 m -105.93 129.69 54.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.298 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 26.3 mm -133.93 128.62 53.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.498 0.189 . . . . 10.0 110.848 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLN . . . . . 1.046 ' HB2' ' HB2' ' B' ' 48' ' ' LYS . 1.3 mp0 -79.28 162.96 25.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.516 ' HB ' HD21 ' B' ' 33' ' ' LEU . 18.6 p -119.15 -84.91 0.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.503 0.927 . . . . 10.0 113.503 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -62.67 101.74 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.411 0.893 . . . . 10.0 113.411 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.51 ' HB3' ' HD3' ' B' ' 48' ' ' LYS . 0.7 OUTLIER 178.05 87.74 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 O-C-N 123.709 0.631 . . . . 10.0 110.468 178.578 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -103.33 -5.08 23.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.987 0.422 . . . . 10.0 111.444 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.36 -30.14 37.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.136 -0.483 . . . . 10.0 112.099 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.84 -8.67 45.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pp -111.86 13.38 20.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.122 0.487 . . . . 10.0 111.245 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.637 -0.696 . . . . 10.0 110.412 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 101' ' ' FES . . . . . 0.419 ' S1 ' ' HA ' ' B' ' 35' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.998 -0.371 . . . . 10.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.25 154.17 35.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.594 -0.521 . . . . 10.0 109.594 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -62.86 -22.96 67.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.88 0.371 . . . . 10.0 111.698 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.62 -45.45 50.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.882 -0.785 . . . . 10.0 108.882 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -63.93 -32.62 74.22 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.697 -0.683 . . . . 10.0 109.772 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.554 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 60.2 mt-30 -61.87 -19.1 62.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.414 -0.812 . . . . 10.0 111.059 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -98.76 -47.43 5.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.016 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 35' ' ' LEU . 96.0 mt -59.71 -26.7 65.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.994 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.78 -50.43 73.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.728 0.299 . . . . 10.0 111.001 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -75.7 -26.09 57.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.728 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.521 HD12 HD23 ' A' ' 32' ' ' LEU . 62.4 mt -70.32 -30.79 67.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.847 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.42 -25.45 61.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.289 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -70.66 130.24 89.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.22 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.17 153.88 15.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 123.125 2.55 . . . . 10.0 112.086 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -63.05 -25.21 68.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.136 0.493 . . . . 10.0 110.423 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -101.51 15.95 27.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.381 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.842 ' HB3' ' HB2' ' A' ' 44' ' ' ARG . 15.8 t70 -69.36 136.39 88.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.278 -0.268 . . . . 10.0 110.278 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.96 -24.49 73.31 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.962 2.442 . . . . 10.0 113.033 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.32 10.85 23.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.957 0.408 . . . . 10.0 110.983 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.842 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 7.4 tpt180 -72.28 137.55 46.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.032 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -118.72 173.81 6.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.579 -0.737 . . . . 10.0 109.233 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.4 111.06 21.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 t -99.56 104.27 15.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.224 0.535 . . . . 10.0 111.091 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.2 m -96.87 141.05 30.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.352 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 14.5 p -128.56 139.31 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.705 0.288 . . . . 10.0 111.567 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 12.8 pt20 -120.78 125.31 47.25 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.778 -0.453 . . . . 10.0 109.778 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.584 HG11 HD21 ' A' ' 75' ' ' LEU . 14.1 t -111.3 143.81 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.346 -0.388 . . . . 10.0 111.183 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.7 145.82 31.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.544 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.86 -30.17 84.4 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.003 2.469 . . . . 10.0 112.433 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.08 -23.37 65.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.94 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.708 HG13 HG23 ' A' ' 214' ' ' THR . 86.8 t -81.13 -38.56 16.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.624 -0.51 . . . . 10.0 109.624 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -59.46 -29.6 67.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.835 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -85.58 -33.7 7.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.508 0.558 . . . . 10.0 112.508 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 388' ' ' PRO . . . -91.74 -17.1 25.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.117 0.784 . . . . 10.0 113.117 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.52 -20.84 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 10.0 111.381 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' A' ' 65' ' ' LEU . . . -70.26 -37.69 74.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.684 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 399' ' ' ARG . 32.4 mt-10 -64.15 -29.76 70.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.523 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.415 HG21 ' HA3' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -69.03 -15.63 63.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 10.0 110.858 179.329 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 mt -109.17 -5.56 15.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.149 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.39 27.4 22.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.908 -0.663 . . . . 10.0 112.23 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.508 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 mt -112.95 164.24 13.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.6 0.238 . . . . 10.0 110.492 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -69.96 140.9 88.93 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.731 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 66' ' ' ALA . 51.5 Cg_exo -55.44 118.82 5.62 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.881 2.387 . . . . 10.0 112.127 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.94 0.0 55.05 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.6 -0.809 . . . . 10.0 113.279 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.79 -38.11 73.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 10.0 111.051 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.11 131.34 41.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.716 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -83.52 157.1 65.08 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.598 0.237 . . . . 10.0 110.403 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.4 -35.26 91.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.225 1.95 . . . . 10.0 111.345 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.505 ' HB2' ' OE1' ' A' ' 233' ' ' GLU . 31.4 mmtp -71.8 -36.96 70.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.946 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -61.27 -42.3 98.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.091 0.472 . . . . 10.0 110.529 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.584 HD21 HG11 ' A' ' 51' ' ' VAL . 45.0 tp -63.84 -46.45 84.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.588 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.32 95.42 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.835 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -61.75 -42.7 99.32 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.817 -0.629 . . . . 10.0 110.367 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -44.34 91.22 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.964 -0.636 . . . . 10.0 112.003 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD11 HG21 ' A' ' 51' ' ' VAL . 16.3 mt -61.77 -40.49 95.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 10.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -62.94 -31.01 72.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.763 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -81.51 -8.73 59.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 10.0 111.803 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.0 mt -79.16 -9.3 59.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.022 0.439 . . . . 10.0 110.761 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.85 -0.43 28.77 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.691 -0.766 . . . . 10.0 112.354 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.75 159.58 27.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 10.0 110.971 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -101.7 -59.4 1.71 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.859 0.362 . . . . 10.0 110.995 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -115.97 125.06 52.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.827 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.3 t -105.48 108.79 25.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.283 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 30.1 m-85 -110.76 168.76 9.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.923 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.43 155.8 27.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.822 -0.626 . . . . 10.0 110.058 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 m -76.64 -21.79 55.0 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.98 0.733 . . . . 10.0 112.98 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.433 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . 44.9 mt -61.43 -37.46 83.58 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.317 -0.239 . . . . 10.0 111.069 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' HZ ' ' HG2' ' A' ' 240' ' ' MET . 43.5 t80 -61.01 -38.37 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.232 0.539 . . . . 10.0 109.598 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.66 -35.26 55.51 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.776 -0.93 . . . . 10.0 110.776 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.11 77.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.696 0.284 . . . . 10.0 110.379 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.33 -35.48 73.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 10.0 109.662 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.42 -42.39 65.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.531 -0.759 . . . . 10.0 109.594 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.6 m -60.51 -42.43 96.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.617 -0.72 . . . . 10.0 110.622 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.9 mt -59.98 -39.95 81.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.771 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.8 mmm -65.92 -51.73 56.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.976 -0.557 . . . . 10.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -65.55 -45.44 83.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.873 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 101' ' ' GLU . 1.8 tp10 -61.52 -43.55 98.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 10.0 110.929 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.05 95.29 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 110.981 -0.848 . . . . 10.0 110.981 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.573 ' HB2' HD13 ' A' ' 433' ' ' LEU . 19.7 m -69.27 -43.64 73.51 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.614 -0.293 . . . . 10.0 110.497 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.426 ' HG2' HD21 ' A' ' 433' ' ' LEU . 0.0 OUTLIER -60.18 -47.02 87.69 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.802 -0.444 . . . . 10.0 109.802 178.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.415 ' CD2' HD23 ' A' ' 261' ' ' LEU . 23.3 tp -59.16 -54.68 44.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.726 -0.67 . . . . 10.0 111.059 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.0 tp -59.35 -39.17 82.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.907 0.384 . . . . 10.0 110.593 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.605 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 53.9 t60 -61.86 -53.09 60.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.526 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.593 ' HG2' ' HB2' ' A' ' 121' ' ' GLU . 68.2 mtt180 -59.72 -38.66 82.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.715 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 41.7 tp -67.21 -50.86 59.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.842 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.5 m -58.14 -44.95 88.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.912 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 23.1 mm-40 -57.95 -31.19 66.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.948 0.404 . . . . 10.0 111.573 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -79.65 -37.28 36.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 65.3 mt -69.31 -32.48 71.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.984 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.534 ' HG2' HD22 ' A' ' 305' ' ' LEU . 22.7 mt-10 -79.54 -7.16 58.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.284 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.139 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.356 -179.91 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 108' ' ' ARG . 1.5 pm0 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.862 0.363 . . . . 10.0 110.891 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -90.09 -172.07 0.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.988 2.458 . . . . 10.0 112.801 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.423 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 91.1 mt -133.93 157.38 77.87 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.486 -0.931 . . . . 10.0 108.486 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.458 ' HB3' ' O ' ' A' ' 369' ' ' TYR . 37.5 Cg_endo -64.92 167.46 45.46 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 124.513 -1.036 . . . . 10.0 113.802 0.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 24.6 ttt -113.92 134.08 55.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.739 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.611 ' HD1' ' HB ' ' A' ' 372' ' ' VAL . 33.3 m-85 -110.8 144.6 39.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.21 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.439 HG23 ' HZ ' ' A' ' 371' ' ' PHE . 0.0 OUTLIER -81.87 156.09 25.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.885 0.328 . . . . 10.0 111.885 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 m -111.63 54.18 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.262 0.553 . . . . 10.0 110.285 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.2 p -90.58 -39.51 12.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 10.0 112.086 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.781 ' SG ' ' HA ' ' A' ' 375' ' ' MET . 36.5 m -105.38 117.87 57.14 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.809 ' HG3' ' HE3' ' A' ' 188' ' ' LYS . 36.5 Cg_endo -64.46 -29.48 62.17 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.015 2.477 . . . . 10.0 111.743 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.21 -39.94 98.5 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.785 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -36.88 69.79 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 45.7 mm -62.92 -44.87 99.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.844 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.16 92.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.584 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 58.5 ttp -68.87 -34.73 75.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 10.0 109.773 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 tp -64.2 -54.45 33.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.754 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -59.8 -24.95 64.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.852 0.686 . . . . 10.0 112.852 -178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.64 -52.67 4.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.218 0.822 . . . . 10.0 113.218 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 m -84.24 -44.18 14.15 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 114.902 1.445 . . . . 10.0 114.902 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -131.7 73.25 79.3 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.9 -12.43 34.41 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.406 2.071 . . . . 10.0 111.82 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.94 -16.14 61.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.127 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.569 ' HA ' ' HD2' ' A' ' 147' ' ' TYR . 69.2 mt -98.97 9.52 43.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.567 HG23 ' HD2' ' A' ' 445' ' ' TYR . 52.4 mt -55.93 -52.46 72.28 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 33.4 Cg_exo -61.46 -23.28 76.43 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.338 2.025 . . . . 10.0 112.9 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.569 ' HD2' ' HA ' ' A' ' 144' ' ' LEU . 98.7 m-85 -75.78 -19.57 58.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.0 0.429 . . . . 10.0 111.047 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.2 t -86.99 159.13 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.786 -0.449 . . . . 10.0 109.786 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.522 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . 31.5 t -69.4 167.62 16.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.991 0.424 . . . . 10.0 110.778 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.4 p -106.56 6.81 30.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.349 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.52 179.42 7.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 10.0 112.124 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 156' ' ' MET . 40.8 mtpt -122.25 169.79 10.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.3 p -68.53 152.56 96.56 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 121.049 -0.26 . . . . 10.0 110.471 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.66 -46.72 23.14 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.265 2.643 . . . . 10.0 112.974 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -35.7 80.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.803 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.463 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 60.1 mmm -74.52 -19.11 60.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.137 0.494 . . . . 10.0 110.833 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 30.9 mtt -80.66 -48.25 12.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.302 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.91 -42.26 99.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.59 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.68 81.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.64 61.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.812 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -72.69 -44.56 61.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.682 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.9 m -69.49 -28.68 38.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 179' ' ' MET . 27.5 mttt -85.73 2.6 44.8 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.824 0.305 . . . . 10.0 111.824 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 168' ' ' GLU . 13.5 p -122.82 -79.62 0.62 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.608 -0.269 . . . . 10.0 110.74 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.577 ' HE2' ' HA ' ' A' ' 240' ' ' MET . 33.8 t80 -55.58 -53.19 59.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.964 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.714 HD11 ' HE3' ' A' ' 170' ' ' LYS . 24.3 tp -61.94 -41.11 97.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 10.0 111.277 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.27 -50.18 74.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.202 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 164' ' ' SER . 41.6 mt-10 -68.41 -37.2 80.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.363 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -64.93 -49.08 71.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.247 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.714 ' HE3' HD11 ' A' ' 166' ' ' LEU . 91.2 mttt -76.88 -15.08 59.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.136 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 73.71 37.2 52.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.765 -0.731 . . . . 10.0 111.647 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.96 135.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.99 133.9 91.89 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.48 -0.327 . . . . 10.0 110.488 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.419 ' HB2' HD13 ' A' ' 205' ' ' LEU . 32.0 Cg_exo -59.55 -16.76 37.85 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.911 2.407 . . . . 10.0 112.399 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -71.94 -22.42 61.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.747 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -107.51 23.88 13.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.236 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 96.0 mtp -125.9 115.21 19.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.127 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.55 131.88 51.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.43 ' HB2' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -112.4 119.87 39.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.149 0.5 . . . . 10.0 111.225 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 46.4 t -116.46 135.82 55.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.7 p -124.46 135.85 53.56 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.803 0.297 . . . . 10.0 111.803 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 212' ' ' ILE . 30.3 mm -99.93 103.11 14.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 213' ' ' THR . 32.4 mmt -114.26 148.43 40.09 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.944 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 183' ' ' MET . 2.5 Cg_endo -83.19 19.31 1.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.283 2.655 . . . . 10.0 112.665 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 73.1 m -145.93 129.17 16.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.05 0.453 . . . . 10.0 111.227 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -28.1 67.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.602 -0.726 . . . . 10.0 111.174 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.516 HH22 ' HA ' ' B' ' 44' ' ' SER . 8.7 mtm180 -80.7 17.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.075 -0.511 . . . . 10.0 112.029 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.809 ' HE3' ' HG3' ' A' ' 131' ' ' PRO . 0.0 OUTLIER -87.87 -33.88 18.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.657 0.265 . . . . 10.0 111.349 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -65.01 -30.64 71.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.915 0.388 . . . . 10.0 110.171 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.81 -25.58 66.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.661 -0.699 . . . . 10.0 111.9 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 131' ' ' PRO . 31.1 tt0 -76.25 -46.9 25.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -73.5 -5.91 43.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.564 -0.744 . . . . 10.0 111.16 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.36 -18.85 57.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.517 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.468 HH11 ' HZ2' ' A' ' 196' ' ' TRP . 78.0 mtt-85 -59.02 118.16 5.5 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.744 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -41.79 -47.99 4.22 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.709 1.374 . . . . 10.0 114.709 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' TRP . . . . . 0.468 ' HZ2' HH11 ' A' ' 194' ' ' ARG . 43.9 p90 -62.27 -9.59 8.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.998 1.481 . . . . 10.0 114.998 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -85.74 56.3 3.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.577 0.703 . . . . 10.0 110.811 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -110.07 171.07 7.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.384 -0.825 . . . . 10.0 110.375 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.59 80.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.688 0.28 . . . . 10.0 110.65 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.3 t0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.116 -0.945 . . . . 10.0 112.17 179.596 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.876 0.369 . . . . 10.0 111.102 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.788 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.229 -0.004 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -94.27 148.82 21.83 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.956 0.16 . . . . 10.0 110.799 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -70.36 -38.62 74.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.166 -1.049 . . . . 10.0 108.166 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 29.8 tp -131.85 121.45 24.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.601 -1.629 . . . . 10.0 106.601 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.98 -44.68 7.24 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.891 1.071 . . . . 10.0 113.891 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 8.7 m-70 -130.36 141.88 50.55 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.987 0.736 . . . . 10.0 112.987 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.72 123.78 60.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.652 -0.869 . . . . 10.0 108.652 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 71.7 mt -119.78 140.05 45.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 183' ' ' MET . 41.1 p -90.23 166.95 13.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.052 0.453 . . . . 10.0 111.96 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.708 HG23 HG13 ' A' ' 55' ' ' VAL . 2.5 m -56.09 -46.71 78.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.476 -0.784 . . . . 10.0 111.773 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.8 m -61.26 -39.79 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.427 ' O ' HG13 ' A' ' 220' ' ' ILE . 41.9 mt-10 -68.7 -46.96 67.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.795 0.331 . . . . 10.0 110.638 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 31.1 tp -62.25 -43.07 99.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.34 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.415 ' HA3' HG21 ' A' ' 62' ' ' THR . . . -60.08 -36.27 89.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.186 -0.531 . . . . 10.0 112.252 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -38.87 80.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.571 0.224 . . . . 10.0 110.462 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 216' ' ' GLU . 79.7 mt -59.1 -45.3 92.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.18 -0.464 . . . . 10.0 110.08 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -59.77 -45.86 90.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.861 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.28 -46.81 82.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.787 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.92 -30.97 71.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 10.0 111.942 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -80.93 -12.7 59.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.926 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.78 30.51 47.74 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.914 -0.66 . . . . 10.0 111.868 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.6 mt -113.21 114.72 47.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.953 0.406 . . . . 10.0 110.532 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.454 ' O ' ' HG ' ' A' ' 231' ' ' LEU . 54.8 t30 -104.07 122.14 44.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.317 -0.401 . . . . 10.0 110.035 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.524 ' HA ' HD12 ' A' ' 231' ' ' LEU . 76.2 mt -60.4 -32.6 71.48 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.316 0.385 . . . . 10.0 111.735 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.04 -16.95 63.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.737 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.43 3.03 34.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 10.0 110.694 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 228' ' ' LEU . 95.9 mt -96.65 151.03 37.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.327 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.18 -179.89 5.62 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.593 2.195 . . . . 10.0 111.123 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.505 ' OE1' ' HB2' ' A' ' 73' ' ' LYS . 2.8 mm-40 -80.55 103.45 10.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.739 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -80.83 -152.62 8.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.017 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -150.98 157.86 43.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.867 0.333 . . . . 10.0 111.061 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -98.54 166.29 11.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.837 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -106.32 152.39 23.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -98.48 121.53 56.36 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.826 0.346 . . . . 10.0 110.944 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.82 -16.62 56.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.169 2.579 . . . . 10.0 112.079 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.577 ' HA ' ' HE2' ' A' ' 165' ' ' TYR . 85.5 mmm -81.15 -10.13 59.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.964 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 105.5 -66.34 0.27 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.029 -0.605 . . . . 10.0 112.043 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 17.0 m -104.69 165.2 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.573 0.225 . . . . 10.0 110.939 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 103.05 118.23 4.44 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.923 -0.656 . . . . 10.0 112.147 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.9 m -64.25 133.86 53.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.047 0.451 . . . . 10.0 111.605 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.02 -167.84 18.64 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.405 -0.678 . . . . 10.0 111.405 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.61 -8.66 58.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.929 0.395 . . . . 10.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 91.8 -1.87 75.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 10.0 112.311 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.63 129.31 39.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.833 -0.432 . . . . 10.0 109.833 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.64 ' HB2' ' HD3' ' A' ' 413' ' ' ARG . 63.5 mt -73.35 144.16 46.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.493 -0.322 . . . . 10.0 110.93 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.557 ' CE1' ' HG2' ' A' ' 408' ' ' GLU . 71.7 t80 -59.37 128.32 36.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.921 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 413' ' ' ARG . . . 128.71 150.27 7.15 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.867 -0.682 . . . . 10.0 111.758 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 8.3 t -92.38 145.1 24.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.883 0.373 . . . . 10.0 110.732 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -9.3 53.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.115 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 89.64 -11.73 69.27 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.955 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.53 165.11 12.35 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.199 -0.76 . . . . 10.0 111.199 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 29.2 t -58.49 -60.73 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.767 0.283 . . . . 10.0 111.22 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' MET . . . . . 0.51 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 25.6 ttp -51.89 -56.05 16.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 10.0 112.155 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -57.86 -49.9 75.12 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.005 0.743 . . . . 10.0 113.005 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.94 85.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.101 0.408 . . . . 10.0 112.101 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.62 76.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.062 0.458 . . . . 10.0 110.136 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.415 HD23 ' CD2' ' A' ' 105' ' ' LEU . 50.4 mt -63.83 -41.42 97.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.085 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.51 ' O ' ' HG3' ' A' ' 266' ' ' GLU . 46.0 ttm105 -59.04 -50.08 75.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.689 -0.687 . . . . 10.0 111.362 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 60.9 m -55.38 -40.74 71.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.613 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.67 -41.76 65.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.924 0.392 . . . . 10.0 110.737 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -63.76 -47.64 80.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 10.0 112.055 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 272' ' ' PRO . 46.2 mt-10 -66.75 -7.77 23.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.929 0.715 . . . . 10.0 112.929 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 80.7 mt -108.58 -41.09 4.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.003 0.43 . . . . 10.0 110.47 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -71.27 -40.28 71.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 21.1 p -102.65 -18.54 15.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.968 -0.56 . . . . 10.0 111.874 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.01 -35.61 2.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.487 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.34 145.45 82.78 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 110.327 -0.249 . . . . 10.0 110.327 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.511 ' HA ' ' HG2' ' A' ' 266' ' ' GLU . 62.5 Cg_endo -73.56 155.87 49.85 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.443 2.096 . . . . 10.0 112.354 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.511 HD12 ' HD2' ' A' ' 274' ' ' PRO . 28.1 tp -115.41 125.31 28.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.945 -0.57 . . . . 10.0 110.32 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.511 ' HD2' HD12 ' A' ' 273' ' ' LEU . 80.7 Cg_endo -77.46 -157.9 0.08 OUTLIER 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.701 2.267 . . . . 10.0 111.591 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -78.53 134.27 37.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.662 -0.496 . . . . 10.0 109.662 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.99 131.62 36.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.057 0.456 . . . . 10.0 111.785 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 1.2 m -103.51 101.43 11.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.78 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.464 HD13 ' HB ' ' A' ' 290' ' ' THR . 3.8 mm? -72.29 132.54 44.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.672 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 26.1 m -106.65 142.07 36.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.85 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -73.37 141.08 47.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.806 0.336 . . . . 10.0 111.13 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 66.8 t -98.88 108.11 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.042 -0.526 . . . . 10.0 109.618 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 77.3 mtm-85 -63.94 133.13 52.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.841 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 114.46 -31.12 6.57 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.776 -0.93 . . . . 10.0 110.776 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 59.5 mtm -132.67 89.02 2.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.77 103.58 0.27 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.606 -0.725 . . . . 10.0 112.034 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' GLY . . . . . 0.559 ' HA3' ' ND2' ' A' ' 354' ' ' ASN . . . 132.59 -19.08 4.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.527 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 42.5 mm -92.94 131.79 39.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -123.8 160.69 26.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.384 -0.598 . . . . 10.0 109.384 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.83 165.6 30.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.022 0.439 . . . . 10.0 111.397 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.464 ' HB ' HD13 ' A' ' 278' ' ' LEU . 14.5 t -157.29 145.54 19.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.123 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -113.79 124.13 51.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.686 0.279 . . . . 10.0 110.861 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 31.2 mt -112.84 105.15 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.593 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 3.9 p -72.4 100.69 2.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.416 . . . . 10.0 110.121 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 78.6 mtp -90.54 104.15 16.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.184 0.516 . . . . 10.0 111.952 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 25.6 t -102.1 111.77 64.66 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.592 -0.892 . . . . 10.0 108.592 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.64 142.14 32.44 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.287 2.658 . . . . 10.0 113.641 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . . . -71.16 134.71 85.06 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.256 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 297' ' ' ALA . 36.8 Cg_exo -62.25 120.58 8.21 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.474 2.116 . . . . 10.0 111.913 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 94.48 20.14 30.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.012 -0.613 . . . . 10.0 113.084 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 90.3 p -110.61 163.8 13.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.91 -0.404 . . . . 10.0 109.91 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.638 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 28.1 pttt -71.05 -27.41 63.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.028 -0.73 . . . . 10.0 109.028 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -64.27 -41.53 96.87 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.875 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -64.3 -40.62 96.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.665 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -70.4 -25.8 63.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.506 -0.77 . . . . 10.0 112.27 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 67.5 mt -57.5 -57.33 13.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.707 0.289 . . . . 10.0 111.325 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.48 -10.64 59.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 10.0 111.341 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -89.21 -36.61 15.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.485 . . . . 10.0 110.488 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.1 -30.64 25.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.108 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -142.02 117.84 10.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.095 0.474 . . . . 10.0 111.163 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -109.09 1.08 20.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.214 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.964 -1.017 . . . . 10.0 109.262 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.824 -0.51 . . . . 10.0 111.824 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.84 -27.58 67.45 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.753 2.302 . . . . 10.0 112.014 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 89.8 mt -115.53 93.51 4.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.287 0.565 . . . . 10.0 110.239 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -79.76 111.82 16.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.509 -0.769 . . . . 10.0 110.548 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -65.1 136.84 57.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.116 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -83.83 -7.2 59.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.547 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 105.38 -7.21 42.98 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.8 -0.714 . . . . 10.0 111.728 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 91.61 156.78 33.06 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.659 -0.782 . . . . 10.0 111.51 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 343' ' ' THR . . . -91.31 86.94 6.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.115 0.484 . . . . 10.0 110.077 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -88.4 157.39 27.83 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.707 -0.759 . . . . 10.0 112.664 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -135.67 152.26 51.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.141 -0.318 . . . . 10.0 110.141 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 55.9 m -155.41 126.14 6.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.601 0.238 . . . . 10.0 110.502 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.35 165.89 14.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.449 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -63.9 -14.73 55.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.62 0.6 . . . . 10.0 112.62 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.9 -11.57 59.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.424 -0.353 . . . . 10.0 111.898 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 105.23 -0.71 40.62 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.476 -0.869 . . . . 10.0 113.986 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 334' ' ' THR . 23.3 mtm180 -77.78 122.92 26.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.476 0.638 . . . . 10.0 110.905 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -118.04 139.33 14.62 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -152.98 -176.78 25.88 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.729 -0.948 . . . . 10.0 110.729 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.59 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 15.1 tt -144.32 139.67 24.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 117.096 0.448 . . . . 10.0 110.724 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 331' ' ' ALA . 11.7 t -99.73 120.99 40.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.211 0.529 . . . . 10.0 110.179 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 14.6 tp -79.28 122.78 26.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.893 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -93.01 102.39 14.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.914 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 31.7 t -103.0 137.1 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.439 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -128.89 149.14 50.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.378 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.5 124.3 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.125 -0.488 . . . . 10.0 109.953 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -108.78 119.46 39.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.2 -0.454 . . . . 10.0 110.103 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.5 106.65 16.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.126 0.488 . . . . 10.0 111.333 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 109.7 133.46 6.65 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.014 -0.613 . . . . 10.0 112.14 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.82 -36.92 80.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 10.0 110.875 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' B' ' 60' ' ' SER . . . -68.12 -28.14 73.46 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.219 -0.752 . . . . 10.0 111.219 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.612 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 1.3 m-20 -80.91 -37.11 30.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.67 94.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.9 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -57.45 -46.52 83.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.119 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 10.5 mtmm -64.01 -47.24 81.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.687 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.8 tp -61.74 -50.31 72.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 10.0 111.797 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 90.9 mt -55.76 -42.28 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.588 -0.278 . . . . 10.0 111.37 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 12.0 m -61.37 -43.22 99.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.982 0.42 . . . . 10.0 110.54 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -70.57 -29.19 65.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.198 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 75.4 mtp -69.91 -40.85 75.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.075 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -66.7 -26.98 67.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.045 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.19 -9.55 59.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.764 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 87.09 9.22 74.0 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.054 -0.593 . . . . 10.0 112.801 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.66 -50.9 14.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.846 0.355 . . . . 10.0 110.645 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -98.46 100.79 12.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.777 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -97.69 109.53 22.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.155 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 82.1 m-85 -136.99 159.79 40.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.999 -0.371 . . . . 10.0 109.999 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -103.43 -34.59 8.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.038 0.447 . . . . 10.0 111.547 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.51 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 45.0 t80 -132.16 129.11 39.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.611 ' HB ' ' HD1' ' A' ' 126' ' ' PHE . 43.6 t -129.67 119.03 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.813 0.671 . . . . 10.0 112.813 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 257' ' ' MET . 5.2 tp10 -91.59 113.86 26.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.77 -1.196 . . . . 10.0 107.77 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 58.2 mt -109.27 118.16 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.257 0.551 . . . . 10.0 112.325 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' MET . . . . . 0.781 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 62.0 mtt -111.82 142.22 44.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.623 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -81.05 -28.03 35.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.196 0.522 . . . . 10.0 110.925 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.57 158.58 36.51 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.472 -0.786 . . . . 10.0 110.156 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.438 ' HG3' ' SG ' ' B' ' 42' ' ' CYS . 42.5 Cg_endo -91.21 12.84 2.22 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.357 2.704 . . . . 10.0 112.596 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.4 ' HB3' ' HA3' ' A' ' 383' ' ' GLY . . . -156.56 41.21 0.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.305 -0.407 . . . . 10.0 111.115 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 65.85 -127.48 30.77 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.461 -0.876 . . . . 10.0 112.359 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' CYS . . . . . 0.509 ' HA ' ' S2 ' ' A' ' 501' ' ' SF4 . 3.4 m -95.33 -25.84 16.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.15 0.426 . . . . 10.0 112.15 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 33.2 m -70.0 -17.5 21.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 111.952 0.352 . . . . 10.0 111.952 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 379' ' ' ALA . . . -109.33 34.92 5.22 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.035 -0.53 . . . . 10.0 112.377 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -80.63 162.99 45.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.762 -0.732 . . . . 10.0 112.206 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -72.69 -12.95 78.29 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.034 -0.603 . . . . 10.0 113.18 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -91.76 2.48 76.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.626 -0.797 . . . . 10.0 111.788 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -92.09 153.46 43.24 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 58' ' ' ALA . 31.3 Cg_exo -64.09 172.15 6.6 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.618 2.212 . . . . 10.0 111.239 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 109.65 8.1 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 28.3 m -87.6 -177.27 5.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.097 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' THR . . . . . 0.443 ' HA ' ' OH ' ' B' ' 35' ' ' TYR . 0.0 OUTLIER -86.19 44.27 1.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.341 0.591 . . . . 10.0 111.172 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -144.28 120.88 11.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.893 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' LYS . . . . . 0.493 ' HB3' ' O ' ' B' ' 36' ' ' SER . 21.1 mttm -71.68 -13.81 61.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.325 -0.398 . . . . 10.0 111.93 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -115.77 27.39 9.33 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.984 0.421 . . . . 10.0 111.06 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.579 HD12 ' HD2' ' A' ' 398' ' ' LYS . 9.5 tp -68.76 -21.91 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.332 0.587 . . . . 10.0 110.353 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -42.53 99.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.475 -0.784 . . . . 10.0 111.111 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -62.79 -39.59 94.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.704 -0.68 . . . . 10.0 111.113 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.579 ' HD2' HD12 ' A' ' 395' ' ' ILE . 52.7 mttp -64.14 -39.0 93.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.075 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 61' ' ' GLU . 98.8 mtt180 -68.1 -39.35 82.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.27 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -63.19 -41.91 99.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.867 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -71.45 -27.78 63.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.413 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -96.88 14.9 23.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.828 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.6 mt -64.56 -40.17 95.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.989 0.423 . . . . 10.0 110.738 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -133.78 158.64 42.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.787 -0.642 . . . . 10.0 109.439 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -79.0 165.49 23.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' LEU . . . . . 0.491 HD13 ' HD2' ' A' ' 409' ' ' LYS . 3.9 mm? -61.02 -34.08 74.29 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.889 0.7 . . . . 10.0 112.889 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -74.09 -28.11 61.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.956 0.408 . . . . 10.0 111.256 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' GLU . . . . . 0.557 ' HG2' ' CE1' ' A' ' 250' ' ' PHE . 36.2 mt-10 -77.44 -32.62 54.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.709 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' LYS . . . . . 0.491 ' HD2' HD13 ' A' ' 406' ' ' LEU . 90.4 mttt -66.29 -35.22 79.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 10.0 111.79 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.3 6.83 21.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.029 0.443 . . . . 10.0 111.767 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 23.6 m -118.87 93.94 4.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.98 0.419 . . . . 10.0 110.683 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 30.1 tp -77.66 111.77 13.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.547 -0.538 . . . . 10.0 109.547 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ARG . . . . . 0.64 ' HD3' ' HB2' ' A' ' 249' ' ' LEU . 5.2 tmm_? -107.76 148.41 29.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.125 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -116.63 137.0 52.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.508 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 4.6 m -69.05 -30.88 69.33 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.041 0.386 . . . . 10.0 112.041 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -69.28 -1.74 8.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -118.28 14.25 13.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.932 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' ASN . . . . . 0.402 ' HA ' HD11 ' A' ' 249' ' ' LEU . 55.3 t-20 -88.5 113.95 57.65 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.555 ' HD3' HD11 ' A' ' 249' ' ' LEU . 51.1 Cg_exo -54.97 -39.94 88.22 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.18 2.586 . . . . 10.0 112.53 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.6 m -61.28 -42.91 99.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.112 0.482 . . . . 10.0 110.564 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 49.7 mm -72.16 -40.51 66.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.881 -0.599 . . . . 10.0 110.171 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.5 -44.82 95.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.475 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -60.79 -45.19 95.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 10.0 110.618 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.447 ' HB2' ' SD ' ' A' ' 240' ' ' MET . 45.2 tp -64.63 -41.19 96.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.882 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' TYR . . . . . 0.657 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 1.2 m-85 -68.13 -33.64 74.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.024 -0.534 . . . . 10.0 110.967 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.66 -61.18 2.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.566 0.95 . . . . 10.0 113.566 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.52 16.99 5.76 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.842 1.423 . . . . 10.0 114.842 -176.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -150.73 -63.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.243 0.831 . . . . 10.0 113.243 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.657 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 96.2 mt -67.37 -36.5 81.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.853 0.686 . . . . 10.0 112.853 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 97.47 -68.12 0.79 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.892 -0.67 . . . . 10.0 111.853 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -161.31 157.47 21.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.767 -0.457 . . . . 10.0 109.767 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.412 ' HA ' ' HE1' ' A' ' 425' ' ' TYR . 52.1 Cg_exo -58.28 132.36 48.43 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.582 2.188 . . . . 10.0 110.915 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' A' ' 103' ' ' SER . 4.6 mp 66.63 9.63 6.78 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.986 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 438' ' ' HIS . . . -70.21 -170.68 8.79 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.32 -0.467 . . . . 10.0 112.865 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -55.28 -62.33 1.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.381 0.511 . . . . 10.0 112.381 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.43 ' HD2' ' HA ' ' A' ' 436' ' ' LYS . 31.3 tptt -60.43 -38.34 83.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.906 0.384 . . . . 10.0 111.83 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -66.69 -46.09 76.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.084 0.469 . . . . 10.0 111.006 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 434' ' ' GLY . 0.1 OUTLIER -70.14 -20.4 63.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.944 0.402 . . . . 10.0 110.976 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -76.07 -65.34 0.93 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.954 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 81.5 mt -92.81 -24.7 18.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.488 1.292 . . . . 10.0 114.488 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 68.3 mt -93.0 -6.14 49.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 438' ' ' HIS . 26.0 m-70 -121.71 165.06 16.36 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.27 -0.269 . . . . 10.0 110.949 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 7.5 t -152.15 -168.95 3.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.641 0.258 . . . . 10.0 111.596 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -139.72 161.48 37.43 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.375 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' TYR . . . . . 0.567 ' HD2' HG23 ' A' ' 145' ' ' ILE . 37.9 m-85 -110.58 168.88 9.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.695 -0.229 . . . . 10.0 111.029 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.08 113.3 36.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 10.0 111.013 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -66.18 105.86 1.5 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.482 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 131.51 -20.41 4.66 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.28 -0.728 . . . . 10.0 111.28 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . 108.12 167.56 21.38 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.844 -0.693 . . . . 10.0 112.069 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.628 -0.701 . . . . 10.0 110.65 -179.958 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.693 ' HE1' ' HB2' ' B' ' 18' ' ' ALA . 86.0 m-85 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.016 -0.364 . . . . 10.0 110.016 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -88.65 116.03 26.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.86 -0.422 . . . . 10.0 109.86 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.48 124.93 69.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.218 0.532 . . . . 10.0 111.435 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' B' ' 13' ' ' THR . 26.8 m -91.18 113.03 25.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.283 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' B' ' 11' ' ' ASP . 64.5 mt -90.14 132.56 35.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.184 -0.462 . . . . 10.0 109.986 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.757 ' HD2' ' HB3' ' B' ' 11' ' ' ASP . 3.6 tptp -100.54 108.33 20.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.438 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.0 p -115.18 164.81 15.77 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.02 -29.21 87.42 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.346 2.031 . . . . 10.0 111.752 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -76.5 -34.81 58.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.387 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.89 171.72 25.07 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.364 -0.695 . . . . 10.0 111.364 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.757 ' HB3' ' HD2' ' B' ' 6' ' ' LYS . 4.0 p30 -94.36 152.49 18.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.94 0.37 . . . . 10.0 111.032 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -147.14 124.13 11.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.669 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 19.2 m -88.23 99.91 12.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.093 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 21.0 pt -101.25 171.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -112.81 117.8 33.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.124 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' CYS . . . . . 0.489 ' HA ' ' HD3' ' B' ' 17' ' ' PRO . 31.6 m -127.08 128.91 24.07 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.91 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.75 ' HD2' ' HB ' ' B' ' 20' ' ' THR . 15.8 Cg_exo -71.8 165.76 31.57 Favored 'Trans proline' 0 CA--C 1.529 0.275 0 C-N-CA 123.059 2.506 . . . . 10.0 110.99 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.693 ' HB2' ' HE1' ' B' ' 1' ' ' TYR . . . -74.52 -16.55 60.83 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.478 0.547 . . . . 10.0 112.478 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -107.52 15.2 25.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.063 0.459 . . . . 10.0 111.301 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.75 ' HB ' ' HD2' ' B' ' 17' ' ' PRO . 5.0 m -129.78 141.92 50.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.486 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -66.53 138.95 57.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.617 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 26.4 mt -56.07 -43.28 75.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 10.0 111.593 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.585 HD11 ' HG2' ' B' ' 38' ' ' ARG . 1.0 OUTLIER -67.06 -21.62 65.89 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -179.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -69.44 -27.23 65.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.208 0.528 . . . . 10.0 110.982 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.86 -25.61 22.07 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.373 -0.603 . . . . 10.0 109.373 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.32 -43.25 74.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.668 -0.696 . . . . 10.0 110.488 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.61 -33.07 75.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.331 0.586 . . . . 10.0 110.121 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -71.98 -37.32 69.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.446 -0.797 . . . . 10.0 110.249 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.48 -34.77 60.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.958 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.61 40.55 1.32 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.075 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.18 144.3 33.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.645 0.259 . . . . 10.0 110.707 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.57 118.78 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.854 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.444 HD23 ' HD2' ' B' ' 34' ' ' PRO . 0.5 OUTLIER -163.96 127.41 1.76 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.335 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.444 ' HD2' HD23 ' B' ' 33' ' ' LEU . 7.0 Cg_exo -74.62 96.79 1.0 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.781 2.321 . . . . 10.0 111.383 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.443 ' OH ' ' HA ' ' A' ' 391' ' ' THR . 43.5 p90 -118.23 156.15 29.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.357 -0.383 . . . . 10.0 110.897 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.493 ' O ' ' HB3' ' A' ' 393' ' ' LYS . 5.0 p -166.45 -88.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.638 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' CYS . . . . . . . . . . . . . 4.1 p -79.32 -56.65 4.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.924 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.585 ' HG2' HD11 ' B' ' 23' ' ' LEU . 0.0 OUTLIER 66.32 39.43 4.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.877 -0.602 . . . . 10.0 111.218 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.05 17.29 23.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.486 . . . . 10.0 111.624 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.92 46.06 54.31 Favored Glycine 0 C--O 1.238 0.361 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.277 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.96 -66.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.372 . . . . 10.0 111.31 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' CYS . . . . . 0.438 ' SG ' ' HG3' ' A' ' 378' ' ' PRO . 3.7 p -83.06 139.49 33.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.909 0.385 . . . . 10.0 111.429 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.626 ' HA ' HD11 ' B' ' 73' ' ' LEU . 0.7 OUTLIER -100.09 36.4 1.85 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.817 -0.628 . . . . 10.0 110.483 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.516 ' HA ' HH22 ' A' ' 187' ' ' ARG . 0.1 OUTLIER -73.1 -39.77 65.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.746 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 63.77 1.07 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.024 -0.535 . . . . 10.0 111.603 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.57 94.93 9.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.202 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' B' ' 87' ' ' THR . . . -75.61 148.3 36.74 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.862 -0.608 . . . . 10.0 112.992 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.691 ' HE2' ' HD1' ' B' ' 71' ' ' PHE . 0.0 OUTLIER -103.39 130.91 50.82 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.1 -0.333 . . . . 10.0 110.1 179.343 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.447 ' HB ' ' HA2' ' B' ' 70' ' ' GLY . 7.2 t -87.48 96.9 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.589 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.88 -38.03 64.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.166 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.67 158.2 35.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.692 -0.685 . . . . 10.0 109.388 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' B' ' 83' ' ' CYS . . . 88.69 -179.3 45.89 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.838 -0.696 . . . . 10.0 112.265 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.8 m -129.25 137.07 50.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.97 0.414 . . . . 10.0 111.288 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' B' ' 79' ' ' PRO . 4.2 m -132.67 155.76 41.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.546 ' HB3' ' CE2' ' B' ' 78' ' ' TYR . 17.8 t70 -119.38 145.69 45.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.787 0.327 . . . . 10.0 110.626 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -132.14 128.14 37.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.159 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.9 -31.9 25.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.145 0.498 . . . . 10.0 110.819 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -134.52 163.68 29.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.919 -0.771 . . . . 10.0 108.919 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.27 172.13 1.57 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.862 0.363 . . . . 10.0 110.626 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.503 ' HA ' ' HA2' ' A' ' 353' ' ' GLY . 0.7 OUTLIER -86.67 -135.64 0.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.546 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 61' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -73.04 -8.93 57.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.055 0.455 . . . . 10.0 110.792 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.401 HD23 ' HB3' ' B' ' 71' ' ' PHE . 5.1 mp -82.14 76.66 9.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.01 -169.53 0.94 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.262 -0.427 . . . . 10.0 111.91 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -27.28 64.1 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.718 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.84 -34.98 75.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.176 0.512 . . . . 10.0 110.279 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.578 ' HB3' ' HB2' ' B' ' 71' ' ' PHE . 15.5 mm-40 -87.02 -24.8 24.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.376 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -60.46 -43.61 96.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 10.0 109.802 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.08 -23.58 67.95 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.65 -0.705 . . . . 10.0 112.355 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -85.9 -18.3 33.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.104 0.478 . . . . 10.0 109.899 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLY . . . . . 0.447 ' HA2' ' HB ' ' B' ' 49' ' ' VAL . . . 106.95 32.11 3.65 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.831 -0.699 . . . . 10.0 112.968 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.691 ' HD1' ' HE2' ' B' ' 48' ' ' LYS . 14.7 m-85 -121.35 109.49 14.96 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.498 -0.413 . . . . 10.0 110.484 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 26.0 m -134.02 175.34 11.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 10.0 111.283 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.626 HD11 ' HA ' ' B' ' 43' ' ' SER . 21.4 tp -115.19 109.32 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.408 -0.59 . . . . 10.0 109.408 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' THR . . . . . 0.415 ' HB ' HD23 ' B' ' 23' ' ' LEU . 0.2 OUTLIER -58.6 -16.88 17.85 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.829 0.677 . . . . 10.0 112.829 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 75' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.29 -22.71 65.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.549 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.73 32.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.963 0.411 . . . . 10.0 110.703 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.39 134.0 55.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' B' ' 55' ' ' ASP . 0.8 OUTLIER -126.21 140.59 37.44 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.79 -0.641 . . . . 10.0 109.993 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 0.762 ' HA ' HG12 ' B' ' 54' ' ' VAL . 7.1 Cg_exo -73.17 107.98 2.5 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.899 2.4 . . . . 10.0 112.496 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.34 -25.81 62.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 73.5 m -159.69 -175.15 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.166 -0.924 . . . . 10.0 108.845 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.52 135.01 51.06 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.352 0.408 . . . . 10.0 110.129 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' CYS . . . . . 0.451 ' HB3' ' HA3' ' B' ' 52' ' ' GLY . 1.0 OUTLIER -156.82 171.21 20.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.286 0.565 . . . . 10.0 112.522 -179.046 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -129.27 114.3 16.08 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.603 -1.258 . . . . 10.0 107.603 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 25.5 mm -114.1 131.33 66.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.05 0.759 . . . . 10.0 113.05 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -97.96 85.69 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' THR . . . . . 0.419 ' HA ' ' HA2' ' B' ' 47' ' ' GLY . 0.8 OUTLIER -78.62 36.77 0.27 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.604 0.964 . . . . 10.0 113.604 -177.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -144.95 24.73 1.47 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.316 0.487 . . . . 10.0 112.316 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.626 ' HB3' ' HD2' ' B' ' 48' ' ' LYS . 1.6 mm-40 -119.44 90.23 3.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.945 0.402 . . . . 10.0 110.3 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -92.39 -8.02 46.07 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.056 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -87.86 -37.48 16.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 10.0 111.009 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.58 ' HB3' ' HD3' ' B' ' 48' ' ' LYS . . . -74.25 87.94 1.99 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.012 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pp 178.27 -23.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.471 -0.786 . . . . 10.0 110.87 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 33.2 t80 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.37 -0.824 . . . . 10.0 110.576 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 501' ' ' SF4 . . . . . 0.509 ' S2 ' ' HA ' ' A' ' 381' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 p -74.93 165.96 24.42 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.923 -0.399 . . . . 10.0 109.923 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 189' ' ' GLN . 96.7 m-70 -64.23 -31.02 72.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.761 0.282 . . . . 10.0 111.761 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.73 -45.15 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.503 -0.555 . . . . 10.0 109.503 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -63.6 -31.32 72.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.386 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.542 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 36.8 mt-30 -62.83 -23.46 67.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.264 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.1 -38.66 10.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.888 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.19 -35.08 76.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.098 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.6 -36.45 74.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.085 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -79.77 -34.83 39.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.382 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.15 -25.4 62.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.239 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.55 -7.5 56.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.011 0.434 . . . . 10.0 110.626 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 91.9 mttt -93.8 121.7 63.87 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.908 -0.587 . . . . 10.0 109.906 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.1 148.89 75.13 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.56 2.173 . . . . 10.0 110.415 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.834 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 61.9 mttt -63.89 -10.41 20.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.978 0.732 . . . . 10.0 112.978 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -98.52 -5.32 32.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.734 0.302 . . . . 10.0 111.288 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.2 135.84 82.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.314 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.91 -17.34 59.31 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.714 2.276 . . . . 10.0 113.171 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.75 14.16 30.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 10.0 110.781 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.834 ' HG2' ' HA ' ' A' ' 39' ' ' LYS . 6.8 tpt180 -87.64 115.51 25.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.504 . . . . 10.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.74 ' HD3' ' HA ' ' A' ' 176' ' ' ASP . 14.0 mttp -93.7 169.11 10.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.816 -0.629 . . . . 10.0 109.882 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.51 111.75 18.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.84 -0.8 . . . . 10.0 108.84 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.33 102.16 13.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.082 0.468 . . . . 10.0 111.646 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.3 m -99.1 140.54 33.11 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.245 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 13.1 p -132.38 135.84 57.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.085 0.469 . . . . 10.0 112.115 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 14.5 pt20 -116.35 127.07 54.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.967 -0.561 . . . . 10.0 109.581 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.426 HG11 HD21 ' A' ' 75' ' ' LEU . 2.0 t -104.03 150.04 7.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.123 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.02 139.08 20.48 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.481 . . . . 10.0 109.962 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.7 -35.03 66.89 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.184 2.59 . . . . 10.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.68 -32.86 74.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.102 0.477 . . . . 10.0 110.768 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.939 HG13 HG23 ' A' ' 214' ' ' THR . 88.0 t -80.53 -40.15 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.776 -0.647 . . . . 10.0 109.374 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -56.6 -33.08 65.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.536 -0.757 . . . . 10.0 112.316 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.38 -37.52 12.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 113.292 0.849 . . . . 10.0 113.292 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.56 -5.56 53.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.528 0.936 . . . . 10.0 113.528 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.34 -26.39 40.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.823 0.344 . . . . 10.0 111.687 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.83 -24.85 65.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.591 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -66.24 -26.14 67.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.279 -0.419 . . . . 10.0 112.049 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.0 p -68.18 -23.59 64.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.066 0.46 . . . . 10.0 110.54 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.6 mt -94.02 -0.78 55.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.164 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.99 18.52 55.85 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.947 -0.644 . . . . 10.0 112.385 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.8 mt -106.34 164.62 11.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.662 0.267 . . . . 10.0 110.764 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.61 153.9 85.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.527 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.43 133.65 59.37 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.567 2.178 . . . . 10.0 111.691 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.49 14.17 62.14 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.667 -0.777 . . . . 10.0 113.082 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.57 -27.04 31.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.953 0.406 . . . . 10.0 111.245 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 p -103.25 129.26 50.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.194 -0.457 . . . . 10.0 109.976 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -77.76 154.74 80.92 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.323 -0.251 . . . . 10.0 110.323 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.84 -41.12 77.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.713 2.276 . . . . 10.0 111.935 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.457 ' HD3' ' HB3' ' A' ' 233' ' ' GLU . 46.8 mttm -66.15 -36.59 83.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.967 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -61.71 -41.67 97.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.013 0.435 . . . . 10.0 110.654 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.426 HD21 HG11 ' A' ' 51' ' ' VAL . 48.8 tp -64.73 -44.53 89.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.432 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.34 95.24 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.73 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 23.9 tp10 -60.32 -46.9 88.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.881 -0.599 . . . . 10.0 110.29 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.04 -43.81 96.79 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.85 -0.613 . . . . 10.0 112.442 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.441 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 30.6 mt -60.02 -43.93 94.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 10.0 111.124 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -64.18 -32.51 74.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.943 0.401 . . . . 10.0 110.619 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -74.68 -12.62 60.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.386 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.7 mt -77.62 -19.61 55.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 10.0 109.937 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.59 7.58 8.07 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.649 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.441 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 47.3 m-85 -72.81 156.63 38.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.729 0.299 . . . . 10.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -98.03 -58.71 1.92 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.993 0.425 . . . . 10.0 111.357 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . 2.9 mp0 -117.61 128.15 54.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.131 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.4 t -113.52 114.26 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.267 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 86' ' ' GLU . 24.5 m-85 -118.1 170.55 8.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.476 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -118.11 149.04 41.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.4 m -64.78 -20.57 66.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.74 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 91' ' ' LEU . 24.7 mt -57.91 -34.57 69.97 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.424 ' HD2' HD13 ' A' ' 158' ' ' LEU . 42.9 t80 -66.99 -37.63 84.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.151 0.5 . . . . 10.0 109.96 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.02 -34.47 58.62 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.994 -0.842 . . . . 10.0 110.994 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.89 -36.38 83.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.605 -0.298 . . . . 10.0 110.509 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.13 -33.93 69.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.07 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.434 HD21 HD23 ' A' ' 424' ' ' LEU . 78.9 mt -76.09 -42.79 46.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.988 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m -59.67 -44.33 93.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.667 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.5 mt -58.68 -42.14 84.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.905 -0.589 . . . . 10.0 110.753 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 87.6 mmm -66.95 -48.45 68.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.229 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -66.87 -53.92 27.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.444 ' HG2' ' SG ' ' A' ' 151' ' ' CYS . 18.9 mt-10 -60.42 -40.95 92.86 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.847 0.356 . . . . 10.0 110.932 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.16 99.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.095 -0.574 . . . . 10.0 111.865 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.8 m -67.94 -39.89 83.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.531 0.205 . . . . 10.0 110.853 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.526 ' HA ' ' HD2' ' A' ' 107' ' ' HIS . 19.6 tt0 -64.57 -41.3 96.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.05 -51.15 69.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.117 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.1 tp -57.3 -46.78 82.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.639 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.73 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -64.77 -40.13 94.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.431 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -58.13 -40.73 82.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.035 0.445 . . . . 10.0 110.25 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 45.4 tp -70.03 -42.25 73.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.85 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 m -58.4 -47.48 83.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.835 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 30.2 mm-40 -57.44 -35.88 70.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.129 0.49 . . . . 10.0 110.468 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.425 ' HE1' ' HA ' ' A' ' 122' ' ' PRO . 44.8 m80 -75.9 -29.44 58.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.771 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 95.7 mt -76.36 -34.0 58.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.173 0.511 . . . . 10.0 110.343 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -79.81 -43.41 22.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.381 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.093 0 O-C-N 123.831 0.707 . . . . 10.0 111.728 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.795 0.331 . . . . 10.0 110.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.425 ' HA ' ' HE1' ' A' ' 112' ' ' HIS . 67.8 Cg_endo -85.27 -165.12 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.798 2.332 . . . . 10.0 112.615 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.401 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 94.1 mt -129.07 157.72 75.03 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 123' ' ' LEU . 18.3 Cg_exo -66.37 167.23 55.02 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.296 -1.127 . . . . 10.0 113.129 0.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 25.7 ttt -113.57 133.35 55.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.774 . . . . 10.0 111.007 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -113.79 144.45 42.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.963 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.459 HG23 ' HZ ' ' A' ' 371' ' ' PHE . 0.0 OUTLIER -74.11 150.32 40.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.67 0.272 . . . . 10.0 110.322 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 p -116.47 20.4 14.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 6.82 28.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.452 ' O ' HG12 ' A' ' 134' ' ' ILE . 54.1 t -120.15 117.78 31.81 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 120.658 0.266 . . . . 10.0 111.567 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.23 -33.79 70.27 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.364 2.71 . . . . 10.0 112.048 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.02 -41.63 97.16 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.946 -0.645 . . . . 10.0 111.571 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -65.8 -44.04 86.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.078 -0.342 . . . . 10.0 110.078 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 130' ' ' CYS . 35.2 mm -57.99 -42.38 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.966 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.45 76.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.168 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.401 ' SD ' ' HB2' ' B' ' 61' ' ' PHE . 12.2 tpt -67.2 -34.19 76.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.007 0.432 . . . . 10.0 110.823 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.41 HD22 HG21 ' A' ' 148' ' ' VAL . 22.0 tp -60.44 -60.7 3.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.57 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -63.73 -20.62 65.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.682 -0.235 . . . . 10.0 111.599 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -81.06 -61.97 1.8 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.607 0.965 . . . . 10.0 113.607 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 m -115.27 1.0 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.714 1.376 . . . . 10.0 114.714 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 144' ' ' LEU . 53.5 m-85 -134.14 60.65 45.86 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 122.05 -0.406 . . . . 10.0 111.102 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.96 -25.43 32.36 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.364 2.043 . . . . 10.0 113.1 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -87.07 1.05 54.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.987 0.422 . . . . 10.0 111.289 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 141' ' ' TYR . 59.8 mt -105.99 4.27 29.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.462 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.582 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 75.6 mt -57.94 -53.72 62.88 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.582 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 49.3 Cg_exo -58.4 -18.94 41.05 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.479 2.119 . . . . 10.0 113.076 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 125' ' ' MET . 96.5 m-85 -78.76 -20.03 50.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.214 0.531 . . . . 10.0 110.459 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.41 HG21 HD22 ' A' ' 137' ' ' LEU . 16.7 t -90.49 154.3 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.587 . . . . 10.0 109.589 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.0 t -68.18 158.31 33.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.069 0.461 . . . . 10.0 111.125 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 88.3 p -100.54 6.41 44.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.237 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 101' ' ' GLU . 4.5 m -80.83 143.9 32.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.228 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -85.66 165.12 17.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.099 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.2 p -67.19 155.11 91.37 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.761 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -45.15 -54.68 4.08 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.604 2.87 . . . . 10.0 114.214 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 155' ' ' GLN . 0.0 OUTLIER -65.14 -34.31 78.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.709 0.633 . . . . 10.0 112.709 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 78.9 mmm -72.81 -23.81 60.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.064 0.459 . . . . 10.0 110.481 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 36.6 mtt -75.8 -48.88 19.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.328 -0.619 . . . . 10.0 109.328 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.424 HD13 ' HD2' ' A' ' 92' ' ' PHE . 49.2 tp -62.82 -40.22 96.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.372 -0.831 . . . . 10.0 111.038 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.47 81.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.471 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.88 -31.87 57.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.534 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -70.26 -43.26 70.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.691 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.8 m -68.89 -27.48 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' A' ' 179' ' ' MET . 44.4 mttt -88.94 7.7 33.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.016 0.376 . . . . 10.0 112.016 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.6 p -129.41 -74.67 0.55 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.814 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -62.97 -50.83 69.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.56 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 162' ' ' VAL . 54.8 tp -64.04 -40.8 97.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 10.0 110.787 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.77 -52.04 67.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.919 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -64.04 -43.72 94.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.389 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -62.45 -38.06 88.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 10.0 111.991 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -89.32 -7.48 55.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 69.06 40.87 83.1 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.104 -0.569 . . . . 10.0 112.642 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 43.2 mt -123.5 142.39 40.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -79.51 136.36 56.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 110.018 -0.364 . . . . 10.0 110.018 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 173' ' ' ALA . 51.3 Cg_exo -57.44 -16.05 21.88 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.237 2.624 . . . . 10.0 113.143 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -72.77 -28.88 62.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 10.0 110.864 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.74 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 58.3 m-20 -101.82 29.62 4.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.401 0.62 . . . . 10.0 110.244 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 95.4 mtp -126.89 124.73 40.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.142 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 32.1 t -107.93 119.31 57.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.338 -0.615 . . . . 10.0 109.338 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.519 ' HB2' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -103.31 109.11 20.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.055 0.455 . . . . 10.0 111.273 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 28.0 t -108.69 142.1 22.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.417 ' OG ' HD21 ' A' ' 208' ' ' LEU . 10.1 p -134.79 138.22 44.08 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.917 -0.313 . . . . 10.0 111.049 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.43 HG21 HD22 ' A' ' 217' ' ' LEU . 21.2 mm -100.35 108.95 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 213' ' ' THR . 31.9 mmt -116.95 149.38 44.04 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.49 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.68 25.02 0.71 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.828 2.352 . . . . 10.0 112.518 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 30.2 t -156.99 139.29 14.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.588 -0.278 . . . . 10.0 110.719 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.89 -24.11 52.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.156 0.503 . . . . 10.0 110.588 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -70.98 -3.05 17.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.717 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -78.13 -27.23 48.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.951 0.405 . . . . 10.0 110.9 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLN . . . . . 0.416 ' HG2' ' CD2' ' A' ' 27' ' ' HIS . 29.3 tp60 -68.45 -34.94 76.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 10.0 109.942 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.56 -26.63 67.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.182 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -76.82 -42.81 38.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.237 0.542 . . . . 10.0 109.81 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.427 ' CB ' HD23 ' A' ' 208' ' ' LEU . . . -74.75 -21.28 59.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.475 -0.784 . . . . 10.0 111.703 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -2.1 38.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.479 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 51.1 mtt180 -63.41 120.71 12.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.187 0.517 . . . . 10.0 110.196 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.09 -42.59 50.46 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.714 1.746 . . . . 10.0 115.714 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' TRP . . . . . 0.45 ' HZ2' HH11 ' A' ' 194' ' ' ARG . 35.3 p90 -67.78 0.73 3.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.465 1.283 . . . . 10.0 114.465 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 194' ' ' ARG . 9.7 m-85 -93.87 68.2 3.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.131 0.491 . . . . 10.0 109.949 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 5.9 p -109.38 167.88 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.187 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.448 HG22 ' HG2' ' A' ' 207' ' ' GLN . 15.9 t -113.31 103.32 15.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.088 -0.708 . . . . 10.0 109.088 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.947 -1.025 . . . . 10.0 111.644 -179.6 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.841 0.353 . . . . 10.0 110.457 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.777 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.231 0.106 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -82.52 139.84 33.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.258 -0.275 . . . . 10.0 110.258 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 197' ' ' PHE . 54.8 mt-30 -65.59 -42.51 91.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.526 0.679 . . . . 10.0 109.502 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.518 HD12 ' HB3' ' A' ' 179' ' ' MET . 19.2 tp -120.06 136.71 54.47 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.84 -64.8 1.09 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.999 0.741 . . . . 10.0 112.999 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 1.4 m-70 -140.28 144.76 36.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.929 0.395 . . . . 10.0 111.857 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 47.3 t -112.2 131.01 64.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.51 138.13 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.479 -0.563 . . . . 10.0 109.479 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 183' ' ' MET . 72.4 p -87.81 166.93 14.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.121 0.486 . . . . 10.0 111.885 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.939 HG23 HG13 ' A' ' 55' ' ' VAL . 1.4 m -57.3 -45.97 83.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.471 -0.786 . . . . 10.0 111.429 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.7 m -61.99 -42.01 93.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.803 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 220' ' ' ILE . 41.8 mt-10 -66.17 -46.47 77.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 10.0 110.86 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 182' ' ' ILE . 34.6 tp -60.85 -45.11 95.83 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.002 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -60.71 -37.4 93.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.026 -0.606 . . . . 10.0 111.954 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ASN . . . . . 0.499 ' HA ' ' HE3' ' A' ' 222' ' ' LYS . 42.4 m-20 -65.37 -39.33 92.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.625 0.25 . . . . 10.0 110.634 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 216' ' ' GLU . 73.4 mt -60.37 -47.57 91.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.368 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -60.2 -41.64 93.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.084 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' A' ' 219' ' ' ASN . 36.9 mtmt -66.41 -47.56 72.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -63.79 -38.27 90.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 10.0 111.708 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -76.06 -18.78 59.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 10.0 111.414 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.76 40.59 12.0 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.901 -0.666 . . . . 10.0 112.119 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.5 mt -120.09 92.83 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.891 0.377 . . . . 10.0 110.54 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -76.39 116.15 16.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 10.0 109.971 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.576 ' HA ' HD12 ' A' ' 231' ' ' LEU . 36.1 mt -60.48 -28.8 68.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.873 -0.603 . . . . 10.0 112.141 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.91 -13.0 61.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.477 -0.329 . . . . 10.0 111.76 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -109.93 18.3 20.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.021 0.439 . . . . 10.0 111.042 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 228' ' ' LEU . 96.1 mt -105.46 150.2 38.7 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.614 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.01 176.65 9.59 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.339 2.026 . . . . 10.0 111.478 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 73' ' ' LYS . 8.2 mm-40 -74.08 99.13 3.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.404 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 77' ' ' GLU . . . -73.73 -168.16 15.8 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.997 -0.62 . . . . 10.0 113.08 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -132.45 154.17 50.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.777 0.322 . . . . 10.0 111.348 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -100.41 165.17 11.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.275 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 246' ' ' ALA . 30.4 m-20 -107.98 155.38 20.4 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.693 -0.484 . . . . 10.0 109.693 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -100.42 120.62 55.77 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.714 0.292 . . . . 10.0 110.788 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.18 -14.99 45.28 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.959 2.439 . . . . 10.0 112.093 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.4 ' HE2' ' HB3' ' A' ' 423' ' ' GLU . 98.2 mmm -83.02 10.83 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.955 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 89.69 -61.51 3.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.193 -0.527 . . . . 10.0 111.939 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.4 m -125.35 144.87 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.732 0.301 . . . . 10.0 110.21 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 155.43 162.85 11.6 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.073 -0.585 . . . . 10.0 111.811 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 m -94.33 107.42 19.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.971 0.415 . . . . 10.0 110.429 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 95.77 -164.16 23.91 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.748 -0.739 . . . . 10.0 111.428 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 237' ' ' ASP . . . -80.95 0.87 33.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.93 0.344 . . . . 10.0 111.93 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 13.82 80.25 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.295 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.17 118.87 53.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.524 HD11 ' HD3' ' A' ' 419' ' ' PRO . 75.1 mt -69.85 136.15 50.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.523 -0.308 . . . . 10.0 111.195 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -54.74 122.43 10.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.528 -0.76 . . . . 10.0 111.312 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 148.09 165.73 12.23 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.354 -0.698 . . . . 10.0 111.354 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 6.7 t -107.62 152.12 24.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.121 0.486 . . . . 10.0 111.115 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.27 -10.18 20.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.065 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.488 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 88.08 -30.82 4.96 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.919 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 150.84 167.29 14.46 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.234 -1.146 . . . . 10.0 110.234 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.51 -54.09 36.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 117.402 0.601 . . . . 10.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' MET . . . . . 0.743 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 28.6 ttp -61.6 -49.03 78.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.541 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.488 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 17.1 tt0 -58.14 -46.97 84.72 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.12 0.415 . . . . 10.0 112.12 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.67 -35.93 79.76 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.715 -0.221 . . . . 10.0 111.394 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.62 -46.52 78.96 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.707 -0.479 . . . . 10.0 109.707 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 79.7 mt -63.16 -41.08 99.19 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.793 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.536 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 44.3 ttm105 -57.63 -51.06 71.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.324 -0.853 . . . . 10.0 111.16 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 28.9 m -56.57 -43.84 80.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.405 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.59 -43.15 69.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.909 0.385 . . . . 10.0 111.249 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.531 ' CD2' ' HB2' ' A' ' 273' ' ' LEU . 47.3 t80 -63.18 -47.51 82.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.135 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.448 ' OE2' ' HA ' ' A' ' 272' ' ' PRO . 75.2 mt-10 -66.0 -36.81 84.31 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 76.0 mt -77.65 -7.92 57.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.167 0.508 . . . . 10.0 111.13 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -104.51 -40.65 5.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.484 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' THR . . . . . 0.45 HG21 ' CE1' ' A' ' 265' ' ' TYR . 77.9 p -97.97 -32.67 11.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.986 0.736 . . . . 10.0 112.986 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 89.06 -3.13 84.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.491 -0.861 . . . . 10.0 111.034 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 12.0 p -104.64 139.47 20.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.989 -0.374 . . . . 10.0 109.989 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.448 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 37.0 Cg_endo -68.07 139.54 47.0 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.423 2.082 . . . . 10.0 111.581 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.642 HD12 ' HD2' ' A' ' 274' ' ' PRO . 40.6 tp -101.48 121.65 50.75 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.241 -0.436 . . . . 10.0 111.143 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' PRO . . . . . 0.642 ' HD2' HD12 ' A' ' 273' ' ' LEU . 73.9 Cg_endo -77.5 -156.19 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.573 2.182 . . . . 10.0 111.335 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -80.94 142.54 33.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.082 -0.34 . . . . 10.0 110.082 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.11 124.6 36.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.069 0.461 . . . . 10.0 112.11 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 4.3 m -90.65 91.9 8.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.238 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 278' ' ' LEU . 3.5 mm? -58.54 123.93 17.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 10.0 111.554 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 6.1 m -98.7 140.84 32.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.491 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.12 128.48 33.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.522 -0.308 . . . . 10.0 110.971 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' VAL . . . . . 0.45 HG22 ' HG2' ' A' ' 289' ' ' GLU . 21.7 t -86.03 110.25 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.351 . . . . 10.0 110.155 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -66.83 123.05 19.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.369 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 117.16 -21.32 10.98 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.4 ' HB3' ' CG1' ' A' ' 287' ' ' ILE . 63.8 mtm -132.91 85.5 2.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -62.65 109.98 1.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.458 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' GLY . . . . . 0.42 ' HA3' ' ND2' ' A' ' 354' ' ' ASN . . . 118.08 -13.52 12.65 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.757 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.4 ' CG1' ' HB3' ' A' ' 284' ' ' MET . 42.9 mm -97.89 129.44 48.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -119.59 149.94 41.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLU . . . . . 0.45 ' HG2' HG22 ' A' ' 281' ' ' VAL . 21.6 pt-20 -133.39 160.1 38.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.992 0.425 . . . . 10.0 112.07 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.83 134.62 13.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.299 -0.864 . . . . 10.0 109.855 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -112.0 110.1 20.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.548 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 31.5 mt -98.97 121.49 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 10.0 111.504 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' THR . . . . . 0.552 HG23 ' HZ ' ' A' ' 333' ' ' PHE . 4.6 m -76.99 104.45 7.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.226 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.432 ' HG2' ' HD1' ' A' ' 265' ' ' TYR . 88.6 mtp -100.6 102.46 13.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.985 0.422 . . . . 10.0 111.74 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.54 118.48 54.42 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.979 -0.749 . . . . 10.0 108.979 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.01 132.99 55.04 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.863 2.375 . . . . 10.0 112.566 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.22 134.52 95.99 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.887 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.37 120.04 7.56 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.717 2.278 . . . . 10.0 111.492 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 92.42 39.39 5.36 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.828 -0.701 . . . . 10.0 111.702 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 98.9 p -128.53 165.12 21.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.861 -0.422 . . . . 10.0 109.861 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.618 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 13.2 pttt -73.11 -29.38 62.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.622 -0.51 . . . . 10.0 109.622 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -66.02 -39.51 90.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.905 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 307' ' ' LYS . 13.5 tt0 -64.32 -45.28 88.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.013 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.58 -31.74 73.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.648 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 90.7 mt -58.86 -57.3 13.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 10.0 110.919 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' LEU . . . . . 0.414 HD21 HD22 ' A' ' 113' ' ' LEU . 92.2 mt -69.26 -26.23 64.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.367 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 303' ' ' GLU . 6.6 tmtt? -79.03 -12.97 60.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.992 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -112.26 -22.74 10.77 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.878 0.696 . . . . 10.0 112.878 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 305' ' ' LEU . 6.9 ptp180 -146.4 123.92 11.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.992 0.425 . . . . 10.0 112.044 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.5 -0.18 4.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.486 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.198 -0.906 . . . . 10.0 109.113 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.438 0 N-CA-C 111.513 -0.635 . . . . 10.0 111.513 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.35 -23.43 51.45 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.729 2.286 . . . . 10.0 111.733 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 147' ' ' TYR . 93.3 mt -119.23 96.48 5.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.137 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -92.66 124.16 36.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.242 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -60.56 129.94 44.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.062 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -72.71 -12.93 61.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.286 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 115.05 -9.59 20.84 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.245 -0.742 . . . . 10.0 111.245 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.52 129.2 2.51 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.855 -0.688 . . . . 10.0 111.565 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -71.78 88.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.08 0.467 . . . . 10.0 110.588 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -105.68 149.06 16.63 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.928 -0.653 . . . . 10.0 112.397 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' PHE . . . . . 0.552 ' HZ ' HG23 ' A' ' 293' ' ' THR . 3.5 p90 -132.05 151.23 51.87 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.435 ' HA ' ' HA2' ' A' ' 340' ' ' GLY . 7.8 t -131.78 142.09 49.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.981 0.42 . . . . 10.0 111.196 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 1.7 m -83.75 165.05 19.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.813 -0.631 . . . . 10.0 109.934 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -70.97 -18.19 62.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.894 0.378 . . . . 10.0 110.986 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -26.12 60.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.683 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 126.39 -16.68 6.65 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.464 -0.874 . . . . 10.0 113.561 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -83.15 163.52 20.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.865 0.333 . . . . 10.0 110.881 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 334' ' ' THR . . . -150.26 169.04 30.25 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.731 -0.747 . . . . 10.0 112.293 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -157.19 164.93 33.1 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.42 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 14.4 tt -122.32 140.95 44.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.998 0.399 . . . . 10.0 110.724 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.42 ' HB ' ' HE2' ' A' ' 333' ' ' PHE . 4.8 t -96.98 100.09 11.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.233 0.54 . . . . 10.0 110.132 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 21.4 tp -62.95 116.72 5.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.457 -0.792 . . . . 10.0 110.776 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -90.71 100.19 13.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.555 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 46.3 t -104.18 132.59 50.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.63 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.556 ' HB3' HG22 ' A' ' 372' ' ' VAL . . . -125.78 144.75 50.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.785 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.71 118.89 57.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.635 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.487 ' HB3' HG12 ' A' ' 374' ' ' ILE . . . -105.52 97.39 7.23 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.238 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ASN . . . . . 0.969 ' HB3' ' HA ' ' A' ' 378' ' ' PRO . 0.7 OUTLIER -88.22 101.0 13.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.006 0.431 . . . . 10.0 110.167 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 126.08 123.83 2.71 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.203 -0.759 . . . . 10.0 111.203 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' LEU . . . . . 0.808 ' HG ' ' HA ' ' A' ' 376' ' ' ALA . 26.7 mt -59.11 -32.01 69.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.938 0.399 . . . . 10.0 111.786 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLY . . . . . 0.459 ' O ' ' HE3' ' A' ' 357' ' ' LYS . . . -72.43 -26.59 71.51 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.236 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 357' ' ' LYS . 86.6 m-20 -74.03 -23.78 59.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 10.0 111.054 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -66.28 -36.09 82.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.632 -0.507 . . . . 10.0 109.632 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' B' ' 60' ' ' SER . 17.7 tttt -68.07 -21.33 64.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.332 -0.849 . . . . 10.0 110.545 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 353' ' ' GLY . 60.4 mttt -94.61 -32.39 13.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 10.0 111.572 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.96 -45.83 16.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.916 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 85.1 mt -58.94 -34.48 52.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.095 0.406 . . . . 10.0 112.095 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -43.2 99.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.993 0.425 . . . . 10.0 110.306 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -72.3 -29.06 63.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.613 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 89.5 mtp -70.35 -48.83 54.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.104 -0.498 . . . . 10.0 109.861 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.52 -36.77 83.63 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.45 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.2 -27.54 68.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.609 . . . . 10.0 110.866 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 105.26 0.03 40.81 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.069 -0.586 . . . . 10.0 112.605 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -75.49 -54.41 7.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 10.0 111.335 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -81.85 100.7 9.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.51 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -94.75 106.09 18.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.478 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -137.44 155.35 49.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.103 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -105.28 -38.05 6.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.062 0.458 . . . . 10.0 110.877 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.743 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 53.5 t80 -130.46 129.79 43.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.699 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 347' ' ' ALA . 62.5 t -134.07 127.01 50.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.803 0.335 . . . . 10.0 111.818 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.458 ' HA ' ' OG1' ' A' ' 127' ' ' THR . 14.1 tt0 -101.88 126.74 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.487 HG12 ' HB3' ' A' ' 349' ' ' ALA . 68.9 mt -116.37 120.1 63.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.254 0.549 . . . . 10.0 111.971 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' MET . . . . . . . . . . . . . 10.0 mmt -105.79 155.52 19.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 10.0 109.442 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 0.808 ' HA ' ' HG ' ' A' ' 352' ' ' LEU . . . -79.24 -28.9 42.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.78 0.324 . . . . 10.0 111.685 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 12.1 m -114.41 149.46 42.19 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.491 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.969 ' HA ' ' HB3' ' A' ' 350' ' ' ASN . 2.9 Cg_endo -83.29 22.56 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.491 2.794 . . . . 10.0 112.24 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -147.64 38.06 0.92 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.279 0.561 . . . . 10.0 109.903 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 69.27 -144.16 40.49 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.736 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' CYS . . . . . 0.702 ' HA ' ' S3 ' ' A' ' 501' ' ' SF4 . 72.4 m -106.94 -10.16 16.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.631 0.253 . . . . 10.0 111.544 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' VAL . . . . . 0.462 HG23 HG22 ' A' ' 396' ' ' THR . 28.0 m -70.63 -12.63 16.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.796 0.332 . . . . 10.0 111.472 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -112.0 27.93 9.79 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.059 -0.591 . . . . 10.0 111.985 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -69.32 169.73 43.23 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.12 -0.562 . . . . 10.0 112.641 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -71.86 -25.47 74.82 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.027 -0.606 . . . . 10.0 113.091 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -76.21 -17.81 79.74 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.275 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -74.01 160.35 81.94 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.903 -0.406 . . . . 10.0 109.903 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.82 159.68 40.55 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.404 2.07 . . . . 10.0 110.983 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ARG . . . . . 0.765 HH21 ' HB3' ' B' ' 34' ' ' PRO . 0.2 OUTLIER -117.07 135.68 53.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.484 -0.326 . . . . 10.0 110.249 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 13.9 t -132.51 162.86 30.14 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.202 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.09 -10.83 59.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.307 0.575 . . . . 10.0 110.187 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -77.53 109.97 11.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.625 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -75.38 1.27 14.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.801 -0.636 . . . . 10.0 111.782 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -124.37 22.36 8.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.17 0.509 . . . . 10.0 110.23 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ILE . . . . . 0.553 HD12 ' HD2' ' A' ' 398' ' ' LYS . 8.6 tp -71.29 -29.93 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.344 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.462 HG22 HG23 ' A' ' 382' ' ' VAL . 0.3 OUTLIER -61.82 -39.05 90.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.036 -0.529 . . . . 10.0 111.603 -179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -62.06 -37.77 86.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.954 0.407 . . . . 10.0 110.716 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' LYS . . . . . 0.553 ' HD2' HD12 ' A' ' 395' ' ' ILE . 52.3 mttp -67.97 -39.67 83.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.59 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -63.44 -42.65 98.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.859 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -70.31 -32.8 70.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.972 -0.558 . . . . 10.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -75.08 -46.04 37.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.515 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -85.24 13.29 6.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.839 0.352 . . . . 10.0 111.865 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -36.95 85.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.564 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.509 ' O ' ' HE3' ' A' ' 409' ' ' LYS . 75.4 m-85 -136.61 151.47 49.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.151 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -75.36 160.94 29.72 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.157 -0.682 . . . . 10.0 109.157 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.42 -35.35 69.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.889 0.376 . . . . 10.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.23 -35.45 81.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.418 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.05 -36.6 66.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.462 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' LYS . . . . . 0.509 ' HE3' ' O ' ' A' ' 404' ' ' TYR . 96.5 mttt -71.02 -32.86 69.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.593 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.1 p -81.6 -3.37 53.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.016 0.436 . . . . 10.0 111.564 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 9.5 m -120.6 96.92 5.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.913 0.387 . . . . 10.0 111.216 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 23.6 tp -78.8 117.19 19.68 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 414' ' ' ARG . 6.1 tmm_? -118.44 139.96 50.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.519 -0.31 . . . . 10.0 111.366 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.493 ' HB2' ' OE1' ' A' ' 417' ' ' GLU . 67.9 mtt85 -101.69 158.94 15.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.386 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 9.2 m -72.59 -33.04 66.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.257 0.466 . . . . 10.0 112.257 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -77.29 4.13 11.37 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.221 0.823 . . . . 10.0 113.221 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' GLU . . . . . 0.493 ' OE1' ' HB2' ' A' ' 414' ' ' ARG . 0.5 OUTLIER -103.52 -3.74 24.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.643 -0.503 . . . . 10.0 109.643 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -84.3 116.33 64.48 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.505 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' PRO . . . . . 0.524 ' HD3' HD11 ' A' ' 249' ' ' LEU . 33.5 Cg_exo -59.62 -38.42 82.02 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.994 2.463 . . . . 10.0 111.983 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.1 m -60.78 -43.94 97.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.552 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.18 -40.3 84.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.782 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' ARG . . . . . 0.435 ' NH2' ' HA ' ' A' ' 417' ' ' GLU . 98.9 mtt180 -59.96 -44.93 94.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.673 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLU . . . . . 0.4 ' HB3' ' HE2' ' A' ' 240' ' ' MET . 46.7 tt0 -61.51 -43.98 97.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' LEU . . . . . 0.434 HD23 HD21 ' A' ' 96' ' ' LEU . 65.3 tp -63.54 -37.93 89.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.193 0.52 . . . . 10.0 111.216 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' TYR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.3 m-85 -74.87 -59.81 2.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.198 -0.455 . . . . 10.0 111.747 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.85 -14.51 62.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 115.074 1.509 . . . . 10.0 115.074 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.8 18.25 7.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -161.94 -61.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.585 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 92.8 mt -67.68 -40.7 84.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 99.89 -77.48 0.47 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.053 -0.594 . . . . 10.0 111.702 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLU . . . . . 0.596 ' HG2' ' HD2' ' A' ' 432' ' ' PRO . 1.0 OUTLIER -149.16 153.06 37.38 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.368 -0.605 . . . . 10.0 109.368 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.596 ' HD2' ' HG2' ' A' ' 431' ' ' GLU . 60.4 Cg_exo -55.1 134.8 65.81 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.565 2.177 . . . . 10.0 110.953 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.402 HD21 ' HG3' ' A' ' 104' ' ' GLU . 6.9 mp 66.75 13.61 9.45 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.532 0.52 . . . . 10.0 112.206 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -69.9 -166.91 5.79 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.513 -0.375 . . . . 10.0 112.979 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -59.64 -62.79 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.848 0.314 . . . . 10.0 111.848 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.512 ' HD2' ' HA ' ' A' ' 436' ' ' LYS . 17.7 tptt -63.03 -34.44 77.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.8 0.334 . . . . 10.0 111.497 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -64.55 -42.15 95.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.078 0.466 . . . . 10.0 110.487 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 0.1 OUTLIER -78.89 -9.68 59.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.03 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -93.19 -48.25 6.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.184 -0.462 . . . . 10.0 112.235 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.52 -34.55 9.5 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 113.828 1.047 . . . . 10.0 113.828 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 58.9 mt -90.25 -12.03 39.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 17.0 m-70 -119.19 167.09 12.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.18 -0.208 . . . . 10.0 110.873 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.5 t -156.37 -170.23 3.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.275 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -135.72 158.26 44.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.242 -0.281 . . . . 10.0 110.242 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -117.62 153.64 32.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.724 0.297 . . . . 10.0 111.262 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.75 128.55 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.007 0.432 . . . . 10.0 111.831 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.41 95.36 0.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.983 -0.553 . . . . 10.0 111.348 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 145.35 -33.32 1.58 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.917 -0.658 . . . . 10.0 111.973 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . 123.89 -174.37 16.78 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.327 -0.709 . . . . 10.0 111.327 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.429 HG11 ' HG2' ' A' ' 194' ' ' ARG . 3.1 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.484 -0.77 . . . . 10.0 111.015 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.662 ' HE2' ' HB2' ' B' ' 18' ' ' ALA . 43.5 m-85 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.256 -0.276 . . . . 10.0 110.256 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -84.14 96.26 8.88 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.983 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.41 125.86 65.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.523 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' B' ' 13' ' ' THR . 35.0 m -92.08 115.71 28.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.308 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.468 HD21 HG21 ' B' ' 22' ' ' ILE . 20.8 mt -87.93 129.77 35.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.022 -0.535 . . . . 10.0 111.091 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' B' ' 86' ' ' GLN . 17.3 tppt? -88.21 97.79 11.2 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.725 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.547 HG22 ' HD2' ' B' ' 8' ' ' PRO . 0.2 OUTLIER -111.82 142.35 26.52 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.594 -0.73 . . . . 10.0 109.194 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 8' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' B' ' 7' ' ' THR . 18.8 Cg_endo -61.0 -17.02 49.21 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.432 2.088 . . . . 10.0 111.73 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -93.5 9.49 36.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 10.0 111.38 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.65 145.97 7.66 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.996 -0.621 . . . . 10.0 112.364 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.89 149.62 34.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.649 0.261 . . . . 10.0 110.402 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -155.54 129.5 8.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.719 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 8.4 m -92.87 120.58 33.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.872 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 19.2 pt -116.79 155.66 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.175 -0.466 . . . . 10.0 111.119 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -94.4 105.88 17.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.741 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' CYS . . . . . 0.417 ' HA ' ' HD3' ' B' ' 17' ' ' PRO . 84.2 m -113.51 121.05 38.37 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.987 -0.552 . . . . 10.0 110.275 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' B' ' 20' ' ' THR . 4.9 Cg_exo -76.14 161.64 35.15 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.689 2.26 . . . . 10.0 110.94 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.662 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . . . -77.48 49.76 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.128 0.489 . . . . 10.0 110.971 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.95 -33.58 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.465 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' B' ' 17' ' ' PRO . 17.0 m -98.71 143.48 29.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.11 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -73.64 152.07 40.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.082 0.468 . . . . 10.0 111.381 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.516 HG12 ' HD3' ' B' ' 79' ' ' PRO . 6.1 mt -58.31 -37.94 66.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.874 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.494 ' HB3' HD22 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -63.06 -25.2 68.26 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.207 0.818 . . . . 10.0 113.207 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -70.14 -46.24 65.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.01 0.433 . . . . 10.0 110.821 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.88 -23.47 59.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.471 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.0 82.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.74 -0.663 . . . . 10.0 111.073 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLU . . . . . 0.423 ' HB3' ' CE2' ' B' ' 35' ' ' TYR . 16.4 pt-20 -68.1 -25.73 65.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.046 0.451 . . . . 10.0 110.742 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -68.09 -27.31 66.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.023 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.88 3.2 36.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.43 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.83 74.3 0.93 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.61 -0.805 . . . . 10.0 112.303 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 62.5 mt -131.42 166.29 21.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.663 0.268 . . . . 10.0 110.949 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -97.03 111.88 23.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.212 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.719 HD23 ' HD2' ' B' ' 34' ' ' PRO . 0.2 OUTLIER -154.01 131.17 5.98 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.348 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.765 ' HB3' HH21 ' A' ' 389' ' ' ARG . 73.4 Cg_endo -78.8 72.66 6.34 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.595 2.196 . . . . 10.0 112.519 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' B' ' 27' ' ' GLU . 0.1 OUTLIER -77.14 101.04 5.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.842 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' B' ' 37' ' ' CYS . 0.0 OUTLIER -103.29 -134.94 0.33 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.072 -0.513 . . . . 10.0 111.485 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 37' ' ' CYS . . . . . 0.5 ' H ' ' HB2' ' B' ' 36' ' ' SER . 5.8 p -60.4 -36.04 77.18 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' B' ' 38' ' ' ARG . 5.0 mtp85 69.94 12.76 7.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.942 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.78 36.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.629 0.233 . . . . 10.0 111.629 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.88 43.82 61.12 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.409 -0.424 . . . . 10.0 112.98 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.09 -49.06 3.35 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.543 -0.386 . . . . 10.0 111.8 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' CYS . . . . . 0.485 ' HB3' ' HD3' ' A' ' 378' ' ' PRO . 0.1 OUTLIER -86.13 165.22 16.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.133 0.492 . . . . 10.0 111.798 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 3.9 p -126.16 6.21 7.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.375 0.607 . . . . 10.0 110.094 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.31 -21.73 55.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.592 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.84 36.74 1.75 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.935 -0.575 . . . . 10.0 109.972 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' B' ' 73' ' ' LEU . . . -89.19 95.01 10.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.715 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.49 156.29 53.48 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.147 -0.549 . . . . 10.0 112.648 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.692 ' HD3' ' HB3' ' B' ' 89' ' ' GLN . 5.9 mptt -110.08 130.42 55.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.732 0.301 . . . . 10.0 110.788 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.464 ' HB ' ' HA2' ' B' ' 70' ' ' GLY . 21.5 t -84.36 112.63 21.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.192 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.633 ' HB3' ' HB ' ' B' ' 84' ' ' THR . . . -85.53 -37.72 19.32 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.38 153.42 17.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.444 -0.798 . . . . 10.0 108.893 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.664 ' HA3' ' HB3' ' B' ' 83' ' ' CYS . . . 93.55 -163.69 26.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.789 -0.719 . . . . 10.0 112.199 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -142.62 143.54 32.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.942 0.401 . . . . 10.0 111.071 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' B' ' 79' ' ' PRO . 6.7 m -129.48 150.86 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.807 -0.633 . . . . 10.0 109.451 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' B' ' 77' ' ' ALA . 31.1 t0 -95.82 118.73 33.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.882 0.372 . . . . 10.0 111.399 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.05 130.6 55.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.359 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 38.6 t -91.08 -57.93 2.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.877 0.37 . . . . 10.0 111.33 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -141.29 117.93 10.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.376 -0.375 . . . . 10.0 111.091 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.637 ' HG2' HD13 ' B' ' 73' ' ' LEU . 6.3 mt-30 -95.44 158.37 15.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.741 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 356' ' ' LYS . 0.8 OUTLIER -74.53 -103.28 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.509 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 61' ' ' PHE . . . . . 0.468 ' HZ ' HD13 ' B' ' 93' ' ' LEU . 5.8 p90 -86.45 -7.27 58.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 10.0 110.744 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.42 173.13 10.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.794 -0.817 . . . . 10.0 108.794 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -142.62 173.41 11.56 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.025 0.203 . . . . 10.0 111.287 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -48.0 -36.92 13.58 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.3 -22.47 61.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.903 0.705 . . . . 10.0 112.903 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.736 ' HB3' ' HB2' ' B' ' 71' ' ' PHE . 12.2 mm-40 -82.95 -10.26 58.88 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.43 0.529 . . . . 10.0 112.43 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' MET . . . . . . . . . . . . . 22.5 ttm -61.09 -52.15 66.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.742 0.306 . . . . 10.0 110.488 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.57 -21.83 79.32 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.775 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -73.86 -23.02 59.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.328 0.585 . . . . 10.0 109.517 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLY . . . . . 0.464 ' HA2' ' HB ' ' B' ' 49' ' ' VAL . . . 101.21 23.78 9.43 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.447 -0.797 . . . . 10.0 112.709 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.736 ' HB2' ' HB3' ' B' ' 66' ' ' GLN . 15.0 m-85 -119.68 108.5 14.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.007 0.403 . . . . 10.0 110.569 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.444 HG21 HG21 ' B' ' 54' ' ' VAL . 15.8 m -129.63 -170.91 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.52 -0.309 . . . . 10.0 110.562 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.637 HD13 ' HG2' ' B' ' 59' ' ' GLN . 2.8 mp -125.94 114.09 18.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -16.24 59.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.382 0.512 . . . . 10.0 112.382 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' CYS . . . . . 0.434 ' HA ' HD21 ' B' ' 23' ' ' LEU . 0.5 OUTLIER -88.1 -17.3 31.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.954 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 30.99 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 120.864 0.364 . . . . 10.0 111.473 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 55' ' ' ASP . . . -149.06 137.45 20.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.749 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -126.86 147.99 63.46 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.957 -0.565 . . . . 10.0 109.757 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 0.639 ' HA ' HG12 ' B' ' 54' ' ' VAL . 50.0 Cg_endo -69.43 119.89 6.79 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.295 1.996 . . . . 10.0 112.293 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -17.03 59.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.628 0.728 . . . . 10.0 109.445 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 67.7 m -159.6 176.25 12.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.942 -1.027 . . . . 10.0 108.511 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -63.13 130.16 43.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.15 -0.315 . . . . 10.0 110.15 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' CYS . . . . . 0.664 ' HB3' ' HA3' ' B' ' 52' ' ' GLY . 1.6 p -154.83 -176.85 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 10.0 111.822 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' B' ' 50' ' ' ALA . 0.3 OUTLIER -121.28 122.9 40.91 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.593 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 34.2 mm -124.11 134.43 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 10.0 111.589 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' GLN . . . . . 0.522 ' HB3' ' HB2' ' B' ' 48' ' ' LYS . 11.5 tt0 -93.3 136.02 33.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 9.7 p -91.03 -73.44 0.54 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.785 1.031 . . . . 10.0 113.785 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -65.79 98.1 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.098 0.777 . . . . 10.0 113.098 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.692 ' HB3' ' HD3' ' B' ' 48' ' ' LYS . 0.8 OUTLIER -173.81 85.7 0.05 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.431 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.47 11.26 32.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.906 0.384 . . . . 10.0 110.766 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.36 -38.35 8.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.96 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.04 73.01 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 10.0 111.549 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.468 HD13 ' HZ ' ' B' ' 61' ' ' PHE . 0.8 OUTLIER -170.77 20.65 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.822 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 4.2 t80 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.747 -0.644 . . . . 10.0 109.406 -179.037 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 501' ' ' SF4 . . . . . 0.702 ' S3 ' ' HA ' ' A' ' 381' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.584 0.23 . . . . 10.0 110.406 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 p -73.93 168.43 19.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.695 -0.23 . . . . 10.0 110.424 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -56.68 -37.88 71.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.534 -0.303 . . . . 10.0 111.532 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 212' ' ' ILE . 59.8 t -72.0 -49.68 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.338 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.66 -27.03 68.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 10.0 111.72 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.529 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 54.3 mt-30 -66.2 -13.72 60.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.78 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.13 -32.86 7.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.486 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.05 -34.04 72.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.944 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.04 81.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.529 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -76.44 -38.02 56.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.694 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.2 -33.08 75.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.55 . . . . 10.0 111.613 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.04 -29.16 69.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 90.0 mttt -73.49 128.21 87.58 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.04 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 37' ' ' LYS . 23.8 Cg_exo -65.25 158.34 52.82 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 122.896 2.397 . . . . 10.0 111.767 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -62.84 -20.64 65.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.244 0.461 . . . . 10.0 112.244 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -97.73 15.17 24.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.901 0.334 . . . . 10.0 111.901 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 8.6 t70 -94.08 130.78 33.26 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.5 -22.9 73.65 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.814 2.343 . . . . 10.0 113.375 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.9 p -93.84 3.13 55.87 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.923 0.392 . . . . 10.0 111.608 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -87.3 129.37 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.02 -0.536 . . . . 10.0 111.209 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -111.22 -176.21 2.9 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.39 111.4 21.72 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.006 -0.368 . . . . 10.0 110.006 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.93 101.13 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.713 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.8 m -96.31 140.29 31.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.888 -0.597 . . . . 10.0 109.784 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 11.1 p -126.23 144.73 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.799 0.333 . . . . 10.0 111.206 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 13.6 pt20 -128.61 129.14 45.49 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.608 HG11 HD21 ' A' ' 75' ' ' LEU . 5.7 t -113.23 150.07 15.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.882 0.373 . . . . 10.0 110.988 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.53 141.26 22.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.989 -0.55 . . . . 10.0 109.76 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.57 -32.09 62.4 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.168 2.579 . . . . 10.0 112.347 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.41 -22.43 66.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.568 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.538 HG13 HG23 ' A' ' 214' ' ' THR . 86.3 t -89.37 -38.54 11.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.202 0.525 . . . . 10.0 109.705 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -57.34 -29.79 64.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.412 -0.813 . . . . 10.0 112.321 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.35 -36.85 13.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.827 0.677 . . . . 10.0 112.827 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.83 -13.99 38.04 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.988 0.736 . . . . 10.0 112.988 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.61 -26.8 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.026 0.38 . . . . 10.0 112.026 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.39 -27.54 66.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.622 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' CD ' HH21 ' A' ' 399' ' ' ARG . 20.7 mt-10 -68.54 -29.53 68.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 10.0 111.382 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.34 -17.42 64.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.979 0.418 . . . . 10.0 110.569 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.7 mt -99.73 -11.8 20.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.585 . . . . 10.0 109.948 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.08 25.13 13.25 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.805 -0.634 . . . . 10.0 112.193 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -110.92 -175.42 2.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.628 0.251 . . . . 10.0 110.443 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.33 149.1 42.11 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.368 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.74 117.54 4.28 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.546 2.164 . . . . 10.0 111.666 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.35 4.02 47.2 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.856 -0.687 . . . . 10.0 113.203 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.0 -29.91 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 10.0 111.259 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -94.02 126.65 39.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.232 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 p -80.62 155.64 73.49 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.784 0.326 . . . . 10.0 111.326 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -41.84 73.23 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.002 2.468 . . . . 10.0 113.023 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -66.95 -34.0 76.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.59 -0.277 . . . . 10.0 111.669 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -66.68 -37.91 85.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.423 . . . . 10.0 110.481 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.608 HD21 HG11 ' A' ' 51' ' ' VAL . 44.9 tp -64.32 -46.82 81.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.072 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.61 85.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.867 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -61.72 -47.35 85.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.135 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.93 -39.87 96.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.924 -0.655 . . . . 10.0 112.449 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.496 HD11 HG21 ' A' ' 51' ' ' VAL . 19.5 mt -62.28 -43.96 97.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.962 0.411 . . . . 10.0 111.179 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -65.59 -27.36 68.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.012 0.434 . . . . 10.0 110.595 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -77.13 -11.43 59.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 10.0 111.359 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.2 -14.04 57.95 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.79 7.19 24.05 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.236 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -69.71 145.2 52.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.829 0.347 . . . . 10.0 111.231 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.86 -64.4 1.2 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.155 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -119.6 135.4 54.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.621 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.8 t -113.46 110.9 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.529 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 48.6 m-85 -111.05 162.38 14.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.896 0.379 . . . . 10.0 110.983 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -111.0 146.39 36.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 m -65.54 -19.67 66.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.497 -0.319 . . . . 10.0 111.555 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.0 mt -57.67 -36.63 72.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.635 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -67.59 -38.08 83.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.171 0.51 . . . . 10.0 109.902 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.33 -36.99 70.55 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.716 -0.954 . . . . 10.0 110.716 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.54 81.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.522 -0.339 . . . . 10.0 110.387 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -36.15 75.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.78 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.21 -41.31 67.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.564 -0.743 . . . . 10.0 109.6 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.3 m -60.72 -44.66 96.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.75 -0.659 . . . . 10.0 110.524 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.7 mt -58.52 -40.37 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 10.0 110.956 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.2 mmm -62.53 -53.11 59.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.286 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -67.28 -40.2 86.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.174 -0.467 . . . . 10.0 111.732 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 101' ' ' GLU . 2.9 tp10 -61.64 -45.91 92.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.894 0.378 . . . . 10.0 110.55 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.58 -35.02 91.23 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.033 -0.827 . . . . 10.0 111.033 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.0 m -70.81 -41.94 70.91 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.584 -0.308 . . . . 10.0 110.62 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -61.93 -47.27 85.63 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.614 -0.513 . . . . 10.0 109.614 178.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.1 -51.48 69.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.998 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.35 -37.63 81.27 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.989 0.423 . . . . 10.0 109.996 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 26.5 t60 -62.96 -51.6 66.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.407 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.527 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 68.4 mtt180 -62.49 -32.39 73.29 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.416 -0.357 . . . . 10.0 111.308 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.61 -50.58 29.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.407 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 m -58.01 -45.52 86.75 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.697 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 71.9 mm-40 -57.47 -36.83 71.96 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.054 0.454 . . . . 10.0 110.713 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.414 ' HE1' ' HA ' ' A' ' 122' ' ' PRO . 28.4 m80 -77.2 -28.51 53.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.509 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.75 -39.21 76.87 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.38 -41.19 69.99 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.323 -0.853 . . . . 10.0 109.965 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-N 115.582 -0.735 . . . . 10.0 111.963 179.625 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 108' ' ' ARG . 1.3 mp0 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.784 0.326 . . . . 10.0 110.475 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.414 ' HA ' ' HE1' ' A' ' 112' ' ' HIS . 74.3 Cg_endo -90.3 -175.06 0.86 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.913 2.408 . . . . 10.0 112.911 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.419 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 95.2 mt -130.21 158.3 74.6 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 123' ' ' LEU . 36.6 Cg_endo -64.27 167.26 42.79 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 124.318 -1.118 . . . . 10.0 113.667 0.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 27.7 ttt -111.87 131.08 55.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.431 -0.804 . . . . 10.0 110.762 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 372' ' ' VAL . 69.7 m-85 -111.14 139.5 46.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.934 -0.576 . . . . 10.0 109.911 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.55 152.32 36.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.643 0.258 . . . . 10.0 110.617 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.9 33.37 5.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.938 0.399 . . . . 10.0 111.266 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 2.8 m -92.53 17.01 10.72 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.725 0.639 . . . . 10.0 112.725 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.461 ' O ' HG12 ' A' ' 134' ' ' ILE . 0.9 OUTLIER -136.3 120.62 12.75 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 112.079 0.399 . . . . 10.0 112.079 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.54 -40.65 45.72 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.093 2.528 . . . . 10.0 112.366 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 376' ' ' ALA . . . -61.17 -40.44 98.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.906 -0.664 . . . . 10.0 111.827 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -65.68 -48.55 71.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.999 -0.371 . . . . 10.0 109.999 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 130' ' ' CYS . 49.7 mm -58.46 -43.24 86.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.812 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.19 -47.09 86.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.461 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 54.8 ttp -68.91 -30.73 69.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.046 0.451 . . . . 10.0 110.534 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 148' ' ' VAL . 10.7 tp -68.19 -57.98 5.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.148 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -59.69 -19.7 51.45 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.91 0.708 . . . . 10.0 112.91 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -104.13 -56.55 2.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.754 1.02 . . . . 10.0 113.754 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.1 m -88.67 -28.65 20.46 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.432 1.271 . . . . 10.0 114.432 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.12 66.71 68.62 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.742 0.645 . . . . 10.0 112.742 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.62 -12.41 29.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.197 1.931 . . . . 10.0 111.58 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -88.34 -13.05 41.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.452 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -101.78 2.57 38.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.462 -0.336 . . . . 10.0 111.825 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.475 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 55.5 mt -54.75 -51.44 78.88 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 113.598 0.962 . . . . 10.0 113.598 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 41.5 Cg_exo -58.69 -20.57 51.51 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.39 2.06 . . . . 10.0 113.292 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 325' ' ' LEU . 97.4 m-85 -79.69 -17.12 54.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.226 0.536 . . . . 10.0 111.028 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.456 HG21 HD22 ' A' ' 137' ' ' LEU . 27.9 t -87.86 152.37 3.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.033 -0.53 . . . . 10.0 109.965 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.465 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . 39.7 t -66.27 160.18 24.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.235 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 p -99.85 1.41 42.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.604 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 60.4 m -75.34 138.79 42.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.335 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 36.2 mtpt -80.77 168.63 18.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.456 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.87 148.9 98.42 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.384 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.44 -51.05 10.23 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.332 2.688 . . . . 10.0 113.458 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.476 ' H ' ' HG3' ' A' ' 155' ' ' GLN . 0.0 OUTLIER -65.67 -34.02 77.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.073 0.397 . . . . 10.0 112.073 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 56.9 mmm -73.74 -23.84 59.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.049 0.452 . . . . 10.0 110.718 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 39.4 mtt -75.46 -47.72 25.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.097 -0.705 . . . . 10.0 109.097 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.5 tp -63.91 -41.63 97.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.751 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.32 85.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.252 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.53 -36.7 63.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.645 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -66.44 -42.73 87.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.816 -0.629 . . . . 10.0 112.024 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.534 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.9 m -69.55 -29.88 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -85.78 1.73 48.46 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.166 0.432 . . . . 10.0 112.166 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.0 p -122.44 -75.93 0.59 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.845 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -62.05 -52.56 63.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.399 . . . . 10.0 111.542 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.534 ' HB3' ' O ' ' A' ' 162' ' ' VAL . 35.9 tp -61.24 -40.74 95.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.513 -0.312 . . . . 10.0 110.997 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.85 76.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.848 0.356 . . . . 10.0 110.667 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -66.47 -34.8 78.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.59 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -75.24 -37.12 61.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.793 0.33 . . . . 10.0 111.781 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.54 ' HB3' HG12 ' A' ' 172' ' ' ILE . 3.1 tttt -79.49 -20.54 47.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.815 0.34 . . . . 10.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 86.32 14.54 66.06 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.056 -0.592 . . . . 10.0 112.785 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 170' ' ' LYS . 14.0 pt -103.44 168.64 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.785 0.326 . . . . 10.0 111.057 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -100.01 142.55 24.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.038 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 173' ' ' ALA . 35.8 Cg_exo -59.28 -19.93 52.84 Favored 'Trans proline' 0 N--CA 1.473 0.287 0 C-N-CA 122.995 2.464 . . . . 10.0 112.881 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -77.23 -19.49 56.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.199 0.523 . . . . 10.0 110.608 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -100.77 17.86 20.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.583 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 83.6 mtp -124.62 123.53 40.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.332 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.3 t -110.84 120.09 60.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.574 ' HB3' HD12 ' A' ' 208' ' ' LEU . 0.0 OUTLIER -104.21 123.51 47.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.289 0.566 . . . . 10.0 112.21 -178.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 22.5 t -118.69 135.63 58.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.41 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.428 ' OG ' HD21 ' A' ' 208' ' ' LEU . 3.7 p -123.21 139.04 54.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.724 0.297 . . . . 10.0 111.368 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 212' ' ' ILE . 24.1 mm -101.64 102.19 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.946 -0.761 . . . . 10.0 108.946 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 213' ' ' THR . 32.2 mmt -114.08 150.16 43.13 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.05 -0.523 . . . . 10.0 111.54 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.77 17.48 1.52 Allowed 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.854 2.369 . . . . 10.0 112.894 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 97.3 m -149.55 129.46 13.4 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.108 -0.331 . . . . 10.0 110.108 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -30.07 70.02 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -64.15 -9.55 17.42 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.649 0.611 . . . . 10.0 112.649 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 188' ' ' LYS . 25.0 mmtt -66.97 -28.2 68.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.349 . . . . 10.0 110.921 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -68.02 -36.75 80.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 10.0 109.989 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -32.56 67.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.815 -0.629 . . . . 10.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -70.63 -41.13 72.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.753 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -75.12 -30.17 60.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.665 -0.698 . . . . 10.0 112.781 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -80.87 70.81 7.75 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 56.0 mtt180 -115.32 148.4 39.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.434 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -48.93 -63.03 1.22 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.637 0.977 . . . . 10.0 113.637 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -66.97 -2.2 5.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.349 1.24 . . . . 10.0 114.349 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.446 ' CD2' ' HB2' ' A' ' 194' ' ' ARG . 2.6 m-30 -82.22 61.98 5.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.379 0.609 . . . . 10.0 111.599 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 12.1 p -113.15 168.94 9.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 10.0 110.396 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 22.4 t -80.66 83.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.221 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.037 -0.983 . . . . 10.0 111.311 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.673 -0.491 . . . . 10.0 109.673 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.796 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.228 -0.052 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -88.1 144.73 26.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.272 -0.27 . . . . 10.0 110.272 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -67.52 -40.67 85.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.242 0.544 . . . . 10.0 109.535 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LEU . . . . . 0.574 HD12 ' HB3' ' A' ' 179' ' ' MET . 29.5 tp -126.24 137.49 53.53 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.375 -1.343 . . . . 10.0 107.375 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -99.24 -57.89 2.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.47 0.915 . . . . 10.0 113.47 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.529 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 12.6 m-70 -134.32 153.15 52.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.028 0.751 . . . . 10.0 113.028 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 46.0 t -126.72 131.76 70.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.557 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 71.3 mt -122.42 139.52 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 183' ' ' MET . 43.2 p -91.98 167.2 12.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.809 0.3 . . . . 10.0 111.809 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.538 HG23 HG13 ' A' ' 55' ' ' VAL . 2.7 m -52.64 -52.92 53.45 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.003 -0.544 . . . . 10.0 112.077 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.0 m -57.87 -36.19 54.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.448 ' O ' HG13 ' A' ' 220' ' ' ILE . 50.1 mt-10 -73.33 -45.3 56.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.58 -0.282 . . . . 10.0 111.027 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.408 HD22 HG21 ' A' ' 182' ' ' ILE . 36.1 tp -62.59 -45.52 92.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.86 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.98 -30.94 78.99 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.931 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -67.97 -41.76 81.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 216' ' ' GLU . 61.7 mt -58.8 -42.77 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.228 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -62.57 -44.74 95.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.554 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -67.51 -43.94 79.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 10.0 111.955 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.71 -23.84 66.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 10.0 111.299 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -94.33 -3.18 50.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.961 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 68.35 38.99 87.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.931 -0.652 . . . . 10.0 112.189 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 57.4 mt -116.07 110.4 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.834 0.349 . . . . 10.0 110.509 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -96.61 113.71 25.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.966 -0.383 . . . . 10.0 109.966 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.619 HD23 HD12 ' A' ' 231' ' ' LEU . 38.6 mt -59.1 -28.97 67.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.807 -0.633 . . . . 10.0 112.183 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.27 -18.46 63.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.6 -0.273 . . . . 10.0 111.569 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -111.26 20.75 17.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.968 0.413 . . . . 10.0 110.974 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.619 HD12 HD23 ' A' ' 228' ' ' LEU . 56.7 mt -104.39 150.92 38.98 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.936 -0.575 . . . . 10.0 110.274 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.47 172.01 16.98 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.284 1.989 . . . . 10.0 111.576 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.8 102.32 11.51 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.642 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -83.48 -154.64 18.05 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.005 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.85 156.99 43.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 10.0 110.716 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -92.66 -174.7 3.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.685 -0.688 . . . . 10.0 110.254 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.5 147.47 42.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.892 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -93.41 120.19 66.72 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.158 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.06 -15.36 47.42 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.133 2.556 . . . . 10.0 112.315 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 86.9 mmm -78.64 0.65 25.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 10.0 111.465 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 103.27 -70.06 0.29 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.135 -0.555 . . . . 10.0 112.774 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.44 169.65 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.901 0.382 . . . . 10.0 111.578 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 104.43 136.5 8.84 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.619 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.2 m -80.2 130.35 35.15 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.178 -0.305 . . . . 10.0 110.178 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 120.06 179.72 16.45 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.228 -0.749 . . . . 10.0 111.228 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.25 -2.18 50.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.847 0.356 . . . . 10.0 111.277 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.86 4.03 79.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.18 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.93 118.68 53.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 30.2 mt -75.51 149.95 38.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.384 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.33 106.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.057 0.456 . . . . 10.0 111.153 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 164.84 127.11 0.86 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.078 -0.809 . . . . 10.0 111.078 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 11.2 t -75.18 148.19 39.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.169 0.509 . . . . 10.0 111.562 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.34 -9.46 25.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.657 -0.701 . . . . 10.0 109.497 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.433 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 89.68 -32.22 4.89 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.687 -0.688 . . . . 10.0 112.47 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 151.69 170.31 18.29 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.365 -1.094 . . . . 10.0 110.365 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.86 -55.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.541 0.67 . . . . 10.0 110.406 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' MET . . . . . 0.541 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 23.5 ttp -59.4 -48.28 82.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.406 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.433 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 36.5 tt0 -61.34 -46.19 91.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 10.0 112.138 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.84 81.96 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 121.046 -0.261 . . . . 10.0 111.167 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.74 -47.46 72.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 257' ' ' MET . 90.1 mt -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.826 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 45.6 ttm105 -58.95 -48.37 81.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.051 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 87.0 m -55.52 -43.32 75.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 10.0 111.546 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.84 -43.93 57.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.849 0.357 . . . . 10.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' TYR . . . . . 0.502 ' HD1' ' HG2' ' A' ' 294' ' ' MET . 84.0 t80 -62.07 -46.09 90.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.079 -0.509 . . . . 10.0 112.063 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 262' ' ' ARG . 52.3 mt-10 -64.98 -23.18 67.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.565 0.579 . . . . 10.0 112.565 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 73.4 mt -90.18 -35.07 15.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.103 0.478 . . . . 10.0 110.467 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -72.62 -43.09 63.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.678 -0.692 . . . . 10.0 111.604 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 70.1 p -96.38 -33.53 11.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.164 -0.471 . . . . 10.0 112.191 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 85.31 9.15 80.15 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.789 -0.925 . . . . 10.0 110.789 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 70.9 p -112.69 146.13 34.41 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.698 -0.251 . . . . 10.0 110.775 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' PRO . . . . . 0.415 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 40.0 Cg_endo -69.99 131.69 21.42 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.501 2.134 . . . . 10.0 111.9 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.454 ' HB3' ' HG3' ' A' ' 262' ' ' ARG . 46.9 tp -103.99 121.47 47.71 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.069 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.55 -156.21 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.191 2.594 . . . . 10.0 111.774 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -78.4 141.21 38.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.484 -0.325 . . . . 10.0 110.618 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 95.6 mt -89.81 141.61 28.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 1.5 m -106.59 105.35 15.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.582 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 288' ' ' LYS . 3.4 mm? -77.98 113.94 16.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.823 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.5 m -89.86 152.52 21.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.272 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -79.75 123.63 27.86 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.51 112.7 5.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.074 0.464 . . . . 10.0 110.643 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 16.0 ttm-85 -66.97 108.35 2.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.602 -0.726 . . . . 10.0 110.353 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 123.5 -18.69 7.68 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.006 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' MET . . . . . 0.481 ' SD ' ' HD2' ' A' ' 361' ' ' LYS . 56.4 mtm -139.98 102.54 4.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.012 0.434 . . . . 10.0 110.609 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.71 138.81 48.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.264 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.83 -13.5 67.04 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.587 -0.733 . . . . 10.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 21.7 mm -99.44 127.81 51.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.018 0.437 . . . . 10.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 278' ' ' LEU . 33.6 mmtt -115.62 157.57 23.98 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.11 159.66 44.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.249 0.547 . . . . 10.0 112.371 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 9.1 t -155.99 152.21 27.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.254 -0.885 . . . . 10.0 109.257 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -128.32 123.41 33.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.808 0.337 . . . . 10.0 110.649 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.91 118.41 58.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.913 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.54 97.75 3.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.044 0.449 . . . . 10.0 110.588 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' MET . . . . . 0.502 ' HG2' ' HD1' ' A' ' 265' ' ' TYR . 81.7 mtp -87.1 113.26 22.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.108 -0.497 . . . . 10.0 111.449 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 36.3 t -112.34 120.42 41.52 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.7 135.57 61.08 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.891 2.394 . . . . 10.0 112.782 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . . . -66.97 132.06 93.84 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.779 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 297' ' ' ALA . 38.8 Cg_exo -59.04 114.13 1.88 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.954 2.436 . . . . 10.0 112.286 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.52 -12.1 39.3 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.681 -0.771 . . . . 10.0 113.123 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 97.0 p -84.33 162.53 20.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.885 0.374 . . . . 10.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -64.5 -26.11 68.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.231 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -64.27 -40.0 95.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.317 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -72.48 -46.05 56.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 10.0 109.901 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 2.2 tm-20 -57.28 -46.63 82.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.395 -0.821 . . . . 10.0 111.324 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.15 -53.51 54.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 10.0 112.008 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.5 tt -60.13 -38.5 83.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.315 -0.402 . . . . 10.0 111.804 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -75.65 -33.31 60.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.563 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 304' ' ' GLU . 0.7 OUTLIER -75.46 -47.52 26.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.78 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -123.33 100.85 7.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.182 0.515 . . . . 10.0 112.073 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -110.19 -1.48 17.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.473 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.365 -0.826 . . . . 10.0 110.529 -179.683 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.299 -0.721 . . . . 10.0 111.299 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.63 -31.33 94.18 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.838 2.359 . . . . 10.0 112.415 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.414 ' HB2' ' CE1' ' A' ' 147' ' ' TYR . 85.1 mt -109.11 110.95 22.33 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -94.84 120.62 35.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.565 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -67.54 131.98 46.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.779 -0.452 . . . . 10.0 109.779 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.08 -1.71 37.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.609 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 103.26 -6.39 50.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.868 -0.682 . . . . 10.0 111.593 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLY . . . . . 0.404 ' HA2' ' NH2' ' A' ' 345' ' ' ARG . . . 92.23 153.86 30.34 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.77 -0.728 . . . . 10.0 111.721 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.5 82.43 8.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.057 0.456 . . . . 10.0 110.182 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -98.29 155.16 20.23 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.8 -0.714 . . . . 10.0 112.938 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -142.76 160.18 40.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.984 -0.376 . . . . 10.0 109.984 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.8 t -141.38 142.59 33.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.91 0.386 . . . . 10.0 110.49 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.44 169.58 8.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.463 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.92 23.88 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 10.0 112.063 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -111.77 -7.85 14.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.276 0.56 . . . . 10.0 109.806 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 102.6 -8.88 55.23 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.728 . . . . 10.0 112.373 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -100.95 176.81 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.054 0.454 . . . . 10.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -173.68 -175.44 41.38 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.922 -0.871 . . . . 10.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -167.65 -173.28 35.61 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.949 -0.643 . . . . 10.0 111.553 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ILE . . . . . 0.429 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 7.9 tt -136.8 131.02 46.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.71 0.291 . . . . 10.0 110.581 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.6 t -90.9 106.87 18.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.103 0.478 . . . . 10.0 110.507 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 25.0 tp -64.07 115.49 4.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.527 -0.76 . . . . 10.0 110.577 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 369' ' ' TYR . 60.5 mtm180 -86.62 105.23 16.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.86 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.74 130.57 59.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.015 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 372' ' ' VAL . . . -126.87 139.18 53.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.307 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.61 114.16 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.797 -0.446 . . . . 10.0 109.797 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.504 ' HB3' HG12 ' A' ' 374' ' ' ILE . . . -98.59 105.08 17.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.496 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ASN . . . . . 0.854 ' HB3' ' HA ' ' A' ' 378' ' ' PRO . 2.3 m-80 -95.99 108.62 21.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.49 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 112.04 126.06 4.67 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.708 -0.957 . . . . 10.0 110.708 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 43.6 mt -59.17 -37.49 77.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.889 0.376 . . . . 10.0 111.478 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -68.99 -26.56 74.61 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.636 -0.793 . . . . 10.0 111.703 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.809 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 93.3 m-20 -84.75 -40.36 17.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.924 0.392 . . . . 10.0 110.007 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.8 94.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.383 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -55.9 -39.56 71.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.434 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.809 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 9.4 mtmm -70.79 -42.82 69.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.511 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.83 -46.86 85.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 10.0 110.974 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 97.7 mt -56.73 -45.5 82.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.562 . . . . 10.0 110.905 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 22.0 m -60.59 -45.27 94.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.7 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.481 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 36.6 mttm -66.02 -32.76 74.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.325 -0.398 . . . . 10.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 367' ' ' ALA . 87.3 mtp -68.49 -42.99 77.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.026 0.441 . . . . 10.0 110.042 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -69.1 -24.41 64.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.003 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -86.0 -7.88 58.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.044 -0.526 . . . . 10.0 111.064 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 81.2 13.95 79.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.789 -0.719 . . . . 10.0 112.949 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -77.64 -37.83 49.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.228 0.537 . . . . 10.0 110.056 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 362' ' ' MET . . . -135.14 126.06 27.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.583 -0.735 . . . . 10.0 109.388 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -119.94 125.76 49.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.81 0.338 . . . . 10.0 110.977 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 345' ' ' ARG . 72.7 m-85 -134.92 158.71 43.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.824 -0.625 . . . . 10.0 109.596 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -97.3 -36.56 10.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.027 0.441 . . . . 10.0 111.248 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' PHE . . . . . 0.541 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 26.8 t80 -125.56 126.95 45.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.57 -0.529 . . . . 10.0 109.57 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 126' ' ' PHE . 25.3 t -130.3 118.76 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.02 0.438 . . . . 10.0 111.882 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.19 129.84 44.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.985 -1.117 . . . . 10.0 107.985 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 349' ' ' ALA . 59.3 mt -121.37 125.26 73.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.241 0.543 . . . . 10.0 112.076 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' MET . . . . . 0.406 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 13.0 mmt -115.17 145.96 41.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.591 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ALA . . . . . 0.457 ' HB2' ' HA3' ' A' ' 132' ' ' GLY . . . -78.14 -26.75 47.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.758 0.313 . . . . 10.0 111.122 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 14.7 m -120.45 121.29 29.33 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.467 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.854 ' HA ' ' HB3' ' A' ' 350' ' ' ASN . 24.0 Cg_exo -65.79 -9.88 24.59 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.221 2.614 . . . . 10.0 112.39 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -96.41 9.77 40.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.584 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 73.21 -153.71 48.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.737 -0.744 . . . . 10.0 112.342 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' CYS . . . . . . . . . . . . . 20.4 m -88.0 -15.53 36.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.018 0.437 . . . . 10.0 110.976 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 34.7 m -77.94 -14.04 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.93 0.395 . . . . 10.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -116.61 25.23 9.19 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.989 -0.624 . . . . 10.0 111.972 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -65.7 168.72 31.34 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.248 -0.501 . . . . 10.0 112.896 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -69.24 -24.31 76.02 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.089 -0.577 . . . . 10.0 113.677 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -85.71 -6.13 83.34 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.648 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -82.76 155.31 68.22 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.74 164.69 33.56 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.428 2.085 . . . . 10.0 110.803 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' B' ' 33' ' ' LEU . 0.0 OUTLIER -128.66 121.95 29.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.231 0.539 . . . . 10.0 111.619 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 49.2 m -110.26 170.01 8.36 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.694 . . . . 10.0 110.003 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -16.24 62.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.823 0.344 . . . . 10.0 111.751 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.74 126.64 31.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.592 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -86.25 -4.98 59.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.025 -0.534 . . . . 10.0 111.922 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -110.83 15.47 21.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.257 0.551 . . . . 10.0 109.812 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 8.2 tp -63.46 -26.99 42.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.893 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -46.17 86.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.31 0.576 . . . . 10.0 110.204 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -67.87 -36.61 80.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.507 -0.77 . . . . 10.0 110.667 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -61.54 -43.03 99.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.636 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ARG . . . . . 0.405 HH21 ' CD ' ' A' ' 61' ' ' GLU . 99.0 mtt180 -68.39 -41.55 80.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.715 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -64.1 -39.48 94.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.923 -0.58 . . . . 10.0 111.344 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -70.88 -24.52 62.51 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.248 0.462 . . . . 10.0 112.248 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -101.54 14.39 32.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.579 0.585 . . . . 10.0 112.579 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.09 -38.33 85.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.138 0.494 . . . . 10.0 110.775 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' TYR . . . . . 0.506 ' O ' ' HE3' ' A' ' 409' ' ' LYS . 83.4 m-85 -136.14 153.83 51.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.536 -0.756 . . . . 10.0 109.318 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -82.79 165.65 19.68 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.657 -0.498 . . . . 10.0 109.657 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.22 -33.86 59.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.692 0.282 . . . . 10.0 111.641 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -63.6 -54.47 35.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.796 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.43 -33.45 75.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.624 . . . . 10.0 111.411 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' LYS . . . . . 0.506 ' HE3' ' O ' ' A' ' 404' ' ' TYR . 95.9 mttt -67.46 -30.18 69.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.662 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 6.1 p -94.17 8.09 42.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.961 0.41 . . . . 10.0 111.312 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 6.3 m -122.08 101.78 7.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.611 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 21.0 tp -83.46 122.36 28.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.176 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 40.9 ttp85 -123.58 148.68 46.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.828 0.347 . . . . 10.0 111.306 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 417' ' ' GLU . 1.2 mpt_? -116.33 136.38 53.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.408 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.7 m -62.91 -29.37 70.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.319 0.488 . . . . 10.0 112.319 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -73.0 4.93 3.7 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.524 0.565 . . . . 10.0 112.524 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' GLU . . . . . 0.432 ' OE2' ' HD3' ' A' ' 414' ' ' ARG . 20.4 mt-10 -122.81 13.81 9.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.481 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -88.27 117.08 67.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.186 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.67 -35.16 92.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.233 2.622 . . . . 10.0 112.558 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 50.2 m -70.81 -38.66 73.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.893 0.378 . . . . 10.0 110.907 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.26 -42.85 78.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.399 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -61.93 -35.64 79.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.98 -0.555 . . . . 10.0 111.41 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -64.21 -49.84 70.42 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.095 0.474 . . . . 10.0 110.006 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.54 -38.78 91.35 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.954 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' TYR . . . . . 0.756 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.4 m-85 -74.24 -11.3 60.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.031 -0.531 . . . . 10.0 111.549 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -97.56 -52.74 3.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.182 0.808 . . . . 10.0 113.182 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.06 17.54 18.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.639 1.348 . . . . 10.0 114.639 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -155.63 -63.82 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.107 0.78 . . . . 10.0 113.107 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' LEU . . . . . 0.756 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 67.9 mt -67.38 -50.69 58.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.877 0.695 . . . . 10.0 112.877 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 92.65 -132.66 11.36 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.556 -0.831 . . . . 10.0 111.512 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 24.2 mm-40 -86.5 144.79 38.33 Favored Pre-proline 0 C--N 1.318 -0.769 0 O-C-N 122.662 -0.316 . . . . 10.0 110.698 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 431' ' ' GLU . 44.8 Cg_exo -58.89 147.06 91.13 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.941 2.427 . . . . 10.0 111.264 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 3.5 mp 62.74 17.85 10.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.515 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -76.35 -176.57 42.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.085 -0.579 . . . . 10.0 112.44 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -60.85 -51.8 67.76 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.394 0.278 . . . . 10.0 111.736 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -38.98 93.29 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.847 0.356 . . . . 10.0 110.781 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.42 75.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.986 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' HIS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 2.5 t-160 -68.81 -31.03 69.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.069 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.1 -40.9 17.7 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.6 mt -96.31 -42.81 7.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 114.577 1.325 . . . . 10.0 114.577 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.58 -17.81 21.99 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 39.2 m-70 -114.57 171.24 7.75 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.245 -0.285 . . . . 10.0 110.644 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.9 t -162.89 -175.75 4.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.526 0.203 . . . . 10.0 111.058 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -129.89 157.82 41.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.527 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.87 164.19 13.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.35 -0.387 . . . . 10.0 110.187 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 95.1 t -120.87 109.37 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.118 0.485 . . . . 10.0 111.792 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -65.89 115.45 6.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.054 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 122.33 -15.36 8.71 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.34 -0.704 . . . . 10.0 111.34 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . 113.39 143.67 8.67 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.869 -0.682 . . . . 10.0 112.136 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' VAL . . . . . 0.441 HG11 ' NH1' ' A' ' 194' ' ' ARG . 36.0 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.314 -0.85 . . . . 10.0 110.922 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 120.797 0.332 . . . . 10.0 110.8 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -89.86 101.23 13.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.106 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -109.92 123.72 66.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.949 -0.569 . . . . 10.0 111.153 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.735 ' HB ' HG23 ' B' ' 84' ' ' THR . 15.9 m -89.3 117.91 28.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.969 -0.559 . . . . 10.0 109.995 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 23.9 mt -91.02 126.78 36.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.151 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LYS . . . . . 0.692 ' HB2' ' HA ' ' B' ' 86' ' ' GLN . 9.4 mttm -87.66 75.22 9.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.902 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.19 148.0 77.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.54 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.54 -12.82 32.89 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.485 2.124 . . . . 10.0 111.92 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.27 -1.8 43.99 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.851 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.9 153.37 7.0 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.842 -0.694 . . . . 10.0 111.635 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.85 140.78 40.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.44 0.162 . . . . 10.0 110.723 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -144.16 122.79 12.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.638 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 41.1 m -86.89 121.26 29.13 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ILE . . . . . 0.463 HD12 ' HB3' ' B' ' 25' ' ' ALA . 46.5 pt -113.34 150.05 15.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.083 0.468 . . . . 10.0 111.932 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -92.01 102.16 14.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.536 -0.756 . . . . 10.0 109.722 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 50.1 t -114.4 128.29 25.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.338 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' B' ' 20' ' ' THR . 14.4 Cg_exo -70.88 164.92 33.95 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.981 2.454 . . . . 10.0 111.152 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.56 -15.36 56.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.12 0.486 . . . . 10.0 111.097 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.65 12.81 35.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.292 0.567 . . . . 10.0 110.847 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' THR . . . . . 0.479 ' HB ' ' HD2' ' B' ' 17' ' ' PRO . 4.7 m -137.29 143.03 41.93 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.95 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -73.55 150.37 41.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.437 -0.347 . . . . 10.0 111.098 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.516 HG12 ' HD3' ' B' ' 79' ' ' PRO . 21.6 mt -54.53 -33.15 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.922 -0.581 . . . . 10.0 112.099 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.455 HD13 HD23 ' B' ' 33' ' ' LEU . 9.9 tp -54.16 -43.24 70.44 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.89 0.7 . . . . 10.0 112.89 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.85 -41.8 98.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.924 0.393 . . . . 10.0 111.938 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.463 ' HB3' HD12 ' B' ' 14' ' ' ILE . . . -74.22 -30.47 62.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.977 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.42 -49.69 75.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.239 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -71.3 -26.4 62.85 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.957 -0.297 . . . . 10.0 111.564 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.04 -37.03 83.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.34 -0.615 . . . . 10.0 109.34 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.91 -8.42 59.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.776 -0.647 . . . . 10.0 110.904 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.39 35.21 20.96 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.891 -0.595 . . . . 10.0 112.818 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.6 158.63 15.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.783 0.325 . . . . 10.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -89.85 113.73 25.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.989 -0.551 . . . . 10.0 111.051 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.741 HD12 ' HD2' ' B' ' 34' ' ' PRO . 19.7 tp -137.15 125.02 14.43 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.782 -0.645 . . . . 10.0 109.277 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.741 ' HD2' HD12 ' B' ' 33' ' ' LEU . 58.2 Cg_endo -71.77 65.94 3.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.067 2.511 . . . . 10.0 113.497 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -89.88 167.02 13.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.892 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' SER . . . . . 0.434 ' N ' ' S1 ' ' B' ' 101' ' ' FES . 2.1 p -152.78 -94.99 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' CYS . . . . . 0.43 ' SG ' ' HG2' ' A' ' 378' ' ' PRO . 25.8 p -72.61 -20.82 61.22 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.313 0.857 . . . . 10.0 113.313 -177.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 68.35 15.59 9.26 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.686 0.279 . . . . 10.0 111.639 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.53 -5.49 35.69 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.564 0.579 . . . . 10.0 112.564 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.446 ' N ' ' S2 ' ' B' ' 101' ' ' FES . . . 74.98 28.13 63.13 Favored Glycine 0 C--O 1.229 -0.199 0 C-N-CA 120.973 -0.632 . . . . 10.0 113.464 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.61 3.63 27.11 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.612 -0.346 . . . . 10.0 111.661 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 m -107.54 129.42 54.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.079 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -79.95 -8.8 59.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.096 0.474 . . . . 10.0 110.264 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -17.51 60.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.177 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 4.4 m -103.63 27.22 7.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.809 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' B' ' 73' ' ' LEU . . . -99.08 106.39 18.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.649 -0.705 . . . . 10.0 110.184 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.44 174.6 54.6 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.07 -0.586 . . . . 10.0 113.073 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.773 ' HD3' ' HB3' ' B' ' 89' ' ' GLN . 1.3 mptt -114.33 137.63 51.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.674 0.273 . . . . 10.0 110.761 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.706 ' HB ' ' HA2' ' B' ' 70' ' ' GLY . 58.3 t -80.75 110.01 15.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.175 -0.466 . . . . 10.0 111.698 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' B' ' 84' ' ' THR . . . -93.19 -29.27 15.81 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.871 -0.789 . . . . 10.0 108.871 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' B' ' 83' ' ' CYS . . . -166.62 155.66 10.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.087 -0.96 . . . . 10.0 108.863 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLY . . . . . 0.746 ' HA3' ' HB3' ' B' ' 83' ' ' CYS . . . 70.37 -165.88 51.34 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.118 -0.563 . . . . 10.0 113.041 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.33 154.04 38.37 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.949 0.405 . . . . 10.0 110.791 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' B' ' 79' ' ' PRO . 13.9 m -119.93 163.93 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.84 110.79 22.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.095 0.474 . . . . 10.0 112.224 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.78 145.65 31.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.345 -0.843 . . . . 10.0 109.061 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -106.69 -60.05 1.72 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.947 0.403 . . . . 10.0 110.826 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -159.71 141.4 13.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.424 ' NE2' ' HB2' ' B' ' 73' ' ' LEU . 0.0 OUTLIER -135.0 -100.93 0.23 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.923 0.342 . . . . 10.0 111.923 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 44.5 p -114.54 -101.55 0.42 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.783 0.325 . . . . 10.0 111.841 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -102.02 76.19 1.58 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.855 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -165.92 107.97 0.75 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.396 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -94.14 164.22 13.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.509 -0.769 . . . . 10.0 109.997 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.22 -29.26 60.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.827 0.346 . . . . 10.0 111.182 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.45 70.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.288 0.566 . . . . 10.0 110.124 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLN . . . . . 0.648 ' HB3' ' HD2' ' B' ' 71' ' ' PHE . 48.3 mt-30 -90.46 -28.93 18.27 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.072 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' MET . . . . . 0.681 ' HA ' ' O ' ' B' ' 71' ' ' PHE . 25.4 ttt -58.04 -53.73 54.99 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.478 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.51 -16.09 73.52 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.886 -0.673 . . . . 10.0 111.805 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -81.18 -9.85 59.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.956 0.408 . . . . 10.0 110.565 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLY . . . . . 0.706 ' HA2' ' HB ' ' B' ' 49' ' ' VAL . . . 110.99 29.31 3.56 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.639 -0.791 . . . . 10.0 113.64 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' PHE . . . . . 0.681 ' O ' ' HA ' ' B' ' 67' ' ' MET . 19.2 m-85 -129.7 130.24 45.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.219 0.51 . . . . 10.0 110.512 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' VAL . . . . . 0.453 HG11 HG22 ' B' ' 54' ' ' VAL . 4.8 m -144.75 -165.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.605 0.24 . . . . 10.0 110.725 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.562 ' HA ' ' HA ' ' B' ' 46' ' ' ALA . 22.7 tp -120.53 143.49 48.55 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.78 -3.69 12.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.956 0.408 . . . . 10.0 110.838 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' CYS . . . . . 0.534 ' H ' ' HG ' ' B' ' 73' ' ' LEU . 42.7 t -72.22 -57.06 4.54 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.332 0.864 . . . . 10.0 113.332 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 14.0 m -126.44 23.82 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.075 0.398 . . . . 10.0 112.075 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' B' ' 73' ' ' LEU . . . -111.83 152.43 27.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.74 0.305 . . . . 10.0 110.744 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -127.51 150.69 73.53 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.877 -0.601 . . . . 10.0 109.636 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' PRO . . . . . 0.516 ' HD3' HG12 ' B' ' 22' ' ' ILE . 70.8 Cg_endo -77.46 127.56 9.04 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.292 1.995 . . . . 10.0 112.14 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.43 -17.74 61.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.379 0.609 . . . . 10.0 109.985 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 8.3 m -152.68 168.09 26.78 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.427 -0.806 . . . . 10.0 109.349 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.24 125.28 24.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' CYS . . . . . 0.746 ' HB3' ' HA3' ' B' ' 52' ' ' GLY . 1.7 p -149.59 -168.52 3.13 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.93 0.715 . . . . 10.0 112.93 -177.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' THR . . . . . 0.735 HG23 ' HB ' ' B' ' 4' ' ' THR . 0.9 OUTLIER -131.07 126.33 35.54 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.244 -0.889 . . . . 10.0 108.716 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 32.7 mm -130.0 133.71 64.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.764 0.316 . . . . 10.0 111.575 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' GLN . . . . . 0.692 ' HA ' ' HB2' ' B' ' 6' ' ' LYS . 51.1 tt0 -82.42 146.18 29.46 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.7 p -94.79 -93.88 0.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.797 1.406 . . . . 10.0 114.797 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -65.74 90.11 0.12 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.743 1.016 . . . . 10.0 113.743 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.773 ' HB3' ' HD3' ' B' ' 48' ' ' LYS . 0.7 OUTLIER -150.66 97.35 2.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.137 -0.483 . . . . 10.0 109.834 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.507 ' HA ' HD21 ' B' ' 93' ' ' LEU . 13.9 pt-20 -119.67 18.75 12.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.12 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -107.21 -11.96 15.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.054 0.454 . . . . 10.0 110.591 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -120.0 81.46 1.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.249 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' B' ' 90' ' ' GLU . 0.7 OUTLIER 179.49 88.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.524 -0.762 . . . . 10.0 110.357 178.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 45.4 t80 . . . . . 0 C--O 1.246 0.894 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 -179.471 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 501' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 101' ' ' FES . . . . . 0.446 ' S2 ' ' N ' ' B' ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.921 -0.4 . . . . 10.0 109.921 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m -69.53 155.04 41.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.572 -0.286 . . . . 10.0 110.271 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -60.29 -31.84 70.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.646 -0.252 . . . . 10.0 111.202 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.544 HG22 HG12 ' A' ' 212' ' ' ILE . 93.7 t -66.83 -45.07 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.939 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -62.83 -36.6 83.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.616 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -59.83 -34.68 73.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -69.87 -40.85 75.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.082 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.76 -28.32 69.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.63 -0.714 . . . . 10.0 111.055 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.38 80.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.861 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -70.65 -35.35 72.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.678 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 91.0 mt -66.51 -32.32 73.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.161 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.09 -25.3 66.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.19 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 93.3 mttt -72.91 136.37 79.97 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.258 -0.428 . . . . 10.0 109.94 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' LYS . 51.5 Cg_exo -54.95 152.7 28.28 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.991 2.461 . . . . 10.0 111.98 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -61.44 -35.28 77.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.303 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.52 14.53 24.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.074 -0.512 . . . . 10.0 112.239 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 44' ' ' ARG . 14.4 t70 -68.35 134.88 91.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.393 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.39 -22.78 67.37 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.271 2.647 . . . . 10.0 113.998 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.3 4.56 24.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 10.0 111.265 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 6.4 tpt180 -82.38 130.47 35.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.516 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 176' ' ' ASP . 18.9 mttp -108.69 178.21 4.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.802 -0.636 . . . . 10.0 109.655 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.16 117.17 23.31 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 t -102.94 102.58 13.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.247 0.546 . . . . 10.0 111.066 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 179' ' ' MET . 2.8 m -97.95 144.24 27.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.531 -0.758 . . . . 10.0 109.295 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 13.7 p -130.66 141.9 45.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.828 0.347 . . . . 10.0 111.52 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 21.7 pt20 -121.86 126.93 49.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 10.0 109.933 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.679 HG11 HD21 ' A' ' 75' ' ' LEU . 3.0 t -110.27 155.4 11.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.581 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.02 144.7 29.28 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.544 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.72 -33.67 88.38 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.937 2.424 . . . . 10.0 111.944 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.3 67.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.65 HG13 HG23 ' A' ' 214' ' ' THR . 98.5 t -85.49 -39.95 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.058 0.456 . . . . 10.0 109.779 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -57.44 -31.72 66.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.697 -0.683 . . . . 10.0 112.284 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.56 -39.21 16.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.992 0.738 . . . . 10.0 112.992 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB2' ' HD3' ' A' ' 399' ' ' ARG . . . -88.18 -14.3 38.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.416 0.895 . . . . 10.0 113.416 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 tp -58.83 -24.04 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 112.046 0.387 . . . . 10.0 112.046 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.44 -33.27 73.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 10.0 111.342 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -65.34 -29.8 70.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 10.0 111.195 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.41 -17.51 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.96 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.5 mt -105.62 3.02 28.72 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.385 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.66 41.56 15.36 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.051 -0.595 . . . . 10.0 112.094 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.4 mt -125.51 178.88 5.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.767 0.318 . . . . 10.0 110.527 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.77 144.14 55.4 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.792 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.45 119.92 7.47 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.726 2.284 . . . . 10.0 111.672 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.67 0.74 56.48 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 10.0 113.348 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.62 75.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.966 0.383 . . . . 10.0 111.234 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.39 126.3 31.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.676 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.7 p -81.98 156.81 69.52 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.359 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.53 -34.82 92.25 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.237 1.958 . . . . 10.0 110.875 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -68.24 -41.24 81.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.805 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -61.72 -41.74 98.02 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.036 0.446 . . . . 10.0 110.528 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.679 HD21 HG11 ' A' ' 51' ' ' VAL . 48.7 tp -62.08 -48.43 80.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.543 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.2 94.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.004 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 36.7 tp10 -61.52 -42.91 99.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.239 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.07 -44.62 91.0 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.01 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.2 mt -62.1 -42.85 99.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.894 0.378 . . . . 10.0 111.206 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -62.99 -31.72 72.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.955 0.407 . . . . 10.0 110.808 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 81' ' ' ARG . 57.4 mtt-85 -81.44 -9.35 59.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.62 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.6 mt -78.72 -15.3 58.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.428 . . . . 10.0 110.252 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.44 -1.48 11.35 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.478 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -66.64 159.44 27.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.338 . . . . 10.0 111.066 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -104.57 -44.52 4.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.466 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -130.67 131.88 45.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.302 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.68 112.71 40.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.638 0.256 . . . . 10.0 110.872 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 33.7 m-85 -114.52 166.52 11.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.436 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -114.92 148.17 39.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.218 -0.446 . . . . 10.0 109.821 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 m -64.67 -20.81 66.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.671 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.1 -36.32 68.03 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.777 0.288 . . . . 10.0 111.777 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -67.01 -40.5 87.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.141 0.496 . . . . 10.0 109.973 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.84 -36.27 81.64 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.941 -0.864 . . . . 10.0 110.941 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.62 -35.06 79.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.731 0.301 . . . . 10.0 110.474 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -33.53 71.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.872 -0.604 . . . . 10.0 109.873 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.602 HD21 HD23 ' A' ' 424' ' ' LEU . 85.9 mt -75.41 -41.27 56.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.692 -0.685 . . . . 10.0 110.032 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.4 m -59.93 -44.02 94.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.582 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.427 HG12 ' HB3' ' A' ' 259' ' ' ALA . 30.9 mt -57.35 -40.99 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.816 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 92.8 mmm -68.71 -51.01 46.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.319 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.476 ' OE2' ' HA ' ' A' ' 432' ' ' PRO . 64.1 mm-40 -64.14 -53.67 45.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.64 -39.39 91.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.357 . . . . 10.0 110.549 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.08 99.65 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.845 -0.693 . . . . 10.0 111.378 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.3 m -67.64 -40.44 84.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.518 0.199 . . . . 10.0 110.795 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -65.04 -39.22 93.01 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.579 -0.526 . . . . 10.0 109.579 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.408 HD21 HD23 ' A' ' 261' ' ' LEU . 41.8 tp -63.88 -49.04 74.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.892 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.5 tp -59.95 -38.53 82.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.939 -0.573 . . . . 10.0 109.745 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -61.26 -49.36 77.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.972 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.486 ' HG2' ' HG2' ' A' ' 121' ' ' GLU . 40.2 mtt180 -59.03 -38.7 79.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.28 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.43 -56.19 8.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.338 -0.392 . . . . 10.0 111.232 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.6 m -55.52 -43.68 75.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 10.0 112.039 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -61.88 -35.37 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.886 0.328 . . . . 10.0 111.886 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -71.83 -28.6 63.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 10.0 110.258 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.583 ' O ' ' HD2' ' A' ' 309' ' ' ARG . 73.5 mt -83.54 -12.92 55.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.286 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.718 ' HA ' ' NH1' ' A' ' 309' ' ' ARG . 4.3 mm-40 -91.38 -42.69 10.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.909 -0.587 . . . . 10.0 109.483 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.021 -0.99 . . . . 10.0 111.012 179.853 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.352 0.596 . . . . 10.0 111.437 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -85.37 -160.71 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.822 2.348 . . . . 10.0 112.822 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 124' ' ' PRO . 82.7 mt -131.29 162.64 54.66 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.654 -0.869 . . . . 10.0 108.654 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 16.7 Cg_exo -68.8 169.76 57.46 Favored 'Cis proline' 0 C--N 1.347 0.458 0 C-N-CA 124.381 -1.091 . . . . 10.0 113.015 0.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 27.1 ttt -113.58 132.98 55.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.375 -0.829 . . . . 10.0 110.217 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.534 ' HD1' ' HB ' ' A' ' 372' ' ' VAL . 33.7 m-85 -111.73 145.79 38.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.174 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.03 140.73 40.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.695 0.622 . . . . 10.0 110.126 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.621 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -103.73 17.01 25.03 Favored 'General case' 0 CA--C 1.537 0.479 1 N-CA-C 130.104 7.075 . . . . 10.0 130.104 -179.214 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.428 ' O ' ' HD3' ' A' ' 131' ' ' PRO . 68.1 m -81.33 -31.01 33.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 112.142 -2.299 . . . . 10.0 114.393 -166.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 375' ' ' MET . 48.7 m -82.36 124.49 78.09 Favored Pre-proline 0 C--N 1.401 2.835 3 O-C-N 142.034 12.084 . . . . 10.0 113.466 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 129' ' ' CYS . 37.7 Cg_endo -68.54 -23.15 37.43 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.138 2.559 . . . . 10.0 112.246 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.97 -32.91 56.15 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 -73.75 -45.36 52.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.46 -0.37 . . . . 10.0 111.04 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.621 HD11 ' O ' ' A' ' 128' ' ' SER . 97.1 mt -58.57 -35.15 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.101 0.408 . . . . 10.0 112.101 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.97 -35.09 80.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.228 0.537 . . . . 10.0 110.531 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 34.9 ttm -70.12 -40.56 74.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 10.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.911 HD22 HG21 ' A' ' 148' ' ' VAL . 2.5 pp -75.21 -11.98 60.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.868 0.366 . . . . 10.0 111.742 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -96.78 -31.44 12.63 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -108.77 -41.66 4.71 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.634 0.976 . . . . 10.0 113.634 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.2 m -90.75 -44.73 9.27 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.314 0.857 . . . . 10.0 113.314 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -127.59 71.92 77.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 112.025 0.38 . . . . 10.0 112.025 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 73.2 Cg_endo -75.22 11.25 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.55 2.167 . . . . 10.0 112.662 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.98 -7.77 29.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.201 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.5 mt -106.39 14.93 26.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.77 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.589 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 76.9 mt -55.05 -54.72 47.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 113.267 0.84 . . . . 10.0 113.267 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 17.4 Cg_exo -68.06 -9.98 27.44 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.451 2.101 . . . . 10.0 113.009 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 125' ' ' MET . 49.3 m-85 -82.53 -25.08 33.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.131 0.491 . . . . 10.0 110.914 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.911 HG21 HD22 ' A' ' 137' ' ' LEU . 2.7 t -88.53 156.76 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.152 -0.476 . . . . 10.0 109.759 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 t -70.66 154.19 42.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.337 . . . . 10.0 110.923 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 96.3 p -96.77 3.9 52.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.088 0.471 . . . . 10.0 110.304 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.9 m -76.0 144.9 40.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.153 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.43 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 30.4 mtpt -86.01 164.76 17.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.944 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.449 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 0.1 OUTLIER -69.66 152.7 96.12 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.466 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.17 -53.84 5.39 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.802 3.001 . . . . 10.0 113.884 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 153' ' ' SER . 0.0 OUTLIER -62.13 -37.73 86.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 10.0 111.669 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 67.1 mmm -73.14 -23.53 60.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.319 -0.401 . . . . 10.0 111.189 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 40.0 mtt -76.87 -50.1 14.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.3 tp -61.65 -42.53 99.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.46 -0.791 . . . . 10.0 110.844 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.516 ' HA ' ' SD ' ' A' ' 179' ' ' MET . . . -59.47 -40.79 88.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.045 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.47 -35.54 68.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.496 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 3.2 ttt -66.9 -44.66 80.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.675 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 33.0 m -69.52 -30.86 46.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.314 0.487 . . . . 10.0 112.314 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -85.9 6.96 25.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.14 0.422 . . . . 10.0 112.14 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.4 p -129.85 -81.28 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.403 -0.362 . . . . 10.0 110.466 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.578 ' HE2' ' HA ' ' A' ' 240' ' ' MET . 11.3 t80 -56.29 -49.37 74.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.481 . . . . 10.0 111.472 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.659 HD11 ' HE3' ' A' ' 170' ' ' LYS . 41.8 tp -65.93 -39.43 90.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.989 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.63 88.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.512 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.51 -42.38 82.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.912 -0.586 . . . . 10.0 111.107 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -65.98 -46.84 76.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.847 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.659 ' HE3' HD11 ' A' ' 166' ' ' LEU . 72.9 mttt -73.73 -27.15 61.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.702 0.287 . . . . 10.0 111.277 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 88.2 44.0 5.45 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.749 -0.739 . . . . 10.0 112.227 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 21.4 mt -126.8 145.11 34.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -74.9 142.38 76.43 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 110.074 -0.343 . . . . 10.0 110.074 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.435 ' HB2' HD13 ' A' ' 205' ' ' LEU . 45.1 Cg_exo -57.78 -22.07 51.41 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.996 2.464 . . . . 10.0 112.978 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.33 -12.7 56.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.977 0.417 . . . . 10.0 111.485 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 59.3 m-20 -101.36 11.41 39.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.181 0.515 . . . . 10.0 109.74 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 95.4 mtp -122.69 118.84 29.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.899 -0.592 . . . . 10.0 111.263 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.31 133.32 58.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.057 -1.09 . . . . 10.0 108.057 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.516 ' SD ' ' HA ' ' A' ' 159' ' ' ALA . 9.6 ttt -123.0 134.56 54.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.565 0.698 . . . . 10.0 112.805 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 20.8 t -117.84 151.6 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.3 p -135.96 141.68 44.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.721 0.296 . . . . 10.0 110.602 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.539 ' HB ' HG13 ' A' ' 51' ' ' VAL . 16.7 mm -105.04 106.6 20.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 213' ' ' THR . 31.0 mmt -117.4 146.9 39.47 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.227 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.11 15.55 2.19 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.748 2.299 . . . . 10.0 112.705 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 20.8 m -141.28 138.54 33.26 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.978 0.362 . . . . 10.0 111.978 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -30.99 69.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.675 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -65.3 -14.23 60.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.946 -0.57 . . . . 10.0 112.452 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 188' ' ' LYS . 59.2 mmtt -70.07 -27.31 64.52 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.903 0.334 . . . . 10.0 111.903 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -67.26 -44.33 79.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.576 -0.527 . . . . 10.0 109.576 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m -64.09 -29.1 70.26 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.039 0.447 . . . . 10.0 110.246 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.67 -44.86 80.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 208' ' ' LEU . . . -78.36 -12.42 60.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.745 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.42 2.09 51.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.792 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 194' ' ' ARG . 58.4 mtt-85 -64.62 119.43 10.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.691 0.282 . . . . 10.0 110.691 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -38.05 -60.27 0.77 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.271 1.582 . . . . 10.0 115.271 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -66.77 -2.06 4.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 115.012 1.486 . . . . 10.0 115.012 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.431 ' O ' ' HG3' ' A' ' 207' ' ' GLN . 6.2 m-85 -86.71 55.65 3.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.355 0.598 . . . . 10.0 109.848 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.17 169.43 8.74 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.591 -0.732 . . . . 10.0 111.538 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.05 143.15 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.037 -0.982 . . . . 10.0 110.28 -179.786 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 120.925 0.393 . . . . 10.0 110.984 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.806 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.228 -0.075 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -92.48 140.4 29.61 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.436 -0.209 . . . . 10.0 110.436 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 197' ' ' PHE . 56.4 mt-30 -69.6 -41.04 76.28 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.487 ' HB3' ' HB1' ' A' ' 192' ' ' ALA . 13.0 tp -128.52 115.86 18.78 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.62 -47.25 8.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.304 1.224 . . . . 10.0 114.304 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -132.65 143.46 49.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.085 0.772 . . . . 10.0 113.085 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.5 t -126.25 129.23 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.463 -0.939 . . . . 10.0 108.463 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.544 HG12 HG22 ' A' ' 28' ' ' VAL . 55.6 mt -120.22 141.76 39.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 183' ' ' MET . 60.3 p -90.1 164.04 14.63 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.99 -0.284 . . . . 10.0 111.292 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.65 HG23 HG13 ' A' ' 55' ' ' VAL . 1.8 m -55.5 -47.39 76.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.602 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.43 -43.09 89.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 10.0 112.007 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.42 ' O ' HG13 ' A' ' 220' ' ' ILE . 52.7 mt-10 -67.76 -48.31 66.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.145 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 182' ' ' ILE . 31.2 tp -57.98 -46.13 85.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.866 0.365 . . . . 10.0 110.969 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.77 -34.74 89.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.952 -0.567 . . . . 10.0 112.291 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.8 -34.17 69.14 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.838 -0.213 . . . . 10.0 110.821 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 216' ' ' GLU . 90.8 mt -64.66 -42.82 96.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -59.12 -46.39 88.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.381 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -68.85 -29.48 67.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.349 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.29 -36.66 74.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.988 0.423 . . . . 10.0 110.938 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -86.43 -10.82 53.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.178 -0.465 . . . . 10.0 111.428 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.45 40.33 13.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.247 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 53.5 mt -120.57 107.88 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.829 0.347 . . . . 10.0 110.325 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -93.28 118.08 30.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.647 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.651 HD23 HD12 ' A' ' 231' ' ' LEU . 85.1 mt -61.43 -30.34 70.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 10.0 111.628 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.85 -5.55 38.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.165 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.19 27.39 7.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.576 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.651 HD12 HD23 ' A' ' 228' ' ' LEU . 77.9 mt -115.34 148.34 40.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.101 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.14 172.93 15.41 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.487 2.125 . . . . 10.0 111.595 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.81 101.72 4.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.399 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 77' ' ' GLU . . . -75.44 -148.83 2.09 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 116.005 -0.543 . . . . 10.0 112.745 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -152.07 154.99 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.853 0.358 . . . . 10.0 111.418 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -100.09 161.82 13.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.75 -0.659 . . . . 10.0 109.966 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -101.75 150.11 23.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -95.03 119.5 65.76 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.378 -0.373 . . . . 10.0 110.05 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.04 -15.8 35.63 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.206 2.604 . . . . 10.0 112.495 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.578 ' HA ' ' HE2' ' A' ' 165' ' ' TYR . 98.9 mmm -75.19 -14.3 60.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.934 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 91.84 -18.83 51.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.818 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.0 m -134.24 157.71 41.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 110.354 -0.239 . . . . 10.0 110.354 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 90.19 155.04 30.62 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.783 -0.723 . . . . 10.0 112.319 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.34 130.19 46.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.694 0.283 . . . . 10.0 110.703 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 125.07 176.69 14.63 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.525 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -81.15 -1.05 43.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.874 0.337 . . . . 10.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.42 6.13 84.13 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.917 -0.658 . . . . 10.0 112.26 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.6 t -108.48 135.81 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.725 HD11 ' HD3' ' A' ' 419' ' ' PRO . 90.1 mt -81.75 159.34 23.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.68 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -67.44 110.67 3.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.976 -0.557 . . . . 10.0 110.832 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.551 ' HA3' ' HB2' ' A' ' 413' ' ' ARG . . . 148.56 141.84 3.54 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.802 -0.713 . . . . 10.0 112.064 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.4 t -84.36 155.02 22.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.997 0.427 . . . . 10.0 111.148 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.22 -16.32 19.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.476 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.51 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 86.11 -6.78 80.51 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.107 -0.568 . . . . 10.0 112.396 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.75 158.4 10.22 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.008 -0.837 . . . . 10.0 111.008 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.23 -55.53 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.863 0.331 . . . . 10.0 110.909 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' MET . . . . . 0.612 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 19.3 ttp -56.99 -48.22 78.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.65 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.51 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 18.2 tt0 -63.26 -48.27 78.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.131 0.419 . . . . 10.0 112.131 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . 0.427 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . -64.26 -34.99 79.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.503 0.192 . . . . 10.0 111.335 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.73 73.26 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.408 HD23 HD21 ' A' ' 105' ' ' LEU . 68.0 mt -62.45 -41.07 98.48 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.728 -0.669 . . . . 10.0 109.8 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.483 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 44.4 ttm105 -59.28 -50.16 75.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.47 -0.787 . . . . 10.0 111.018 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 50.9 m -57.56 -43.62 84.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.053 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.24 77.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.911 0.386 . . . . 10.0 110.72 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.526 ' CD2' ' HB2' ' A' ' 273' ' ' LEU . 50.3 t80 -63.26 -48.8 76.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.705 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.419 ' OE2' ' HA ' ' A' ' 272' ' ' PRO . 59.5 mt-10 -63.91 -27.37 69.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.111 0.782 . . . . 10.0 113.111 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 82.2 mt -86.82 -26.64 23.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.03 0.443 . . . . 10.0 111.046 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -84.93 -36.97 21.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.679 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.443 HG21 ' CE1' ' A' ' 265' ' ' TYR . 63.0 p -100.81 -32.74 10.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.718 0.636 . . . . 10.0 112.718 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 87.23 0.99 84.59 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.732 -0.947 . . . . 10.0 110.732 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 42.0 p -109.38 145.09 31.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 110.286 -0.264 . . . . 10.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.419 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 42.6 Cg_endo -69.26 146.2 62.47 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.604 2.202 . . . . 10.0 112.203 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.543 HD12 ' HD2' ' A' ' 274' ' ' PRO . 32.1 tp -115.2 123.56 31.51 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.931 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' A' ' 273' ' ' LEU . 87.7 Cg_endo -80.29 -157.3 0.08 OUTLIER 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.696 2.264 . . . . 10.0 111.3 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -79.28 140.07 37.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.569 0.224 . . . . 10.0 110.584 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 90.5 mt -91.69 128.2 37.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.984 0.421 . . . . 10.0 111.248 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 7.1 m -96.1 93.47 6.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.182 0.515 . . . . 10.0 111.002 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 288' ' ' LYS . 4.3 mm? -64.54 122.33 16.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.515 -0.766 . . . . 10.0 111.346 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.2 m -105.18 138.87 40.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.516 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.97 144.12 56.96 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.765 0.283 . . . . 10.0 111.765 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.59 HG22 ' HG2' ' A' ' 289' ' ' GLU . 16.7 t -93.84 123.71 46.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.31 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -66.06 118.81 10.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.208 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.99 -23.85 12.46 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.906 -0.664 . . . . 10.0 111.808 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.434 ' HB3' HG13 ' A' ' 287' ' ' ILE . 75.7 mtm -126.98 98.65 5.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.985 0.421 . . . . 10.0 110.351 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -69.17 133.28 47.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.176 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . 0.435 ' HA3' HD21 ' A' ' 354' ' ' ASN . . . 89.64 -6.99 82.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.038 -0.601 . . . . 10.0 112.459 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 284' ' ' MET . 37.1 mm -101.19 127.92 53.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.87 0.367 . . . . 10.0 110.312 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 278' ' ' LEU . 65.8 mttm -122.97 142.81 50.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.59 ' HG2' HG22 ' A' ' 281' ' ' VAL . 15.8 pt-20 -126.05 163.56 22.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.119 0.485 . . . . 10.0 111.562 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.418 ' CG2' ' HB ' ' A' ' 346' ' ' VAL . 10.0 t -157.19 131.4 8.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.861 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -105.7 121.83 44.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.279 -0.419 . . . . 10.0 109.944 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 36.2 mt -109.12 111.7 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.457 -0.338 . . . . 10.0 111.419 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.07 103.55 3.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.584 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 87.4 mtp -98.38 115.12 27.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.127 0.489 . . . . 10.0 111.442 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 269' ' ' THR . 70.2 t -109.3 124.79 32.99 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.632 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.01 129.77 34.84 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.737 2.291 . . . . 10.0 112.631 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -62.11 132.23 93.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.848 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.11 118.4 5.35 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.584 2.189 . . . . 10.0 111.978 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 95.07 21.47 25.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.875 -0.679 . . . . 10.0 112.797 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.1 p -119.78 164.04 16.56 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.7 -0.294 . . . . 10.0 110.478 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.667 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 71.4 tttt -62.83 -32.12 73.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.992 0.425 . . . . 10.0 109.911 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . 0.409 ' HA ' HD12 ' A' ' 305' ' ' LEU . 47.9 m-85 -60.59 -36.64 79.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.645 -0.707 . . . . 10.0 111.177 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -70.36 -36.71 74.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.98 -0.554 . . . . 10.0 110.428 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -28.29 62.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.779 -0.646 . . . . 10.0 111.312 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 90.0 mt -58.18 -53.91 52.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.44 -1.67 31.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.295 0.48 . . . . 10.0 112.295 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -104.5 -36.0 7.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.946 0.403 . . . . 10.0 111.07 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -26.41 54.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.717 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . 0.718 ' NH1' ' HA ' ' A' ' 114' ' ' GLU . 5.1 ptp85 -148.42 165.36 31.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.531 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -138.25 -57.67 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.015 0.436 . . . . 10.0 110.591 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.745 -0.645 . . . . 10.0 110.077 179.419 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.909 -0.476 . . . . 10.0 111.909 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.64 -26.07 33.72 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.792 2.328 . . . . 10.0 111.555 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.511 ' HB2' ' CE2' ' A' ' 147' ' ' TYR . 93.1 mt -113.13 105.1 13.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.732 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.76 31.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.498 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -56.19 137.29 52.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.706 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -79.69 -12.68 59.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.979 0.419 . . . . 10.0 111.607 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 114.25 -10.68 22.27 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.829 -0.7 . . . . 10.0 111.405 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 89.79 141.8 8.92 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.003 -0.618 . . . . 10.0 112.084 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -77.75 96.01 4.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.093 0.473 . . . . 10.0 110.106 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -103.22 163.16 15.82 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.791 -0.718 . . . . 10.0 112.737 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -147.5 153.78 39.94 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.473 ' HA ' ' HA3' ' A' ' 340' ' ' GLY . 6.2 t -144.36 161.04 40.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.917 0.389 . . . . 10.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . 0.457 ' HB2' ' OD1' ' A' ' 337' ' ' ASP . 1.4 m -110.19 166.26 11.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.726 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -72.96 7.06 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 335' ' ' SER . 2.0 p-10 -104.0 -16.76 15.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.968 0.413 . . . . 10.0 110.269 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.34 -4.13 33.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 10.0 113.293 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -108.52 122.04 46.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.99 0.424 . . . . 10.0 110.69 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 334' ' ' THR . . . -136.67 -145.1 4.95 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.864 -0.684 . . . . 10.0 111.917 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 179.0 -165.46 34.42 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.55 -0.62 . . . . 10.0 111.55 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.456 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 14.5 tt -137.89 138.56 43.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 13.2 t -102.25 119.33 38.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.298 0.57 . . . . 10.0 110.414 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 11.7 tp -79.0 126.19 30.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.683 -0.689 . . . . 10.0 111.407 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -95.09 106.11 18.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.583 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 371' ' ' PHE . 29.4 t -107.46 139.81 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.12 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 372' ' ' VAL . . . -136.69 144.9 44.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.804 0.335 . . . . 10.0 110.962 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 52.5 t -119.58 125.83 74.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.318 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 358' ' ' LEU . . . -108.8 119.77 40.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.066 -0.515 . . . . 10.0 109.912 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -100.92 103.06 14.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.574 -0.285 . . . . 10.0 111.398 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 113.11 146.01 9.55 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.605 -0.807 . . . . 10.0 114.239 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.11 -32.4 68.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.186 0.517 . . . . 10.0 109.842 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -75.73 -10.83 84.84 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.916 -0.874 . . . . 10.0 110.916 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.594 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 3.2 t-20 -91.49 -31.4 15.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.643 -0.503 . . . . 10.0 109.643 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.2 93.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.663 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -58.84 -40.91 85.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.495 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 8.7 pttm -83.86 -10.86 57.7 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.431 0.53 . . . . 10.0 112.431 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 349' ' ' ALA . 29.1 tp -91.95 -49.44 6.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.816 0.341 . . . . 10.0 111.119 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 85.0 mt -58.25 -37.55 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 10.0 111.103 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.94 -26.75 68.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.266 -0.424 . . . . 10.0 111.346 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -78.86 -33.15 46.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 10.0 109.926 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 91.0 mtp -75.06 -37.54 61.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.001 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -63.14 -34.57 77.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.011 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -79.38 -12.75 59.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.263 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 84.4 15.47 68.77 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.843 -0.694 . . . . 10.0 112.395 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -83.28 -52.38 6.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.023 0.439 . . . . 10.0 109.94 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.417 ' HB1' ' HE2' ' A' ' 369' ' ' TYR . . . -94.09 100.28 12.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.579 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.61 115.0 26.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' TYR . . . . . 0.417 ' HE2' ' HB1' ' A' ' 367' ' ' ALA . 85.1 m-85 -137.9 159.86 40.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.677 -0.49 . . . . 10.0 109.677 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -107.16 -39.46 5.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.968 0.413 . . . . 10.0 110.979 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.612 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 20.5 t80 -128.16 123.57 34.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.368 -0.605 . . . . 10.0 109.368 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.534 ' HB ' ' HD1' ' A' ' 126' ' ' PHE . 45.4 t -129.38 126.57 63.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.848 0.356 . . . . 10.0 111.746 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -104.12 124.09 48.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.672 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.74 121.92 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.843 0.354 . . . . 10.0 110.896 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' MET . . . . . 0.6 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 67.2 mtt -105.65 152.36 23.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.343 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 121.029 0.443 . . . . 10.0 110.998 -179.893 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 112.572 0.582 . . . . 10.0 112.572 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -128.56 48.77 0.95 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.511 -0.852 . . . . 10.0 112.663 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -87.54 168.97 38.7 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.449 -0.881 . . . . 10.0 111.74 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -67.79 -15.19 66.41 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.232 -0.508 . . . . 10.0 113.294 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -89.29 -5.44 72.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.696 -0.764 . . . . 10.0 111.749 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -82.42 156.3 68.66 Favored Pre-proline 0 C--O 1.239 0.501 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.8 160.73 39.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.715 2.277 . . . . 10.0 111.532 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 107.54 14.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.92 0.391 . . . . 10.0 111.282 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.778 -0.646 . . . . 10.0 109.868 179.617 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.884 0.373 . . . . 10.0 111.391 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -64.26 -37.18 86.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.662 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -62.97 -44.93 94.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.063 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.401 ' HD3' ' HB2' ' A' ' 58' ' ' ALA . 97.3 mtt180 -68.44 -35.76 78.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.029 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -66.36 -40.2 89.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.518 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -73.4 -29.67 62.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.05 -0.523 . . . . 10.0 111.622 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -91.61 10.07 29.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 10.0 111.784 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 9.5 mt -66.55 -41.45 88.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.738 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -136.16 153.46 51.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.495 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 407' ' ' ASP . 63.8 t30 -79.52 174.24 11.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.583 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 406' ' ' LEU . 3.6 mm? -59.55 -39.51 84.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 405' ' ' ASN . 11.7 p30 -70.72 -46.63 62.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.351 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -60.63 -35.32 75.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.646 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -71.12 -40.63 71.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.888 0.375 . . . . 10.0 111.293 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 10.8 m -73.97 -31.14 62.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.996 -0.547 . . . . 10.0 111.829 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 5.6 m -87.0 107.69 18.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 40.2 tp -85.65 136.65 33.29 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.692 -0.484 . . . . 10.0 109.692 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . 0.551 ' HB2' ' HA3' ' A' ' 251' ' ' GLY . 3.9 tmm_? -145.77 125.12 13.05 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.216 -0.29 . . . . 10.0 110.216 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.619 ' HB2' ' OE1' ' A' ' 417' ' ' GLU . 5.3 mtt85 -100.83 158.52 15.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.136 0.493 . . . . 10.0 110.462 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.6 m -64.5 -24.91 67.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.551 0.945 . . . . 10.0 113.551 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . 0.473 ' CE1' ' HD3' ' A' ' 414' ' ' ARG 0.282 32.5 p-80 -78.71 4.23 14.31 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . 0.619 ' OE1' ' HB2' ' A' ' 414' ' ' ARG . 1.7 mp0 -112.12 -3.93 14.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.992 0.425 . . . . 10.0 109.975 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.42 ' HB3' ' HB ' ' A' ' 421' ' ' ILE . 50.4 t-20 -77.75 118.37 71.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.624 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.725 ' HD3' HD11 ' A' ' 249' ' ' LEU . 37.7 Cg_exo -59.05 -38.68 86.13 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.022 2.481 . . . . 10.0 111.636 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 53.9 m -65.28 -46.27 81.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.313 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 418' ' ' ASN . 39.2 mm -65.22 -43.02 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.132 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.587 ' NH2' ' HA ' ' A' ' 417' ' ' GLU . 97.1 mtt180 -58.97 -45.45 90.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.366 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -63.33 -49.64 73.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.93 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.602 HD23 HD21 ' A' ' 96' ' ' LEU . 61.3 tp -56.37 -39.17 72.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.998 0.427 . . . . 10.0 110.947 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . 0.882 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.1 m-85 -77.35 4.62 10.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.948 -0.569 . . . . 10.0 111.498 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -118.76 -54.61 2.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.739 0.304 . . . . 10.0 111.692 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -25.27 53.47 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.714 1.005 . . . . 10.0 113.714 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -126.71 -50.13 1.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 114.589 1.329 . . . . 10.0 114.589 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.882 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 90.9 mt -73.08 -39.74 65.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.391 0.886 . . . . 10.0 113.391 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 86.25 -60.57 4.56 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.574 -0.822 . . . . 10.0 112.836 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 432' ' ' PRO . 2.1 tt0 -165.95 151.1 7.77 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.615 0.208 . . . . 10.0 110.727 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.476 ' HA ' ' OE2' ' A' ' 100' ' ' GLU . 32.5 Cg_exo -59.64 142.4 98.74 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.819 2.346 . . . . 10.0 111.312 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 7.9 mp 63.35 16.95 9.92 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.708 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -78.67 -168.79 34.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.2 -0.524 . . . . 10.0 112.214 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . 0.426 ' O ' ' HG3' ' A' ' 439' ' ' GLU . 31.4 t-80 -59.99 -60.83 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.512 0.196 . . . . 10.0 111.328 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.443 ' HD2' ' OE2' ' A' ' 439' ' ' GLU . 8.3 tptt -59.4 -35.46 74.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.278 -0.419 . . . . 10.0 111.29 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -65.19 -42.84 93.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.156 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 9.6 t-80 -68.02 -26.9 66.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.901 0.382 . . . . 10.0 110.521 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . 0.443 ' OE2' ' HD2' ' A' ' 436' ' ' LYS . 45.4 mt-10 -73.06 -64.88 0.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 62.4 mt -99.04 -17.96 18.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.986 1.476 . . . . 10.0 114.986 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 60.8 mt -100.0 -11.14 20.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.557 0.577 . . . . 10.0 112.557 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 28.0 m-70 -122.59 163.6 19.7 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 121.305 -0.158 . . . . 10.0 110.595 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 5.9 t -155.07 -171.95 4.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.667 0.27 . . . . 10.0 111.081 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -133.84 168.09 19.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.374 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' TYR . . . . . 0.546 ' HD2' HG23 ' A' ' 145' ' ' ILE . 51.0 m-85 -109.85 161.02 15.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.446 -0.343 . . . . 10.0 110.358 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.15 120.91 66.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.977 0.418 . . . . 10.0 111.31 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.13 107.23 3.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.738 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.26 -6.32 11.89 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.128 -0.789 . . . . 10.0 111.128 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.493 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.045 179.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.998 -0.371 . . . . 10.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.25 154.17 35.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.594 -0.521 . . . . 10.0 109.594 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -62.86 -22.96 67.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.88 0.371 . . . . 10.0 111.698 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.62 -45.45 50.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.882 -0.785 . . . . 10.0 108.882 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -63.93 -32.62 74.22 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.697 -0.683 . . . . 10.0 109.772 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.554 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 60.2 mt-30 -61.87 -19.1 62.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.414 -0.812 . . . . 10.0 111.059 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -98.76 -47.43 5.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.016 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 35' ' ' LEU . 96.0 mt -59.71 -26.7 65.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.994 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.78 -50.43 73.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.728 0.299 . . . . 10.0 111.001 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -75.7 -26.09 57.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.728 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.521 HD12 HD23 ' A' ' 32' ' ' LEU . 62.4 mt -70.32 -30.79 67.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.847 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.42 -25.45 61.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.289 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -70.66 130.24 89.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.22 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.17 153.88 15.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 123.125 2.55 . . . . 10.0 112.086 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -63.05 -25.21 68.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.136 0.493 . . . . 10.0 110.423 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -101.51 15.95 27.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.381 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.842 ' HB3' ' HB2' ' A' ' 44' ' ' ARG . 15.8 t70 -69.36 136.39 88.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.278 -0.268 . . . . 10.0 110.278 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.96 -24.49 73.31 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.962 2.442 . . . . 10.0 113.033 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.32 10.85 23.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.957 0.408 . . . . 10.0 110.983 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.842 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 7.4 tpt180 -72.28 137.55 46.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.032 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -118.72 173.81 6.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.579 -0.737 . . . . 10.0 109.233 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.4 111.06 21.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 t -99.56 104.27 15.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.224 0.535 . . . . 10.0 111.091 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.2 m -96.87 141.05 30.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.352 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 14.5 p -128.56 139.31 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.705 0.288 . . . . 10.0 111.567 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 12.8 pt20 -120.78 125.31 47.25 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.778 -0.453 . . . . 10.0 109.778 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.584 HG11 HD21 ' A' ' 75' ' ' LEU . 14.1 t -111.3 143.81 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.346 -0.388 . . . . 10.0 111.183 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.7 145.82 31.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.544 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.86 -30.17 84.4 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.003 2.469 . . . . 10.0 112.433 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.08 -23.37 65.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.94 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.708 HG13 HG23 ' A' ' 214' ' ' THR . 86.8 t -81.13 -38.56 16.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.624 -0.51 . . . . 10.0 109.624 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -59.46 -29.6 67.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.835 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -85.58 -33.7 7.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.508 0.558 . . . . 10.0 112.508 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 388' ' ' PRO . . . -91.74 -17.1 25.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.117 0.784 . . . . 10.0 113.117 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.52 -20.84 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 10.0 111.381 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' A' ' 65' ' ' LEU . . . -70.26 -37.69 74.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.684 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 399' ' ' ARG . 32.4 mt-10 -64.15 -29.76 70.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.523 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.415 HG21 ' HA3' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -69.03 -15.63 63.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 10.0 110.858 179.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 mt -109.17 -5.56 15.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.149 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.39 27.4 22.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.908 -0.663 . . . . 10.0 112.23 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.508 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 mt -112.95 164.24 13.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.6 0.238 . . . . 10.0 110.492 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -69.96 140.9 88.93 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.731 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 66' ' ' ALA . 51.5 Cg_exo -55.44 118.82 5.62 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.881 2.387 . . . . 10.0 112.127 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.94 0.0 55.05 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.6 -0.809 . . . . 10.0 113.279 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.79 -38.11 73.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 10.0 111.051 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.11 131.34 41.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.716 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -83.52 157.1 65.08 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.598 0.237 . . . . 10.0 110.403 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.4 -35.26 91.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.225 1.95 . . . . 10.0 111.345 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.505 ' HB2' ' OE1' ' A' ' 233' ' ' GLU . 31.4 mmtp -71.8 -36.96 70.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.946 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -61.27 -42.3 98.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.091 0.472 . . . . 10.0 110.529 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.584 HD21 HG11 ' A' ' 51' ' ' VAL . 45.0 tp -63.84 -46.45 84.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.588 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.32 95.42 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.835 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -61.75 -42.7 99.32 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.817 -0.629 . . . . 10.0 110.367 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -44.34 91.22 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.964 -0.636 . . . . 10.0 112.003 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD11 HG21 ' A' ' 51' ' ' VAL . 16.3 mt -61.77 -40.49 95.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 10.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -62.94 -31.01 72.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.763 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -81.51 -8.73 59.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 10.0 111.803 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.0 mt -79.16 -9.3 59.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.022 0.439 . . . . 10.0 110.761 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.85 -0.43 28.77 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.691 -0.766 . . . . 10.0 112.354 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.75 159.58 27.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 10.0 110.971 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -101.7 -59.4 1.71 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.859 0.362 . . . . 10.0 110.995 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -115.97 125.06 52.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.827 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.3 t -105.48 108.79 25.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.283 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 30.1 m-85 -110.76 168.76 9.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.923 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.43 155.8 27.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.822 -0.626 . . . . 10.0 110.058 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 m -76.64 -21.79 55.0 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.98 0.733 . . . . 10.0 112.98 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.433 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . 44.9 mt -61.43 -37.46 83.58 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.317 -0.239 . . . . 10.0 111.069 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.402 ' HZ ' ' HG2' ' A' ' 240' ' ' MET . 43.5 t80 -61.01 -38.37 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.232 0.539 . . . . 10.0 109.598 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.66 -35.26 55.51 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.776 -0.93 . . . . 10.0 110.776 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.11 77.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.696 0.284 . . . . 10.0 110.379 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.33 -35.48 73.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 10.0 109.662 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.42 -42.39 65.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.531 -0.759 . . . . 10.0 109.594 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.6 m -60.51 -42.43 96.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.617 -0.72 . . . . 10.0 110.622 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.9 mt -59.98 -39.95 81.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.771 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.8 mmm -65.92 -51.73 56.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.976 -0.557 . . . . 10.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -65.55 -45.44 83.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.873 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 101' ' ' GLU . 1.8 tp10 -61.52 -43.55 98.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 10.0 110.929 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.05 95.29 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 110.981 -0.848 . . . . 10.0 110.981 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.573 ' HB2' HD13 ' A' ' 433' ' ' LEU . 19.7 m -69.27 -43.64 73.51 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.614 -0.293 . . . . 10.0 110.497 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.426 ' HG2' HD21 ' A' ' 433' ' ' LEU . 0.0 OUTLIER -60.18 -47.02 87.69 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.802 -0.444 . . . . 10.0 109.802 178.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.415 ' CD2' HD23 ' A' ' 261' ' ' LEU . 23.3 tp -59.16 -54.68 44.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.726 -0.67 . . . . 10.0 111.059 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.0 tp -59.35 -39.17 82.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.907 0.384 . . . . 10.0 110.593 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.605 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 53.9 t60 -61.86 -53.09 60.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.526 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.593 ' HG2' ' HB2' ' A' ' 121' ' ' GLU . 68.2 mtt180 -59.72 -38.66 82.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.715 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 41.7 tp -67.21 -50.86 59.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.842 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.5 m -58.14 -44.95 88.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.912 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 23.1 mm-40 -57.95 -31.19 66.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.948 0.404 . . . . 10.0 111.573 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -79.65 -37.28 36.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 65.3 mt -69.31 -32.48 71.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.984 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.534 ' HG2' HD22 ' A' ' 305' ' ' LEU . 22.7 mt-10 -79.54 -7.16 58.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.284 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.139 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.356 -179.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 108' ' ' ARG . 1.5 pm0 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.862 0.363 . . . . 10.0 110.891 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -90.09 -172.07 0.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.988 2.458 . . . . 10.0 112.801 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.423 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 91.1 mt -133.93 157.38 77.87 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.486 -0.931 . . . . 10.0 108.486 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.458 ' HB3' ' O ' ' A' ' 369' ' ' TYR . 37.5 Cg_endo -64.92 167.46 45.46 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 124.513 -1.036 . . . . 10.0 113.802 0.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 24.6 ttt -113.92 134.08 55.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.739 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.611 ' HD1' ' HB ' ' A' ' 372' ' ' VAL . 33.3 m-85 -110.8 144.6 39.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.21 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.439 HG23 ' HZ ' ' A' ' 371' ' ' PHE . 0.0 OUTLIER -81.87 156.09 25.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.885 0.328 . . . . 10.0 111.885 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 m -111.63 54.18 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.262 0.553 . . . . 10.0 110.285 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.2 p -90.58 -39.51 12.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 10.0 112.086 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.781 ' SG ' ' HA ' ' A' ' 375' ' ' MET . 36.5 m -105.38 117.87 57.14 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.809 ' HG3' ' HE3' ' A' ' 188' ' ' LYS . 36.5 Cg_endo -64.46 -29.48 62.17 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.015 2.477 . . . . 10.0 111.743 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.21 -39.94 98.5 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.785 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -36.88 69.79 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 45.7 mm -62.92 -44.87 99.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.844 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.16 92.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.584 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 58.5 ttp -68.87 -34.73 75.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 10.0 109.773 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 tp -64.2 -54.45 33.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.754 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -59.8 -24.95 64.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.852 0.686 . . . . 10.0 112.852 -178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.64 -52.67 4.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.218 0.822 . . . . 10.0 113.218 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 m -84.24 -44.18 14.15 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 114.902 1.445 . . . . 10.0 114.902 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -131.7 73.25 79.3 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.9 -12.43 34.41 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.406 2.071 . . . . 10.0 111.82 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.94 -16.14 61.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.127 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.569 ' HA ' ' HD2' ' A' ' 147' ' ' TYR . 69.2 mt -98.97 9.52 43.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.567 HG23 ' HD2' ' A' ' 445' ' ' TYR . 52.4 mt -55.93 -52.46 72.28 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 33.4 Cg_exo -61.46 -23.28 76.43 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.338 2.025 . . . . 10.0 112.9 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.569 ' HD2' ' HA ' ' A' ' 144' ' ' LEU . 98.7 m-85 -75.78 -19.57 58.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.0 0.429 . . . . 10.0 111.047 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.2 t -86.99 159.13 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.786 -0.449 . . . . 10.0 109.786 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.522 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . 31.5 t -69.4 167.62 16.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.991 0.424 . . . . 10.0 110.778 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.4 p -106.56 6.81 30.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.349 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.52 179.42 7.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 10.0 112.124 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 156' ' ' MET . 40.8 mtpt -122.25 169.79 10.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.3 p -68.53 152.56 96.56 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 121.049 -0.26 . . . . 10.0 110.471 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.66 -46.72 23.14 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.265 2.643 . . . . 10.0 112.974 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -35.7 80.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.803 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.463 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 60.1 mmm -74.52 -19.11 60.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.137 0.494 . . . . 10.0 110.833 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 30.9 mtt -80.66 -48.25 12.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.302 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.91 -42.26 99.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.59 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.68 81.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.64 61.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.812 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -72.69 -44.56 61.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.682 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.9 m -69.49 -28.68 38.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 179' ' ' MET . 27.5 mttt -85.73 2.6 44.8 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.824 0.305 . . . . 10.0 111.824 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 168' ' ' GLU . 13.5 p -122.82 -79.62 0.62 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.608 -0.269 . . . . 10.0 110.74 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.577 ' HE2' ' HA ' ' A' ' 240' ' ' MET . 33.8 t80 -55.58 -53.19 59.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.964 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.714 HD11 ' HE3' ' A' ' 170' ' ' LYS . 24.3 tp -61.94 -41.11 97.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 10.0 111.277 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.27 -50.18 74.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.202 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 164' ' ' SER . 41.6 mt-10 -68.41 -37.2 80.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.363 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -64.93 -49.08 71.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.247 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.714 ' HE3' HD11 ' A' ' 166' ' ' LEU . 91.2 mttt -76.88 -15.08 59.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.136 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 73.71 37.2 52.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.765 -0.731 . . . . 10.0 111.647 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.96 135.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.99 133.9 91.89 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.48 -0.327 . . . . 10.0 110.488 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.419 ' HB2' HD13 ' A' ' 205' ' ' LEU . 32.0 Cg_exo -59.55 -16.76 37.85 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.911 2.407 . . . . 10.0 112.399 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -71.94 -22.42 61.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.747 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -107.51 23.88 13.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.236 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 96.0 mtp -125.9 115.21 19.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.127 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.55 131.88 51.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.43 ' HB2' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -112.4 119.87 39.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.149 0.5 . . . . 10.0 111.225 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 46.4 t -116.46 135.82 55.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.7 p -124.46 135.85 53.56 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.803 0.297 . . . . 10.0 111.803 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 212' ' ' ILE . 30.3 mm -99.93 103.11 14.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 213' ' ' THR . 32.4 mmt -114.26 148.43 40.09 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.944 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 183' ' ' MET . 2.5 Cg_endo -83.19 19.31 1.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.283 2.655 . . . . 10.0 112.665 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 73.1 m -145.93 129.17 16.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.05 0.453 . . . . 10.0 111.227 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -28.1 67.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.602 -0.726 . . . . 10.0 111.174 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 8.7 mtm180 -80.7 17.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.075 -0.511 . . . . 10.0 112.029 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.809 ' HE3' ' HG3' ' A' ' 131' ' ' PRO . 0.0 OUTLIER -87.87 -33.88 18.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.657 0.265 . . . . 10.0 111.349 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -65.01 -30.64 71.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.915 0.388 . . . . 10.0 110.171 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.81 -25.58 66.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.661 -0.699 . . . . 10.0 111.9 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 131' ' ' PRO . 31.1 tt0 -76.25 -46.9 25.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -73.5 -5.91 43.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.564 -0.744 . . . . 10.0 111.16 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.36 -18.85 57.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.517 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.468 HH11 ' HZ2' ' A' ' 196' ' ' TRP . 78.0 mtt-85 -59.02 118.16 5.5 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.744 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -41.79 -47.99 4.22 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.709 1.374 . . . . 10.0 114.709 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' TRP . . . . . 0.468 ' HZ2' HH11 ' A' ' 194' ' ' ARG . 43.9 p90 -62.27 -9.59 8.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.998 1.481 . . . . 10.0 114.998 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -85.74 56.3 3.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.577 0.703 . . . . 10.0 110.811 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -110.07 171.07 7.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.384 -0.825 . . . . 10.0 110.375 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.59 80.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.688 0.28 . . . . 10.0 110.65 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.3 t0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.116 -0.945 . . . . 10.0 112.17 179.596 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.876 0.369 . . . . 10.0 111.102 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.788 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.229 -0.004 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -94.27 148.82 21.83 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.956 0.16 . . . . 10.0 110.799 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -70.36 -38.62 74.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.166 -1.049 . . . . 10.0 108.166 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 29.8 tp -131.85 121.45 24.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.601 -1.629 . . . . 10.0 106.601 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.98 -44.68 7.24 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.891 1.071 . . . . 10.0 113.891 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 8.7 m-70 -130.36 141.88 50.55 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.987 0.736 . . . . 10.0 112.987 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.72 123.78 60.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.652 -0.869 . . . . 10.0 108.652 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 71.7 mt -119.78 140.05 45.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 183' ' ' MET . 41.1 p -90.23 166.95 13.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.052 0.453 . . . . 10.0 111.96 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.708 HG23 HG13 ' A' ' 55' ' ' VAL . 2.5 m -56.09 -46.71 78.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.476 -0.784 . . . . 10.0 111.773 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.8 m -61.26 -39.79 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.427 ' O ' HG13 ' A' ' 220' ' ' ILE . 41.9 mt-10 -68.7 -46.96 67.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.795 0.331 . . . . 10.0 110.638 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 31.1 tp -62.25 -43.07 99.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.34 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.415 ' HA3' HG21 ' A' ' 62' ' ' THR . . . -60.08 -36.27 89.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.186 -0.531 . . . . 10.0 112.252 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -38.87 80.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.571 0.224 . . . . 10.0 110.462 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 216' ' ' GLU . 79.7 mt -59.1 -45.3 92.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.18 -0.464 . . . . 10.0 110.08 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -59.77 -45.86 90.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.861 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.28 -46.81 82.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.787 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.92 -30.97 71.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 10.0 111.942 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -80.93 -12.7 59.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.926 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.78 30.51 47.74 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.914 -0.66 . . . . 10.0 111.868 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.6 mt -113.21 114.72 47.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.953 0.406 . . . . 10.0 110.532 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.454 ' O ' ' HG ' ' A' ' 231' ' ' LEU . 54.8 t30 -104.07 122.14 44.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.317 -0.401 . . . . 10.0 110.035 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.524 ' HA ' HD12 ' A' ' 231' ' ' LEU . 76.2 mt -60.4 -32.6 71.48 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.316 0.385 . . . . 10.0 111.735 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.04 -16.95 63.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.737 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.43 3.03 34.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 10.0 110.694 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 228' ' ' LEU . 95.9 mt -96.65 151.03 37.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.327 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.18 -179.89 5.62 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.593 2.195 . . . . 10.0 111.123 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.505 ' OE1' ' HB2' ' A' ' 73' ' ' LYS . 2.8 mm-40 -80.55 103.45 10.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.739 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -80.83 -152.62 8.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.017 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -150.98 157.86 43.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.867 0.333 . . . . 10.0 111.061 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -98.54 166.29 11.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.837 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -106.32 152.39 23.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -98.48 121.53 56.36 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.826 0.346 . . . . 10.0 110.944 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.82 -16.62 56.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.169 2.579 . . . . 10.0 112.079 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.577 ' HA ' ' HE2' ' A' ' 165' ' ' TYR . 85.5 mmm -81.15 -10.13 59.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.964 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 105.5 -66.34 0.27 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.029 -0.605 . . . . 10.0 112.043 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 17.0 m -104.69 165.2 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.573 0.225 . . . . 10.0 110.939 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 103.05 118.23 4.44 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.923 -0.656 . . . . 10.0 112.147 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.9 m -64.25 133.86 53.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.047 0.451 . . . . 10.0 111.605 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.02 -167.84 18.64 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.405 -0.678 . . . . 10.0 111.405 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.61 -8.66 58.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.929 0.395 . . . . 10.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 91.8 -1.87 75.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 10.0 112.311 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.63 129.31 39.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.833 -0.432 . . . . 10.0 109.833 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.64 ' HB2' ' HD3' ' A' ' 413' ' ' ARG . 63.5 mt -73.35 144.16 46.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.493 -0.322 . . . . 10.0 110.93 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.557 ' CE1' ' HG2' ' A' ' 408' ' ' GLU . 71.7 t80 -59.37 128.32 36.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.921 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 413' ' ' ARG . . . 128.71 150.27 7.15 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.867 -0.682 . . . . 10.0 111.758 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 8.3 t -92.38 145.1 24.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.883 0.373 . . . . 10.0 110.732 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -9.3 53.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.115 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 89.64 -11.73 69.27 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.955 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.53 165.11 12.35 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.199 -0.76 . . . . 10.0 111.199 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 29.2 t -58.49 -60.73 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.767 0.283 . . . . 10.0 111.22 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' MET . . . . . 0.51 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 25.6 ttp -51.89 -56.05 16.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 10.0 112.155 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -57.86 -49.9 75.12 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.005 0.743 . . . . 10.0 113.005 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.94 85.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.101 0.408 . . . . 10.0 112.101 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.62 76.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.062 0.458 . . . . 10.0 110.136 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.415 HD23 ' CD2' ' A' ' 105' ' ' LEU . 50.4 mt -63.83 -41.42 97.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.085 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.51 ' O ' ' HG3' ' A' ' 266' ' ' GLU . 46.0 ttm105 -59.04 -50.08 75.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.689 -0.687 . . . . 10.0 111.362 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 60.9 m -55.38 -40.74 71.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.613 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.67 -41.76 65.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.924 0.392 . . . . 10.0 110.737 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -63.76 -47.64 80.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 10.0 112.055 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 272' ' ' PRO . 46.2 mt-10 -66.75 -7.77 23.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.929 0.715 . . . . 10.0 112.929 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 80.7 mt -108.58 -41.09 4.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.003 0.43 . . . . 10.0 110.47 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -71.27 -40.28 71.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 21.1 p -102.65 -18.54 15.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.968 -0.56 . . . . 10.0 111.874 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.01 -35.61 2.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.487 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.34 145.45 82.78 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 110.327 -0.249 . . . . 10.0 110.327 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.511 ' HA ' ' HG2' ' A' ' 266' ' ' GLU . 62.5 Cg_endo -73.56 155.87 49.85 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.443 2.096 . . . . 10.0 112.354 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.511 HD12 ' HD2' ' A' ' 274' ' ' PRO . 28.1 tp -115.41 125.31 28.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.945 -0.57 . . . . 10.0 110.32 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.511 ' HD2' HD12 ' A' ' 273' ' ' LEU . 80.7 Cg_endo -77.46 -157.9 0.08 OUTLIER 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.701 2.267 . . . . 10.0 111.591 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -78.53 134.27 37.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.662 -0.496 . . . . 10.0 109.662 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.99 131.62 36.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.057 0.456 . . . . 10.0 111.785 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 1.2 m -103.51 101.43 11.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.78 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.464 HD13 ' HB ' ' A' ' 290' ' ' THR . 3.8 mm? -72.29 132.54 44.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.672 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 26.1 m -106.65 142.07 36.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.85 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -73.37 141.08 47.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.806 0.336 . . . . 10.0 111.13 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 66.8 t -98.88 108.11 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.042 -0.526 . . . . 10.0 109.618 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 77.3 mtm-85 -63.94 133.13 52.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.841 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 114.46 -31.12 6.57 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.776 -0.93 . . . . 10.0 110.776 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 59.5 mtm -132.67 89.02 2.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.77 103.58 0.27 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.606 -0.725 . . . . 10.0 112.034 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . 0.559 ' HA3' ' ND2' ' A' ' 354' ' ' ASN . . . 132.59 -19.08 4.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.527 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 42.5 mm -92.94 131.79 39.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -123.8 160.69 26.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.384 -0.598 . . . . 10.0 109.384 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.83 165.6 30.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.022 0.439 . . . . 10.0 111.397 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.464 ' HB ' HD13 ' A' ' 278' ' ' LEU . 14.5 t -157.29 145.54 19.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.123 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -113.79 124.13 51.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.686 0.279 . . . . 10.0 110.861 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 31.2 mt -112.84 105.15 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.593 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 3.9 p -72.4 100.69 2.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.416 . . . . 10.0 110.121 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 78.6 mtp -90.54 104.15 16.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.184 0.516 . . . . 10.0 111.952 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 25.6 t -102.1 111.77 64.66 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.592 -0.892 . . . . 10.0 108.592 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.64 142.14 32.44 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.287 2.658 . . . . 10.0 113.641 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . . . -71.16 134.71 85.06 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.256 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 297' ' ' ALA . 36.8 Cg_exo -62.25 120.58 8.21 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.474 2.116 . . . . 10.0 111.913 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 94.48 20.14 30.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.012 -0.613 . . . . 10.0 113.084 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 90.3 p -110.61 163.8 13.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.91 -0.404 . . . . 10.0 109.91 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.638 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 28.1 pttt -71.05 -27.41 63.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.028 -0.73 . . . . 10.0 109.028 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -64.27 -41.53 96.87 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.875 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -64.3 -40.62 96.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.665 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -70.4 -25.8 63.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.506 -0.77 . . . . 10.0 112.27 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 67.5 mt -57.5 -57.33 13.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.707 0.289 . . . . 10.0 111.325 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.48 -10.64 59.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 10.0 111.341 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -89.21 -36.61 15.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.485 . . . . 10.0 110.488 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.1 -30.64 25.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.108 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -142.02 117.84 10.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.095 0.474 . . . . 10.0 111.163 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -109.09 1.08 20.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.214 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.964 -1.017 . . . . 10.0 109.262 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.824 -0.51 . . . . 10.0 111.824 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.84 -27.58 67.45 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.753 2.302 . . . . 10.0 112.014 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 89.8 mt -115.53 93.51 4.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.287 0.565 . . . . 10.0 110.239 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -79.76 111.82 16.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.509 -0.769 . . . . 10.0 110.548 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -65.1 136.84 57.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.116 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -83.83 -7.2 59.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.547 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 105.38 -7.21 42.98 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.8 -0.714 . . . . 10.0 111.728 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 91.61 156.78 33.06 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.659 -0.782 . . . . 10.0 111.51 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 343' ' ' THR . . . -91.31 86.94 6.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.115 0.484 . . . . 10.0 110.077 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -88.4 157.39 27.83 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.707 -0.759 . . . . 10.0 112.664 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -135.67 152.26 51.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.141 -0.318 . . . . 10.0 110.141 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 55.9 m -155.41 126.14 6.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.601 0.238 . . . . 10.0 110.502 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.35 165.89 14.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.449 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -63.9 -14.73 55.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.62 0.6 . . . . 10.0 112.62 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.9 -11.57 59.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.424 -0.353 . . . . 10.0 111.898 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 105.23 -0.71 40.62 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.476 -0.869 . . . . 10.0 113.986 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 334' ' ' THR . 23.3 mtm180 -77.78 122.92 26.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.476 0.638 . . . . 10.0 110.905 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -118.04 139.33 14.62 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -152.98 -176.78 25.88 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.729 -0.948 . . . . 10.0 110.729 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.59 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 15.1 tt -144.32 139.67 24.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 117.096 0.448 . . . . 10.0 110.724 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 331' ' ' ALA . 11.7 t -99.73 120.99 40.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.211 0.529 . . . . 10.0 110.179 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 14.6 tp -79.28 122.78 26.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.893 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -93.01 102.39 14.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.914 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 31.7 t -103.0 137.1 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.439 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -128.89 149.14 50.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.378 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.5 124.3 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.125 -0.488 . . . . 10.0 109.953 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -108.78 119.46 39.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.2 -0.454 . . . . 10.0 110.103 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.5 106.65 16.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.126 0.488 . . . . 10.0 111.333 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 109.7 133.46 6.65 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.014 -0.613 . . . . 10.0 112.14 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.82 -36.92 80.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 10.0 110.875 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . 0.411 ' O ' ' HG3' ' A' ' 357' ' ' LYS . . . -68.12 -28.14 73.46 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.219 -0.752 . . . . 10.0 111.219 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.612 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 1.3 m-20 -80.91 -37.11 30.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.67 94.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.9 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -57.45 -46.52 83.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.119 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 10.5 mtmm -64.01 -47.24 81.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.687 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.8 tp -61.74 -50.31 72.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 10.0 111.797 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 90.9 mt -55.76 -42.28 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.588 -0.278 . . . . 10.0 111.37 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 12.0 m -61.37 -43.22 99.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.982 0.42 . . . . 10.0 110.54 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -70.57 -29.19 65.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.198 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 75.4 mtp -69.91 -40.85 75.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.075 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -66.7 -26.98 67.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.045 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.19 -9.55 59.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.764 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 87.09 9.22 74.0 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.054 -0.593 . . . . 10.0 112.801 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.66 -50.9 14.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.846 0.355 . . . . 10.0 110.645 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -98.46 100.79 12.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.777 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -97.69 109.53 22.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.155 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 82.1 m-85 -136.99 159.79 40.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.999 -0.371 . . . . 10.0 109.999 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -103.43 -34.59 8.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.038 0.447 . . . . 10.0 111.547 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.51 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 45.0 t80 -132.16 129.11 39.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.611 ' HB ' ' HD1' ' A' ' 126' ' ' PHE . 43.6 t -129.67 119.03 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.813 0.671 . . . . 10.0 112.813 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 257' ' ' MET . 5.2 tp10 -91.59 113.86 26.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.77 -1.196 . . . . 10.0 107.77 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 58.2 mt -109.27 118.16 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.257 0.551 . . . . 10.0 112.325 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' MET . . . . . 0.781 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 62.0 mtt -111.82 142.22 44.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.623 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.196 0.522 . . . . 10.0 110.925 179.738 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 C--O 1.236 0.345 0 N-CA-C 111.952 0.352 . . . . 10.0 111.952 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -109.33 34.92 5.22 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.035 -0.53 . . . . 10.0 112.377 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -80.63 162.99 45.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.762 -0.732 . . . . 10.0 112.206 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -72.69 -12.95 78.29 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.034 -0.603 . . . . 10.0 113.18 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -91.76 2.48 76.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.626 -0.797 . . . . 10.0 111.788 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -92.09 153.46 43.24 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 58' ' ' ALA . 31.3 Cg_exo -64.09 172.15 6.6 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.618 2.212 . . . . 10.0 111.239 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 109.65 8.1 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 28.3 m . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.097 178.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.958 0.409 . . . . 10.0 111.111 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -62.79 -39.59 94.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.704 -0.68 . . . . 10.0 111.113 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -64.14 -39.0 93.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.075 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 61' ' ' GLU . 98.8 mtt180 -68.1 -39.35 82.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.27 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -63.19 -41.91 99.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.867 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -71.45 -27.78 63.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.413 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -96.88 14.9 23.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.828 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.6 mt -64.56 -40.17 95.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.989 0.423 . . . . 10.0 110.738 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -133.78 158.64 42.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.787 -0.642 . . . . 10.0 109.439 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -79.0 165.49 23.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . 0.491 HD13 ' HD2' ' A' ' 409' ' ' LYS . 3.9 mm? -61.02 -34.08 74.29 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.889 0.7 . . . . 10.0 112.889 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -74.09 -28.11 61.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.956 0.408 . . . . 10.0 111.256 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . 0.557 ' HG2' ' CE1' ' A' ' 250' ' ' PHE . 36.2 mt-10 -77.44 -32.62 54.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.709 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . 0.491 ' HD2' HD13 ' A' ' 406' ' ' LEU . 90.4 mttt -66.29 -35.22 79.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 10.0 111.79 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.3 6.83 21.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.029 0.443 . . . . 10.0 111.767 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 23.6 m -118.87 93.94 4.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.98 0.419 . . . . 10.0 110.683 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 30.1 tp -77.66 111.77 13.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.547 -0.538 . . . . 10.0 109.547 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . 0.64 ' HD3' ' HB2' ' A' ' 249' ' ' LEU . 5.2 tmm_? -107.76 148.41 29.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.125 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -116.63 137.0 52.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.508 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 4.6 m -69.05 -30.88 69.33 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.041 0.386 . . . . 10.0 112.041 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -69.28 -1.74 8.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -118.28 14.25 13.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.932 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . 0.402 ' HA ' HD11 ' A' ' 249' ' ' LEU . 55.3 t-20 -88.5 113.95 57.65 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.555 ' HD3' HD11 ' A' ' 249' ' ' LEU . 51.1 Cg_exo -54.97 -39.94 88.22 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.18 2.586 . . . . 10.0 112.53 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.6 m -61.28 -42.91 99.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.112 0.482 . . . . 10.0 110.564 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 49.7 mm -72.16 -40.51 66.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.881 -0.599 . . . . 10.0 110.171 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.5 -44.82 95.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.475 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -60.79 -45.19 95.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 10.0 110.618 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.447 ' HB2' ' SD ' ' A' ' 240' ' ' MET . 45.2 tp -64.63 -41.19 96.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.882 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . 0.657 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 1.2 m-85 -68.13 -33.64 74.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.024 -0.534 . . . . 10.0 110.967 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.66 -61.18 2.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.566 0.95 . . . . 10.0 113.566 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.52 16.99 5.76 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.842 1.423 . . . . 10.0 114.842 -176.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -150.73 -63.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.243 0.831 . . . . 10.0 113.243 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.657 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 96.2 mt -67.37 -36.5 81.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.853 0.686 . . . . 10.0 112.853 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 97.47 -68.12 0.79 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.892 -0.67 . . . . 10.0 111.853 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -161.31 157.47 21.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.767 -0.457 . . . . 10.0 109.767 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.412 ' HA ' ' HE1' ' A' ' 425' ' ' TYR . 52.1 Cg_exo -58.28 132.36 48.43 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.582 2.188 . . . . 10.0 110.915 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' A' ' 103' ' ' SER . 4.6 mp 66.63 9.63 6.78 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.986 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 438' ' ' HIS . . . -70.21 -170.68 8.79 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.32 -0.467 . . . . 10.0 112.865 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -55.28 -62.33 1.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.381 0.511 . . . . 10.0 112.381 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.43 ' HD2' ' HA ' ' A' ' 436' ' ' LYS . 31.3 tptt -60.43 -38.34 83.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.906 0.384 . . . . 10.0 111.83 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -66.69 -46.09 76.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.084 0.469 . . . . 10.0 111.006 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 434' ' ' GLY . 0.1 OUTLIER -70.14 -20.4 63.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.944 0.402 . . . . 10.0 110.976 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -76.07 -65.34 0.93 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.954 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 81.5 mt -92.81 -24.7 18.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.488 1.292 . . . . 10.0 114.488 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 68.3 mt -93.0 -6.14 49.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 438' ' ' HIS . 26.0 m-70 -121.71 165.06 16.36 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.27 -0.269 . . . . 10.0 110.949 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 7.5 t -152.15 -168.95 3.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.641 0.258 . . . . 10.0 111.596 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -139.72 161.48 37.43 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.375 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' TYR . . . . . 0.567 ' HD2' HG23 ' A' ' 145' ' ' ILE . 37.9 m-85 -110.58 168.88 9.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.695 -0.229 . . . . 10.0 111.029 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.08 113.3 36.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 10.0 111.013 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -66.18 105.86 1.5 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.482 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 131.51 -20.41 4.66 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.28 -0.728 . . . . 10.0 111.28 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.641 0 C-N-CA 120.844 -0.693 . . . . 10.0 112.069 179.844 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 p -74.93 165.96 24.42 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.923 -0.399 . . . . 10.0 109.923 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 189' ' ' GLN . 96.7 m-70 -64.23 -31.02 72.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.761 0.282 . . . . 10.0 111.761 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.73 -45.15 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.503 -0.555 . . . . 10.0 109.503 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -63.6 -31.32 72.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.386 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.542 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 36.8 mt-30 -62.83 -23.46 67.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.264 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.1 -38.66 10.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.888 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.19 -35.08 76.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.098 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.6 -36.45 74.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.085 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -79.77 -34.83 39.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.382 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.15 -25.4 62.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.239 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.55 -7.5 56.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.011 0.434 . . . . 10.0 110.626 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 91.9 mttt -93.8 121.7 63.87 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.908 -0.587 . . . . 10.0 109.906 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.1 148.89 75.13 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.56 2.173 . . . . 10.0 110.415 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.834 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 61.9 mttt -63.89 -10.41 20.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.978 0.732 . . . . 10.0 112.978 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -98.52 -5.32 32.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.734 0.302 . . . . 10.0 111.288 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.2 135.84 82.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.314 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.91 -17.34 59.31 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.714 2.276 . . . . 10.0 113.171 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.75 14.16 30.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 10.0 110.781 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.834 ' HG2' ' HA ' ' A' ' 39' ' ' LYS . 6.8 tpt180 -87.64 115.51 25.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.504 . . . . 10.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.74 ' HD3' ' HA ' ' A' ' 176' ' ' ASP . 14.0 mttp -93.7 169.11 10.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.816 -0.629 . . . . 10.0 109.882 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.51 111.75 18.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.84 -0.8 . . . . 10.0 108.84 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.33 102.16 13.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.082 0.468 . . . . 10.0 111.646 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.3 m -99.1 140.54 33.11 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.245 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 13.1 p -132.38 135.84 57.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.085 0.469 . . . . 10.0 112.115 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 14.5 pt20 -116.35 127.07 54.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.967 -0.561 . . . . 10.0 109.581 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.426 HG11 HD21 ' A' ' 75' ' ' LEU . 2.0 t -104.03 150.04 7.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.123 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.02 139.08 20.48 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.481 . . . . 10.0 109.962 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.7 -35.03 66.89 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.184 2.59 . . . . 10.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.68 -32.86 74.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.102 0.477 . . . . 10.0 110.768 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.939 HG13 HG23 ' A' ' 214' ' ' THR . 88.0 t -80.53 -40.15 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.776 -0.647 . . . . 10.0 109.374 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -56.6 -33.08 65.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.536 -0.757 . . . . 10.0 112.316 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.38 -37.52 12.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 113.292 0.849 . . . . 10.0 113.292 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.56 -5.56 53.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.528 0.936 . . . . 10.0 113.528 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.34 -26.39 40.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.823 0.344 . . . . 10.0 111.687 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.83 -24.85 65.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.591 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -66.24 -26.14 67.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.279 -0.419 . . . . 10.0 112.049 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.0 p -68.18 -23.59 64.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.066 0.46 . . . . 10.0 110.54 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.6 mt -94.02 -0.78 55.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.164 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.99 18.52 55.85 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.947 -0.644 . . . . 10.0 112.385 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.8 mt -106.34 164.62 11.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.662 0.267 . . . . 10.0 110.764 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.61 153.9 85.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.527 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.43 133.65 59.37 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.567 2.178 . . . . 10.0 111.691 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.49 14.17 62.14 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.667 -0.777 . . . . 10.0 113.082 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.57 -27.04 31.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.953 0.406 . . . . 10.0 111.245 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 p -103.25 129.26 50.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.194 -0.457 . . . . 10.0 109.976 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -77.76 154.74 80.92 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.323 -0.251 . . . . 10.0 110.323 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.84 -41.12 77.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.713 2.276 . . . . 10.0 111.935 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.457 ' HD3' ' HB3' ' A' ' 233' ' ' GLU . 46.8 mttm -66.15 -36.59 83.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.967 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -61.71 -41.67 97.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.013 0.435 . . . . 10.0 110.654 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.426 HD21 HG11 ' A' ' 51' ' ' VAL . 48.8 tp -64.73 -44.53 89.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.432 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.34 95.24 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.73 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.469 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 23.9 tp10 -60.32 -46.9 88.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.881 -0.599 . . . . 10.0 110.29 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.04 -43.81 96.79 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.85 -0.613 . . . . 10.0 112.442 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.441 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 30.6 mt -60.02 -43.93 94.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 10.0 111.124 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -64.18 -32.51 74.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.943 0.401 . . . . 10.0 110.619 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -74.68 -12.62 60.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.386 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.7 mt -77.62 -19.61 55.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 10.0 109.937 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.59 7.58 8.07 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.649 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.441 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 47.3 m-85 -72.81 156.63 38.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.729 0.299 . . . . 10.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -98.03 -58.71 1.92 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.993 0.425 . . . . 10.0 111.357 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . 2.9 mp0 -117.61 128.15 54.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.131 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.4 t -113.52 114.26 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.267 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 86' ' ' GLU . 24.5 m-85 -118.1 170.55 8.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.476 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -118.11 149.04 41.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.4 m -64.78 -20.57 66.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.74 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 91' ' ' LEU . 24.7 mt -57.91 -34.57 69.97 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.424 ' HD2' HD13 ' A' ' 158' ' ' LEU . 42.9 t80 -66.99 -37.63 84.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.151 0.5 . . . . 10.0 109.96 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.02 -34.47 58.62 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.994 -0.842 . . . . 10.0 110.994 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.89 -36.38 83.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.605 -0.298 . . . . 10.0 110.509 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.13 -33.93 69.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.07 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.434 HD21 HD23 ' A' ' 424' ' ' LEU . 78.9 mt -76.09 -42.79 46.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.988 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m -59.67 -44.33 93.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.667 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.5 mt -58.68 -42.14 84.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.905 -0.589 . . . . 10.0 110.753 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 87.6 mmm -66.95 -48.45 68.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.229 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -66.87 -53.92 27.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.444 ' HG2' ' SG ' ' A' ' 151' ' ' CYS . 18.9 mt-10 -60.42 -40.95 92.86 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.847 0.356 . . . . 10.0 110.932 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.16 99.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.095 -0.574 . . . . 10.0 111.865 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.8 m -67.94 -39.89 83.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.531 0.205 . . . . 10.0 110.853 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.526 ' HA ' ' HD2' ' A' ' 107' ' ' HIS . 19.6 tt0 -64.57 -41.3 96.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.05 -51.15 69.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.117 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.1 tp -57.3 -46.78 82.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.639 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.73 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -64.77 -40.13 94.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.431 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -58.13 -40.73 82.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.035 0.445 . . . . 10.0 110.25 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 45.4 tp -70.03 -42.25 73.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.85 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 m -58.4 -47.48 83.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.835 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 30.2 mm-40 -57.44 -35.88 70.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.129 0.49 . . . . 10.0 110.468 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.425 ' HE1' ' HA ' ' A' ' 122' ' ' PRO . 44.8 m80 -75.9 -29.44 58.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.771 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 95.7 mt -76.36 -34.0 58.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.173 0.511 . . . . 10.0 110.343 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -79.81 -43.41 22.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.381 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.093 0 O-C-N 123.831 0.707 . . . . 10.0 111.728 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.795 0.331 . . . . 10.0 110.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.425 ' HA ' ' HE1' ' A' ' 112' ' ' HIS . 67.8 Cg_endo -85.27 -165.12 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.798 2.332 . . . . 10.0 112.615 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.401 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 94.1 mt -129.07 157.72 75.03 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 123' ' ' LEU . 18.3 Cg_exo -66.37 167.23 55.02 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.296 -1.127 . . . . 10.0 113.129 0.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 25.7 ttt -113.57 133.35 55.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.774 . . . . 10.0 111.007 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -113.79 144.45 42.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.963 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.459 HG23 ' HZ ' ' A' ' 371' ' ' PHE . 0.0 OUTLIER -74.11 150.32 40.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.67 0.272 . . . . 10.0 110.322 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 p -116.47 20.4 14.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 6.82 28.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.452 ' O ' HG12 ' A' ' 134' ' ' ILE . 54.1 t -120.15 117.78 31.81 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 120.658 0.266 . . . . 10.0 111.567 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.23 -33.79 70.27 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.364 2.71 . . . . 10.0 112.048 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.02 -41.63 97.16 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.946 -0.645 . . . . 10.0 111.571 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -65.8 -44.04 86.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.078 -0.342 . . . . 10.0 110.078 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 130' ' ' CYS . 35.2 mm -57.99 -42.38 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.966 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.45 76.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.168 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 12.2 tpt -67.2 -34.19 76.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.007 0.432 . . . . 10.0 110.823 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.41 HD22 HG21 ' A' ' 148' ' ' VAL . 22.0 tp -60.44 -60.7 3.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.57 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -63.73 -20.62 65.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.682 -0.235 . . . . 10.0 111.599 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -81.06 -61.97 1.8 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.607 0.965 . . . . 10.0 113.607 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 m -115.27 1.0 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.714 1.376 . . . . 10.0 114.714 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 144' ' ' LEU . 53.5 m-85 -134.14 60.65 45.86 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 122.05 -0.406 . . . . 10.0 111.102 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.96 -25.43 32.36 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.364 2.043 . . . . 10.0 113.1 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -87.07 1.05 54.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.987 0.422 . . . . 10.0 111.289 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 141' ' ' TYR . 59.8 mt -105.99 4.27 29.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.462 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.582 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 75.6 mt -57.94 -53.72 62.88 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.582 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 49.3 Cg_exo -58.4 -18.94 41.05 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.479 2.119 . . . . 10.0 113.076 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 125' ' ' MET . 96.5 m-85 -78.76 -20.03 50.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.214 0.531 . . . . 10.0 110.459 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.41 HG21 HD22 ' A' ' 137' ' ' LEU . 16.7 t -90.49 154.3 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.587 . . . . 10.0 109.589 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.0 t -68.18 158.31 33.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.069 0.461 . . . . 10.0 111.125 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 88.3 p -100.54 6.41 44.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.237 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 101' ' ' GLU . 4.5 m -80.83 143.9 32.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.228 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -85.66 165.12 17.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.099 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.2 p -67.19 155.11 91.37 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.761 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -45.15 -54.68 4.08 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.604 2.87 . . . . 10.0 114.214 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 155' ' ' GLN . 0.0 OUTLIER -65.14 -34.31 78.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.709 0.633 . . . . 10.0 112.709 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 78.9 mmm -72.81 -23.81 60.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.064 0.459 . . . . 10.0 110.481 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 36.6 mtt -75.8 -48.88 19.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.328 -0.619 . . . . 10.0 109.328 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.424 HD13 ' HD2' ' A' ' 92' ' ' PHE . 49.2 tp -62.82 -40.22 96.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.372 -0.831 . . . . 10.0 111.038 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.47 81.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.471 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.88 -31.87 57.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.534 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -70.26 -43.26 70.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.691 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.8 m -68.89 -27.48 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' A' ' 179' ' ' MET . 44.4 mttt -88.94 7.7 33.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.016 0.376 . . . . 10.0 112.016 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.6 p -129.41 -74.67 0.55 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.814 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -62.97 -50.83 69.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.56 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 162' ' ' VAL . 54.8 tp -64.04 -40.8 97.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 10.0 110.787 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.77 -52.04 67.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.919 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -64.04 -43.72 94.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.389 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -62.45 -38.06 88.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 10.0 111.991 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -89.32 -7.48 55.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 69.06 40.87 83.1 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.104 -0.569 . . . . 10.0 112.642 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 43.2 mt -123.5 142.39 40.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -79.51 136.36 56.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 110.018 -0.364 . . . . 10.0 110.018 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 173' ' ' ALA . 51.3 Cg_exo -57.44 -16.05 21.88 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.237 2.624 . . . . 10.0 113.143 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -72.77 -28.88 62.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 10.0 110.864 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.74 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 58.3 m-20 -101.82 29.62 4.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.401 0.62 . . . . 10.0 110.244 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 95.4 mtp -126.89 124.73 40.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.142 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 32.1 t -107.93 119.31 57.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.338 -0.615 . . . . 10.0 109.338 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.519 ' HB2' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -103.31 109.11 20.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.055 0.455 . . . . 10.0 111.273 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 28.0 t -108.69 142.1 22.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.417 ' OG ' HD21 ' A' ' 208' ' ' LEU . 10.1 p -134.79 138.22 44.08 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.917 -0.313 . . . . 10.0 111.049 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.43 HG21 HD22 ' A' ' 217' ' ' LEU . 21.2 mm -100.35 108.95 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 213' ' ' THR . 31.9 mmt -116.95 149.38 44.04 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.49 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.68 25.02 0.71 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.828 2.352 . . . . 10.0 112.518 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 30.2 t -156.99 139.29 14.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.588 -0.278 . . . . 10.0 110.719 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.89 -24.11 52.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.156 0.503 . . . . 10.0 110.588 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -70.98 -3.05 17.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.717 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -78.13 -27.23 48.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.951 0.405 . . . . 10.0 110.9 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . 0.416 ' HG2' ' CD2' ' A' ' 27' ' ' HIS . 29.3 tp60 -68.45 -34.94 76.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 10.0 109.942 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.56 -26.63 67.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.182 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -76.82 -42.81 38.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.237 0.542 . . . . 10.0 109.81 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.427 ' CB ' HD23 ' A' ' 208' ' ' LEU . . . -74.75 -21.28 59.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.475 -0.784 . . . . 10.0 111.703 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -2.1 38.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.479 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 51.1 mtt180 -63.41 120.71 12.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.187 0.517 . . . . 10.0 110.196 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.09 -42.59 50.46 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.714 1.746 . . . . 10.0 115.714 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' TRP . . . . . 0.45 ' HZ2' HH11 ' A' ' 194' ' ' ARG . 35.3 p90 -67.78 0.73 3.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.465 1.283 . . . . 10.0 114.465 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 194' ' ' ARG . 9.7 m-85 -93.87 68.2 3.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.131 0.491 . . . . 10.0 109.949 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 5.9 p -109.38 167.88 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.187 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.448 HG22 ' HG2' ' A' ' 207' ' ' GLN . 15.9 t -113.31 103.32 15.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.088 -0.708 . . . . 10.0 109.088 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.947 -1.025 . . . . 10.0 111.644 -179.6 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.841 0.353 . . . . 10.0 110.457 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.777 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.231 0.106 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -82.52 139.84 33.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.258 -0.275 . . . . 10.0 110.258 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 197' ' ' PHE . 54.8 mt-30 -65.59 -42.51 91.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.526 0.679 . . . . 10.0 109.502 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.518 HD12 ' HB3' ' A' ' 179' ' ' MET . 19.2 tp -120.06 136.71 54.47 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.84 -64.8 1.09 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.999 0.741 . . . . 10.0 112.999 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 1.4 m-70 -140.28 144.76 36.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.929 0.395 . . . . 10.0 111.857 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 47.3 t -112.2 131.01 64.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.51 138.13 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.479 -0.563 . . . . 10.0 109.479 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 183' ' ' MET . 72.4 p -87.81 166.93 14.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.121 0.486 . . . . 10.0 111.885 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.939 HG23 HG13 ' A' ' 55' ' ' VAL . 1.4 m -57.3 -45.97 83.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.471 -0.786 . . . . 10.0 111.429 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.7 m -61.99 -42.01 93.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.803 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 220' ' ' ILE . 41.8 mt-10 -66.17 -46.47 77.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 10.0 110.86 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 182' ' ' ILE . 34.6 tp -60.85 -45.11 95.83 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.002 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -60.71 -37.4 93.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.026 -0.606 . . . . 10.0 111.954 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . 0.499 ' HA ' ' HE3' ' A' ' 222' ' ' LYS . 42.4 m-20 -65.37 -39.33 92.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.625 0.25 . . . . 10.0 110.634 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 216' ' ' GLU . 73.4 mt -60.37 -47.57 91.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.368 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -60.2 -41.64 93.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.084 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' A' ' 219' ' ' ASN . 36.9 mtmt -66.41 -47.56 72.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -63.79 -38.27 90.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 10.0 111.708 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -76.06 -18.78 59.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 10.0 111.414 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.76 40.59 12.0 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.901 -0.666 . . . . 10.0 112.119 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.5 mt -120.09 92.83 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.891 0.377 . . . . 10.0 110.54 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -76.39 116.15 16.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 10.0 109.971 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.576 ' HA ' HD12 ' A' ' 231' ' ' LEU . 36.1 mt -60.48 -28.8 68.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.873 -0.603 . . . . 10.0 112.141 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.91 -13.0 61.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.477 -0.329 . . . . 10.0 111.76 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -109.93 18.3 20.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.021 0.439 . . . . 10.0 111.042 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 228' ' ' LEU . 96.1 mt -105.46 150.2 38.7 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.614 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.01 176.65 9.59 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.339 2.026 . . . . 10.0 111.478 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 73' ' ' LYS . 8.2 mm-40 -74.08 99.13 3.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.404 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 77' ' ' GLU . . . -73.73 -168.16 15.8 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.997 -0.62 . . . . 10.0 113.08 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -132.45 154.17 50.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.777 0.322 . . . . 10.0 111.348 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -100.41 165.17 11.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.275 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 246' ' ' ALA . 30.4 m-20 -107.98 155.38 20.4 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.693 -0.484 . . . . 10.0 109.693 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -100.42 120.62 55.77 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.714 0.292 . . . . 10.0 110.788 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.18 -14.99 45.28 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.959 2.439 . . . . 10.0 112.093 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.4 ' HE2' ' HB3' ' A' ' 423' ' ' GLU . 98.2 mmm -83.02 10.83 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.955 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 89.69 -61.51 3.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.193 -0.527 . . . . 10.0 111.939 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.4 m -125.35 144.87 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.732 0.301 . . . . 10.0 110.21 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 155.43 162.85 11.6 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.073 -0.585 . . . . 10.0 111.811 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 m -94.33 107.42 19.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.971 0.415 . . . . 10.0 110.429 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 95.77 -164.16 23.91 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.748 -0.739 . . . . 10.0 111.428 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 237' ' ' ASP . . . -80.95 0.87 33.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.93 0.344 . . . . 10.0 111.93 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 13.82 80.25 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.295 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.17 118.87 53.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.524 HD11 ' HD3' ' A' ' 419' ' ' PRO . 75.1 mt -69.85 136.15 50.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.523 -0.308 . . . . 10.0 111.195 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -54.74 122.43 10.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.528 -0.76 . . . . 10.0 111.312 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 148.09 165.73 12.23 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.354 -0.698 . . . . 10.0 111.354 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 6.7 t -107.62 152.12 24.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.121 0.486 . . . . 10.0 111.115 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.27 -10.18 20.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.065 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.488 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 88.08 -30.82 4.96 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.919 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 150.84 167.29 14.46 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.234 -1.146 . . . . 10.0 110.234 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.51 -54.09 36.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 117.402 0.601 . . . . 10.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' MET . . . . . 0.743 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 28.6 ttp -61.6 -49.03 78.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.541 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.488 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 17.1 tt0 -58.14 -46.97 84.72 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.12 0.415 . . . . 10.0 112.12 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.67 -35.93 79.76 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.715 -0.221 . . . . 10.0 111.394 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.62 -46.52 78.96 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.707 -0.479 . . . . 10.0 109.707 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 79.7 mt -63.16 -41.08 99.19 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.793 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.536 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 44.3 ttm105 -57.63 -51.06 71.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.324 -0.853 . . . . 10.0 111.16 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 28.9 m -56.57 -43.84 80.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.405 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.59 -43.15 69.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.909 0.385 . . . . 10.0 111.249 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.531 ' CD2' ' HB2' ' A' ' 273' ' ' LEU . 47.3 t80 -63.18 -47.51 82.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.135 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.448 ' OE2' ' HA ' ' A' ' 272' ' ' PRO . 75.2 mt-10 -66.0 -36.81 84.31 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 76.0 mt -77.65 -7.92 57.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.167 0.508 . . . . 10.0 111.13 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -104.51 -40.65 5.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.484 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . 0.45 HG21 ' CE1' ' A' ' 265' ' ' TYR . 77.9 p -97.97 -32.67 11.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.986 0.736 . . . . 10.0 112.986 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 89.06 -3.13 84.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.491 -0.861 . . . . 10.0 111.034 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 12.0 p -104.64 139.47 20.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.989 -0.374 . . . . 10.0 109.989 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.448 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 37.0 Cg_endo -68.07 139.54 47.0 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.423 2.082 . . . . 10.0 111.581 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.642 HD12 ' HD2' ' A' ' 274' ' ' PRO . 40.6 tp -101.48 121.65 50.75 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.241 -0.436 . . . . 10.0 111.143 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . 0.642 ' HD2' HD12 ' A' ' 273' ' ' LEU . 73.9 Cg_endo -77.5 -156.19 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.573 2.182 . . . . 10.0 111.335 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -80.94 142.54 33.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.082 -0.34 . . . . 10.0 110.082 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.11 124.6 36.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.069 0.461 . . . . 10.0 112.11 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 4.3 m -90.65 91.9 8.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.238 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 278' ' ' LEU . 3.5 mm? -58.54 123.93 17.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 10.0 111.554 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 6.1 m -98.7 140.84 32.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.491 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.12 128.48 33.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.522 -0.308 . . . . 10.0 110.971 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . 0.45 HG22 ' HG2' ' A' ' 289' ' ' GLU . 21.7 t -86.03 110.25 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.351 . . . . 10.0 110.155 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -66.83 123.05 19.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.369 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 117.16 -21.32 10.98 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.4 ' HB3' ' CG1' ' A' ' 287' ' ' ILE . 63.8 mtm -132.91 85.5 2.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -62.65 109.98 1.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.458 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . 0.42 ' HA3' ' ND2' ' A' ' 354' ' ' ASN . . . 118.08 -13.52 12.65 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.757 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.4 ' CG1' ' HB3' ' A' ' 284' ' ' MET . 42.9 mm -97.89 129.44 48.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -119.59 149.94 41.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . 0.45 ' HG2' HG22 ' A' ' 281' ' ' VAL . 21.6 pt-20 -133.39 160.1 38.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.992 0.425 . . . . 10.0 112.07 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.83 134.62 13.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.299 -0.864 . . . . 10.0 109.855 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -112.0 110.1 20.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.548 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 31.5 mt -98.97 121.49 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 10.0 111.504 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . 0.552 HG23 ' HZ ' ' A' ' 333' ' ' PHE . 4.6 m -76.99 104.45 7.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.226 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . 0.432 ' HG2' ' HD1' ' A' ' 265' ' ' TYR . 88.6 mtp -100.6 102.46 13.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.985 0.422 . . . . 10.0 111.74 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.54 118.48 54.42 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.979 -0.749 . . . . 10.0 108.979 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.01 132.99 55.04 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.863 2.375 . . . . 10.0 112.566 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.22 134.52 95.99 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.887 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.37 120.04 7.56 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.717 2.278 . . . . 10.0 111.492 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 92.42 39.39 5.36 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.828 -0.701 . . . . 10.0 111.702 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 98.9 p -128.53 165.12 21.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.861 -0.422 . . . . 10.0 109.861 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.618 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 13.2 pttt -73.11 -29.38 62.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.622 -0.51 . . . . 10.0 109.622 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -66.02 -39.51 90.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.905 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 307' ' ' LYS . 13.5 tt0 -64.32 -45.28 88.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.013 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.58 -31.74 73.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.648 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 90.7 mt -58.86 -57.3 13.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 10.0 110.919 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . 0.414 HD21 HD22 ' A' ' 113' ' ' LEU . 92.2 mt -69.26 -26.23 64.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.367 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 303' ' ' GLU . 6.6 tmtt? -79.03 -12.97 60.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.992 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -112.26 -22.74 10.77 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.878 0.696 . . . . 10.0 112.878 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 305' ' ' LEU . 6.9 ptp180 -146.4 123.92 11.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.992 0.425 . . . . 10.0 112.044 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.5 -0.18 4.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.486 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.198 -0.906 . . . . 10.0 109.113 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.438 0 N-CA-C 111.513 -0.635 . . . . 10.0 111.513 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.35 -23.43 51.45 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.729 2.286 . . . . 10.0 111.733 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 147' ' ' TYR . 93.3 mt -119.23 96.48 5.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.137 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -92.66 124.16 36.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.242 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -60.56 129.94 44.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.062 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -72.71 -12.93 61.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.286 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 115.05 -9.59 20.84 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.245 -0.742 . . . . 10.0 111.245 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.52 129.2 2.51 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.855 -0.688 . . . . 10.0 111.565 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -71.78 88.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.08 0.467 . . . . 10.0 110.588 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -105.68 149.06 16.63 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.928 -0.653 . . . . 10.0 112.397 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . 0.552 ' HZ ' HG23 ' A' ' 293' ' ' THR . 3.5 p90 -132.05 151.23 51.87 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.435 ' HA ' ' HA2' ' A' ' 340' ' ' GLY . 7.8 t -131.78 142.09 49.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.981 0.42 . . . . 10.0 111.196 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 1.7 m -83.75 165.05 19.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.813 -0.631 . . . . 10.0 109.934 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -70.97 -18.19 62.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.894 0.378 . . . . 10.0 110.986 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -26.12 60.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.683 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 126.39 -16.68 6.65 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.464 -0.874 . . . . 10.0 113.561 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -83.15 163.52 20.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.865 0.333 . . . . 10.0 110.881 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 334' ' ' THR . . . -150.26 169.04 30.25 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.731 -0.747 . . . . 10.0 112.293 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -157.19 164.93 33.1 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.42 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 14.4 tt -122.32 140.95 44.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.998 0.399 . . . . 10.0 110.724 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.42 ' HB ' ' HE2' ' A' ' 333' ' ' PHE . 4.8 t -96.98 100.09 11.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.233 0.54 . . . . 10.0 110.132 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 21.4 tp -62.95 116.72 5.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.457 -0.792 . . . . 10.0 110.776 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -90.71 100.19 13.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.555 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 46.3 t -104.18 132.59 50.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.63 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.556 ' HB3' HG22 ' A' ' 372' ' ' VAL . . . -125.78 144.75 50.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.785 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.71 118.89 57.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.635 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.487 ' HB3' HG12 ' A' ' 374' ' ' ILE . . . -105.52 97.39 7.23 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.238 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.22 101.0 13.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.006 0.431 . . . . 10.0 110.167 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 126.08 123.83 2.71 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.203 -0.759 . . . . 10.0 111.203 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . 0.808 ' HG ' ' HA ' ' A' ' 376' ' ' ALA . 26.7 mt -59.11 -32.01 69.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.938 0.399 . . . . 10.0 111.786 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . 0.459 ' O ' ' HE3' ' A' ' 357' ' ' LYS . . . -72.43 -26.59 71.51 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.236 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 357' ' ' LYS . 86.6 m-20 -74.03 -23.78 59.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 10.0 111.054 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -66.28 -36.09 82.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.632 -0.507 . . . . 10.0 109.632 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -68.07 -21.33 64.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.332 -0.849 . . . . 10.0 110.545 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 353' ' ' GLY . 60.4 mttt -94.61 -32.39 13.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 10.0 111.572 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.96 -45.83 16.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.916 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 85.1 mt -58.94 -34.48 52.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.095 0.406 . . . . 10.0 112.095 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -43.2 99.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.993 0.425 . . . . 10.0 110.306 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -72.3 -29.06 63.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.613 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 89.5 mtp -70.35 -48.83 54.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.104 -0.498 . . . . 10.0 109.861 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.52 -36.77 83.63 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.45 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.2 -27.54 68.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.609 . . . . 10.0 110.866 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 105.26 0.03 40.81 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.069 -0.586 . . . . 10.0 112.605 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -75.49 -54.41 7.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 10.0 111.335 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -81.85 100.7 9.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.51 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -94.75 106.09 18.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.478 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -137.44 155.35 49.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.103 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -105.28 -38.05 6.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.062 0.458 . . . . 10.0 110.877 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.743 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 53.5 t80 -130.46 129.79 43.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.699 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 347' ' ' ALA . 62.5 t -134.07 127.01 50.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.803 0.335 . . . . 10.0 111.818 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.458 ' HA ' ' OG1' ' A' ' 127' ' ' THR . 14.1 tt0 -101.88 126.74 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.487 HG12 ' HB3' ' A' ' 349' ' ' ALA . 68.9 mt -116.37 120.1 63.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.254 0.549 . . . . 10.0 111.971 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' MET . . . . . . . . . . . . . 10.0 mmt -105.79 155.52 19.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 10.0 109.442 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 0.808 ' HA ' ' HG ' ' A' ' 352' ' ' LEU . . . . . . . . 0 C--N 1.321 -0.658 0 CA-C-O 120.78 0.324 . . . . 10.0 111.685 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . 0.462 HG23 HG22 ' A' ' 396' ' ' THR . 28.0 m . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.796 0.332 . . . . 10.0 111.472 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -112.0 27.93 9.79 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.059 -0.591 . . . . 10.0 111.985 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -69.32 169.73 43.23 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.12 -0.562 . . . . 10.0 112.641 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -71.86 -25.47 74.82 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.027 -0.606 . . . . 10.0 113.091 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -76.21 -17.81 79.74 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.275 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -74.01 160.35 81.94 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.903 -0.406 . . . . 10.0 109.903 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.82 159.68 40.55 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.404 2.07 . . . . 10.0 110.983 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.07 135.68 53.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.484 -0.326 . . . . 10.0 110.249 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 13.9 t . . . . . 0 C--N 1.32 -0.7 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.202 -179.842 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' THR . . . . . 0.462 HG22 HG23 ' A' ' 382' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.608 0.242 . . . . 10.0 111.603 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -62.06 -37.77 86.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.954 0.407 . . . . 10.0 110.716 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -67.97 -39.67 83.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.59 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -63.44 -42.65 98.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.859 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -70.31 -32.8 70.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.972 -0.558 . . . . 10.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -75.08 -46.04 37.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.515 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -85.24 13.29 6.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.839 0.352 . . . . 10.0 111.865 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -36.95 85.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.564 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.509 ' O ' ' HE3' ' A' ' 409' ' ' LYS . 75.4 m-85 -136.61 151.47 49.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.151 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -75.36 160.94 29.72 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.157 -0.682 . . . . 10.0 109.157 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.42 -35.35 69.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.889 0.376 . . . . 10.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.23 -35.45 81.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.418 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.05 -36.6 66.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.462 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . 0.509 ' HE3' ' O ' ' A' ' 404' ' ' TYR . 96.5 mttt -71.02 -32.86 69.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.593 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.1 p -81.6 -3.37 53.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.016 0.436 . . . . 10.0 111.564 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 9.5 m -120.6 96.92 5.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.913 0.387 . . . . 10.0 111.216 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 23.6 tp -78.8 117.19 19.68 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 414' ' ' ARG . 6.1 tmm_? -118.44 139.96 50.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.519 -0.31 . . . . 10.0 111.366 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.493 ' HB2' ' OE1' ' A' ' 417' ' ' GLU . 67.9 mtt85 -101.69 158.94 15.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.386 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 9.2 m -72.59 -33.04 66.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.257 0.466 . . . . 10.0 112.257 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -77.29 4.13 11.37 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.221 0.823 . . . . 10.0 113.221 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . 0.493 ' OE1' ' HB2' ' A' ' 414' ' ' ARG . 0.5 OUTLIER -103.52 -3.74 24.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.643 -0.503 . . . . 10.0 109.643 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -84.3 116.33 64.48 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.505 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . 0.524 ' HD3' HD11 ' A' ' 249' ' ' LEU . 33.5 Cg_exo -59.62 -38.42 82.02 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.994 2.463 . . . . 10.0 111.983 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.1 m -60.78 -43.94 97.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.552 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.18 -40.3 84.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.782 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . 0.435 ' NH2' ' HA ' ' A' ' 417' ' ' GLU . 98.9 mtt180 -59.96 -44.93 94.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.673 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . 0.4 ' HB3' ' HE2' ' A' ' 240' ' ' MET . 46.7 tt0 -61.51 -43.98 97.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . 0.434 HD23 HD21 ' A' ' 96' ' ' LEU . 65.3 tp -63.54 -37.93 89.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.193 0.52 . . . . 10.0 111.216 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.3 m-85 -74.87 -59.81 2.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.198 -0.455 . . . . 10.0 111.747 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.85 -14.51 62.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 115.074 1.509 . . . . 10.0 115.074 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.8 18.25 7.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -161.94 -61.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.585 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 92.8 mt -67.68 -40.7 84.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 99.89 -77.48 0.47 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.053 -0.594 . . . . 10.0 111.702 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . 0.596 ' HG2' ' HD2' ' A' ' 432' ' ' PRO . 1.0 OUTLIER -149.16 153.06 37.38 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.368 -0.605 . . . . 10.0 109.368 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.596 ' HD2' ' HG2' ' A' ' 431' ' ' GLU . 60.4 Cg_exo -55.1 134.8 65.81 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.565 2.177 . . . . 10.0 110.953 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.402 HD21 ' HG3' ' A' ' 104' ' ' GLU . 6.9 mp 66.75 13.61 9.45 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.532 0.52 . . . . 10.0 112.206 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -69.9 -166.91 5.79 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.513 -0.375 . . . . 10.0 112.979 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -59.64 -62.79 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.848 0.314 . . . . 10.0 111.848 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . 0.512 ' HD2' ' HA ' ' A' ' 436' ' ' LYS . 17.7 tptt -63.03 -34.44 77.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.8 0.334 . . . . 10.0 111.497 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -64.55 -42.15 95.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.078 0.466 . . . . 10.0 110.487 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 0.1 OUTLIER -78.89 -9.68 59.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.03 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -93.19 -48.25 6.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.184 -0.462 . . . . 10.0 112.235 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.52 -34.55 9.5 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 113.828 1.047 . . . . 10.0 113.828 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 58.9 mt -90.25 -12.03 39.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 17.0 m-70 -119.19 167.09 12.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.18 -0.208 . . . . 10.0 110.873 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.5 t -156.37 -170.23 3.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.275 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -135.72 158.26 44.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.242 -0.281 . . . . 10.0 110.242 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -117.62 153.64 32.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.724 0.297 . . . . 10.0 111.262 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.75 128.55 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.007 0.432 . . . . 10.0 111.831 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.41 95.36 0.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.983 -0.553 . . . . 10.0 111.348 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 145.35 -33.32 1.58 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.917 -0.658 . . . . 10.0 111.973 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 111.327 -0.709 . . . . 10.0 111.327 -179.599 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.584 0.23 . . . . 10.0 110.406 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 p -73.93 168.43 19.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.695 -0.23 . . . . 10.0 110.424 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -56.68 -37.88 71.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.534 -0.303 . . . . 10.0 111.532 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 212' ' ' ILE . 59.8 t -72.0 -49.68 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.338 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.66 -27.03 68.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 10.0 111.72 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.529 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 54.3 mt-30 -66.2 -13.72 60.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.78 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.13 -32.86 7.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.486 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.05 -34.04 72.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.944 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.04 81.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.529 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -76.44 -38.02 56.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.694 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.2 -33.08 75.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.55 . . . . 10.0 111.613 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.04 -29.16 69.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 90.0 mttt -73.49 128.21 87.58 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.04 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 37' ' ' LYS . 23.8 Cg_exo -65.25 158.34 52.82 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 122.896 2.397 . . . . 10.0 111.767 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -62.84 -20.64 65.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.244 0.461 . . . . 10.0 112.244 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -97.73 15.17 24.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.901 0.334 . . . . 10.0 111.901 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 8.6 t70 -94.08 130.78 33.26 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.5 -22.9 73.65 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.814 2.343 . . . . 10.0 113.375 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.9 p -93.84 3.13 55.87 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.923 0.392 . . . . 10.0 111.608 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -87.3 129.37 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.02 -0.536 . . . . 10.0 111.209 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -111.22 -176.21 2.9 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.39 111.4 21.72 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.006 -0.368 . . . . 10.0 110.006 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.93 101.13 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.713 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.8 m -96.31 140.29 31.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.888 -0.597 . . . . 10.0 109.784 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 11.1 p -126.23 144.73 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.799 0.333 . . . . 10.0 111.206 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 13.6 pt20 -128.61 129.14 45.49 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.608 HG11 HD21 ' A' ' 75' ' ' LEU . 5.7 t -113.23 150.07 15.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.882 0.373 . . . . 10.0 110.988 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.53 141.26 22.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.989 -0.55 . . . . 10.0 109.76 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.57 -32.09 62.4 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.168 2.579 . . . . 10.0 112.347 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.41 -22.43 66.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.568 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.538 HG13 HG23 ' A' ' 214' ' ' THR . 86.3 t -89.37 -38.54 11.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.202 0.525 . . . . 10.0 109.705 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -57.34 -29.79 64.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.412 -0.813 . . . . 10.0 112.321 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.35 -36.85 13.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.827 0.677 . . . . 10.0 112.827 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.83 -13.99 38.04 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.988 0.736 . . . . 10.0 112.988 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.61 -26.8 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.026 0.38 . . . . 10.0 112.026 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.39 -27.54 66.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.622 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' CD ' HH21 ' A' ' 399' ' ' ARG . 20.7 mt-10 -68.54 -29.53 68.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 10.0 111.382 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.34 -17.42 64.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.979 0.418 . . . . 10.0 110.569 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.7 mt -99.73 -11.8 20.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.585 . . . . 10.0 109.948 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.08 25.13 13.25 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.805 -0.634 . . . . 10.0 112.193 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -110.92 -175.42 2.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.628 0.251 . . . . 10.0 110.443 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.33 149.1 42.11 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.368 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.74 117.54 4.28 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.546 2.164 . . . . 10.0 111.666 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.35 4.02 47.2 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.856 -0.687 . . . . 10.0 113.203 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.0 -29.91 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 10.0 111.259 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -94.02 126.65 39.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.232 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 p -80.62 155.64 73.49 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.784 0.326 . . . . 10.0 111.326 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -41.84 73.23 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.002 2.468 . . . . 10.0 113.023 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -66.95 -34.0 76.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.59 -0.277 . . . . 10.0 111.669 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -66.68 -37.91 85.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.423 . . . . 10.0 110.481 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.608 HD21 HG11 ' A' ' 51' ' ' VAL . 44.9 tp -64.32 -46.82 81.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.072 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.61 85.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.867 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -61.72 -47.35 85.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.135 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.93 -39.87 96.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.924 -0.655 . . . . 10.0 112.449 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.496 HD11 HG21 ' A' ' 51' ' ' VAL . 19.5 mt -62.28 -43.96 97.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.962 0.411 . . . . 10.0 111.179 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -65.59 -27.36 68.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.012 0.434 . . . . 10.0 110.595 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -77.13 -11.43 59.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 10.0 111.359 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.2 -14.04 57.95 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.79 7.19 24.05 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.236 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -69.71 145.2 52.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.829 0.347 . . . . 10.0 111.231 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.86 -64.4 1.2 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.155 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -119.6 135.4 54.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.621 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.8 t -113.46 110.9 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.529 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 48.6 m-85 -111.05 162.38 14.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.896 0.379 . . . . 10.0 110.983 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -111.0 146.39 36.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 m -65.54 -19.67 66.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.497 -0.319 . . . . 10.0 111.555 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.0 mt -57.67 -36.63 72.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.635 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -67.59 -38.08 83.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.171 0.51 . . . . 10.0 109.902 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.33 -36.99 70.55 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.716 -0.954 . . . . 10.0 110.716 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.54 81.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.522 -0.339 . . . . 10.0 110.387 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -36.15 75.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.78 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.21 -41.31 67.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.564 -0.743 . . . . 10.0 109.6 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.3 m -60.72 -44.66 96.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.75 -0.659 . . . . 10.0 110.524 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.7 mt -58.52 -40.37 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 10.0 110.956 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.2 mmm -62.53 -53.11 59.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.286 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -67.28 -40.2 86.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.174 -0.467 . . . . 10.0 111.732 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 101' ' ' GLU . 2.9 tp10 -61.64 -45.91 92.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.894 0.378 . . . . 10.0 110.55 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.58 -35.02 91.23 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.033 -0.827 . . . . 10.0 111.033 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.0 m -70.81 -41.94 70.91 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.584 -0.308 . . . . 10.0 110.62 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -61.93 -47.27 85.63 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.614 -0.513 . . . . 10.0 109.614 178.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.1 -51.48 69.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.998 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.35 -37.63 81.27 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.989 0.423 . . . . 10.0 109.996 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 26.5 t60 -62.96 -51.6 66.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.407 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.527 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 68.4 mtt180 -62.49 -32.39 73.29 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.416 -0.357 . . . . 10.0 111.308 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.61 -50.58 29.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.407 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 m -58.01 -45.52 86.75 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.697 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 71.9 mm-40 -57.47 -36.83 71.96 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.054 0.454 . . . . 10.0 110.713 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.414 ' HE1' ' HA ' ' A' ' 122' ' ' PRO . 28.4 m80 -77.2 -28.51 53.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.509 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.75 -39.21 76.87 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.38 -41.19 69.99 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.323 -0.853 . . . . 10.0 109.965 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-N 115.582 -0.735 . . . . 10.0 111.963 179.625 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 108' ' ' ARG . 1.3 mp0 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.784 0.326 . . . . 10.0 110.475 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.414 ' HA ' ' HE1' ' A' ' 112' ' ' HIS . 74.3 Cg_endo -90.3 -175.06 0.86 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.913 2.408 . . . . 10.0 112.911 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.419 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 95.2 mt -130.21 158.3 74.6 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 123' ' ' LEU . 36.6 Cg_endo -64.27 167.26 42.79 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 124.318 -1.118 . . . . 10.0 113.667 0.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 27.7 ttt -111.87 131.08 55.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.431 -0.804 . . . . 10.0 110.762 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 372' ' ' VAL . 69.7 m-85 -111.14 139.5 46.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.934 -0.576 . . . . 10.0 109.911 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.55 152.32 36.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.643 0.258 . . . . 10.0 110.617 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.9 33.37 5.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.938 0.399 . . . . 10.0 111.266 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 2.8 m -92.53 17.01 10.72 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.725 0.639 . . . . 10.0 112.725 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.461 ' O ' HG12 ' A' ' 134' ' ' ILE . 0.9 OUTLIER -136.3 120.62 12.75 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 112.079 0.399 . . . . 10.0 112.079 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.54 -40.65 45.72 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.093 2.528 . . . . 10.0 112.366 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 376' ' ' ALA . . . -61.17 -40.44 98.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.906 -0.664 . . . . 10.0 111.827 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -65.68 -48.55 71.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.999 -0.371 . . . . 10.0 109.999 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 130' ' ' CYS . 49.7 mm -58.46 -43.24 86.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.812 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.19 -47.09 86.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.461 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 54.8 ttp -68.91 -30.73 69.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.046 0.451 . . . . 10.0 110.534 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 148' ' ' VAL . 10.7 tp -68.19 -57.98 5.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.148 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -59.69 -19.7 51.45 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.91 0.708 . . . . 10.0 112.91 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -104.13 -56.55 2.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.754 1.02 . . . . 10.0 113.754 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.1 m -88.67 -28.65 20.46 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.432 1.271 . . . . 10.0 114.432 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.12 66.71 68.62 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.742 0.645 . . . . 10.0 112.742 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.62 -12.41 29.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.197 1.931 . . . . 10.0 111.58 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -88.34 -13.05 41.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.452 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -101.78 2.57 38.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.462 -0.336 . . . . 10.0 111.825 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.475 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 55.5 mt -54.75 -51.44 78.88 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 113.598 0.962 . . . . 10.0 113.598 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 41.5 Cg_exo -58.69 -20.57 51.51 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.39 2.06 . . . . 10.0 113.292 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 325' ' ' LEU . 97.4 m-85 -79.69 -17.12 54.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.226 0.536 . . . . 10.0 111.028 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.456 HG21 HD22 ' A' ' 137' ' ' LEU . 27.9 t -87.86 152.37 3.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.033 -0.53 . . . . 10.0 109.965 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . 0.465 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . 39.7 t -66.27 160.18 24.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.235 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 p -99.85 1.41 42.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.604 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 60.4 m -75.34 138.79 42.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.335 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 36.2 mtpt -80.77 168.63 18.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.456 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.87 148.9 98.42 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.384 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.44 -51.05 10.23 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.332 2.688 . . . . 10.0 113.458 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.476 ' H ' ' HG3' ' A' ' 155' ' ' GLN . 0.0 OUTLIER -65.67 -34.02 77.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.073 0.397 . . . . 10.0 112.073 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 56.9 mmm -73.74 -23.84 59.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.049 0.452 . . . . 10.0 110.718 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 39.4 mtt -75.46 -47.72 25.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.097 -0.705 . . . . 10.0 109.097 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.5 tp -63.91 -41.63 97.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.751 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.32 85.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.252 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.53 -36.7 63.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.645 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -66.44 -42.73 87.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.816 -0.629 . . . . 10.0 112.024 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.534 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.9 m -69.55 -29.88 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -85.78 1.73 48.46 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.166 0.432 . . . . 10.0 112.166 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.0 p -122.44 -75.93 0.59 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.845 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -62.05 -52.56 63.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.399 . . . . 10.0 111.542 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.534 ' HB3' ' O ' ' A' ' 162' ' ' VAL . 35.9 tp -61.24 -40.74 95.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.513 -0.312 . . . . 10.0 110.997 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.85 76.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.848 0.356 . . . . 10.0 110.667 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -66.47 -34.8 78.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.59 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -75.24 -37.12 61.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.793 0.33 . . . . 10.0 111.781 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.54 ' HB3' HG12 ' A' ' 172' ' ' ILE . 3.1 tttt -79.49 -20.54 47.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.815 0.34 . . . . 10.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 86.32 14.54 66.06 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.056 -0.592 . . . . 10.0 112.785 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 170' ' ' LYS . 14.0 pt -103.44 168.64 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.785 0.326 . . . . 10.0 111.057 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -100.01 142.55 24.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.038 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 173' ' ' ALA . 35.8 Cg_exo -59.28 -19.93 52.84 Favored 'Trans proline' 0 N--CA 1.473 0.287 0 C-N-CA 122.995 2.464 . . . . 10.0 112.881 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -77.23 -19.49 56.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.199 0.523 . . . . 10.0 110.608 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -100.77 17.86 20.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.583 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 83.6 mtp -124.62 123.53 40.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.332 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.3 t -110.84 120.09 60.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.574 ' HB3' HD12 ' A' ' 208' ' ' LEU . 0.0 OUTLIER -104.21 123.51 47.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.289 0.566 . . . . 10.0 112.21 -178.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 22.5 t -118.69 135.63 58.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.41 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.428 ' OG ' HD21 ' A' ' 208' ' ' LEU . 3.7 p -123.21 139.04 54.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.724 0.297 . . . . 10.0 111.368 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 212' ' ' ILE . 24.1 mm -101.64 102.19 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.946 -0.761 . . . . 10.0 108.946 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 213' ' ' THR . 32.2 mmt -114.08 150.16 43.13 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.05 -0.523 . . . . 10.0 111.54 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.77 17.48 1.52 Allowed 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.854 2.369 . . . . 10.0 112.894 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 97.3 m -149.55 129.46 13.4 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.108 -0.331 . . . . 10.0 110.108 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -30.07 70.02 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -64.15 -9.55 17.42 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.649 0.611 . . . . 10.0 112.649 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 188' ' ' LYS . 25.0 mmtt -66.97 -28.2 68.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.349 . . . . 10.0 110.921 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -68.02 -36.75 80.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 10.0 109.989 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -32.56 67.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.815 -0.629 . . . . 10.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -70.63 -41.13 72.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.753 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -75.12 -30.17 60.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.665 -0.698 . . . . 10.0 112.781 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -80.87 70.81 7.75 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 56.0 mtt180 -115.32 148.4 39.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.434 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -48.93 -63.03 1.22 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.637 0.977 . . . . 10.0 113.637 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -66.97 -2.2 5.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.349 1.24 . . . . 10.0 114.349 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.446 ' CD2' ' HB2' ' A' ' 194' ' ' ARG . 2.6 m-30 -82.22 61.98 5.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.379 0.609 . . . . 10.0 111.599 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 12.1 p -113.15 168.94 9.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 10.0 110.396 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 22.4 t -80.66 83.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.221 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.037 -0.983 . . . . 10.0 111.311 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.673 -0.491 . . . . 10.0 109.673 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.796 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.228 -0.052 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -88.1 144.73 26.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.272 -0.27 . . . . 10.0 110.272 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -67.52 -40.67 85.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.242 0.544 . . . . 10.0 109.535 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LEU . . . . . 0.574 HD12 ' HB3' ' A' ' 179' ' ' MET . 29.5 tp -126.24 137.49 53.53 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.375 -1.343 . . . . 10.0 107.375 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -99.24 -57.89 2.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.47 0.915 . . . . 10.0 113.47 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.529 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 12.6 m-70 -134.32 153.15 52.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.028 0.751 . . . . 10.0 113.028 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 46.0 t -126.72 131.76 70.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.557 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 71.3 mt -122.42 139.52 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 183' ' ' MET . 43.2 p -91.98 167.2 12.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.809 0.3 . . . . 10.0 111.809 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.538 HG23 HG13 ' A' ' 55' ' ' VAL . 2.7 m -52.64 -52.92 53.45 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.003 -0.544 . . . . 10.0 112.077 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.0 m -57.87 -36.19 54.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.448 ' O ' HG13 ' A' ' 220' ' ' ILE . 50.1 mt-10 -73.33 -45.3 56.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.58 -0.282 . . . . 10.0 111.027 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.408 HD22 HG21 ' A' ' 182' ' ' ILE . 36.1 tp -62.59 -45.52 92.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.86 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.98 -30.94 78.99 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.931 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -67.97 -41.76 81.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 216' ' ' GLU . 61.7 mt -58.8 -42.77 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.228 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -62.57 -44.74 95.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.554 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -67.51 -43.94 79.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 10.0 111.955 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.71 -23.84 66.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 10.0 111.299 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -94.33 -3.18 50.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.961 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 68.35 38.99 87.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.931 -0.652 . . . . 10.0 112.189 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 57.4 mt -116.07 110.4 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.834 0.349 . . . . 10.0 110.509 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -96.61 113.71 25.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.966 -0.383 . . . . 10.0 109.966 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.619 HD23 HD12 ' A' ' 231' ' ' LEU . 38.6 mt -59.1 -28.97 67.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.807 -0.633 . . . . 10.0 112.183 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.27 -18.46 63.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.6 -0.273 . . . . 10.0 111.569 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -111.26 20.75 17.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.968 0.413 . . . . 10.0 110.974 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.619 HD12 HD23 ' A' ' 228' ' ' LEU . 56.7 mt -104.39 150.92 38.98 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.936 -0.575 . . . . 10.0 110.274 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.47 172.01 16.98 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.284 1.989 . . . . 10.0 111.576 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.8 102.32 11.51 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.642 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -83.48 -154.64 18.05 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.005 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.85 156.99 43.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 10.0 110.716 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -92.66 -174.7 3.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.685 -0.688 . . . . 10.0 110.254 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.5 147.47 42.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.892 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -93.41 120.19 66.72 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.158 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.06 -15.36 47.42 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.133 2.556 . . . . 10.0 112.315 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 86.9 mmm -78.64 0.65 25.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 10.0 111.465 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 103.27 -70.06 0.29 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.135 -0.555 . . . . 10.0 112.774 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.44 169.65 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.901 0.382 . . . . 10.0 111.578 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 104.43 136.5 8.84 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.619 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.2 m -80.2 130.35 35.15 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.178 -0.305 . . . . 10.0 110.178 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 120.06 179.72 16.45 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.228 -0.749 . . . . 10.0 111.228 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.25 -2.18 50.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.847 0.356 . . . . 10.0 111.277 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.86 4.03 79.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.18 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.93 118.68 53.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 30.2 mt -75.51 149.95 38.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.384 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.33 106.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.057 0.456 . . . . 10.0 111.153 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 164.84 127.11 0.86 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.078 -0.809 . . . . 10.0 111.078 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 11.2 t -75.18 148.19 39.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.169 0.509 . . . . 10.0 111.562 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.34 -9.46 25.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.657 -0.701 . . . . 10.0 109.497 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.433 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 89.68 -32.22 4.89 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.687 -0.688 . . . . 10.0 112.47 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 151.69 170.31 18.29 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.365 -1.094 . . . . 10.0 110.365 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.86 -55.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.541 0.67 . . . . 10.0 110.406 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' MET . . . . . 0.541 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 23.5 ttp -59.4 -48.28 82.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.406 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.433 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 36.5 tt0 -61.34 -46.19 91.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 10.0 112.138 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.84 81.96 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 121.046 -0.261 . . . . 10.0 111.167 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.74 -47.46 72.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 257' ' ' MET . 90.1 mt -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.826 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 45.6 ttm105 -58.95 -48.37 81.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.051 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 87.0 m -55.52 -43.32 75.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 10.0 111.546 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.84 -43.93 57.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.849 0.357 . . . . 10.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' TYR . . . . . 0.502 ' HD1' ' HG2' ' A' ' 294' ' ' MET . 84.0 t80 -62.07 -46.09 90.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.079 -0.509 . . . . 10.0 112.063 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 262' ' ' ARG . 52.3 mt-10 -64.98 -23.18 67.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.565 0.579 . . . . 10.0 112.565 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 73.4 mt -90.18 -35.07 15.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.103 0.478 . . . . 10.0 110.467 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -72.62 -43.09 63.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.678 -0.692 . . . . 10.0 111.604 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 70.1 p -96.38 -33.53 11.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.164 -0.471 . . . . 10.0 112.191 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 85.31 9.15 80.15 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.789 -0.925 . . . . 10.0 110.789 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 70.9 p -112.69 146.13 34.41 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.698 -0.251 . . . . 10.0 110.775 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' PRO . . . . . 0.415 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 40.0 Cg_endo -69.99 131.69 21.42 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.501 2.134 . . . . 10.0 111.9 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.454 ' HB3' ' HG3' ' A' ' 262' ' ' ARG . 46.9 tp -103.99 121.47 47.71 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.069 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.55 -156.21 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.191 2.594 . . . . 10.0 111.774 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -78.4 141.21 38.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.484 -0.325 . . . . 10.0 110.618 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 95.6 mt -89.81 141.61 28.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 1.5 m -106.59 105.35 15.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.582 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 288' ' ' LYS . 3.4 mm? -77.98 113.94 16.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.823 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.5 m -89.86 152.52 21.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.272 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -79.75 123.63 27.86 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.51 112.7 5.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.074 0.464 . . . . 10.0 110.643 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 16.0 ttm-85 -66.97 108.35 2.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.602 -0.726 . . . . 10.0 110.353 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 123.5 -18.69 7.68 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.006 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . 0.481 ' SD ' ' HD2' ' A' ' 361' ' ' LYS . 56.4 mtm -139.98 102.54 4.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.012 0.434 . . . . 10.0 110.609 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.71 138.81 48.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.264 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.83 -13.5 67.04 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.587 -0.733 . . . . 10.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 21.7 mm -99.44 127.81 51.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.018 0.437 . . . . 10.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 278' ' ' LEU . 33.6 mmtt -115.62 157.57 23.98 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.11 159.66 44.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.249 0.547 . . . . 10.0 112.371 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 9.1 t -155.99 152.21 27.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.254 -0.885 . . . . 10.0 109.257 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -128.32 123.41 33.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.808 0.337 . . . . 10.0 110.649 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.91 118.41 58.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.913 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.54 97.75 3.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.044 0.449 . . . . 10.0 110.588 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' MET . . . . . 0.502 ' HG2' ' HD1' ' A' ' 265' ' ' TYR . 81.7 mtp -87.1 113.26 22.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.108 -0.497 . . . . 10.0 111.449 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 36.3 t -112.34 120.42 41.52 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.7 135.57 61.08 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.891 2.394 . . . . 10.0 112.782 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . . . -66.97 132.06 93.84 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.779 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 297' ' ' ALA . 38.8 Cg_exo -59.04 114.13 1.88 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.954 2.436 . . . . 10.0 112.286 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.52 -12.1 39.3 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.681 -0.771 . . . . 10.0 113.123 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 97.0 p -84.33 162.53 20.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.885 0.374 . . . . 10.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -64.5 -26.11 68.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.231 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -64.27 -40.0 95.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.317 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -72.48 -46.05 56.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 10.0 109.901 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 2.2 tm-20 -57.28 -46.63 82.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.395 -0.821 . . . . 10.0 111.324 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.15 -53.51 54.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 10.0 112.008 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.5 tt -60.13 -38.5 83.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.315 -0.402 . . . . 10.0 111.804 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -75.65 -33.31 60.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.563 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 304' ' ' GLU . 0.7 OUTLIER -75.46 -47.52 26.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.78 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -123.33 100.85 7.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.182 0.515 . . . . 10.0 112.073 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -110.19 -1.48 17.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.473 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.365 -0.826 . . . . 10.0 110.529 -179.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.299 -0.721 . . . . 10.0 111.299 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.63 -31.33 94.18 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.838 2.359 . . . . 10.0 112.415 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.414 ' HB2' ' CE1' ' A' ' 147' ' ' TYR . 85.1 mt -109.11 110.95 22.33 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -94.84 120.62 35.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.565 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -67.54 131.98 46.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.779 -0.452 . . . . 10.0 109.779 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.08 -1.71 37.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.609 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 103.26 -6.39 50.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.868 -0.682 . . . . 10.0 111.593 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' GLY . . . . . 0.404 ' HA2' ' NH2' ' A' ' 345' ' ' ARG . . . 92.23 153.86 30.34 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.77 -0.728 . . . . 10.0 111.721 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.5 82.43 8.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.057 0.456 . . . . 10.0 110.182 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -98.29 155.16 20.23 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.8 -0.714 . . . . 10.0 112.938 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -142.76 160.18 40.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.984 -0.376 . . . . 10.0 109.984 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.8 t -141.38 142.59 33.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.91 0.386 . . . . 10.0 110.49 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.44 169.58 8.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.463 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.92 23.88 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 10.0 112.063 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -111.77 -7.85 14.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.276 0.56 . . . . 10.0 109.806 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 102.6 -8.88 55.23 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.728 . . . . 10.0 112.373 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -100.95 176.81 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.054 0.454 . . . . 10.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -173.68 -175.44 41.38 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.922 -0.871 . . . . 10.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -167.65 -173.28 35.61 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.949 -0.643 . . . . 10.0 111.553 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ILE . . . . . 0.429 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 7.9 tt -136.8 131.02 46.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.71 0.291 . . . . 10.0 110.581 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.6 t -90.9 106.87 18.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.103 0.478 . . . . 10.0 110.507 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 25.0 tp -64.07 115.49 4.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.527 -0.76 . . . . 10.0 110.577 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 369' ' ' TYR . 60.5 mtm180 -86.62 105.23 16.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.86 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.74 130.57 59.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.015 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 372' ' ' VAL . . . -126.87 139.18 53.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.307 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.61 114.16 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.797 -0.446 . . . . 10.0 109.797 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.504 ' HB3' HG12 ' A' ' 374' ' ' ILE . . . -98.59 105.08 17.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.496 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -95.99 108.62 21.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.49 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 112.04 126.06 4.67 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.708 -0.957 . . . . 10.0 110.708 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 43.6 mt -59.17 -37.49 77.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.889 0.376 . . . . 10.0 111.478 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -68.99 -26.56 74.61 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.636 -0.793 . . . . 10.0 111.703 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.809 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 93.3 m-20 -84.75 -40.36 17.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.924 0.392 . . . . 10.0 110.007 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.8 94.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.383 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -55.9 -39.56 71.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.434 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.809 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 9.4 mtmm -70.79 -42.82 69.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.511 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.83 -46.86 85.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 10.0 110.974 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 97.7 mt -56.73 -45.5 82.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.562 . . . . 10.0 110.905 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 22.0 m -60.59 -45.27 94.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.7 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.481 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 36.6 mttm -66.02 -32.76 74.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.325 -0.398 . . . . 10.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 367' ' ' ALA . 87.3 mtp -68.49 -42.99 77.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.026 0.441 . . . . 10.0 110.042 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -69.1 -24.41 64.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.003 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -86.0 -7.88 58.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.044 -0.526 . . . . 10.0 111.064 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 81.2 13.95 79.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.789 -0.719 . . . . 10.0 112.949 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -77.64 -37.83 49.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.228 0.537 . . . . 10.0 110.056 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 362' ' ' MET . . . -135.14 126.06 27.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.583 -0.735 . . . . 10.0 109.388 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -119.94 125.76 49.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.81 0.338 . . . . 10.0 110.977 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 345' ' ' ARG . 72.7 m-85 -134.92 158.71 43.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.824 -0.625 . . . . 10.0 109.596 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -97.3 -36.56 10.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.027 0.441 . . . . 10.0 111.248 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . 0.541 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 26.8 t80 -125.56 126.95 45.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.57 -0.529 . . . . 10.0 109.57 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 126' ' ' PHE . 25.3 t -130.3 118.76 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.02 0.438 . . . . 10.0 111.882 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.19 129.84 44.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.985 -1.117 . . . . 10.0 107.985 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 349' ' ' ALA . 59.3 mt -121.37 125.26 73.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.241 0.543 . . . . 10.0 112.076 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' MET . . . . . 0.406 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 13.0 mmt -115.17 145.96 41.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.591 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' ALA . . . . . 0.457 ' HB2' ' HA3' ' A' ' 132' ' ' GLY . . . . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 120.758 0.313 . . . . 10.0 111.122 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.93 0.395 . . . . 10.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -116.61 25.23 9.19 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.989 -0.624 . . . . 10.0 111.972 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -65.7 168.72 31.34 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.248 -0.501 . . . . 10.0 112.896 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -69.24 -24.31 76.02 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.089 -0.577 . . . . 10.0 113.677 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -85.71 -6.13 83.34 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.648 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -82.76 155.31 68.22 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.74 164.69 33.56 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.428 2.085 . . . . 10.0 110.803 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ARG . . . . . 0.513 ' HB2' ' HE ' ' A' ' 389' ' ' ARG . 0.0 OUTLIER -128.66 121.95 29.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.231 0.539 . . . . 10.0 111.619 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.694 . . . . 10.0 110.003 179.809 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 121.31 0.576 . . . . 10.0 110.204 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -67.87 -36.61 80.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.507 -0.77 . . . . 10.0 110.667 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -61.54 -43.03 99.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.636 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ARG . . . . . 0.405 HH21 ' CD ' ' A' ' 61' ' ' GLU . 99.0 mtt180 -68.39 -41.55 80.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.715 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -64.1 -39.48 94.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.923 -0.58 . . . . 10.0 111.344 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -70.88 -24.52 62.51 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.248 0.462 . . . . 10.0 112.248 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -101.54 14.39 32.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.579 0.585 . . . . 10.0 112.579 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.09 -38.33 85.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.138 0.494 . . . . 10.0 110.775 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' TYR . . . . . 0.506 ' O ' ' HE3' ' A' ' 409' ' ' LYS . 83.4 m-85 -136.14 153.83 51.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.536 -0.756 . . . . 10.0 109.318 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -82.79 165.65 19.68 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.657 -0.498 . . . . 10.0 109.657 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.22 -33.86 59.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.692 0.282 . . . . 10.0 111.641 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -63.6 -54.47 35.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.796 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.43 -33.45 75.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.624 . . . . 10.0 111.411 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' LYS . . . . . 0.506 ' HE3' ' O ' ' A' ' 404' ' ' TYR . 95.9 mttt -67.46 -30.18 69.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.662 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 6.1 p -94.17 8.09 42.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.961 0.41 . . . . 10.0 111.312 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 6.3 m -122.08 101.78 7.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.611 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 21.0 tp -83.46 122.36 28.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.176 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 40.9 ttp85 -123.58 148.68 46.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.828 0.347 . . . . 10.0 111.306 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 417' ' ' GLU . 1.2 mpt_? -116.33 136.38 53.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.408 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.7 m -62.91 -29.37 70.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.319 0.488 . . . . 10.0 112.319 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -73.0 4.93 3.7 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.524 0.565 . . . . 10.0 112.524 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' GLU . . . . . 0.432 ' OE2' ' HD3' ' A' ' 414' ' ' ARG . 20.4 mt-10 -122.81 13.81 9.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.481 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -88.27 117.08 67.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.186 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.67 -35.16 92.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.233 2.622 . . . . 10.0 112.558 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 50.2 m -70.81 -38.66 73.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.893 0.378 . . . . 10.0 110.907 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.26 -42.85 78.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.399 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -61.93 -35.64 79.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.98 -0.555 . . . . 10.0 111.41 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -64.21 -49.84 70.42 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.095 0.474 . . . . 10.0 110.006 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.54 -38.78 91.35 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.954 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . 0.756 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.4 m-85 -74.24 -11.3 60.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.031 -0.531 . . . . 10.0 111.549 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -97.56 -52.74 3.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.182 0.808 . . . . 10.0 113.182 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.06 17.54 18.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.639 1.348 . . . . 10.0 114.639 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -155.63 -63.82 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.107 0.78 . . . . 10.0 113.107 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' LEU . . . . . 0.756 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 67.9 mt -67.38 -50.69 58.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.877 0.695 . . . . 10.0 112.877 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 92.65 -132.66 11.36 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.556 -0.831 . . . . 10.0 111.512 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 24.2 mm-40 -86.5 144.79 38.33 Favored Pre-proline 0 C--N 1.318 -0.769 0 O-C-N 122.662 -0.316 . . . . 10.0 110.698 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 431' ' ' GLU . 44.8 Cg_exo -58.89 147.06 91.13 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.941 2.427 . . . . 10.0 111.264 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 3.5 mp 62.74 17.85 10.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.515 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -76.35 -176.57 42.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.085 -0.579 . . . . 10.0 112.44 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -60.85 -51.8 67.76 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.394 0.278 . . . . 10.0 111.736 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -38.98 93.29 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.847 0.356 . . . . 10.0 110.781 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.42 75.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.986 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' HIS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 2.5 t-160 -68.81 -31.03 69.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.069 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.1 -40.9 17.7 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.6 mt -96.31 -42.81 7.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 114.577 1.325 . . . . 10.0 114.577 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.58 -17.81 21.99 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 39.2 m-70 -114.57 171.24 7.75 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.245 -0.285 . . . . 10.0 110.644 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.9 t -162.89 -175.75 4.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.526 0.203 . . . . 10.0 111.058 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -129.89 157.82 41.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.527 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.87 164.19 13.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.35 -0.387 . . . . 10.0 110.187 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 95.1 t -120.87 109.37 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.118 0.485 . . . . 10.0 111.792 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -65.89 115.45 6.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.054 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 122.33 -15.36 8.71 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.34 -0.704 . . . . 10.0 111.34 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 C-N-CA 120.869 -0.682 . . . . 10.0 112.136 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 N--CA 1.48 1.062 0 N-CA-C 109.921 -0.4 . . . . 10.0 109.921 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m -69.53 155.04 41.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.572 -0.286 . . . . 10.0 110.271 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -60.29 -31.84 70.63 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.646 -0.252 . . . . 10.0 111.202 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.544 HG22 HG12 ' A' ' 212' ' ' ILE . 93.7 t -66.83 -45.07 88.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.939 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -62.83 -36.6 83.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.857 -0.611 . . . . 10.0 110.616 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -59.83 -34.68 73.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.909 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -69.87 -40.85 75.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.029 -0.532 . . . . 10.0 110.082 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.7 mt -64.76 -28.32 69.5 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.63 -0.714 . . . . 10.0 111.055 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.45 -46.38 80.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.861 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -70.65 -35.35 72.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.678 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 31' ' ' ALA . 91.0 mt -66.51 -32.32 73.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.161 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.09 -25.3 66.16 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.117 -0.492 . . . . 10.0 111.19 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 93.3 mttt -72.91 136.37 79.97 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.258 -0.428 . . . . 10.0 109.94 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 37' ' ' LYS . 51.5 Cg_exo -54.95 152.7 28.28 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.991 2.461 . . . . 10.0 111.98 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -61.44 -35.28 77.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.303 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.52 14.53 24.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.074 -0.512 . . . . 10.0 112.239 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 44' ' ' ARG . 14.4 t70 -68.35 134.88 91.03 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.393 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.39 -22.78 67.37 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.271 2.647 . . . . 10.0 113.998 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.3 4.56 24.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 10.0 111.265 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 6.4 tpt180 -82.38 130.47 35.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.516 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 176' ' ' ASP . 18.9 mttp -108.69 178.21 4.55 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.802 -0.636 . . . . 10.0 109.655 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.16 117.17 23.31 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.961 -0.385 . . . . 10.0 109.961 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 t -102.94 102.58 13.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.247 0.546 . . . . 10.0 111.066 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 179' ' ' MET . 2.8 m -97.95 144.24 27.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.531 -0.758 . . . . 10.0 109.295 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 13.7 p -130.66 141.9 45.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.828 0.347 . . . . 10.0 111.52 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 21.7 pt20 -121.86 126.93 49.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 10.0 109.933 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.679 HG11 HD21 ' A' ' 75' ' ' LEU . 3.0 t -110.27 155.4 11.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.581 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -105.02 144.7 29.28 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.282 -0.417 . . . . 10.0 110.544 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.72 -33.67 88.38 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.937 2.424 . . . . 10.0 111.944 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.01 -24.3 67.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.098 -0.501 . . . . 10.0 111.123 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.65 HG13 HG23 ' A' ' 214' ' ' THR . 98.5 t -85.49 -39.95 14.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.058 0.456 . . . . 10.0 109.779 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? -57.44 -31.72 66.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.697 -0.683 . . . . 10.0 112.284 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.56 -39.21 16.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.992 0.738 . . . . 10.0 112.992 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.401 ' HB2' ' HD3' ' A' ' 399' ' ' ARG . . . -88.18 -14.3 38.95 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.416 0.895 . . . . 10.0 113.416 -177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.3 tp -58.83 -24.04 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 112.046 0.387 . . . . 10.0 112.046 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.44 -33.27 73.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 10.0 111.342 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -65.34 -29.8 70.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 10.0 111.195 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.41 -17.51 64.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 10.0 110.96 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.5 mt -105.62 3.02 28.72 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.982 -0.553 . . . . 10.0 110.385 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.66 41.56 15.36 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.051 -0.595 . . . . 10.0 112.094 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.4 mt -125.51 178.88 5.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.767 0.318 . . . . 10.0 110.527 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.77 144.14 55.4 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.792 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -58.45 119.92 7.47 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.726 2.284 . . . . 10.0 111.672 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.67 0.74 56.48 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.72 . . . . 10.0 113.348 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.62 75.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.966 0.383 . . . . 10.0 111.234 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -80.39 126.3 31.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.676 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.7 p -81.98 156.81 69.52 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.359 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.53 -34.82 92.25 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.237 1.958 . . . . 10.0 110.875 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.1 mmtt -68.24 -41.24 81.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.805 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -61.72 -41.74 98.02 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.036 0.446 . . . . 10.0 110.528 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.679 HD21 HG11 ' A' ' 51' ' ' VAL . 48.7 tp -62.08 -48.43 80.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.543 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.2 94.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.107 -0.497 . . . . 10.0 111.004 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 36.7 tp10 -61.52 -42.91 99.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.898 -0.592 . . . . 10.0 110.239 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.07 -44.62 91.0 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.851 -0.69 . . . . 10.0 112.01 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.2 mt -62.1 -42.85 99.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.894 0.378 . . . . 10.0 111.206 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 51.7 ttm-85 -62.99 -31.72 72.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.955 0.407 . . . . 10.0 110.808 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 81' ' ' ARG . 57.4 mtt-85 -81.44 -9.35 59.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.145 -0.479 . . . . 10.0 111.62 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.6 mt -78.72 -15.3 58.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.428 . . . . 10.0 110.252 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.44 -1.48 11.35 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.625 -0.798 . . . . 10.0 112.478 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -66.64 159.44 27.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.811 0.338 . . . . 10.0 111.066 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -104.57 -44.52 4.87 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.466 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -130.67 131.88 45.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.16 -0.473 . . . . 10.0 110.302 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.68 112.71 40.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.638 0.256 . . . . 10.0 110.872 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 33.7 m-85 -114.52 166.52 11.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.432 -0.349 . . . . 10.0 110.436 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -114.92 148.17 39.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.218 -0.446 . . . . 10.0 109.821 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 m -64.67 -20.81 66.52 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.225 -0.443 . . . . 10.0 111.671 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.4 mt -56.1 -36.32 68.03 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.777 0.288 . . . . 10.0 111.777 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -67.01 -40.5 87.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.141 0.496 . . . . 10.0 109.973 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -68.84 -36.27 81.64 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.941 -0.864 . . . . 10.0 110.941 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.62 -35.06 79.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.731 0.301 . . . . 10.0 110.474 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.61 -33.53 71.6 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.872 -0.604 . . . . 10.0 109.873 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.602 HD21 HD23 ' A' ' 424' ' ' LEU . 85.9 mt -75.41 -41.27 56.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.692 -0.685 . . . . 10.0 110.032 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.4 m -59.93 -44.02 94.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.876 -0.602 . . . . 10.0 110.582 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.427 HG12 ' HB3' ' A' ' 259' ' ' ALA . 30.9 mt -57.35 -40.99 77.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.732 -0.667 . . . . 10.0 110.816 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 92.8 mmm -68.71 -51.01 46.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.319 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.476 ' OE2' ' HA ' ' A' ' 432' ' ' PRO . 64.1 mm-40 -64.14 -53.67 45.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -61.64 -39.39 91.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.851 0.357 . . . . 10.0 110.549 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.08 99.65 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.845 -0.693 . . . . 10.0 111.378 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.3 m -67.64 -40.44 84.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.518 0.199 . . . . 10.0 110.795 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -65.04 -39.22 93.01 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.579 -0.526 . . . . 10.0 109.579 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.408 HD21 HD23 ' A' ' 261' ' ' LEU . 41.8 tp -63.88 -49.04 74.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.748 -0.66 . . . . 10.0 109.892 178.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.5 tp -59.95 -38.53 82.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.939 -0.573 . . . . 10.0 109.745 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -61.26 -49.36 77.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.769 -0.65 . . . . 10.0 109.972 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.486 ' HG2' ' HG2' ' A' ' 121' ' ' GLU . 40.2 mtt180 -59.03 -38.7 79.93 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 10.0 111.28 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 43.0 tp -69.43 -56.19 8.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.338 -0.392 . . . . 10.0 111.232 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 8.6 m -55.52 -43.68 75.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.173 -0.467 . . . . 10.0 112.039 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -61.88 -35.37 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.886 0.328 . . . . 10.0 111.886 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.7 m80 -71.83 -28.6 63.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 10.0 110.258 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.583 ' O ' ' HD2' ' A' ' 309' ' ' ARG . 73.5 mt -83.54 -12.92 55.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.713 -0.676 . . . . 10.0 110.286 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.718 ' HA ' ' NH1' ' A' ' 309' ' ' ARG . 4.3 mm-40 -91.38 -42.69 10.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.909 -0.587 . . . . 10.0 109.483 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.021 -0.99 . . . . 10.0 111.012 179.853 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.486 ' HG2' ' HG2' ' A' ' 108' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.352 0.596 . . . . 10.0 111.437 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -85.37 -160.71 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.822 2.348 . . . . 10.0 112.822 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.495 ' HB3' ' HA ' ' A' ' 124' ' ' PRO . 82.7 mt -131.29 162.64 54.66 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 108.654 -0.869 . . . . 10.0 108.654 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.495 ' HA ' ' HB3' ' A' ' 123' ' ' LEU . 16.7 Cg_exo -68.8 169.76 57.46 Favored 'Cis proline' 0 C--N 1.347 0.458 0 C-N-CA 124.381 -1.091 . . . . 10.0 113.015 0.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 27.1 ttt -113.58 132.98 55.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.375 -0.829 . . . . 10.0 110.217 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.534 ' HD1' ' HB ' ' A' ' 372' ' ' VAL . 33.7 m-85 -111.73 145.79 38.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.174 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.03 140.73 40.43 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.695 0.622 . . . . 10.0 110.126 179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.621 ' O ' HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -103.73 17.01 25.03 Favored 'General case' 0 CA--C 1.537 0.479 1 N-CA-C 130.104 7.075 . . . . 10.0 130.104 -179.214 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.428 ' O ' ' HD3' ' A' ' 131' ' ' PRO . 68.1 m -81.33 -31.01 33.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 112.142 -2.299 . . . . 10.0 114.393 -166.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.6 ' SG ' ' HA ' ' A' ' 375' ' ' MET . 48.7 m -82.36 124.49 78.09 Favored Pre-proline 0 C--N 1.401 2.835 3 O-C-N 142.034 12.084 . . . . 10.0 113.466 178.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 129' ' ' CYS . 37.7 Cg_endo -68.54 -23.15 37.43 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 123.138 2.559 . . . . 10.0 112.246 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -74.97 -32.91 56.15 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 110.747 -0.941 . . . . 10.0 110.747 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 16.4 t-105 -73.75 -45.36 52.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.46 -0.37 . . . . 10.0 111.04 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.621 HD11 ' O ' ' A' ' 128' ' ' SER . 97.1 mt -58.57 -35.15 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.101 0.408 . . . . 10.0 112.101 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.97 -35.09 80.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.228 0.537 . . . . 10.0 110.531 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 34.9 ttm -70.12 -40.56 74.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 10.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.911 HD22 HG21 ' A' ' 148' ' ' VAL . 2.5 pp -75.21 -11.98 60.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.868 0.366 . . . . 10.0 111.742 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -96.78 -31.44 12.63 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -108.77 -41.66 4.71 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.634 0.976 . . . . 10.0 113.634 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.2 m -90.75 -44.73 9.27 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.314 0.857 . . . . 10.0 113.314 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -127.59 71.92 77.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 112.025 0.38 . . . . 10.0 112.025 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 137' ' ' LEU . 73.2 Cg_endo -75.22 11.25 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.55 2.167 . . . . 10.0 112.662 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.98 -7.77 29.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.09 -0.504 . . . . 10.0 110.201 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 96.5 mt -106.39 14.93 26.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.77 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.589 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 76.9 mt -55.05 -54.72 47.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 113.267 0.84 . . . . 10.0 113.267 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 17.4 Cg_exo -68.06 -9.98 27.44 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.451 2.101 . . . . 10.0 113.009 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 125' ' ' MET . 49.3 m-85 -82.53 -25.08 33.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.131 0.491 . . . . 10.0 110.914 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.911 HG21 HD22 ' A' ' 137' ' ' LEU . 2.7 t -88.53 156.76 3.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.152 -0.476 . . . . 10.0 109.759 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.4 t -70.66 154.19 42.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.337 . . . . 10.0 110.923 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 96.3 p -96.77 3.9 52.06 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.088 0.471 . . . . 10.0 110.304 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 8.9 m -76.0 144.9 40.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.88 -0.6 . . . . 10.0 111.153 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.43 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 30.4 mtpt -86.01 164.76 17.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.978 -0.555 . . . . 10.0 110.944 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.449 ' HB2' ' OE1' ' A' ' 155' ' ' GLN . 0.1 OUTLIER -69.66 152.7 96.12 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.787 -0.642 . . . . 10.0 111.466 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -46.17 -53.84 5.39 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.802 3.001 . . . . 10.0 113.884 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' A' ' 153' ' ' SER . 0.0 OUTLIER -62.13 -37.73 86.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.819 0.342 . . . . 10.0 111.669 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 67.1 mmm -73.14 -23.53 60.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.319 -0.401 . . . . 10.0 111.189 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 40.0 mtt -76.87 -50.1 14.13 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.3 tp -61.65 -42.53 99.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.46 -0.791 . . . . 10.0 110.844 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.516 ' HA ' ' SD ' ' A' ' 179' ' ' MET . . . -59.47 -40.79 88.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.002 -0.544 . . . . 10.0 111.045 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -72.47 -35.54 68.25 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.496 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 3.2 ttt -66.9 -44.66 80.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.6 . . . . 10.0 111.675 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 33.0 m -69.52 -30.86 46.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.314 0.487 . . . . 10.0 112.314 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -85.9 6.96 25.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.14 0.422 . . . . 10.0 112.14 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.4 p -129.85 -81.28 0.55 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.403 -0.362 . . . . 10.0 110.466 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.578 ' HE2' ' HA ' ' A' ' 240' ' ' MET . 11.3 t80 -56.29 -49.37 74.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.143 -0.481 . . . . 10.0 111.472 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.659 HD11 ' HE3' ' A' ' 170' ' ' LYS . 41.8 tp -65.93 -39.43 90.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.989 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.63 88.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.512 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.51 -42.38 82.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.912 -0.586 . . . . 10.0 111.107 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -65.98 -46.84 76.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.373 -0.376 . . . . 10.0 111.847 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.659 ' HE3' HD11 ' A' ' 166' ' ' LEU . 72.9 mttt -73.73 -27.15 61.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.702 0.287 . . . . 10.0 111.277 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 88.2 44.0 5.45 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.749 -0.739 . . . . 10.0 112.227 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 21.4 mt -126.8 145.11 34.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.592 -0.521 . . . . 10.0 109.592 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -74.9 142.38 76.43 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 110.074 -0.343 . . . . 10.0 110.074 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.435 ' HB2' HD13 ' A' ' 205' ' ' LEU . 45.1 Cg_exo -57.78 -22.07 51.41 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.996 2.464 . . . . 10.0 112.978 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.33 -12.7 56.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.977 0.417 . . . . 10.0 111.485 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 45' ' ' LYS . 59.3 m-20 -101.36 11.41 39.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.181 0.515 . . . . 10.0 109.74 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 95.4 mtp -122.69 118.84 29.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.899 -0.592 . . . . 10.0 111.263 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.31 133.32 58.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 108.057 -1.09 . . . . 10.0 108.057 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.516 ' SD ' ' HA ' ' A' ' 159' ' ' ALA . 9.6 ttt -123.0 134.56 54.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.565 0.698 . . . . 10.0 112.805 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 20.8 t -117.84 151.6 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.226 -1.027 . . . . 10.0 108.226 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.3 p -135.96 141.68 44.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.721 0.296 . . . . 10.0 110.602 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.539 ' HB ' HG13 ' A' ' 51' ' ' VAL . 16.7 mm -105.04 106.6 20.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.751 -0.833 . . . . 10.0 108.751 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 213' ' ' THR . 31.0 mmt -117.4 146.9 39.47 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.227 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -85.11 15.55 2.19 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.748 2.299 . . . . 10.0 112.705 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 20.8 m -141.28 138.54 33.26 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.978 0.362 . . . . 10.0 111.978 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.05 -30.99 69.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.748 -0.66 . . . . 10.0 111.675 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -65.3 -14.23 60.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.946 -0.57 . . . . 10.0 112.452 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 188' ' ' LYS . 59.2 mmtt -70.07 -27.31 64.52 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.903 0.334 . . . . 10.0 111.903 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -67.26 -44.33 79.64 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.576 -0.527 . . . . 10.0 109.576 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 m -64.09 -29.1 70.26 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.039 0.447 . . . . 10.0 110.246 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -66.67 -44.86 80.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 208' ' ' LEU . . . -78.36 -12.42 60.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.745 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.42 2.09 51.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.84 -0.618 . . . . 10.0 111.792 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 194' ' ' ARG . 58.4 mtt-85 -64.62 119.43 10.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.691 0.282 . . . . 10.0 110.691 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -38.05 -60.27 0.77 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.271 1.582 . . . . 10.0 115.271 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -66.77 -2.06 4.59 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 115.012 1.486 . . . . 10.0 115.012 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.431 ' O ' ' HG3' ' A' ' 207' ' ' GLN . 6.2 m-85 -86.71 55.65 3.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.355 0.598 . . . . 10.0 109.848 178.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.17 169.43 8.74 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.591 -0.732 . . . . 10.0 111.538 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.05 143.15 12.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.2 t70 . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.037 -0.982 . . . . 10.0 110.28 -179.786 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 120.925 0.393 . . . . 10.0 110.984 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.806 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.228 -0.075 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -92.48 140.4 29.61 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.436 -0.209 . . . . 10.0 110.436 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.431 ' HG3' ' O ' ' A' ' 197' ' ' PHE . 56.4 mt-30 -69.6 -41.04 76.28 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.487 ' HB3' ' HB1' ' A' ' 192' ' ' ALA . 13.0 tp -128.52 115.86 18.78 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 177.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.62 -47.25 8.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.304 1.224 . . . . 10.0 114.304 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -132.65 143.46 49.67 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.085 0.772 . . . . 10.0 113.085 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.5 t -126.25 129.23 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.463 -0.939 . . . . 10.0 108.463 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.544 HG12 HG22 ' A' ' 28' ' ' VAL . 55.6 mt -120.22 141.76 39.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 183' ' ' MET . 60.3 p -90.1 164.04 14.63 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.99 -0.284 . . . . 10.0 111.292 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.65 HG23 HG13 ' A' ' 55' ' ' VAL . 1.8 m -55.5 -47.39 76.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.602 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 2.9 m -59.43 -43.09 89.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 10.0 112.007 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.42 ' O ' HG13 ' A' ' 220' ' ' ILE . 52.7 mt-10 -67.76 -48.31 66.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.417 -0.356 . . . . 10.0 111.145 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 182' ' ' ILE . 31.2 tp -57.98 -46.13 85.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.866 0.365 . . . . 10.0 110.969 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -61.77 -34.74 89.73 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.952 -0.567 . . . . 10.0 112.291 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -71.8 -34.17 69.14 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.838 -0.213 . . . . 10.0 110.821 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 216' ' ' GLU . 90.8 mt -64.66 -42.82 96.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.815 -0.439 . . . . 10.0 109.815 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -59.12 -46.39 88.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.963 -0.562 . . . . 10.0 110.381 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -68.85 -29.48 67.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 10.0 111.349 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -70.29 -36.66 74.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.988 0.423 . . . . 10.0 110.938 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -86.43 -10.82 53.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.178 -0.465 . . . . 10.0 111.428 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.45 40.33 13.27 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.87 -0.681 . . . . 10.0 112.247 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 53.5 mt -120.57 107.88 21.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.829 0.347 . . . . 10.0 110.325 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -93.28 118.08 30.84 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.295 -0.412 . . . . 10.0 110.647 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.651 HD23 HD12 ' A' ' 231' ' ' LEU . 85.1 mt -61.43 -30.34 70.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.075 -0.511 . . . . 10.0 111.628 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.85 -5.55 38.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.165 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.19 27.39 7.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.525 . . . . 10.0 110.576 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.651 HD12 HD23 ' A' ' 228' ' ' LEU . 77.9 mt -115.34 148.34 40.61 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.101 179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.14 172.93 15.41 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.487 2.125 . . . . 10.0 111.595 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -74.81 101.72 4.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.399 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 77' ' ' GLU . . . -75.44 -148.83 2.09 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 116.005 -0.543 . . . . 10.0 112.745 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -152.07 154.99 37.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.853 0.358 . . . . 10.0 111.418 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -100.09 161.82 13.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.75 -0.659 . . . . 10.0 109.966 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -101.75 150.11 23.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -95.03 119.5 65.76 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.378 -0.373 . . . . 10.0 110.05 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.04 -15.8 35.63 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.206 2.604 . . . . 10.0 112.495 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.578 ' HA ' ' HE2' ' A' ' 165' ' ' TYR . 98.9 mmm -75.19 -14.3 60.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 10.0 110.934 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 91.84 -18.83 51.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.067 -0.587 . . . . 10.0 112.818 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.0 m -134.24 157.71 41.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 110.354 -0.239 . . . . 10.0 110.354 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 90.19 155.04 30.62 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.783 -0.723 . . . . 10.0 112.319 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.34 130.19 46.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.694 0.283 . . . . 10.0 110.703 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 125.07 176.69 14.63 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.945 -0.645 . . . . 10.0 111.525 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -81.15 -1.05 43.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.874 0.337 . . . . 10.0 111.564 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.42 6.13 84.13 Favored Glycine 0 C--O 1.227 -0.288 0 C-N-CA 120.917 -0.658 . . . . 10.0 112.26 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.6 t -108.48 135.81 46.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.836 -0.431 . . . . 10.0 109.836 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.725 HD11 ' HD3' ' A' ' 419' ' ' PRO . 90.1 mt -81.75 159.34 23.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.449 -0.341 . . . . 10.0 110.68 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -67.44 110.67 3.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.976 -0.557 . . . . 10.0 110.832 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.551 ' HA3' ' HB2' ' A' ' 413' ' ' ARG . . . 148.56 141.84 3.54 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.802 -0.713 . . . . 10.0 112.064 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 10.4 t -84.36 155.02 22.52 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.997 0.427 . . . . 10.0 111.148 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -98.22 -16.32 19.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.896 -0.593 . . . . 10.0 110.476 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.51 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 86.11 -6.78 80.51 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 121.107 -0.568 . . . . 10.0 112.396 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.75 158.4 10.22 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.008 -0.837 . . . . 10.0 111.008 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.23 -55.53 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.863 0.331 . . . . 10.0 110.909 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' MET . . . . . 0.612 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 19.3 ttp -56.99 -48.22 78.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 10.0 111.65 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.51 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 18.2 tt0 -63.26 -48.27 78.87 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.131 0.419 . . . . 10.0 112.131 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.427 ' HB3' HG12 ' A' ' 98' ' ' ILE . . . -64.26 -34.99 79.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.503 0.192 . . . . 10.0 111.335 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.09 -47.73 73.26 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.46 -0.57 . . . . 10.0 109.46 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.408 HD23 HD21 ' A' ' 105' ' ' LEU . 68.0 mt -62.45 -41.07 98.48 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.728 -0.669 . . . . 10.0 109.8 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.483 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 44.4 ttm105 -59.28 -50.16 75.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.47 -0.787 . . . . 10.0 111.018 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 50.9 m -57.56 -43.62 84.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 10.0 111.053 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.24 77.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.911 0.386 . . . . 10.0 110.72 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.526 ' CD2' ' HB2' ' A' ' 273' ' ' LEU . 50.3 t80 -63.26 -48.8 76.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.081 -0.509 . . . . 10.0 111.705 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.419 ' OE2' ' HA ' ' A' ' 272' ' ' PRO . 59.5 mt-10 -63.91 -27.37 69.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.111 0.782 . . . . 10.0 113.111 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 82.2 mt -86.82 -26.64 23.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.03 0.443 . . . . 10.0 111.046 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -84.93 -36.97 21.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.679 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.443 HG21 ' CE1' ' A' ' 265' ' ' TYR . 63.0 p -100.81 -32.74 10.54 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.718 0.636 . . . . 10.0 112.718 -178.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 87.23 0.99 84.59 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.732 -0.947 . . . . 10.0 110.732 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 42.0 p -109.38 145.09 31.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 N-CA-C 110.286 -0.264 . . . . 10.0 110.286 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.419 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 42.6 Cg_endo -69.26 146.2 62.47 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 122.604 2.202 . . . . 10.0 112.203 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.543 HD12 ' HD2' ' A' ' 274' ' ' PRO . 32.1 tp -115.2 123.56 31.51 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.236 -0.438 . . . . 10.0 110.931 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.543 ' HD2' HD12 ' A' ' 273' ' ' LEU . 87.7 Cg_endo -80.29 -157.3 0.08 OUTLIER 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.696 2.264 . . . . 10.0 111.3 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -79.28 140.07 37.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.569 0.224 . . . . 10.0 110.584 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 90.5 mt -91.69 128.2 37.43 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.984 0.421 . . . . 10.0 111.248 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 7.1 m -96.1 93.47 6.98 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.182 0.515 . . . . 10.0 111.002 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.436 ' HB3' ' HB3' ' A' ' 288' ' ' LYS . 4.3 mm? -64.54 122.33 16.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.515 -0.766 . . . . 10.0 111.346 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 3.2 m -105.18 138.87 40.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.516 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.97 144.12 56.96 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.765 0.283 . . . . 10.0 111.765 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.59 HG22 ' HG2' ' A' ' 289' ' ' GLU . 16.7 t -93.84 123.71 46.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.31 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -66.06 118.81 10.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.208 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.99 -23.85 12.46 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.906 -0.664 . . . . 10.0 111.808 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.434 ' HB3' HG13 ' A' ' 287' ' ' ILE . 75.7 mtm -126.98 98.65 5.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.985 0.421 . . . . 10.0 110.351 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -69.17 133.28 47.79 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.971 -0.559 . . . . 10.0 111.176 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . 0.435 ' HA3' HD21 ' A' ' 354' ' ' ASN . . . 89.64 -6.99 82.75 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.038 -0.601 . . . . 10.0 112.459 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 284' ' ' MET . 37.1 mm -101.19 127.92 53.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.87 0.367 . . . . 10.0 110.312 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 278' ' ' LEU . 65.8 mttm -122.97 142.81 50.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.59 ' HG2' HG22 ' A' ' 281' ' ' VAL . 15.8 pt-20 -126.05 163.56 22.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.119 0.485 . . . . 10.0 111.562 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.418 ' CG2' ' HB ' ' A' ' 346' ' ' VAL . 10.0 t -157.19 131.4 8.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.861 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -105.7 121.83 44.82 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.279 -0.419 . . . . 10.0 109.944 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 36.2 mt -109.12 111.7 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.457 -0.338 . . . . 10.0 111.419 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -73.07 103.55 3.87 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.584 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 87.4 mtp -98.38 115.12 27.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.127 0.489 . . . . 10.0 111.442 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 269' ' ' THR . 70.2 t -109.3 124.79 32.99 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.632 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.01 129.77 34.84 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.737 2.291 . . . . 10.0 112.631 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -62.11 132.23 93.72 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.867 -0.606 . . . . 10.0 110.848 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.11 118.4 5.35 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.584 2.189 . . . . 10.0 111.978 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 95.07 21.47 25.29 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.875 -0.679 . . . . 10.0 112.797 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 83.1 p -119.78 164.04 16.56 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.7 -0.294 . . . . 10.0 110.478 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.667 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 71.4 tttt -62.83 -32.12 73.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.992 0.425 . . . . 10.0 109.911 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . 0.409 ' HA ' HD12 ' A' ' 305' ' ' LEU . 47.9 m-85 -60.59 -36.64 79.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.645 -0.707 . . . . 10.0 111.177 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -70.36 -36.71 74.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.98 -0.554 . . . . 10.0 110.428 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.31 -28.29 62.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.779 -0.646 . . . . 10.0 111.312 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 90.0 mt -58.18 -53.91 52.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.913 0.338 . . . . 10.0 111.913 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.44 -1.67 31.42 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.295 0.48 . . . . 10.0 112.295 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -104.5 -36.0 7.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.946 0.403 . . . . 10.0 111.07 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -26.41 54.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.717 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . 0.718 ' NH1' ' HA ' ' A' ' 114' ' ' GLU . 5.1 ptp85 -148.42 165.36 31.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.531 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -138.25 -57.67 0.65 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.015 0.436 . . . . 10.0 110.591 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.745 -0.645 . . . . 10.0 110.077 179.419 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 111.909 -0.476 . . . . 10.0 111.909 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.64 -26.07 33.72 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.792 2.328 . . . . 10.0 111.555 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.511 ' HB2' ' CE2' ' A' ' 147' ' ' TYR . 93.1 mt -113.13 105.1 13.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.732 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.76 31.49 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.037 -0.529 . . . . 10.0 110.498 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -56.19 137.29 52.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.706 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -79.69 -12.68 59.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.979 0.419 . . . . 10.0 111.607 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 114.25 -10.68 22.27 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.829 -0.7 . . . . 10.0 111.405 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 89.79 141.8 8.92 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 121.003 -0.618 . . . . 10.0 112.084 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -77.75 96.01 4.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.093 0.473 . . . . 10.0 110.106 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -103.22 163.16 15.82 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.791 -0.718 . . . . 10.0 112.737 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -147.5 153.78 39.94 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.473 ' HA ' ' HA3' ' A' ' 340' ' ' GLY . 6.2 t -144.36 161.04 40.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.917 0.389 . . . . 10.0 111.121 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . 0.457 ' HB2' ' OD1' ' A' ' 337' ' ' ASP . 1.4 m -110.19 166.26 11.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.726 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -72.96 7.06 2.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 335' ' ' SER . 2.0 p-10 -104.0 -16.76 15.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.968 0.413 . . . . 10.0 110.269 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 108.34 -4.13 33.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.853 -0.689 . . . . 10.0 113.293 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -108.52 122.04 46.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.99 0.424 . . . . 10.0 110.69 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 334' ' ' THR . . . -136.67 -145.1 4.95 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.864 -0.684 . . . . 10.0 111.917 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . 179.0 -165.46 34.42 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 111.55 -0.62 . . . . 10.0 111.55 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.456 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 14.5 tt -137.89 138.56 43.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 13.2 t -102.25 119.33 38.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.298 0.57 . . . . 10.0 110.414 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 11.7 tp -79.0 126.19 30.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.683 -0.689 . . . . 10.0 111.407 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -95.09 106.11 18.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.583 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 371' ' ' PHE . 29.4 t -107.46 139.81 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.12 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 372' ' ' VAL . . . -136.69 144.9 44.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.804 0.335 . . . . 10.0 110.962 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 52.5 t -119.58 125.83 74.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.318 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 358' ' ' LEU . . . -108.8 119.77 40.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.066 -0.515 . . . . 10.0 109.912 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -100.92 103.06 14.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.574 -0.285 . . . . 10.0 111.398 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' B' ' 41' ' ' ALA . . . 113.11 146.01 9.55 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.605 -0.807 . . . . 10.0 114.239 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 14.6 mt -71.11 -32.4 68.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.186 0.517 . . . . 10.0 109.842 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' B' ' 60' ' ' SER . . . -75.73 -10.83 84.84 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 110.916 -0.874 . . . . 10.0 110.916 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.594 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 3.2 t-20 -91.49 -31.4 15.98 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.643 -0.503 . . . . 10.0 109.643 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.2 93.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.663 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -58.84 -40.91 85.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.495 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 8.7 pttm -83.86 -10.86 57.7 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.431 0.53 . . . . 10.0 112.431 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 349' ' ' ALA . 29.1 tp -91.95 -49.44 6.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.816 0.341 . . . . 10.0 111.119 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 85.0 mt -58.25 -37.55 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 10.0 111.103 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.94 -26.75 68.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.266 -0.424 . . . . 10.0 111.346 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -78.86 -33.15 46.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 10.0 109.926 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 91.0 mtp -75.06 -37.54 61.62 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.001 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -63.14 -34.57 77.9 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.795 -0.639 . . . . 10.0 111.011 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -79.38 -12.75 59.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 10.0 111.263 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 84.4 15.47 68.77 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.843 -0.694 . . . . 10.0 112.395 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -83.28 -52.38 6.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.023 0.439 . . . . 10.0 109.94 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.417 ' HB1' ' HE2' ' A' ' 369' ' ' TYR . . . -94.09 100.28 12.42 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.579 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -95.61 115.0 26.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' TYR . . . . . 0.417 ' HE2' ' HB1' ' A' ' 367' ' ' ALA . 85.1 m-85 -137.9 159.86 40.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.677 -0.49 . . . . 10.0 109.677 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -107.16 -39.46 5.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.968 0.413 . . . . 10.0 110.979 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.612 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 20.5 t80 -128.16 123.57 34.7 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.368 -0.605 . . . . 10.0 109.368 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.534 ' HB ' ' HD1' ' A' ' 126' ' ' PHE . 45.4 t -129.38 126.57 63.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.848 0.356 . . . . 10.0 111.746 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -104.12 124.09 48.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.862 -0.608 . . . . 10.0 109.672 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 5.2 mp -111.74 121.92 65.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.843 0.354 . . . . 10.0 110.896 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' MET . . . . . 0.6 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 67.2 mtt -105.65 152.36 23.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.727 -0.67 . . . . 10.0 110.343 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -101.36 9.26 41.77 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.029 0.443 . . . . 10.0 110.998 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 378' ' ' PRO . 92.9 m -111.74 160.48 29.49 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.704 -0.68 . . . . 10.0 110.106 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.583 ' HB3' ' SG ' ' B' ' 37' ' ' CYS . 24.9 Cg_endo -62.84 -36.44 61.54 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.616 2.211 . . . . 10.0 112.474 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -157.63 100.71 1.79 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.013 0.435 . . . . 10.0 110.543 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 377' ' ' CYS . . . 78.29 -132.8 12.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.871 -0.68 . . . . 10.0 112.977 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' CYS . . . . . . . . . . . . . 11.5 t -131.14 -8.17 3.84 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.105 0.479 . . . . 10.0 110.819 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 11.5 m -81.14 4.77 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 112.572 0.582 . . . . 10.0 112.572 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -128.56 48.77 0.95 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.511 -0.852 . . . . 10.0 112.663 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -87.54 168.97 38.7 Favored Glycine 0 C--N 1.318 -0.445 0 C-N-CA 120.449 -0.881 . . . . 10.0 111.74 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -67.79 -15.19 66.41 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.232 -0.508 . . . . 10.0 113.294 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -89.29 -5.44 72.65 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.696 -0.764 . . . . 10.0 111.749 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -82.42 156.3 68.66 Favored Pre-proline 0 C--O 1.239 0.501 0 N-CA-C 109.944 -0.391 . . . . 10.0 109.944 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.8 160.73 39.32 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.715 2.277 . . . . 10.0 111.532 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 107.54 14.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.92 0.391 . . . . 10.0 111.282 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 62.4 m -108.43 163.03 13.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.778 -0.646 . . . . 10.0 109.868 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.65 81.75 3.3 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.174 0.511 . . . . 10.0 111.196 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . 0.785 ' HB3' ' HB ' ' A' ' 395' ' ' ILE . 14.3 t0 -165.87 125.32 1.67 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.644 . . . . 10.0 109.527 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -78.57 -15.0 59.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.015 0.436 . . . . 10.0 110.337 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -124.71 38.76 4.13 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.755 -0.657 . . . . 10.0 110.501 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.785 ' HB ' ' HB3' ' A' ' 392' ' ' ASP . 10.9 tp -71.48 -18.78 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.341 0.591 . . . . 10.0 110.64 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.51 -42.55 95.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.642 -0.708 . . . . 10.0 111.391 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -64.26 -37.18 86.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.662 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.468 ' HD2' HD12 ' A' ' 395' ' ' ILE . 62.7 mttp -62.97 -44.93 94.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.063 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.401 ' HD3' ' HB2' ' A' ' 58' ' ' ALA . 97.3 mtt180 -68.44 -35.76 78.06 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.029 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 49.5 tp60 -66.36 -40.2 89.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.518 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -73.4 -29.67 62.76 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.05 -0.523 . . . . 10.0 111.622 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -91.61 10.07 29.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.962 0.41 . . . . 10.0 111.784 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 9.5 mt -66.55 -41.45 88.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 10.0 110.738 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -136.16 153.46 51.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.086 -0.506 . . . . 10.0 110.495 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . 0.49 ' HB3' ' OD1' ' A' ' 407' ' ' ASP . 63.8 t30 -79.52 174.24 11.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.583 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 406' ' ' LEU . 3.6 mm? -59.55 -39.51 84.25 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . 0.49 ' OD1' ' HB3' ' A' ' 405' ' ' ASN . 11.7 p30 -70.72 -46.63 62.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.351 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -60.63 -35.32 75.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 10.0 111.646 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -71.12 -40.63 71.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.888 0.375 . . . . 10.0 111.293 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 10.8 m -73.97 -31.14 62.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.996 -0.547 . . . . 10.0 111.829 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 5.6 m -87.0 107.69 18.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.293 -0.412 . . . . 10.0 110.822 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 40.2 tp -85.65 136.65 33.29 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.692 -0.484 . . . . 10.0 109.692 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . 0.551 ' HB2' ' HA3' ' A' ' 251' ' ' GLY . 3.9 tmm_? -145.77 125.12 13.05 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.216 -0.29 . . . . 10.0 110.216 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.619 ' HB2' ' OE1' ' A' ' 417' ' ' GLU . 5.3 mtt85 -100.83 158.52 15.91 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.136 0.493 . . . . 10.0 110.462 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 1.6 m -64.5 -24.91 67.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.551 0.945 . . . . 10.0 113.551 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . 0.473 ' CE1' ' HD3' ' A' ' 414' ' ' ARG 0.282 32.5 p-80 -78.71 4.23 14.31 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -178.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . 0.619 ' OE1' ' HB2' ' A' ' 414' ' ' ARG . 1.7 mp0 -112.12 -3.93 14.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.992 0.425 . . . . 10.0 109.975 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.42 ' HB3' ' HB ' ' A' ' 421' ' ' ILE . 50.4 t-20 -77.75 118.37 71.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.624 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.725 ' HD3' HD11 ' A' ' 249' ' ' LEU . 37.7 Cg_exo -59.05 -38.68 86.13 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.022 2.481 . . . . 10.0 111.636 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 53.9 m -65.28 -46.27 81.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.313 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 418' ' ' ASN . 39.2 mm -65.22 -43.02 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 10.0 110.132 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.587 ' NH2' ' HA ' ' A' ' 417' ' ' GLU . 97.1 mtt180 -58.97 -45.45 90.53 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.366 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -63.33 -49.64 73.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.807 -0.633 . . . . 10.0 110.93 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.602 HD23 HD21 ' A' ' 96' ' ' LEU . 61.3 tp -56.37 -39.17 72.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.998 0.427 . . . . 10.0 110.947 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . 0.882 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.1 m-85 -77.35 4.62 10.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.948 -0.569 . . . . 10.0 111.498 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -118.76 -54.61 2.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.739 0.304 . . . . 10.0 111.692 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -25.27 53.47 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.714 1.005 . . . . 10.0 113.714 -178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -126.71 -50.13 1.49 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 114.589 1.329 . . . . 10.0 114.589 -178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.882 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 90.9 mt -73.08 -39.74 65.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.391 0.886 . . . . 10.0 113.391 -178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 86.25 -60.57 4.56 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.574 -0.822 . . . . 10.0 112.836 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 432' ' ' PRO . 2.1 tt0 -165.95 151.1 7.77 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.615 0.208 . . . . 10.0 110.727 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.476 ' HA ' ' OE2' ' A' ' 100' ' ' GLU . 32.5 Cg_exo -59.64 142.4 98.74 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.819 2.346 . . . . 10.0 111.312 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 7.9 mp 63.35 16.95 9.92 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.708 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -78.67 -168.79 34.74 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.2 -0.524 . . . . 10.0 112.214 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . 0.426 ' O ' ' HG3' ' A' ' 439' ' ' GLU . 31.4 t-80 -59.99 -60.83 3.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.512 0.196 . . . . 10.0 111.328 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.443 ' HD2' ' OE2' ' A' ' 439' ' ' GLU . 8.3 tptt -59.4 -35.46 74.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.278 -0.419 . . . . 10.0 111.29 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -65.19 -42.84 93.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.156 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 9.6 t-80 -68.02 -26.9 66.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.901 0.382 . . . . 10.0 110.521 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . 0.443 ' OE2' ' HD2' ' A' ' 436' ' ' LYS . 45.4 mt-10 -73.06 -64.88 0.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 62.4 mt -99.04 -17.96 18.0 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 114.986 1.476 . . . . 10.0 114.986 -176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 60.8 mt -100.0 -11.14 20.86 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.557 0.577 . . . . 10.0 112.557 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.518 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 28.0 m-70 -122.59 163.6 19.7 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 121.305 -0.158 . . . . 10.0 110.595 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 5.9 t -155.07 -171.95 4.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.667 0.27 . . . . 10.0 111.081 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -133.84 168.09 19.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.281 -0.418 . . . . 10.0 110.374 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' TYR . . . . . 0.546 ' HD2' HG23 ' A' ' 145' ' ' ILE . 51.0 m-85 -109.85 161.02 15.86 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.446 -0.343 . . . . 10.0 110.358 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.15 120.91 66.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.977 0.418 . . . . 10.0 111.31 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.13 107.23 3.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 10.0 109.738 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 120.26 -6.32 11.89 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.128 -0.789 . . . . 10.0 111.128 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . 95.86 179.18 36.15 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.04 -0.6 . . . . 10.0 112.045 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 C--O 1.254 1.295 0 CA-C-O 118.167 -0.92 . . . . 10.0 110.138 -179.904 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.556 ' HE2' ' HB2' ' B' ' 18' ' ' ALA . 97.5 m-85 . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 109.938 -0.393 . . . . 10.0 109.938 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.453 ' HG3' ' OE2' ' B' ' 15' ' ' GLU . 38.3 mttp -84.12 114.02 21.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.129 0.49 . . . . 10.0 110.266 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' B' ' 13' ' ' THR . 6.9 p -112.56 127.77 69.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.856 -0.611 . . . . 10.0 111.38 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.561 ' HB ' HG23 ' B' ' 84' ' ' THR . 1.3 m -85.71 89.56 7.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.763 -0.653 . . . . 10.0 109.273 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 80.7 mt -76.35 109.97 10.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.113 0.482 . . . . 10.0 111.327 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.788 ' HB3' ' HA ' ' B' ' 86' ' ' GLN . 12.9 tppt? -79.88 123.67 27.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.645 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.53 HG21 HD22 ' B' ' 31' ' ' LEU . 0.6 OUTLIER -128.32 166.38 24.64 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.146 -0.479 . . . . 10.0 109.816 -179.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.94 -21.47 72.37 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.084 1.856 . . . . 10.0 110.73 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.3 9.13 39.35 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.482 -0.781 . . . . 10.0 111.792 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.26 -122.83 4.57 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.297 -0.954 . . . . 10.0 113.185 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -145.03 157.98 43.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.895 0.379 . . . . 10.0 110.466 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . 0.437 ' HB2' ' HE2' ' B' ' 12' ' ' LYS . 1.5 tppt? -143.38 97.83 3.15 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.056 -0.52 . . . . 10.0 110.445 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' B' ' 3' ' ' VAL . 2.6 m -87.77 92.84 9.26 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.62 -0.511 . . . . 10.0 109.62 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.411 ' H ' HG13 ' B' ' 14' ' ' ILE . 1.9 pp -112.79 173.56 2.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.338 -0.392 . . . . 10.0 111.444 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.453 ' OE2' ' HG3' ' B' ' 2' ' ' LYS . 8.3 mm-40 -91.55 117.87 30.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.051 -0.522 . . . . 10.0 111.174 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' B' ' 17' ' ' PRO . 44.6 t -109.8 125.65 30.76 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.755 -0.657 . . . . 10.0 109.659 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 16' ' ' CYS . 17.2 Cg_exo -68.96 154.84 70.14 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.818 2.345 . . . . 10.0 110.889 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.556 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . . . -77.84 -14.74 59.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.405 -0.361 . . . . 10.0 111.693 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.44 -5.42 20.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.38 -0.373 . . . . 10.0 111.519 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . . . . . . . . . 2.9 m -119.11 135.52 54.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.836 0.35 . . . . 10.0 111.496 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' B' ' 24' ' ' ASP . 1.8 p90 -65.42 140.05 58.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.96 -0.564 . . . . 10.0 111.022 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.521 ' H ' HG13 ' B' ' 22' ' ' ILE . 2.1 mt -53.87 -34.82 26.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.744 -0.662 . . . . 10.0 112.493 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.479 ' HB3' ' CD2' ' B' ' 21' ' ' TYR . 1.3 tm? -53.58 -49.32 67.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.078 0.399 . . . . 10.0 112.078 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.542 ' HB2' ' CZ ' ' B' ' 21' ' ' TYR . 4.9 t70 -64.12 -45.79 87.04 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.062 0.458 . . . . 10.0 110.895 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -31.55 72.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.89 -0.596 . . . . 10.0 112.034 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.98 -56.37 13.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.371 -0.377 . . . . 10.0 111.817 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -36.69 80.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.413 -0.358 . . . . 10.0 111.499 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -63.0 -27.22 69.27 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.177 0.513 . . . . 10.0 110.275 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -88.71 -42.9 11.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.499 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.63 82.18 0.14 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.899 -0.667 . . . . 10.0 112.558 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . 0.53 HD22 HG21 ' B' ' 7' ' ' THR . 13.2 mt -150.04 162.43 40.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.867 0.365 . . . . 10.0 111.081 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -93.26 98.79 11.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.134 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.516 HD21 ' HB ' ' B' ' 87' ' ' THR . 20.9 mt -152.57 149.68 23.11 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.394 -0.366 . . . . 10.0 110.258 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 33' ' ' LEU . 2.9 Cg_endo -83.7 117.35 2.33 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.013 2.475 . . . . 10.0 111.661 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.419 ' HA ' ' S1 ' ' B' ' 101' ' ' FES . 11.7 p90 -125.86 128.77 48.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.413 -0.358 . . . . 10.0 111.262 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . . . . . . . . . 4.6 m -169.1 -57.1 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.329 -0.396 . . . . 10.0 111.735 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 378' ' ' PRO . 7.2 p -84.45 -65.06 1.05 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.259 0.837 . . . . 10.0 113.259 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' B' ' 75' ' ' CYS . 3.7 ttp-105 81.58 -32.3 0.1 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.22 23.85 0.05 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.401 0.889 . . . . 10.0 113.401 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.95 74.14 0.69 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.112 -0.566 . . . . 10.0 112.582 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . 0.49 ' HB3' ' SG ' ' B' ' 37' ' ' CYS . . . -112.23 -76.18 0.6 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.713 0.292 . . . . 10.0 111.495 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.46 145.54 30.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.882 0.373 . . . . 10.0 111.268 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.67 -0.6 57.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.194 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m -72.0 -17.32 62.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.074 0.464 . . . . 10.0 110.977 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . 0.508 ' O ' HG22 ' B' ' 74' ' ' THR . 18.0 m -101.34 31.35 3.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.804 -0.634 . . . . 10.0 110.395 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.02 123.89 37.68 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.995 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.52 164.99 35.01 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.061 -0.59 . . . . 10.0 111.956 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 1.046 ' HB2' ' HB2' ' B' ' 86' ' ' GLN . 0.1 OUTLIER -110.96 116.67 31.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.247 -0.279 . . . . 10.0 110.247 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.55 ' HB ' ' HA2' ' B' ' 70' ' ' GLY . 4.9 t -73.35 98.43 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.306 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.64 -38.5 47.74 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.053 0.454 . . . . 10.0 110.343 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -163.76 -179.89 6.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.631 -0.713 . . . . 10.0 109.35 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.733 ' HA3' ' HB3' ' B' ' 83' ' ' CYS . . . 79.22 -147.29 30.03 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.046 -0.597 . . . . 10.0 112.859 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.98 136.34 20.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.853 0.359 . . . . 10.0 110.786 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . . . . . . . . . 5.5 m -128.07 156.01 39.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -122.4 119.37 30.83 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.266 0.469 . . . . 10.0 112.266 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -135.08 133.13 38.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 10.0 109.209 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -116.73 -58.56 2.06 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.026 0.441 . . . . 10.0 110.925 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -95.34 99.79 11.67 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.065 -0.716 . . . . 10.0 109.065 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.66 -160.19 1.03 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.481 0.548 . . . . 10.0 112.481 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.51 ' HA ' ' HA2' ' A' ' 353' ' ' GLY . 3.7 m -93.44 -147.14 0.24 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.031 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -72.62 -16.16 61.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.201 0.445 . . . . 10.0 112.201 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.32 87.06 3.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.158 0.504 . . . . 10.0 110.198 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.504 ' HB3' ' H ' ' B' ' 64' ' ' ASP . 0.6 OUTLIER -88.23 -153.98 0.26 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.532 -0.758 . . . . 10.0 112.727 -178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . 0.504 ' H ' ' HB3' ' B' ' 63' ' ' ASP . 43.1 m-20 -53.5 -44.02 68.71 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.972 0.73 . . . . 10.0 112.972 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.76 -37.8 71.57 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.104 0.478 . . . . 10.0 111.076 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.477 ' HB3' ' HB2' ' B' ' 71' ' ' PHE . 14.7 mm100 -81.93 -38.66 24.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.84 -0.618 . . . . 10.0 110.172 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' MET . . . . . . . . . . . . . 57.2 ttp -60.44 -43.71 96.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.847 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.9 -16.28 72.37 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 116.066 -0.515 . . . . 10.0 112.444 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -90.6 -34.86 15.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.059 0.457 . . . . 10.0 110.163 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.55 ' HA2' ' HB ' ' B' ' 49' ' ' VAL . . . 135.85 37.73 0.18 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.776 -0.726 . . . . 10.0 113.261 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.477 ' HB2' ' HB3' ' B' ' 66' ' ' GLN . 52.7 m-85 -129.52 118.25 21.77 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.134 0.467 . . . . 10.0 110.646 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 12.3 p -143.13 143.07 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 120.834 0.35 . . . . 10.0 111.528 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.36 96.2 9.92 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.508 HG22 ' O ' ' B' ' 45' ' ' CYS . 9.9 t -61.56 -8.01 3.89 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.33 1.233 . . . . 10.0 114.33 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' B' ' 38' ' ' ARG . 56.0 m -82.18 -25.44 34.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.855 0.359 . . . . 10.0 110.922 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.66 26.83 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.302 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.47 150.26 44.98 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.83 -0.623 . . . . 10.0 111.1 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.403 ' HA ' ' HD3' ' B' ' 79' ' ' PRO . 34.5 p90 -133.24 155.36 80.99 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.407 -0.815 . . . . 10.0 109.181 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 0.441 ' HD3' HG12 ' B' ' 22' ' ' ILE . 6.1 Cg_exo -78.23 115.92 3.81 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.505 2.137 . . . . 10.0 111.433 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.07 -20.4 64.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.462 0.648 . . . . 10.0 109.397 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 15.0 m -153.59 159.08 42.05 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.305 -0.861 . . . . 10.0 109.077 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.28 135.8 57.76 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.855 -0.424 . . . . 10.0 109.855 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . 0.733 ' HB3' ' HA3' ' B' ' 52' ' ' GLY . 2.3 p -169.24 -179.95 3.72 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 10.0 112.259 -179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.561 HG23 ' HB ' ' B' ' 4' ' ' THR . 22.5 m -105.93 129.69 54.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.298 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 26.3 mm -133.93 128.62 53.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.498 0.189 . . . . 10.0 110.848 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . 1.046 ' HB2' ' HB2' ' B' ' 48' ' ' LYS . 1.3 mp0 -79.28 162.96 25.31 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.992 -0.744 . . . . 10.0 108.992 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.516 ' HB ' HD21 ' B' ' 33' ' ' LEU . 18.6 p -119.15 -84.91 0.66 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.503 0.927 . . . . 10.0 113.503 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -62.67 101.74 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.411 0.893 . . . . 10.0 113.411 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.51 ' HB3' ' HD3' ' B' ' 48' ' ' LYS . 0.7 OUTLIER 178.05 87.74 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.172 0 O-C-N 123.709 0.631 . . . . 10.0 110.468 178.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -103.33 -5.08 23.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.987 0.422 . . . . 10.0 111.444 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -80.36 -30.14 37.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.136 -0.483 . . . . 10.0 112.099 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.84 -8.67 45.79 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.896 0.702 . . . . 10.0 112.896 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 pp -111.86 13.38 20.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.122 0.487 . . . . 10.0 111.245 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.637 -0.696 . . . . 10.0 110.412 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' FES . . . . . 0.419 ' S1 ' ' HA ' ' B' ' 35' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.998 -0.371 . . . . 10.0 109.998 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.25 154.17 35.87 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.594 -0.521 . . . . 10.0 109.594 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -62.86 -22.96 67.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.88 0.371 . . . . 10.0 111.698 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.1 t -73.62 -45.45 50.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.882 -0.785 . . . . 10.0 108.882 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -63.93 -32.62 74.22 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.697 -0.683 . . . . 10.0 109.772 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.554 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 60.2 mt-30 -61.87 -19.1 62.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.414 -0.812 . . . . 10.0 111.059 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -98.76 -47.43 5.32 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.016 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 35' ' ' LEU . 96.0 mt -59.71 -26.7 65.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.722 -0.672 . . . . 10.0 111.994 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.78 -50.43 73.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.728 0.299 . . . . 10.0 111.001 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -75.7 -26.09 57.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.728 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.521 HD12 HD23 ' A' ' 32' ' ' LEU . 62.4 mt -70.32 -30.79 67.85 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.847 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.42 -25.45 61.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.995 -0.548 . . . . 10.0 110.289 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -70.66 130.24 89.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.835 -0.62 . . . . 10.0 110.22 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.17 153.88 15.34 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 123.125 2.55 . . . . 10.0 112.086 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -63.05 -25.21 68.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.136 0.493 . . . . 10.0 110.423 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -101.51 15.95 27.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.477 -0.783 . . . . 10.0 111.381 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.842 ' HB3' ' HB2' ' A' ' 44' ' ' ARG . 15.8 t70 -69.36 136.39 88.76 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.278 -0.268 . . . . 10.0 110.278 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.96 -24.49 73.31 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.962 2.442 . . . . 10.0 113.033 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -110.32 10.85 23.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.957 0.408 . . . . 10.0 110.983 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.842 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 7.4 tpt180 -72.28 137.55 46.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.032 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -118.72 173.81 6.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.579 -0.737 . . . . 10.0 109.233 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.4 111.06 21.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 9.4 t -99.56 104.27 15.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.224 0.535 . . . . 10.0 111.091 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.2 m -96.87 141.05 30.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.352 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 14.5 p -128.56 139.31 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.705 0.288 . . . . 10.0 111.567 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 12.8 pt20 -120.78 125.31 47.25 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.778 -0.453 . . . . 10.0 109.778 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.584 HG11 HD21 ' A' ' 75' ' ' LEU . 14.1 t -111.3 143.81 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.346 -0.388 . . . . 10.0 111.183 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -92.7 145.82 31.07 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.544 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.86 -30.17 84.4 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.003 2.469 . . . . 10.0 112.433 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.08 -23.37 65.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.94 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.708 HG13 HG23 ' A' ' 214' ' ' THR . 86.8 t -81.13 -38.56 16.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 109.624 -0.51 . . . . 10.0 109.624 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.7 tmm_? -59.46 -29.6 67.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.982 -0.554 . . . . 10.0 111.835 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.5 p -85.58 -33.7 7.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.508 0.558 . . . . 10.0 112.508 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' A' ' 388' ' ' PRO . . . -91.74 -17.1 25.92 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.117 0.784 . . . . 10.0 113.117 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.4 tp -60.52 -20.84 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 10.0 111.381 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' A' ' 65' ' ' LEU . . . -70.26 -37.69 74.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.684 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 399' ' ' ARG . 32.4 mt-10 -64.15 -29.76 70.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.523 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.415 HG21 ' HA3' ' A' ' 218' ' ' GLY . 0.0 OUTLIER -69.03 -15.63 63.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.054 0.454 . . . . 10.0 110.858 179.329 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.4 mt -109.17 -5.56 15.9 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.149 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.39 27.4 22.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.908 -0.663 . . . . 10.0 112.23 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.508 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 mt -112.95 164.24 13.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.6 0.238 . . . . 10.0 110.492 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -69.96 140.9 88.93 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.077 -0.51 . . . . 10.0 110.731 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 66' ' ' ALA . 51.5 Cg_exo -55.44 118.82 5.62 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.881 2.387 . . . . 10.0 112.127 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.94 0.0 55.05 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.6 -0.809 . . . . 10.0 113.279 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -70.79 -38.11 73.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 10.0 111.051 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.11 131.34 41.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.828 -0.624 . . . . 10.0 110.716 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -83.52 157.1 65.08 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 120.598 0.237 . . . . 10.0 110.403 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.4 -35.26 91.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.225 1.95 . . . . 10.0 111.345 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.505 ' HB2' ' OE1' ' A' ' 233' ' ' GLU . 31.4 mmtp -71.8 -36.96 70.45 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.103 -0.499 . . . . 10.0 111.946 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -61.27 -42.3 98.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.091 0.472 . . . . 10.0 110.529 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.584 HD21 HG11 ' A' ' 51' ' ' VAL . 45.0 tp -63.84 -46.45 84.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.72 -0.673 . . . . 10.0 110.588 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.32 95.42 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.835 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -61.75 -42.7 99.32 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.817 -0.629 . . . . 10.0 110.367 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.19 -44.34 91.22 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.964 -0.636 . . . . 10.0 112.003 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD11 HG21 ' A' ' 51' ' ' VAL . 16.3 mt -61.77 -40.49 95.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.002 0.43 . . . . 10.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -62.94 -31.01 72.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.763 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -81.51 -8.73 59.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 10.0 111.803 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.0 mt -79.16 -9.3 59.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.022 0.439 . . . . 10.0 110.761 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.85 -0.43 28.77 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.691 -0.766 . . . . 10.0 112.354 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -66.75 159.58 27.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 10.0 110.971 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -101.7 -59.4 1.71 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.859 0.362 . . . . 10.0 110.995 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -115.97 125.06 52.01 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.827 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.3 t -105.48 108.79 25.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.254 -0.43 . . . . 10.0 110.283 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 30.1 m-85 -110.76 168.76 9.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 10.0 110.923 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.43 155.8 27.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.822 -0.626 . . . . 10.0 110.058 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.7 m -76.64 -21.79 55.0 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.98 0.733 . . . . 10.0 112.98 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.433 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . 44.9 mt -61.43 -37.46 83.58 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 122.317 -0.239 . . . . 10.0 111.069 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.402 ' HZ ' ' HG2' ' A' ' 240' ' ' MET . 43.5 t80 -61.01 -38.37 85.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.232 0.539 . . . . 10.0 109.598 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.66 -35.26 55.51 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.776 -0.93 . . . . 10.0 110.776 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.11 77.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.696 0.284 . . . . 10.0 110.379 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.33 -35.48 73.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.849 -0.614 . . . . 10.0 109.662 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.6 mt -72.42 -42.39 65.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.531 -0.759 . . . . 10.0 109.594 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.6 m -60.51 -42.43 96.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.617 -0.72 . . . . 10.0 110.622 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.9 mt -59.98 -39.95 81.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.053 -0.521 . . . . 10.0 110.771 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 90.8 mmm -65.92 -51.73 56.08 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.976 -0.557 . . . . 10.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -65.55 -45.44 83.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.362 -0.381 . . . . 10.0 111.873 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 101' ' ' GLU . 1.8 tp10 -61.52 -43.55 98.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.875 0.369 . . . . 10.0 110.929 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -61.74 -38.05 95.29 Favored Glycine 0 N--CA 1.45 -0.379 0 N-CA-C 110.981 -0.848 . . . . 10.0 110.981 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.573 ' HB2' HD13 ' A' ' 433' ' ' LEU . 19.7 m -69.27 -43.64 73.51 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.614 -0.293 . . . . 10.0 110.497 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.426 ' HG2' HD21 ' A' ' 433' ' ' LEU . 0.0 OUTLIER -60.18 -47.02 87.69 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.802 -0.444 . . . . 10.0 109.802 178.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.415 ' CD2' HD23 ' A' ' 261' ' ' LEU . 23.3 tp -59.16 -54.68 44.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.726 -0.67 . . . . 10.0 111.059 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.0 tp -59.35 -39.17 82.34 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.907 0.384 . . . . 10.0 110.593 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.605 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 53.9 t60 -61.86 -53.09 60.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.526 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.593 ' HG2' ' HB2' ' A' ' 121' ' ' GLU . 68.2 mtt180 -59.72 -38.66 82.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.384 -0.371 . . . . 10.0 111.715 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 41.7 tp -67.21 -50.86 59.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.436 -0.347 . . . . 10.0 110.842 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.5 m -58.14 -44.95 88.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.912 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 23.1 mm-40 -57.95 -31.19 66.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.948 0.404 . . . . 10.0 111.573 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -79.65 -37.28 36.32 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 65.3 mt -69.31 -32.48 71.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.259 -0.428 . . . . 10.0 110.984 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.534 ' HG2' HD22 ' A' ' 305' ' ' LEU . 22.7 mt-10 -79.54 -7.16 58.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.155 -0.475 . . . . 10.0 111.284 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.139 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.356 -179.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.593 ' HB2' ' HG2' ' A' ' 108' ' ' ARG . 1.5 pm0 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.862 0.363 . . . . 10.0 110.891 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -90.09 -172.07 0.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.988 2.458 . . . . 10.0 112.801 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.423 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 91.1 mt -133.93 157.38 77.87 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.486 -0.931 . . . . 10.0 108.486 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.458 ' HB3' ' O ' ' A' ' 369' ' ' TYR . 37.5 Cg_endo -64.92 167.46 45.46 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 124.513 -1.036 . . . . 10.0 113.802 0.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 24.6 ttt -113.92 134.08 55.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.739 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.611 ' HD1' ' HB ' ' A' ' 372' ' ' VAL . 33.3 m-85 -110.8 144.6 39.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.21 179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.439 HG23 ' HZ ' ' A' ' 371' ' ' PHE . 0.0 OUTLIER -81.87 156.09 25.0 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.885 0.328 . . . . 10.0 111.885 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 9.7 m -111.63 54.18 0.7 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.262 0.553 . . . . 10.0 110.285 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.2 p -90.58 -39.51 12.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.975 -0.557 . . . . 10.0 112.086 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.781 ' SG ' ' HA ' ' A' ' 375' ' ' MET . 36.5 m -105.38 117.87 57.14 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.809 ' HG3' ' HE3' ' A' ' 188' ' ' LYS . 36.5 Cg_endo -64.46 -29.48 62.17 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.015 2.477 . . . . 10.0 111.743 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.21 -39.94 98.5 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 121.07 -0.586 . . . . 10.0 111.785 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -36.88 69.79 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 45.7 mm -62.92 -44.87 99.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.554 . . . . 10.0 109.844 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.44 -39.16 92.46 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.584 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 58.5 ttp -68.87 -34.73 75.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.94 -0.573 . . . . 10.0 109.773 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.3 tp -64.2 -54.45 33.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.616 -0.72 . . . . 10.0 110.754 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -59.8 -24.95 64.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.852 0.686 . . . . 10.0 112.852 -178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -95.64 -52.67 4.01 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.218 0.822 . . . . 10.0 113.218 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.8 m -84.24 -44.18 14.15 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 114.902 1.445 . . . . 10.0 114.902 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -131.7 73.25 79.3 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.9 -12.43 34.41 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.406 2.071 . . . . 10.0 111.82 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.94 -16.14 61.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.786 -0.643 . . . . 10.0 111.127 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.569 ' HA ' ' HD2' ' A' ' 147' ' ' TYR . 69.2 mt -98.97 9.52 43.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.412 0.523 . . . . 10.0 112.412 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.567 HG23 ' HD2' ' A' ' 445' ' ' TYR . 52.4 mt -55.93 -52.46 72.28 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.475 0.917 . . . . 10.0 113.475 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 33.4 Cg_exo -61.46 -23.28 76.43 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.338 2.025 . . . . 10.0 112.9 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.569 ' HD2' ' HA ' ' A' ' 144' ' ' LEU . 98.7 m-85 -75.78 -19.57 58.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.0 0.429 . . . . 10.0 111.047 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.2 t -86.99 159.13 3.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 109.786 -0.449 . . . . 10.0 109.786 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.522 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . 31.5 t -69.4 167.62 16.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.991 0.424 . . . . 10.0 110.778 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.4 p -106.56 6.81 30.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.349 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 61.8 m -79.52 179.42 7.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.091 0.472 . . . . 10.0 112.124 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 156' ' ' MET . 40.8 mtpt -122.25 169.79 10.56 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 70.3 p -68.53 152.56 96.56 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 121.049 -0.26 . . . . 10.0 110.471 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -48.66 -46.72 23.14 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.265 2.643 . . . . 10.0 112.974 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -35.7 80.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.353 -0.385 . . . . 10.0 111.803 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.463 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 60.1 mmm -74.52 -19.11 60.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.137 0.494 . . . . 10.0 110.833 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 30.9 mtt -80.66 -48.25 12.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.302 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.91 -42.26 99.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.59 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.68 81.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.174 -0.466 . . . . 10.0 111.091 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.61 -30.64 61.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.812 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -72.69 -44.56 61.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.074 -0.512 . . . . 10.0 111.682 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.491 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.9 m -69.49 -28.68 38.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 112.113 0.412 . . . . 10.0 112.113 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 179' ' ' MET . 27.5 mttt -85.73 2.6 44.8 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.824 0.305 . . . . 10.0 111.824 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 168' ' ' GLU . 13.5 p -122.82 -79.62 0.62 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.608 -0.269 . . . . 10.0 110.74 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.577 ' HE2' ' HA ' ' A' ' 240' ' ' MET . 33.8 t80 -55.58 -53.19 59.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.964 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.714 HD11 ' HE3' ' A' ' 170' ' ' LYS . 24.3 tp -61.94 -41.11 97.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 10.0 111.277 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.27 -50.18 74.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.202 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 164' ' ' SER . 41.6 mt-10 -68.41 -37.2 80.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.179 -0.464 . . . . 10.0 111.363 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -64.93 -49.08 71.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.393 -0.367 . . . . 10.0 111.247 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.714 ' HE3' HD11 ' A' ' 166' ' ' LEU . 91.2 mttt -76.88 -15.08 59.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.294 -0.412 . . . . 10.0 111.136 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 73.71 37.2 52.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.765 -0.731 . . . . 10.0 111.647 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 54.8 mt -115.96 135.12 57.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.99 133.9 91.89 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.48 -0.327 . . . . 10.0 110.488 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.419 ' HB2' HD13 ' A' ' 205' ' ' LEU . 32.0 Cg_exo -59.55 -16.76 37.85 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.911 2.407 . . . . 10.0 112.399 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -71.94 -22.42 61.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.747 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -107.51 23.88 13.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.236 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 96.0 mtp -125.9 115.21 19.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.514 -0.766 . . . . 10.0 110.127 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 39.7 t -103.55 131.88 51.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.387 -0.597 . . . . 10.0 109.387 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.43 ' HB2' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -112.4 119.87 39.72 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.149 0.5 . . . . 10.0 111.225 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 46.4 t -116.46 135.82 55.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.056 -0.72 . . . . 10.0 109.056 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 4.7 p -124.46 135.85 53.56 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.803 0.297 . . . . 10.0 111.803 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 212' ' ' ILE . 30.3 mm -99.93 103.11 14.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 213' ' ' THR . 32.4 mmt -114.26 148.43 40.09 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.944 -178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 183' ' ' MET . 2.5 Cg_endo -83.19 19.31 1.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.283 2.655 . . . . 10.0 112.665 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 73.1 m -145.93 129.17 16.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.05 0.453 . . . . 10.0 111.227 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -28.1 67.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.602 -0.726 . . . . 10.0 111.174 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.516 HH22 ' HA ' ' B' ' 44' ' ' SER . 8.7 mtm180 -80.7 17.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.075 -0.511 . . . . 10.0 112.029 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.809 ' HE3' ' HG3' ' A' ' 131' ' ' PRO . 0.0 OUTLIER -87.87 -33.88 18.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.657 0.265 . . . . 10.0 111.349 179.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -65.01 -30.64 71.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.915 0.388 . . . . 10.0 110.171 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.81 -25.58 66.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.661 -0.699 . . . . 10.0 111.9 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 131' ' ' PRO . 31.1 tt0 -76.25 -46.9 25.91 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -73.5 -5.91 43.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.564 -0.744 . . . . 10.0 111.16 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.36 -18.85 57.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.017 -0.538 . . . . 10.0 110.517 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.468 HH11 ' HZ2' ' A' ' 196' ' ' TRP . 78.0 mtt-85 -59.02 118.16 5.5 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.088 -0.506 . . . . 10.0 111.744 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -41.79 -47.99 4.22 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.709 1.374 . . . . 10.0 114.709 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . 0.468 ' HZ2' HH11 ' A' ' 194' ' ' ARG . 43.9 p90 -62.27 -9.59 8.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.998 1.481 . . . . 10.0 114.998 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -85.74 56.3 3.91 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.577 0.703 . . . . 10.0 110.811 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -110.07 171.07 7.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.384 -0.825 . . . . 10.0 110.375 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 13.7 t -90.59 80.94 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.688 0.28 . . . . 10.0 110.65 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.3 t0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.116 -0.945 . . . . 10.0 112.17 179.596 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 48.1 m . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.876 0.369 . . . . 10.0 111.102 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.788 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.229 -0.004 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -94.27 148.82 21.83 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.956 0.16 . . . . 10.0 110.799 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 61.0 mt-30 -70.36 -38.62 74.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.166 -1.049 . . . . 10.0 108.166 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . . . . . . . . . 29.8 tp -131.85 121.45 24.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.601 -1.629 . . . . 10.0 106.601 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.98 -44.68 7.24 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 113.891 1.071 . . . . 10.0 113.891 -176.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.554 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 8.7 m-70 -130.36 141.88 50.55 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.987 0.736 . . . . 10.0 112.987 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 62.6 t -128.72 123.78 60.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 108.652 -0.869 . . . . 10.0 108.652 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 71.7 mt -119.78 140.05 45.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 183' ' ' MET . 41.1 p -90.23 166.95 13.06 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.052 0.453 . . . . 10.0 111.96 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.708 HG23 HG13 ' A' ' 55' ' ' VAL . 2.5 m -56.09 -46.71 78.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.476 -0.784 . . . . 10.0 111.773 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 3.8 m -61.26 -39.79 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 111.949 0.351 . . . . 10.0 111.949 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.427 ' O ' HG13 ' A' ' 220' ' ' ILE . 41.9 mt-10 -68.7 -46.96 67.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.795 0.331 . . . . 10.0 110.638 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 31.1 tp -62.25 -43.07 99.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.34 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.415 ' HA3' HG21 ' A' ' 62' ' ' THR . . . -60.08 -36.27 89.96 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.186 -0.531 . . . . 10.0 112.252 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.79 -38.87 80.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.571 0.224 . . . . 10.0 110.462 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 216' ' ' GLU . 79.7 mt -59.1 -45.3 92.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.18 -0.464 . . . . 10.0 110.08 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -59.77 -45.86 90.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.937 -0.574 . . . . 10.0 110.861 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.28 -46.81 82.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.787 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -66.92 -30.97 71.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 10.0 111.942 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -80.93 -12.7 59.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.515 -0.311 . . . . 10.0 110.926 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 78.78 30.51 47.74 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.914 -0.66 . . . . 10.0 111.868 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 73.6 mt -113.21 114.72 47.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.953 0.406 . . . . 10.0 110.532 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.454 ' O ' ' HG ' ' A' ' 231' ' ' LEU . 54.8 t30 -104.07 122.14 44.66 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.317 -0.401 . . . . 10.0 110.035 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.524 ' HA ' HD12 ' A' ' 231' ' ' LEU . 76.2 mt -60.4 -32.6 71.48 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.316 0.385 . . . . 10.0 111.735 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -69.04 -16.95 63.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.324 -0.398 . . . . 10.0 111.737 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.43 3.03 34.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 10.0 110.694 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 228' ' ' LEU . 95.9 mt -96.65 151.03 37.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.327 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.18 -179.89 5.62 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.593 2.195 . . . . 10.0 111.123 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.505 ' OE1' ' HB2' ' A' ' 73' ' ' LYS . 2.8 mm-40 -80.55 103.45 10.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.405 -0.361 . . . . 10.0 110.739 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -80.83 -152.62 8.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.017 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -150.98 157.86 43.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.867 0.333 . . . . 10.0 111.061 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -98.54 166.29 11.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.954 -0.566 . . . . 10.0 109.837 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -106.32 152.39 23.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -98.48 121.53 56.36 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.826 0.346 . . . . 10.0 110.944 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.82 -16.62 56.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 123.169 2.579 . . . . 10.0 112.079 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.577 ' HA ' ' HE2' ' A' ' 165' ' ' TYR . 85.5 mmm -81.15 -10.13 59.69 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.964 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 105.5 -66.34 0.27 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.029 -0.605 . . . . 10.0 112.043 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 17.0 m -104.69 165.2 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.573 0.225 . . . . 10.0 110.939 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 103.05 118.23 4.44 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.923 -0.656 . . . . 10.0 112.147 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 14.9 m -64.25 133.86 53.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.047 0.451 . . . . 10.0 111.605 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.02 -167.84 18.64 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.405 -0.678 . . . . 10.0 111.405 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -85.61 -8.66 58.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.929 0.395 . . . . 10.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 91.8 -1.87 75.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.759 -0.734 . . . . 10.0 112.311 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.63 129.31 39.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.833 -0.432 . . . . 10.0 109.833 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.64 ' HB2' ' HD3' ' A' ' 413' ' ' ARG . 63.5 mt -73.35 144.16 46.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.493 -0.322 . . . . 10.0 110.93 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.557 ' CE1' ' HG2' ' A' ' 408' ' ' GLU . 71.7 t80 -59.37 128.32 36.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.921 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 413' ' ' ARG . . . 128.71 150.27 7.15 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.867 -0.682 . . . . 10.0 111.758 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 8.3 t -92.38 145.1 24.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.883 0.373 . . . . 10.0 110.732 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -9.3 53.08 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.081 -0.509 . . . . 10.0 110.115 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 89.64 -11.73 69.27 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.86 -0.609 . . . . 10.0 112.955 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 122.53 165.11 12.35 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.199 -0.76 . . . . 10.0 111.199 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 29.2 t -58.49 -60.73 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.767 0.283 . . . . 10.0 111.22 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' MET . . . . . 0.51 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 25.6 ttp -51.89 -56.05 16.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 10.0 112.155 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -57.86 -49.9 75.12 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 113.005 0.743 . . . . 10.0 113.005 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.94 85.63 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.101 0.408 . . . . 10.0 112.101 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.09 -47.62 76.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.062 0.458 . . . . 10.0 110.136 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.415 HD23 ' CD2' ' A' ' 105' ' ' LEU . 50.4 mt -63.83 -41.42 97.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.085 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.51 ' O ' ' HG3' ' A' ' 266' ' ' GLU . 46.0 ttm105 -59.04 -50.08 75.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.689 -0.687 . . . . 10.0 111.362 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 60.9 m -55.38 -40.74 71.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.387 -0.369 . . . . 10.0 111.613 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.67 -41.76 65.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.924 0.392 . . . . 10.0 110.737 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -63.76 -47.64 80.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 10.0 112.055 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 272' ' ' PRO . 46.2 mt-10 -66.75 -7.77 23.47 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.929 0.715 . . . . 10.0 112.929 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 80.7 mt -108.58 -41.09 4.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.003 0.43 . . . . 10.0 110.47 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -71.27 -40.28 71.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 21.1 p -102.65 -18.54 15.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.968 -0.56 . . . . 10.0 111.874 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 83.01 -35.61 2.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.792 -0.718 . . . . 10.0 111.487 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.34 145.45 82.78 Favored Pre-proline 0 N--CA 1.449 -0.476 0 N-CA-C 110.327 -0.249 . . . . 10.0 110.327 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.511 ' HA ' ' HG2' ' A' ' 266' ' ' GLU . 62.5 Cg_endo -73.56 155.87 49.85 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.443 2.096 . . . . 10.0 112.354 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.511 HD12 ' HD2' ' A' ' 274' ' ' PRO . 28.1 tp -115.41 125.31 28.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.945 -0.57 . . . . 10.0 110.32 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.511 ' HD2' HD12 ' A' ' 273' ' ' LEU . 80.7 Cg_endo -77.46 -157.9 0.08 OUTLIER 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.701 2.267 . . . . 10.0 111.591 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -78.53 134.27 37.29 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.662 -0.496 . . . . 10.0 109.662 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 75.6 mt -78.99 131.62 36.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.057 0.456 . . . . 10.0 111.785 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 1.2 m -103.51 101.43 11.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.78 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.464 HD13 ' HB ' ' A' ' 290' ' ' THR . 3.8 mm? -72.29 132.54 44.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.672 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 26.1 m -106.65 142.07 36.89 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.726 -0.67 . . . . 10.0 109.85 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -73.37 141.08 47.03 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.806 0.336 . . . . 10.0 111.13 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 66.8 t -98.88 108.11 21.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.042 -0.526 . . . . 10.0 109.618 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 77.3 mtm-85 -63.94 133.13 52.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.841 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 114.46 -31.12 6.57 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.776 -0.93 . . . . 10.0 110.776 -179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 59.5 mtm -132.67 89.02 2.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.456 -0.572 . . . . 10.0 109.456 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.77 103.58 0.27 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.606 -0.725 . . . . 10.0 112.034 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . 0.559 ' HA3' ' ND2' ' A' ' 354' ' ' ASN . . . 132.59 -19.08 4.54 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.887 -0.673 . . . . 10.0 111.527 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 42.5 mm -92.94 131.79 39.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -123.8 160.69 26.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.384 -0.598 . . . . 10.0 109.384 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.83 165.6 30.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.022 0.439 . . . . 10.0 111.397 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.464 ' HB ' HD13 ' A' ' 278' ' ' LEU . 14.5 t -157.29 145.54 19.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.123 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -113.79 124.13 51.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.686 0.279 . . . . 10.0 110.861 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 31.2 mt -112.84 105.15 18.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.231 -0.44 . . . . 10.0 110.593 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 3.9 p -72.4 100.69 2.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.286 -0.416 . . . . 10.0 110.121 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 78.6 mtp -90.54 104.15 16.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.184 0.516 . . . . 10.0 111.952 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 25.6 t -102.1 111.77 64.66 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.592 -0.892 . . . . 10.0 108.592 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.64 142.14 32.44 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.287 2.658 . . . . 10.0 113.641 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . . . -71.16 134.71 85.06 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.608 -0.724 . . . . 10.0 110.256 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 297' ' ' ALA . 36.8 Cg_exo -62.25 120.58 8.21 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.474 2.116 . . . . 10.0 111.913 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 94.48 20.14 30.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.012 -0.613 . . . . 10.0 113.084 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 90.3 p -110.61 163.8 13.36 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.91 -0.404 . . . . 10.0 109.91 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.638 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 28.1 pttt -71.05 -27.41 63.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.028 -0.73 . . . . 10.0 109.028 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -64.27 -41.53 96.87 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.492 -0.776 . . . . 10.0 109.875 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -64.3 -40.62 96.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.596 -0.729 . . . . 10.0 109.665 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -70.4 -25.8 63.4 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.506 -0.77 . . . . 10.0 112.27 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 67.5 mt -57.5 -57.33 13.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.707 0.289 . . . . 10.0 111.325 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 90.1 mt -73.48 -10.64 59.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 10.0 111.341 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -89.21 -36.61 15.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.485 . . . . 10.0 110.488 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.1 -30.64 25.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.108 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 ptp180 -142.02 117.84 10.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.095 0.474 . . . . 10.0 111.163 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -109.09 1.08 20.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.214 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.964 -1.017 . . . . 10.0 109.262 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.824 -0.51 . . . . 10.0 111.824 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -63.84 -27.58 67.45 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.753 2.302 . . . . 10.0 112.014 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 89.8 mt -115.53 93.51 4.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.287 0.565 . . . . 10.0 110.239 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -79.76 111.82 16.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.509 -0.769 . . . . 10.0 110.548 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -65.1 136.84 57.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.116 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -83.83 -7.2 59.5 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.206 -0.452 . . . . 10.0 111.547 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 105.38 -7.21 42.98 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.8 -0.714 . . . . 10.0 111.728 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 91.61 156.78 33.06 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.659 -0.782 . . . . 10.0 111.51 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.416 ' O ' HG22 ' A' ' 343' ' ' THR . . . -91.31 86.94 6.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.115 0.484 . . . . 10.0 110.077 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -88.4 157.39 27.83 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.707 -0.759 . . . . 10.0 112.664 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -135.67 152.26 51.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.141 -0.318 . . . . 10.0 110.141 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 55.9 m -155.41 126.14 6.95 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.601 0.238 . . . . 10.0 110.502 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.35 165.89 14.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.371 -0.377 . . . . 10.0 110.449 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -63.9 -14.73 55.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.62 0.6 . . . . 10.0 112.62 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -80.9 -11.57 59.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.424 -0.353 . . . . 10.0 111.898 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 105.23 -0.71 40.62 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.476 -0.869 . . . . 10.0 113.986 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 334' ' ' THR . 23.3 mtm180 -77.78 122.92 26.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.476 0.638 . . . . 10.0 110.905 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -118.04 139.33 14.62 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.845 -0.693 . . . . 10.0 112.24 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -152.98 -176.78 25.88 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.729 -0.948 . . . . 10.0 110.729 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.59 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 15.1 tt -144.32 139.67 24.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 117.096 0.448 . . . . 10.0 110.724 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 331' ' ' ALA . 11.7 t -99.73 120.99 40.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.211 0.529 . . . . 10.0 110.179 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 14.6 tp -79.28 122.78 26.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.577 -0.738 . . . . 10.0 110.893 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -93.01 102.39 14.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.977 -0.556 . . . . 10.0 109.914 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 31.7 t -103.0 137.1 32.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.191 -0.459 . . . . 10.0 110.439 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . . . . . . . . . . . -128.89 149.14 50.9 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.378 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.5 124.3 68.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.125 -0.488 . . . . 10.0 109.953 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -108.78 119.46 39.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.2 -0.454 . . . . 10.0 110.103 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.5 106.65 16.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.126 0.488 . . . . 10.0 111.333 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 109.7 133.46 6.65 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.014 -0.613 . . . . 10.0 112.14 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.82 -36.92 80.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.096 0.474 . . . . 10.0 110.875 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' B' ' 60' ' ' SER . . . -68.12 -28.14 73.46 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 111.219 -0.752 . . . . 10.0 111.219 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.612 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 1.3 m-20 -80.91 -37.11 30.22 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -61.14 -40.67 94.72 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.652 -0.704 . . . . 10.0 109.9 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -57.45 -46.52 83.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.17 -0.468 . . . . 10.0 110.119 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.612 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 10.5 mtmm -64.01 -47.24 81.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.768 -0.651 . . . . 10.0 110.687 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 56.8 tp -61.74 -50.31 72.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.778 -0.647 . . . . 10.0 111.797 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 90.9 mt -55.76 -42.28 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.588 -0.278 . . . . 10.0 111.37 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 12.0 m -61.37 -43.22 99.23 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.982 0.42 . . . . 10.0 110.54 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 10.3 mttm -70.57 -29.19 65.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.349 -0.387 . . . . 10.0 111.198 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 75.4 mtp -69.91 -40.85 75.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.321 -0.4 . . . . 10.0 110.075 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -66.7 -26.98 67.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 10.0 111.045 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -82.19 -9.55 59.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.764 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 87.09 9.22 74.0 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.054 -0.593 . . . . 10.0 112.801 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.66 -50.9 14.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.846 0.355 . . . . 10.0 110.645 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -98.46 100.79 12.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.777 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -97.69 109.53 22.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.155 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 82.1 m-85 -136.99 159.79 40.83 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.999 -0.371 . . . . 10.0 109.999 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -103.43 -34.59 8.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.038 0.447 . . . . 10.0 111.547 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.51 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 45.0 t80 -132.16 129.11 39.39 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.397 -0.594 . . . . 10.0 109.397 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.611 ' HB ' ' HD1' ' A' ' 126' ' ' PHE . 43.6 t -129.67 119.03 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.813 0.671 . . . . 10.0 112.813 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 257' ' ' MET . 5.2 tp10 -91.59 113.86 26.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.77 -1.196 . . . . 10.0 107.77 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 58.2 mt -109.27 118.16 56.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.257 0.551 . . . . 10.0 112.325 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' MET . . . . . 0.781 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 62.0 mtt -111.82 142.22 44.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.59 -0.732 . . . . 10.0 109.623 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . . . . . . . . . . . -81.05 -28.03 35.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.196 0.522 . . . . 10.0 110.925 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.57 158.58 36.51 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.472 -0.786 . . . . 10.0 110.156 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.438 ' HG3' ' SG ' ' B' ' 42' ' ' CYS . 42.5 Cg_endo -91.21 12.84 2.22 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.357 2.704 . . . . 10.0 112.596 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.4 ' HB3' ' HA3' ' A' ' 383' ' ' GLY . . . -156.56 41.21 0.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.305 -0.407 . . . . 10.0 111.115 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 65.85 -127.48 30.77 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.461 -0.876 . . . . 10.0 112.359 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' CYS . . . . . 0.509 ' HA ' ' S2 ' ' A' ' 501' ' ' SF4 . 3.4 m -95.33 -25.84 16.15 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.15 0.426 . . . . 10.0 112.15 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 33.2 m -70.0 -17.5 21.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 111.952 0.352 . . . . 10.0 111.952 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 379' ' ' ALA . . . -109.33 34.92 5.22 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 116.035 -0.53 . . . . 10.0 112.377 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -80.63 162.99 45.79 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.762 -0.732 . . . . 10.0 112.206 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -72.69 -12.95 78.29 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 121.034 -0.603 . . . . 10.0 113.18 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -91.76 2.48 76.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.626 -0.797 . . . . 10.0 111.788 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -92.09 153.46 43.24 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' A' ' 58' ' ' ALA . 31.3 Cg_exo -64.09 172.15 6.6 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.618 2.212 . . . . 10.0 111.239 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.88 109.65 8.1 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.925 0.343 . . . . 10.0 111.925 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 28.3 m -87.6 -177.27 5.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.065 -0.516 . . . . 10.0 110.097 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . 0.443 ' HA ' ' OH ' ' B' ' 35' ' ' TYR . 0.0 OUTLIER -86.19 44.27 1.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.341 0.591 . . . . 10.0 111.172 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -144.28 120.88 11.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.871 -0.604 . . . . 10.0 109.893 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . 0.493 ' HB3' ' O ' ' B' ' 36' ' ' SER . 21.1 mttm -71.68 -13.81 61.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.325 -0.398 . . . . 10.0 111.93 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -115.77 27.39 9.33 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.984 0.421 . . . . 10.0 111.06 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.579 HD12 ' HD2' ' A' ' 398' ' ' LYS . 9.5 tp -68.76 -21.91 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.332 0.587 . . . . 10.0 110.353 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -42.53 99.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.475 -0.784 . . . . 10.0 111.111 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -62.79 -39.59 94.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.704 -0.68 . . . . 10.0 111.113 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.579 ' HD2' HD12 ' A' ' 395' ' ' ILE . 52.7 mttp -64.14 -39.0 93.09 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.917 -0.583 . . . . 10.0 111.075 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 61' ' ' GLU . 98.8 mtt180 -68.1 -39.35 82.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.27 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -63.19 -41.91 99.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.692 -0.686 . . . . 10.0 110.867 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -71.45 -27.78 63.51 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.413 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -96.88 14.9 23.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.418 -0.355 . . . . 10.0 111.828 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 5.6 mt -64.56 -40.17 95.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.989 0.423 . . . . 10.0 110.738 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -133.78 158.64 42.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.787 -0.642 . . . . 10.0 109.439 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -79.0 165.49 23.39 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.038 -0.356 . . . . 10.0 110.038 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . 0.491 HD13 ' HD2' ' A' ' 409' ' ' LYS . 3.9 mm? -61.02 -34.08 74.29 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.889 0.7 . . . . 10.0 112.889 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -74.09 -28.11 61.21 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.956 0.408 . . . . 10.0 111.256 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . 0.557 ' HG2' ' CE1' ' A' ' 250' ' ' PHE . 36.2 mt-10 -77.44 -32.62 54.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.998 -0.546 . . . . 10.0 109.709 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . 0.491 ' HD2' HD13 ' A' ' 406' ' ' LEU . 90.4 mttt -66.29 -35.22 79.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.594 -0.73 . . . . 10.0 111.79 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.3 6.83 21.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.029 0.443 . . . . 10.0 111.767 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 23.6 m -118.87 93.94 4.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.98 0.419 . . . . 10.0 110.683 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 30.1 tp -77.66 111.77 13.79 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.547 -0.538 . . . . 10.0 109.547 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . 0.64 ' HD3' ' HB2' ' A' ' 249' ' ' LEU . 5.2 tmm_? -107.76 148.41 29.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.125 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -116.63 137.0 52.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.508 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 4.6 m -69.05 -30.88 69.33 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.041 0.386 . . . . 10.0 112.041 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -69.28 -1.74 8.86 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -118.28 14.25 13.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 10.0 110.932 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . 0.402 ' HA ' HD11 ' A' ' 249' ' ' LEU . 55.3 t-20 -88.5 113.95 57.65 Favored Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.555 ' HD3' HD11 ' A' ' 249' ' ' LEU . 51.1 Cg_exo -54.97 -39.94 88.22 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.18 2.586 . . . . 10.0 112.53 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.6 m -61.28 -42.91 99.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.112 0.482 . . . . 10.0 110.564 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 49.7 mm -72.16 -40.51 66.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.881 -0.599 . . . . 10.0 110.171 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.5 -44.82 95.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 10.0 111.475 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -60.79 -45.19 95.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.915 0.388 . . . . 10.0 110.618 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.447 ' HB2' ' SD ' ' A' ' 240' ' ' MET . 45.2 tp -64.63 -41.19 96.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.882 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . 0.657 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 1.2 m-85 -68.13 -33.64 74.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.024 -0.534 . . . . 10.0 110.967 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.66 -61.18 2.09 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.566 0.95 . . . . 10.0 113.566 -178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.52 16.99 5.76 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.842 1.423 . . . . 10.0 114.842 -176.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -150.73 -63.17 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.243 0.831 . . . . 10.0 113.243 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.657 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 96.2 mt -67.37 -36.5 81.5 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.853 0.686 . . . . 10.0 112.853 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 97.47 -68.12 0.79 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.892 -0.67 . . . . 10.0 111.853 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -161.31 157.47 21.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.767 -0.457 . . . . 10.0 109.767 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.412 ' HA ' ' HE1' ' A' ' 425' ' ' TYR . 52.1 Cg_exo -58.28 132.36 48.43 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.582 2.188 . . . . 10.0 110.915 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.573 HD13 ' HB2' ' A' ' 103' ' ' SER . 4.6 mp 66.63 9.63 6.78 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.986 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 438' ' ' HIS . . . -70.21 -170.68 8.79 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.32 -0.467 . . . . 10.0 112.865 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -55.28 -62.33 1.74 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.381 0.511 . . . . 10.0 112.381 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.43 ' HD2' ' HA ' ' A' ' 436' ' ' LYS . 31.3 tptt -60.43 -38.34 83.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.906 0.384 . . . . 10.0 111.83 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -66.69 -46.09 76.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.084 0.469 . . . . 10.0 111.006 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 434' ' ' GLY . 0.1 OUTLIER -70.14 -20.4 63.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.944 0.402 . . . . 10.0 110.976 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -76.07 -65.34 0.93 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.594 -0.73 . . . . 10.0 112.954 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 81.5 mt -92.81 -24.7 18.43 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 114.488 1.292 . . . . 10.0 114.488 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 68.3 mt -93.0 -6.14 49.04 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 -178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 438' ' ' HIS . 26.0 m-70 -121.71 165.06 16.36 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.27 -0.269 . . . . 10.0 110.949 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 7.5 t -152.15 -168.95 3.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.641 0.258 . . . . 10.0 111.596 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -139.72 161.48 37.43 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.237 -0.438 . . . . 10.0 110.375 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' TYR . . . . . 0.567 ' HD2' HG23 ' A' ' 145' ' ' ILE . 37.9 m-85 -110.58 168.88 9.13 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.695 -0.229 . . . . 10.0 111.029 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 90.7 t -124.08 113.3 36.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.431 -0.35 . . . . 10.0 111.013 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -66.18 105.86 1.5 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.482 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 131.51 -20.41 4.66 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.28 -0.728 . . . . 10.0 111.28 -179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . 108.12 167.56 21.38 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.844 -0.693 . . . . 10.0 112.069 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.628 -0.701 . . . . 10.0 110.65 -179.958 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.693 ' HE1' ' HB2' ' B' ' 18' ' ' ALA . 86.0 m-85 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.016 -0.364 . . . . 10.0 110.016 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -88.65 116.03 26.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.86 -0.422 . . . . 10.0 109.86 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.48 124.93 69.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.218 0.532 . . . . 10.0 111.435 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' B' ' 13' ' ' THR . 26.8 m -91.18 113.03 25.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.931 -0.577 . . . . 10.0 110.283 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' B' ' 11' ' ' ASP . 64.5 mt -90.14 132.56 35.38 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.184 -0.462 . . . . 10.0 109.986 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.757 ' HD2' ' HB3' ' B' ' 11' ' ' ASP . 3.6 tptp -100.54 108.33 20.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.438 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 11.0 p -115.18 164.81 15.77 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.374 -0.602 . . . . 10.0 109.374 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.02 -29.21 87.42 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.346 2.031 . . . . 10.0 111.752 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -76.5 -34.81 58.61 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.387 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.89 171.72 25.07 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.364 -0.695 . . . . 10.0 111.364 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.757 ' HB3' ' HD2' ' B' ' 6' ' ' LYS . 4.0 p30 -94.36 152.49 18.6 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.94 0.37 . . . . 10.0 111.032 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -147.14 124.13 11.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.669 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 19.2 m -88.23 99.91 12.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.093 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 21.0 pt -101.25 171.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -112.81 117.8 33.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.28 -0.418 . . . . 10.0 110.124 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . 0.489 ' HA ' ' HD3' ' B' ' 17' ' ' PRO . 31.6 m -127.08 128.91 24.07 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.188 -0.46 . . . . 10.0 110.91 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.75 ' HD2' ' HB ' ' B' ' 20' ' ' THR . 15.8 Cg_exo -71.8 165.76 31.57 Favored 'Trans proline' 0 CA--C 1.529 0.275 0 C-N-CA 123.059 2.506 . . . . 10.0 110.99 178.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.693 ' HB2' ' HE1' ' B' ' 1' ' ' TYR . . . -74.52 -16.55 60.83 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.478 0.547 . . . . 10.0 112.478 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -107.52 15.2 25.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.063 0.459 . . . . 10.0 111.301 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.75 ' HB ' ' HD2' ' B' ' 17' ' ' PRO . 5.0 m -129.78 141.92 50.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.486 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -66.53 138.95 57.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.343 -0.39 . . . . 10.0 110.617 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . . . . . . . . . 26.4 mt -56.07 -43.28 75.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 10.0 111.593 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.585 HD11 ' HG2' ' B' ' 38' ' ' ARG . 1.0 OUTLIER -67.06 -21.62 65.89 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.136 0.791 . . . . 10.0 113.136 -179.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -69.44 -27.23 65.07 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 121.208 0.528 . . . . 10.0 110.982 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.86 -25.61 22.07 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.373 -0.603 . . . . 10.0 109.373 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.32 -43.25 74.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.668 -0.696 . . . . 10.0 110.488 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.61 -33.07 75.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.331 0.586 . . . . 10.0 110.121 179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -71.98 -37.32 69.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.446 -0.797 . . . . 10.0 110.249 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.48 -34.77 60.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.958 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.61 40.55 1.32 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.695 -0.764 . . . . 10.0 112.075 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.18 144.3 33.07 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.645 0.259 . . . . 10.0 110.707 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.57 118.78 11.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.836 -0.62 . . . . 10.0 110.854 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.444 HD23 ' HD2' ' B' ' 34' ' ' PRO . 0.5 OUTLIER -163.96 127.41 1.76 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.335 179.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.444 ' HD2' HD23 ' B' ' 33' ' ' LEU . 7.0 Cg_exo -74.62 96.79 1.0 Allowed 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.781 2.321 . . . . 10.0 111.383 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.443 ' OH ' ' HA ' ' A' ' 391' ' ' THR . 43.5 p90 -118.23 156.15 29.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.357 -0.383 . . . . 10.0 110.897 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.493 ' O ' ' HB3' ' A' ' 393' ' ' LYS . 5.0 p -166.45 -88.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.096 -0.502 . . . . 10.0 110.638 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' CYS . . . . . . . . . . . . . 4.1 p -79.32 -56.65 4.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.006 -0.543 . . . . 10.0 111.924 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.585 ' HG2' HD11 ' B' ' 23' ' ' LEU . 0.0 OUTLIER 66.32 39.43 4.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.877 -0.602 . . . . 10.0 111.218 -179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -106.05 17.29 23.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.132 -0.486 . . . . 10.0 111.624 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.92 46.06 54.31 Favored Glycine 0 C--O 1.238 0.361 0 C-N-CA 120.776 -0.726 . . . . 10.0 112.277 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.96 -66.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.88 0.372 . . . . 10.0 111.31 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . 0.438 ' SG ' ' HG3' ' A' ' 378' ' ' PRO . 3.7 p -83.06 139.49 33.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.909 0.385 . . . . 10.0 111.429 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.626 ' HA ' HD11 ' B' ' 73' ' ' LEU . 0.7 OUTLIER -100.09 36.4 1.85 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.817 -0.628 . . . . 10.0 110.483 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.516 ' HA ' HH22 ' A' ' 187' ' ' ARG . 0.1 OUTLIER -73.1 -39.77 65.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.826 -0.624 . . . . 10.0 110.746 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.72 63.77 1.07 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.024 -0.535 . . . . 10.0 111.603 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -87.57 94.93 9.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.108 -0.496 . . . . 10.0 110.202 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' B' ' 87' ' ' THR . . . -75.61 148.3 36.74 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.862 -0.608 . . . . 10.0 112.992 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.691 ' HE2' ' HD1' ' B' ' 71' ' ' PHE . 0.0 OUTLIER -103.39 130.91 50.82 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.1 -0.333 . . . . 10.0 110.1 179.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.447 ' HB ' ' HA2' ' B' ' 70' ' ' GLY . 7.2 t -87.48 96.9 6.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.398 -0.365 . . . . 10.0 110.589 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.88 -38.03 64.54 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.166 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.67 158.2 35.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.692 -0.685 . . . . 10.0 109.388 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.451 ' HA3' ' HB3' ' B' ' 83' ' ' CYS . . . 88.69 -179.3 45.89 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.838 -0.696 . . . . 10.0 112.265 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.8 m -129.25 137.07 50.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.97 0.414 . . . . 10.0 111.288 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.762 HG12 ' HA ' ' B' ' 79' ' ' PRO . 4.2 m -132.67 155.76 41.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.945 -0.761 . . . . 10.0 108.945 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.546 ' HB3' ' CE2' ' B' ' 78' ' ' TYR . 17.8 t70 -119.38 145.69 45.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.787 0.327 . . . . 10.0 110.626 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.14 128.14 37.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.824 -0.626 . . . . 10.0 110.159 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.9 -31.9 25.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.145 0.498 . . . . 10.0 110.819 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -134.52 163.68 29.18 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.919 -0.771 . . . . 10.0 108.919 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.27 172.13 1.57 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.862 0.363 . . . . 10.0 110.626 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.503 ' HA ' ' HA2' ' A' ' 353' ' ' GLY . 0.7 OUTLIER -86.67 -135.64 0.08 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.972 -0.558 . . . . 10.0 109.546 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -73.04 -8.93 57.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.055 0.455 . . . . 10.0 110.792 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.401 HD23 ' HB3' ' B' ' 71' ' ' PHE . 5.1 mp -82.14 76.66 9.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.875 -0.787 . . . . 10.0 108.875 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.01 -169.53 0.94 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.262 -0.427 . . . . 10.0 111.91 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -27.28 64.1 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.903 -0.59 . . . . 10.0 111.718 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.84 -34.98 75.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.176 0.512 . . . . 10.0 110.279 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.578 ' HB3' ' HB2' ' B' ' 71' ' ' PHE . 15.5 mm-40 -87.02 -24.8 24.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.993 -0.549 . . . . 10.0 110.376 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -60.46 -43.61 96.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 10.0 109.802 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.08 -23.58 67.95 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.65 -0.705 . . . . 10.0 112.355 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -85.9 -18.3 33.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.104 0.478 . . . . 10.0 109.899 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.447 ' HA2' ' HB ' ' B' ' 49' ' ' VAL . . . 106.95 32.11 3.65 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.831 -0.699 . . . . 10.0 112.968 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.691 ' HD1' ' HE2' ' B' ' 48' ' ' LYS . 14.7 m-85 -121.35 109.49 14.96 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 122.498 -0.413 . . . . 10.0 110.484 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 26.0 m -134.02 175.34 11.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 10.0 111.283 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.626 HD11 ' HA ' ' B' ' 43' ' ' SER . 21.4 tp -115.19 109.32 17.81 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.408 -0.59 . . . . 10.0 109.408 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . 0.415 ' HB ' HD23 ' B' ' 23' ' ' LEU . 0.2 OUTLIER -58.6 -16.88 17.85 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.829 0.677 . . . . 10.0 112.829 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' CYS . . . . . . . . . . . . . 3.7 m -67.29 -22.71 65.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.549 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.73 32.25 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.963 0.411 . . . . 10.0 110.703 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.39 134.0 55.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.15 -0.477 . . . . 10.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' B' ' 55' ' ' ASP . 0.8 OUTLIER -126.21 140.59 37.44 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.79 -0.641 . . . . 10.0 109.993 179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 0.762 ' HA ' HG12 ' B' ' 54' ' ' VAL . 7.1 Cg_exo -73.17 107.98 2.5 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.899 2.4 . . . . 10.0 112.496 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.34 -25.81 62.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.265 -0.643 . . . . 10.0 109.265 178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 73.5 m -159.69 -175.15 4.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.166 -0.924 . . . . 10.0 108.845 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.52 135.01 51.06 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.352 0.408 . . . . 10.0 110.129 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . 0.451 ' HB3' ' HA3' ' B' ' 52' ' ' GLY . 1.0 OUTLIER -156.82 171.21 20.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.286 0.565 . . . . 10.0 112.522 -179.046 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . . . . . . . . . 3.9 m -129.27 114.3 16.08 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.603 -1.258 . . . . 10.0 107.603 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 25.5 mm -114.1 131.33 66.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.05 0.759 . . . . 10.0 113.05 -177.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -97.96 85.69 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . 0.419 ' HA ' ' HA2' ' B' ' 47' ' ' GLY . 0.8 OUTLIER -78.62 36.77 0.27 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.604 0.964 . . . . 10.0 113.604 -177.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -144.95 24.73 1.47 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.316 0.487 . . . . 10.0 112.316 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.626 ' HB3' ' HD2' ' B' ' 48' ' ' LYS . 1.6 mm-40 -119.44 90.23 3.29 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.945 0.402 . . . . 10.0 110.3 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -92.39 -8.02 46.07 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.84 -0.618 . . . . 10.0 112.056 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -87.86 -37.48 16.48 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 10.0 111.009 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.58 ' HB3' ' HD3' ' B' ' 48' ' ' LYS . . . -74.25 87.94 1.99 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.042 -0.526 . . . . 10.0 111.012 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pp 178.27 -23.44 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.471 -0.786 . . . . 10.0 110.87 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 33.2 t80 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.37 -0.824 . . . . 10.0 110.576 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' SF4 . . . . . 0.509 ' S2 ' ' HA ' ' A' ' 381' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.263 -0.273 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.9 p -74.93 165.96 24.42 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.923 -0.399 . . . . 10.0 109.923 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.416 ' CD2' ' HG2' ' A' ' 189' ' ' GLN . 96.7 m-70 -64.23 -31.02 72.06 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.761 0.282 . . . . 10.0 111.761 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.73 -45.15 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.503 -0.555 . . . . 10.0 109.503 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -63.6 -31.32 72.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.386 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.542 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 36.8 mt-30 -62.83 -23.46 67.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.739 -0.664 . . . . 10.0 110.264 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -95.1 -38.66 10.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.888 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.2 mt -61.19 -35.08 76.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.098 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.6 -36.45 74.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 10.0 111.085 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -79.77 -34.83 39.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.118 -0.492 . . . . 10.0 110.382 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.15 -25.4 62.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.887 -0.597 . . . . 10.0 111.239 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.55 -7.5 56.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.011 0.434 . . . . 10.0 110.626 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 44' ' ' ARG . 91.9 mttt -93.8 121.7 63.87 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.908 -0.587 . . . . 10.0 109.906 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -58.1 148.89 75.13 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.56 2.173 . . . . 10.0 110.415 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.834 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 61.9 mttt -63.89 -10.41 20.69 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.978 0.732 . . . . 10.0 112.978 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -98.52 -5.32 32.45 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.734 0.302 . . . . 10.0 111.288 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -72.2 135.84 82.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 10.0 110.314 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.91 -17.34 59.31 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.714 2.276 . . . . 10.0 113.171 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.75 14.16 30.15 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.973 0.416 . . . . 10.0 110.781 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.834 ' HG2' ' HA ' ' A' ' 39' ' ' LYS . 6.8 tpt180 -87.64 115.51 25.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.09 -0.504 . . . . 10.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.74 ' HD3' ' HA ' ' A' ' 176' ' ' ASP . 14.0 mttp -93.7 169.11 10.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.816 -0.629 . . . . 10.0 109.882 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.51 111.75 18.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.84 -0.8 . . . . 10.0 108.84 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 t -95.33 102.16 13.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.082 0.468 . . . . 10.0 111.646 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.3 m -99.1 140.54 33.11 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.245 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 13.1 p -132.38 135.84 57.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.085 0.469 . . . . 10.0 112.115 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 14.5 pt20 -116.35 127.07 54.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.967 -0.561 . . . . 10.0 109.581 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.426 HG11 HD21 ' A' ' 75' ' ' LEU . 2.0 t -104.03 150.04 7.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.123 -178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.02 139.08 20.48 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.143 -0.481 . . . . 10.0 109.962 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -52.7 -35.03 66.89 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.184 2.59 . . . . 10.0 112.563 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.68 -32.86 74.02 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.102 0.477 . . . . 10.0 110.768 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.939 HG13 HG23 ' A' ' 214' ' ' THR . 88.0 t -80.53 -40.15 19.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.776 -0.647 . . . . 10.0 109.374 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -56.6 -33.08 65.89 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.536 -0.757 . . . . 10.0 112.316 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.38 -37.52 12.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 113.292 0.849 . . . . 10.0 113.292 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.56 -5.56 53.85 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.528 0.936 . . . . 10.0 113.528 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.9 tp -62.34 -26.39 40.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.823 0.344 . . . . 10.0 111.687 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.83 -24.85 65.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.337 -0.392 . . . . 10.0 111.591 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -66.24 -26.14 67.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.279 -0.419 . . . . 10.0 112.049 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.0 p -68.18 -23.59 64.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.066 0.46 . . . . 10.0 110.54 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.6 mt -94.02 -0.78 55.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.164 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.99 18.52 55.85 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.947 -0.644 . . . . 10.0 112.385 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.8 mt -106.34 164.62 11.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.662 0.267 . . . . 10.0 110.764 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.61 153.9 85.5 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.527 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.43 133.65 59.37 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.567 2.178 . . . . 10.0 111.691 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.49 14.17 62.14 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.667 -0.777 . . . . 10.0 113.082 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.57 -27.04 31.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.953 0.406 . . . . 10.0 111.245 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 p -103.25 129.26 50.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.194 -0.457 . . . . 10.0 109.976 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.3 p -77.76 154.74 80.92 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 110.323 -0.251 . . . . 10.0 110.323 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -53.84 -41.12 77.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.713 2.276 . . . . 10.0 111.935 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.457 ' HD3' ' HB3' ' A' ' 233' ' ' GLU . 46.8 mttm -66.15 -36.59 83.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.013 -0.539 . . . . 10.0 111.967 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -61.71 -41.67 97.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.013 0.435 . . . . 10.0 110.654 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.426 HD21 HG11 ' A' ' 51' ' ' VAL . 48.8 tp -64.73 -44.53 89.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.432 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.34 95.24 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.913 -0.585 . . . . 10.0 110.73 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' HB2' ' HA3' ' A' ' 234' ' ' GLY . 23.9 tp10 -60.32 -46.9 88.26 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.881 -0.599 . . . . 10.0 110.29 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.04 -43.81 96.79 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.85 -0.613 . . . . 10.0 112.442 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.441 ' O ' ' HD2' ' A' ' 84' ' ' PHE . 30.6 mt -60.02 -43.93 94.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 10.0 111.124 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 54.3 ttm-85 -64.18 -32.51 74.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.943 0.401 . . . . 10.0 110.619 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -74.68 -12.62 60.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.386 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.7 mt -77.62 -19.61 55.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.995 0.426 . . . . 10.0 109.937 178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 121.59 7.58 8.07 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.649 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.441 ' HD2' ' O ' ' A' ' 79' ' ' LEU . 47.3 m-85 -72.81 156.63 38.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.729 0.299 . . . . 10.0 111.069 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -98.03 -58.71 1.92 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.993 0.425 . . . . 10.0 111.357 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . 2.9 mp0 -117.61 128.15 54.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.131 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.4 t -113.52 114.26 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.156 -0.475 . . . . 10.0 110.267 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 86' ' ' GLU . 24.5 m-85 -118.1 170.55 8.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.245 -0.434 . . . . 10.0 110.476 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -118.11 149.04 41.69 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.4 m -64.78 -20.57 66.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.451 -0.341 . . . . 10.0 111.74 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 91' ' ' LEU . 24.7 mt -57.91 -34.57 69.97 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.92 0.341 . . . . 10.0 111.92 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.424 ' HD2' HD13 ' A' ' 158' ' ' LEU . 42.9 t80 -66.99 -37.63 84.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.151 0.5 . . . . 10.0 109.96 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -73.02 -34.47 58.62 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.994 -0.842 . . . . 10.0 110.994 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.89 -36.38 83.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.605 -0.298 . . . . 10.0 110.509 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.13 -33.93 69.69 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.07 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.434 HD21 HD23 ' A' ' 424' ' ' LEU . 78.9 mt -76.09 -42.79 46.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.988 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.8 m -59.67 -44.33 93.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.667 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 47.5 mt -58.68 -42.14 84.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.905 -0.589 . . . . 10.0 110.753 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 87.6 mmm -66.95 -48.45 68.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.229 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -66.87 -53.92 27.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.444 ' HG2' ' SG ' ' A' ' 151' ' ' CYS . 18.9 mt-10 -60.42 -40.95 92.86 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.847 0.356 . . . . 10.0 110.932 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -63.26 -41.16 99.64 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.095 -0.574 . . . . 10.0 111.865 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 46.8 m -67.94 -39.89 83.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.531 0.205 . . . . 10.0 110.853 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.526 ' HA ' ' HD2' ' A' ' 107' ' ' HIS . 19.6 tt0 -64.57 -41.3 96.37 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.358 -0.608 . . . . 10.0 109.358 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.8 tp -62.05 -51.15 69.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.117 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 54.1 tp -57.3 -46.78 82.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.098 -0.501 . . . . 10.0 110.639 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.73 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -64.77 -40.13 94.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.342 -0.39 . . . . 10.0 111.431 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.3 mtt180 -58.13 -40.73 82.05 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.035 0.445 . . . . 10.0 110.25 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.491 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 45.4 tp -70.03 -42.25 73.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.85 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.6 m -58.4 -47.48 83.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.707 -0.679 . . . . 10.0 111.835 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 30.2 mm-40 -57.44 -35.88 70.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.129 0.49 . . . . 10.0 110.468 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.425 ' HE1' ' HA ' ' A' ' 122' ' ' PRO . 44.8 m80 -75.9 -29.44 58.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.815 -0.63 . . . . 10.0 111.771 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 95.7 mt -76.36 -34.0 58.93 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.173 0.511 . . . . 10.0 110.343 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -79.81 -43.41 22.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 10.0 110.381 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.093 0 O-C-N 123.831 0.707 . . . . 10.0 111.728 179.87 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.795 0.331 . . . . 10.0 110.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.425 ' HA ' ' HE1' ' A' ' 112' ' ' HIS . 67.8 Cg_endo -85.27 -165.12 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.798 2.332 . . . . 10.0 112.615 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.401 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 94.1 mt -129.07 157.72 75.03 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 123' ' ' LEU . 18.3 Cg_exo -66.37 167.23 55.02 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 124.296 -1.127 . . . . 10.0 113.129 0.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 147' ' ' TYR . 25.7 ttt -113.57 133.35 55.32 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.497 -0.774 . . . . 10.0 111.007 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -113.79 144.45 42.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.963 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.459 HG23 ' HZ ' ' A' ' 371' ' ' PHE . 0.0 OUTLIER -74.11 150.32 40.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.67 0.272 . . . . 10.0 110.322 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.0 p -116.47 20.4 14.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 6.82 28.14 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.776 0.658 . . . . 10.0 112.776 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.452 ' O ' HG12 ' A' ' 134' ' ' ILE . 54.1 t -120.15 117.78 31.81 Favored Pre-proline 0 C--O 1.234 0.274 0 CA-C-O 120.658 0.266 . . . . 10.0 111.567 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.23 -33.79 70.27 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 123.364 2.71 . . . . 10.0 112.048 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.02 -41.63 97.16 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.946 -0.645 . . . . 10.0 111.571 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -65.8 -44.04 86.88 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.078 -0.342 . . . . 10.0 110.078 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 130' ' ' CYS . 35.2 mm -57.99 -42.38 82.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.966 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.45 76.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.078 -0.51 . . . . 10.0 111.168 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.401 ' SD ' ' HB2' ' B' ' 61' ' ' PHE . 12.2 tpt -67.2 -34.19 76.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.007 0.432 . . . . 10.0 110.823 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.41 HD22 HG21 ' A' ' 148' ' ' VAL . 22.0 tp -60.44 -60.7 3.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.689 -0.687 . . . . 10.0 110.57 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -63.73 -20.62 65.88 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.682 -0.235 . . . . 10.0 111.599 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -81.06 -61.97 1.8 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.607 0.965 . . . . 10.0 113.607 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 m -115.27 1.0 13.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 114.714 1.376 . . . . 10.0 114.714 -176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 144' ' ' LEU . 53.5 m-85 -134.14 60.65 45.86 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 122.05 -0.406 . . . . 10.0 111.102 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.96 -25.43 32.36 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.364 2.043 . . . . 10.0 113.1 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -87.07 1.05 54.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.987 0.422 . . . . 10.0 111.289 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 141' ' ' TYR . 59.8 mt -105.99 4.27 29.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.299 -0.41 . . . . 10.0 111.462 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.582 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 75.6 mt -57.94 -53.72 62.88 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 113.032 0.753 . . . . 10.0 113.032 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.582 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 49.3 Cg_exo -58.4 -18.94 41.05 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.479 2.119 . . . . 10.0 113.076 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.511 ' O ' ' HA ' ' A' ' 125' ' ' MET . 96.5 m-85 -78.76 -20.03 50.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.214 0.531 . . . . 10.0 110.459 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.41 HG21 HD22 ' A' ' 137' ' ' LEU . 16.7 t -90.49 154.3 3.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.91 -0.587 . . . . 10.0 109.589 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.0 t -68.18 158.31 33.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.069 0.461 . . . . 10.0 111.125 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 88.3 p -100.54 6.41 44.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.237 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 101' ' ' GLU . 4.5 m -80.83 143.9 32.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.228 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -85.66 165.12 17.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.099 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 58.2 p -67.19 155.11 91.37 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.368 -0.378 . . . . 10.0 110.761 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -45.15 -54.68 4.08 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.604 2.87 . . . . 10.0 114.214 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.438 HE21 ' HB2' ' A' ' 155' ' ' GLN . 0.0 OUTLIER -65.14 -34.31 78.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.709 0.633 . . . . 10.0 112.709 -179.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 78.9 mmm -72.81 -23.81 60.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.064 0.459 . . . . 10.0 110.481 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 36.6 mtt -75.8 -48.88 19.83 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.328 -0.619 . . . . 10.0 109.328 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.424 HD13 ' HD2' ' A' ' 92' ' ' PHE . 49.2 tp -62.82 -40.22 96.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.372 -0.831 . . . . 10.0 111.038 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -58.92 -39.47 81.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.471 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.88 -31.87 57.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.325 -0.398 . . . . 10.0 110.534 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -70.26 -43.26 70.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.691 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.8 m -68.89 -27.48 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.091 0.404 . . . . 10.0 112.091 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.519 ' HE3' ' HB2' ' A' ' 179' ' ' MET . 44.4 mttt -88.94 7.7 33.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.016 0.376 . . . . 10.0 112.016 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.6 p -129.41 -74.67 0.55 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.814 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -62.97 -50.83 69.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.218 -0.446 . . . . 10.0 111.56 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 162' ' ' VAL . 54.8 tp -64.04 -40.8 97.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 10.0 110.787 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.77 -52.04 67.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.919 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -64.04 -43.72 94.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 10.0 111.389 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -62.45 -38.06 88.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 10.0 111.991 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -89.32 -7.48 55.26 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.117 0.414 . . . . 10.0 112.117 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 69.06 40.87 83.1 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.104 -0.569 . . . . 10.0 112.642 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 43.2 mt -123.5 142.39 40.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.882 -0.414 . . . . 10.0 109.882 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -79.51 136.36 56.03 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 110.018 -0.364 . . . . 10.0 110.018 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 173' ' ' ALA . 51.3 Cg_exo -57.44 -16.05 21.88 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.237 2.624 . . . . 10.0 113.143 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -72.77 -28.88 62.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.974 0.416 . . . . 10.0 110.864 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.74 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 58.3 m-20 -101.82 29.62 4.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.401 0.62 . . . . 10.0 110.244 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 95.4 mtp -126.89 124.73 40.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.142 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 32.1 t -107.93 119.31 57.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.338 -0.615 . . . . 10.0 109.338 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.519 ' HB2' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -103.31 109.11 20.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.055 0.455 . . . . 10.0 111.273 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 28.0 t -108.69 142.1 22.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.417 ' OG ' HD21 ' A' ' 208' ' ' LEU . 10.1 p -134.79 138.22 44.08 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.917 -0.313 . . . . 10.0 111.049 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.43 HG21 HD22 ' A' ' 217' ' ' LEU . 21.2 mm -100.35 108.95 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 213' ' ' THR . 31.9 mmt -116.95 149.38 44.04 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.268 -0.424 . . . . 10.0 111.49 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.68 25.02 0.71 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.828 2.352 . . . . 10.0 112.518 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 30.2 t -156.99 139.29 14.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.588 -0.278 . . . . 10.0 110.719 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.89 -24.11 52.54 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.156 0.503 . . . . 10.0 110.588 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.7 mtm180 -70.98 -3.05 17.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.717 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -78.13 -27.23 48.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.951 0.405 . . . . 10.0 110.9 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . 0.416 ' HG2' ' CD2' ' A' ' 27' ' ' HIS . 29.3 tp60 -68.45 -34.94 76.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 10.0 109.942 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.56 -26.63 67.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.933 -0.576 . . . . 10.0 111.182 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -76.82 -42.81 38.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.237 0.542 . . . . 10.0 109.81 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.427 ' CB ' HD23 ' A' ' 208' ' ' LEU . . . -74.75 -21.28 59.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.475 -0.784 . . . . 10.0 111.703 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -2.1 38.06 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.479 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 51.1 mtt180 -63.41 120.71 12.17 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.187 0.517 . . . . 10.0 110.196 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.09 -42.59 50.46 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 115.714 1.746 . . . . 10.0 115.714 -176.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . 0.45 ' HZ2' HH11 ' A' ' 194' ' ' ARG . 35.3 p90 -67.78 0.73 3.05 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.465 1.283 . . . . 10.0 114.465 -178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 194' ' ' ARG . 9.7 m-85 -93.87 68.2 3.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.131 0.491 . . . . 10.0 109.949 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 5.9 p -109.38 167.88 9.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.842 -0.617 . . . . 10.0 111.187 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.448 HG22 ' HG2' ' A' ' 207' ' ' GLN . 15.9 t -113.31 103.32 15.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.088 -0.708 . . . . 10.0 109.088 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 23.4 t70 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.947 -1.025 . . . . 10.0 111.644 -179.6 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 120.841 0.353 . . . . 10.0 110.457 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.777 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.231 0.106 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -82.52 139.84 33.66 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.258 -0.275 . . . . 10.0 110.258 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 197' ' ' PHE . 54.8 mt-30 -65.59 -42.51 91.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.526 0.679 . . . . 10.0 109.502 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.518 HD12 ' HB3' ' A' ' 179' ' ' MET . 19.2 tp -120.06 136.71 54.47 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.84 -64.8 1.09 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.999 0.741 . . . . 10.0 112.999 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.542 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 1.4 m-70 -140.28 144.76 36.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.929 0.395 . . . . 10.0 111.857 -177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 47.3 t -112.2 131.01 64.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 71.9 mt -119.51 138.13 51.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.479 -0.563 . . . . 10.0 109.479 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 183' ' ' MET . 72.4 p -87.81 166.93 14.24 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.121 0.486 . . . . 10.0 111.885 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.939 HG23 HG13 ' A' ' 55' ' ' VAL . 1.4 m -57.3 -45.97 83.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.471 -0.786 . . . . 10.0 111.429 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 4.7 m -61.99 -42.01 93.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.429 -0.351 . . . . 10.0 111.803 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.454 ' O ' HG13 ' A' ' 220' ' ' ILE . 41.8 mt-10 -66.17 -46.47 77.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.408 -0.36 . . . . 10.0 110.86 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 182' ' ' ILE . 34.6 tp -60.85 -45.11 95.83 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.32 -0.4 . . . . 10.0 111.002 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -60.71 -37.4 93.47 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.026 -0.606 . . . . 10.0 111.954 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . 0.499 ' HA ' ' HE3' ' A' ' 222' ' ' LYS . 42.4 m-20 -65.37 -39.33 92.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.625 0.25 . . . . 10.0 110.634 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 216' ' ' GLU . 73.4 mt -60.37 -47.57 91.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.368 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -60.2 -41.64 93.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 10.0 111.084 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' A' ' 219' ' ' ASN . 36.9 mtmt -66.41 -47.56 72.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.011 -0.54 . . . . 10.0 111.27 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 -63.79 -38.27 90.48 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 10.0 111.708 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -76.06 -18.78 59.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 10.0 111.414 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 80.76 40.59 12.0 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.901 -0.666 . . . . 10.0 112.119 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.5 mt -120.09 92.83 2.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.891 0.377 . . . . 10.0 110.54 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -76.39 116.15 16.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.177 -0.465 . . . . 10.0 109.971 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.576 ' HA ' HD12 ' A' ' 231' ' ' LEU . 36.1 mt -60.48 -28.8 68.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.873 -0.603 . . . . 10.0 112.141 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.91 -13.0 61.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.477 -0.329 . . . . 10.0 111.76 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -109.93 18.3 20.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.021 0.439 . . . . 10.0 111.042 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 228' ' ' LEU . 96.1 mt -105.46 150.2 38.7 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.614 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.01 176.65 9.59 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.339 2.026 . . . . 10.0 111.478 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 73' ' ' LYS . 8.2 mm-40 -74.08 99.13 3.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.021 -0.536 . . . . 10.0 110.404 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 77' ' ' GLU . . . -73.73 -168.16 15.8 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.997 -0.62 . . . . 10.0 113.08 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -132.45 154.17 50.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.777 0.322 . . . . 10.0 111.348 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -100.41 165.17 11.58 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.699 -0.682 . . . . 10.0 109.275 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 246' ' ' ALA . 30.4 m-20 -107.98 155.38 20.4 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.693 -0.484 . . . . 10.0 109.693 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -100.42 120.62 55.77 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-O 120.714 0.292 . . . . 10.0 110.788 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -63.18 -14.99 45.28 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.959 2.439 . . . . 10.0 112.093 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.4 ' HE2' ' HB3' ' A' ' 423' ' ' GLU . 98.2 mmm -83.02 10.83 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.955 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 89.69 -61.51 3.47 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.193 -0.527 . . . . 10.0 111.939 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.4 m -125.35 144.87 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.732 0.301 . . . . 10.0 110.21 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 155.43 162.85 11.6 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 121.073 -0.585 . . . . 10.0 111.811 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 1.7 m -94.33 107.42 19.38 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.971 0.415 . . . . 10.0 110.429 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 95.77 -164.16 23.91 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.748 -0.739 . . . . 10.0 111.428 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 237' ' ' ASP . . . -80.95 0.87 33.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.93 0.344 . . . . 10.0 111.93 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 13.82 80.25 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.83 -0.7 . . . . 10.0 112.295 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.17 118.87 53.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.524 HD11 ' HD3' ' A' ' 419' ' ' PRO . 75.1 mt -69.85 136.15 50.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.523 -0.308 . . . . 10.0 111.195 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -54.74 122.43 10.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.528 -0.76 . . . . 10.0 111.312 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 148.09 165.73 12.23 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.354 -0.698 . . . . 10.0 111.354 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 6.7 t -107.62 152.12 24.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.121 0.486 . . . . 10.0 111.115 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.27 -10.18 20.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.682 -0.69 . . . . 10.0 110.065 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.488 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 88.08 -30.82 4.96 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.797 -0.638 . . . . 10.0 111.919 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 150.84 167.29 14.46 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.234 -1.146 . . . . 10.0 110.234 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.51 -54.09 36.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 117.402 0.601 . . . . 10.0 109.915 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' MET . . . . . 0.743 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 28.6 ttp -61.6 -49.03 78.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.541 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.488 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 17.1 tt0 -58.14 -46.97 84.72 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.12 0.415 . . . . 10.0 112.12 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -67.67 -35.93 79.76 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.715 -0.221 . . . . 10.0 111.394 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.62 -46.52 78.96 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.707 -0.479 . . . . 10.0 109.707 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 79.7 mt -63.16 -41.08 99.19 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.793 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.536 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 44.3 ttm105 -57.63 -51.06 71.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.324 -0.853 . . . . 10.0 111.16 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 28.9 m -56.57 -43.84 80.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.405 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.59 -43.15 69.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.909 0.385 . . . . 10.0 111.249 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.531 ' CD2' ' HB2' ' A' ' 273' ' ' LEU . 47.3 t80 -63.18 -47.51 82.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.054 -0.521 . . . . 10.0 112.135 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.448 ' OE2' ' HA ' ' A' ' 272' ' ' PRO . 75.2 mt-10 -66.0 -36.81 84.31 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 76.0 mt -77.65 -7.92 57.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.167 0.508 . . . . 10.0 111.13 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -104.51 -40.65 5.97 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.674 -0.694 . . . . 10.0 111.484 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . 0.45 HG21 ' CE1' ' A' ' 265' ' ' TYR . 77.9 p -97.97 -32.67 11.53 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.986 0.736 . . . . 10.0 112.986 -177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 89.06 -3.13 84.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.491 -0.861 . . . . 10.0 111.034 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 12.0 p -104.64 139.47 20.13 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.989 -0.374 . . . . 10.0 109.989 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.448 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 37.0 Cg_endo -68.07 139.54 47.0 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.423 2.082 . . . . 10.0 111.581 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.642 HD12 ' HD2' ' A' ' 274' ' ' PRO . 40.6 tp -101.48 121.65 50.75 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.241 -0.436 . . . . 10.0 111.143 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . 0.642 ' HD2' HD12 ' A' ' 273' ' ' LEU . 73.9 Cg_endo -77.5 -156.19 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.573 2.182 . . . . 10.0 111.335 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -80.94 142.54 33.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.082 -0.34 . . . . 10.0 110.082 179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.11 124.6 36.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.069 0.461 . . . . 10.0 112.11 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 4.3 m -90.65 91.9 8.6 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.238 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 278' ' ' LEU . 3.5 mm? -58.54 123.93 17.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 10.0 111.554 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 6.1 m -98.7 140.84 32.31 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.491 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.12 128.48 33.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.522 -0.308 . . . . 10.0 110.971 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . 0.45 HG22 ' HG2' ' A' ' 289' ' ' GLU . 21.7 t -86.03 110.25 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.838 0.351 . . . . 10.0 110.155 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -66.83 123.05 19.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.243 -0.435 . . . . 10.0 110.369 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 117.16 -21.32 10.98 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.4 ' HB3' ' CG1' ' A' ' 287' ' ' ILE . 63.8 mtm -132.91 85.5 2.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.609 -0.515 . . . . 10.0 109.609 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -62.65 109.98 1.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.533 -0.758 . . . . 10.0 111.458 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . 0.42 ' HA3' ' ND2' ' A' ' 354' ' ' ASN . . . 118.08 -13.52 12.65 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.757 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.4 ' CG1' ' HB3' ' A' ' 284' ' ' MET . 42.9 mm -97.89 129.44 48.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.912 -0.403 . . . . 10.0 109.912 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 47.9 mmtt -119.59 149.94 41.12 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . 0.45 ' HG2' HG22 ' A' ' 281' ' ' VAL . 21.6 pt-20 -133.39 160.1 38.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.992 0.425 . . . . 10.0 112.07 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.83 134.62 13.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.299 -0.864 . . . . 10.0 109.855 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -112.0 110.1 20.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.502 -0.317 . . . . 10.0 110.548 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 31.5 mt -98.97 121.49 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.936 0.398 . . . . 10.0 111.504 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . 0.552 HG23 ' HZ ' ' A' ' 333' ' ' PHE . 4.6 m -76.99 104.45 7.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.112 -0.495 . . . . 10.0 110.226 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.432 ' HG2' ' HD1' ' A' ' 265' ' ' TYR . 88.6 mtp -100.6 102.46 13.62 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.985 0.422 . . . . 10.0 111.74 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.54 118.48 54.42 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.979 -0.749 . . . . 10.0 108.979 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -57.01 132.99 55.04 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.863 2.375 . . . . 10.0 112.566 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . . . . . . . . . . . -64.22 134.52 95.99 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.887 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.37 120.04 7.56 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.717 2.278 . . . . 10.0 111.492 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 92.42 39.39 5.36 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.828 -0.701 . . . . 10.0 111.702 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 98.9 p -128.53 165.12 21.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.861 -0.422 . . . . 10.0 109.861 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.618 ' O ' ' HG ' ' A' ' 305' ' ' LEU . 13.2 pttt -73.11 -29.38 62.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.622 -0.51 . . . . 10.0 109.622 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -66.02 -39.51 90.29 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.905 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 307' ' ' LYS . 13.5 tt0 -64.32 -45.28 88.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.652 -0.704 . . . . 10.0 110.013 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.58 -31.74 73.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.799 -0.637 . . . . 10.0 111.648 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.618 ' HG ' ' O ' ' A' ' 301' ' ' LYS . 90.7 mt -58.86 -57.3 13.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 10.0 110.919 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . 0.414 HD21 HD22 ' A' ' 113' ' ' LEU . 92.2 mt -69.26 -26.23 64.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.028 -0.533 . . . . 10.0 111.367 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 303' ' ' GLU . 6.6 tmtt? -79.03 -12.97 60.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.992 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -112.26 -22.74 10.77 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.878 0.696 . . . . 10.0 112.878 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 305' ' ' LEU . 6.9 ptp180 -146.4 123.92 11.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.992 0.425 . . . . 10.0 112.044 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.5 -0.18 4.99 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.486 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.198 -0.906 . . . . 10.0 109.113 -179.818 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.438 0 N-CA-C 111.513 -0.635 . . . . 10.0 111.513 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.35 -23.43 51.45 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.729 2.286 . . . . 10.0 111.733 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 147' ' ' TYR . 93.3 mt -119.23 96.48 5.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.137 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -92.66 124.16 36.47 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.242 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 2.1 t90 -60.56 129.94 44.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.435 -0.348 . . . . 10.0 110.062 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -72.71 -12.93 61.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.286 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 115.05 -9.59 20.84 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.245 -0.742 . . . . 10.0 111.245 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 86.52 129.2 2.51 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.855 -0.688 . . . . 10.0 111.565 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -71.78 88.91 1.02 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.08 0.467 . . . . 10.0 110.588 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -105.68 149.06 16.63 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.928 -0.653 . . . . 10.0 112.397 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . 0.552 ' HZ ' HG23 ' A' ' 293' ' ' THR . 3.5 p90 -132.05 151.23 51.87 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.435 ' HA ' ' HA2' ' A' ' 340' ' ' GLY . 7.8 t -131.78 142.09 49.66 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.981 0.42 . . . . 10.0 111.196 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 1.7 m -83.75 165.05 19.2 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.813 -0.631 . . . . 10.0 109.934 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -70.97 -18.19 62.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.894 0.378 . . . . 10.0 110.986 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -26.12 60.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.963 -0.562 . . . . 10.0 111.683 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 126.39 -16.68 6.65 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.464 -0.874 . . . . 10.0 113.561 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -83.15 163.52 20.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.865 0.333 . . . . 10.0 110.881 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 334' ' ' THR . . . -150.26 169.04 30.25 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.731 -0.747 . . . . 10.0 112.293 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -157.19 164.93 33.1 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.42 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 14.4 tt -122.32 140.95 44.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.998 0.399 . . . . 10.0 110.724 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.42 ' HB ' ' HE2' ' A' ' 333' ' ' PHE . 4.8 t -96.98 100.09 11.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.233 0.54 . . . . 10.0 110.132 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 21.4 tp -62.95 116.72 5.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.457 -0.792 . . . . 10.0 110.776 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -90.71 100.19 13.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.013 -0.54 . . . . 10.0 110.555 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 46.3 t -104.18 132.59 50.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 10.0 110.63 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.556 ' HB3' HG22 ' A' ' 372' ' ' VAL . . . -125.78 144.75 50.5 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.785 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 60.5 t -121.71 118.89 57.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.93 -0.577 . . . . 10.0 109.635 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.487 ' HB3' HG12 ' A' ' 374' ' ' ILE . . . -105.52 97.39 7.23 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.104 -0.498 . . . . 10.0 110.238 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ASN . . . . . 0.969 ' HB3' ' HA ' ' A' ' 378' ' ' PRO . 0.7 OUTLIER -88.22 101.0 13.41 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.006 0.431 . . . . 10.0 110.167 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 126.08 123.83 2.71 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.203 -0.759 . . . . 10.0 111.203 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . 0.808 ' HG ' ' HA ' ' A' ' 376' ' ' ALA . 26.7 mt -59.11 -32.01 69.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.938 0.399 . . . . 10.0 111.786 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . 0.459 ' O ' ' HE3' ' A' ' 357' ' ' LYS . . . -72.43 -26.59 71.51 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.527 -0.844 . . . . 10.0 111.236 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 357' ' ' LYS . 86.6 m-20 -74.03 -23.78 59.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.907 0.384 . . . . 10.0 111.054 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -66.28 -36.09 82.08 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.632 -0.507 . . . . 10.0 109.632 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' B' ' 60' ' ' SER . 17.7 tttt -68.07 -21.33 64.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.332 -0.849 . . . . 10.0 110.545 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 353' ' ' GLY . 60.4 mttt -94.61 -32.39 13.44 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 10.0 111.572 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 55.4 tp -80.96 -45.83 16.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.306 -0.406 . . . . 10.0 111.916 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 85.1 mt -58.94 -34.48 52.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.095 0.406 . . . . 10.0 112.095 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -43.2 99.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.993 0.425 . . . . 10.0 110.306 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 44.2 mttm -72.3 -29.06 63.5 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.613 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' MET . . . . . . . . . . . . . 89.5 mtp -70.35 -48.83 54.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.104 -0.498 . . . . 10.0 109.861 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.52 -36.77 83.63 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.45 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.2 -27.54 68.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.609 . . . . 10.0 110.866 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 105.26 0.03 40.81 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.069 -0.586 . . . . 10.0 112.605 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -75.49 -54.41 7.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.88 0.371 . . . . 10.0 111.335 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . . . . . . . . . . . -81.85 100.7 9.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.154 -0.475 . . . . 10.0 111.51 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -94.75 106.09 18.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.478 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -137.44 155.35 49.44 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.103 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -105.28 -38.05 6.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.062 0.458 . . . . 10.0 110.877 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.743 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 53.5 t80 -130.46 129.79 43.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.048 -0.524 . . . . 10.0 109.699 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 347' ' ' ALA . 62.5 t -134.07 127.01 50.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.803 0.335 . . . . 10.0 111.818 -179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.458 ' HA ' ' OG1' ' A' ' 127' ' ' THR . 14.1 tt0 -101.88 126.74 48.85 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.24 -1.022 . . . . 10.0 108.24 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.487 HG12 ' HB3' ' A' ' 349' ' ' ALA . 68.9 mt -116.37 120.1 63.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.254 0.549 . . . . 10.0 111.971 -179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' MET . . . . . . . . . . . . . 10.0 mmt -105.79 155.52 19.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.462 -0.79 . . . . 10.0 109.442 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 0.808 ' HA ' ' HG ' ' A' ' 352' ' ' LEU . . . -79.24 -28.9 42.45 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.78 0.324 . . . . 10.0 111.685 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 12.1 m -114.41 149.46 42.19 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.234 -0.439 . . . . 10.0 110.491 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.969 ' HA ' ' HB3' ' A' ' 350' ' ' ASN . 2.9 Cg_endo -83.29 22.56 0.91 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.491 2.794 . . . . 10.0 112.24 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -147.64 38.06 0.92 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.279 0.561 . . . . 10.0 109.903 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 69.27 -144.16 40.49 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.48 -0.782 . . . . 10.0 111.736 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' CYS . . . . . 0.702 ' HA ' ' S3 ' ' A' ' 501' ' ' SF4 . 72.4 m -106.94 -10.16 16.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.631 0.253 . . . . 10.0 111.544 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . 0.462 HG23 HG22 ' A' ' 396' ' ' THR . 28.0 m -70.63 -12.63 16.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 120.796 0.332 . . . . 10.0 111.472 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -112.0 27.93 9.79 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 121.059 -0.591 . . . . 10.0 111.985 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -69.32 169.73 43.23 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.12 -0.562 . . . . 10.0 112.641 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -71.86 -25.47 74.82 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.027 -0.606 . . . . 10.0 113.091 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -76.21 -17.81 79.74 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.742 -0.742 . . . . 10.0 112.275 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -74.01 160.35 81.94 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 109.903 -0.406 . . . . 10.0 109.903 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.82 159.68 40.55 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.404 2.07 . . . . 10.0 110.983 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . 0.765 HH21 ' HB3' ' B' ' 34' ' ' PRO . 0.2 OUTLIER -117.07 135.68 53.55 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.484 -0.326 . . . . 10.0 110.249 -180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 13.9 t -132.51 162.86 30.14 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.339 -0.391 . . . . 10.0 110.202 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.09 -10.83 59.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.307 0.575 . . . . 10.0 110.187 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -77.53 109.97 11.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.625 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -75.38 1.27 14.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.801 -0.636 . . . . 10.0 111.782 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -124.37 22.36 8.51 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 121.17 0.509 . . . . 10.0 110.23 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . 0.553 HD12 ' HD2' ' A' ' 398' ' ' LYS . 8.6 tp -71.29 -29.93 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.344 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.462 HG22 HG23 ' A' ' 382' ' ' VAL . 0.3 OUTLIER -61.82 -39.05 90.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.036 -0.529 . . . . 10.0 111.603 -179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -62.06 -37.77 86.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.954 0.407 . . . . 10.0 110.716 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . 0.553 ' HD2' HD12 ' A' ' 395' ' ' ILE . 52.3 mttp -67.97 -39.67 83.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.784 -0.644 . . . . 10.0 110.59 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -63.44 -42.65 98.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 10.0 110.859 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -70.31 -32.8 70.72 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.972 -0.558 . . . . 10.0 111.088 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -75.08 -46.04 37.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.36 -0.382 . . . . 10.0 111.515 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -85.24 13.29 6.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.839 0.352 . . . . 10.0 111.865 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.7 -36.95 85.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 10.0 110.564 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.509 ' O ' ' HE3' ' A' ' 409' ' ' LYS . 75.4 m-85 -136.61 151.47 49.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.926 -0.579 . . . . 10.0 110.151 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -75.36 160.94 29.72 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.157 -0.682 . . . . 10.0 109.157 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.42 -35.35 69.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.889 0.376 . . . . 10.0 110.864 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.23 -35.45 81.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.814 -0.63 . . . . 10.0 111.418 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.05 -36.6 66.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.248 -0.433 . . . . 10.0 110.462 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . 0.509 ' HE3' ' O ' ' A' ' 404' ' ' TYR . 96.5 mttt -71.02 -32.86 69.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.593 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 3.1 p -81.6 -3.37 53.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.016 0.436 . . . . 10.0 111.564 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 9.5 m -120.6 96.92 5.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.913 0.387 . . . . 10.0 111.216 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 23.6 tp -78.8 117.19 19.68 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . 0.466 ' HD2' ' O ' ' A' ' 414' ' ' ARG . 6.1 tmm_? -118.44 139.96 50.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.519 -0.31 . . . . 10.0 111.366 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.493 ' HB2' ' OE1' ' A' ' 417' ' ' GLU . 67.9 mtt85 -101.69 158.94 15.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.439 -0.346 . . . . 10.0 110.386 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 9.2 m -72.59 -33.04 66.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.257 0.466 . . . . 10.0 112.257 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 23.0 p-80 -77.29 4.13 11.37 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 113.221 0.823 . . . . 10.0 113.221 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . 0.493 ' OE1' ' HB2' ' A' ' 414' ' ' ARG . 0.5 OUTLIER -103.52 -3.74 24.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.643 -0.503 . . . . 10.0 109.643 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -84.3 116.33 64.48 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.606 -0.725 . . . . 10.0 110.505 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . 0.524 ' HD3' HD11 ' A' ' 249' ' ' LEU . 33.5 Cg_exo -59.62 -38.42 82.02 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.994 2.463 . . . . 10.0 111.983 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 1.1 m -60.78 -43.94 97.44 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 10.0 110.552 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 47.0 mm -67.18 -40.3 84.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.782 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . 0.435 ' NH2' ' HA ' ' A' ' 417' ' ' GLU . 98.9 mtt180 -59.96 -44.93 94.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.77 -0.65 . . . . 10.0 110.673 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . 0.4 ' HB3' ' HE2' ' A' ' 240' ' ' MET . 46.7 tt0 -61.51 -43.98 97.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.945 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . 0.434 HD23 HD21 ' A' ' 96' ' ' LEU . 65.3 tp -63.54 -37.93 89.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.193 0.52 . . . . 10.0 111.216 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.3 m-85 -74.87 -59.81 2.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.198 -0.455 . . . . 10.0 111.747 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -66.85 -14.51 62.8 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 115.074 1.509 . . . . 10.0 115.074 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.8 18.25 7.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 -178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -161.94 -61.39 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.321 0.489 . . . . 10.0 112.321 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.585 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 92.8 mt -67.68 -40.7 84.4 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.521 0.563 . . . . 10.0 112.521 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 99.89 -77.48 0.47 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.053 -0.594 . . . . 10.0 111.702 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . 0.596 ' HG2' ' HD2' ' A' ' 432' ' ' PRO . 1.0 OUTLIER -149.16 153.06 37.38 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 109.368 -0.605 . . . . 10.0 109.368 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.596 ' HD2' ' HG2' ' A' ' 431' ' ' GLU . 60.4 Cg_exo -55.1 134.8 65.81 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.565 2.177 . . . . 10.0 110.953 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.402 HD21 ' HG3' ' A' ' 104' ' ' GLU . 6.9 mp 66.75 13.61 9.45 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.532 0.52 . . . . 10.0 112.206 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -69.9 -166.91 5.79 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.513 -0.375 . . . . 10.0 112.979 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -59.64 -62.79 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.848 0.314 . . . . 10.0 111.848 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.512 ' HD2' ' HA ' ' A' ' 436' ' ' LYS . 17.7 tptt -63.03 -34.44 77.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.8 0.334 . . . . 10.0 111.497 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -64.55 -42.15 95.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.078 0.466 . . . . 10.0 110.487 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 0.1 OUTLIER -78.89 -9.68 59.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.03 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -93.19 -48.25 6.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.184 -0.462 . . . . 10.0 112.235 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 88.3 mt -101.52 -34.55 9.5 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 113.828 1.047 . . . . 10.0 113.828 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 58.9 mt -90.25 -12.03 39.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.406 0.521 . . . . 10.0 112.406 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 17.0 m-70 -119.19 167.09 12.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.18 -0.208 . . . . 10.0 110.873 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 9.5 t -156.37 -170.23 3.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.275 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -135.72 158.26 44.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.242 -0.281 . . . . 10.0 110.242 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -117.62 153.64 32.93 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.724 0.297 . . . . 10.0 111.262 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 19.9 t -110.75 128.55 67.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.007 0.432 . . . . 10.0 111.831 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -69.41 95.36 0.8 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.983 -0.553 . . . . 10.0 111.348 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 145.35 -33.32 1.58 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.917 -0.658 . . . . 10.0 111.973 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . 123.89 -174.37 16.78 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 111.327 -0.709 . . . . 10.0 111.327 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.429 HG11 ' HG2' ' A' ' 194' ' ' ARG . 3.1 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.484 -0.77 . . . . 10.0 111.015 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.662 ' HE2' ' HB2' ' B' ' 18' ' ' ALA . 43.5 m-85 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.256 -0.276 . . . . 10.0 110.256 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -84.14 96.26 8.88 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 116.166 -0.47 . . . . 10.0 110.983 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 p -108.41 125.86 65.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.831 -0.622 . . . . 10.0 110.523 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' B' ' 13' ' ' THR . 35.0 m -92.08 115.71 28.3 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.308 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.468 HD21 HG21 ' B' ' 22' ' ' ILE . 20.8 mt -87.93 129.77 35.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.022 -0.535 . . . . 10.0 111.091 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' B' ' 86' ' ' GLN . 17.3 tppt? -88.21 97.79 11.2 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.725 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.547 HG22 ' HD2' ' B' ' 8' ' ' PRO . 0.2 OUTLIER -111.82 142.35 26.52 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.594 -0.73 . . . . 10.0 109.194 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' B' ' 7' ' ' THR . 18.8 Cg_endo -61.0 -17.02 49.21 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.432 2.088 . . . . 10.0 111.73 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 1.5 m -93.5 9.49 36.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.847 -0.615 . . . . 10.0 111.38 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.65 145.97 7.66 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.996 -0.621 . . . . 10.0 112.364 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.89 149.62 34.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.649 0.261 . . . . 10.0 110.402 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -155.54 129.5 8.68 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.41 -0.359 . . . . 10.0 110.719 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 8.4 m -92.87 120.58 33.35 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.036 -0.529 . . . . 10.0 109.872 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . . . . . . . . . 19.2 pt -116.79 155.66 18.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.175 -0.466 . . . . 10.0 111.119 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -94.4 105.88 17.85 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.741 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . 0.417 ' HA ' ' HD3' ' B' ' 17' ' ' PRO . 84.2 m -113.51 121.05 38.37 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.987 -0.552 . . . . 10.0 110.275 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' B' ' 20' ' ' THR . 4.9 Cg_exo -76.14 161.64 35.15 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.689 2.26 . . . . 10.0 110.94 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.662 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . . . -77.48 49.76 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.128 0.489 . . . . 10.0 110.971 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.95 -33.58 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.763 -0.653 . . . . 10.0 110.465 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' B' ' 17' ' ' PRO . 17.0 m -98.71 143.48 29.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.976 -0.556 . . . . 10.0 110.11 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -73.64 152.07 40.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.082 0.468 . . . . 10.0 111.381 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.516 HG12 ' HD3' ' B' ' 79' ' ' PRO . 6.1 mt -58.31 -37.94 66.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.874 -178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.494 ' HB3' HD22 ' B' ' 33' ' ' LEU . 0.7 OUTLIER -63.06 -25.2 68.26 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.207 0.818 . . . . 10.0 113.207 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -70.14 -46.24 65.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.01 0.433 . . . . 10.0 110.821 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.88 -23.47 59.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.471 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.0 82.83 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.74 -0.663 . . . . 10.0 111.073 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . 0.423 ' HB3' ' CE2' ' B' ' 35' ' ' TYR . 16.4 pt-20 -68.1 -25.73 65.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.046 0.451 . . . . 10.0 110.742 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -68.09 -27.31 66.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.745 -0.661 . . . . 10.0 111.023 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -102.88 3.2 36.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.274 -0.421 . . . . 10.0 111.43 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.83 74.3 0.93 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.61 -0.805 . . . . 10.0 112.303 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 62.5 mt -131.42 166.29 21.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.663 0.268 . . . . 10.0 110.949 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -97.03 111.88 23.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.843 -0.617 . . . . 10.0 110.212 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.719 HD23 ' HD2' ' B' ' 34' ' ' PRO . 0.2 OUTLIER -154.01 131.17 5.98 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.348 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.765 ' HB3' HH21 ' A' ' 389' ' ' ARG . 73.4 Cg_endo -78.8 72.66 6.34 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.595 2.196 . . . . 10.0 112.519 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' B' ' 27' ' ' GLU . 0.1 OUTLIER -77.14 101.04 5.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 10.0 110.842 179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' B' ' 37' ' ' CYS . 0.0 OUTLIER -103.29 -134.94 0.33 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.072 -0.513 . . . . 10.0 111.485 -179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' CYS . . . . . 0.5 ' H ' ' HB2' ' B' ' 36' ' ' SER . 5.8 p -60.4 -36.04 77.18 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 112.578 0.584 . . . . 10.0 112.578 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' B' ' 38' ' ' ARG . 5.0 mtp85 69.94 12.76 7.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.127 -0.488 . . . . 10.0 111.942 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.78 36.86 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.629 0.233 . . . . 10.0 111.629 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.88 43.82 61.12 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 121.409 -0.424 . . . . 10.0 112.98 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.09 -49.06 3.35 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.543 -0.386 . . . . 10.0 111.8 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . 0.485 ' HB3' ' HD3' ' A' ' 378' ' ' PRO . 0.1 OUTLIER -86.13 165.22 16.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.133 0.492 . . . . 10.0 111.798 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 3.9 p -126.16 6.21 7.14 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.375 0.607 . . . . 10.0 110.094 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.31 -21.73 55.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.542 -0.754 . . . . 10.0 110.592 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.84 36.74 1.75 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.935 -0.575 . . . . 10.0 109.972 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' B' ' 73' ' ' LEU . . . -89.19 95.01 10.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.975 -0.557 . . . . 10.0 110.715 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.49 156.29 53.48 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.147 -0.549 . . . . 10.0 112.648 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.692 ' HD3' ' HB3' ' B' ' 89' ' ' GLN . 5.9 mptt -110.08 130.42 55.54 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.732 0.301 . . . . 10.0 110.788 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.464 ' HB ' ' HA2' ' B' ' 70' ' ' GLY . 21.5 t -84.36 112.63 21.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.287 -0.415 . . . . 10.0 110.192 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.633 ' HB3' ' HB ' ' B' ' 84' ' ' THR . . . -85.53 -37.72 19.32 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.578 -0.527 . . . . 10.0 109.578 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . . . . . . . . . . . -162.38 153.42 17.64 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.444 -0.798 . . . . 10.0 108.893 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.664 ' HA3' ' HB3' ' B' ' 83' ' ' CYS . . . 93.55 -163.69 26.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.789 -0.719 . . . . 10.0 112.199 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.2 m -142.62 143.54 32.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.942 0.401 . . . . 10.0 111.071 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' B' ' 79' ' ' PRO . 6.7 m -129.48 150.86 35.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.807 -0.633 . . . . 10.0 109.451 178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' B' ' 77' ' ' ALA . 31.1 t0 -95.82 118.73 33.03 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.882 0.372 . . . . 10.0 111.399 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.05 130.6 55.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.359 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 38.6 t -91.08 -57.93 2.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.877 0.37 . . . . 10.0 111.33 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -141.29 117.93 10.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.376 -0.375 . . . . 10.0 111.091 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.637 ' HG2' HD13 ' B' ' 73' ' ' LEU . 25.6 mt-30 -95.44 158.37 15.49 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.124 -0.489 . . . . 10.0 110.741 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.435 ' O ' ' HD2' ' A' ' 356' ' ' LYS . 0.8 OUTLIER -74.53 -103.28 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.509 -179.377 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . 0.468 ' HZ ' HD13 ' B' ' 93' ' ' LEU . 5.8 p90 -86.45 -7.27 58.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.197 0.523 . . . . 10.0 110.744 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.42 173.13 10.5 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.794 -0.817 . . . . 10.0 108.794 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -142.62 173.41 11.56 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 123.025 0.203 . . . . 10.0 111.287 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -48.0 -36.92 13.58 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.286 0.847 . . . . 10.0 113.286 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.3 -22.47 61.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.903 0.705 . . . . 10.0 112.903 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.736 ' HB3' ' HB2' ' B' ' 71' ' ' PHE . 12.2 mm-40 -82.95 -10.26 58.88 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.43 0.529 . . . . 10.0 112.43 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' MET . . . . . . . . . . . . . 22.5 ttm -61.09 -52.15 66.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.742 0.306 . . . . 10.0 110.488 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.57 -21.83 79.32 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.946 -0.57 . . . . 10.0 111.775 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -73.86 -23.02 59.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.328 0.585 . . . . 10.0 109.517 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.464 ' HA2' ' HB ' ' B' ' 49' ' ' VAL . . . 101.21 23.78 9.43 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.447 -0.797 . . . . 10.0 112.709 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.736 ' HB2' ' HB3' ' B' ' 66' ' ' GLN . 15.0 m-85 -119.68 108.5 14.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.007 0.403 . . . . 10.0 110.569 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.577 ' HA ' ' NE2' ' B' ' 59' ' ' GLN . 15.8 m -129.63 -170.91 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.52 -0.309 . . . . 10.0 110.562 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.637 HD13 ' HG2' ' B' ' 59' ' ' GLN . 2.8 mp -125.94 114.09 18.04 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.28 -16.24 59.67 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.382 0.512 . . . . 10.0 112.382 -178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' CYS . . . . . 0.434 ' HA ' HD21 ' B' ' 23' ' ' LEU . 0.5 OUTLIER -88.1 -17.3 31.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.954 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.5 30.99 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 CA-C-O 120.864 0.364 . . . . 10.0 111.473 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' B' ' 55' ' ' ASP . . . -149.06 137.45 20.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.749 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -126.86 147.99 63.46 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.957 -0.565 . . . . 10.0 109.757 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 0.639 ' HA ' HG12 ' B' ' 54' ' ' VAL . 50.0 Cg_endo -69.43 119.89 6.79 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.295 1.996 . . . . 10.0 112.293 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -17.03 59.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.628 0.728 . . . . 10.0 109.445 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 67.7 m -159.6 176.25 12.25 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.942 -1.027 . . . . 10.0 108.511 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -63.13 130.16 43.43 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.15 -0.315 . . . . 10.0 110.15 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . 0.664 ' HB3' ' HA3' ' B' ' 52' ' ' GLY . 1.6 p -154.83 -176.85 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.789 0.328 . . . . 10.0 111.822 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.633 ' HB ' ' HB3' ' B' ' 50' ' ' ALA . 0.3 OUTLIER -121.28 122.9 40.91 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.848 -0.615 . . . . 10.0 109.593 179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 34.2 mm -124.11 134.43 66.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 10.0 111.589 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . 0.522 ' HB3' ' HB2' ' B' ' 48' ' ' LYS . 11.5 tt0 -93.3 136.02 33.96 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.5 -0.926 . . . . 10.0 108.5 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 9.7 p -91.03 -73.44 0.54 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.785 1.031 . . . . 10.0 113.785 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -65.79 98.1 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.098 0.777 . . . . 10.0 113.098 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.692 ' HB3' ' HD3' ' B' ' 48' ' ' LYS . 0.8 OUTLIER -173.81 85.7 0.05 OUTLIER 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.147 -0.479 . . . . 10.0 111.431 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -105.47 11.26 32.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.906 0.384 . . . . 10.0 110.766 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -100.36 -38.35 8.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.96 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.04 73.01 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.251 -0.431 . . . . 10.0 111.549 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.468 HD13 ' HZ ' ' B' ' 61' ' ' PHE . 0.8 OUTLIER -170.77 20.65 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.61 -0.723 . . . . 10.0 109.822 179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 4.2 t80 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.747 -0.644 . . . . 10.0 109.406 -179.037 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' SF4 . . . . . 0.702 ' S3 ' ' HA ' ' A' ' 381' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.9 mt . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.584 0.23 . . . . 10.0 110.406 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 p -73.93 168.43 19.48 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.695 -0.23 . . . . 10.0 110.424 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -56.68 -37.88 71.48 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.534 -0.303 . . . . 10.0 111.532 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.416 HG22 HG12 ' A' ' 212' ' ' ILE . 59.8 t -72.0 -49.68 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.338 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -62.66 -27.03 68.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 10.0 111.72 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.529 ' HB3' ' CE1' ' A' ' 210' ' ' HIS . 54.3 mt-30 -66.2 -13.72 60.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.47 . . . . 10.0 110.78 179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -107.13 -32.86 7.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.486 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.05 -34.04 72.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.944 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.04 81.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.316 -0.402 . . . . 10.0 111.529 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -76.44 -38.02 56.13 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.694 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.2 -33.08 75.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.55 . . . . 10.0 111.613 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.04 -29.16 69.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.123 -0.489 . . . . 10.0 111.042 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 90.0 mttt -73.49 128.21 87.58 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.997 -0.547 . . . . 10.0 111.04 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 37' ' ' LYS . 23.8 Cg_exo -65.25 158.34 52.82 Favored 'Trans proline' 0 CA--C 1.527 0.127 0 C-N-CA 122.896 2.397 . . . . 10.0 111.767 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -62.84 -20.64 65.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.244 0.461 . . . . 10.0 112.244 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -97.73 15.17 24.4 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.901 0.334 . . . . 10.0 111.901 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 8.6 t70 -94.08 130.78 33.26 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.5 -22.9 73.65 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.814 2.343 . . . . 10.0 113.375 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.9 p -93.84 3.13 55.87 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.923 0.392 . . . . 10.0 111.608 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -87.3 129.37 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.02 -0.536 . . . . 10.0 111.209 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -111.22 -176.21 2.9 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.39 111.4 21.72 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 110.006 -0.368 . . . . 10.0 110.006 179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.93 101.13 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.261 -0.427 . . . . 10.0 110.713 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.8 m -96.31 140.29 31.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.888 -0.597 . . . . 10.0 109.784 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 180' ' ' VAL . 11.1 p -126.23 144.73 35.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.799 0.333 . . . . 10.0 111.206 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 88' ' ' PHE . 13.6 pt20 -128.61 129.14 45.49 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.608 HG11 HD21 ' A' ' 75' ' ' LEU . 5.7 t -113.23 150.07 15.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 120.882 0.373 . . . . 10.0 110.988 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.53 141.26 22.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.989 -0.55 . . . . 10.0 109.76 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -53.57 -32.09 62.4 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.168 2.579 . . . . 10.0 112.347 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.41 -22.43 66.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.568 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.538 HG13 HG23 ' A' ' 214' ' ' THR . 86.3 t -89.37 -38.54 11.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.202 0.525 . . . . 10.0 109.705 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.3 tmm_? -57.34 -29.79 64.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.412 -0.813 . . . . 10.0 112.321 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.7 p -83.35 -36.85 13.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.827 0.677 . . . . 10.0 112.827 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.83 -13.99 38.04 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.988 0.736 . . . . 10.0 112.988 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.61 -26.8 32.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 112.026 0.38 . . . . 10.0 112.026 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -68.39 -27.54 66.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.622 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' CD ' HH21 ' A' ' 399' ' ' ARG . 20.7 mt-10 -68.54 -29.53 68.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.732 0.301 . . . . 10.0 111.382 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.34 -17.42 64.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.979 0.418 . . . . 10.0 110.569 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.7 mt -99.73 -11.8 20.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.585 . . . . 10.0 109.948 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.08 25.13 13.25 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.805 -0.634 . . . . 10.0 112.193 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.6 mt -110.92 -175.42 2.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.628 0.251 . . . . 10.0 110.443 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.33 149.1 42.11 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.368 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.74 117.54 4.28 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.546 2.164 . . . . 10.0 111.666 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 103.35 4.02 47.2 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.856 -0.687 . . . . 10.0 113.203 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.0 -29.91 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.942 0.401 . . . . 10.0 111.259 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -94.02 126.65 39.37 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.232 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 p -80.62 155.64 73.49 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.784 0.326 . . . . 10.0 111.326 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -41.84 73.23 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.002 2.468 . . . . 10.0 113.023 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -66.95 -34.0 76.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.59 -0.277 . . . . 10.0 111.669 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -66.68 -37.91 85.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.987 0.423 . . . . 10.0 110.481 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.608 HD21 HG11 ' A' ' 51' ' ' VAL . 44.9 tp -64.32 -46.82 81.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.865 -0.607 . . . . 10.0 110.072 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.55 -38.61 85.04 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.867 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -61.72 -47.35 85.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.135 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.93 -39.87 96.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.924 -0.655 . . . . 10.0 112.449 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.496 HD11 HG21 ' A' ' 51' ' ' VAL . 19.5 mt -62.28 -43.96 97.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.962 0.411 . . . . 10.0 111.179 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -65.59 -27.36 68.36 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.012 0.434 . . . . 10.0 110.595 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -77.13 -11.43 59.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.077 -0.51 . . . . 10.0 111.359 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.2 -14.04 57.95 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.406 -0.591 . . . . 10.0 109.406 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.79 7.19 24.05 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.491 -0.777 . . . . 10.0 112.236 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -69.71 145.2 52.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.829 0.347 . . . . 10.0 111.231 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.86 -64.4 1.2 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.082 -0.508 . . . . 10.0 111.155 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -119.6 135.4 54.81 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.621 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 20.8 t -113.46 110.9 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.263 -0.426 . . . . 10.0 110.529 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 50' ' ' GLN . 48.6 m-85 -111.05 162.38 14.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.896 0.379 . . . . 10.0 110.983 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -111.0 146.39 36.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 m -65.54 -19.67 66.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.497 -0.319 . . . . 10.0 111.555 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 23.0 mt -57.67 -36.63 72.17 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.635 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -67.59 -38.08 83.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.171 0.51 . . . . 10.0 109.902 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.33 -36.99 70.55 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.716 -0.954 . . . . 10.0 110.716 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.54 81.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.522 -0.339 . . . . 10.0 110.387 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.69 -36.15 75.91 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.78 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.21 -41.31 67.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.564 -0.743 . . . . 10.0 109.6 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 6.3 m -60.72 -44.66 96.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.75 -0.659 . . . . 10.0 110.524 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.7 mt -58.52 -40.37 78.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.87 -0.604 . . . . 10.0 110.956 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.2 mmm -62.53 -53.11 59.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.001 -0.545 . . . . 10.0 111.286 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -67.28 -40.2 86.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.174 -0.467 . . . . 10.0 111.732 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 101' ' ' GLU . 2.9 tp10 -61.64 -45.91 92.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.894 0.378 . . . . 10.0 110.55 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -62.58 -35.02 91.23 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.033 -0.827 . . . . 10.0 111.033 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.0 m -70.81 -41.94 70.91 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.584 -0.308 . . . . 10.0 110.62 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -61.93 -47.27 85.63 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.614 -0.513 . . . . 10.0 109.614 178.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.1 -51.48 69.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.67 -0.695 . . . . 10.0 110.998 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.35 -37.63 81.27 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.989 0.423 . . . . 10.0 109.996 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.589 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 26.5 t60 -62.96 -51.6 66.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.407 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.527 ' HG2' ' HB3' ' A' ' 121' ' ' GLU . 68.4 mtt180 -62.49 -32.39 73.29 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.416 -0.357 . . . . 10.0 111.308 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.7 tp -71.61 -50.58 29.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.407 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 27.4 m -58.01 -45.52 86.75 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.101 -0.5 . . . . 10.0 111.697 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 107' ' ' HIS . 71.9 mm-40 -57.47 -36.83 71.96 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.054 0.454 . . . . 10.0 110.713 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.414 ' HE1' ' HA ' ' A' ' 122' ' ' PRO . 28.4 m80 -77.2 -28.51 53.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 10.0 111.509 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.2 mt -69.75 -39.21 76.87 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.38 -41.19 69.99 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.323 -0.853 . . . . 10.0 109.965 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 CA-C-N 115.582 -0.735 . . . . 10.0 111.963 179.625 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 108' ' ' ARG . 1.3 mp0 . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.784 0.326 . . . . 10.0 110.475 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.414 ' HA ' ' HE1' ' A' ' 112' ' ' HIS . 74.3 Cg_endo -90.3 -175.06 0.86 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.913 2.408 . . . . 10.0 112.911 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.419 ' HA ' ' C ' ' A' ' 124' ' ' PRO . 95.2 mt -130.21 158.3 74.6 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 123' ' ' LEU . 36.6 Cg_endo -64.27 167.26 42.79 Favored 'Cis proline' 0 C--N 1.347 0.471 0 C-N-CA 124.318 -1.118 . . . . 10.0 113.667 0.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 27.7 ttt -111.87 131.08 55.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.431 -0.804 . . . . 10.0 110.762 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 372' ' ' VAL . 69.7 m-85 -111.14 139.5 46.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.934 -0.576 . . . . 10.0 109.911 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.55 152.32 36.02 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.643 0.258 . . . . 10.0 110.617 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.9 33.37 5.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.938 0.399 . . . . 10.0 111.266 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 2.8 m -92.53 17.01 10.72 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.725 0.639 . . . . 10.0 112.725 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.461 ' O ' HG12 ' A' ' 134' ' ' ILE . 0.9 OUTLIER -136.3 120.62 12.75 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 112.079 0.399 . . . . 10.0 112.079 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.54 -40.65 45.72 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.093 2.528 . . . . 10.0 112.366 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.457 ' HA3' ' HB2' ' A' ' 376' ' ' ALA . . . -61.17 -40.44 98.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.906 -0.664 . . . . 10.0 111.827 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 11.5 t-105 -65.68 -48.55 71.7 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.999 -0.371 . . . . 10.0 109.999 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 130' ' ' CYS . 49.7 mm -58.46 -43.24 86.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.44 -0.345 . . . . 10.0 110.812 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.19 -47.09 86.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.461 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 54.8 ttp -68.91 -30.73 69.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.046 0.451 . . . . 10.0 110.534 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 148' ' ' VAL . 10.7 tp -68.19 -57.98 5.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.148 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -59.69 -19.7 51.45 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.91 0.708 . . . . 10.0 112.91 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.9 tptm -104.13 -56.55 2.18 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 113.754 1.02 . . . . 10.0 113.754 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.1 m -88.67 -28.65 20.46 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 114.432 1.271 . . . . 10.0 114.432 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.12 66.71 68.62 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.742 0.645 . . . . 10.0 112.742 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.62 -12.41 29.09 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.197 1.931 . . . . 10.0 111.58 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -88.34 -13.05 41.68 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.452 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.7 mt -101.78 2.57 38.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.462 -0.336 . . . . 10.0 111.825 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.475 ' HB ' ' HD3' ' A' ' 146' ' ' PRO . 55.5 mt -54.75 -51.44 78.88 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 113.598 0.962 . . . . 10.0 113.598 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.475 ' HD3' ' HB ' ' A' ' 145' ' ' ILE . 41.5 Cg_exo -58.69 -20.57 51.51 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.39 2.06 . . . . 10.0 113.292 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 325' ' ' LEU . 97.4 m-85 -79.69 -17.12 54.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.226 0.536 . . . . 10.0 111.028 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.456 HG21 HD22 ' A' ' 137' ' ' LEU . 27.9 t -87.86 152.37 3.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.033 -0.53 . . . . 10.0 109.965 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.465 ' HA ' ' NH2' ' A' ' 108' ' ' ARG . 39.7 t -66.27 160.18 24.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.048 -0.524 . . . . 10.0 111.235 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 p -99.85 1.41 42.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.708 -0.678 . . . . 10.0 110.604 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' CYS . . . . . . . . . . . . . 60.4 m -75.34 138.79 42.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.974 -0.557 . . . . 10.0 111.335 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.423 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 36.2 mtpt -80.77 168.63 18.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.456 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.87 148.9 98.42 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.997 -0.547 . . . . 10.0 110.384 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -47.44 -51.05 10.23 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.332 2.688 . . . . 10.0 113.458 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.476 ' H ' ' HG3' ' A' ' 155' ' ' GLN . 0.0 OUTLIER -65.67 -34.02 77.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.073 0.397 . . . . 10.0 112.073 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 56.9 mmm -73.74 -23.84 59.81 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.049 0.452 . . . . 10.0 110.718 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 39.4 mtt -75.46 -47.72 25.93 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.097 -0.705 . . . . 10.0 109.097 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.5 tp -63.91 -41.63 97.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.675 -0.693 . . . . 10.0 110.751 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.32 85.6 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.223 -0.444 . . . . 10.0 111.252 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.53 -36.7 63.16 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.183 -0.462 . . . . 10.0 110.645 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -66.44 -42.73 87.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.816 -0.629 . . . . 10.0 112.024 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.534 ' O ' ' HB3' ' A' ' 166' ' ' LEU . 35.9 m -69.55 -29.88 43.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -85.78 1.73 48.46 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.166 0.432 . . . . 10.0 112.166 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.0 p -122.44 -75.93 0.59 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.845 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -62.05 -52.56 63.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.321 -0.399 . . . . 10.0 111.542 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.534 ' HB3' ' O ' ' A' ' 162' ' ' VAL . 35.9 tp -61.24 -40.74 95.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.513 -0.312 . . . . 10.0 110.997 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.85 76.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.848 0.356 . . . . 10.0 110.667 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -66.47 -34.8 78.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.59 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -75.24 -37.12 61.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.793 0.33 . . . . 10.0 111.781 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.54 ' HB3' HG12 ' A' ' 172' ' ' ILE . 3.1 tttt -79.49 -20.54 47.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.815 0.34 . . . . 10.0 111.155 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 86.32 14.54 66.06 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.056 -0.592 . . . . 10.0 112.785 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 170' ' ' LYS . 14.0 pt -103.44 168.64 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.785 0.326 . . . . 10.0 111.057 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . . . -100.01 142.55 24.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.257 -0.429 . . . . 10.0 110.038 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 173' ' ' ALA . 35.8 Cg_exo -59.28 -19.93 52.84 Favored 'Trans proline' 0 N--CA 1.473 0.287 0 C-N-CA 122.995 2.464 . . . . 10.0 112.881 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -77.23 -19.49 56.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.199 0.523 . . . . 10.0 110.608 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -100.77 17.86 20.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.71 -0.677 . . . . 10.0 109.583 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 83.6 mtp -124.62 123.53 40.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.007 -0.542 . . . . 10.0 111.332 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.3 t -110.84 120.09 60.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.574 ' HB3' HD12 ' A' ' 208' ' ' LEU . 0.0 OUTLIER -104.21 123.51 47.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.289 0.566 . . . . 10.0 112.21 -178.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 22.5 t -118.69 135.63 58.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.41 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.428 ' OG ' HD21 ' A' ' 208' ' ' LEU . 3.7 p -123.21 139.04 54.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.724 0.297 . . . . 10.0 111.368 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 212' ' ' ILE . 24.1 mm -101.64 102.19 13.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.946 -0.761 . . . . 10.0 108.946 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . 0.493 ' O ' ' HA ' ' A' ' 213' ' ' THR . 32.2 mmt -114.08 150.16 43.13 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.05 -0.523 . . . . 10.0 111.54 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.77 17.48 1.52 Allowed 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.854 2.369 . . . . 10.0 112.894 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' CYS . . . . . . . . . . . . . 97.3 m -149.55 129.46 13.4 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.108 -0.331 . . . . 10.0 110.108 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -30.07 70.02 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.193 0.442 . . . . 10.0 112.193 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -64.15 -9.55 17.42 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.649 0.611 . . . . 10.0 112.649 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 188' ' ' LYS . 25.0 mmtt -66.97 -28.2 68.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.349 . . . . 10.0 110.921 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -68.02 -36.75 80.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.139 -0.482 . . . . 10.0 109.989 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.75 -32.56 67.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.815 -0.629 . . . . 10.0 110.877 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -70.63 -41.13 72.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 10.0 110.753 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -75.12 -30.17 60.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.665 -0.698 . . . . 10.0 112.781 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -80.87 70.81 7.75 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.446 ' HB2' ' CD2' ' A' ' 197' ' ' PHE . 56.0 mtt180 -115.32 148.4 39.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.566 . . . . 10.0 110.434 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -48.93 -63.03 1.22 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.637 0.977 . . . . 10.0 113.637 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -66.97 -2.2 5.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.349 1.24 . . . . 10.0 114.349 -177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.446 ' CD2' ' HB2' ' A' ' 194' ' ' ARG . 2.6 m-30 -82.22 61.98 5.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.379 0.609 . . . . 10.0 111.599 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' CYS . . . . . . . . . . . . . 12.1 p -113.15 168.94 9.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.544 -0.753 . . . . 10.0 110.396 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 22.4 t -80.66 83.66 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.221 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.037 -0.983 . . . . 10.0 111.311 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.673 -0.491 . . . . 10.0 109.673 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.796 ' CB ' ' C ' ' A' ' 205' ' ' LEU . . . . . . . . 0 C--O 1.228 -0.052 . . . . . . . . 10.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -88.1 144.73 26.33 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 110.272 -0.27 . . . . 10.0 110.272 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -67.52 -40.67 85.12 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.242 0.544 . . . . 10.0 109.535 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LEU . . . . . 0.574 HD12 ' HB3' ' A' ' 179' ' ' MET . 29.5 tp -126.24 137.49 53.53 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.375 -1.343 . . . . 10.0 107.375 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -99.24 -57.89 2.06 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.47 0.915 . . . . 10.0 113.47 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.529 ' CE1' ' HB3' ' A' ' 30' ' ' GLN . 12.6 m-70 -134.32 153.15 52.04 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.028 0.751 . . . . 10.0 113.028 -177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 46.0 t -126.72 131.76 70.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.27 -0.877 . . . . 10.0 109.557 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 182' ' ' ILE . 71.3 mt -122.42 139.52 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 183' ' ' MET . 43.2 p -91.98 167.2 12.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.809 0.3 . . . . 10.0 111.809 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.538 HG23 HG13 ' A' ' 55' ' ' VAL . 2.7 m -52.64 -52.92 53.45 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.003 -0.544 . . . . 10.0 112.077 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.0 m -57.87 -36.19 54.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.448 ' O ' HG13 ' A' ' 220' ' ' ILE . 50.1 mt-10 -73.33 -45.3 56.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.58 -0.282 . . . . 10.0 111.027 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.408 HD22 HG21 ' A' ' 182' ' ' ILE . 36.1 tp -62.59 -45.52 92.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 10.0 110.86 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -62.98 -30.94 78.99 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.898 -0.668 . . . . 10.0 111.931 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -67.97 -41.76 81.92 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.866 -0.42 . . . . 10.0 109.866 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 216' ' ' GLU . 61.7 mt -58.8 -42.77 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.138 -0.483 . . . . 10.0 110.228 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -62.57 -44.74 95.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.967 -0.56 . . . . 10.0 110.554 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -67.51 -43.94 79.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 10.0 111.955 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.71 -23.84 66.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.319 . . . . 10.0 111.299 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -94.33 -3.18 50.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.313 -0.403 . . . . 10.0 110.961 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 68.35 38.99 87.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.931 -0.652 . . . . 10.0 112.189 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 57.4 mt -116.07 110.4 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.834 0.349 . . . . 10.0 110.509 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -96.61 113.71 25.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.966 -0.383 . . . . 10.0 109.966 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.619 HD23 HD12 ' A' ' 231' ' ' LEU . 38.6 mt -59.1 -28.97 67.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.807 -0.633 . . . . 10.0 112.183 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -70.27 -18.46 63.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.6 -0.273 . . . . 10.0 111.569 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -111.26 20.75 17.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.968 0.413 . . . . 10.0 110.974 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.619 HD12 HD23 ' A' ' 228' ' ' LEU . 56.7 mt -104.39 150.92 38.98 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.936 -0.575 . . . . 10.0 110.274 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.47 172.01 16.98 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.284 1.989 . . . . 10.0 111.576 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -82.8 102.32 11.51 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.058 -0.519 . . . . 10.0 110.642 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -83.48 -154.64 18.05 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.915 -0.584 . . . . 10.0 112.005 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.85 156.99 43.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.963 0.411 . . . . 10.0 110.716 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -92.66 -174.7 3.73 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.685 -0.688 . . . . 10.0 110.254 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.5 147.47 42.73 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.032 -0.531 . . . . 10.0 109.892 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -93.41 120.19 66.72 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.158 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.06 -15.36 47.42 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.133 2.556 . . . . 10.0 112.315 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . . . . . . . . . 86.9 mmm -78.64 0.65 25.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 10.0 111.465 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . 103.27 -70.06 0.29 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.135 -0.555 . . . . 10.0 112.774 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.8 m -113.44 169.65 4.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.901 0.382 . . . . 10.0 111.578 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 104.43 136.5 8.84 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.619 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 16.2 m -80.2 130.35 35.15 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.178 -0.305 . . . . 10.0 110.178 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 120.06 179.72 16.45 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.228 -0.749 . . . . 10.0 111.228 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ALA . . . . . . . . . . . . . . . -95.25 -2.18 50.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.847 0.356 . . . . 10.0 111.277 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.86 4.03 79.41 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.18 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 t -105.93 118.68 53.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 30.2 mt -75.51 149.95 38.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.97 -0.559 . . . . 10.0 110.384 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.33 106.18 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.057 0.456 . . . . 10.0 111.153 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 164.84 127.11 0.86 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.078 -0.809 . . . . 10.0 111.078 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 11.2 t -75.18 148.19 39.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.169 0.509 . . . . 10.0 111.562 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.34 -9.46 25.33 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.657 -0.701 . . . . 10.0 109.497 178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.433 ' HA3' ' OE1' ' A' ' 258' ' ' GLU . . . 89.68 -32.22 4.89 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.687 -0.688 . . . . 10.0 112.47 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 151.69 170.31 18.29 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.365 -1.094 . . . . 10.0 110.365 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.86 -55.69 18.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.541 0.67 . . . . 10.0 110.406 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' MET . . . . . 0.541 ' HG3' ' HE2' ' A' ' 371' ' ' PHE . 23.5 ttp -59.4 -48.28 82.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.656 -0.702 . . . . 10.0 111.406 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.433 ' OE1' ' HA3' ' A' ' 254' ' ' GLY . 36.5 tt0 -61.34 -46.19 91.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 10.0 112.138 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . . . . . . . . . . . -65.63 -35.84 81.96 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 121.046 -0.261 . . . . 10.0 111.167 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.74 -47.46 72.2 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 257' ' ' MET . 90.1 mt -62.7 -42.75 99.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.757 -0.656 . . . . 10.0 109.826 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 273' ' ' LEU . 45.6 ttm105 -58.95 -48.37 81.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.618 -0.719 . . . . 10.0 111.051 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 87.0 m -55.52 -43.32 75.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.425 -0.352 . . . . 10.0 111.546 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -73.84 -43.93 57.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.849 0.357 . . . . 10.0 111.085 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . 0.502 ' HD1' ' HG2' ' A' ' 294' ' ' MET . 84.0 t80 -62.07 -46.09 90.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.079 -0.509 . . . . 10.0 112.063 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 262' ' ' ARG . 52.3 mt-10 -64.98 -23.18 67.14 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.565 0.579 . . . . 10.0 112.565 -178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' LEU . . . . . . . . . . . . . 73.4 mt -90.18 -35.07 15.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.103 0.478 . . . . 10.0 110.467 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -72.62 -43.09 63.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.678 -0.692 . . . . 10.0 111.604 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' THR . . . . . . . . . . . . . 70.1 p -96.38 -33.53 11.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.164 -0.471 . . . . 10.0 112.191 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 85.31 9.15 80.15 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 110.789 -0.925 . . . . 10.0 110.789 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 70.9 p -112.69 146.13 34.41 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.698 -0.251 . . . . 10.0 110.775 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' PRO . . . . . 0.415 ' HA ' ' OE2' ' A' ' 266' ' ' GLU . 40.0 Cg_endo -69.99 131.69 21.42 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.501 2.134 . . . . 10.0 111.9 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.454 ' HB3' ' HG3' ' A' ' 262' ' ' ARG . 46.9 tp -103.99 121.47 47.71 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 10.0 111.069 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -76.55 -156.21 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.191 2.594 . . . . 10.0 111.774 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 17.1 mmm180 -78.4 141.21 38.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.484 -0.325 . . . . 10.0 110.618 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 95.6 mt -89.81 141.61 28.47 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.294 -0.412 . . . . 10.0 110.882 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' SER . . . . . . . . . . . . . 1.5 m -106.59 105.35 15.35 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.582 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 288' ' ' LYS . 3.4 mm? -77.98 113.94 16.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 10.0 110.823 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' SER . . . . . . . . . . . . . 1.5 m -89.86 152.52 21.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.95 -0.568 . . . . 10.0 110.272 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -79.75 123.63 27.86 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' VAL . . . . . . . . . . . . . 84.5 t -70.51 112.7 5.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.074 0.464 . . . . 10.0 110.643 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 16.0 ttm-85 -66.97 108.35 2.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.602 -0.726 . . . . 10.0 110.353 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 123.5 -18.69 7.68 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.805 -0.712 . . . . 10.0 112.006 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . 0.481 ' SD ' ' HD2' ' A' ' 361' ' ' LYS . 56.4 mtm -139.98 102.54 4.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.012 0.434 . . . . 10.0 110.609 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.71 138.81 48.8 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.942 -0.572 . . . . 10.0 111.264 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 94.83 -13.5 67.04 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.587 -0.733 . . . . 10.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 21.7 mm -99.44 127.81 51.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.018 0.437 . . . . 10.0 110.138 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 278' ' ' LEU . 33.6 mmtt -115.62 157.57 23.98 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.11 159.66 44.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.249 0.547 . . . . 10.0 112.371 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 9.1 t -155.99 152.21 27.87 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.254 -0.885 . . . . 10.0 109.257 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -128.32 123.41 33.92 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.808 0.337 . . . . 10.0 110.649 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.91 118.41 58.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.913 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.54 97.75 3.8 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.044 0.449 . . . . 10.0 110.588 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . 0.502 ' HG2' ' HD1' ' A' ' 265' ' ' TYR . 81.7 mtp -87.1 113.26 22.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.108 -0.497 . . . . 10.0 111.449 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 36.3 t -112.34 120.42 41.52 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.7 135.57 61.08 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.891 2.394 . . . . 10.0 112.782 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . . . -66.97 132.06 93.84 Favored Pre-proline 0 C--O 1.235 0.332 0 CA-C-N 115.754 -0.657 . . . . 10.0 110.779 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 297' ' ' ALA . 38.8 Cg_exo -59.04 114.13 1.88 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.954 2.436 . . . . 10.0 112.286 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 107.52 -12.1 39.3 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.681 -0.771 . . . . 10.0 113.123 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 97.0 p -84.33 162.53 20.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.885 0.374 . . . . 10.0 110.871 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -64.5 -26.11 68.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 10.0 110.231 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -64.27 -40.0 95.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.839 -0.619 . . . . 10.0 110.317 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -72.48 -46.05 56.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.926 -0.579 . . . . 10.0 109.901 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 308' ' ' HIS . 2.2 tm-20 -57.28 -46.63 82.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.395 -0.821 . . . . 10.0 111.324 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 79.1 mt -62.15 -53.51 54.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.378 -0.374 . . . . 10.0 112.008 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' LEU . . . . . . . . . . . . . 3.5 tt -60.13 -38.5 83.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.315 -0.402 . . . . 10.0 111.804 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -75.65 -33.31 60.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.379 -0.373 . . . . 10.0 111.563 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' HIS . . . . . 0.527 ' HB2' ' O ' ' A' ' 304' ' ' GLU . 0.7 OUTLIER -75.46 -47.52 26.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.432 -0.349 . . . . 10.0 111.78 -179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -123.33 100.85 7.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.182 0.515 . . . . 10.0 112.073 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -110.19 -1.48 17.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.753 -0.658 . . . . 10.0 110.473 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.365 -0.826 . . . . 10.0 110.529 -179.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.299 -0.721 . . . . 10.0 111.299 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -59.63 -31.33 94.18 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.838 2.359 . . . . 10.0 112.415 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.414 ' HB2' ' CE1' ' A' ' 147' ' ' TYR . 85.1 mt -109.11 110.95 22.33 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ALA . . . . . . . . . . . . . . . -94.84 120.62 35.37 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.565 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -67.54 131.98 46.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.779 -0.452 . . . . 10.0 109.779 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -79.08 -1.71 37.09 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.23 -0.441 . . . . 10.0 111.609 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 103.26 -6.39 50.31 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.868 -0.682 . . . . 10.0 111.593 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . 0.404 ' HA2' ' NH2' ' A' ' 345' ' ' ARG . . . 92.23 153.86 30.34 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.77 -0.728 . . . . 10.0 111.721 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -84.5 82.43 8.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.057 0.456 . . . . 10.0 110.182 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 342' ' ' ILE . . . -98.29 155.16 20.23 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.8 -0.714 . . . . 10.0 112.938 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -142.76 160.18 40.81 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.984 -0.376 . . . . 10.0 109.984 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.8 t -141.38 142.59 33.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.91 0.386 . . . . 10.0 110.49 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.44 169.58 8.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.463 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.92 23.88 0.53 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.039 0.447 . . . . 10.0 112.063 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -111.77 -7.85 14.19 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.276 0.56 . . . . 10.0 109.806 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . 102.6 -8.88 55.23 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.597 -0.728 . . . . 10.0 112.373 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 26.6 mtm180 -100.95 176.81 5.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.054 0.454 . . . . 10.0 111.149 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . -173.68 -175.44 41.38 Favored Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.922 -0.871 . . . . 10.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLY . . . . . . . . . . . . . . . -167.65 -173.28 35.61 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.949 -0.643 . . . . 10.0 111.553 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ILE . . . . . 0.429 ' HA ' ' HA2' ' A' ' 332' ' ' GLY . 7.9 tt -136.8 131.02 46.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 120.71 0.291 . . . . 10.0 110.581 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . . . . . . . . . 1.6 t -90.9 106.87 18.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.103 0.478 . . . . 10.0 110.507 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 25.0 tp -64.07 115.49 4.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.527 -0.76 . . . . 10.0 110.577 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ARG . . . . . 0.435 ' HB3' ' CD1' ' A' ' 369' ' ' TYR . 60.5 mtm180 -86.62 105.23 16.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.86 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.74 130.57 59.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.382 -0.372 . . . . 10.0 111.015 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 372' ' ' VAL . . . -126.87 139.18 53.27 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.083 -0.508 . . . . 10.0 110.307 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.61 114.16 43.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.797 -0.446 . . . . 10.0 109.797 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.504 ' HB3' HG12 ' A' ' 374' ' ' ILE . . . -98.59 105.08 17.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.496 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ASN . . . . . 0.854 ' HB3' ' HA ' ' A' ' 378' ' ' PRO . 2.3 m-80 -95.99 108.62 21.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.075 -0.511 . . . . 10.0 110.49 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLY . . . . . . . . . . . . . . . 112.04 126.06 4.67 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.708 -0.957 . . . . 10.0 110.708 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' LEU . . . . . . . . . . . . . 43.6 mt -59.17 -37.49 77.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.889 0.376 . . . . 10.0 111.478 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . -68.99 -26.56 74.61 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.636 -0.793 . . . . 10.0 111.703 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.809 ' HA ' ' HE2' ' A' ' 357' ' ' LYS . 93.3 m-20 -84.75 -40.36 17.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.924 0.392 . . . . 10.0 110.007 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.8 94.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.383 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -55.9 -39.56 71.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.434 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.809 ' HE2' ' HA ' ' A' ' 354' ' ' ASN . 9.4 mtmm -70.79 -42.82 69.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.511 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.83 -46.86 85.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.13 -0.487 . . . . 10.0 110.974 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ILE . . . . . . . . . . . . . 97.7 mt -56.73 -45.5 82.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.965 -0.562 . . . . 10.0 110.905 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 22.0 m -60.59 -45.27 94.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 10.0 110.7 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.481 ' HD2' ' SD ' ' A' ' 284' ' ' MET . 36.6 mttm -66.02 -32.76 74.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.325 -0.398 . . . . 10.0 111.209 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' MET . . . . . 0.47 ' HA ' ' O ' ' A' ' 367' ' ' ALA . 87.3 mtp -68.49 -42.99 77.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.026 0.441 . . . . 10.0 110.042 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -69.1 -24.41 64.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 10.0 111.003 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -86.0 -7.88 58.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.044 -0.526 . . . . 10.0 111.064 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLY . . . . . . . . . . . . . . . 81.2 13.95 79.87 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.789 -0.719 . . . . 10.0 112.949 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -77.64 -37.83 49.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.228 0.537 . . . . 10.0 110.056 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 362' ' ' MET . . . -135.14 126.06 27.57 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.583 -0.735 . . . . 10.0 109.388 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -119.94 125.76 49.22 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.81 0.338 . . . . 10.0 110.977 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' TYR . . . . . 0.435 ' CD1' ' HB3' ' A' ' 345' ' ' ARG . 72.7 m-85 -134.92 158.71 43.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.824 -0.625 . . . . 10.0 109.596 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -97.3 -36.56 10.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.027 0.441 . . . . 10.0 111.248 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . 0.541 ' HE2' ' HG3' ' A' ' 257' ' ' MET . 26.8 t80 -125.56 126.95 45.61 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.57 -0.529 . . . . 10.0 109.57 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 126' ' ' PHE . 25.3 t -130.3 118.76 44.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.02 0.438 . . . . 10.0 111.882 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.19 129.84 44.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.985 -1.117 . . . . 10.0 107.985 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . 0.504 HG12 ' HB3' ' A' ' 349' ' ' ALA . 59.3 mt -121.37 125.26 73.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.241 0.543 . . . . 10.0 112.076 -179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' MET . . . . . 0.406 ' HA ' ' SG ' ' A' ' 130' ' ' CYS . 13.0 mmt -115.17 145.96 41.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.591 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ALA . . . . . 0.457 ' HB2' ' HA3' ' A' ' 132' ' ' GLY . . . -78.14 -26.75 47.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.758 0.313 . . . . 10.0 111.122 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 378' ' ' PRO . 14.7 m -120.45 121.29 29.33 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.04 -0.527 . . . . 10.0 110.467 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.854 ' HA ' ' HB3' ' A' ' 350' ' ' ASN . 24.0 Cg_exo -65.79 -9.88 24.59 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.221 2.614 . . . . 10.0 112.39 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -96.41 9.77 40.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.055 -0.52 . . . . 10.0 110.584 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 73.21 -153.71 48.48 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.737 -0.744 . . . . 10.0 112.342 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' CYS . . . . . . . . . . . . . 20.4 m -88.0 -15.53 36.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.018 0.437 . . . . 10.0 110.976 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' VAL . . . . . . . . . . . . . 34.7 m -77.94 -14.04 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.93 0.395 . . . . 10.0 111.12 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -116.61 25.23 9.19 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.989 -0.624 . . . . 10.0 111.972 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -65.7 168.72 31.34 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.248 -0.501 . . . . 10.0 112.896 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -69.24 -24.31 76.02 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 121.089 -0.577 . . . . 10.0 113.677 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . -85.71 -6.13 83.34 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.681 -0.771 . . . . 10.0 112.648 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -82.76 155.31 68.22 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.74 164.69 33.56 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.428 2.085 . . . . 10.0 110.803 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' B' ' 33' ' ' LEU . 0.0 OUTLIER -128.66 121.95 29.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.231 0.539 . . . . 10.0 111.619 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' SER . . . . . . . . . . . . . 49.2 m -110.26 170.01 8.36 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.672 -0.694 . . . . 10.0 110.003 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -16.24 62.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.823 0.344 . . . . 10.0 111.751 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -74.74 126.64 31.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.307 -0.406 . . . . 10.0 110.592 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -86.25 -4.98 59.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.025 -0.534 . . . . 10.0 111.922 -178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' ALA . . . . . . . . . . . . . . . -110.83 15.47 21.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.257 0.551 . . . . 10.0 109.812 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 8.2 tp -63.46 -26.99 42.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.451 -0.795 . . . . 10.0 111.893 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.64 -46.17 86.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.31 0.576 . . . . 10.0 110.204 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -67.87 -36.61 80.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.507 -0.77 . . . . 10.0 110.667 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -61.54 -43.03 99.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.024 -0.535 . . . . 10.0 110.636 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . 0.405 HH21 ' CD ' ' A' ' 61' ' ' GLU . 99.0 mtt180 -68.39 -41.55 80.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.03 -0.532 . . . . 10.0 110.715 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLN . . . . . . . . . . . . . 57.6 tp60 -64.1 -39.48 94.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.923 -0.58 . . . . 10.0 111.344 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -70.88 -24.52 62.51 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.248 0.462 . . . . 10.0 112.248 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ALA . . . . . . . . . . . . . . . -101.54 14.39 32.12 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.579 0.585 . . . . 10.0 112.579 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . . . . . . . . . 13.3 mt -67.09 -38.33 85.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.138 0.494 . . . . 10.0 110.775 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' TYR . . . . . 0.506 ' O ' ' HE3' ' A' ' 409' ' ' LYS . 83.4 m-85 -136.14 153.83 51.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.536 -0.756 . . . . 10.0 109.318 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -82.79 165.65 19.68 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.657 -0.498 . . . . 10.0 109.657 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -54.22 -33.86 59.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.692 0.282 . . . . 10.0 111.641 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -63.6 -54.47 35.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 10.0 110.796 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.43 -33.45 75.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.624 . . . . 10.0 111.411 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' LYS . . . . . 0.506 ' HE3' ' O ' ' A' ' 404' ' ' TYR . 95.9 mttt -67.46 -30.18 69.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 10.0 111.662 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' SER . . . . . . . . . . . . . 6.1 p -94.17 8.09 42.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.961 0.41 . . . . 10.0 111.312 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' THR . . . . . . . . . . . . . 6.3 m -122.08 101.78 7.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.232 -0.44 . . . . 10.0 110.611 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' LEU . . . . . . . . . . . . . 21.0 tp -83.46 122.36 28.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.155 -0.475 . . . . 10.0 110.176 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ARG . . . . . . . . . . . . . 40.9 ttp85 -123.58 148.68 46.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.828 0.347 . . . . 10.0 111.306 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 417' ' ' GLU . 1.2 mpt_? -116.33 136.38 53.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.408 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' SER . . . . . . . . . . . . . 2.7 m -62.91 -29.37 70.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.319 0.488 . . . . 10.0 112.319 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -73.0 4.93 3.7 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.524 0.565 . . . . 10.0 112.524 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' GLU . . . . . 0.432 ' OE2' ' HD3' ' A' ' 414' ' ' ARG . 20.4 mt-10 -122.81 13.81 9.97 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.481 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -88.27 117.08 67.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.186 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.67 -35.16 92.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.233 2.622 . . . . 10.0 112.558 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' SER . . . . . . . . . . . . . 50.2 m -70.81 -38.66 73.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.893 0.378 . . . . 10.0 110.907 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ILE . . . . . . . . . . . . . 45.9 mm -70.26 -42.85 78.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.399 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -61.93 -35.64 79.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.98 -0.555 . . . . 10.0 111.41 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -64.21 -49.84 70.42 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.095 0.474 . . . . 10.0 110.006 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.54 -38.78 91.35 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.64 -0.709 . . . . 10.0 110.954 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . 0.756 ' HA ' ' HB2' ' A' ' 429' ' ' LEU . 3.4 m-85 -74.24 -11.3 60.24 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.031 -0.531 . . . . 10.0 111.549 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -97.56 -52.74 3.67 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.182 0.808 . . . . 10.0 113.182 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.06 17.54 18.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.639 1.348 . . . . 10.0 114.639 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -155.63 -63.82 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.107 0.78 . . . . 10.0 113.107 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' LEU . . . . . 0.756 ' HB2' ' HA ' ' A' ' 425' ' ' TYR . 67.9 mt -67.38 -50.69 58.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.877 0.695 . . . . 10.0 112.877 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 92.65 -132.66 11.36 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.556 -0.831 . . . . 10.0 111.512 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 432' ' ' PRO . 24.2 mm-40 -86.5 144.79 38.33 Favored Pre-proline 0 C--N 1.318 -0.769 0 O-C-N 122.662 -0.316 . . . . 10.0 110.698 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 431' ' ' GLU . 44.8 Cg_exo -58.89 147.06 91.13 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.941 2.427 . . . . 10.0 111.264 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 3.5 mp 62.74 17.85 10.16 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.515 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' GLY . . . . . . . . . . . . . . . -76.35 -176.57 42.11 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.085 -0.579 . . . . 10.0 112.44 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -60.85 -51.8 67.76 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.394 0.278 . . . . 10.0 111.736 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -38.98 93.29 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.847 0.356 . . . . 10.0 110.781 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.42 75.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.986 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' HIS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 442' ' ' HIS . 2.5 t-160 -68.81 -31.03 69.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.7 -0.682 . . . . 10.0 111.069 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.1 -40.9 17.7 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.832 0.678 . . . . 10.0 112.832 -178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.6 mt -96.31 -42.81 7.97 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 114.577 1.325 . . . . 10.0 114.577 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 54.9 mt -94.58 -17.81 21.99 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.655 ' HB2' ' HA ' ' A' ' 438' ' ' HIS . 39.2 m-70 -114.57 171.24 7.75 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.245 -0.285 . . . . 10.0 110.644 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' THR . . . . . . . . . . . . . 3.9 t -162.89 -175.75 4.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.526 0.203 . . . . 10.0 111.058 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -129.89 157.82 41.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.406 -0.361 . . . . 10.0 110.527 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.87 164.19 13.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.35 -0.387 . . . . 10.0 110.187 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' VAL . . . . . . . . . . . . . 95.1 t -120.87 109.37 25.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.118 0.485 . . . . 10.0 111.792 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ALA . . . . . . . . . . . . . . . -65.89 115.45 6.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.816 -0.629 . . . . 10.0 110.054 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 122.33 -15.36 8.71 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.34 -0.704 . . . . 10.0 111.34 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' GLY . . . . . . . . . . . . . . . 113.39 143.67 8.67 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 120.869 -0.682 . . . . 10.0 112.136 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . 0.441 HG11 ' NH1' ' A' ' 194' ' ' ARG . 36.0 m . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.314 -0.85 . . . . 10.0 110.922 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 120.797 0.332 . . . . 10.0 110.8 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -89.86 101.23 13.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.106 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.7 p -109.92 123.72 66.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.949 -0.569 . . . . 10.0 111.153 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.735 ' HB ' HG23 ' B' ' 84' ' ' THR . 15.9 m -89.3 117.91 28.6 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.969 -0.559 . . . . 10.0 109.995 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 23.9 mt -91.02 126.78 36.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.151 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LYS . . . . . 0.692 ' HB2' ' HA ' ' B' ' 86' ' ' GLN . 9.4 mttm -87.66 75.22 9.06 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.699 -0.682 . . . . 10.0 110.902 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.19 148.0 77.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.54 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.54 -12.82 32.89 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.485 2.124 . . . . 10.0 111.92 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.27 -1.8 43.99 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.851 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.9 153.37 7.0 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.842 -0.694 . . . . 10.0 111.635 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.85 140.78 40.74 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.44 0.162 . . . . 10.0 110.723 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LYS . . . . . . . . . . . . . 43.9 tptt -144.16 122.79 12.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.379 -0.373 . . . . 10.0 110.638 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 41.1 m -86.89 121.26 29.13 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ILE . . . . . 0.463 HD12 ' HB3' ' B' ' 25' ' ' ALA . 46.5 pt -113.34 150.05 15.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.083 0.468 . . . . 10.0 111.932 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -92.01 102.16 14.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.536 -0.756 . . . . 10.0 109.722 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' CYS . . . . . . . . . . . . . 50.1 t -114.4 128.29 25.98 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.169 -0.469 . . . . 10.0 111.338 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' PRO . . . . . 0.479 ' HD2' ' HB ' ' B' ' 20' ' ' THR . 14.4 Cg_exo -70.88 164.92 33.95 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.981 2.454 . . . . 10.0 111.152 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -80.56 -15.36 56.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.12 0.486 . . . . 10.0 111.097 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -102.65 12.81 35.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.292 0.567 . . . . 10.0 110.847 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' THR . . . . . 0.479 ' HB ' ' HD2' ' B' ' 17' ' ' PRO . 4.7 m -137.29 143.03 41.93 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.083 -0.508 . . . . 10.0 109.95 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -73.55 150.37 41.53 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.437 -0.347 . . . . 10.0 111.098 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.516 HG12 ' HD3' ' B' ' 79' ' ' PRO . 21.6 mt -54.53 -33.15 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.922 -0.581 . . . . 10.0 112.099 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.455 HD13 HD23 ' B' ' 33' ' ' LEU . 9.9 tp -54.16 -43.24 70.44 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.89 0.7 . . . . 10.0 112.89 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.85 -41.8 98.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.924 0.393 . . . . 10.0 111.938 -178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.463 ' HB3' HD12 ' B' ' 14' ' ' ILE . . . -74.22 -30.47 62.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 10.0 110.977 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.42 -49.69 75.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.516 . . . . 10.0 111.239 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -71.3 -26.4 62.85 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.957 -0.297 . . . . 10.0 111.564 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.04 -37.03 83.37 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.34 -0.615 . . . . 10.0 109.34 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.91 -8.42 59.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.776 -0.647 . . . . 10.0 110.904 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.39 35.21 20.96 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.891 -0.595 . . . . 10.0 112.818 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' LEU . . . . . . . . . . . . . 79.6 mt -94.6 158.63 15.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.783 0.325 . . . . 10.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -89.85 113.73 25.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.989 -0.551 . . . . 10.0 111.051 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.741 HD12 ' HD2' ' B' ' 34' ' ' PRO . 19.7 tp -137.15 125.02 14.43 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.782 -0.645 . . . . 10.0 109.277 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.741 ' HD2' HD12 ' B' ' 33' ' ' LEU . 58.2 Cg_endo -71.77 65.94 3.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.067 2.511 . . . . 10.0 113.497 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -89.88 167.02 13.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.892 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' SER . . . . . 0.434 ' N ' ' S1 ' ' B' ' 101' ' ' FES . 2.1 p -152.78 -94.99 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' CYS . . . . . 0.43 ' SG ' ' HG2' ' A' ' 378' ' ' PRO . 25.8 p -72.61 -20.82 61.22 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.313 0.857 . . . . 10.0 113.313 -177.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 68.35 15.59 9.26 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.686 0.279 . . . . 10.0 111.639 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ALA . . . . . . . . . . . . . . . -97.53 -5.49 35.69 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.564 0.579 . . . . 10.0 112.564 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.446 ' N ' ' S2 ' ' B' ' 101' ' ' FES . . . 74.98 28.13 63.13 Favored Glycine 0 C--O 1.229 -0.199 0 C-N-CA 120.973 -0.632 . . . . 10.0 113.464 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.61 3.63 27.11 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.612 -0.346 . . . . 10.0 111.661 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 m -107.54 129.42 54.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.434 -0.348 . . . . 10.0 111.079 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 2.2 p -79.95 -8.8 59.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.096 0.474 . . . . 10.0 110.264 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -17.51 60.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.818 -0.628 . . . . 10.0 110.177 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' CYS . . . . . . . . . . . . . 4.4 m -103.63 27.22 7.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.593 -0.731 . . . . 10.0 109.809 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' B' ' 73' ' ' LEU . . . -99.08 106.39 18.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.649 -0.705 . . . . 10.0 110.184 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.44 174.6 54.6 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.07 -0.586 . . . . 10.0 113.073 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.773 ' HD3' ' HB3' ' B' ' 89' ' ' GLN . 1.3 mptt -114.33 137.63 51.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.674 0.273 . . . . 10.0 110.761 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.706 ' HB ' ' HA2' ' B' ' 70' ' ' GLY . 58.3 t -80.75 110.01 15.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.175 -0.466 . . . . 10.0 111.698 -179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.479 ' HB3' ' HB ' ' B' ' 84' ' ' THR . . . -93.19 -29.27 15.81 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.871 -0.789 . . . . 10.0 108.871 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' B' ' 83' ' ' CYS . . . -166.62 155.66 10.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.087 -0.96 . . . . 10.0 108.863 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLY . . . . . 0.746 ' HA3' ' HB3' ' B' ' 83' ' ' CYS . . . 70.37 -165.88 51.34 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.118 -0.563 . . . . 10.0 113.041 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.33 154.04 38.37 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.949 0.405 . . . . 10.0 110.791 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' B' ' 79' ' ' PRO . 13.9 m -119.93 163.93 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.72 -0.474 . . . . 10.0 109.72 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -94.84 110.79 22.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.095 0.474 . . . . 10.0 112.224 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -144.78 145.65 31.76 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.345 -0.843 . . . . 10.0 109.061 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 2.1 m -106.69 -60.05 1.72 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.947 0.403 . . . . 10.0 110.826 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -159.71 141.4 13.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.424 ' NE2' ' HB2' ' B' ' 73' ' ' LEU . 0.0 OUTLIER -135.0 -100.93 0.23 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 111.923 0.342 . . . . 10.0 111.923 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 44.5 p -114.54 -101.55 0.42 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.783 0.325 . . . . 10.0 111.841 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -102.02 76.19 1.58 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.028 -0.533 . . . . 10.0 109.855 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tt -165.92 107.97 0.75 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.889 -0.596 . . . . 10.0 110.396 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -94.14 164.22 13.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.509 -0.769 . . . . 10.0 109.997 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -56.22 -29.26 60.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.827 0.346 . . . . 10.0 111.182 179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.45 70.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.288 0.566 . . . . 10.0 110.124 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.648 ' HB3' ' HD2' ' B' ' 71' ' ' PHE . 48.3 mt-30 -90.46 -28.93 18.27 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.547 -0.751 . . . . 10.0 110.072 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' MET . . . . . 0.681 ' HA ' ' O ' ' B' ' 71' ' ' PHE . 25.4 ttt -58.04 -53.73 54.99 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.969 -0.56 . . . . 10.0 110.478 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.51 -16.09 73.52 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.886 -0.673 . . . . 10.0 111.805 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -81.18 -9.85 59.73 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.956 0.408 . . . . 10.0 110.565 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLY . . . . . 0.706 ' HA2' ' HB ' ' B' ' 49' ' ' VAL . . . 110.99 29.31 3.56 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.639 -0.791 . . . . 10.0 113.64 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' PHE . . . . . 0.681 ' O ' ' HA ' ' B' ' 67' ' ' MET . 19.2 m-85 -129.7 130.24 45.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.219 0.51 . . . . 10.0 110.512 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . 0.453 HG11 HG22 ' B' ' 54' ' ' VAL . 4.8 m -144.75 -165.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.605 0.24 . . . . 10.0 110.725 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.562 ' HA ' ' HA ' ' B' ' 46' ' ' ALA . 22.7 tp -120.53 143.49 48.55 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.538 -0.541 . . . . 10.0 109.538 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -114.78 -3.69 12.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.956 0.408 . . . . 10.0 110.838 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' CYS . . . . . 0.534 ' H ' ' HG ' ' B' ' 73' ' ' LEU . 42.7 t -72.22 -57.06 4.54 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 113.332 0.864 . . . . 10.0 113.332 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 14.0 m -126.44 23.82 3.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.075 0.398 . . . . 10.0 112.075 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' B' ' 73' ' ' LEU . . . -111.83 152.43 27.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.74 0.305 . . . . 10.0 110.744 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -127.51 150.69 73.53 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.877 -0.601 . . . . 10.0 109.636 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' PRO . . . . . 0.516 ' HD3' HG12 ' B' ' 22' ' ' ILE . 70.8 Cg_endo -77.46 127.56 9.04 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.292 1.995 . . . . 10.0 112.14 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.43 -17.74 61.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.379 0.609 . . . . 10.0 109.985 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' SER . . . . . . . . . . . . . 8.3 m -152.68 168.09 26.78 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.427 -0.806 . . . . 10.0 109.349 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.24 125.28 24.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.546 -0.909 . . . . 10.0 108.546 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . 0.746 ' HB3' ' HA3' ' B' ' 52' ' ' GLY . 1.7 p -149.59 -168.52 3.13 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.93 0.715 . . . . 10.0 112.93 -177.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' THR . . . . . 0.735 HG23 ' HB ' ' B' ' 4' ' ' THR . 0.9 OUTLIER -131.07 126.33 35.54 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.244 -0.889 . . . . 10.0 108.716 179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ILE . . . . . . . . . . . . . 32.7 mm -130.0 133.71 64.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.764 0.316 . . . . 10.0 111.575 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . 0.692 ' HA ' ' HB2' ' B' ' 6' ' ' LYS . 9.0 tt0 -82.42 146.18 29.46 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' THR . . . . . . . . . . . . . 10.7 p -94.79 -93.88 0.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 114.797 1.406 . . . . 10.0 114.797 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -65.74 90.11 0.12 Allowed 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.743 1.016 . . . . 10.0 113.743 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.773 ' HB3' ' HD3' ' B' ' 48' ' ' LYS . 0.7 OUTLIER -150.66 97.35 2.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.137 -0.483 . . . . 10.0 109.834 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.507 ' HA ' HD21 ' B' ' 93' ' ' LEU . 13.9 pt-20 -119.67 18.75 12.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.327 -0.397 . . . . 10.0 111.12 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -107.21 -11.96 15.48 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.054 0.454 . . . . 10.0 110.591 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -120.0 81.46 1.74 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 10.0 111.249 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' B' ' 90' ' ' GLU . 0.7 OUTLIER 179.49 88.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.524 -0.762 . . . . 10.0 110.357 178.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 45.4 t80 . . . . . 0 C--O 1.246 0.894 0 N-CA-C 109.053 -0.721 . . . . 10.0 109.053 -179.471 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' FES . . . . . 0.446 ' S2 ' ' N ' ' B' ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_